data_2lp6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lp6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 47.1 mtm-85 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 108.375 -0.972 . . . . 63.409999999999997 108.375 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 63.6 mt -97.12 132.57 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.656 0.782 . . . . 74.439999999999998 109.358 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -89.42 129.61 35.9 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.289 -0.634 . . . . 75.519999999999996 109.289 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.58 164.99 25.12 Favored Glycine 0 C--N 1.345 1.03 0 O-C-N 123.253 0.346 . . . . 73.109999999999999 112.929 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.57 120.65 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.993 0.917 . . . . 73.209999999999994 109.253 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 22' ' ' MET . 23.7 t -68.9 102.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 109.687 -0.486 . . . . 72.019999999999996 109.687 173.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' A' ' 25' ' ' LYS . 56.4 mt -70.23 -37.3 74.97 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.761 0.824 . . . . 73.299999999999997 110.321 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -156.96 158.13 36.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.87 -0.604 . . . . 74.140000000000001 111.603 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.525 ' HH ' ' HB1' ' A' ' 79' ' ' ALA . 88.9 m-85 -116.96 162.15 18.22 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.955 0.902 . . . . 74.129999999999995 109.113 172.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.568 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 22.7 mtm180 . . . . . 0 C--O 1.248 1.017 0 N-CA-C 107.666 -1.235 . . . . 72.150000000000006 107.666 171.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.578 ' H ' ' HA2' ' A' ' 74' ' ' GLY . 4.3 p-10 . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 109.791 -0.448 . . . . 74.219999999999999 109.791 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 11' ' ' ARG . 16.7 t -90.32 149.39 4.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.546 -0.909 . . . . 74.519999999999996 108.546 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.486 ' HB2' HG12 ' A' ' 7' ' ' VAL . 21.5 ptp -149.26 140.91 23.49 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.02 0.438 . . . . 74.400000000000006 111.309 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -86.34 97.97 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.249 -1.389 . . . . 74.400000000000006 107.249 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.01 133.18 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.747 0.819 . . . . 75.120000000000005 108.973 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HB2' HD11 ' A' ' 8' ' ' LEU . 33.7 ttpt -107.56 97.0 17.97 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.107 -1.071 . . . . 75.109999999999999 108.107 170.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 11.5 Cg_exo -68.5 122.39 9.38 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.986 1.791 . . . . 75.430000000000007 110.74 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.63 -29.56 66.6 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.255 1.022 . . . . 75.120000000000005 112.008 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.44 ' HB3' HG22 ' A' ' 3' ' ' ILE . 35.7 t70 -88.46 -28.5 20.82 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.859 0.864 . . . . 72.230000000000004 112.157 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 89.4 t -104.82 99.71 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.391 0.676 . . . . 74.120000000000005 109.808 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -119.41 12.13 12.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.396 0.678 . . . . 64.209999999999994 110.359 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.1 m -122.43 149.07 44.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.819 0.847 . . . . 72.439999999999998 110.613 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.57 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 53.8 ttt180 -63.88 -36.91 85.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.237 1.015 . . . . 75.340000000000003 111.357 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -65.29 -48.69 72.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.523 0.729 . . . . 72.200000000000003 110.532 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.444 ' HB2' HG11 ' A' ' 29' ' ' VAL . 50.2 mt-10 -63.21 -30.37 71.53 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.74 -1.118 . . . . 72.209999999999994 110.976 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.73 -36.2 37.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.692 0.797 . . . . 64.109999999999999 111.512 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -73.39 -27.49 61.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.73 0.812 . . . . 52.149999999999999 110.915 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -82.11 -1.19 47.92 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.094 -0.503 . . . . 75.409999999999997 111.363 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.456 HD13 HG21 ' A' ' 29' ' ' VAL . 93.4 mt -98.59 1.95 46.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.574 0.75 . . . . 75.200000000000003 112.144 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.59 HD11 HG12 ' A' ' 60' ' ' VAL . 51.2 mm -67.94 109.58 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.361 0.528 . . . . 75.109999999999999 110.278 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.95 -15.82 18.65 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.566 -0.743 . . . . 75.420000000000002 112.551 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.9 152.87 43.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.905 0.482 . . . . 74.409999999999997 111.228 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 54' ' ' LYS . 26.6 tp -94.86 114.61 26.49 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 124.389 1.056 . . . . 74.299999999999997 109.668 -167.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.72 131.43 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.23 -0.656 . . . . 73.319999999999993 109.23 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.4 mt -107.66 101.31 10.63 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.66 -0.867 . . . . 73.120000000000005 108.66 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -100.22 140.8 33.94 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.916 0.486 . . . . 74.109999999999999 109.807 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -91.74 101.05 13.66 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.203 1.001 . . . . 75.510000000000005 108.775 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.3 p -65.0 150.58 95.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.035 0.534 . . . . 71.409999999999997 111.149 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.54 -19.37 36.47 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.409 2.739 . . . . 75.519999999999996 113.049 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.4 t -71.78 -8.59 55.17 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.056 0.942 . . . . 72.430000000000007 112.347 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.19 32.81 30.71 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.492 -0.243 . . . . 74.219999999999999 112.492 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -128.02 146.11 50.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.863 0.865 . . . . 70.209999999999994 108.864 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -99.43 100.09 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.844 -0.799 . . . . 75.519999999999996 108.844 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 75' ' ' LEU . 21.5 mt -74.99 137.28 41.45 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.156 -0.929 . . . . 75.230000000000004 109.034 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HB3' HD12 ' A' ' 42' ' ' LEU . 24.0 mtmm -96.92 139.31 33.14 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.128 -0.693 . . . . 74.310000000000002 109.128 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -140.82 177.4 20.88 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 116.198 -0.456 . . . . 73.510000000000005 112.717 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -139.3 126.73 21.57 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.515 -0.55 . . . . 75.400000000000006 109.515 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.441 HG21 ' HB ' ' A' ' 67' ' ' VAL . 63.1 mt -68.75 103.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.041 -0.725 . . . . 71.200000000000003 109.041 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.429 HG13 ' HD3' ' A' ' 70' ' ' ARG . 27.6 m -83.84 -35.24 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.59 -0.732 . . . . 73.510000000000005 110.98 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -163.99 153.73 14.53 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.625 0.77 . . . . 65.209999999999994 109.584 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.59 HG12 HD11 ' A' ' 39' ' ' ILE . 12.2 m -91.55 170.46 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.289 0.636 . . . . 74.140000000000001 110.043 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -122.79 103.66 8.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.951 -1.129 . . . . 74.120000000000005 107.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.12 -150.63 51.71 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 124.335 1.022 . . . . 43.109999999999999 114.292 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.57 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 55.2 p -98.47 -9.91 24.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.664 0.786 . . . . 73.239999999999995 111.81 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.12 -12.52 19.95 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.735 0.814 . . . . 75.340000000000003 112.86 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.32 -1.34 87.56 Favored Glycine 0 C--N 1.349 1.25 0 N-CA-C 112.393 -0.283 . . . . 72.540000000000006 112.393 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.48 119.37 10.92 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.47 0.708 . . . . 72.0 110.162 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.441 ' HB ' HG21 ' A' ' 57' ' ' ILE . 29.6 m -101.65 148.27 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 122.661 0.384 . . . . 74.430000000000007 110.289 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -113.71 113.7 25.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.379 -0.6 . . . . 75.129999999999995 109.379 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.63 134.3 55.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.968 -0.56 . . . . 53.229999999999997 111.433 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.554 ' HG2' HG23 ' A' ' 21' ' ' VAL . 67.9 mtp85 -102.57 123.31 46.06 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.162 0.985 . . . . 75.120000000000005 109.005 174.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 12.5 m-85 -99.04 126.9 44.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.178 0.591 . . . . 75.019999999999996 111.156 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 54' ' ' LYS . 22.1 pt-20 -50.28 -38.06 39.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.376 1.471 . . . . 71.450000000000003 113.652 -172.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -75.39 -24.85 57.24 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.259 0.624 . . . . 74.349999999999994 111.54 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.578 ' HA2' ' H ' ' A' ' 20' ' ' ASN . . . 63.83 24.76 68.58 Favored Glycine 0 C--N 1.348 1.195 0 O-C-N 123.633 0.583 . . . . 64.200000000000003 114.432 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.466 ' HB2' HD12 ' A' ' 53' ' ' LEU . 84.4 mt -86.59 136.31 35.09 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 123.088 0.555 . . . . 74.420000000000002 110.6 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 11.4 Cg_exo -71.08 174.32 10.82 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.561 2.84 . . . . 74.25 112.098 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.85 -65.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.1 -0.5 . . . . 72.040000000000006 112.549 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 60.28 31.79 20.55 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 123.062 1.411 . . . . 74.019999999999996 110.272 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.525 ' HB1' ' HH ' ' A' ' 10' ' ' TYR . . . -88.33 31.61 0.81 Allowed 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 114.107 -1.406 . . . . 72.349999999999994 111.291 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -35.68 111.1 0.12 Allowed 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 126.289 1.835 . . . . 74.420000000000002 114.194 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.41 -4.25 26.54 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.9 -0.591 . . . . 54.340000000000003 113.102 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.81 157.93 35.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.331 0.652 . . . . 73.510000000000005 111.611 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -102.06 141.4 34.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.274 0.559 . . . . 73.040000000000006 112.127 -172.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.9 m -116.29 166.61 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.209 1.003 . . . . 73.230000000000004 110.326 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -128.71 109.15 11.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.506 -0.553 . . . . 74.230000000000004 109.506 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 61.3 mt -82.37 100.1 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.241 1.016 . . . . 74.129999999999995 109.346 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.5 t -72.76 117.64 16.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.229 0 N-CA-C 109.098 -0.705 . . . . 71.109999999999999 109.098 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 C--N 1.35 0.61 0 N-CA-C 107.351 -1.352 . . . . 74.129999999999995 107.351 172.879 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 108.818 -0.808 . . . . 74.409999999999997 108.818 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 74.2 mt -112.34 133.73 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.121 -1.066 . . . . 71.329999999999998 108.121 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -88.14 133.36 34.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.525 -0.546 . . . . 72.129999999999995 109.525 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -122.24 165.53 15.01 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 110.891 -0.883 . . . . 54.420000000000002 110.891 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.3 t -111.54 128.38 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 123.691 0.796 . . . . 74.239999999999995 109.313 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.69 93.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.446 1.099 . . . . 75.310000000000002 108.813 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 25' ' ' LYS . 64.7 mt -71.27 -51.19 25.9 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.343 -0.39 . . . . 73.420000000000002 110.062 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 p -159.48 156.18 27.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.737 -0.665 . . . . 74.329999999999998 110.875 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -92.5 104.88 17.15 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.243 -1.021 . . . . 74.319999999999993 108.243 169.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 109.004 -0.739 . . . . 72.219999999999999 109.004 178.608 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.68 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 29.1 t-20 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.358 0.599 . . . . 71.430000000000007 109.904 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 70' ' ' ARG . 58.9 t -101.52 151.15 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.465 1.106 . . . . 65.209999999999994 109.313 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 44.6 ttm -130.86 122.65 27.43 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.404 -0.961 . . . . 72.109999999999999 108.404 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.96 118.26 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.975 -1.121 . . . . 75.299999999999997 107.975 172.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -122.12 153.32 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.271 1.029 . . . . 71.439999999999998 108.738 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HB2' HD13 ' A' ' 8' ' ' LEU . 57.6 tttp -122.76 110.5 31.67 Favored Pre-proline 0 N--CA 1.473 0.698 0 N-CA-C 109.131 -0.692 . . . . 75.109999999999999 109.131 168.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 65' ' ' GLY . 27.2 Cg_exo -59.65 125.76 18.73 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.234 1.956 . . . . 74.329999999999998 110.192 167.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.83 -33.22 74.79 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.656 0.782 . . . . 72.019999999999996 111.327 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.55 -28.02 69.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.942 0.897 . . . . 63.229999999999997 111.449 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 35' ' ' ALA . 78.6 t -109.47 131.61 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.228 1.011 . . . . 72.0 111.4 -170.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -128.89 15.67 6.34 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.214 1.006 . . . . 71.329999999999998 110.525 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 m -143.75 154.06 43.07 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.335 0.654 . . . . 74.200000000000003 111.145 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.571 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 52.1 ttt180 -61.01 -50.28 74.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.259 1.024 . . . . 73.109999999999999 111.89 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 47.6 mt-10 -74.45 -30.45 61.88 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.58 0.352 . . . . 75.200000000000003 111.061 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -67.21 -25.4 66.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.069 0.548 . . . . 75.150000000000006 110.919 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.475 ' HB2' HG12 ' A' ' 29' ' ' VAL . . . -87.13 -30.63 20.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.546 0.738 . . . . 74.200000000000003 110.307 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 10.0 t -85.92 -6.97 58.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.068 0.947 . . . . 73.430000000000007 111.606 -172.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -82.82 -19.31 37.87 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.414 -0.587 . . . . 71.439999999999998 109.414 167.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.0 mt -87.82 6.31 35.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.631 0.772 . . . . 71.219999999999999 111.478 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 57' ' ' ILE . 42.5 mm -63.03 119.26 6.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 109.663 -0.495 . . . . 75.340000000000003 109.663 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.59 -4.53 40.02 Favored Glycine 0 C--O 1.239 0.46 0 CA-C-N 116.159 -0.473 . . . . 64.540000000000006 112.93 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -80.11 150.61 30.19 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 109.067 -0.716 . . . . 74.219999999999999 109.067 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.582 HD21 ' HD2' ' A' ' 54' ' ' LYS . 27.1 tp -89.86 159.55 16.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.208 -0.905 . . . . 75.109999999999999 109.024 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.486 HG21 HG12 ' A' ' 86' ' ' ILE . 90.4 t -128.32 114.53 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 107.509 -1.293 . . . . 73.030000000000001 107.509 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.32 108.75 21.52 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.705 1.202 . . . . 72.230000000000004 108.846 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -144.87 123.47 12.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.325 0.65 . . . . 74.530000000000001 109.823 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 27.1 ttpp -88.11 135.89 33.22 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.944 0.498 . . . . 70.129999999999995 109.73 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.9 p -73.75 158.28 86.32 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.856 0.863 . . . . 70.230000000000004 110.765 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.21 -8.1 19.32 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.433 2.089 . . . . 71.340000000000003 112.444 167.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -72.89 -21.71 60.87 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.644 0.777 . . . . 72.239999999999995 111.271 168.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.05 -19.44 37.85 Favored Glycine 0 C--N 1.352 1.439 0 C-N-CA 123.038 0.352 . . . . 73.219999999999999 113.442 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 134.42 34.76 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.275 0.63 . . . . 73.450000000000003 109.923 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 62.2 mt -78.3 123.72 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.481 -0.563 . . . . 73.219999999999999 109.481 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 73' ' ' LYS . 10.6 mt -102.97 131.05 50.21 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.28 -1.007 . . . . 72.109999999999999 108.28 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.582 ' HD2' HD21 ' A' ' 42' ' ' LEU . 32.1 mtmm -111.77 132.25 54.78 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.067 -0.716 . . . . 73.329999999999998 109.067 173.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.46 151.37 20.55 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 111.026 -0.829 . . . . 43.520000000000003 111.026 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -115.34 135.04 54.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.266 1.033 . . . . 74.420000000000002 110.708 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.489 HG23 ' HB ' ' A' ' 67' ' ' VAL . 56.7 mt -67.78 96.25 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.597 -0.89 . . . . 70.120000000000005 108.597 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 m -86.75 -31.4 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.012 0.525 . . . . 73.439999999999998 111.171 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -154.42 179.37 9.07 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 107.988 -1.116 . . . . 74.230000000000004 107.988 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.3 m -128.64 161.87 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.364 0.666 . . . . 72.409999999999997 109.959 170.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.483 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 21.8 t-80 -144.53 103.39 3.94 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.125 -0.695 . . . . 74.450000000000003 109.125 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.47 145.59 9.29 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 112.521 -0.232 . . . . 61.200000000000003 112.521 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.571 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 43.8 p -90.16 11.94 19.43 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.246 1.018 . . . . 75.439999999999998 111.928 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -106.58 17.08 23.77 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.03 0.932 . . . . 74.109999999999999 110.98 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 26' ' ' PRO . . . 76.63 36.18 38.61 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.097 -0.501 . . . . 75.109999999999999 113.909 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 61' ' ' HIS . . . -89.75 123.68 33.97 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.641 -0.874 . . . . 71.409999999999997 108.641 172.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.5 m -102.06 152.86 5.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-O 121.898 0.856 . . . . 71.230000000000004 111.35 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -101.62 103.66 14.49 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.551 1.54 . . . . 65.420000000000002 108.331 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.61 117.11 33.24 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.162 0.585 . . . . 74.239999999999995 110.762 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HD2' HG22 ' A' ' 21' ' ' VAL . 12.5 mmm-85 -89.44 102.62 15.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.326 1.05 . . . . 74.140000000000001 109.916 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.2 136.08 34.1 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.423 0.689 . . . . 55.32 110.976 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.528 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 14.3 pt-20 -57.33 -52.4 65.51 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.681 1.193 . . . . 73.340000000000003 111.039 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.539 ' HB2' HD22 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -92.92 -54.04 3.91 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.332 -0.988 . . . . 75.340000000000003 108.332 -179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.68 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 60.77 50.01 72.25 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 124.823 1.327 . . . . 65.430000000000007 112.894 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.9 mt -67.74 111.71 8.38 Favored Pre-proline 0 C--N 1.351 0.633 0 C-N-CA 123.271 0.628 . . . . 75.409999999999997 110.102 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.58 173.42 9.53 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.009 2.473 . . . . 72.310000000000002 111.218 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 165.32 -168.31 39.3 Favored Glycine 0 C--O 1.238 0.383 0 N-CA-C 111.315 -0.714 . . . . 75.230000000000004 111.315 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -94.8 67.38 3.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.192 0.996 . . . . 75.109999999999999 109.232 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.09 26.5 9.22 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.689 -1.141 . . . . 64.340000000000003 109.714 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.58 119.26 12.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.516 0.727 . . . . 71.040000000000006 110.698 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.01 -2.12 38.25 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.982 -0.554 . . . . 32.32 112.558 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.55 162.84 27.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.439 0.696 . . . . 73.430000000000007 109.943 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.53 131.92 45.21 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.386 0.674 . . . . 75.109999999999999 111.034 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.26 159.24 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.598 1.159 . . . . 74.219999999999999 108.608 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.2 106.5 14.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.522 -0.918 . . . . 74.340000000000003 108.522 170.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 43' ' ' VAL . 71.7 mt -83.42 108.73 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.383 -0.969 . . . . 72.150000000000006 108.383 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.73 143.87 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.946 0.898 . . . . 72.099999999999994 110.015 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 CA--C 1.55 0.979 0 N-CA-C 108.837 -0.801 . . . . 73.299999999999997 108.837 174.556 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 108.648 -0.871 . . . . 74.329999999999998 108.648 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 28' ' ' ASP . 53.0 mt -97.18 134.49 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 122.976 0.51 . . . . 73.400000000000006 110.476 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -89.27 121.61 31.72 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.005 0.922 . . . . 74.140000000000001 108.778 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -119.82 176.34 16.12 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-O 119.753 -0.471 . . . . 73.230000000000004 112.054 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.44 126.99 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.77 0.828 . . . . 75.219999999999999 109.653 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.43 99.4 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.618 0.767 . . . . 73.030000000000001 109.3 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.504 HD12 ' HB2' ' A' ' 25' ' ' LYS . 66.5 mt -71.59 -48.04 50.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.438 0.695 . . . . 72.420000000000002 110.033 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -157.02 159.96 38.51 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.451 -0.795 . . . . 73.010000000000005 110.487 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -99.65 159.22 15.21 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.245 -1.021 . . . . 74.420000000000002 108.245 167.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.547 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 108.129 -1.063 . . . . 74.340000000000003 108.129 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.501 HD22 ' HA3' ' A' ' 74' ' ' GLY . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 108.966 -0.753 . . . . 71.230000000000004 108.966 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 11.7 t -98.26 162.88 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.545 -0.909 . . . . 75.230000000000004 108.545 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.0 ttm -147.18 124.0 11.25 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.63 -1.248 . . . . 74.319999999999993 107.63 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.65 118.3 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 123.876 0.735 . . . . 75.549999999999997 109.278 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.8 mt -129.15 158.08 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.256 1.022 . . . . 72.319999999999993 108.386 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.504 ' HB2' HD12 ' A' ' 8' ' ' LEU . 27.7 ttpp -141.41 108.44 6.16 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 109.671 -0.492 . . . . 71.049999999999997 109.671 170.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 14.2 Cg_endo -56.54 143.16 89.15 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 123.887 3.058 . . . . 75.310000000000002 112.864 171.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.7 mt -80.44 -38.15 30.62 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.348 1.059 . . . . 72.340000000000003 110.467 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.424 ' HB3' HG23 ' A' ' 3' ' ' ILE . 26.2 t70 -67.96 -27.64 66.77 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.135 -0.939 . . . . 63.43 111.593 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.477 HG22 HD12 ' A' ' 38' ' ' LEU . 76.5 t -110.79 120.06 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.194 0.998 . . . . 75.439999999999998 110.477 -176.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -127.67 21.64 6.47 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.695 0.798 . . . . 71.340000000000003 110.556 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.3 p -140.28 158.62 43.75 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.718 0.807 . . . . 74.510000000000005 110.676 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.644 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 48.3 ttt85 -65.96 -50.32 64.76 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.833 0.853 . . . . 75.200000000000003 112.775 -169.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -30.21 57.62 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.652 0.595 . . . . 70.409999999999997 111.163 -171.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.497 ' HA ' ' HD2' ' A' ' 37' ' ' LYS . 42.7 mm-40 -69.1 -20.29 64.07 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.25 -0.432 . . . . 72.420000000000002 111.318 170.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.2 -26.22 20.23 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.736 0.814 . . . . 60.119999999999997 110.575 170.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -80.84 -12.59 59.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.789 0.835 . . . . 75.5 110.692 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HD2' ' HA ' ' A' ' 34' ' ' GLU . 15.0 ptmt -85.46 -16.39 39.8 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.126 0.489 . . . . 72.120000000000005 109.776 170.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.477 HD12 HG22 ' A' ' 29' ' ' VAL . 43.2 mt -81.98 -8.5 59.67 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.27 0.628 . . . . 75.530000000000001 111.149 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 57' ' ' ILE . 43.1 mm -59.92 130.22 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.494 -0.558 . . . . 75.109999999999999 109.494 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.94 -19.06 56.12 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-O 119.872 -0.405 . . . . 63.329999999999998 112.844 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 87' ' ' VAL . 94.3 mtt180 -78.32 156.65 29.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.989 0.516 . . . . 75.310000000000002 111.309 -176.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' A' ' 54' ' ' LYS . 21.6 tp -90.99 128.88 36.99 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.531 0.732 . . . . 74.530000000000001 109.517 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.408 HG22 HG12 ' A' ' 86' ' ' ILE . 56.5 t -99.28 115.12 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.054 -0.721 . . . . 64.430000000000007 109.054 172.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.17 122.62 34.83 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.397 -0.964 . . . . 75.140000000000001 108.397 173.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 37.6 t90 -135.86 132.22 36.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.24 -0.652 . . . . 63.030000000000001 109.24 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -90.61 122.66 33.59 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.292 -1.003 . . . . 64.319999999999993 108.292 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.8 p -83.86 159.51 60.24 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.095 0.558 . . . . 71.129999999999995 111.078 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.39 -14.91 44.21 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.337 2.025 . . . . 74.209999999999994 111.764 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.1 t -68.99 -23.2 64.08 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.895 0.878 . . . . 73.439999999999998 111.124 173.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.99 20.29 26.39 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 116.324 -0.398 . . . . 74.120000000000005 112.78 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -111.15 137.13 49.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.763 0.825 . . . . 72.430000000000007 110.128 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.3 mt -86.07 93.48 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.063 -1.088 . . . . 74.129999999999995 108.063 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.51 HD22 ' HB2' ' A' ' 73' ' ' LYS . 51.1 mt -80.59 133.14 35.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.04 -0.982 . . . . 72.530000000000001 109.766 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HB3' HD12 ' A' ' 42' ' ' LEU . 30.6 mtmm -116.01 138.58 51.08 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.092 -0.707 . . . . 75.230000000000004 109.092 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.02 176.16 21.43 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-N 115.602 -0.726 . . . . 74.420000000000002 111.312 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -135.76 133.85 38.4 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.565 0.682 . . . . 73.299999999999997 109.826 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 39' ' ' ILE . 58.1 mt -73.84 108.32 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.384 -0.599 . . . . 64.430000000000007 109.384 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.33 -20.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.708 0.803 . . . . 71.219999999999999 111.464 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -158.45 162.66 37.55 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.524 -0.547 . . . . 75.109999999999999 109.524 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.436 HG11 HD13 ' A' ' 39' ' ' ILE . 33.8 m -108.34 169.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.663 0.785 . . . . 74.540000000000006 109.731 171.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -125.26 104.59 8.57 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.034 -0.728 . . . . 74.530000000000001 109.034 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.56 -140.31 44.44 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 123.971 0.794 . . . . 72.219999999999999 113.331 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.644 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 63.5 p -115.34 4.26 14.37 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.794 0.838 . . . . 63.509999999999998 111.716 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -82.38 1.55 36.72 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.253 0.621 . . . . 75.120000000000005 112.13 -171.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.41 0.88 87.87 Favored Glycine 0 C--N 1.355 1.611 0 CA-C-O 120.069 -0.295 . . . . 70.099999999999994 112.966 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.88 121.51 16.18 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.322 0.649 . . . . 73.540000000000006 110.177 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.2 141.42 18.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.426 0.632 . . . . 71.239999999999995 110.824 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.532 ' HE ' HG12 ' A' ' 21' ' ' VAL . 64.7 ttt180 -103.8 104.32 14.31 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.879 0.872 . . . . 61.5 108.95 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -112.37 136.23 52.1 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.289 0.636 . . . . 70.040000000000006 110.592 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.403 ' HG2' HG23 ' A' ' 21' ' ' VAL . 72.0 mtp180 -106.32 117.24 33.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.809 0.444 . . . . 75.219999999999999 110.005 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -92.41 143.69 26.12 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.933 0.893 . . . . 72.409999999999997 111.129 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.442 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 15.8 pt-20 -60.6 -30.98 70.17 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.49 1.116 . . . . 74.140000000000001 111.601 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.51 ' HB2' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -119.69 -72.73 0.67 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.744 -0.836 . . . . 71.329999999999998 108.744 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.501 ' HA3' HD22 ' A' ' 20' ' ' ASN . . . 66.57 57.26 10.39 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 111.759 -0.537 . . . . 73.120000000000005 111.759 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.12 123.17 85.65 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.824 0.85 . . . . 74.219999999999999 110.584 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.13 151.45 38.97 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 123.843 3.028 . . . . 73.299999999999997 113.489 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.56 171.52 37.47 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.395 -0.821 . . . . 64.439999999999998 111.106 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -87.39 69.01 9.88 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.773 0.797 . . . . 75.349999999999994 109.399 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -119.51 27.93 8.47 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.046 -0.979 . . . . 74.340000000000003 110.369 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.08 135.91 47.98 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.572 0.349 . . . . 75.310000000000002 110.385 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.17 -6.47 63.79 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.01 -0.541 . . . . 74.209999999999994 112.574 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.91 155.61 35.03 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.233 0.613 . . . . 60.520000000000003 109.44 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 97.3 m-85 -102.09 145.04 29.91 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.135 0.493 . . . . 64.209999999999994 112.147 -169.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.79 165.42 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.298 -0.865 . . . . 74.310000000000002 109.901 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -128.74 110.35 12.1 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.463 0.705 . . . . 73.019999999999996 109.118 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 43' ' ' VAL . 59.0 mt -84.22 113.18 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.094 0.958 . . . . 44.340000000000003 109.073 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 27.5 t -87.58 146.31 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.38 1.072 . . . . 65.420000000000002 110.022 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 N--CA 1.486 1.326 0 C-N-CA 124.138 0.975 . . . . 75.109999999999999 110.856 -179.149 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.492 ' HG2' HG23 ' A' ' 87' ' ' VAL . 73.6 mtt180 . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 109.188 -0.671 . . . . 74.019999999999996 109.188 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 48.4 mt -98.81 131.35 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.78 0.832 . . . . 73.549999999999997 108.85 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.11 120.58 29.61 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.788 -0.819 . . . . 74.230000000000004 108.788 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -125.24 170.71 17.17 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.861 -0.496 . . . . 62.32 111.861 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.7 t -126.54 138.95 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.239 1.016 . . . . 74.239999999999995 109.513 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.39 114.29 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.44 1.096 . . . . 73.329999999999998 110.12 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 25' ' ' LYS . 42.4 mt -92.61 -55.68 3.3 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.729 0.412 . . . . 62.340000000000003 110.479 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -153.87 152.33 30.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.837 0.455 . . . . 72.200000000000003 111.949 -174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -110.09 128.74 55.62 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.047 0.939 . . . . 72.140000000000001 108.574 170.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 106.058 -1.83 . . . . 73.140000000000001 106.058 171.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' A' ' 71' ' ' PHE . 3.5 p-10 . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 121.467 0.651 . . . . 74.219999999999999 110.789 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.419 HG22 ' HD3' ' A' ' 70' ' ' ARG . 47.3 t -88.07 143.5 11.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.885 -1.524 . . . . 74.0 106.885 159.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.4 ttt -137.26 113.58 10.04 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.46 -0.941 . . . . 73.239999999999995 108.46 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.513 HG23 HD12 ' A' ' 8' ' ' LEU . 46.0 mm -80.37 119.83 30.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.104 -1.073 . . . . 70.209999999999994 108.104 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 84' ' ' VAL . 98.0 mt -129.87 143.99 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.187 0.995 . . . . 75.329999999999998 108.398 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.516 ' HB2' HD13 ' A' ' 8' ' ' LEU . 64.4 tttp -116.06 111.22 42.94 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 109.01 -0.737 . . . . 72.109999999999999 109.01 167.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.564 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 16.4 Cg_exo -66.33 131.27 26.07 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.12 1.88 . . . . 65.120000000000005 110.729 167.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.38 -31.91 72.64 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.016 0.926 . . . . 74.230000000000004 111.885 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.82 -29.88 64.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.791 0.836 . . . . 75.140000000000001 111.55 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.578 HG13 ' HB2' ' A' ' 34' ' ' GLU . 72.0 t -103.1 107.73 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.0 0.92 . . . . 72.530000000000001 110.677 -170.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -124.45 17.8 8.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.486 1.114 . . . . 74.510000000000005 109.839 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.3 t -139.62 156.32 46.92 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.366 1.067 . . . . 73.25 109.97 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -67.68 -37.67 82.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.308 0.643 . . . . 73.209999999999994 110.903 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.66 -45.09 95.45 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.929 0.891 . . . . 71.230000000000004 111.594 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.578 ' HB2' HG13 ' A' ' 29' ' ' VAL . 42.1 mt-10 -65.17 -32.72 74.55 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.888 -1.051 . . . . 74.409999999999997 110.553 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.0 -28.76 49.28 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.901 0.88 . . . . 63.310000000000002 111.36 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -75.69 -25.96 57.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.146 0.978 . . . . 75.5 111.474 -173.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -84.43 -3.19 58.2 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.098 0.407 . . . . 72.239999999999995 112.098 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 29' ' ' VAL . 29.9 mt -90.52 -2.87 57.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.814 0.445 . . . . 73.340000000000003 111.428 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -66.2 117.57 7.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.087 0.555 . . . . 74.439999999999998 109.835 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.97 1.98 57.14 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.152 -0.931 . . . . 61.030000000000001 113.202 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -87.62 161.0 17.95 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.327 1.063 . . . . 73.099999999999994 111.055 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.4 tp -90.1 139.25 30.81 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.338 1.055 . . . . 74.310000000000002 108.314 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 t -126.7 122.21 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.552 -0.907 . . . . 74.129999999999995 108.552 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.19 102.25 11.67 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.947 0.899 . . . . 73.420000000000002 109.745 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.444 ' HZ2' ' HB2' ' A' ' 79' ' ' ALA . 29.4 t90 -95.47 144.22 26.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.248 -0.649 . . . . 75.239999999999995 109.248 170.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -103.36 100.33 10.21 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.603 1.161 . . . . 64.219999999999999 108.162 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.7 p -64.62 150.38 94.04 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.583 0.753 . . . . 74.530000000000001 111.246 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.88 -5.35 15.39 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.646 2.231 . . . . 74.239999999999995 112.289 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.5 t -70.72 -19.54 62.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.705 1.202 . . . . 71.040000000000006 111.163 169.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.51 36.08 8.96 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.887 -0.597 . . . . 62.210000000000001 112.068 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -127.67 131.99 49.75 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.025 0.93 . . . . 74.299999999999997 109.014 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -90.26 93.11 4.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.661 -1.237 . . . . 73.519999999999996 107.661 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 75' ' ' LEU . 34.9 mt -74.86 137.35 41.76 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.819 -1.082 . . . . 75.340000000000003 109.508 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -98.0 137.65 36.5 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.003 0.921 . . . . 74.430000000000007 108.92 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.56 176.31 22.41 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 123.687 0.617 . . . . 72.200000000000003 111.635 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.3 ttmt -147.37 129.98 15.95 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.907 0.353 . . . . 75.140000000000001 110.752 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.4 mt -73.04 105.03 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.874 -1.057 . . . . 74.140000000000001 109.175 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 m -84.55 -36.14 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.821 -0.627 . . . . 75.329999999999998 110.816 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -148.22 -174.74 4.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.676 0.79 . . . . 74.150000000000006 111.203 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -114.31 170.53 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.235 1.014 . . . . 73.319999999999993 110.125 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -136.89 101.63 4.64 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.378 -0.971 . . . . 71.219999999999999 108.378 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.76 -172.56 10.17 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.268 -0.878 . . . . 65.310000000000002 115.181 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.3 p -91.22 11.93 21.82 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.808 1.243 . . . . 75.219999999999999 110.853 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.84 -25.35 60.03 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.937 1.295 . . . . 73.010000000000005 109.718 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.4 -2.43 65.23 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.653 -0.703 . . . . 64.430000000000007 112.788 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.4 129.76 40.91 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.028 0.531 . . . . 50.219999999999999 109.898 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.9 m -102.0 149.9 6.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 C-N-CA 123.665 0.786 . . . . 74.430000000000007 110.805 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -99.76 102.63 14.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.013 -1.449 . . . . 75.439999999999998 107.506 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.57 157.53 17.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.002 0.521 . . . . 74.329999999999998 110.743 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.419 ' HD3' HG22 ' A' ' 21' ' ' VAL . 10.0 mmm180 -131.65 99.7 4.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.366 1.066 . . . . 73.209999999999994 109.703 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.403 ' HB2' ' OD1' ' A' ' 20' ' ' ASN . 16.7 m-85 -88.97 138.51 31.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.181 0.593 . . . . 74.439999999999998 109.818 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.17 -43.23 99.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.83 1.252 . . . . 73.129999999999995 112.43 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -87.64 -53.4 4.81 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.613 -0.721 . . . . 73.239999999999995 111.808 -167.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.73 35.66 39.68 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-O 120.006 -0.33 . . . . 61.329999999999998 113.428 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.604 ' HB2' HD11 ' A' ' 53' ' ' LEU . 41.4 mt -69.42 126.52 92.7 Favored Pre-proline 0 C--N 1.353 0.728 0 C-N-CA 122.409 0.284 . . . . 73.340000000000003 110.44 177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.56 158.94 46.99 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.866 2.377 . . . . 75.200000000000003 110.918 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.3 115.1 0.35 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.243 -1.143 . . . . 73.310000000000002 110.243 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -65.95 75.97 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.089 1.355 . . . . 74.409999999999997 111.059 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.444 ' HB2' ' HZ2' ' A' ' 45' ' ' TRP . . . -120.83 28.41 7.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.056 1.342 . . . . 75.519999999999996 109.468 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.3 mt -64.5 103.65 0.69 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 108.59 -0.893 . . . . 72.140000000000001 108.59 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.06 -5.52 8.93 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 116.154 -0.476 . . . . 72.239999999999995 113.109 -172.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -76.02 172.28 13.03 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.956 0.902 . . . . 73.510000000000005 108.905 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -107.51 143.62 35.65 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.526 0.679 . . . . 75.219999999999999 111.419 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG21 HG23 ' A' ' 24' ' ' ILE . 19.6 m -113.24 164.29 9.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-N 114.319 -1.31 . . . . 75.239999999999995 108.405 172.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -127.76 109.74 11.94 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.936 0.494 . . . . 71.349999999999994 109.921 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 54.6 mt -82.59 92.66 2.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.078 -1.082 . . . . 74.239999999999995 108.078 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.492 HG23 ' HG2' ' A' ' 2' ' ' ARG . 96.4 t -77.48 128.79 37.97 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 CA-C-N 113.917 -1.492 . . . . 70.349999999999994 110.105 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 108.167 -1.049 . . . . 74.120000000000005 108.167 174.117 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.424 ' HG2' ' HA ' ' A' ' 87' ' ' VAL . 59.9 mtm-85 . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.414 -0.587 . . . . 74.329999999999998 109.414 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.535 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 55.9 mt -121.92 137.32 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.866 0.866 . . . . 74.519999999999996 109.41 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -89.09 131.86 35.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.297 -0.631 . . . . 73.299999999999997 109.297 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -137.97 137.52 8.9 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-O 120.169 -0.24 . . . . 72.25 112.983 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t -98.97 117.08 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.808 0.843 . . . . 74.430000000000007 110.261 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.98 106.76 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.529 1.132 . . . . 74.0 110.669 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.7 -50.56 15.01 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.37 0.668 . . . . 74.219999999999999 110.05 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -154.35 172.05 18.32 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.1 -0.954 . . . . 51.549999999999997 110.684 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -120.33 122.61 41.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.963 -1.125 . . . . 74.409999999999997 107.963 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 1.8 tpm_? . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 106.777 -1.564 . . . . 71.430000000000007 106.777 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.514 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 36.8 t30 . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.326 0.584 . . . . 72.129999999999995 110.477 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.523 HG23 ' HG2' ' A' ' 70' ' ' ARG . 67.7 t -105.74 155.39 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 125.89 1.676 . . . . 74.510000000000005 109.785 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 44.3 ttm -137.73 127.47 25.36 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.662 -0.866 . . . . 75.340000000000003 108.662 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -88.01 110.57 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.47 -0.937 . . . . 74.239999999999995 108.47 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 84' ' ' VAL . 79.7 mt -117.39 149.21 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.364 1.066 . . . . 75.019999999999996 109.051 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HG2' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -123.95 97.67 40.66 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 108.082 -1.081 . . . . 72.5 108.082 174.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.813 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 36.9 Cg_exo -60.85 125.62 17.64 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.919 2.412 . . . . 73.140000000000001 112.639 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.16 -42.33 89.14 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.623 0.769 . . . . 74.310000000000002 112.541 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.47 0.76 55.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.641 0.776 . . . . 73.219999999999999 111.983 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.813 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 59.4 t -114.3 107.89 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.296 1.038 . . . . 73.209999999999994 108.355 174.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -121.9 6.48 9.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.404 0.682 . . . . 74.019999999999996 111.77 -173.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 m -127.68 142.65 51.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.855 0.862 . . . . 74.430000000000007 108.875 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.52 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 57.3 ttt180 -57.4 -34.78 69.25 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.007 0.923 . . . . 74.510000000000005 111.27 175.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -60.26 -42.65 95.79 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.663 0.785 . . . . 71.299999999999997 111.825 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.615 ' HB2' HG12 ' A' ' 29' ' ' VAL . 36.5 mt-10 -64.44 -44.33 91.51 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.163 -0.926 . . . . 71.239999999999995 109.376 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.9 -26.01 66.66 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.438 -0.801 . . . . 72.209999999999994 111.55 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -73.56 -33.93 64.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.35 1.06 . . . . 74.150000000000006 110.777 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -85.86 -2.94 58.75 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.791 0.293 . . . . 75.239999999999995 111.791 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.483 HD13 HG23 ' A' ' 29' ' ' VAL . 50.5 mt -86.19 -1.58 57.57 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 119.232 -0.413 . . . . 75.319999999999993 112.06 174.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.434 HD13 HG23 ' A' ' 57' ' ' ILE . 43.2 mm -64.22 122.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.672 -0.862 . . . . 71.420000000000002 108.672 172.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.06 -4.94 55.93 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.508 -0.315 . . . . 73.019999999999996 113.163 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -84.8 148.09 26.5 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.197 0.499 . . . . 74.019999999999996 109.729 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.3 tp -88.83 141.5 28.45 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.4 1.08 . . . . 74.400000000000006 108.507 -173.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.51 126.02 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.4 -0.593 . . . . 72.420000000000002 109.4 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.1 mt -111.49 105.66 14.32 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.078 0.951 . . . . 74.209999999999994 109.421 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -110.47 133.27 53.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.306 0.642 . . . . 72.430000000000007 109.374 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -92.59 111.98 23.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.791 -1.188 . . . . 73.420000000000002 107.791 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.5 p -68.47 152.51 96.57 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.238 0.615 . . . . 75.219999999999999 111.338 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.41 -18.12 57.43 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.972 2.448 . . . . 64.200000000000003 111.917 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.6 m -61.55 -21.07 63.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.156 1.383 . . . . 73.230000000000004 111.988 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.71 20.35 44.29 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 116.352 -0.385 . . . . 63.350000000000001 112.425 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -108.29 146.98 32.09 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.875 0.87 . . . . 75.409999999999997 109.192 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -101.36 93.43 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.669 -1.234 . . . . 71.120000000000005 107.669 172.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.6 mt -77.88 130.28 36.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.938 -1.028 . . . . 74.219999999999999 109.103 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -107.3 146.62 31.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.277 0.631 . . . . 73.430000000000007 109.32 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.32 -171.31 21.12 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.214 -0.903 . . . . 70.409999999999997 111.497 -175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -152.22 135.34 15.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.001 0.401 . . . . 65.140000000000001 110.954 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 39' ' ' ILE . 70.6 mt -69.83 110.64 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 O-C-N 124.095 0.872 . . . . 71.340000000000003 108.686 175.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.44 -8.54 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.513 0.725 . . . . 74.109999999999999 111.291 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -158.48 150.79 21.76 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.73 -0.471 . . . . 75.239999999999995 109.73 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.7 m -98.62 159.46 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.436 0.694 . . . . 71.230000000000004 109.537 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.404 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 59.7 t-80 -144.44 104.48 4.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.126 0.57 . . . . 72.109999999999999 109.808 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.91 168.94 40.49 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 121.336 0.409 . . . . 72.209999999999994 113.655 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.52 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 21.4 p -85.0 -9.22 58.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.482 1.113 . . . . 74.329999999999998 112.29 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -81.87 5.95 17.29 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.509 0.724 . . . . 74.400000000000006 112.686 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.432 ' HA3' HG13 ' A' ' 29' ' ' VAL . . . 84.84 9.11 81.56 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 119.518 -0.601 . . . . 75.450000000000003 113.802 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.492 ' HB1' ' HG2' ' A' ' 25' ' ' LYS . . . -67.18 133.9 50.67 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 122.656 0.383 . . . . 75.409999999999997 110.201 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.3 150.06 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.547 0.739 . . . . 54.43 111.231 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -103.0 105.21 15.48 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.546 1.138 . . . . 74.409999999999997 108.369 171.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.84 120.24 41.92 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.453 0.701 . . . . 71.519999999999996 109.936 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG2' HG23 ' A' ' 21' ' ' VAL . 41.2 mtm105 -88.92 118.81 28.9 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.174 -0.676 . . . . 75.439999999999998 109.174 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -90.78 122.94 33.95 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.336 0.654 . . . . 74.510000000000005 109.773 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.0 -39.3 74.43 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.223 1.009 . . . . 74.400000000000006 111.873 -173.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -76.81 -55.06 5.82 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.251 -0.886 . . . . 73.239999999999995 109.528 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 61.26 34.55 88.55 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 114.6 -1.182 . . . . 74.25 113.865 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 96.0 mt -69.66 137.83 88.21 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.588 0.755 . . . . 74.549999999999997 110.353 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 12.8 Cg_exo -68.76 143.85 57.39 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.96 2.44 . . . . 74.519999999999996 112.445 -174.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.76 104.02 0.17 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.722 -0.951 . . . . 63.109999999999999 110.722 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -73.68 91.18 1.87 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.733 0.813 . . . . 74.319999999999993 110.025 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.83 30.77 7.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.717 1.207 . . . . 74.340000000000003 109.91 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.1 mt -43.9 103.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.323 1.049 . . . . 73.340000000000003 112.259 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.15 4.75 20.38 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.814 -0.63 . . . . 34.5 113.913 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -91.36 168.11 11.8 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.055 0.942 . . . . 71.349999999999994 110.901 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -100.15 154.6 18.31 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.722 0.809 . . . . 74.430000000000007 112.627 -172.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.444 HG21 HD13 ' A' ' 24' ' ' ILE . 18.5 m -131.18 158.21 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.92 1.288 . . . . 73.519999999999996 109.062 176.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.97 108.25 17.52 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.058 -0.719 . . . . 75.239999999999995 109.058 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.535 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 68.1 mt -89.14 94.09 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.976 -1.12 . . . . 72.140000000000001 107.976 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.424 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . 48.6 t -74.01 133.48 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.143 -0.935 . . . . 74.349999999999994 109.043 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 tm? . . . . . 0 CA--C 1.549 0.913 0 N-CA-C 108.743 -0.836 . . . . 73.200000000000003 108.743 176.536 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.466 -0.568 . . . . 75.5 109.466 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.509 HD11 HH11 ' A' ' 41' ' ' ARG . 65.7 mt -111.84 124.06 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.91 -1.144 . . . . 74.0 107.91 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 7.1 ptpp? -88.35 127.29 35.48 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.314 0.578 . . . . 73.299999999999997 110.912 -173.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -123.76 160.45 18.31 Favored Glycine 0 C--O 1.218 -0.872 0 CA-C-N 115.59 -0.732 . . . . 70.030000000000001 111.834 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.14 129.56 50.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 123.542 0.737 . . . . 74.25 109.379 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.641 HG13 ' HE2' ' A' ' 22' ' ' MET . 60.4 t -66.93 99.87 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.954 0.902 . . . . 71.019999999999996 109.459 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.725 HD13 ' HG2' ' A' ' 25' ' ' LYS . 72.2 mt -74.46 -59.32 2.78 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.776 -0.453 . . . . 74.219999999999999 109.776 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.4 t -166.08 162.07 17.6 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.923 -0.581 . . . . 75.099999999999994 111.355 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.494 ' HB3' HD22 ' A' ' 20' ' ' ASN . 62.4 m-85 -115.87 145.35 42.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.965 1.306 . . . . 74.019999999999996 108.892 171.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 107.426 -1.324 . . . . 64.519999999999996 107.426 173.667 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.494 HD22 ' HB3' ' A' ' 10' ' ' TYR . 44.6 t-20 . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 109.223 -0.658 . . . . 75.349999999999994 109.223 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.8 t -88.44 105.1 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.448 -0.945 . . . . 73.319999999999993 108.448 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.652 ' HE3' HG12 ' A' ' 24' ' ' ILE . 24.8 ttt -98.83 136.46 38.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.268 -1.333 . . . . 73.200000000000003 109.11 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.485 HG23 HD12 ' A' ' 8' ' ' LEU . 27.7 mm -104.48 131.0 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 108.238 -1.023 . . . . 73.019999999999996 108.238 174.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.652 HG12 ' HE3' ' A' ' 22' ' ' MET . 22.9 mt -124.97 150.31 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.941 0.897 . . . . 74.129999999999995 109.239 -174.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.725 ' HG2' HD13 ' A' ' 8' ' ' LEU . 1.1 mmmm -120.37 98.59 48.52 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 123.115 0.566 . . . . 75.430000000000007 110.404 170.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.442 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 23.8 Cg_exo -63.07 135.88 53.42 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.116 1.877 . . . . 72.319999999999993 110.377 169.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.5 mt -60.73 -30.99 70.31 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.31 0.576 . . . . 71.239999999999995 111.149 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.23 -27.17 61.44 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.334 1.453 . . . . 73.140000000000001 111.79 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 34' ' ' GLU . 94.6 t -115.93 121.09 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.9 0.88 . . . . 74.319999999999993 110.427 -170.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -135.29 14.68 3.5 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.671 0.788 . . . . 73.5 111.26 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 m -137.67 151.27 48.08 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.845 0.858 . . . . 61.350000000000001 109.781 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.617 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 50.0 ttt180 -60.37 -38.82 85.1 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.253 1.021 . . . . 75.329999999999998 112.184 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.57 -40.1 95.78 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.049 0.54 . . . . 73.340000000000003 111.44 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HB2' HG11 ' A' ' 29' ' ' VAL . 48.0 mt-10 -64.73 -35.64 81.71 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.9 0.75 . . . . 63.420000000000002 110.828 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.79 -30.6 51.38 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.987 0.915 . . . . 73.239999999999995 111.274 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -73.19 -31.63 64.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.065 0.946 . . . . 72.409999999999997 111.25 -173.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -79.28 -11.71 59.94 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 120.831 0.348 . . . . 74.129999999999995 110.899 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.583 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 51.5 mt -109.73 23.62 14.16 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.205 1.002 . . . . 74.310000000000002 111.561 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.5 mm -75.47 135.39 27.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.565 -0.531 . . . . 74.540000000000006 109.565 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.6 -9.3 44.55 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-O 119.103 -0.831 . . . . 65.5 113.061 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.583 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 79.1 mtm180 -62.11 149.11 42.25 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.334 0.654 . . . . 73.209999999999994 112.408 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 tp -91.64 120.68 32.62 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.369 1.068 . . . . 75.319999999999993 109.262 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.0 t -100.21 137.28 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 122.911 0.484 . . . . 64.530000000000001 110.031 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.7 mt -131.34 120.13 22.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.787 1.235 . . . . 74.329999999999998 107.761 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -130.28 128.44 41.57 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.435 -0.579 . . . . 74.129999999999995 109.435 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -84.43 110.84 18.94 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.347 -0.612 . . . . 72.030000000000001 109.347 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.8 t -77.2 153.72 82.23 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 124.255 1.022 . . . . 63.43 109.537 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.3 -8.55 14.85 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.137 2.558 . . . . 75.099999999999994 114.686 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.9 p -70.9 -15.32 62.61 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.262 0.625 . . . . 74.310000000000002 111.506 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.23 -10.53 63.54 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 123.719 0.676 . . . . 53.310000000000002 112.388 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.57 132.41 35.11 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.627 0.771 . . . . 74.450000000000003 110.755 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.8 106.5 13.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.944 -0.761 . . . . 75.5 108.944 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.8 117.93 16.15 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.726 -0.842 . . . . 74.340000000000003 108.726 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -109.16 146.67 33.74 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 123.021 0.528 . . . . 73.430000000000007 110.424 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.82 -171.75 27.2 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 114.825 -1.079 . . . . 34.219999999999999 110.999 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.73 134.18 20.81 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.057 0.428 . . . . 74.030000000000001 111.086 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.524 HD11 ' HB2' ' A' ' 41' ' ' ARG . 78.1 mt -67.5 106.87 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.509 0 O-C-N 124.41 1.069 . . . . 74.109999999999999 109.402 175.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.511 HG11 ' HE ' ' A' ' 70' ' ' ARG . 27.6 m -91.52 -31.74 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.567 0.747 . . . . 62.240000000000002 111.559 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -155.76 176.29 12.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.863 -0.791 . . . . 74.109999999999999 108.863 -173.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.2 m -92.51 170.06 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 109.092 -0.707 . . . . 74.329999999999998 109.092 170.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -136.17 103.4 5.31 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.267 -1.012 . . . . 73.340000000000003 108.267 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.7 -149.04 42.71 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.657 -0.702 . . . . 71.099999999999994 113.24 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.617 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -117.97 -17.37 9.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.472 0.709 . . . . 72.540000000000006 112.105 -171.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 25.29 2.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.497 0.719 . . . . 74.439999999999998 112.232 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.22 18.13 78.66 Favored Glycine 0 C--N 1.346 1.13 0 N-CA-C 114.97 0.748 . . . . 73.409999999999997 114.97 167.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.12 38.19 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.582 -0.896 . . . . 61.439999999999998 108.582 171.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.8 m -102.43 139.46 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.046 0.451 . . . . 73.030000000000001 109.973 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -99.58 105.53 17.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.118 0.967 . . . . 74.230000000000004 108.747 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.51 121.58 44.7 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.832 0.853 . . . . 70.349999999999994 110.817 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.511 ' HE ' HG11 ' A' ' 58' ' ' VAL . 39.1 mtm180 -89.33 113.12 24.36 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.979 -0.748 . . . . 72.329999999999998 108.979 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -81.5 136.15 35.62 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.337 1.055 . . . . 74.109999999999999 110.329 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.66 -24.78 36.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.404 0.682 . . . . 75.0 110.904 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -77.39 -54.77 6.05 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.485 -0.78 . . . . 73.120000000000005 109.685 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.04 25.1 63.82 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 124.042 0.838 . . . . 71.030000000000001 114.263 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.63 158.46 78.5 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.949 0.9 . . . . 73.430000000000007 110.848 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.58 150.6 51.32 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.996 2.464 . . . . 74.129999999999995 112.733 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.24 -71.96 0.3 Allowed Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.915 -0.584 . . . . 73.120000000000005 112.43 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 76.02 -40.43 0.4 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 126.075 1.75 . . . . 75.019999999999996 112.604 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.81 30.07 0.11 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.126 0.97 . . . . 65.25 112.661 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.18 149.42 28.32 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.216 1.006 . . . . 74.439999999999998 110.707 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.449 ' H ' ' HB ' ' A' ' 7' ' ' VAL . . . 87.72 4.12 79.8 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 116.601 -0.272 . . . . 73.510000000000005 113.076 -169.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -85.38 170.9 12.28 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.76 0.824 . . . . 74.519999999999996 110.176 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.69 133.24 36.2 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.516 0.674 . . . . 73.319999999999993 112.169 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 11.4 m -100.71 159.34 3.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 114.452 -1.249 . . . . 72.319999999999993 108.946 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -109.19 108.9 19.71 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.473 -0.936 . . . . 72.430000000000007 108.473 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.9 95.13 4.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.584 -0.895 . . . . 75.420000000000002 108.584 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.22 136.73 24.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 115.246 -0.888 . . . . 75.439999999999998 109.593 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 108.642 -0.873 . . . . 75.420000000000002 108.642 178.714 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 . . . . . 0 CA--C 1.537 0.468 0 N-CA-C 107.421 -1.326 . . . . 75.329999999999998 107.421 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 mt -98.55 155.69 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.411 1.084 . . . . 75.519999999999996 108.96 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.533 ' HG3' HD13 ' A' ' 27' ' ' LEU . 19.1 ptmt -114.36 140.92 48.26 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.865 -0.791 . . . . 75.030000000000001 108.865 173.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -139.32 164.57 25.9 Favored Glycine 0 C--O 1.216 -0.995 0 N-CA-C 111.647 -0.581 . . . . 44.119999999999997 111.647 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.37 131.38 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.348 0.659 . . . . 75.230000000000004 109.926 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.1 93.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.304 -0.998 . . . . 74.409999999999997 108.304 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 25' ' ' LYS . 79.8 mt -68.4 -59.31 3.27 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 110.131 -0.322 . . . . 73.400000000000006 110.131 -176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 t -154.38 155.67 35.46 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.074 -0.512 . . . . 75.049999999999997 110.722 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -95.78 138.81 32.91 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.458 -0.941 . . . . 73.439999999999998 108.458 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 108.585 -0.894 . . . . 73.120000000000005 108.585 173.393 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.025 -0.731 . . . . 63.030000000000001 109.025 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.418 HG23 ' HG2' ' A' ' 70' ' ' ARG . 62.2 t -88.12 145.9 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 108.282 -1.007 . . . . 72.310000000000002 108.282 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.3 ttt -136.22 111.51 9.09 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.485 -1.302 . . . . 70.109999999999999 107.485 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 mm -78.51 119.13 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 114.98 -1.009 . . . . 72.25 108.387 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.432 HG21 HG22 ' A' ' 84' ' ' VAL . 81.5 mt -130.93 153.12 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.488 1.115 . . . . 73.400000000000006 108.089 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HB2' HD11 ' A' ' 8' ' ' LEU . 87.5 tttt -127.33 121.88 22.69 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 108.912 -0.773 . . . . 73.400000000000006 108.912 164.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -69.87 140.23 41.74 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.768 2.312 . . . . 71.439999999999998 110.768 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.533 HD13 ' HG3' ' A' ' 4' ' ' LYS . 92.7 mt -69.84 -29.78 67.11 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.384 0.673 . . . . 73.540000000000006 111.276 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.08 -22.23 60.62 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.996 -1.002 . . . . 71.450000000000003 111.303 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 34' ' ' GLU . 57.9 t -110.23 123.96 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.335 1.054 . . . . 72.209999999999994 110.746 -174.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -135.16 11.13 3.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.845 0.858 . . . . 65.329999999999998 110.429 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.445 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 27.5 m -131.09 165.33 23.49 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.426 0.69 . . . . 74.0 111.126 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -68.93 -43.73 74.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.703 1.201 . . . . 75.510000000000005 110.97 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -70.65 -32.54 69.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.746 0.818 . . . . 72.019999999999996 110.763 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.537 ' HB2' HG13 ' A' ' 29' ' ' VAL . 44.7 mt-10 -68.51 -30.89 69.81 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.78 -0.645 . . . . 73.450000000000003 110.5 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.38 -32.04 33.04 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.578 0.751 . . . . 72.349999999999994 110.728 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -75.18 -23.77 57.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.869 0.868 . . . . 73.25 111.382 -174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -80.23 -13.67 59.04 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 120.73 0.3 . . . . 72.150000000000006 110.968 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.9 mt -90.32 3.87 52.42 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 122.961 0.504 . . . . 75.040000000000006 112.084 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.454 HD13 HG23 ' A' ' 57' ' ' ILE . 48.9 mm -65.63 124.36 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 108.819 -0.808 . . . . 71.530000000000001 108.819 171.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.06 9.56 62.08 Favored Glycine 0 N--CA 1.475 1.288 0 CA-C-O 119.967 -0.351 . . . . 74.400000000000006 113.371 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.734 ' HG3' ' HA ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -89.85 146.72 24.23 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.691 0.796 . . . . 74.310000000000002 110.673 178.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.8 tp -93.98 115.41 27.75 Favored 'General case' 0 C--N 1.345 0.398 0 O-C-N 124.037 0.835 . . . . 75.239999999999995 109.41 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.9 t -98.99 120.43 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 109.629 -0.508 . . . . 75.310000000000002 109.629 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt -105.9 128.05 53.53 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.765 1.226 . . . . 64.109999999999999 109.077 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -147.33 119.27 8.15 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.377 -0.601 . . . . 72.430000000000007 109.377 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 28.3 ttpp -82.06 112.27 18.97 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.194 -0.669 . . . . 73.129999999999995 109.194 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.0 p -64.7 155.51 81.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.781 0.832 . . . . 62.119999999999997 110.94 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.71 -9.09 19.57 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.988 2.459 . . . . 75.340000000000003 112.523 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 t -74.67 -10.12 59.23 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.927 0.891 . . . . 63.350000000000001 111.347 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.47 -12.37 63.18 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 123.633 0.635 . . . . 65.409999999999997 113.188 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -83.51 126.66 33.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.564 0.746 . . . . 75.120000000000005 109.563 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 63.1 mt -79.57 96.74 2.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 107.31 -1.367 . . . . 72.340000000000003 107.31 168.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 73' ' ' LYS . 50.3 mt -73.62 126.43 30.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.094 -0.957 . . . . 75.409999999999997 108.953 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -106.65 139.82 40.49 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.991 -0.744 . . . . 74.519999999999996 108.991 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.24 -179.64 28.02 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 123.51 0.506 . . . . 72.0 111.939 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -149.38 137.32 20.47 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.949 0.404 . . . . 73.319999999999993 111.073 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.454 HG23 HD13 ' A' ' 39' ' ' ILE . 67.3 mt -74.85 103.49 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 114.77 -1.105 . . . . 75.329999999999998 109.643 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.21 -18.59 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 114.965 -1.016 . . . . 65.329999999999998 111.345 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.509 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 20.8 ttm180 -160.13 160.67 33.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.084 0.554 . . . . 75.409999999999997 109.755 -175.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 m -95.1 171.05 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.496 0.718 . . . . 73.310000000000002 109.469 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -128.36 103.03 6.92 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.795 -0.817 . . . . 74.099999999999994 108.795 173.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.35 -150.52 46.96 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 124.291 0.994 . . . . 75.319999999999993 114.089 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -109.54 7.08 24.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.473 1.109 . . . . 75.109999999999999 110.89 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -67.23 -28.05 67.74 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.171 0.588 . . . . 74.540000000000006 111.047 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.17 3.3 58.92 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.639 -0.709 . . . . 65.150000000000006 111.903 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.44 130.21 42.19 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.515 -0.55 . . . . 73.549999999999997 109.515 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.6 m -102.37 153.97 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.581 0.752 . . . . 74.219999999999999 110.573 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.509 ' HD2' ' HB3' ' A' ' 59' ' ' ARG . 17.8 ttm180 -111.84 103.31 11.56 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.491 -0.929 . . . . 75.200000000000003 108.491 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.84 116.58 30.91 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.449 0.699 . . . . 62.43 109.813 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.418 ' HG2' HG23 ' A' ' 21' ' ' VAL . 43.3 mtm180 -90.24 118.01 29.43 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.69 -0.856 . . . . 73.030000000000001 108.69 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -91.37 128.41 37.19 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.488 0.715 . . . . 72.510000000000005 109.801 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.12 -32.97 68.64 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.629 1.172 . . . . 72.209999999999994 112.468 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.494 ' HB2' HD21 ' A' ' 53' ' ' LEU . 70.9 mmtt -90.5 -37.94 13.55 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.132 0.573 . . . . 72.030000000000001 109.565 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.17 35.73 34.6 Favored Glycine 0 C--N 1.36 1.871 0 O-C-N 124.503 1.127 . . . . 75.040000000000006 114.315 174.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -76.28 133.15 71.95 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 122.992 0.517 . . . . 73.030000000000001 110.622 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.23 120.17 6.41 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.772 1.648 . . . . 75.510000000000005 110.404 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.12 -15.2 31.3 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.523 -0.762 . . . . 73.209999999999994 111.868 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 67.68 12.74 9.0 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.765 1.226 . . . . 72.040000000000006 111.35 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.12 32.47 2.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.836 1.254 . . . . 73.340000000000003 111.833 -168.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -51.79 108.02 0.24 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.522 0.729 . . . . 72.340000000000003 111.413 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.0 -14.46 7.05 Favored Glycine 0 N--CA 1.475 1.272 0 CA-C-N 116.11 -0.496 . . . . 72.340000000000003 112.396 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -77.56 172.83 12.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.75 0.82 . . . . 71.129999999999995 110.311 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 9.7 m-85 -108.62 130.01 55.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.283 0.633 . . . . 71.120000000000005 111.394 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG22 HG21 ' A' ' 24' ' ' ILE . 16.1 m -97.97 168.25 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.553 1.141 . . . . 72.519999999999996 109.029 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -120.35 106.76 12.17 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.787 -0.82 . . . . 63.310000000000002 108.787 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.19 92.37 3.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.41 -0.959 . . . . 64.400000000000006 108.41 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.78 124.77 36.74 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-N 115.063 -0.971 . . . . 75.230000000000004 108.86 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.734 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.239 0.533 0 N-CA-C 106.663 -1.606 . . . . 74.340000000000003 106.663 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.537 ' HD2' ' HB3' ' A' ' 85' ' ' GLU . 90.6 mtm-85 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.803 -0.443 . . . . 73.010000000000005 109.803 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.672 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 47.8 mt -116.82 124.4 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.566 -1.272 . . . . 74.140000000000001 107.566 176.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -88.74 140.21 29.68 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 118.419 0.554 . . . . 74.430000000000007 109.658 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.59 135.97 7.34 Favored Glycine 0 C--O 1.218 -0.886 0 N-CA-C 111.998 -0.441 . . . . 71.439999999999998 111.998 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -91.18 116.88 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.369 0.668 . . . . 74.439999999999998 109.266 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.484 HG12 ' SD ' ' A' ' 22' ' ' MET . 91.1 t -55.12 103.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.585 1.154 . . . . 75.400000000000006 110.4 175.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.413 HD13 HG22 ' A' ' 23' ' ' ILE . 93.9 mt -75.21 -57.05 4.13 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 122.88 0.472 . . . . 74.439999999999998 110.22 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.3 p -163.95 164.08 23.34 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.415 -0.811 . . . . 72.409999999999997 110.271 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.97 134.93 34.09 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.147 -0.686 . . . . 74.25 109.147 168.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.481 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 1.7 tmt_? . . . . . 0 C--O 1.241 0.648 0 N-CA-C 105.424 -2.065 . . . . 74.150000000000006 105.424 165.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.645 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 52.1 t30 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 120.886 0.374 . . . . 71.549999999999997 110.302 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 39.8 t -93.53 144.14 10.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.606 -0.887 . . . . 74.540000000000006 108.606 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.484 ' SD ' HG12 ' A' ' 7' ' ' VAL . 42.8 ttp -133.56 121.64 22.4 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.179 -0.675 . . . . 74.349999999999994 109.179 174.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 8' ' ' LEU . 41.1 mm -79.78 126.42 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.577 1.151 . . . . 74.230000000000004 108.832 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -126.08 152.07 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.581 1.153 . . . . 74.340000000000003 109.588 -171.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -116.22 92.66 36.68 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.756 0.822 . . . . 71.109999999999999 109.515 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.07 131.54 33.0 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.441 1.427 . . . . 74.310000000000002 109.876 172.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.437 HD11 ' HE2' ' A' ' 83' ' ' TYR . 91.1 mt -63.96 -31.51 72.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.584 0.754 . . . . 74.5 111.764 -171.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.16 -28.58 67.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.539 0.735 . . . . 73.099999999999994 111.122 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.66 144.19 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.865 0.866 . . . . 74.439999999999998 111.772 -168.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -147.52 -25.57 0.38 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.375 1.07 . . . . 72.510000000000005 111.592 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.593 ' HB2' ' HG2' ' A' ' 34' ' ' GLU . 15.7 m -109.88 169.84 8.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.403 0.681 . . . . 73.409999999999997 111.186 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 78.8 ttt180 -65.96 -42.83 89.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.954 0.902 . . . . 74.209999999999994 111.082 -177.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.99 -30.87 62.71 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.813 0.695 . . . . 72.439999999999998 110.892 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 31' ' ' SER . 20.0 mm-40 -65.92 -30.8 71.44 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.752 0.658 . . . . 74.200000000000003 110.491 173.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -81.66 -33.21 31.45 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.772 0.829 . . . . 72.129999999999995 110.851 175.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -75.44 -24.96 57.09 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.107 0.963 . . . . 75.430000000000007 111.203 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 34' ' ' GLU . 22.0 pttp -75.07 -1.51 23.23 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 122.205 0.202 . . . . 74.010000000000005 111.111 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.1 11.5 25.64 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.319 0.648 . . . . 74.439999999999998 112.53 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mm -69.24 126.28 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.414 -0.587 . . . . 74.310000000000002 109.414 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.38 57.74 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.179 -0.464 . . . . 63.43 113.242 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.07 139.14 37.03 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.017 0.527 . . . . 75.510000000000005 110.301 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -90.1 113.68 25.46 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.275 1.03 . . . . 72.109999999999999 108.75 -173.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -98.04 114.31 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.222 0.609 . . . . 74.420000000000002 109.517 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.476 HD21 ' HG2' ' A' ' 54' ' ' LYS . 42.4 mt -101.04 99.99 10.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.23 -1.026 . . . . 72.140000000000001 108.23 176.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.479 ' CD1' HG12 ' A' ' 84' ' ' VAL . 32.6 t90 -103.27 131.63 50.17 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.959 -0.756 . . . . 73.140000000000001 108.959 174.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -91.99 126.61 37.15 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.151 -1.055 . . . . 75.349999999999994 108.151 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.9 p -73.17 141.43 81.03 Favored Pre-proline 0 C--O 1.244 0.816 0 N-CA-C 109.381 -0.6 . . . . 62.299999999999997 109.381 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.69 -23.55 33.5 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.471 2.78 . . . . 72.310000000000002 113.877 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.4 m -64.17 -54.78 28.24 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.646 0.779 . . . . 75.510000000000005 110.928 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.18 32.32 0.1 Allowed Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.351 -0.386 . . . . 74.530000000000001 113.614 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -114.69 173.53 6.43 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.607 0.763 . . . . 73.340000000000003 109.542 173.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.0 105.05 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.446 -0.946 . . . . 74.219999999999999 108.446 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.475 HD23 ' HB2' ' A' ' 73' ' ' LYS . 21.2 mt -83.34 110.23 17.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.236 -1.024 . . . . 75.200000000000003 108.236 172.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HG2' HD21 ' A' ' 44' ' ' LEU . 51.7 mtpt -94.46 139.74 30.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.003 -0.74 . . . . 73.439999999999998 109.003 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.65 -171.28 19.36 Favored Glycine 0 N--CA 1.463 0.493 0 O-C-N 123.455 0.472 . . . . 52.140000000000001 112.297 -173.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -151.94 133.99 15.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.957 0.503 . . . . 72.540000000000006 110.052 -178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.429 HG22 ' HB ' ' A' ' 67' ' ' VAL . 73.6 mt -69.32 98.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.729 -0.841 . . . . 74.0 108.729 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.37 -33.44 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.183 0.593 . . . . 64.450000000000003 111.019 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -148.78 167.61 25.14 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.349 -0.982 . . . . 75.439999999999998 108.349 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 m -103.01 170.63 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.394 0.678 . . . . 65.430000000000007 109.229 172.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -132.57 122.57 24.97 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.522 -0.918 . . . . 73.099999999999994 108.522 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.67 -153.95 52.4 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.92 0.763 . . . . 73.540000000000006 113.072 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.528 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 73.6 p -116.76 -11.47 10.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.193 0.997 . . . . 73.510000000000005 111.193 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -98.73 52.94 1.0 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.229 0.537 . . . . 71.530000000000001 112.091 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.38 -0.4 33.3 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 117.312 1.685 . . . . 65.329999999999998 117.312 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.46 124.85 28.85 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.91 0.855 . . . . 63.530000000000001 109.582 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 57' ' ' ILE . 34.7 m -103.25 160.12 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.371 0.668 . . . . 64.430000000000007 109.918 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -119.79 104.29 10.09 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.703 1.201 . . . . 71.239999999999995 108.499 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.12 127.41 54.14 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.447 0.699 . . . . 75.310000000000002 110.864 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -89.61 111.5 22.46 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.59 1.156 . . . . 72.120000000000005 109.611 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -92.08 166.33 12.72 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.056 0.542 . . . . 74.519999999999996 111.047 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.503 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 7.8 pt-20 -67.29 -39.05 85.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.937 0.895 . . . . 74.150000000000006 110.466 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.503 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 14.4 mmmm -118.8 -69.16 0.87 Allowed 'General case' 0 C--N 1.345 0.375 0 C-N-CA 124.089 0.956 . . . . 73.209999999999994 109.398 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.645 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 71.93 57.86 5.57 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 123.924 0.765 . . . . 75.430000000000007 111.231 -173.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.33 124.51 89.99 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.758 0.823 . . . . 74.420000000000002 111.22 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.59 174.57 8.24 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.335 2.69 . . . . 73.340000000000003 112.71 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.33 172.1 13.13 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.341 -0.704 . . . . 72.010000000000005 111.341 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -86.48 68.91 10.34 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.508 1.147 . . . . 75.340000000000003 109.618 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.09 17.51 17.72 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.468 -1.242 . . . . 63.32 109.714 175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.2 mt -76.41 121.88 23.7 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.92 0.888 . . . . 71.230000000000004 109.486 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.48 -6.98 14.14 Favored Glycine 0 N--CA 1.469 0.849 0 N-CA-C 111.966 -0.454 . . . . 73.329999999999998 111.966 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.58 155.64 29.55 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.814 0.846 . . . . 75.510000000000005 109.86 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.437 ' HE2' HD11 ' A' ' 27' ' ' LEU . 62.1 m-85 -91.33 133.09 35.73 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.94 0.496 . . . . 73.510000000000005 111.448 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG12 ' CD1' ' A' ' 45' ' ' TRP . 6.7 m -100.01 149.39 5.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 N-CA-C 107.632 -1.248 . . . . 72.519999999999996 107.632 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 2' ' ' ARG . 8.5 mm-40 -111.34 106.73 15.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.053 -1.091 . . . . 74.530000000000001 108.053 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.672 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 62.2 mt -96.94 104.63 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.444 0.697 . . . . 74.219999999999999 109.235 -173.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.9 t -95.31 134.75 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.221 1.008 . . . . 72.5 110.103 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 107.302 -1.37 . . . . 64.310000000000002 107.302 168.777 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 106.845 -1.539 . . . . 73.310000000000002 106.845 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 28' ' ' ASP . 50.9 mt -94.67 125.86 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.275 -0.639 . . . . 74.400000000000006 109.275 -175.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -88.67 133.29 34.25 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.466 -0.939 . . . . 71.310000000000002 108.466 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.98 166.19 22.13 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.361 0.413 . . . . 71.299999999999997 112.13 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.61 135.2 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.193 0.997 . . . . 75.319999999999993 109.173 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.76 114.53 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.568 0.747 . . . . 75.329999999999998 110.292 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 25' ' ' LYS . 89.6 mt -81.79 -61.2 1.99 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.358 0.663 . . . . 75.430000000000007 110.843 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.2 t -152.46 160.5 43.26 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.849 -0.614 . . . . 73.409999999999997 110.37 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -91.02 157.55 17.2 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.361 0.601 . . . . 74.310000000000002 111.182 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.491 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.6 tpp180 . . . . . 0 C--O 1.238 0.495 0 N-CA-C 106.263 -1.754 . . . . 73.530000000000001 106.263 163.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 . . . . . 0 C--O 1.241 0.629 0 N-CA-C 109.31 -0.626 . . . . 72.010000000000005 109.31 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.538 HG21 ' HG2' ' A' ' 70' ' ' ARG . 5.1 t -96.96 150.62 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 108.464 -0.939 . . . . 71.409999999999997 108.464 -176.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -154.79 140.88 18.43 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.758 0.313 . . . . 72.299999999999997 110.77 168.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 8' ' ' LEU . 45.4 mm -77.17 120.48 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.307 -0.861 . . . . 72.299999999999997 108.682 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.4 mt -115.45 147.83 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.35 1.06 . . . . 75.5 108.84 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HB2' HD11 ' A' ' 8' ' ' LEU . 86.6 tttt -108.13 101.8 43.3 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 123.821 0.848 . . . . 74.519999999999996 109.424 171.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.58 115.97 3.03 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 122.067 1.845 . . . . 62.409999999999997 110.067 165.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.38 -34.07 71.97 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.159 0.984 . . . . 72.319999999999993 112.132 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HB3' HG22 ' A' ' 3' ' ' ILE . 22.2 t70 -69.31 -27.73 65.64 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.253 1.021 . . . . 73.129999999999995 111.899 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.582 HG11 ' HB2' ' A' ' 34' ' ' GLU . 25.9 t -113.09 119.06 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.235 1.014 . . . . 72.209999999999994 111.24 -170.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -120.36 -5.52 9.87 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.116 0.566 . . . . 73.450000000000003 111.893 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.42 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 69.2 m -111.18 152.86 26.57 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.038 0.535 . . . . 64.319999999999993 110.347 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 55.6 ttt85 -64.27 -35.36 80.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 73.439999999999998 111.826 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.62 -38.72 84.3 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.951 0.5 . . . . 73.040000000000006 110.7 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.582 ' HB2' HG11 ' A' ' 29' ' ' VAL . 33.8 mt-10 -67.39 -31.77 72.22 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.114 -0.948 . . . . 73.120000000000005 110.07 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.22 -23.05 32.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.977 0.911 . . . . 72.120000000000005 111.218 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.4 t -79.42 -27.6 41.73 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.769 0.828 . . . . 64.349999999999994 110.086 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -80.16 -9.19 59.7 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.329 -0.396 . . . . 74.450000000000003 110.758 170.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.438 HD13 HG22 ' A' ' 29' ' ' VAL . 47.2 mt -89.61 -3.45 58.27 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.139 0.576 . . . . 64.519999999999996 111.987 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.622 HD12 HG13 ' A' ' 60' ' ' VAL . 49.7 mm -63.65 107.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.242 -0.651 . . . . 64.409999999999997 109.242 174.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.1 5.4 30.62 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.323 -0.71 . . . . 74.239999999999995 114.145 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.437 ' HD2' HD21 ' A' ' 88' ' ' LEU . 28.9 mmt180 -84.72 159.72 20.46 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.364 1.082 . . . . 74.430000000000007 111.373 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 54' ' ' LYS . 61.0 tp -90.83 117.19 29.25 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.29 1.036 . . . . 75.510000000000005 109.331 -175.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 t -107.35 117.14 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.204 -0.665 . . . . 73.040000000000006 109.204 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -101.15 104.44 15.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.641 0.776 . . . . 75.219999999999999 109.529 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -91.75 141.95 28.12 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.554 -0.536 . . . . 73.200000000000003 109.554 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -103.08 108.95 20.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.962 -1.017 . . . . 75.230000000000004 108.87 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.2 p -60.3 160.82 15.57 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.731 0.813 . . . . 74.409999999999997 111.036 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.9 -21.67 71.65 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.937 2.424 . . . . 71.349999999999994 112.613 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.3 m -77.51 -6.96 55.44 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.017 0.927 . . . . 64.200000000000003 111.765 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.65 3.64 77.29 Favored Glycine 0 C--N 1.35 1.342 0 C-N-CA 123.197 0.427 . . . . 72.329999999999998 112.863 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -85.77 156.47 20.59 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.007 0.923 . . . . 74.030000000000001 108.898 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.8 mt -117.62 114.35 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.594 0.358 . . . . 74.430000000000007 110.367 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.504 HD12 ' HB2' ' A' ' 73' ' ' LYS . 31.5 mt -92.25 150.58 20.8 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.723 -0.843 . . . . 74.25 108.723 173.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HB3' HD11 ' A' ' 42' ' ' LEU . 23.5 mtmm -98.22 156.15 16.83 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.717 -0.475 . . . . 75.530000000000001 109.717 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.8 -174.97 29.21 Favored Glycine 0 C--O 1.239 0.441 0 N-CA-C 111.036 -0.825 . . . . 75.129999999999995 111.036 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -152.87 136.17 15.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 111.758 0.281 . . . . 70.239999999999995 111.758 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.402 HD13 HD13 ' A' ' 86' ' ' ILE . 78.2 mt -69.2 102.82 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.622 0 O-C-N 124.038 0.836 . . . . 74.109999999999999 108.895 171.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -84.29 -28.35 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.329 -0.851 . . . . 74.530000000000001 110.711 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -164.03 165.32 22.55 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.811 0.844 . . . . 74.099999999999994 109.396 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.622 HG13 HD12 ' A' ' 39' ' ' ILE . 35.4 m -92.8 169.41 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.508 0.723 . . . . 75.299999999999997 110.522 174.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -127.6 104.59 7.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.295 1.038 . . . . 73.340000000000003 109.223 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.49 -153.01 52.89 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.851 -0.613 . . . . 61.32 113.154 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 32.5 p -111.83 -0.63 15.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.789 0.836 . . . . 72.319999999999993 111.831 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -83.78 5.88 23.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.47 0.708 . . . . 74.340000000000003 112.425 -168.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.28 -16.37 57.61 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-O 119.909 -0.384 . . . . 75.299999999999997 113.063 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.68 122.55 14.41 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.613 0.765 . . . . 75.230000000000004 110.018 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.84 175.06 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.955 0.902 . . . . 74.540000000000006 110.632 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -128.5 111.39 13.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.278 1.031 . . . . 73.019999999999996 108.592 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.8 133.02 56.52 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.381 0.672 . . . . 64.409999999999997 110.774 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.538 ' HG2' HG21 ' A' ' 21' ' ' VAL . 97.0 mtt180 -103.75 128.85 51.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.947 0.899 . . . . 75.120000000000005 109.095 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -106.11 134.6 48.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.494 0.717 . . . . 73.219999999999999 110.743 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 20.8 pt-20 -51.58 -48.09 63.3 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 124.89 1.369 . . . . 75.219999999999999 112.552 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.558 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 13.4 mmmm -92.93 -39.5 11.11 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.152 0.581 . . . . 74.329999999999998 109.478 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.99 55.0 28.11 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 124.284 0.99 . . . . 64.409999999999997 113.908 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.62 124.09 89.25 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.054 0.541 . . . . 74.519999999999996 110.591 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.14 150.67 33.67 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.107 2.538 . . . . 72.409999999999997 112.129 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.09 -151.79 14.6 Favored Glycine 0 C--N 1.344 0.972 0 N-CA-C 111.33 -0.708 . . . . 73.540000000000006 111.33 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -113.03 73.89 0.84 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.218 1.009 . . . . 75.129999999999995 108.882 172.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.27 -9.76 59.37 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.383 -1.28 . . . . 75.340000000000003 112.617 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.6 mt -61.24 115.1 3.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.621 0.768 . . . . 75.329999999999998 110.716 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.68 -18.87 49.29 Favored Glycine 0 N--CA 1.473 1.148 0 CA-C-N 116.465 -0.334 . . . . 73.329999999999998 112.826 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.08 163.49 27.06 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.698 0.799 . . . . 75.099999999999994 110.442 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -105.05 148.71 26.48 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.751 0.786 . . . . 75.209999999999994 112.279 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.14 164.45 17.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 114.35 -1.295 . . . . 75.310000000000002 108.269 171.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.13 107.66 11.0 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.008 -0.738 . . . . 74.420000000000002 109.008 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.402 HD13 HD13 ' A' ' 57' ' ' ILE . 57.4 mt -82.72 92.23 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.0 -1.111 . . . . 74.340000000000003 108.0 177.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.2 t -79.53 141.82 14.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 114.421 -1.263 . . . . 75.010000000000005 108.837 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.437 HD21 ' HD2' ' A' ' 41' ' ' ARG . 1.0 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 107.66 -1.237 . . . . 75.25 107.66 171.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 107.647 -1.242 . . . . 75.450000000000003 107.647 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.24 139.85 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.464 0.706 . . . . 71.439999999999998 109.142 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -88.14 119.16 28.26 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.283 -1.006 . . . . 63.509999999999998 108.283 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -116.98 168.84 12.89 Favored Glycine 0 C--N 1.34 0.802 0 O-C-N 123.673 0.608 . . . . 72.319999999999993 111.583 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.43 130.29 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.958 0.903 . . . . 53.409999999999997 109.175 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.2 t -68.11 104.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.095 0.958 . . . . 74.140000000000001 109.348 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 25' ' ' LYS . 83.1 mt -84.29 -55.13 4.34 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.462 0.305 . . . . 73.230000000000004 110.807 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m -154.22 170.27 21.65 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.524 0.564 . . . . 64.400000000000006 112.524 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -122.58 157.56 31.86 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.053 1.341 . . . . 74.010000000000005 109.193 170.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.535 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.7 tpt180 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 107.656 -1.238 . . . . 75.099999999999994 107.656 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 110.315 -0.254 . . . . 72.200000000000003 110.315 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 85.8 t -86.41 145.0 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.32 -0.993 . . . . 74.120000000000005 108.32 -171.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.3 ttt -137.56 109.49 7.17 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.791 -1.559 . . . . 64.209999999999994 106.791 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.432 HG21 HD13 ' A' ' 8' ' ' LEU . 45.5 mm -81.14 120.32 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 107.119 -1.437 . . . . 72.5 107.119 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -127.65 146.64 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.49 1.116 . . . . 64.420000000000002 108.319 -175.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.519 ' HB2' HD11 ' A' ' 8' ' ' LEU . 41.1 ttmt -118.68 112.84 36.66 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 109.292 -0.632 . . . . 71.010000000000005 109.292 168.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.427 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 17.2 Cg_exo -62.65 126.2 17.76 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.057 1.838 . . . . 73.030000000000001 110.229 168.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.76 -27.45 69.29 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.715 0.806 . . . . 74.430000000000007 111.7 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.76 -27.13 66.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.41 1.084 . . . . 75.209999999999994 111.868 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 34' ' ' GLU . 71.6 t -106.72 128.0 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.964 0.906 . . . . 72.329999999999998 111.823 -169.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -127.9 5.01 5.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.53 1.132 . . . . 73.340000000000003 110.839 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -132.48 157.79 43.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.477 0.711 . . . . 71.239999999999995 110.53 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 68.9 ttt180 -64.13 -42.92 96.62 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.769 0.827 . . . . 75.200000000000003 111.101 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.54 -38.88 92.53 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.867 0.73 . . . . 75.140000000000001 111.148 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.578 ' HB2' HG11 ' A' ' 29' ' ' VAL . 41.0 mt-10 -64.94 -34.02 77.42 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 124.117 0.886 . . . . 72.310000000000002 110.448 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 29' ' ' VAL . . . -82.08 -26.39 33.69 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.098 0.959 . . . . 74.040000000000006 111.537 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 t -82.06 -23.81 35.62 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.907 0.883 . . . . 74.439999999999998 110.931 -172.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.73 1.29 39.46 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.59 0.356 . . . . 75.420000000000002 110.834 170.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 75.7 mt -102.22 11.88 37.54 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.431 0.693 . . . . 73.510000000000005 111.343 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 60' ' ' VAL . 49.9 mm -73.99 130.82 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 109.49 -0.559 . . . . 62.219999999999999 109.49 174.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.23 1.39 75.55 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.029 -0.532 . . . . 71.540000000000006 112.532 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.587 ' HG3' ' HA ' ' A' ' 88' ' ' LEU . 5.6 mpt_? -81.64 138.58 35.29 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.079 0.552 . . . . 74.439999999999998 109.98 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.2 tp -90.37 113.56 25.47 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.63 -0.878 . . . . 74.120000000000005 108.63 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 t -98.09 116.05 39.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 123.427 0.691 . . . . 64.450000000000003 109.254 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.3 mt -102.01 129.19 48.24 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.464 1.106 . . . . 75.409999999999997 108.549 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -142.38 127.38 18.4 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.14 0.576 . . . . 74.019999999999996 109.484 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -89.76 115.24 26.97 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.123 -0.695 . . . . 74.519999999999996 109.123 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -64.71 158.45 68.5 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.823 0.849 . . . . 75.519999999999996 111.006 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -59.33 -20.17 54.38 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.465 2.776 . . . . 72.450000000000003 113.432 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.6 m -75.15 -3.28 31.93 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.89 0.876 . . . . 64.430000000000007 112.234 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.87 9.76 80.23 Favored Glycine 0 C--N 1.353 1.525 0 C-N-CA 123.069 0.366 . . . . 62.5 112.936 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -96.16 132.16 41.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.583 0.753 . . . . 74.310000000000002 110.001 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.1 mt -85.55 101.87 10.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-O 121.3 0.571 . . . . 75.409999999999997 109.613 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 75' ' ' LEU . 13.5 mt -80.97 128.49 33.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.462 -0.79 . . . . 71.099999999999994 108.879 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -117.43 132.47 56.56 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.106 0.963 . . . . 54.530000000000001 109.123 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.95 -177.79 28.6 Favored Glycine 0 C--N 1.336 0.55 0 O-C-N 123.635 0.584 . . . . 52.43 112.177 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -151.77 136.67 17.23 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.115 0.413 . . . . 74.420000000000002 112.115 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.407 HG23 ' HB ' ' A' ' 67' ' ' VAL . 64.7 mt -67.94 103.62 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.935 0.894 . . . . 74.150000000000006 109.568 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.27 -30.83 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.532 -0.758 . . . . 73.450000000000003 111.547 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -163.95 160.45 21.98 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.62 0.768 . . . . 71.439999999999998 109.254 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 39' ' ' ILE . 20.2 m -101.18 170.48 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.847 0.859 . . . . 74.219999999999999 111.065 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -131.3 103.14 6.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.06 0.944 . . . . 75.400000000000006 109.021 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.66 -166.85 26.08 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.74 -0.664 . . . . 72.25 114.452 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 75.7 p -90.77 8.56 34.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.382 1.073 . . . . 65.439999999999998 111.333 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -79.84 -2.72 44.71 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.871 0.869 . . . . 72.420000000000002 111.783 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.24 -4.89 61.23 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-O 120.103 -0.276 . . . . 71.409999999999997 113.645 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.96 112.28 5.51 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 123.429 0.692 . . . . 73.349999999999994 109.635 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.407 ' HB ' HG23 ' A' ' 57' ' ' ILE . 29.1 m -100.19 143.77 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.04 0.936 . . . . 75.109999999999999 109.153 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -101.72 103.07 13.82 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.322 -0.992 . . . . 74.140000000000001 108.322 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.82 120.28 41.58 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.556 0.742 . . . . 74.019999999999996 109.935 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -88.8 106.31 18.29 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.973 0.509 . . . . 73.340000000000003 109.699 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -88.15 120.99 30.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.632 -0.877 . . . . 74.140000000000001 108.632 170.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.42 -20.71 60.66 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.134 0.492 . . . . 73.010000000000005 109.876 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -76.68 -77.64 0.14 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.641 0.777 . . . . 74.230000000000004 109.197 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.1 45.01 63.42 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.646 0.591 . . . . 53.109999999999999 114.395 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.431 ' HB2' HD22 ' A' ' 53' ' ' LEU . 81.7 mt -73.15 157.08 88.88 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.759 0.824 . . . . 74.549999999999997 111.195 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.08 124.08 14.51 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 123.402 2.735 . . . . 75.439999999999998 113.273 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.09 87.74 0.08 OUTLIER Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.776 -1.33 . . . . 74.349999999999994 109.776 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -73.92 71.43 1.54 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.092 0.957 . . . . 71.239999999999995 109.846 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.05 29.01 8.16 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.445 1.098 . . . . 75.019999999999996 110.685 -169.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 mt -52.46 118.46 3.6 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.5 0.72 . . . . 74.019999999999996 110.378 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.07 -10.51 15.17 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 112.01 -0.436 . . . . 63.539999999999999 112.01 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -77.23 169.56 18.11 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.876 0.87 . . . . 71.439999999999998 109.678 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 63.0 m-85 -112.26 127.47 55.98 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.639 0.376 . . . . 75.430000000000007 111.952 -170.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 m -100.38 162.72 3.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-N 115.171 -0.922 . . . . 74.540000000000006 109.824 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -111.62 108.99 18.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.905 0.882 . . . . 74.140000000000001 108.681 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.1 mt -92.18 92.9 3.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.1 -1.074 . . . . 73.230000000000004 108.1 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.81 134.03 27.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.082 -0.963 . . . . 74.140000000000001 109.09 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.587 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 4.4 mm? . . . . . 0 C--O 1.241 0.615 0 C-N-CA 123.751 0.82 . . . . 74.430000000000007 110.608 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.751 0.31 . . . . 74.219999999999999 110.364 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 mt -132.57 128.83 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.686 -1.227 . . . . 73.140000000000001 107.686 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -87.79 128.18 35.33 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.941 -0.763 . . . . 74.010000000000005 108.941 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 25' ' ' LYS . . . -124.74 142.44 13.94 Favored Glycine 0 C--N 1.34 0.799 0 O-C-N 123.914 0.759 . . . . 73.0 111.486 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -92.76 131.04 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.511 0.655 . . . . 72.409999999999997 109.906 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.8 97.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.951 0.9 . . . . 75.549999999999997 109.251 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.461 HD22 ' HE2' ' A' ' 25' ' ' LYS . 81.5 mt -77.34 -53.45 7.67 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.673 -0.492 . . . . 71.299999999999997 109.673 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -165.11 179.19 6.49 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.847 0.356 . . . . 71.019999999999996 111.411 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -129.96 134.8 47.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.793 1.237 . . . . 73.430000000000007 108.298 174.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.072 -1.455 . . . . 73.310000000000002 107.072 163.052 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 110.001 -0.37 . . . . 74.209999999999994 110.001 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.448 HG23 ' HG2' ' A' ' 70' ' ' ARG . 42.6 t -87.77 144.13 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.696 0.799 . . . . 55.149999999999999 109.56 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.6 ttt -131.15 117.16 18.68 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.168 -1.049 . . . . 71.120000000000005 108.168 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.453 HG22 HD13 ' A' ' 8' ' ' LEU . 28.0 mm -77.29 111.44 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.625 -0.879 . . . . 75.010000000000005 108.625 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.1 mt -112.74 145.6 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.403 1.081 . . . . 74.010000000000005 109.302 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HE2' HD22 ' A' ' 8' ' ' LEU . 22.6 ttmm -111.65 87.55 8.29 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.347 1.059 . . . . 72.030000000000001 109.012 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HD3' HG23 ' A' ' 67' ' ' VAL . 32.2 Cg_endo -62.23 107.48 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.95 1.767 . . . . 74.329999999999998 110.212 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.13 -32.48 73.87 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.507 1.123 . . . . 71.329999999999998 112.073 -174.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.89 -26.11 68.63 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.335 1.054 . . . . 73.230000000000004 111.464 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 34' ' ' GLU . 66.2 t -112.43 137.57 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 125.195 1.398 . . . . 73.319999999999993 111.489 -171.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -134.84 8.66 3.55 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.657 1.183 . . . . 72.010000000000005 110.504 170.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.5 m -124.37 147.27 48.34 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.773 0.829 . . . . 75.129999999999995 110.609 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.474 ' HD2' HG22 ' A' ' 63' ' ' THR . 71.2 ttt180 -67.81 -34.02 75.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.691 0.796 . . . . 75.329999999999998 111.193 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -67.1 -43.0 83.64 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.485 0.714 . . . . 62.140000000000001 110.485 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HB2' HG12 ' A' ' 29' ' ' VAL . 27.2 mm-40 -72.77 -22.91 60.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.165 -0.925 . . . . 72.310000000000002 110.961 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.96 -32.58 30.67 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.554 0.742 . . . . 73.540000000000006 110.165 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.0 t -75.71 -24.47 56.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.573 0.749 . . . . 74.329999999999998 111.385 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -81.39 -2.29 48.79 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 122.311 -0.243 . . . . 71.420000000000002 111.224 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.3 mt -88.68 -12.15 43.21 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 123.331 0.652 . . . . 75.030000000000001 111.185 175.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.587 HD11 HG12 ' A' ' 60' ' ' VAL . 42.1 mm -65.79 104.57 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.084 0 C-N-CA 123.183 0.593 . . . . 75.310000000000002 110.174 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.13 -6.34 10.95 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.447 -0.641 . . . . 71.239999999999995 112.93 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -84.11 155.32 22.69 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 117.756 0.778 . . . . 75.430000000000007 111.257 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 54' ' ' LYS . 58.8 tp -93.14 117.26 29.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.49 1.116 . . . . 71.25 109.983 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.34 135.33 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.359 -0.608 . . . . 71.230000000000004 109.359 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.7 mt -118.37 105.15 11.42 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.392 1.077 . . . . 73.340000000000003 108.128 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 44.8 t90 -110.23 128.4 55.48 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.644 -0.873 . . . . 61.140000000000001 108.644 171.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -98.25 117.43 32.62 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.674 -0.861 . . . . 64.450000000000003 108.674 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.3 p -74.56 162.36 73.99 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 124.024 0.93 . . . . 74.540000000000006 111.29 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.19 -14.55 45.75 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.973 2.448 . . . . 75.239999999999995 112.465 171.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -73.3 -19.38 61.05 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.707 1.203 . . . . 71.030000000000001 111.879 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.06 5.33 60.9 Favored Glycine 0 C--N 1.356 1.693 0 C-N-CA 123.437 0.542 . . . . 70.200000000000003 112.733 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -94.24 118.32 31.41 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.88 0.872 . . . . 71.150000000000006 109.817 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.85 97.2 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.017 -1.105 . . . . 72.230000000000004 108.017 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 mt -73.64 123.2 23.57 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.958 -1.127 . . . . 74.219999999999999 107.958 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.0 mtmm -104.26 140.53 37.73 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.32 -0.622 . . . . 74.530000000000001 109.32 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.93 173.42 25.42 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 116.207 -0.451 . . . . 75.329999999999998 112.112 -178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -127.57 131.77 49.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.071 -0.715 . . . . 72.400000000000006 109.071 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.485 HG23 HD12 ' A' ' 39' ' ' ILE . 62.8 mt -67.61 99.89 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 108.499 -0.926 . . . . 71.340000000000003 108.499 171.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.76 -34.31 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 115.256 -0.883 . . . . 73.420000000000002 111.24 -176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -154.2 157.11 38.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.786 -0.82 . . . . 73.230000000000004 108.786 -173.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.587 HG12 HD11 ' A' ' 39' ' ' ILE . 27.2 m -91.71 168.82 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.659 0.784 . . . . 74.519999999999996 110.05 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.455 ' HB2' ' HG3' ' A' ' 68' ' ' ARG . 82.9 t60 -132.81 103.28 6.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.964 -1.125 . . . . 73.329999999999998 107.964 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.2 -162.76 49.0 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.379 -0.373 . . . . 53.310000000000002 113.181 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 32' ' ' ARG . 73.5 p -110.96 -24.01 10.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.591 0.756 . . . . 64.329999999999998 112.18 -172.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -91.83 46.7 1.29 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.803 0.668 . . . . 71.310000000000002 112.803 -170.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.74 55.75 10.87 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.771 -0.65 . . . . 62.399999999999999 114.056 170.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.39 141.99 49.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.214 -1.032 . . . . 64.310000000000002 108.214 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 57' ' ' ILE . 22.1 m -130.85 171.94 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.141 0.977 . . . . 74.420000000000002 109.894 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.455 ' HG3' ' HB2' ' A' ' 61' ' ' HIS . 73.0 mtm180 -134.35 109.1 8.57 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.218 1.007 . . . . 71.340000000000003 109.091 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.89 127.25 53.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.257 -0.883 . . . . 65.439999999999998 110.278 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HG2' HG23 ' A' ' 21' ' ' VAL . 33.8 mtm180 -90.27 110.06 21.13 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.254 -0.647 . . . . 75.239999999999995 109.254 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.29 142.11 29.6 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.236 1.014 . . . . 74.439999999999998 110.173 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 11.0 pt-20 -50.04 -45.36 52.13 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.568 1.547 . . . . 73.099999999999994 111.885 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.531 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 32.8 mmtp -96.48 -46.94 6.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.371 -0.831 . . . . 74.420000000000002 108.854 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.6 45.69 92.93 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 124.589 1.181 . . . . 74.450000000000003 112.87 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.0 140.58 86.0 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.147 0.579 . . . . 65.239999999999995 110.696 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.16 123.93 13.04 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.153 2.569 . . . . 74.040000000000006 111.88 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -110.65 131.91 10.66 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.934 -0.575 . . . . 70.439999999999998 111.94 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -83.24 3.9 29.21 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.038 0.935 . . . . 72.120000000000005 110.297 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.409 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -94.43 29.86 2.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.693 1.197 . . . . 71.450000000000003 112.014 -177.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.7 mt -53.11 108.68 0.35 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 122.7 0.4 . . . . 73.049999999999997 110.54 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.58 -10.63 7.59 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 123.836 0.731 . . . . 72.450000000000003 112.53 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.91 163.58 27.74 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.309 1.044 . . . . 72.239999999999995 111.64 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -96.71 124.63 40.75 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.526 0.73 . . . . 74.439999999999998 110.64 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 m -99.67 149.11 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.872 1.269 . . . . 72.109999999999999 107.748 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -108.73 107.36 17.78 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.839 -0.801 . . . . 75.25 108.839 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.57 90.9 3.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.097 -1.446 . . . . 73.439999999999998 107.097 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.69 150.68 3.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 114.816 -1.084 . . . . 75.129999999999995 109.079 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.472 0.658 0 C-N-CA 123.22 0.608 . . . . 72.049999999999997 110.854 174.793 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.619 ' HG2' HG22 ' A' ' 87' ' ' VAL . 61.4 mtt180 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 107.256 -1.387 . . . . 63.119999999999997 107.256 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.46 HD13 HH11 ' A' ' 41' ' ' ARG . 61.5 mt -109.29 128.75 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.07 -1.085 . . . . 71.239999999999995 108.07 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -86.73 121.47 29.28 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.146 -0.687 . . . . 74.540000000000006 109.146 -170.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -127.44 169.63 19.22 Favored Glycine 0 C--N 1.341 0.847 0 O-C-N 124.003 0.814 . . . . 74.310000000000002 111.66 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.1 t -133.27 133.69 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.262 1.025 . . . . 72.040000000000006 109.167 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.97 102.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.539 0.736 . . . . 72.439999999999998 109.846 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 25' ' ' LYS . 86.7 mt -70.85 -53.86 13.65 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.688 -0.687 . . . . 73.510000000000005 109.471 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 t -158.61 168.83 25.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.759 -0.655 . . . . 73.329999999999998 111.113 -176.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -107.74 142.97 36.93 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.289 1.036 . . . . 73.0 108.752 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 . . . . . 0 C--O 1.22 -0.493 0 N-CA-C 107.205 -1.406 . . . . 75.329999999999998 107.205 169.632 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.51 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 21.7 t-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.288 -0.634 . . . . 71.129999999999995 109.288 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.529 HG23 ' HG2' ' A' ' 70' ' ' ARG . 22.0 t -89.27 104.68 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 106.451 -1.685 . . . . 74.340000000000003 106.451 172.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 47.7 ttm -93.27 130.15 39.09 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 122.681 0.392 . . . . 73.510000000000005 110.758 -171.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.443 HG23 HD13 ' A' ' 8' ' ' LEU . 32.9 mm -81.04 102.18 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.448 -0.945 . . . . 73.219999999999999 108.448 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -109.07 147.25 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.281 1.032 . . . . 74.150000000000006 109.009 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HB2' HD11 ' A' ' 8' ' ' LEU . 39.5 ttmt -118.35 102.37 50.41 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 108.622 -0.881 . . . . 74.230000000000004 108.622 167.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 18.1 Cg_endo -61.96 111.27 1.18 Allowed 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 121.545 1.497 . . . . 75.540000000000006 109.287 167.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.4 mt -55.39 -32.09 62.36 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.221 1.008 . . . . 70.400000000000006 112.266 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.14 -30.12 68.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.131 0.972 . . . . 72.409999999999997 111.718 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' A' ' 34' ' ' GLU . 93.6 t -107.1 117.89 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.195 0.998 . . . . 74.420000000000002 110.13 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -121.19 4.63 10.33 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.36 0.664 . . . . 75.209999999999994 111.522 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.517 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 6.0 m -130.24 145.36 51.74 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.272 0.629 . . . . 70.209999999999994 109.69 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.653 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 73.3 ttt180 -59.09 -46.65 87.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.769 0.827 . . . . 73.519999999999996 111.302 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.25 -39.97 84.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 123.924 0.765 . . . . 73.209999999999994 111.719 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.518 ' HB2' HG12 ' A' ' 29' ' ' VAL . 47.4 mt-10 -59.99 -49.79 76.29 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.172 0.92 . . . . 64.439999999999998 109.647 176.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.53 -24.02 61.88 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.128 0.971 . . . . 74.329999999999998 111.947 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -73.29 -39.19 65.53 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.749 0.82 . . . . 71.25 110.68 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -77.74 -10.36 59.49 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.412 -0.358 . . . . 75.019999999999996 110.976 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.604 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 55.6 mt -97.74 26.71 4.87 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.486 1.115 . . . . 73.400000000000006 111.625 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.626 HD11 HG11 ' A' ' 60' ' ' VAL . 45.2 mm -85.76 135.98 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 109.191 -0.67 . . . . 73.340000000000003 109.191 172.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.55 -7.24 39.25 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.579 -0.567 . . . . 75.310000000000002 113.517 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.604 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 16.5 ptt180 -80.59 154.17 27.6 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.223 0.511 . . . . 72.209999999999994 110.372 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' ' 54' ' ' LYS . 60.8 tp -90.93 146.59 23.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.127 0.971 . . . . 75.120000000000005 109.408 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.514 HG23 HG21 ' A' ' 86' ' ' ILE . 47.4 t -122.19 125.82 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.851 0.86 . . . . 73.510000000000005 109.279 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.0 mt -103.79 100.26 10.06 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.855 -0.795 . . . . 74.519999999999996 108.855 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -104.52 147.95 27.03 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.934 0.894 . . . . 75.420000000000002 109.439 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HZ1' ' HB3' ' A' ' 46' ' ' LYS . 5.9 ttpm? -99.63 109.05 21.57 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.348 -0.982 . . . . 74.319999999999993 108.348 175.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.4 p -68.93 154.13 95.31 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.805 0.842 . . . . 74.420000000000002 111.045 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HG3' ' HB3' ' A' ' 79' ' ' ALA . 46.2 Cg_exo -59.98 -13.29 22.33 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.391 2.727 . . . . 74.349999999999994 113.506 172.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -81.37 -5.01 57.41 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.782 0.833 . . . . 73.540000000000006 111.606 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.08 -10.56 71.72 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-O 119.986 -0.341 . . . . 73.519999999999996 113.429 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -82.35 154.46 25.26 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.657 0.783 . . . . 75.200000000000003 110.373 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -102.29 103.64 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.383 -0.969 . . . . 74.239999999999995 108.383 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.7 mt -82.43 153.41 25.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.367 -0.833 . . . . 75.430000000000007 110.892 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HB3' HD13 ' A' ' 42' ' ' LEU . 59.0 mtpt -117.03 117.0 28.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.529 -1.214 . . . . 74.510000000000005 108.02 -176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -128.2 132.82 7.5 Favored Glycine 0 CA--C 1.503 -0.672 0 N-CA-C 111.549 -0.62 . . . . 73.019999999999996 111.549 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -101.66 128.18 48.07 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 117.439 0.62 . . . . 74.450000000000003 109.86 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 78.9 mt -66.8 106.94 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 124.211 0.944 . . . . 75.430000000000007 109.373 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -84.31 -30.3 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.032 0.933 . . . . 73.140000000000001 111.162 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -168.4 167.27 11.98 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.126 0.571 . . . . 75.120000000000005 110.209 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.626 HG11 HD11 ' A' ' 39' ' ' ILE . 23.9 m -91.37 169.96 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.322 1.049 . . . . 73.140000000000001 111.292 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -141.57 105.56 4.77 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.84 1.256 . . . . 70.239999999999995 108.558 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.22 173.52 49.74 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.729 -0.214 . . . . 64.340000000000003 112.64 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.653 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 63.2 p -93.0 6.93 46.16 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.707 0.803 . . . . 74.319999999999993 111.372 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -93.67 14.96 17.46 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.185 0.994 . . . . 75.430000000000007 111.874 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.18 -4.65 70.5 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-O 119.722 -0.488 . . . . 65.200000000000003 113.959 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.97 143.89 55.42 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.379 0.672 . . . . 70.129999999999995 110.332 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.449 HG12 HG12 ' A' ' 60' ' ' VAL . 14.0 m -126.49 169.91 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.678 1.191 . . . . 72.340000000000003 110.989 -175.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -128.13 107.64 9.97 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.221 1.008 . . . . 74.25 109.327 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.5 125.86 51.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.787 0.835 . . . . 72.310000000000002 110.141 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.529 ' HG2' HG23 ' A' ' 21' ' ' VAL . 88.3 mtt180 -89.0 104.51 17.05 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.246 -0.65 . . . . 70.299999999999997 109.246 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.77 135.42 34.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.013 0.925 . . . . 75.209999999999994 109.173 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -31.16 62.69 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.408 1.083 . . . . 64.230000000000004 112.075 -174.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -107.44 -63.11 1.34 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.082 0.953 . . . . 73.549999999999997 109.357 173.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 67.57 56.9 9.96 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.206 -0.907 . . . . 41.240000000000002 111.421 -171.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 97.0 mt -68.36 132.78 91.35 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.25 1.02 . . . . 75.420000000000002 111.257 -170.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 3.9 Cg_exo -76.48 176.35 10.19 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 123.216 2.611 . . . . 75.219999999999999 112.979 -170.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.02 177.69 15.03 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.766 -0.652 . . . . 72.430000000000007 111.595 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.8 76.46 7.98 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.894 0.854 . . . . 74.549999999999997 109.567 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.441 ' HB3' ' HG3' ' A' ' 48' ' ' PRO . . . -119.75 28.03 8.37 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.982 -1.008 . . . . 73.25 110.201 172.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.08 109.14 4.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.343 -0.614 . . . . 73.409999999999997 109.343 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.15 -5.86 21.72 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-O 119.649 -0.529 . . . . 74.340000000000003 112.331 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.05 143.42 56.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.504 0.722 . . . . 71.530000000000001 110.074 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -93.69 123.99 37.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.693 0.797 . . . . 74.299999999999997 110.87 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 m -100.69 144.04 13.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.472 -0.785 . . . . 72.439999999999998 109.065 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.95 108.04 19.01 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.426 -0.953 . . . . 74.420000000000002 108.426 170.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.514 HG21 HG23 ' A' ' 43' ' ' VAL . 38.8 mt -89.04 97.97 7.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 115.067 -0.969 . . . . 74.310000000000002 108.858 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.619 HG22 ' HG2' ' A' ' 2' ' ' ARG . 13.0 t -89.89 131.39 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.675 -0.693 . . . . 74.420000000000002 110.316 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 106.822 -1.547 . . . . 73.510000000000005 106.822 172.553 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.407 ' HG2' ' HB3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.074 -0.713 . . . . 74.430000000000007 109.074 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.507 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 56.6 mt -105.55 128.95 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.739 -1.208 . . . . 74.120000000000005 107.739 170.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -88.65 124.27 33.92 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.165 0.507 . . . . 74.439999999999998 110.009 -174.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -121.54 135.23 10.42 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.702 -0.681 . . . . 75.230000000000004 111.876 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.7 t -90.22 132.82 33.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 117.737 0.769 . . . . 74.549999999999997 109.988 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.85 103.06 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.721 0 O-C-N 124.504 1.127 . . . . 71.140000000000001 109.482 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' A' ' 25' ' ' LYS . 71.8 mt -78.32 -56.09 4.73 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.547 0.529 . . . . 75.420000000000002 109.776 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 m -152.85 170.21 20.9 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.453 0.644 . . . . 75.299999999999997 111.712 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -117.81 147.46 43.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.589 1.156 . . . . 74.25 108.152 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 65.7 ttt180 . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 110.103 -0.332 . . . . 74.420000000000002 110.103 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 110.221 -0.289 . . . . 73.219999999999999 110.221 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 50.3 t -102.5 152.33 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.31 1.044 . . . . 72.540000000000006 108.867 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.1 ttt -150.04 129.78 13.24 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.399 -0.593 . . . . 73.400000000000006 109.399 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 8' ' ' LEU . 49.6 mm -93.41 111.53 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.132 0.973 . . . . 74.109999999999999 109.363 -177.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.7 mt -125.71 149.3 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.087 0.955 . . . . 74.439999999999998 108.769 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HB2' HD11 ' A' ' 8' ' ' LEU . 36.5 ttpt -133.19 116.83 14.44 Favored Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 109.994 -0.373 . . . . 74.329999999999998 109.994 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.7 Cg_exo -68.3 125.96 13.64 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 122.535 2.157 . . . . 73.25 110.528 173.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.6 mt -70.64 -30.25 66.83 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.86 0.464 . . . . 75.109999999999999 111.555 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.47 -19.11 62.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.365 0.666 . . . . 74.230000000000004 111.067 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.559 HG11 ' HB2' ' A' ' 34' ' ' GLU . 49.1 t -108.96 147.62 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.709 1.204 . . . . 63.439999999999998 109.678 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.04 -0.69 0.88 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.368 0.667 . . . . 73.140000000000001 112.358 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 m -128.04 147.39 50.51 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.575 0.75 . . . . 72.140000000000001 110.509 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 68.8 ttt180 -64.35 -34.62 78.58 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.474 0.71 . . . . 72.109999999999999 112.139 -176.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.11 -39.23 78.15 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.455 0.702 . . . . 75.25 111.49 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.559 ' HB2' HG11 ' A' ' 29' ' ' VAL . 29.5 mt-10 -69.88 -45.24 68.11 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.001 -0.999 . . . . 74.299999999999997 109.977 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.81 -30.08 69.85 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.044 0.538 . . . . 64.230000000000004 111.227 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 t -75.23 -30.5 60.57 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.099 0.96 . . . . 75.549999999999997 111.626 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.531 ' HZ1' ' HB2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -84.81 -1.27 56.2 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 120.293 0.092 . . . . 73.010000000000005 111.157 173.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 34' ' ' GLU . 73.6 mt -91.76 -9.26 44.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.121 0.568 . . . . 73.209999999999994 111.632 174.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.495 HD12 HG11 ' A' ' 60' ' ' VAL . 42.8 mm -63.11 119.65 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 123.439 0.462 . . . . 73.549999999999997 110.306 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.35 -0.71 46.72 Favored Glycine 0 N--CA 1.466 0.673 0 CA-C-O 119.716 -0.491 . . . . 70.319999999999993 113.167 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -88.93 160.81 16.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.382 0.591 . . . . 75.5 111.053 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 55' ' ' GLY . 36.5 tp -90.28 144.37 25.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.998 -1.001 . . . . 64.299999999999997 109.794 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.9 t -124.96 115.75 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.922 0.889 . . . . 72.239999999999995 108.668 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.07 105.9 16.31 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.902 -0.777 . . . . 75.019999999999996 108.902 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.402 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 36.1 t90 -109.06 143.18 38.73 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.033 -0.729 . . . . 73.329999999999998 109.033 175.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -97.97 118.99 35.8 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.811 -0.811 . . . . 74.329999999999998 108.811 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.0 p -78.98 153.38 77.55 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.106 0.562 . . . . 74.219999999999999 109.83 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.84 -7.84 19.64 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.788 2.325 . . . . 73.420000000000002 112.434 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -71.25 -17.51 62.48 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 124.568 1.147 . . . . 70.010000000000005 110.983 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.58 16.23 46.81 Favored Glycine 0 C--N 1.356 1.666 0 C-N-CA 123.042 0.353 . . . . 52.409999999999997 113.131 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -109.85 149.32 30.03 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.709 0.804 . . . . 74.530000000000001 109.892 -176.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -93.75 98.51 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.617 -1.253 . . . . 71.549999999999997 107.617 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.402 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 54.6 mt -78.2 125.96 30.11 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.269 -0.641 . . . . 72.239999999999995 109.269 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -96.46 127.52 42.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.388 -0.823 . . . . 73.420000000000002 109.335 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -127.08 177.57 17.31 Favored Glycine 0 CA--C 1.504 -0.649 0 CA-C-N 114.862 -1.063 . . . . 50.420000000000002 110.738 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -149.38 135.28 18.82 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.7 -0.482 . . . . 74.120000000000005 109.7 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.484 HG23 HD13 ' A' ' 39' ' ' ILE . 78.5 mt -67.96 95.71 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 O-C-N 124.531 1.144 . . . . 74.25 108.826 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.41 -24.8 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.291 -0.868 . . . . 71.540000000000006 110.688 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -150.99 164.13 37.13 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.846 -0.616 . . . . 72.430000000000007 109.454 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.495 HG11 HD12 ' A' ' 39' ' ' ILE . 32.9 m -92.09 168.39 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.778 -0.823 . . . . 64.109999999999999 108.778 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -142.05 103.65 4.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.834 -0.802 . . . . 75.420000000000002 108.834 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.91 -171.4 45.31 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 115.477 -0.783 . . . . 72.409999999999997 113.551 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 51.7 p -94.67 0.12 54.81 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.944 0.897 . . . . 72.239999999999995 111.43 176.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -81.12 2.04 29.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.457 1.103 . . . . 74.010000000000005 111.784 -173.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' HA3' HG12 ' A' ' 29' ' ' VAL . . . 78.44 6.74 88.06 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.261 0.351 . . . . 65.109999999999999 113.074 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.95 147.89 48.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.032 0.533 . . . . 74.099999999999994 110.138 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' HB ' HG22 ' A' ' 57' ' ' ILE . 30.5 m -121.69 140.53 45.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.678 0.791 . . . . 75.519999999999996 110.77 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -98.75 104.48 16.53 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.085 -1.08 . . . . 74.310000000000002 108.085 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.7 126.32 52.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.505 0.722 . . . . 70.239999999999995 110.147 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -101.56 126.14 48.32 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.854 0.462 . . . . 74.219999999999999 110.105 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.533 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 11.0 m-85 -93.37 126.34 38.45 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.025 0.93 . . . . 72.140000000000001 110.398 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.477 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 12.1 pt-20 -61.23 -28.83 69.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.273 1.029 . . . . 74.200000000000003 111.827 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.477 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 14.4 mmmm -101.07 -68.23 0.82 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.76 -0.83 . . . . 74.409999999999997 108.76 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.04 56.43 18.41 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.832 -0.622 . . . . 64.409999999999997 112.805 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.9 mt -68.7 156.55 90.72 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.7 0.8 . . . . 75.209999999999994 110.913 173.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.28 139.23 81.99 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.921 2.414 . . . . 71.109999999999999 112.695 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.72 140.62 2.96 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.633 -0.712 . . . . 74.519999999999996 112.207 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -121.11 97.09 5.36 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.919 0.888 . . . . 74.409999999999997 109.375 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.16 30.14 7.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.767 1.227 . . . . 71.430000000000007 110.899 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.4 mt -45.27 113.65 0.61 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.695 0.798 . . . . 75.209999999999994 112.242 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.41 -15.55 20.08 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-N 116.419 -0.355 . . . . 72.439999999999998 113.288 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.88 158.97 31.44 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.163 0.985 . . . . 65.109999999999999 111.908 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -100.83 127.3 47.34 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.806 0.842 . . . . 75.25 110.862 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 m -100.42 158.6 3.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 108.739 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.407 ' HB3' ' HG2' ' A' ' 2' ' ' ARG . 35.3 mt-10 -103.96 108.13 19.33 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.99 0.516 . . . . 73.340000000000003 109.869 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.507 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 74.7 mt -86.68 94.11 4.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.612 -1.255 . . . . 71.420000000000002 107.612 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 t -89.63 137.31 21.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 114.633 -1.167 . . . . 73.329999999999998 109.164 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 107.201 -1.407 . . . . 72.420000000000002 107.201 169.62 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 108.405 -0.961 . . . . 74.349999999999994 108.405 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 61.3 mt -95.65 136.4 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.483 -0.932 . . . . 74.319999999999993 108.483 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.644 ' HB3' ' HZ1' ' A' ' 4' ' ' LYS . 6.1 ttpm? -88.36 126.82 35.39 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.214 0.605 . . . . 74.329999999999998 109.749 -171.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -129.95 175.49 19.11 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 123.624 0.578 . . . . 64.200000000000003 112.115 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.4 t -140.13 132.03 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.528 1.131 . . . . 65.430000000000007 109.627 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.83 107.4 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.131 0.973 . . . . 72.129999999999995 110.308 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.55 HD11 HG23 ' A' ' 23' ' ' ILE . 86.6 mt -79.99 -55.27 5.08 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.36 0.664 . . . . 74.219999999999999 110.004 176.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 p -158.71 173.25 16.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.616 -0.72 . . . . 63.450000000000003 111.254 -173.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.485 ' HE1' ' HE1' ' A' ' 22' ' ' MET . 17.2 m-85 -122.89 159.72 27.61 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.632 0.773 . . . . 72.209999999999994 109.058 172.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 . . . . . 0 C--O 1.242 0.686 0 N-CA-C 107.462 -1.31 . . . . 64.299999999999997 107.462 161.692 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.588 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 36.1 t30 . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.47 0.176 . . . . 74.230000000000004 111.237 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.535 HG11 ' HG3' ' A' ' 68' ' ' ARG . 90.3 t -88.28 134.02 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 122.974 0.51 . . . . 72.230000000000004 109.658 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.485 ' HE1' ' HE1' ' A' ' 10' ' ' TYR . 43.1 ttm -130.85 112.88 13.41 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.23 -1.396 . . . . 75.510000000000005 107.23 170.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.55 HG23 HD11 ' A' ' 8' ' ' LEU . 50.8 mm -78.52 111.71 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.079 -1.082 . . . . 73.219999999999999 108.079 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 84' ' ' VAL . 84.6 mt -109.98 137.48 42.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 C-N-CA 124.221 1.008 . . . . 74.450000000000003 109.427 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HB2' HD12 ' A' ' 8' ' ' LEU . 81.9 tttt -96.96 104.0 17.09 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.624 -0.88 . . . . 75.129999999999995 108.624 166.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.504 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 3.3 Cg_exo -68.68 112.27 2.82 Favored 'Trans proline' 0 C--N 1.369 1.622 0 N-CA-C 107.802 -1.653 . . . . 72.209999999999994 107.802 168.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.66 -27.27 69.11 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.588 0.755 . . . . 73.299999999999997 112.576 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.43 -28.31 64.95 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.606 0.762 . . . . 71.209999999999994 111.238 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 34' ' ' GLU . 88.7 t -98.5 145.61 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.98 1.312 . . . . 74.340000000000003 109.785 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -158.12 33.0 0.25 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.272 0.558 . . . . 65.219999999999999 109.734 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.5 m -150.19 141.22 22.97 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.403 0.681 . . . . 73.010000000000005 110.116 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.609 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 59.2 ttt180 -62.71 -32.65 73.79 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.353 0.661 . . . . 74.540000000000006 110.971 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -52.15 -51.81 55.62 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.93 0.769 . . . . 72.319999999999993 110.271 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.441 ' HB2' HG13 ' A' ' 29' ' ' VAL . 44.0 mt-10 -60.24 -52.49 65.06 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 114.577 -1.192 . . . . 74.209999999999994 110.361 177.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.12 70.56 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.666 0.787 . . . . 62.140000000000001 112.193 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.5 t -76.91 -28.62 55.37 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.9 0.88 . . . . 65.450000000000003 111.321 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -94.3 2.52 55.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.733 0.413 . . . . 75.239999999999995 110.922 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.558 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 46.6 mt -113.11 24.2 12.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.473 1.109 . . . . 75.150000000000006 110.678 175.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.76 132.13 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.938 -0.764 . . . . 72.120000000000005 108.938 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.02 -14.74 19.09 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.866 -0.408 . . . . 75.230000000000004 113.333 171.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 15.1 ptt180 -75.62 155.77 35.55 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.143 0.471 . . . . 73.530000000000001 110.449 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.8 tp -89.78 154.34 19.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.144 0.977 . . . . 70.019999999999996 109.959 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 86' ' ' ILE . 36.4 t -132.73 144.39 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.331 1.052 . . . . 70.230000000000004 108.418 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -127.53 117.99 23.12 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.7 -0.852 . . . . 75.409999999999997 108.7 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -130.3 132.36 45.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.64 0.776 . . . . 73.040000000000006 109.385 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -83.8 118.88 24.22 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.972 -0.751 . . . . 61.149999999999999 108.972 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.7 p -66.8 163.13 45.84 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.808 0.843 . . . . 73.340000000000003 111.437 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.36 -13.3 37.5 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.282 1.988 . . . . 74.540000000000006 112.123 167.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -85.2 -8.8 58.41 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.251 1.02 . . . . 64.439999999999998 110.878 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.56 -21.12 47.55 Favored Glycine 0 C--N 1.352 1.434 0 C-N-CA 123.013 0.339 . . . . 62.299999999999997 113.593 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -76.59 132.36 39.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.516 0.727 . . . . 71.319999999999993 111.049 -176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -78.33 102.15 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.936 -0.764 . . . . 75.129999999999995 108.936 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.51 135.43 39.32 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.038 -0.983 . . . . 75.299999999999997 109.862 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -96.31 133.52 40.56 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.971 -0.751 . . . . 73.209999999999994 108.971 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -131.25 169.84 21.61 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 110.821 -0.912 . . . . 72.5 110.821 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -145.15 134.86 23.46 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.171 -0.677 . . . . 73.400000000000006 109.171 177.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.471 HG22 ' HB ' ' A' ' 67' ' ' VAL . 93.7 mt -72.27 102.45 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 114.908 -1.042 . . . . 74.439999999999998 109.308 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.72 -19.33 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 115.056 -0.975 . . . . 74.140000000000001 111.521 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -153.89 168.43 26.38 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 122.562 0.345 . . . . 74.530000000000001 110.165 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.52 169.79 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 123.532 0.733 . . . . 72.450000000000003 110.359 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -141.32 104.09 4.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.683 0.793 . . . . 73.340000000000003 109.203 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.3 -172.39 34.59 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 115.934 -0.575 . . . . 71.049999999999997 113.519 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.609 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 17.5 p -91.4 2.93 56.05 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.197 0.999 . . . . 73.329999999999998 111.728 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -84.75 -3.34 58.54 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.43 1.092 . . . . 75.219999999999999 112.132 -171.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.14 -1.71 88.59 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.966 -0.352 . . . . 74.140000000000001 113.264 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.63 135.44 55.93 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 109.28 -0.637 . . . . 72.430000000000007 109.28 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 57' ' ' ILE . 29.2 m -111.63 157.14 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.996 0.918 . . . . 75.219999999999999 110.889 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.535 ' HG3' HG11 ' A' ' 21' ' ' VAL . 41.3 ttm180 -106.52 109.27 21.14 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.002 0.921 . . . . 75.439999999999998 109.226 174.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.05 121.85 45.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.421 0.688 . . . . 73.030000000000001 110.267 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -88.07 111.24 21.33 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.276 -0.639 . . . . 71.430000000000007 109.276 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.414 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 39.2 m-85 -87.26 147.14 25.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.606 0.762 . . . . 75.150000000000006 110.758 175.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -49.66 -47.47 50.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.157 1.383 . . . . 75.400000000000006 111.822 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -108.7 -57.73 2.1 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.211 1.004 . . . . 75.219999999999999 108.411 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.588 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 63.42 57.16 15.97 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 114.598 -1.183 . . . . 61.340000000000003 111.661 -175.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.485 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 39.0 mt -67.56 115.49 27.5 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 109.653 -0.499 . . . . 74.200000000000003 109.653 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 12.4 Cg_exo -68.44 164.59 32.13 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 123.337 2.691 . . . . 75.510000000000005 111.949 -173.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 170.72 168.6 32.7 Favored Glycine 0 C--N 1.329 0.176 0 N-CA-C 111.139 -0.784 . . . . 75.209999999999994 111.139 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -85.6 28.71 0.74 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.299 0.639 . . . . 73.420000000000002 111.798 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.78 23.73 1.14 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.587 1.155 . . . . 72.430000000000007 111.404 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.61 113.76 3.53 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.682 0.793 . . . . 74.519999999999996 109.578 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.66 -5.67 14.32 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.948 -0.569 . . . . 61.240000000000002 112.487 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -80.44 152.73 28.64 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.508 0.723 . . . . 70.019999999999996 111.201 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -85.82 145.26 27.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.848 0.459 . . . . 74.450000000000003 111.765 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.48 HG23 HD13 ' A' ' 24' ' ' ILE . 18.2 m -116.73 157.7 17.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 C-N-CA 124.144 0.978 . . . . 71.239999999999995 108.97 171.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -113.69 109.94 19.39 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.323 -0.621 . . . . 65.319999999999993 109.323 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 69.3 mt -89.13 98.04 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.57 0.748 . . . . 73.439999999999998 109.443 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.9 t -79.69 136.41 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.496 -0.775 . . . . 72.239999999999995 109.703 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? . . . . . 0 CA--C 1.551 0.994 0 N-CA-C 108.438 -0.949 . . . . 75.400000000000006 108.438 175.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 39.1 ptt180 . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 121.021 0.439 . . . . 74.319999999999993 110.998 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 56.8 mt -101.07 145.28 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 108.016 -1.105 . . . . 65.340000000000003 108.016 174.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 27' ' ' LEU . 20.5 ptmt -90.29 124.73 35.14 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.413 -0.588 . . . . 74.200000000000003 109.413 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -123.59 150.98 16.95 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 111.273 -0.731 . . . . 74.150000000000006 111.273 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.7 t -99.05 135.5 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.015 0.908 . . . . 73.299999999999997 110.802 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.82 104.07 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.876 1.27 . . . . 75.099999999999994 109.057 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.556 HD21 ' HG2' ' A' ' 25' ' ' LYS . 59.4 mt -82.28 -60.74 2.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.671 -0.492 . . . . 75.450000000000003 109.671 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -153.45 169.77 22.35 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.357 0.663 . . . . 73.349999999999994 111.701 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -122.82 143.09 50.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.508 1.123 . . . . 73.400000000000006 108.611 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.419 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 41.6 ttm180 . . . . . 0 CA--C 1.532 0.281 0 C-N-CA 123.958 0.903 . . . . 73.109999999999999 108.893 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.542 -0.911 . . . . 72.439999999999998 108.542 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 21.9 t -87.36 146.81 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.522 0.729 . . . . 63.310000000000002 109.208 -172.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -138.54 112.79 8.68 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.159 -1.423 . . . . 71.319999999999993 107.159 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.515 HG23 HD13 ' A' ' 8' ' ' LEU . 24.7 mm -75.06 112.43 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.272 -1.01 . . . . 72.510000000000005 108.272 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -122.62 162.63 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.703 1.201 . . . . 74.140000000000001 107.832 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.556 ' HG2' HD21 ' A' ' 8' ' ' LEU . 20.3 ptmt -145.94 131.05 9.09 Favored Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 109.511 -0.552 . . . . 71.230000000000004 109.511 163.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.51 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 9.8 Cg_exo -69.94 127.94 15.15 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 121.967 1.778 . . . . 74.409999999999997 110.562 171.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.44 HD11 ' HE2' ' A' ' 4' ' ' LYS . 64.6 mt -60.68 -37.0 80.15 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.327 0.651 . . . . 74.120000000000005 112.107 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -74.4 -29.26 61.45 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.971 -0.558 . . . . 75.239999999999995 110.8 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 45.8 t -87.39 97.78 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.914 0.864 . . . . 63.200000000000003 109.98 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -101.04 -6.63 24.15 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.815 1.246 . . . . 73.040000000000006 110.169 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 m -117.44 147.13 42.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.923 0.889 . . . . 74.549999999999997 110.352 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.573 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 75.6 ttt-85 -65.16 -34.75 79.12 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.035 0.534 . . . . 64.150000000000006 111.576 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -59.67 -43.62 93.91 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.538 0.685 . . . . 72.420000000000002 109.759 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HB2' HG11 ' A' ' 29' ' ' VAL . 21.2 mm-40 -68.86 -31.67 70.78 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.724 -1.125 . . . . 73.439999999999998 111.062 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.56 -35.0 58.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.53 0.732 . . . . 72.140000000000001 111.766 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -79.91 -25.63 40.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.395 1.078 . . . . 73.219999999999999 111.152 -168.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 63.3 pttt -77.61 -13.63 59.86 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.419 -0.355 . . . . 75.430000000000007 110.848 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.537 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 96.1 mt -89.05 8.34 30.28 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.777 0.831 . . . . 62.549999999999997 111.834 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.459 HD13 HG11 ' A' ' 60' ' ' VAL . 33.1 mm -65.87 103.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.272 -1.01 . . . . 72.430000000000007 108.272 172.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.61 0.8 17.96 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.52 -0.6 . . . . 60.140000000000001 113.446 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.786 ' HD3' HG22 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -74.37 156.24 37.28 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.747 0.773 . . . . 75.109999999999999 110.585 177.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 tp -94.43 143.88 26.04 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.172 0.589 . . . . 74.150000000000006 109.894 176.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.93 125.79 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.992 -1.114 . . . . 75.329999999999998 107.992 172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -115.01 109.5 18.19 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.735 -1.209 . . . . 73.209999999999994 107.735 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.3 t90 -131.74 117.51 18.69 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.251 -0.648 . . . . 75.239999999999995 109.251 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -86.46 105.86 17.07 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.653 0.781 . . . . 75.239999999999995 109.048 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.6 p -64.22 153.73 84.86 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 124.318 1.047 . . . . 61.43 112.459 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.33 -8.07 17.7 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.075 2.517 . . . . 73.219999999999999 112.622 168.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -61.63 -27.52 68.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.881 0.872 . . . . 73.349999999999994 110.693 167.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.42 24.85 13.18 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 115.253 -0.885 . . . . 54.149999999999999 111.901 -175.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -124.08 139.49 53.89 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.791 0.836 . . . . 74.019999999999996 110.554 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -85.18 95.1 4.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.235 -1.024 . . . . 75.129999999999995 108.235 173.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.443 HD23 ' HB2' ' A' ' 73' ' ' LYS . 28.6 mt -75.4 111.37 10.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.937 -0.764 . . . . 75.400000000000006 108.937 177.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -97.26 135.1 39.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.464 0.706 . . . . 71.010000000000005 109.662 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.46 170.98 24.51 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.581 0.551 . . . . 54.310000000000002 113.069 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -152.85 141.99 21.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.819 0.848 . . . . 75.25 109.66 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 29.9 mt -70.38 122.43 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 123.418 0.449 . . . . 75.400000000000006 110.284 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.3 m -87.25 -34.1 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.416 0.686 . . . . 70.349999999999994 110.08 172.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -167.36 150.52 6.26 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.337 0.655 . . . . 74.430000000000007 109.878 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.459 HG11 HD13 ' A' ' 39' ' ' ILE . 16.6 m -90.44 169.69 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.175 0.59 . . . . 73.329999999999998 109.639 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -135.59 101.88 4.93 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.833 -0.803 . . . . 73.409999999999997 108.833 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.79 -171.7 25.87 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 115.386 0.914 . . . . 43.409999999999997 115.386 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.573 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 40.3 p -93.81 12.1 26.95 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.646 1.179 . . . . 71.109999999999999 111.8 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -74.15 -17.76 60.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.816 0.846 . . . . 73.120000000000005 110.642 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.14 -4.95 78.24 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.515 -0.634 . . . . 74.349999999999994 111.515 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.89 141.69 51.18 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.605 0.762 . . . . 75.230000000000004 110.945 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.478 HG21 ' NH2' ' A' ' 41' ' ' ARG . 27.4 m -135.7 152.47 31.24 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 C-N-CA 124.539 1.135 . . . . 72.200000000000003 109.691 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -107.27 102.7 11.99 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.006 -1.109 . . . . 73.409999999999997 108.006 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -107.24 116.03 31.21 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.237 -0.892 . . . . 73.25 108.948 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -89.1 131.81 35.08 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.566 -0.531 . . . . 75.230000000000004 109.566 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -101.62 135.49 43.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.402 1.081 . . . . 74.230000000000004 109.432 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -54.62 -44.39 73.1 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.482 1.114 . . . . 74.540000000000006 111.15 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.443 ' HB2' HD23 ' A' ' 53' ' ' LEU . 73.3 mmtt -77.86 -42.49 33.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.507 -0.77 . . . . 74.530000000000001 109.293 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.55 33.7 72.93 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 124.137 0.898 . . . . 64.5 114.101 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.427 HD11 HD21 ' A' ' 53' ' ' LEU . 43.6 mt -69.71 121.57 82.98 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.067 0.547 . . . . 74.329999999999998 110.782 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.39 123.38 8.15 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.601 2.201 . . . . 74.319999999999993 110.969 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -135.17 142.78 14.25 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.916 -0.474 . . . . 74.329999999999998 111.916 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -88.38 70.28 9.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.159 -1.052 . . . . 74.439999999999998 108.159 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.39 28.58 7.93 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.139 -1.391 . . . . 74.409999999999997 110.315 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.29 104.05 1.4 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.841 -0.618 . . . . 74.209999999999994 110.209 -174.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.81 -1.76 8.57 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.019 -0.537 . . . . 62.310000000000002 113.015 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.81 174.16 10.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.38 0.672 . . . . 75.109999999999999 111.318 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 85.8 m-85 -115.62 129.86 56.65 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.209 0.603 . . . . 74.450000000000003 111.344 -173.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.6 m -99.71 156.52 3.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 124.383 1.073 . . . . 72.109999999999999 109.583 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -103.9 109.86 21.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.282 0.633 . . . . 73.329999999999998 109.513 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.786 HG22 ' HD3' ' A' ' 41' ' ' ARG . 82.1 mt -91.51 93.06 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.239 1.015 . . . . 75.400000000000006 108.91 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.99 105.98 12.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 115.257 -0.883 . . . . 74.239999999999995 109.896 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 106.403 -1.703 . . . . 73.540000000000006 106.403 166.918 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.648 -0.501 . . . . 73.420000000000002 109.648 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 mt -106.11 118.68 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.017 -1.105 . . . . 74.230000000000004 108.017 170.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HG3' HD11 ' A' ' 27' ' ' LEU . 17.4 ptpt -88.01 149.27 24.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.401 -0.592 . . . . 73.209999999999994 109.401 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -147.01 177.65 25.16 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 123.522 0.514 . . . . 63.32 112.082 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.6 t -113.03 132.66 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.893 0.877 . . . . 64.140000000000001 110.167 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.8 t -66.83 118.2 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.576 0.75 . . . . 74.329999999999998 109.636 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 25' ' ' LYS . 88.8 mt -90.64 -51.64 5.29 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.973 0.509 . . . . 75.420000000000002 109.918 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.427 ' HG ' ' HB ' ' A' ' 23' ' ' ILE . 69.1 p -164.77 163.02 21.41 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.098 -0.501 . . . . 64.450000000000003 111.551 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -111.32 157.29 20.35 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.782 0.833 . . . . 75.5 108.953 171.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 . . . . . 0 C--O 1.245 0.829 0 N-CA-C 108.893 -0.78 . . . . 72.439999999999998 108.893 173.266 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 121.634 0.731 . . . . 73.230000000000004 110.524 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.42 140.71 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.967 -1.015 . . . . 72.540000000000006 108.867 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.5 ttt -132.29 116.52 17.0 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.027 -1.101 . . . . 74.349999999999994 108.027 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.486 HG22 HD13 ' A' ' 8' ' ' LEU . 31.2 mm -83.98 120.41 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.563 0.745 . . . . 73.239999999999995 109.028 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.418 HD12 HG23 ' A' ' 84' ' ' VAL . 87.2 mt -126.12 152.67 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.654 1.182 . . . . 74.239999999999995 108.262 -176.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HZ2' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -125.81 102.69 28.32 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.104 -1.073 . . . . 73.310000000000002 108.104 170.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.556 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 24.3 Cg_exo -61.05 143.0 99.0 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.756 2.304 . . . . 71.319999999999993 112.064 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.437 HD11 ' HG3' ' A' ' 4' ' ' LYS . 88.9 mt -67.99 -43.11 79.66 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.394 0.677 . . . . 74.030000000000001 111.541 -177.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.56 -25.99 66.07 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.812 0.845 . . . . 63.109999999999999 111.597 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 55.6 t -105.29 116.3 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.273 1.029 . . . . 73.219999999999999 110.981 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -128.64 13.64 6.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.389 0.676 . . . . 74.329999999999998 110.68 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.1 t -145.6 164.45 31.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.557 0.743 . . . . 64.329999999999998 110.525 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.606 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 74.5 ttt180 -59.26 -51.04 71.66 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.404 1.082 . . . . 73.430000000000007 112.141 -170.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -75.08 -29.08 60.57 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.406 -0.815 . . . . 74.129999999999995 110.82 -169.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' HB2' HG11 ' A' ' 29' ' ' VAL . 42.4 mt-10 -64.86 -30.81 71.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.538 -0.756 . . . . 75.25 109.917 173.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.74 -32.74 23.31 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.011 0.924 . . . . 73.109999999999999 111.169 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.0 m -78.04 -16.45 58.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.35 0.66 . . . . 61.340000000000003 111.898 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.585 ' HB3' ' HZ3' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -82.31 -16.11 50.53 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.807 0.337 . . . . 75.010000000000005 110.495 171.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.13 5.93 42.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.126 0.57 . . . . 74.439999999999998 112.033 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.542 HD11 HG11 ' A' ' 60' ' ' VAL . 46.5 mm -68.54 104.68 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.741 -0.837 . . . . 75.019999999999996 108.741 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.79 -4.79 11.63 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.787 -0.642 . . . . 53.520000000000003 113.143 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HD2' HD12 ' A' ' 88' ' ' LEU . 24.1 mmt180 -84.58 149.77 25.66 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.82 0.81 . . . . 72.329999999999998 110.604 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 55' ' ' GLY . 48.0 tp -89.78 138.12 31.75 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 124.177 0.991 . . . . 75.129999999999995 108.754 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.69 138.01 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.852 -0.795 . . . . 74.450000000000003 108.852 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.4 132.95 52.67 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.269 -1.012 . . . . 73.140000000000001 108.269 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -138.93 128.69 24.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.075 0.55 . . . . 74.530000000000001 109.571 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 17.6 tppt? -78.98 120.89 24.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.718 0.807 . . . . 74.129999999999995 109.354 174.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 7.6 m -83.83 138.16 40.59 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 115.259 -0.882 . . . . 74.120000000000005 109.23 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.07 -17.77 39.97 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.225 2.617 . . . . 62.32 113.619 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -82.81 13.05 4.12 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.586 0.755 . . . . 74.329999999999998 111.89 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.95 41.27 49.31 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 112.539 -0.224 . . . . 72.0 112.539 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 75.3 mmtt -124.12 169.61 11.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.947 0.899 . . . . 75.349999999999994 109.403 -178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -131.85 107.83 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.216 -1.031 . . . . 74.200000000000003 108.216 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' A' ' 73' ' ' LYS . 22.6 mt -83.45 124.89 31.14 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.88 -0.6 . . . . 73.5 109.399 176.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -105.1 130.44 53.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.429 -0.952 . . . . 73.200000000000003 108.429 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.417 ' O ' HD11 ' A' ' 42' ' ' LEU . . . -145.28 -179.6 21.69 Favored Glycine 0 N--CA 1.464 0.562 0 O-C-N 123.31 0.381 . . . . 74.340000000000003 112.304 -175.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -152.56 133.32 13.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.875 0.337 . . . . 75.049999999999997 110.819 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.536 HD12 HD11 ' A' ' 86' ' ' ILE . 68.3 mt -67.87 103.92 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 124.08 0.862 . . . . 75.140000000000001 109.524 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.2 m -89.58 -35.24 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.287 0.635 . . . . 75.099999999999994 111.517 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -164.41 149.82 10.29 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.37 -0.604 . . . . 71.120000000000005 109.37 -175.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 39' ' ' ILE . 13.9 m -94.78 171.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.473 0.709 . . . . 65.25 110.853 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -128.46 113.96 16.19 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.887 0.875 . . . . 73.230000000000004 109.651 174.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.76 -154.97 50.64 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 123.902 0.751 . . . . 72.310000000000002 113.549 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.606 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 22.7 p -105.04 7.56 34.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.56 1.144 . . . . 74.129999999999995 111.826 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -85.75 2.42 45.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.407 0.683 . . . . 75.430000000000007 112.832 -171.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.35 71.52 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.142 -0.255 . . . . 74.209999999999994 113.423 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.4 117.86 17.66 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.427 0.691 . . . . 74.219999999999999 110.077 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.5 ' HB ' HG21 ' A' ' 57' ' ' ILE . 34.6 m -102.18 150.84 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.755 0.822 . . . . 64.409999999999997 110.719 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -103.12 104.52 14.68 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.641 -1.244 . . . . 73.150000000000006 107.641 171.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.13 118.04 35.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.11 -1.07 . . . . 73.230000000000004 108.11 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.8 mtm105 -89.98 118.21 29.37 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.566 -0.531 . . . . 74.310000000000002 109.566 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -98.19 132.06 44.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.9 0.88 . . . . 73.420000000000002 109.809 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -52.88 -41.94 64.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.947 1.299 . . . . 64.129999999999995 112.264 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.525 ' HB2' HD21 ' A' ' 53' ' ' LEU . 43.6 mmtm -90.06 -47.8 7.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.128 0.971 . . . . 74.239999999999995 109.281 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.12 38.39 94.3 Favored Glycine 0 C--N 1.356 1.686 0 O-C-N 123.887 0.742 . . . . 71.310000000000002 114.331 175.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.06 131.37 92.27 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 122.934 0.493 . . . . 73.129999999999995 110.68 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.7 176.24 10.25 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.801 2.334 . . . . 73.120000000000005 111.919 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.18 157.81 19.0 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.174 -0.466 . . . . 71.430000000000007 112.31 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -94.19 26.37 3.33 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.607 0.718 . . . . 75.219999999999999 110.555 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.48 28.63 1.08 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.432 1.093 . . . . 72.150000000000006 111.033 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -61.76 109.36 1.2 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.746 0.818 . . . . 73.299999999999997 110.036 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.94 -14.79 7.05 Favored Glycine 0 C--N 1.347 1.144 0 O-C-N 123.31 0.381 . . . . 61.219999999999999 113.011 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.12 160.39 31.28 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.661 0.784 . . . . 74.310000000000002 111.287 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 13.0 m-85 -87.32 131.67 34.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.614 0.766 . . . . 74.340000000000003 111.69 -177.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.418 HG23 HD12 ' A' ' 24' ' ' ILE . 16.6 m -104.5 151.14 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.452 -0.944 . . . . 74.030000000000001 108.452 167.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -108.97 108.72 19.57 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.085 -0.709 . . . . 55.420000000000002 109.085 171.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.536 HD11 HD12 ' A' ' 57' ' ' ILE . 59.6 mt -85.88 91.39 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.721 -1.214 . . . . 74.409999999999997 107.721 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.2 t -75.62 147.47 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.69 -1.141 . . . . 65.219999999999999 109.83 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD12 ' HD2' ' A' ' 41' ' ' ARG . 4.5 mm? . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 123.552 0.741 . . . . 62.219999999999999 110.735 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.442 ' HD2' HG23 ' A' ' 87' ' ' VAL . 34.2 mtm-85 . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 107.894 -1.15 . . . . 74.450000000000003 107.894 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.679 HD13 HD23 ' A' ' 38' ' ' LEU . 25.9 mt -101.1 134.96 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 109.713 -0.477 . . . . 71.439999999999998 109.713 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -89.69 121.52 31.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.577 0.751 . . . . 73.010000000000005 109.417 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -114.57 167.86 12.42 Favored Glycine 0 N--CA 1.48 1.611 0 CA-C-O 119.698 -0.501 . . . . 64.5 113.055 -175.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.2 t -124.13 122.9 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.973 0.909 . . . . 75.340000000000003 109.571 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.2 t -69.76 97.85 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.26 0.624 . . . . 74.530000000000001 109.777 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 25' ' ' LYS . 67.6 mt -75.83 -47.84 23.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.212 0.605 . . . . 73.5 110.853 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.7 m -151.43 152.45 33.07 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.7 0.8 . . . . 73.129999999999995 110.927 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.32 142.11 35.66 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.664 0.786 . . . . 74.450000000000003 109.44 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 105.286 -2.116 . . . . 74.140000000000001 105.286 159.52 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.461 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 4.5 t30 . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 106.91 -1.515 . . . . 62.140000000000001 106.91 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' A' ' 70' ' ' ARG . 14.6 t -88.08 148.89 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.067 -1.457 . . . . 75.5 107.067 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.6 ptp -153.34 144.96 23.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.669 0.271 . . . . 74.540000000000006 110.678 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.07 119.81 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.179 -1.045 . . . . 72.010000000000005 108.179 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.484 HD13 HG22 ' A' ' 84' ' ' VAL . 89.2 mt -121.25 123.03 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.951 0.9 . . . . 64.209999999999994 109.644 -175.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HB2' HD12 ' A' ' 8' ' ' LEU . 87.9 tttt -99.64 109.26 54.78 Favored Pre-proline 0 N--CA 1.482 1.173 0 CA-C-N 119.172 0.896 . . . . 75.439999999999998 109.859 172.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 20.4 Cg_exo -67.46 138.12 45.09 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.799 2.333 . . . . 72.420000000000002 112.39 171.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.33 -39.04 89.08 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.657 1.183 . . . . 74.409999999999997 111.82 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -77.72 -28.22 50.78 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.642 0.777 . . . . 70.510000000000005 112.097 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 54.7 t -92.02 113.52 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.789 0.836 . . . . 63.229999999999997 110.67 -170.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' ' 30' ' ' ASN . 0.8 OUTLIER -101.17 -30.21 11.68 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.917 0.887 . . . . 73.150000000000006 111.066 -174.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.8 p -119.99 166.72 12.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.948 0.499 . . . . 71.430000000000007 111.331 -172.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 67.7 ttt180 -61.97 -37.55 85.2 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.845 0.858 . . . . 74.239999999999995 111.022 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.87 -45.3 93.2 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.014 0.526 . . . . 71.439999999999998 111.137 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 41.5 mt-10 -66.87 -22.09 65.99 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.384 -0.825 . . . . 74.019999999999996 111.215 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.62 -28.25 28.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.617 0.767 . . . . 73.230000000000004 110.877 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -79.29 -24.2 43.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.217 0.607 . . . . 72.450000000000003 111.517 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.466 ' HB3' ' HZ3' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -61.63 -20.47 63.41 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.165 0.439 . . . . 64.329999999999998 110.622 169.447 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.679 HD23 HD13 ' A' ' 3' ' ' ILE . 88.9 mt -88.36 -1.15 57.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.761 0.824 . . . . 72.549999999999997 112.913 -175.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.6 HD12 HG13 ' A' ' 60' ' ' VAL . 38.6 mm -72.3 103.91 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.475 0.579 . . . . 73.439999999999998 109.553 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.7 -4.54 17.01 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.696 -0.684 . . . . 74.310000000000002 113.025 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HA ' HD21 ' A' ' 88' ' ' LEU . 27.6 mmt180 -75.52 153.54 37.4 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.774 0.787 . . . . 74.540000000000006 109.759 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.429 HD11 ' O ' ' A' ' 55' ' ' GLY . 56.2 tp -89.33 146.01 24.98 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.047 -1.094 . . . . 74.140000000000001 108.047 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.2 t -126.24 115.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.951 -0.759 . . . . 74.030000000000001 108.951 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.3 mt -100.36 106.19 17.78 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.917 0.887 . . . . 72.420000000000002 108.718 176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 53.9 t90 -123.72 130.64 52.95 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.903 0.881 . . . . 72.340000000000003 108.866 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 34.8 ttpt -88.0 113.88 24.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.369 0.667 . . . . 74.329999999999998 109.271 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.0 p -65.96 152.4 93.58 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.55 0.74 . . . . 73.099999999999994 111.501 176.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.8 -7.98 22.44 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.516 2.144 . . . . 74.099999999999994 112.039 170.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 t -71.17 -29.69 65.51 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.59 0.756 . . . . 74.129999999999995 110.302 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.59 -34.46 2.67 Favored Glycine 0 C--N 1.354 1.581 0 C-N-CA 122.951 0.31 . . . . 63.450000000000003 113.311 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -73.13 157.17 37.76 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.509 0.724 . . . . 73.400000000000006 111.483 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 70.5 mt -95.82 104.12 15.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.537 -1.283 . . . . 73.109999999999999 107.537 167.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 75' ' ' LEU . 26.9 mt -74.78 136.31 41.69 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.717 -0.674 . . . . 74.530000000000001 110.363 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -103.93 128.45 51.44 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.868 0.867 . . . . 65.319999999999993 109.004 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.429 ' O ' HD11 ' A' ' 42' ' ' LEU . . . -135.38 176.94 19.78 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 123.896 0.747 . . . . 44.420000000000002 112.03 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -146.63 129.59 16.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.492 -0.559 . . . . 75.129999999999995 109.492 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.437 HG21 ' HB ' ' A' ' 67' ' ' VAL . 80.9 mt -67.81 97.22 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.583 -0.895 . . . . 75.299999999999997 108.583 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.92 -31.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.09 -0.959 . . . . 71.239999999999995 111.143 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -158.57 162.88 37.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.61 0.764 . . . . 74.040000000000006 109.03 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.6 HG13 HD12 ' A' ' 39' ' ' ILE . 34.1 m -92.3 168.62 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.501 0.721 . . . . 74.219999999999999 110.382 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -137.22 103.8 5.22 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.285 -0.635 . . . . 71.519999999999996 109.285 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.6 178.66 50.37 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 116.028 -0.533 . . . . 74.109999999999999 113.651 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.567 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 71.7 p -97.76 1.19 48.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.963 0.905 . . . . 71.430000000000007 111.692 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.03 12.18 8.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.669 0.787 . . . . 65.099999999999994 112.014 -176.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.85 -12.16 70.21 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 120.083 -0.287 . . . . 55.409999999999997 113.435 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.32 143.2 56.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.959 0.504 . . . . 73.530000000000001 110.722 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 35.9 m -118.87 -171.91 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.527 1.531 . . . . 75.420000000000002 109.339 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -145.63 108.4 4.51 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.05 -0.722 . . . . 72.099999999999994 109.05 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.03 125.32 50.87 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.874 0.87 . . . . 74.420000000000002 111.125 -176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.509 ' HG2' HG23 ' A' ' 21' ' ' VAL . 97.2 mtt180 -91.13 115.1 27.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.762 0.825 . . . . 74.140000000000001 110.139 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.406 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 14.9 m-85 -89.19 119.94 30.12 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.886 -0.783 . . . . 75.349999999999994 108.886 172.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.44 -19.74 62.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.5 0.72 . . . . 73.310000000000002 112.2 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.433 ' HB3' ' HZ3' ' A' ' 73' ' ' LYS . 3.3 mmmp? -69.79 -55.9 8.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.061 0.945 . . . . 75.230000000000004 110.541 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.461 ' HA2' ' HB2' ' A' ' 20' ' ' ASN . . . 81.0 46.33 7.14 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 114.6 0.6 . . . . 74.519999999999996 114.6 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.486 ' HB2' HD11 ' A' ' 53' ' ' LEU . 31.5 mt -96.77 143.3 25.89 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 117.659 0.73 . . . . 73.329999999999998 110.668 171.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -90.08 -174.84 0.87 Allowed 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.435 2.756 . . . . 72.439999999999998 113.44 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 146.87 153.47 5.91 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.039 -0.982 . . . . 73.340000000000003 111.46 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -99.8 87.46 3.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.236 0.614 . . . . 74.450000000000003 109.483 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.04 31.33 6.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.818 0.847 . . . . 70.120000000000005 111.041 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.09 105.53 0.33 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.924 -0.398 . . . . 75.519999999999996 109.924 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.27 3.61 18.99 Favored Glycine 0 C--N 1.35 1.333 0 C-N-CA 123.929 0.776 . . . . 53.119999999999997 112.548 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -86.82 163.55 17.16 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.967 0.507 . . . . 74.430000000000007 110.428 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 97.0 m-85 -109.55 125.55 52.64 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.12 0.568 . . . . 73.030000000000001 111.513 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 24' ' ' ILE . 18.8 m -100.99 162.35 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.165 0.986 . . . . 74.340000000000003 111.008 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -103.98 110.25 22.32 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.033 0.933 . . . . 74.019999999999996 109.69 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.0 mt -87.82 91.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 107.372 -1.344 . . . . 73.329999999999998 107.372 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.442 HG23 ' HD2' ' A' ' 2' ' ' ARG . 21.9 t -98.27 151.83 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.781 1.233 . . . . 74.400000000000006 109.632 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.452 HD21 ' HA ' ' A' ' 41' ' ' ARG . 2.0 tm? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 108.611 -0.885 . . . . 73.219999999999999 108.611 169.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.479 ' HG3' ' HB3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 109.702 -0.481 . . . . 74.010000000000005 109.702 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.51 HG23 ' HB2' ' A' ' 28' ' ' ASP . 80.3 mt -95.56 135.72 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.767 0.827 . . . . 75.349999999999994 109.7 -175.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.413 ' HE2' ' CD2' ' A' ' 83' ' ' TYR . 85.6 tttt -90.25 138.49 31.48 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.691 -0.855 . . . . 75.219999999999999 108.691 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.69 -179.79 16.97 Favored Glycine 0 N--CA 1.469 0.847 0 N-CA-C 111.606 -0.598 . . . . 52.100000000000001 111.606 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.17 130.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.847 0.859 . . . . 75.129999999999995 109.641 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.408 HG21 ' HE1' ' A' ' 22' ' ' MET . 48.7 t -67.18 100.87 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.599 1.159 . . . . 73.549999999999997 109.743 175.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 25' ' ' LYS . 67.0 mt -82.52 -56.66 3.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.822 0.449 . . . . 74.319999999999993 111.565 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 m -147.21 135.23 21.41 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.671 0.389 . . . . 71.319999999999993 111.352 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -80.98 122.63 27.53 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.516 -0.92 . . . . 73.219999999999999 108.516 168.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.606 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 37.0 mmt180 . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 108.592 -0.892 . . . . 75.519999999999996 108.592 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.419 ' OD1' ' HA2' ' A' ' 74' ' ' GLY . 2.9 p-10 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 109.137 -0.69 . . . . 62.520000000000003 109.137 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 11' ' ' ARG . 10.7 t -87.95 157.17 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.221 -1.029 . . . . 74.150000000000006 108.221 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.408 ' HE1' HG21 ' A' ' 7' ' ' VAL . 36.6 ttp -141.71 114.18 8.3 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.263 -1.384 . . . . 75.530000000000001 107.263 169.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.6 mm -67.42 124.45 22.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 N-CA-C 108.108 -1.071 . . . . 72.120000000000005 108.108 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.421 HG23 HG21 ' A' ' 84' ' ' VAL . 96.3 mt -134.27 137.06 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.948 -1.13 . . . . 74.530000000000001 107.948 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.589 ' HZ1' ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -102.11 113.43 65.86 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.727 -0.842 . . . . 75.420000000000002 108.727 169.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 15.8 Cg_exo -68.3 119.8 6.79 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.585 1.523 . . . . 75.299999999999997 110.177 169.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.88 -35.99 81.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.485 0.714 . . . . 71.319999999999993 111.602 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HB2' HG23 ' A' ' 3' ' ' ILE . 7.8 m-20 -76.45 -28.95 56.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.755 0.422 . . . . 74.530000000000001 111.23 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 50.0 t -115.56 102.27 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.475 0.71 . . . . 74.219999999999999 110.459 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.517 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 26.3 p30 -110.15 2.14 19.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.036 0.934 . . . . 74.010000000000005 111.425 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.9 m -97.83 156.14 16.72 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.65 0.78 . . . . 55.219999999999999 110.477 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 31.7 ttt180 -74.54 -42.8 58.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.2 0.6 . . . . 75.409999999999997 110.918 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.53 -40.43 92.91 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.788 0.835 . . . . 74.219999999999999 110.987 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.451 ' HB2' HG11 ' A' ' 29' ' ' VAL . 5.9 mm-40 -70.83 -28.57 64.7 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.268 -0.878 . . . . 65.510000000000005 110.243 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.26 43.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.561 0.744 . . . . 55.439999999999998 111.192 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.8 t -78.78 -23.54 45.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.915 0.886 . . . . 72.239999999999995 110.018 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -92.75 2.12 56.91 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.642 0.377 . . . . 75.329999999999998 111.124 171.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.478 HD22 HD13 ' A' ' 3' ' ' ILE . 43.2 mt -85.94 -11.23 53.65 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.092 0.557 . . . . 74.0 111.137 170.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.489 HD12 HG11 ' A' ' 60' ' ' VAL . 42.7 mm -63.38 126.64 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 109.214 -0.661 . . . . 72.129999999999995 109.214 177.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.64 7.67 66.48 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.612 -0.549 . . . . 73.010000000000005 113.426 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -96.1 150.86 20.03 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 117.851 0.826 . . . . 74.5 111.202 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.444 HD11 ' HE2' ' A' ' 54' ' ' LYS . 43.8 tp -91.17 115.95 28.42 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.758 -1.11 . . . . 75.099999999999994 109.897 -171.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.404 HG23 HG12 ' A' ' 86' ' ' ILE . 62.0 t -97.38 115.04 36.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.29 -0.633 . . . . 63.549999999999997 109.29 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.9 mt -93.7 101.88 14.03 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.153 0.981 . . . . 75.430000000000007 108.419 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.409 ' CD1' HG12 ' A' ' 84' ' ' VAL . 31.2 t90 -104.38 131.21 51.99 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.399 -0.963 . . . . 72.239999999999995 108.399 172.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -96.03 114.67 26.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.16 -1.422 . . . . 74.340000000000003 107.16 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.1 p -57.95 155.74 22.44 Favored Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 124.115 0.966 . . . . 74.439999999999998 111.026 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.78 -25.25 50.75 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.126 2.551 . . . . 74.129999999999995 112.82 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -58.55 -38.15 77.21 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.921 1.288 . . . . 74.109999999999999 111.505 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.68 -8.91 11.73 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 115.635 -0.711 . . . . 72.209999999999994 112.015 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -82.05 153.54 26.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.602 1.161 . . . . 73.549999999999997 110.141 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.7 mt -110.12 109.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.816 0.446 . . . . 74.430000000000007 110.203 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.559 HD23 HD12 ' A' ' 75' ' ' LEU . 57.3 mt -80.54 142.26 34.31 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.991 0.916 . . . . 72.519999999999996 110.319 174.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HE2' HD11 ' A' ' 42' ' ' LEU . 13.9 mmmm -96.24 128.73 43.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.886 0.874 . . . . 75.310000000000002 109.513 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.05 173.31 22.48 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 111.459 -0.656 . . . . 55.130000000000003 111.459 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -152.61 132.06 12.94 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.991 0.396 . . . . 74.019999999999996 110.709 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.4 HD11 HD12 ' A' ' 86' ' ' ILE . 65.5 mt -68.22 104.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 123.878 0.736 . . . . 54.549999999999997 109.692 176.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.79 -38.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.182 -0.463 . . . . 72.299999999999997 110.132 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -136.23 176.89 8.28 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.835 0.854 . . . . 75.409999999999997 110.532 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 39' ' ' ILE . 31.0 m -123.45 169.99 14.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 124.529 1.132 . . . . 74.450000000000003 109.651 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -144.61 105.31 4.14 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.303 -0.999 . . . . 73.040000000000006 108.303 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.17 168.73 42.2 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.182 -0.463 . . . . 71.409999999999997 113.587 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 59.8 p -93.78 2.28 56.27 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.04 0.936 . . . . 71.019999999999996 110.987 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -84.54 7.92 18.37 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.094 0.958 . . . . 75.510000000000005 112.476 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 30' ' ' ASN . . . 69.12 63.91 3.23 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 112.004 -0.438 . . . . 61.409999999999997 112.004 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.67 113.45 15.39 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.232 -1.395 . . . . 74.310000000000002 107.232 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.42 167.17 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.087 0.955 . . . . 74.010000000000005 110.42 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -123.13 102.56 8.04 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.173 0.989 . . . . 75.430000000000007 108.786 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.29 116.91 32.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.776 0.83 . . . . 53.420000000000002 110.397 -176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 22.1 mtm180 -91.33 119.75 31.62 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 122.338 0.255 . . . . 73.200000000000003 111.254 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -93.29 129.3 39.42 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.339 1.056 . . . . 71.510000000000005 110.756 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.27 -31.04 62.38 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.908 -1.042 . . . . 75.420000000000002 112.649 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.62 -31.71 24.1 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.547 0.339 . . . . 73.010000000000005 110.883 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.419 ' HA2' ' OD1' ' A' ' 20' ' ' ASN . . . 61.87 37.1 93.79 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 115.595 0.998 . . . . 73.230000000000004 115.595 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.559 HD12 HD23 ' A' ' 53' ' ' LEU . 79.7 mt -85.04 150.02 54.36 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 122.565 0.346 . . . . 73.5 110.466 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.99 -176.04 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.1 2.533 . . . . 74.510000000000005 112.516 174.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.83 -39.7 0.02 OUTLIER Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.556 -0.747 . . . . 64.239999999999995 112.403 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 56.55 30.4 17.18 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 123.047 1.403 . . . . 74.310000000000002 109.402 -171.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.82 31.47 5.81 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.935 -1.484 . . . . 60.299999999999997 110.564 -169.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -56.01 111.79 1.03 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.661 -0.496 . . . . 65.420000000000002 109.661 172.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.58 -7.26 18.0 Favored Glycine 0 N--CA 1.476 1.342 0 C-N-CA 123.233 0.444 . . . . 71.209999999999994 112.447 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.07 169.86 17.57 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.925 0.89 . . . . 70.109999999999999 108.664 175.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.413 ' CD2' ' HE2' ' A' ' 4' ' ' LYS . 92.7 m-85 -115.36 135.24 54.33 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.097 0.408 . . . . 74.549999999999997 111.173 -171.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG21 HG23 ' A' ' 24' ' ' ILE . 13.8 m -101.28 168.34 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.973 0.909 . . . . 75.209999999999994 109.249 174.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 2' ' ' ARG . 49.3 mt-10 -132.43 107.13 8.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.043 -0.725 . . . . 73.109999999999999 109.043 173.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.404 HG12 HG23 ' A' ' 43' ' ' VAL . 46.7 mt -85.21 94.45 3.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 125.227 1.411 . . . . 75.510000000000005 109.258 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.62 150.14 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.421 0.688 . . . . 72.530000000000001 109.599 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.553 1.095 0 N-CA-C 107.065 -1.457 . . . . 74.439999999999998 107.065 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 108.651 -0.87 . . . . 74.519999999999996 108.651 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.71 124.75 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.635 0.774 . . . . 75.099999999999994 109.061 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -88.52 127.67 35.54 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.938 -0.764 . . . . 75.25 108.938 -176.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.62 -168.95 12.26 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 116.373 -0.376 . . . . 61.32 112.299 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -144.3 135.38 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.026 1.33 . . . . 61.140000000000001 109.695 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.5 t -72.61 115.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.833 0.853 . . . . 71.420000000000002 109.62 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 25' ' ' LYS . 84.3 mt -89.69 -47.81 7.69 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 123.461 0.476 . . . . 75.510000000000005 110.541 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.2 m -152.02 154.82 36.75 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.919 0.488 . . . . 71.439999999999998 111.535 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -110.47 137.85 47.63 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.397 1.079 . . . . 70.510000000000005 108.691 171.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.416 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 87.9 mtt180 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 107.706 -1.22 . . . . 73.439999999999998 107.706 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 120.682 0.277 . . . . 74.519999999999996 110.327 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.418 HG11 ' HD3' ' A' ' 68' ' ' ARG . 84.3 t -90.39 106.09 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.565 0.746 . . . . 70.420000000000002 109.019 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.7 ttm -100.46 124.75 46.39 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.294 -0.632 . . . . 74.420000000000002 109.294 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -82.02 115.54 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 107.786 -1.19 . . . . 74.230000000000004 107.786 172.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.401 ' HB ' HG22 ' A' ' 67' ' ' VAL . 69.4 mt -109.24 150.41 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.799 0.84 . . . . 72.209999999999994 109.938 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.518 ' HB2' HD11 ' A' ' 8' ' ' LEU . 59.5 tttp -119.49 96.97 50.06 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 125.007 1.323 . . . . 73.140000000000001 108.962 175.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.7 106.64 0.94 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.083 1.855 . . . . 74.230000000000004 110.164 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.1 mt -53.08 -38.43 62.53 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.793 1.237 . . . . 72.209999999999994 113.324 -172.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.73 -27.11 58.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.978 0.511 . . . . 62.509999999999998 111.631 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -100.98 107.73 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.32 0.648 . . . . 74.530000000000001 111.529 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -91.62 -19.26 22.9 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.369 1.068 . . . . 73.299999999999997 111.875 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -104.53 133.42 49.42 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 122.025 -0.422 . . . . 73.540000000000006 111.05 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 49.1 ttt180 -58.97 -43.93 91.46 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.375 1.07 . . . . 73.0 111.553 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.7 -40.5 97.33 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.006 0.922 . . . . 60.340000000000003 111.524 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.69 -33.51 75.05 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.479 -0.782 . . . . 65.439999999999998 111.14 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.93 -25.77 60.15 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 122.996 0.518 . . . . 74.109999999999999 111.637 171.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -74.99 -34.11 61.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.763 0.825 . . . . 60.229999999999997 111.924 -172.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -68.93 -22.42 64.14 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 120.922 0.391 . . . . 74.450000000000003 110.39 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.55 1.74 52.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.051 0.94 . . . . 74.030000000000001 112.449 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.423 HD11 HG11 ' A' ' 60' ' ' VAL . 31.7 mm -66.53 135.79 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 118.394 0.543 . . . . 74.140000000000001 110.729 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.16 -8.58 31.16 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.683 -0.689 . . . . 65.239999999999995 113.367 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -80.26 153.44 28.5 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.362 0.581 . . . . 73.120000000000005 110.959 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 54' ' ' LYS . 59.5 tp -90.28 146.75 23.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.471 -0.786 . . . . 75.230000000000004 109.257 -174.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.437 HG23 HG12 ' A' ' 86' ' ' ILE . 40.1 t -116.95 131.83 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.83 -0.804 . . . . 73.450000000000003 108.83 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -113.14 105.73 13.8 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.603 -1.258 . . . . 71.040000000000006 107.603 175.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -125.28 124.3 41.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.33 0.652 . . . . 73.409999999999997 109.468 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HE3' ' HA2' ' A' ' 50' ' ' GLY . 45.9 tttp -81.22 122.52 27.5 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.99 -0.744 . . . . 72.239999999999995 108.99 176.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 82.2 p -65.39 152.62 91.75 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.034 0.534 . . . . 75.030000000000001 110.346 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.47 -12.9 30.0 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.268 1.979 . . . . 74.420000000000002 112.145 173.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.6 m -70.27 -42.78 71.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.417 1.087 . . . . 75.409999999999997 110.726 170.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.459 ' HA2' ' HE3' ' A' ' 46' ' ' LYS . . . 135.06 -22.78 3.56 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 116.104 -0.498 . . . . 61.32 113.126 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -74.09 122.51 22.81 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.605 0.762 . . . . 73.409999999999997 110.292 -174.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 72.3 mt -78.83 106.95 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.593 -0.892 . . . . 70.319999999999993 108.593 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.73 155.34 20.39 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.409 1.084 . . . . 74.420000000000002 109.791 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB3' HD13 ' A' ' 42' ' ' LEU . 47.1 mtpt -123.7 145.46 48.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.934 0.894 . . . . 74.319999999999993 109.229 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.76 132.61 3.04 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-O 119.824 -0.431 . . . . 74.519999999999996 112.903 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -93.05 128.77 39.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.285 0.543 . . . . 74.219999999999999 109.976 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 67' ' ' VAL . 92.2 mt -72.13 116.52 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.618 0.767 . . . . 72.439999999999998 109.411 174.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -112.92 -3.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.727 0.811 . . . . 71.129999999999995 112.284 -172.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -165.57 161.47 18.48 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.909 0.484 . . . . 73.349999999999994 110.48 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 16.0 m -91.5 168.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.781 0.832 . . . . 74.010000000000005 109.732 168.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -143.94 105.07 4.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.076 -0.511 . . . . 74.150000000000006 109.767 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.19 176.31 38.17 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 123.377 0.423 . . . . 62.229999999999997 113.841 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.508 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 30.1 p -91.04 10.1 28.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.394 1.077 . . . . 70.030000000000001 111.059 177.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -91.75 12.37 21.53 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.907 0.883 . . . . 74.420000000000002 111.749 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.07 12.03 75.23 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 113.984 0.354 . . . . 64.010000000000005 113.984 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.55 162.26 27.25 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.174 0.59 . . . . 75.510000000000005 109.728 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 15.2 m -132.18 177.92 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.098 0.959 . . . . 72.030000000000001 110.521 -178.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.418 ' HD3' HG11 ' A' ' 21' ' ' VAL . 7.4 tmm_? -138.59 116.45 11.56 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.25 -1.389 . . . . 72.400000000000006 107.25 -175.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -116.41 146.05 42.8 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.715 0.806 . . . . 53.0 111.496 -176.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -99.25 100.83 11.98 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.235 1.014 . . . . 73.519999999999996 109.311 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -77.24 124.17 27.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.321 0.648 . . . . 74.230000000000004 110.984 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.508 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 9.9 pt-20 -62.1 -35.9 80.1 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.05 0.94 . . . . 64.420000000000002 111.122 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.508 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 74.5 mmtt -99.65 -65.38 0.97 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.595 0.758 . . . . 75.420000000000002 109.017 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.0 52.97 36.22 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 124.131 0.894 . . . . 61.420000000000002 114.61 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.51 137.33 93.33 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.35 0.66 . . . . 74.400000000000006 110.563 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.52 169.74 15.11 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.024 2.482 . . . . 64.209999999999994 112.845 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.73 161.67 22.69 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 115.266 -0.879 . . . . 73.129999999999995 110.905 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -91.0 38.8 0.97 Allowed 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.301 1.048 . . . . 75.25 109.306 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.21 29.8 4.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.647 1.179 . . . . 73.209999999999994 110.538 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.12 107.9 0.96 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.703 -0.851 . . . . 74.019999999999996 108.703 169.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.46 -12.14 16.16 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 116.279 -0.419 . . . . 61.030000000000001 112.645 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -77.62 152.82 33.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.842 0.457 . . . . 73.299999999999997 110.693 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -87.8 135.58 33.32 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.193 0.997 . . . . 75.129999999999995 112.349 -169.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.5 152.69 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.947 0.899 . . . . 72.239999999999995 109.138 171.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -114.14 108.72 17.35 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.19 -1.041 . . . . 72.209999999999994 108.19 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.437 HG12 HG23 ' A' ' 43' ' ' VAL . 61.9 mt -96.22 119.25 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.358 0.663 . . . . 72.230000000000004 109.62 -174.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.7 t -113.44 142.83 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 123.348 0.659 . . . . 73.239999999999995 111.183 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 CA--C 1.549 0.939 0 C-N-CA 124.119 0.968 . . . . 74.420000000000002 111.845 176.431 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.6 mtm180 . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.51 -0.922 . . . . 73.340000000000003 108.51 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.618 HD13 HD21 ' A' ' 38' ' ' LEU . 73.4 mt -129.97 130.45 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.596 0.758 . . . . 74.120000000000005 109.164 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.406 ' HG3' HD13 ' A' ' 27' ' ' LEU . 19.6 ptmt -88.54 130.07 35.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.765 -0.828 . . . . 71.400000000000006 108.765 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -128.18 140.64 11.93 Favored Glycine 0 C--O 1.217 -0.954 0 CA-C-N 116.459 -0.337 . . . . 75.329999999999998 112.363 -175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.7 t -91.93 121.98 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.01 0.524 . . . . 75.430000000000007 111.086 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.52 97.48 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.378 1.071 . . . . 73.219999999999999 109.65 172.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' A' ' 25' ' ' LYS . 88.1 mt -72.91 -48.83 33.7 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.52 -0.764 . . . . 74.310000000000002 110.036 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.46 ' HA ' HD21 ' A' ' 80' ' ' LEU . 70.0 p -162.37 168.05 22.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.869 -0.605 . . . . 71.420000000000002 110.932 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -105.13 123.77 48.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.927 -1.138 . . . . 72.150000000000006 107.927 169.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 107.734 -1.209 . . . . 74.310000000000002 107.734 176.752 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.422 ' OD1' ' HA3' ' A' ' 74' ' ' GLY . 8.8 p30 . . . . . 0 C--O 1.243 0.738 0 CA-C-O 121.802 0.811 . . . . 73.530000000000001 112.015 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t -106.88 121.24 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 114.266 -1.334 . . . . 74.319999999999993 109.251 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 45.7 ttm -89.52 123.78 33.93 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.507 -0.923 . . . . 72.519999999999996 108.507 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.7 116.02 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.31 -0.996 . . . . 70.450000000000003 108.31 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 84' ' ' VAL . 84.8 mt -120.46 150.67 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.036 0.935 . . . . 73.329999999999998 109.647 -172.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HB2' HD11 ' A' ' 8' ' ' LEU . 78.9 tttt -123.45 91.73 49.48 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.496 0.719 . . . . 75.310000000000002 109.416 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HD2' ' HA ' ' A' ' 66' ' ' ALA . 36.9 Cg_endo -63.72 110.4 1.27 Allowed 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 122.751 2.301 . . . . 60.100000000000001 111.272 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.406 HD13 ' HG3' ' A' ' 4' ' ' LYS . 85.8 mt -62.18 -37.72 86.35 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.639 1.176 . . . . 63.520000000000003 112.875 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -65.86 -26.25 67.56 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.265 0.626 . . . . 75.510000000000005 111.546 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.595 HG11 ' HB2' ' A' ' 34' ' ' GLU . 40.3 t -100.32 131.59 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.197 0.999 . . . . 75.409999999999997 110.96 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -130.32 -3.48 4.37 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.664 0.785 . . . . 62.329999999999998 111.451 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.8 m -123.28 154.48 38.79 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.447 0.699 . . . . 74.150000000000006 110.563 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.573 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 63.0 ttt180 -64.95 -30.84 71.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.134 0.974 . . . . 72.299999999999997 111.634 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -69.48 -39.66 77.55 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.889 0.876 . . . . 65.420000000000002 110.146 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.595 ' HB2' HG11 ' A' ' 29' ' ' VAL . 36.5 mt-10 -70.42 -38.61 74.61 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.667 -1.151 . . . . 75.209999999999994 109.526 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.36 -30.81 69.84 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.645 0.778 . . . . 75.420000000000002 111.228 174.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 t -74.15 -30.82 62.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.397 0.679 . . . . 72.409999999999997 110.041 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -90.78 4.1 52.57 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.743 0.417 . . . . 73.409999999999997 110.98 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.618 HD21 HD13 ' A' ' 3' ' ' ILE . 34.3 mt -87.83 -18.31 29.57 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.618 0.367 . . . . 74.519999999999996 110.415 165.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.539 HD12 HG21 ' A' ' 57' ' ' ILE . 50.2 mm -59.86 106.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.195 0.598 . . . . 74.540000000000006 109.393 174.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.19 -29.35 4.6 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 116.052 -0.522 . . . . 53.149999999999999 112.527 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 153.94 39.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.208 0.603 . . . . 74.209999999999994 111.901 -173.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.544 HD11 ' HE2' ' A' ' 54' ' ' LYS . 60.9 tp -90.41 123.73 34.38 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.42 1.088 . . . . 72.349999999999994 109.674 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.8 115.18 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 109.412 -0.588 . . . . 75.340000000000003 109.412 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt -104.36 110.12 22.24 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.557 1.143 . . . . 71.340000000000003 108.732 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -124.49 127.73 47.91 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.307 -0.627 . . . . 75.239999999999995 109.307 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -88.12 106.7 18.34 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.367 -0.975 . . . . 64.150000000000006 108.367 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.9 p -64.31 157.37 71.53 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.046 0.938 . . . . 72.209999999999994 112.406 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.92 -23.78 73.88 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.842 2.361 . . . . 62.100000000000001 112.074 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.1 t -61.91 -23.27 66.22 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.538 1.135 . . . . 62.329999999999998 111.343 173.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.86 19.18 34.94 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.712 -0.676 . . . . 74.310000000000002 112.64 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.0 143.02 40.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.554 0.742 . . . . 75.340000000000003 110.105 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.5 mt -89.08 102.09 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.724 -0.843 . . . . 72.109999999999999 108.724 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 75' ' ' LEU . 26.3 mt -82.71 138.09 34.2 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.142 0.577 . . . . 75.329999999999998 110.369 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HE2' HD11 ' A' ' 42' ' ' LEU . 13.4 mmmm -96.09 132.92 40.97 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.572 -0.899 . . . . 74.140000000000001 108.572 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.18 172.94 22.7 Favored Glycine 0 C--N 1.332 0.353 0 O-C-N 123.618 0.574 . . . . 73.129999999999995 112.075 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -151.81 131.71 13.34 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.122 0.569 . . . . 74.140000000000001 109.843 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.539 HG21 HD12 ' A' ' 39' ' ' ILE . 73.0 mt -70.8 108.93 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 109.137 -0.69 . . . . 63.240000000000002 109.137 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.75 -14.94 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.182 0.993 . . . . 74.219999999999999 111.225 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 23.7 tpp180 -149.29 148.82 30.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.327 0.651 . . . . 74.140000000000001 109.371 -173.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 m -98.74 171.41 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.335 0.654 . . . . 74.129999999999995 109.988 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -124.13 103.64 8.39 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.386 -0.968 . . . . 72.450000000000003 108.386 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.94 -134.1 52.3 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 124.144 0.903 . . . . 75.519999999999996 113.602 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.573 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 69.3 p -119.62 -4.55 10.28 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.741 0.816 . . . . 62.020000000000003 111.993 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -73.93 -7.81 53.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.069 0.548 . . . . 75.140000000000001 112.017 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.51 -10.98 70.71 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 119.649 -0.528 . . . . 73.140000000000001 113.209 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.541 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . . . -60.68 149.68 34.5 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.999 0.52 . . . . 63.109999999999999 109.652 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.519 HG22 ' HD3' ' A' ' 26' ' ' PRO . 35.1 m -131.13 178.97 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 121.921 0.867 . . . . 72.329999999999998 111.96 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 97.8 mtt180 -133.86 118.99 18.59 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.259 1.424 . . . . 74.530000000000001 108.379 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.72 133.57 55.85 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.968 0.507 . . . . 71.129999999999995 110.715 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -88.7 123.21 32.92 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.182 0.593 . . . . 74.150000000000006 109.633 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -105.23 133.41 50.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.716 0.806 . . . . 75.409999999999997 109.46 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -61.13 -37.02 81.32 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.678 0.791 . . . . 75.319999999999993 111.852 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -98.08 -61.03 1.44 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.82 0.848 . . . . 74.109999999999999 108.974 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.422 ' HA3' ' OD1' ' A' ' 20' ' ' ASN . . . 60.91 54.68 34.91 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 124.083 0.864 . . . . 73.209999999999994 112.93 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 53' ' ' LEU . 51.6 mt -68.46 115.92 34.77 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.24 1.016 . . . . 74.409999999999997 110.513 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.7 179.84 5.85 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 123.283 2.656 . . . . 52.140000000000001 112.332 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.81 176.94 25.07 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 110.723 -0.951 . . . . 75.219999999999999 110.723 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -77.39 70.02 3.73 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 122.038 0.923 . . . . 71.310000000000002 109.086 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.73 13.6 11.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.811 -1.086 . . . . 73.299999999999997 111.922 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.46 HD21 ' HA ' ' A' ' 9' ' ' SER . 60.9 mt -74.27 103.21 4.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.464 -0.939 . . . . 72.120000000000005 108.464 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.4 -18.2 6.89 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 112.116 -0.394 . . . . 52.219999999999999 112.116 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.96 169.93 16.99 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.986 0.514 . . . . 71.200000000000003 111.336 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -108.28 155.9 19.98 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.232 0.613 . . . . 73.549999999999997 111.043 -170.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 24' ' ' ILE . 20.2 m -122.15 160.28 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.462 1.105 . . . . 74.530000000000001 108.773 174.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -106.02 108.5 20.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.177 -0.675 . . . . 71.129999999999995 109.177 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 2' ' ' ARG . 77.9 mt -93.93 92.12 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.336 -1.357 . . . . 65.400000000000006 107.336 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.66 127.6 48.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.247 1.019 . . . . 73.450000000000003 110.266 -172.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 C--O 1.238 0.465 0 N-CA-C 107.915 -1.143 . . . . 74.140000000000001 107.915 173.961 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 110.48 -0.193 . . . . 72.409999999999997 110.48 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 47.1 mtm-85 -125.12 127.56 47.06 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.375 -0.972 . . . . 63.409999999999997 108.375 170.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 63.6 mt -97.12 132.57 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.656 0.782 . . . . 74.439999999999998 109.358 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -89.42 129.61 35.9 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.289 -0.634 . . . . 75.519999999999996 109.289 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.58 164.99 25.12 Favored Glycine 0 C--N 1.345 1.03 0 O-C-N 123.253 0.346 . . . . 73.109999999999999 112.929 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.57 120.65 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.993 0.917 . . . . 73.209999999999994 109.253 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 22' ' ' MET . 23.7 t -68.9 102.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 109.687 -0.486 . . . . 72.019999999999996 109.687 173.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' A' ' 25' ' ' LYS . 56.4 mt -70.23 -37.3 74.97 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.761 0.824 . . . . 73.299999999999997 110.321 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -156.96 158.13 36.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.87 -0.604 . . . . 74.140000000000001 111.603 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.525 ' HH ' ' HB1' ' A' ' 79' ' ' ALA . 88.9 m-85 -116.96 162.15 18.22 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.955 0.902 . . . . 74.129999999999995 109.113 172.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.568 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 22.7 mtm180 -135.4 128.31 31.34 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.666 -1.235 . . . . 72.150000000000006 107.666 171.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -73.98 121.34 20.86 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.28 -0.637 . . . . 74.319999999999993 109.28 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -69.54 101.06 1.52 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.678 -0.692 . . . . 63.539999999999999 109.948 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -88.62 -2.37 58.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.692 -1.14 . . . . 75.400000000000006 110.566 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -76.79 173.49 11.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.112 0.965 . . . . 74.099999999999994 110.111 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -64.02 -44.93 91.08 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.008 0.432 . . . . 75.530000000000001 109.902 172.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -76.51 89.17 3.26 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.302 -0.863 . . . . 71.439999999999998 108.806 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -70.67 87.97 0.69 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.577 0.703 . . . . 70.319999999999993 109.555 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.42 105.69 8.69 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.334 -0.987 . . . . 63.340000000000003 108.334 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.578 ' H ' ' HA2' ' A' ' 74' ' ' GLY . 4.3 p-10 -63.11 118.84 8.46 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 123.681 0.613 . . . . 74.219999999999999 109.791 -171.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 11' ' ' ARG . 16.7 t -90.32 149.39 4.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.546 -0.909 . . . . 74.519999999999996 108.546 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.486 ' HB2' HG12 ' A' ' 7' ' ' VAL . 21.5 ptp -149.26 140.91 23.49 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.02 0.438 . . . . 74.400000000000006 111.309 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -86.34 97.97 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.249 -1.389 . . . . 74.400000000000006 107.249 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.01 133.18 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.747 0.819 . . . . 75.120000000000005 108.973 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HB2' HD11 ' A' ' 8' ' ' LEU . 33.7 ttpt -107.56 97.0 17.97 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.107 -1.071 . . . . 75.109999999999999 108.107 170.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 11.5 Cg_exo -68.5 122.39 9.38 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.986 1.791 . . . . 75.430000000000007 110.74 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.63 -29.56 66.6 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.255 1.022 . . . . 75.120000000000005 112.008 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.44 ' HB3' HG22 ' A' ' 3' ' ' ILE . 35.7 t70 -88.46 -28.5 20.82 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.859 0.864 . . . . 72.230000000000004 112.157 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 89.4 t -104.82 99.71 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.391 0.676 . . . . 74.120000000000005 109.808 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -119.41 12.13 12.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.396 0.678 . . . . 64.209999999999994 110.359 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.1 m -122.43 149.07 44.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.819 0.847 . . . . 72.439999999999998 110.613 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.57 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 53.8 ttt180 -63.88 -36.91 85.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.237 1.015 . . . . 75.340000000000003 111.357 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -65.29 -48.69 72.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.523 0.729 . . . . 72.200000000000003 110.532 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.444 ' HB2' HG11 ' A' ' 29' ' ' VAL . 50.2 mt-10 -63.21 -30.37 71.53 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.74 -1.118 . . . . 72.209999999999994 110.976 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.73 -36.2 37.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.692 0.797 . . . . 64.109999999999999 111.512 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -73.39 -27.49 61.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.73 0.812 . . . . 52.149999999999999 110.915 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -82.11 -1.19 47.92 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.094 -0.503 . . . . 75.409999999999997 111.363 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.456 HD13 HG21 ' A' ' 29' ' ' VAL . 93.4 mt -98.59 1.95 46.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.574 0.75 . . . . 75.200000000000003 112.144 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.59 HD11 HG12 ' A' ' 60' ' ' VAL . 51.2 mm -67.94 109.58 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.361 0.528 . . . . 75.109999999999999 110.278 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.95 -15.82 18.65 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.566 -0.743 . . . . 75.420000000000002 112.551 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.531 ' HG3' ' H ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -70.9 152.87 43.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.905 0.482 . . . . 74.409999999999997 111.228 -177.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 54' ' ' LYS . 26.6 tp -94.86 114.61 26.49 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 124.389 1.056 . . . . 74.299999999999997 109.668 -167.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.72 131.43 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.23 -0.656 . . . . 73.319999999999993 109.23 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.4 mt -107.66 101.31 10.63 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.66 -0.867 . . . . 73.120000000000005 108.66 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -100.22 140.8 33.94 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.916 0.486 . . . . 74.109999999999999 109.807 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -91.74 101.05 13.66 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.203 1.001 . . . . 75.510000000000005 108.775 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.3 p -65.0 150.58 95.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.035 0.534 . . . . 71.409999999999997 111.149 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.54 -19.37 36.47 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.409 2.739 . . . . 75.519999999999996 113.049 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.4 t -71.78 -8.59 55.17 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.056 0.942 . . . . 72.430000000000007 112.347 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.19 32.81 30.71 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.492 -0.243 . . . . 74.219999999999999 112.492 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -128.02 146.11 50.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.863 0.865 . . . . 70.209999999999994 108.864 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -99.43 100.09 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.844 -0.799 . . . . 75.519999999999996 108.844 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 75' ' ' LEU . 21.5 mt -74.99 137.28 41.45 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.156 -0.929 . . . . 75.230000000000004 109.034 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HB3' HD12 ' A' ' 42' ' ' LEU . 24.0 mtmm -96.92 139.31 33.14 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.128 -0.693 . . . . 74.310000000000002 109.128 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -140.82 177.4 20.88 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 116.198 -0.456 . . . . 73.510000000000005 112.717 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -139.3 126.73 21.57 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.515 -0.55 . . . . 75.400000000000006 109.515 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.441 HG21 ' HB ' ' A' ' 67' ' ' VAL . 63.1 mt -68.75 103.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.041 -0.725 . . . . 71.200000000000003 109.041 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.429 HG13 ' HD3' ' A' ' 70' ' ' ARG . 27.6 m -83.84 -35.24 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.59 -0.732 . . . . 73.510000000000005 110.98 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -163.99 153.73 14.53 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.625 0.77 . . . . 65.209999999999994 109.584 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.59 HG12 HD11 ' A' ' 39' ' ' ILE . 12.2 m -91.55 170.46 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.289 0.636 . . . . 74.140000000000001 110.043 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -122.79 103.66 8.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.951 -1.129 . . . . 74.120000000000005 107.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.12 -150.63 51.71 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 124.335 1.022 . . . . 43.109999999999999 114.292 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.57 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 55.2 p -98.47 -9.91 24.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.664 0.786 . . . . 73.239999999999995 111.81 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.12 -12.52 19.95 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.735 0.814 . . . . 75.340000000000003 112.86 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.32 -1.34 87.56 Favored Glycine 0 C--N 1.349 1.25 0 N-CA-C 112.393 -0.283 . . . . 72.540000000000006 112.393 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.48 119.37 10.92 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.47 0.708 . . . . 72.0 110.162 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.441 ' HB ' HG21 ' A' ' 57' ' ' ILE . 29.6 m -101.65 148.27 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 122.661 0.384 . . . . 74.430000000000007 110.289 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -113.71 113.7 25.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.379 -0.6 . . . . 75.129999999999995 109.379 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.63 134.3 55.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.968 -0.56 . . . . 53.229999999999997 111.433 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.554 ' HG2' HG23 ' A' ' 21' ' ' VAL . 67.9 mtp85 -102.57 123.31 46.06 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.162 0.985 . . . . 75.120000000000005 109.005 174.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 12.5 m-85 -99.04 126.9 44.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.178 0.591 . . . . 75.019999999999996 111.156 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 54' ' ' LYS . 22.1 pt-20 -50.28 -38.06 39.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.376 1.471 . . . . 71.450000000000003 113.652 -172.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -75.39 -24.85 57.24 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.259 0.624 . . . . 74.349999999999994 111.54 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.578 ' HA2' ' H ' ' A' ' 20' ' ' ASN . . . 63.83 24.76 68.58 Favored Glycine 0 C--N 1.348 1.195 0 O-C-N 123.633 0.583 . . . . 64.200000000000003 114.432 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.466 ' HB2' HD12 ' A' ' 53' ' ' LEU . 84.4 mt -86.59 136.31 35.09 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 123.088 0.555 . . . . 74.420000000000002 110.6 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 11.4 Cg_exo -71.08 174.32 10.82 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.561 2.84 . . . . 74.25 112.098 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.85 -65.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.1 -0.5 . . . . 72.040000000000006 112.549 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 60.28 31.79 20.55 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 123.062 1.411 . . . . 74.019999999999996 110.272 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.525 ' HB1' ' HH ' ' A' ' 10' ' ' TYR . . . -88.33 31.61 0.81 Allowed 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 114.107 -1.406 . . . . 72.349999999999994 111.291 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -35.68 111.1 0.12 Allowed 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 126.289 1.835 . . . . 74.420000000000002 114.194 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.41 -4.25 26.54 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.9 -0.591 . . . . 54.340000000000003 113.102 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.81 157.93 35.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.331 0.652 . . . . 73.510000000000005 111.611 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -102.06 141.4 34.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.274 0.559 . . . . 73.040000000000006 112.127 -172.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.9 m -116.29 166.61 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.209 1.003 . . . . 73.230000000000004 110.326 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -128.71 109.15 11.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.506 -0.553 . . . . 74.230000000000004 109.506 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 61.3 mt -82.37 100.1 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.241 1.016 . . . . 74.129999999999995 109.346 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.5 t -72.76 117.64 16.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.229 0 N-CA-C 109.098 -0.705 . . . . 71.109999999999999 109.098 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -63.34 86.61 0.03 OUTLIER 'General case' 0 C--N 1.35 0.61 0 N-CA-C 107.351 -1.352 . . . . 74.129999999999995 107.351 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.531 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -75.86 -62.99 1.41 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.421 -1.263 . . . . 72.549999999999997 110.035 -179.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 58.29 81.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.567 1.167 . . . . 72.340000000000003 110.732 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 119.051 -0.499 . . . . 65.230000000000004 110.046 173.344 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mmt . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 109.762 -0.458 . . . . 72.349999999999994 109.762 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -150.05 141.69 23.56 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.637 1.175 . . . . 74.409999999999997 108.818 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 74.2 mt -112.34 133.73 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.121 -1.066 . . . . 71.329999999999998 108.121 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -88.14 133.36 34.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.525 -0.546 . . . . 72.129999999999995 109.525 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -122.24 165.53 15.01 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 110.891 -0.883 . . . . 54.420000000000002 110.891 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.3 t -111.54 128.38 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 123.691 0.796 . . . . 74.239999999999995 109.313 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.69 93.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.446 1.099 . . . . 75.310000000000002 108.813 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 25' ' ' LYS . 64.7 mt -71.27 -51.19 25.9 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.343 -0.39 . . . . 73.420000000000002 110.062 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 p -159.48 156.18 27.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.737 -0.665 . . . . 74.329999999999998 110.875 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -92.5 104.88 17.15 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.243 -1.021 . . . . 74.319999999999993 108.243 169.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -83.35 112.35 19.83 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.004 -0.739 . . . . 72.219999999999999 109.004 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -74.08 148.4 41.9 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.818 -0.438 . . . . 73.109999999999999 109.818 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -137.87 157.69 45.88 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.023 0.929 . . . . 74.219999999999999 109.337 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -78.22 77.16 4.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.743 0.782 . . . . 74.019999999999996 109.815 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -65.54 131.26 45.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.132 -1.394 . . . . 73.530000000000001 111.452 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -64.01 -51.48 64.04 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.271 0.628 . . . . 71.530000000000001 109.954 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -118.37 -65.68 1.15 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.445 -0.946 . . . . 73.040000000000006 108.445 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -160.43 118.02 2.51 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 123.191 0.307 . . . . 74.530000000000001 111.174 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -154.69 136.91 14.82 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.636 1.575 . . . . 73.439999999999998 107.854 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.68 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 29.1 t-20 -138.53 141.24 39.32 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.358 0.599 . . . . 71.430000000000007 109.904 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 70' ' ' ARG . 58.9 t -101.52 151.15 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.465 1.106 . . . . 65.209999999999994 109.313 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 44.6 ttm -130.86 122.65 27.43 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.404 -0.961 . . . . 72.109999999999999 108.404 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.96 118.26 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.975 -1.121 . . . . 75.299999999999997 107.975 172.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -122.12 153.32 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.271 1.029 . . . . 71.439999999999998 108.738 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HB2' HD13 ' A' ' 8' ' ' LEU . 57.6 tttp -122.76 110.5 31.67 Favored Pre-proline 0 N--CA 1.473 0.698 0 N-CA-C 109.131 -0.692 . . . . 75.109999999999999 109.131 168.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 65' ' ' GLY . 27.2 Cg_exo -59.65 125.76 18.73 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.234 1.956 . . . . 74.329999999999998 110.192 167.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.83 -33.22 74.79 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.656 0.782 . . . . 72.019999999999996 111.327 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.55 -28.02 69.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.942 0.897 . . . . 63.229999999999997 111.449 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 35' ' ' ALA . 78.6 t -109.47 131.61 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.228 1.011 . . . . 72.0 111.4 -170.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -128.89 15.67 6.34 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.214 1.006 . . . . 71.329999999999998 110.525 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 m -143.75 154.06 43.07 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.335 0.654 . . . . 74.200000000000003 111.145 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.571 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 52.1 ttt180 -61.01 -50.28 74.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.259 1.024 . . . . 73.109999999999999 111.89 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 47.6 mt-10 -74.45 -30.45 61.88 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.58 0.352 . . . . 75.200000000000003 111.061 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -67.21 -25.4 66.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.069 0.548 . . . . 75.150000000000006 110.919 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.475 ' HB2' HG12 ' A' ' 29' ' ' VAL . . . -87.13 -30.63 20.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.546 0.738 . . . . 74.200000000000003 110.307 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 10.0 t -85.92 -6.97 58.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.068 0.947 . . . . 73.430000000000007 111.606 -172.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -82.82 -19.31 37.87 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.414 -0.587 . . . . 71.439999999999998 109.414 167.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.0 mt -87.82 6.31 35.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.631 0.772 . . . . 71.219999999999999 111.478 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 57' ' ' ILE . 42.5 mm -63.03 119.26 6.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 109.663 -0.495 . . . . 75.340000000000003 109.663 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.59 -4.53 40.02 Favored Glycine 0 C--O 1.239 0.46 0 CA-C-N 116.159 -0.473 . . . . 64.540000000000006 112.93 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -80.11 150.61 30.19 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 109.067 -0.716 . . . . 74.219999999999999 109.067 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.582 HD21 ' HD2' ' A' ' 54' ' ' LYS . 27.1 tp -89.86 159.55 16.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.208 -0.905 . . . . 75.109999999999999 109.024 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.486 HG21 HG12 ' A' ' 86' ' ' ILE . 90.4 t -128.32 114.53 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 107.509 -1.293 . . . . 73.030000000000001 107.509 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.32 108.75 21.52 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.705 1.202 . . . . 72.230000000000004 108.846 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -144.87 123.47 12.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.325 0.65 . . . . 74.530000000000001 109.823 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 27.1 ttpp -88.11 135.89 33.22 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.944 0.498 . . . . 70.129999999999995 109.73 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.9 p -73.75 158.28 86.32 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.856 0.863 . . . . 70.230000000000004 110.765 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.21 -8.1 19.32 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.433 2.089 . . . . 71.340000000000003 112.444 167.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -72.89 -21.71 60.87 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.644 0.777 . . . . 72.239999999999995 111.271 168.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.05 -19.44 37.85 Favored Glycine 0 C--N 1.352 1.439 0 C-N-CA 123.038 0.352 . . . . 73.219999999999999 113.442 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 134.42 34.76 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.275 0.63 . . . . 73.450000000000003 109.923 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 62.2 mt -78.3 123.72 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.481 -0.563 . . . . 73.219999999999999 109.481 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 73' ' ' LYS . 10.6 mt -102.97 131.05 50.21 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.28 -1.007 . . . . 72.109999999999999 108.28 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.582 ' HD2' HD21 ' A' ' 42' ' ' LEU . 32.1 mtmm -111.77 132.25 54.78 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.067 -0.716 . . . . 73.329999999999998 109.067 173.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.46 151.37 20.55 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 111.026 -0.829 . . . . 43.520000000000003 111.026 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -115.34 135.04 54.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.266 1.033 . . . . 74.420000000000002 110.708 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.489 HG23 ' HB ' ' A' ' 67' ' ' VAL . 56.7 mt -67.78 96.25 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.597 -0.89 . . . . 70.120000000000005 108.597 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 m -86.75 -31.4 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.012 0.525 . . . . 73.439999999999998 111.171 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -154.42 179.37 9.07 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 107.988 -1.116 . . . . 74.230000000000004 107.988 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.3 m -128.64 161.87 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.364 0.666 . . . . 72.409999999999997 109.959 170.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.483 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 21.8 t-80 -144.53 103.39 3.94 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.125 -0.695 . . . . 74.450000000000003 109.125 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.47 145.59 9.29 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 112.521 -0.232 . . . . 61.200000000000003 112.521 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.571 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 43.8 p -90.16 11.94 19.43 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.246 1.018 . . . . 75.439999999999998 111.928 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -106.58 17.08 23.77 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.03 0.932 . . . . 74.109999999999999 110.98 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 26' ' ' PRO . . . 76.63 36.18 38.61 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.097 -0.501 . . . . 75.109999999999999 113.909 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 61' ' ' HIS . . . -89.75 123.68 33.97 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.641 -0.874 . . . . 71.409999999999997 108.641 172.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.5 m -102.06 152.86 5.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-O 121.898 0.856 . . . . 71.230000000000004 111.35 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -101.62 103.66 14.49 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.551 1.54 . . . . 65.420000000000002 108.331 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.61 117.11 33.24 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.162 0.585 . . . . 74.239999999999995 110.762 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HD2' HG22 ' A' ' 21' ' ' VAL . 12.5 mmm-85 -89.44 102.62 15.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.326 1.05 . . . . 74.140000000000001 109.916 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.2 136.08 34.1 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.423 0.689 . . . . 55.32 110.976 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.528 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 14.3 pt-20 -57.33 -52.4 65.51 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.681 1.193 . . . . 73.340000000000003 111.039 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.539 ' HB2' HD22 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -92.92 -54.04 3.91 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.332 -0.988 . . . . 75.340000000000003 108.332 -179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.68 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 60.77 50.01 72.25 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 124.823 1.327 . . . . 65.430000000000007 112.894 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.9 mt -67.74 111.71 8.38 Favored Pre-proline 0 C--N 1.351 0.633 0 C-N-CA 123.271 0.628 . . . . 75.409999999999997 110.102 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.58 173.42 9.53 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.009 2.473 . . . . 72.310000000000002 111.218 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 165.32 -168.31 39.3 Favored Glycine 0 C--O 1.238 0.383 0 N-CA-C 111.315 -0.714 . . . . 75.230000000000004 111.315 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -94.8 67.38 3.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.192 0.996 . . . . 75.109999999999999 109.232 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.09 26.5 9.22 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.689 -1.141 . . . . 64.340000000000003 109.714 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.58 119.26 12.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.516 0.727 . . . . 71.040000000000006 110.698 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.01 -2.12 38.25 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.982 -0.554 . . . . 32.32 112.558 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.55 162.84 27.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.439 0.696 . . . . 73.430000000000007 109.943 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.53 131.92 45.21 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.386 0.674 . . . . 75.109999999999999 111.034 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.26 159.24 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.598 1.159 . . . . 74.219999999999999 108.608 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.2 106.5 14.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.522 -0.918 . . . . 74.340000000000003 108.522 170.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 43' ' ' VAL . 71.7 mt -83.42 108.73 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.383 -0.969 . . . . 72.150000000000006 108.383 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.73 143.87 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.946 0.898 . . . . 72.099999999999994 110.015 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.78 132.92 54.71 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 108.837 -0.801 . . . . 73.299999999999997 108.837 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -139.04 127.82 23.42 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.817 -1.179 . . . . 75.209999999999994 107.817 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -157.79 18.79 0.26 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.221 0.609 . . . . 72.129999999999995 110.718 -172.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 124.51 1.124 . . . . 74.310000000000002 110.097 -178.48 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.0 mtp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.869 0.366 . . . . 73.400000000000006 110.513 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 -128.52 139.35 52.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.172 0.989 . . . . 74.329999999999998 108.648 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 28' ' ' ASP . 53.0 mt -97.18 134.49 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 122.976 0.51 . . . . 73.400000000000006 110.476 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -89.27 121.61 31.72 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.005 0.922 . . . . 74.140000000000001 108.778 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -119.82 176.34 16.12 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-O 119.753 -0.471 . . . . 73.230000000000004 112.054 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.44 126.99 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.77 0.828 . . . . 75.219999999999999 109.653 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.43 99.4 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.618 0.767 . . . . 73.030000000000001 109.3 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.504 HD12 ' HB2' ' A' ' 25' ' ' LYS . 66.5 mt -71.59 -48.04 50.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.438 0.695 . . . . 72.420000000000002 110.033 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -157.02 159.96 38.51 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.451 -0.795 . . . . 73.010000000000005 110.487 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -99.65 159.22 15.21 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.245 -1.021 . . . . 74.420000000000002 108.245 167.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.547 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -136.98 106.6 6.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.129 -1.063 . . . . 74.340000000000003 108.129 176.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.03 146.85 43.42 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.782 0.433 . . . . 74.439999999999998 110.46 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -96.09 151.47 19.44 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.438 0.695 . . . . 74.299999999999997 109.482 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -57.59 -33.37 68.13 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.733 0.813 . . . . 73.5 111.003 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.96 136.45 33.01 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.1 -1.445 . . . . 70.010000000000005 107.1 171.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -53.62 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.477 1.511 . . . . 74.219999999999999 113.099 -169.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 44.83 37.9 2.58 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.59 1.556 . . . . 73.319999999999993 113.255 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -74.07 -38.07 64.04 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.078 -0.965 . . . . 72.049999999999997 109.736 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -156.05 70.51 0.69 Allowed 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.607 -1.257 . . . . 74.400000000000006 107.607 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.501 HD22 ' HA3' ' A' ' 74' ' ' GLY . 0.1 OUTLIER -76.63 160.74 29.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.169 -0.923 . . . . 71.230000000000004 108.966 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 11.7 t -98.26 162.88 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.545 -0.909 . . . . 75.230000000000004 108.545 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.0 ttm -147.18 124.0 11.25 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.63 -1.248 . . . . 74.319999999999993 107.63 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.65 118.3 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 123.876 0.735 . . . . 75.549999999999997 109.278 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.8 mt -129.15 158.08 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.256 1.022 . . . . 72.319999999999993 108.386 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.504 ' HB2' HD12 ' A' ' 8' ' ' LEU . 27.7 ttpp -141.41 108.44 6.16 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 109.671 -0.492 . . . . 71.049999999999997 109.671 170.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 14.2 Cg_endo -56.54 143.16 89.15 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 123.887 3.058 . . . . 75.310000000000002 112.864 171.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.7 mt -80.44 -38.15 30.62 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.348 1.059 . . . . 72.340000000000003 110.467 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.424 ' HB3' HG23 ' A' ' 3' ' ' ILE . 26.2 t70 -67.96 -27.64 66.77 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.135 -0.939 . . . . 63.43 111.593 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.477 HG22 HD12 ' A' ' 38' ' ' LEU . 76.5 t -110.79 120.06 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.194 0.998 . . . . 75.439999999999998 110.477 -176.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -127.67 21.64 6.47 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.695 0.798 . . . . 71.340000000000003 110.556 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.3 p -140.28 158.62 43.75 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.718 0.807 . . . . 74.510000000000005 110.676 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.644 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 48.3 ttt85 -65.96 -50.32 64.76 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.833 0.853 . . . . 75.200000000000003 112.775 -169.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -30.21 57.62 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.652 0.595 . . . . 70.409999999999997 111.163 -171.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.497 ' HA ' ' HD2' ' A' ' 37' ' ' LYS . 42.7 mm-40 -69.1 -20.29 64.07 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.25 -0.432 . . . . 72.420000000000002 111.318 170.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.2 -26.22 20.23 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.736 0.814 . . . . 60.119999999999997 110.575 170.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -80.84 -12.59 59.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.789 0.835 . . . . 75.5 110.692 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HD2' ' HA ' ' A' ' 34' ' ' GLU . 15.0 ptmt -85.46 -16.39 39.8 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.126 0.489 . . . . 72.120000000000005 109.776 170.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.477 HD12 HG22 ' A' ' 29' ' ' VAL . 43.2 mt -81.98 -8.5 59.67 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.27 0.628 . . . . 75.530000000000001 111.149 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 57' ' ' ILE . 43.1 mm -59.92 130.22 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.494 -0.558 . . . . 75.109999999999999 109.494 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.94 -19.06 56.12 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-O 119.872 -0.405 . . . . 63.329999999999998 112.844 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 87' ' ' VAL . 94.3 mtt180 -78.32 156.65 29.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.989 0.516 . . . . 75.310000000000002 111.309 -176.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.777 ' HB2' ' HA ' ' A' ' 90' ' ' HIS . 21.6 tp -90.99 128.88 36.99 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.531 0.732 . . . . 74.530000000000001 109.517 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.408 HG22 HG12 ' A' ' 86' ' ' ILE . 56.5 t -99.28 115.12 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.054 -0.721 . . . . 64.430000000000007 109.054 172.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.17 122.62 34.83 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.397 -0.964 . . . . 75.140000000000001 108.397 173.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 37.6 t90 -135.86 132.22 36.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.24 -0.652 . . . . 63.030000000000001 109.24 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -90.61 122.66 33.59 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.292 -1.003 . . . . 64.319999999999993 108.292 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.8 p -83.86 159.51 60.24 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.095 0.558 . . . . 71.129999999999995 111.078 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.39 -14.91 44.21 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.337 2.025 . . . . 74.209999999999994 111.764 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.1 t -68.99 -23.2 64.08 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.895 0.878 . . . . 73.439999999999998 111.124 173.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.99 20.29 26.39 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 116.324 -0.398 . . . . 74.120000000000005 112.78 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -111.15 137.13 49.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.763 0.825 . . . . 72.430000000000007 110.128 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.3 mt -86.07 93.48 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.063 -1.088 . . . . 74.129999999999995 108.063 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.51 HD22 ' HB2' ' A' ' 73' ' ' LYS . 51.1 mt -80.59 133.14 35.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.04 -0.982 . . . . 72.530000000000001 109.766 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HB3' HD12 ' A' ' 42' ' ' LEU . 30.6 mtmm -116.01 138.58 51.08 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.092 -0.707 . . . . 75.230000000000004 109.092 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.02 176.16 21.43 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-N 115.602 -0.726 . . . . 74.420000000000002 111.312 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -135.76 133.85 38.4 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.565 0.682 . . . . 73.299999999999997 109.826 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 39' ' ' ILE . 58.1 mt -73.84 108.32 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.384 -0.599 . . . . 64.430000000000007 109.384 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.33 -20.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.708 0.803 . . . . 71.219999999999999 111.464 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -158.45 162.66 37.55 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.524 -0.547 . . . . 75.109999999999999 109.524 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.436 HG11 HD13 ' A' ' 39' ' ' ILE . 33.8 m -108.34 169.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.663 0.785 . . . . 74.540000000000006 109.731 171.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -125.26 104.59 8.57 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.034 -0.728 . . . . 74.530000000000001 109.034 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.56 -140.31 44.44 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 123.971 0.794 . . . . 72.219999999999999 113.331 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.644 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 63.5 p -115.34 4.26 14.37 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.794 0.838 . . . . 63.509999999999998 111.716 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -82.38 1.55 36.72 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.253 0.621 . . . . 75.120000000000005 112.13 -171.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.41 0.88 87.87 Favored Glycine 0 C--N 1.355 1.611 0 CA-C-O 120.069 -0.295 . . . . 70.099999999999994 112.966 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.88 121.51 16.18 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.322 0.649 . . . . 73.540000000000006 110.177 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.2 141.42 18.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.426 0.632 . . . . 71.239999999999995 110.824 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.532 ' HE ' HG12 ' A' ' 21' ' ' VAL . 64.7 ttt180 -103.8 104.32 14.31 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.879 0.872 . . . . 61.5 108.95 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -112.37 136.23 52.1 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.289 0.636 . . . . 70.040000000000006 110.592 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.403 ' HG2' HG23 ' A' ' 21' ' ' VAL . 72.0 mtp180 -106.32 117.24 33.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.809 0.444 . . . . 75.219999999999999 110.005 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -92.41 143.69 26.12 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.933 0.893 . . . . 72.409999999999997 111.129 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.442 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 15.8 pt-20 -60.6 -30.98 70.17 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.49 1.116 . . . . 74.140000000000001 111.601 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.51 ' HB2' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -119.69 -72.73 0.67 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.744 -0.836 . . . . 71.329999999999998 108.744 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.501 ' HA3' HD22 ' A' ' 20' ' ' ASN . . . 66.57 57.26 10.39 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 111.759 -0.537 . . . . 73.120000000000005 111.759 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.12 123.17 85.65 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.824 0.85 . . . . 74.219999999999999 110.584 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.13 151.45 38.97 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 123.843 3.028 . . . . 73.299999999999997 113.489 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.56 171.52 37.47 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.395 -0.821 . . . . 64.439999999999998 111.106 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -87.39 69.01 9.88 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.773 0.797 . . . . 75.349999999999994 109.399 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -119.51 27.93 8.47 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.046 -0.979 . . . . 74.340000000000003 110.369 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.08 135.91 47.98 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.572 0.349 . . . . 75.310000000000002 110.385 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.17 -6.47 63.79 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.01 -0.541 . . . . 74.209999999999994 112.574 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.91 155.61 35.03 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.233 0.613 . . . . 60.520000000000003 109.44 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 97.3 m-85 -102.09 145.04 29.91 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.135 0.493 . . . . 64.209999999999994 112.147 -169.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.79 165.42 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.298 -0.865 . . . . 74.310000000000002 109.901 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -128.74 110.35 12.1 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.463 0.705 . . . . 73.019999999999996 109.118 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 43' ' ' VAL . 59.0 mt -84.22 113.18 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.094 0.958 . . . . 44.340000000000003 109.073 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 27.5 t -87.58 146.31 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.38 1.072 . . . . 65.420000000000002 110.022 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -57.02 -48.68 77.9 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.138 0.975 . . . . 75.109999999999999 110.856 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.32 -177.49 6.5 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.112 0.965 . . . . 73.519999999999996 110.452 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.777 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . 37.9 p-80 -137.88 -68.27 0.47 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.504 0.322 . . . . 74.329999999999998 110.944 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 . . . . . 0 C--O 1.246 0.907 0 N-CA-C 108.115 -1.069 . . . . 74.209999999999994 108.115 -178.4 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 120.939 0.4 . . . . 73.200000000000003 110.227 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' HG2' HG23 ' A' ' 87' ' ' VAL . 73.6 mtt180 -103.49 123.54 47.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.93 0.892 . . . . 74.019999999999996 109.188 173.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 48.4 mt -98.81 131.35 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.78 0.832 . . . . 73.549999999999997 108.85 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.11 120.58 29.61 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.788 -0.819 . . . . 74.230000000000004 108.788 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -125.24 170.71 17.17 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.861 -0.496 . . . . 62.32 111.861 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.7 t -126.54 138.95 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.239 1.016 . . . . 74.239999999999995 109.513 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.39 114.29 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.44 1.096 . . . . 73.329999999999998 110.12 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 25' ' ' LYS . 42.4 mt -92.61 -55.68 3.3 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.729 0.412 . . . . 62.340000000000003 110.479 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -153.87 152.33 30.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.837 0.455 . . . . 72.200000000000003 111.949 -174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -110.09 128.74 55.62 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.047 0.939 . . . . 72.140000000000001 108.574 170.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.79 106.19 9.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.058 -1.83 . . . . 73.140000000000001 106.058 171.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -76.91 125.41 29.26 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.252 0.478 . . . . 74.209999999999994 109.796 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.5 t -73.6 119.42 17.8 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.303 1.041 . . . . 64.409999999999997 110.795 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -68.87 106.63 2.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.845 0.858 . . . . 71.420000000000002 110.186 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.537 ' HG3' ' H ' ' A' ' 17' ' ' GLN . 11.2 tp10 -163.84 164.94 23.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.607 0.763 . . . . 75.239999999999995 109.763 -176.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.87 -35.78 79.13 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.607 -0.516 . . . . 70.200000000000003 109.607 171.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.537 ' H ' ' HG3' ' A' ' 15' ' ' GLU . 33.8 tt0 -88.2 113.01 23.39 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.504 -0.924 . . . . 72.120000000000005 108.504 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -57.62 119.78 7.18 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 124.091 0.869 . . . . 71.109999999999999 109.972 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -153.02 171.36 18.5 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.962 -1.125 . . . . 63.219999999999999 107.962 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' A' ' 71' ' ' PHE . 3.5 p-10 -149.0 150.21 32.44 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.467 0.651 . . . . 74.219999999999999 110.789 174.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.419 HG22 ' HD3' ' A' ' 70' ' ' ARG . 47.3 t -88.07 143.5 11.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.885 -1.524 . . . . 74.0 106.885 159.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.4 ttt -137.26 113.58 10.04 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.46 -0.941 . . . . 73.239999999999995 108.46 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.513 HG23 HD12 ' A' ' 8' ' ' LEU . 46.0 mm -80.37 119.83 30.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.104 -1.073 . . . . 70.209999999999994 108.104 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 84' ' ' VAL . 98.0 mt -129.87 143.99 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.187 0.995 . . . . 75.329999999999998 108.398 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.516 ' HB2' HD13 ' A' ' 8' ' ' LEU . 64.4 tttp -116.06 111.22 42.94 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 109.01 -0.737 . . . . 72.109999999999999 109.01 167.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.564 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 16.4 Cg_exo -66.33 131.27 26.07 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.12 1.88 . . . . 65.120000000000005 110.729 167.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.38 -31.91 72.64 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.016 0.926 . . . . 74.230000000000004 111.885 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.82 -29.88 64.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.791 0.836 . . . . 75.140000000000001 111.55 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.578 HG13 ' HB2' ' A' ' 34' ' ' GLU . 72.0 t -103.1 107.73 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.0 0.92 . . . . 72.530000000000001 110.677 -170.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -124.45 17.8 8.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.486 1.114 . . . . 74.510000000000005 109.839 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.3 t -139.62 156.32 46.92 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.366 1.067 . . . . 73.25 109.97 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -67.68 -37.67 82.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.308 0.643 . . . . 73.209999999999994 110.903 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.66 -45.09 95.45 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.929 0.891 . . . . 71.230000000000004 111.594 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.578 ' HB2' HG13 ' A' ' 29' ' ' VAL . 42.1 mt-10 -65.17 -32.72 74.55 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.888 -1.051 . . . . 74.409999999999997 110.553 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.0 -28.76 49.28 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.901 0.88 . . . . 63.310000000000002 111.36 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -75.69 -25.96 57.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.146 0.978 . . . . 75.5 111.474 -173.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -84.43 -3.19 58.2 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.098 0.407 . . . . 72.239999999999995 112.098 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 29' ' ' VAL . 29.9 mt -90.52 -2.87 57.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.814 0.445 . . . . 73.340000000000003 111.428 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -66.2 117.57 7.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.087 0.555 . . . . 74.439999999999998 109.835 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.97 1.98 57.14 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.152 -0.931 . . . . 61.030000000000001 113.202 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -87.62 161.0 17.95 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.327 1.063 . . . . 73.099999999999994 111.055 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.4 tp -90.1 139.25 30.81 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.338 1.055 . . . . 74.310000000000002 108.314 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 t -126.7 122.21 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.552 -0.907 . . . . 74.129999999999995 108.552 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.19 102.25 11.67 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.947 0.899 . . . . 73.420000000000002 109.745 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.444 ' HZ2' ' HB2' ' A' ' 79' ' ' ALA . 29.4 t90 -95.47 144.22 26.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.248 -0.649 . . . . 75.239999999999995 109.248 170.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -103.36 100.33 10.21 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.603 1.161 . . . . 64.219999999999999 108.162 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.7 p -64.62 150.38 94.04 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.583 0.753 . . . . 74.530000000000001 111.246 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.88 -5.35 15.39 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.646 2.231 . . . . 74.239999999999995 112.289 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.5 t -70.72 -19.54 62.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.705 1.202 . . . . 71.040000000000006 111.163 169.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.51 36.08 8.96 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.887 -0.597 . . . . 62.210000000000001 112.068 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -127.67 131.99 49.75 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.025 0.93 . . . . 74.299999999999997 109.014 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -90.26 93.11 4.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.661 -1.237 . . . . 73.519999999999996 107.661 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 75' ' ' LEU . 34.9 mt -74.86 137.35 41.76 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.819 -1.082 . . . . 75.340000000000003 109.508 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -98.0 137.65 36.5 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.003 0.921 . . . . 74.430000000000007 108.92 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.56 176.31 22.41 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 123.687 0.617 . . . . 72.200000000000003 111.635 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.3 ttmt -147.37 129.98 15.95 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.907 0.353 . . . . 75.140000000000001 110.752 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.4 mt -73.04 105.03 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.874 -1.057 . . . . 74.140000000000001 109.175 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 m -84.55 -36.14 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.821 -0.627 . . . . 75.329999999999998 110.816 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -148.22 -174.74 4.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.676 0.79 . . . . 74.150000000000006 111.203 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -114.31 170.53 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.235 1.014 . . . . 73.319999999999993 110.125 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -136.89 101.63 4.64 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.378 -0.971 . . . . 71.219999999999999 108.378 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.76 -172.56 10.17 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.268 -0.878 . . . . 65.310000000000002 115.181 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.3 p -91.22 11.93 21.82 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.808 1.243 . . . . 75.219999999999999 110.853 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.84 -25.35 60.03 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.937 1.295 . . . . 73.010000000000005 109.718 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.4 -2.43 65.23 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.653 -0.703 . . . . 64.430000000000007 112.788 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.4 129.76 40.91 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.028 0.531 . . . . 50.219999999999999 109.898 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.9 m -102.0 149.9 6.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 C-N-CA 123.665 0.786 . . . . 74.430000000000007 110.805 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -99.76 102.63 14.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.013 -1.449 . . . . 75.439999999999998 107.506 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.57 157.53 17.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.002 0.521 . . . . 74.329999999999998 110.743 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.419 ' HD3' HG22 ' A' ' 21' ' ' VAL . 10.0 mmm180 -131.65 99.7 4.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.366 1.066 . . . . 73.209999999999994 109.703 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.403 ' HB2' ' OD1' ' A' ' 20' ' ' ASN . 16.7 m-85 -88.97 138.51 31.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.181 0.593 . . . . 74.439999999999998 109.818 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.17 -43.23 99.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.83 1.252 . . . . 73.129999999999995 112.43 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -87.64 -53.4 4.81 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.613 -0.721 . . . . 73.239999999999995 111.808 -167.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.73 35.66 39.68 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-O 120.006 -0.33 . . . . 61.329999999999998 113.428 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.604 ' HB2' HD11 ' A' ' 53' ' ' LEU . 41.4 mt -69.42 126.52 92.7 Favored Pre-proline 0 C--N 1.353 0.728 0 C-N-CA 122.409 0.284 . . . . 73.340000000000003 110.44 177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.56 158.94 46.99 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.866 2.377 . . . . 75.200000000000003 110.918 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.3 115.1 0.35 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.243 -1.143 . . . . 73.310000000000002 110.243 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -65.95 75.97 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.089 1.355 . . . . 74.409999999999997 111.059 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.444 ' HB2' ' HZ2' ' A' ' 45' ' ' TRP . . . -120.83 28.41 7.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.056 1.342 . . . . 75.519999999999996 109.468 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.3 mt -64.5 103.65 0.69 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 108.59 -0.893 . . . . 72.140000000000001 108.59 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.06 -5.52 8.93 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 116.154 -0.476 . . . . 72.239999999999995 113.109 -172.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -76.02 172.28 13.03 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.956 0.902 . . . . 73.510000000000005 108.905 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -107.51 143.62 35.65 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.526 0.679 . . . . 75.219999999999999 111.419 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG21 HG23 ' A' ' 24' ' ' ILE . 19.6 m -113.24 164.29 9.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-N 114.319 -1.31 . . . . 75.239999999999995 108.405 172.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -127.76 109.74 11.94 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.936 0.494 . . . . 71.349999999999994 109.921 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 54.6 mt -82.59 92.66 2.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.078 -1.082 . . . . 74.239999999999995 108.078 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.492 HG23 ' HG2' ' A' ' 2' ' ' ARG . 96.4 t -77.48 128.79 37.97 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 CA-C-N 113.917 -1.492 . . . . 70.349999999999994 110.105 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.25 137.63 57.7 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 108.167 -1.049 . . . . 74.120000000000005 108.167 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -58.48 134.15 56.42 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.273 1.029 . . . . 72.340000000000003 113.13 -173.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -107.2 92.96 4.29 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.94 0.896 . . . . 75.319999999999993 108.9 173.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 . . . . . 0 C--O 1.249 1.05 0 N-CA-C 108.357 -0.979 . . . . 65.109999999999999 108.357 -179.762 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 ttm . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.338 -0.615 . . . . 75.219999999999999 109.338 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.424 ' HG2' ' HA ' ' A' ' 87' ' ' VAL . 59.9 mtm-85 -134.71 153.84 51.82 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.365 1.066 . . . . 74.329999999999998 109.414 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.535 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 55.9 mt -121.92 137.32 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.866 0.866 . . . . 74.519999999999996 109.41 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -89.09 131.86 35.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.297 -0.631 . . . . 73.299999999999997 109.297 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -137.97 137.52 8.9 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-O 120.169 -0.24 . . . . 72.25 112.983 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t -98.97 117.08 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.808 0.843 . . . . 74.430000000000007 110.261 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.98 106.76 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.529 1.132 . . . . 74.0 110.669 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.7 -50.56 15.01 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.37 0.668 . . . . 74.219999999999999 110.05 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -154.35 172.05 18.32 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.1 -0.954 . . . . 51.549999999999997 110.684 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -120.33 122.61 41.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.963 -1.125 . . . . 74.409999999999997 107.963 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 1.8 tpm_? -101.83 104.2 14.94 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 106.777 -1.564 . . . . 71.430000000000007 106.777 174.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.446 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 66.6 mtp85 -100.32 115.38 29.83 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.15 0.5 . . . . 74.150000000000006 111.994 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.6 t -67.84 134.24 50.56 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 108.103 -1.073 . . . . 74.120000000000005 108.103 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -58.02 117.27 4.15 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 124.107 0.88 . . . . 75.409999999999997 110.357 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 60.37 20.18 9.78 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.473 1.109 . . . . 74.319999999999993 113.074 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.0 t30 68.09 30.54 5.83 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.351 1.06 . . . . 75.239999999999995 110.695 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -58.1 -64.41 0.92 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.124 0.97 . . . . 74.230000000000004 111.864 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -99.35 25.8 6.61 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.156 0.582 . . . . 72.340000000000003 109.761 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 73.17 134.99 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.244 1.817 . . . . 73.120000000000005 112.146 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.514 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 36.8 t30 -73.54 137.7 44.54 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 123.395 0.678 . . . . 72.129999999999995 110.477 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.523 HG23 ' HG2' ' A' ' 70' ' ' ARG . 67.7 t -105.74 155.39 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 125.89 1.676 . . . . 74.510000000000005 109.785 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 44.3 ttm -137.73 127.47 25.36 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.662 -0.866 . . . . 75.340000000000003 108.662 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -88.01 110.57 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.47 -0.937 . . . . 74.239999999999995 108.47 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 84' ' ' VAL . 79.7 mt -117.39 149.21 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.364 1.066 . . . . 75.019999999999996 109.051 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HG2' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -123.95 97.67 40.66 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 108.082 -1.081 . . . . 72.5 108.082 174.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.813 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 36.9 Cg_exo -60.85 125.62 17.64 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.919 2.412 . . . . 73.140000000000001 112.639 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.16 -42.33 89.14 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.623 0.769 . . . . 74.310000000000002 112.541 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.47 0.76 55.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.641 0.776 . . . . 73.219999999999999 111.983 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.813 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 59.4 t -114.3 107.89 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.296 1.038 . . . . 73.209999999999994 108.355 174.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -121.9 6.48 9.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.404 0.682 . . . . 74.019999999999996 111.77 -173.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 m -127.68 142.65 51.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.855 0.862 . . . . 74.430000000000007 108.875 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.52 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 57.3 ttt180 -57.4 -34.78 69.25 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.007 0.923 . . . . 74.510000000000005 111.27 175.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -60.26 -42.65 95.79 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.663 0.785 . . . . 71.299999999999997 111.825 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.615 ' HB2' HG12 ' A' ' 29' ' ' VAL . 36.5 mt-10 -64.44 -44.33 91.51 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.163 -0.926 . . . . 71.239999999999995 109.376 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.9 -26.01 66.66 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.438 -0.801 . . . . 72.209999999999994 111.55 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -73.56 -33.93 64.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.35 1.06 . . . . 74.150000000000006 110.777 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -85.86 -2.94 58.75 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.791 0.293 . . . . 75.239999999999995 111.791 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.483 HD13 HG23 ' A' ' 29' ' ' VAL . 50.5 mt -86.19 -1.58 57.57 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 119.232 -0.413 . . . . 75.319999999999993 112.06 174.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.434 HD13 HG23 ' A' ' 57' ' ' ILE . 43.2 mm -64.22 122.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.672 -0.862 . . . . 71.420000000000002 108.672 172.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.06 -4.94 55.93 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.508 -0.315 . . . . 73.019999999999996 113.163 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -84.8 148.09 26.5 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.197 0.499 . . . . 74.019999999999996 109.729 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.3 tp -88.83 141.5 28.45 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.4 1.08 . . . . 74.400000000000006 108.507 -173.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.51 126.02 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.4 -0.593 . . . . 72.420000000000002 109.4 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.1 mt -111.49 105.66 14.32 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.078 0.951 . . . . 74.209999999999994 109.421 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -110.47 133.27 53.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.306 0.642 . . . . 72.430000000000007 109.374 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -92.59 111.98 23.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.791 -1.188 . . . . 73.420000000000002 107.791 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.5 p -68.47 152.51 96.57 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.238 0.615 . . . . 75.219999999999999 111.338 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.41 -18.12 57.43 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.972 2.448 . . . . 64.200000000000003 111.917 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.6 m -61.55 -21.07 63.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.156 1.383 . . . . 73.230000000000004 111.988 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.71 20.35 44.29 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 116.352 -0.385 . . . . 63.350000000000001 112.425 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -108.29 146.98 32.09 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.875 0.87 . . . . 75.409999999999997 109.192 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -101.36 93.43 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.669 -1.234 . . . . 71.120000000000005 107.669 172.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.6 mt -77.88 130.28 36.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.938 -1.028 . . . . 74.219999999999999 109.103 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -107.3 146.62 31.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.277 0.631 . . . . 73.430000000000007 109.32 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.32 -171.31 21.12 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.214 -0.903 . . . . 70.409999999999997 111.497 -175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -152.22 135.34 15.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.001 0.401 . . . . 65.140000000000001 110.954 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 39' ' ' ILE . 70.6 mt -69.83 110.64 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 O-C-N 124.095 0.872 . . . . 71.340000000000003 108.686 175.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.44 -8.54 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.513 0.725 . . . . 74.109999999999999 111.291 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -158.48 150.79 21.76 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.73 -0.471 . . . . 75.239999999999995 109.73 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.7 m -98.62 159.46 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.436 0.694 . . . . 71.230000000000004 109.537 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.404 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 59.7 t-80 -144.44 104.48 4.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.126 0.57 . . . . 72.109999999999999 109.808 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.91 168.94 40.49 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 121.336 0.409 . . . . 72.209999999999994 113.655 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.52 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 21.4 p -85.0 -9.22 58.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.482 1.113 . . . . 74.329999999999998 112.29 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -81.87 5.95 17.29 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.509 0.724 . . . . 74.400000000000006 112.686 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.432 ' HA3' HG13 ' A' ' 29' ' ' VAL . . . 84.84 9.11 81.56 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 119.518 -0.601 . . . . 75.450000000000003 113.802 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.492 ' HB1' ' HG2' ' A' ' 25' ' ' LYS . . . -67.18 133.9 50.67 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 122.656 0.383 . . . . 75.409999999999997 110.201 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.3 150.06 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.547 0.739 . . . . 54.43 111.231 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -103.0 105.21 15.48 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.546 1.138 . . . . 74.409999999999997 108.369 171.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.84 120.24 41.92 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.453 0.701 . . . . 71.519999999999996 109.936 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG2' HG23 ' A' ' 21' ' ' VAL . 41.2 mtm105 -88.92 118.81 28.9 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.174 -0.676 . . . . 75.439999999999998 109.174 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -90.78 122.94 33.95 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.336 0.654 . . . . 74.510000000000005 109.773 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.0 -39.3 74.43 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.223 1.009 . . . . 74.400000000000006 111.873 -173.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -76.81 -55.06 5.82 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.251 -0.886 . . . . 73.239999999999995 109.528 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 61.26 34.55 88.55 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 114.6 -1.182 . . . . 74.25 113.865 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 96.0 mt -69.66 137.83 88.21 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.588 0.755 . . . . 74.549999999999997 110.353 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 12.8 Cg_exo -68.76 143.85 57.39 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.96 2.44 . . . . 74.519999999999996 112.445 -174.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.76 104.02 0.17 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.722 -0.951 . . . . 63.109999999999999 110.722 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -73.68 91.18 1.87 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.733 0.813 . . . . 74.319999999999993 110.025 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.83 30.77 7.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.717 1.207 . . . . 74.340000000000003 109.91 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.1 mt -43.9 103.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.323 1.049 . . . . 73.340000000000003 112.259 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.15 4.75 20.38 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.814 -0.63 . . . . 34.5 113.913 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -91.36 168.11 11.8 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.055 0.942 . . . . 71.349999999999994 110.901 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -100.15 154.6 18.31 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.722 0.809 . . . . 74.430000000000007 112.627 -172.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG21 HD13 ' A' ' 24' ' ' ILE . 18.5 m -131.18 158.21 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.92 1.288 . . . . 73.519999999999996 109.062 176.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.97 108.25 17.52 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.058 -0.719 . . . . 75.239999999999995 109.058 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.535 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 68.1 mt -89.14 94.09 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.976 -1.12 . . . . 72.140000000000001 107.976 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.424 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . 48.6 t -74.01 133.48 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.143 -0.935 . . . . 74.349999999999994 109.043 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -61.34 127.64 32.48 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.743 -0.836 . . . . 73.200000000000003 108.743 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.53 144.38 21.7 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.237 -1.023 . . . . 73.340000000000003 108.237 -174.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -152.94 136.24 15.76 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.314 0.645 . . . . 72.0 109.79 -177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 42.3 t60 . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 118.59 -0.719 . . . . 75.010000000000005 110.04 -177.825 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.968 -0.382 . . . . 74.340000000000003 109.968 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -99.7 135.26 41.39 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.525 0.73 . . . . 75.5 109.466 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.509 HD11 HH11 ' A' ' 41' ' ' ARG . 65.7 mt -111.84 124.06 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.91 -1.144 . . . . 74.0 107.91 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 7.1 ptpp? -88.35 127.29 35.48 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.314 0.578 . . . . 73.299999999999997 110.912 -173.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -123.76 160.45 18.31 Favored Glycine 0 C--O 1.218 -0.872 0 CA-C-N 115.59 -0.732 . . . . 70.030000000000001 111.834 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.14 129.56 50.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 123.542 0.737 . . . . 74.25 109.379 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.641 HG13 ' HE2' ' A' ' 22' ' ' MET . 60.4 t -66.93 99.87 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.954 0.902 . . . . 71.019999999999996 109.459 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.725 HD13 ' HG2' ' A' ' 25' ' ' LYS . 72.2 mt -74.46 -59.32 2.78 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.776 -0.453 . . . . 74.219999999999999 109.776 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.4 t -166.08 162.07 17.6 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.923 -0.581 . . . . 75.099999999999994 111.355 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.494 ' HB3' HD22 ' A' ' 20' ' ' ASN . 62.4 m-85 -115.87 145.35 42.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.965 1.306 . . . . 74.019999999999996 108.892 171.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -136.27 106.17 6.26 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.426 -1.324 . . . . 64.519999999999996 107.426 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -75.46 136.67 40.67 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.723 -0.473 . . . . 73.109999999999999 109.723 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.2 t -77.73 145.23 36.66 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.653 0.381 . . . . 63.409999999999997 110.706 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -72.06 -26.44 62.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.885 0.874 . . . . 72.010000000000005 110.263 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -68.99 -59.57 2.96 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.049 0.94 . . . . 75.150000000000006 109.29 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -129.56 116.34 18.76 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.184 0.994 . . . . 72.209999999999994 108.894 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -56.06 -44.53 78.99 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.469 1.108 . . . . 74.099999999999994 111.398 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -74.85 -28.59 60.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.92 -1.036 . . . . 73.239999999999995 111.696 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -82.16 84.12 7.14 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.543 -0.91 . . . . 73.299999999999997 108.543 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.494 HD22 ' HB3' ' A' ' 10' ' ' TYR . 44.6 t-20 -97.2 127.7 43.41 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.618 -1.174 . . . . 75.349999999999994 109.223 -174.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.8 t -88.44 105.1 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.448 -0.945 . . . . 73.319999999999993 108.448 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.652 ' HE3' HG12 ' A' ' 24' ' ' ILE . 24.8 ttt -98.83 136.46 38.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.268 -1.333 . . . . 73.200000000000003 109.11 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.485 HG23 HD12 ' A' ' 8' ' ' LEU . 27.7 mm -104.48 131.0 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 108.238 -1.023 . . . . 73.019999999999996 108.238 174.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.652 HG12 ' HE3' ' A' ' 22' ' ' MET . 22.9 mt -124.97 150.31 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.941 0.897 . . . . 74.129999999999995 109.239 -174.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.725 ' HG2' HD13 ' A' ' 8' ' ' LEU . 1.1 mmmm -120.37 98.59 48.52 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 123.115 0.566 . . . . 75.430000000000007 110.404 170.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.442 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 23.8 Cg_exo -63.07 135.88 53.42 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.116 1.877 . . . . 72.319999999999993 110.377 169.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.5 mt -60.73 -30.99 70.31 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.31 0.576 . . . . 71.239999999999995 111.149 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.23 -27.17 61.44 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.334 1.453 . . . . 73.140000000000001 111.79 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 34' ' ' GLU . 94.6 t -115.93 121.09 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.9 0.88 . . . . 74.319999999999993 110.427 -170.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -135.29 14.68 3.5 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.671 0.788 . . . . 73.5 111.26 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 m -137.67 151.27 48.08 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.845 0.858 . . . . 61.350000000000001 109.781 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.617 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 50.0 ttt180 -60.37 -38.82 85.1 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.253 1.021 . . . . 75.329999999999998 112.184 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.57 -40.1 95.78 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.049 0.54 . . . . 73.340000000000003 111.44 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HB2' HG11 ' A' ' 29' ' ' VAL . 48.0 mt-10 -64.73 -35.64 81.71 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.9 0.75 . . . . 63.420000000000002 110.828 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.79 -30.6 51.38 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.987 0.915 . . . . 73.239999999999995 111.274 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -73.19 -31.63 64.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.065 0.946 . . . . 72.409999999999997 111.25 -173.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -79.28 -11.71 59.94 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 120.831 0.348 . . . . 74.129999999999995 110.899 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.583 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 51.5 mt -109.73 23.62 14.16 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.205 1.002 . . . . 74.310000000000002 111.561 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.5 mm -75.47 135.39 27.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.565 -0.531 . . . . 74.540000000000006 109.565 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.6 -9.3 44.55 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-O 119.103 -0.831 . . . . 65.5 113.061 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.583 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 79.1 mtm180 -62.11 149.11 42.25 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.334 0.654 . . . . 73.209999999999994 112.408 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 tp -91.64 120.68 32.62 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.369 1.068 . . . . 75.319999999999993 109.262 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.0 t -100.21 137.28 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 122.911 0.484 . . . . 64.530000000000001 110.031 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.7 mt -131.34 120.13 22.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.787 1.235 . . . . 74.329999999999998 107.761 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -130.28 128.44 41.57 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.435 -0.579 . . . . 74.129999999999995 109.435 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -84.43 110.84 18.94 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.347 -0.612 . . . . 72.030000000000001 109.347 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.8 t -77.2 153.72 82.23 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 124.255 1.022 . . . . 63.43 109.537 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.3 -8.55 14.85 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.137 2.558 . . . . 75.099999999999994 114.686 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.9 p -70.9 -15.32 62.61 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.262 0.625 . . . . 74.310000000000002 111.506 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.23 -10.53 63.54 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 123.719 0.676 . . . . 53.310000000000002 112.388 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.57 132.41 35.11 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.627 0.771 . . . . 74.450000000000003 110.755 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.8 106.5 13.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.944 -0.761 . . . . 75.5 108.944 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.8 117.93 16.15 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.726 -0.842 . . . . 74.340000000000003 108.726 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -109.16 146.67 33.74 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 123.021 0.528 . . . . 73.430000000000007 110.424 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.82 -171.75 27.2 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 114.825 -1.079 . . . . 34.219999999999999 110.999 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.73 134.18 20.81 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.057 0.428 . . . . 74.030000000000001 111.086 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.524 HD11 ' HB2' ' A' ' 41' ' ' ARG . 78.1 mt -67.5 106.87 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.509 0 O-C-N 124.41 1.069 . . . . 74.109999999999999 109.402 175.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.511 HG11 ' HE ' ' A' ' 70' ' ' ARG . 27.6 m -91.52 -31.74 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.567 0.747 . . . . 62.240000000000002 111.559 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -155.76 176.29 12.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.863 -0.791 . . . . 74.109999999999999 108.863 -173.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.2 m -92.51 170.06 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 109.092 -0.707 . . . . 74.329999999999998 109.092 170.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -136.17 103.4 5.31 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.267 -1.012 . . . . 73.340000000000003 108.267 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.7 -149.04 42.71 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.657 -0.702 . . . . 71.099999999999994 113.24 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.617 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -117.97 -17.37 9.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.472 0.709 . . . . 72.540000000000006 112.105 -171.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 25.29 2.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.497 0.719 . . . . 74.439999999999998 112.232 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.22 18.13 78.66 Favored Glycine 0 C--N 1.346 1.13 0 N-CA-C 114.97 0.748 . . . . 73.409999999999997 114.97 167.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.12 38.19 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.582 -0.896 . . . . 61.439999999999998 108.582 171.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.8 m -102.43 139.46 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.046 0.451 . . . . 73.030000000000001 109.973 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -99.58 105.53 17.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.118 0.967 . . . . 74.230000000000004 108.747 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.51 121.58 44.7 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.832 0.853 . . . . 70.349999999999994 110.817 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.511 ' HE ' HG11 ' A' ' 58' ' ' VAL . 39.1 mtm180 -89.33 113.12 24.36 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.979 -0.748 . . . . 72.329999999999998 108.979 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -81.5 136.15 35.62 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.337 1.055 . . . . 74.109999999999999 110.329 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.66 -24.78 36.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.404 0.682 . . . . 75.0 110.904 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -77.39 -54.77 6.05 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.485 -0.78 . . . . 73.120000000000005 109.685 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.04 25.1 63.82 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 124.042 0.838 . . . . 71.030000000000001 114.263 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.63 158.46 78.5 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.949 0.9 . . . . 73.430000000000007 110.848 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.58 150.6 51.32 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.996 2.464 . . . . 74.129999999999995 112.733 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.24 -71.96 0.3 Allowed Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.915 -0.584 . . . . 73.120000000000005 112.43 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 76.02 -40.43 0.4 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 126.075 1.75 . . . . 75.019999999999996 112.604 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.81 30.07 0.11 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.126 0.97 . . . . 65.25 112.661 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.18 149.42 28.32 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.216 1.006 . . . . 74.439999999999998 110.707 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.449 ' H ' ' HB ' ' A' ' 7' ' ' VAL . . . 87.72 4.12 79.8 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 116.601 -0.272 . . . . 73.510000000000005 113.076 -169.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -85.38 170.9 12.28 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.76 0.824 . . . . 74.519999999999996 110.176 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.69 133.24 36.2 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.516 0.674 . . . . 73.319999999999993 112.169 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 11.4 m -100.71 159.34 3.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 114.452 -1.249 . . . . 72.319999999999993 108.946 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -109.19 108.9 19.71 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.473 -0.936 . . . . 72.430000000000007 108.473 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.9 95.13 4.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.584 -0.895 . . . . 75.420000000000002 108.584 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.22 136.73 24.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 115.246 -0.888 . . . . 75.439999999999998 109.593 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.64 96.4 0.27 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.642 -0.873 . . . . 75.420000000000002 108.642 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.75 141.87 58.18 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.799 0.84 . . . . 74.140000000000001 110.592 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 32.8 m170 61.75 66.46 0.84 Allowed 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.743 1.217 . . . . 74.109999999999999 109.902 -173.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 34.3 p80 . . . . . 0 C--O 1.253 1.284 0 CA-C-N 114.998 -1.001 . . . . 72.109999999999999 109.748 174.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 121.168 0.509 . . . . 74.510000000000005 110.383 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -133.27 118.94 19.16 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.421 -1.326 . . . . 75.329999999999998 107.421 173.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 mt -98.55 155.69 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.411 1.084 . . . . 75.519999999999996 108.96 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.533 ' HG3' HD13 ' A' ' 27' ' ' LEU . 19.1 ptmt -114.36 140.92 48.26 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.865 -0.791 . . . . 75.030000000000001 108.865 173.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -139.32 164.57 25.9 Favored Glycine 0 C--O 1.216 -0.995 0 N-CA-C 111.647 -0.581 . . . . 44.119999999999997 111.647 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.37 131.38 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.348 0.659 . . . . 75.230000000000004 109.926 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.1 93.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.304 -0.998 . . . . 74.409999999999997 108.304 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 25' ' ' LYS . 79.8 mt -68.4 -59.31 3.27 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 110.131 -0.322 . . . . 73.400000000000006 110.131 -176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 t -154.38 155.67 35.46 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.074 -0.512 . . . . 75.049999999999997 110.722 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -95.78 138.81 32.91 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.458 -0.941 . . . . 73.439999999999998 108.458 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -130.06 107.11 9.08 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.585 -0.894 . . . . 73.120000000000005 108.585 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -76.18 138.85 40.95 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 110.111 -0.329 . . . . 74.319999999999993 110.111 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 62.9 m -86.28 131.98 34.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.348 0.659 . . . . 73.349999999999994 109.766 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -65.36 -30.19 70.99 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.226 1.01 . . . . 75.109999999999999 112.474 -175.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -98.62 -62.77 1.19 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.706 0.803 . . . . 75.230000000000004 109.128 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.551 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 11.7 m120 -75.5 88.69 2.67 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.791 -0.64 . . . . 74.140000000000001 110.354 -176.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -61.98 -24.42 67.01 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.733 0.813 . . . . 75.019999999999996 112.37 -175.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -110.09 -42.09 4.28 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.452 0.701 . . . . 71.319999999999993 111.046 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.551 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 53.7 t30 -78.11 72.45 4.64 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.758 0.789 . . . . 72.140000000000001 108.923 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -89.63 159.72 17.01 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.981 -1.009 . . . . 63.030000000000001 109.025 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.418 HG23 ' HG2' ' A' ' 70' ' ' ARG . 62.2 t -88.12 145.9 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 108.282 -1.007 . . . . 72.310000000000002 108.282 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.3 ttt -136.22 111.51 9.09 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.485 -1.302 . . . . 70.109999999999999 107.485 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 mm -78.51 119.13 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 114.98 -1.009 . . . . 72.25 108.387 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.432 HG21 HG22 ' A' ' 84' ' ' VAL . 81.5 mt -130.93 153.12 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.488 1.115 . . . . 73.400000000000006 108.089 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HB2' HD11 ' A' ' 8' ' ' LEU . 87.5 tttt -127.33 121.88 22.69 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 108.912 -0.773 . . . . 73.400000000000006 108.912 164.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -69.87 140.23 41.74 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.768 2.312 . . . . 71.439999999999998 110.768 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.533 HD13 ' HG3' ' A' ' 4' ' ' LYS . 92.7 mt -69.84 -29.78 67.11 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.384 0.673 . . . . 73.540000000000006 111.276 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.08 -22.23 60.62 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.996 -1.002 . . . . 71.450000000000003 111.303 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 34' ' ' GLU . 57.9 t -110.23 123.96 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.335 1.054 . . . . 72.209999999999994 110.746 -174.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -135.16 11.13 3.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.845 0.858 . . . . 65.329999999999998 110.429 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.445 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 27.5 m -131.09 165.33 23.49 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.426 0.69 . . . . 74.0 111.126 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -68.93 -43.73 74.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.703 1.201 . . . . 75.510000000000005 110.97 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -70.65 -32.54 69.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.746 0.818 . . . . 72.019999999999996 110.763 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.537 ' HB2' HG13 ' A' ' 29' ' ' VAL . 44.7 mt-10 -68.51 -30.89 69.81 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.78 -0.645 . . . . 73.450000000000003 110.5 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.38 -32.04 33.04 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.578 0.751 . . . . 72.349999999999994 110.728 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -75.18 -23.77 57.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.869 0.868 . . . . 73.25 111.382 -174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -80.23 -13.67 59.04 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 120.73 0.3 . . . . 72.150000000000006 110.968 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.9 mt -90.32 3.87 52.42 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 122.961 0.504 . . . . 75.040000000000006 112.084 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.454 HD13 HG23 ' A' ' 57' ' ' ILE . 48.9 mm -65.63 124.36 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 108.819 -0.808 . . . . 71.530000000000001 108.819 171.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.06 9.56 62.08 Favored Glycine 0 N--CA 1.475 1.288 0 CA-C-O 119.967 -0.351 . . . . 74.400000000000006 113.371 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.734 ' HG3' ' HA ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -89.85 146.72 24.23 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.691 0.796 . . . . 74.310000000000002 110.673 178.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.8 tp -93.98 115.41 27.75 Favored 'General case' 0 C--N 1.345 0.398 0 O-C-N 124.037 0.835 . . . . 75.239999999999995 109.41 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.9 t -98.99 120.43 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 109.629 -0.508 . . . . 75.310000000000002 109.629 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt -105.9 128.05 53.53 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.765 1.226 . . . . 64.109999999999999 109.077 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -147.33 119.27 8.15 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.377 -0.601 . . . . 72.430000000000007 109.377 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 28.3 ttpp -82.06 112.27 18.97 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.194 -0.669 . . . . 73.129999999999995 109.194 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.0 p -64.7 155.51 81.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.781 0.832 . . . . 62.119999999999997 110.94 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.71 -9.09 19.57 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.988 2.459 . . . . 75.340000000000003 112.523 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 t -74.67 -10.12 59.23 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.927 0.891 . . . . 63.350000000000001 111.347 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.47 -12.37 63.18 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 123.633 0.635 . . . . 65.409999999999997 113.188 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -83.51 126.66 33.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.564 0.746 . . . . 75.120000000000005 109.563 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 63.1 mt -79.57 96.74 2.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 107.31 -1.367 . . . . 72.340000000000003 107.31 168.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 73' ' ' LYS . 50.3 mt -73.62 126.43 30.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.094 -0.957 . . . . 75.409999999999997 108.953 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -106.65 139.82 40.49 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.991 -0.744 . . . . 74.519999999999996 108.991 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.24 -179.64 28.02 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 123.51 0.506 . . . . 72.0 111.939 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -149.38 137.32 20.47 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.949 0.404 . . . . 73.319999999999993 111.073 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.454 HG23 HD13 ' A' ' 39' ' ' ILE . 67.3 mt -74.85 103.49 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 114.77 -1.105 . . . . 75.329999999999998 109.643 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.21 -18.59 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 114.965 -1.016 . . . . 65.329999999999998 111.345 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.509 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 20.8 ttm180 -160.13 160.67 33.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.084 0.554 . . . . 75.409999999999997 109.755 -175.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 m -95.1 171.05 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.496 0.718 . . . . 73.310000000000002 109.469 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -128.36 103.03 6.92 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.795 -0.817 . . . . 74.099999999999994 108.795 173.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.35 -150.52 46.96 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 124.291 0.994 . . . . 75.319999999999993 114.089 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -109.54 7.08 24.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.473 1.109 . . . . 75.109999999999999 110.89 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -67.23 -28.05 67.74 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.171 0.588 . . . . 74.540000000000006 111.047 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.17 3.3 58.92 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.639 -0.709 . . . . 65.150000000000006 111.903 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.44 130.21 42.19 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.515 -0.55 . . . . 73.549999999999997 109.515 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.6 m -102.37 153.97 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.581 0.752 . . . . 74.219999999999999 110.573 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.509 ' HD2' ' HB3' ' A' ' 59' ' ' ARG . 17.8 ttm180 -111.84 103.31 11.56 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.491 -0.929 . . . . 75.200000000000003 108.491 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.84 116.58 30.91 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.449 0.699 . . . . 62.43 109.813 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.418 ' HG2' HG23 ' A' ' 21' ' ' VAL . 43.3 mtm180 -90.24 118.01 29.43 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.69 -0.856 . . . . 73.030000000000001 108.69 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -91.37 128.41 37.19 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.488 0.715 . . . . 72.510000000000005 109.801 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.12 -32.97 68.64 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.629 1.172 . . . . 72.209999999999994 112.468 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.494 ' HB2' HD21 ' A' ' 53' ' ' LEU . 70.9 mmtt -90.5 -37.94 13.55 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.132 0.573 . . . . 72.030000000000001 109.565 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.17 35.73 34.6 Favored Glycine 0 C--N 1.36 1.871 0 O-C-N 124.503 1.127 . . . . 75.040000000000006 114.315 174.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -76.28 133.15 71.95 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 122.992 0.517 . . . . 73.030000000000001 110.622 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.23 120.17 6.41 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.772 1.648 . . . . 75.510000000000005 110.404 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.12 -15.2 31.3 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.523 -0.762 . . . . 73.209999999999994 111.868 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 67.68 12.74 9.0 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.765 1.226 . . . . 72.040000000000006 111.35 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.12 32.47 2.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.836 1.254 . . . . 73.340000000000003 111.833 -168.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -51.79 108.02 0.24 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.522 0.729 . . . . 72.340000000000003 111.413 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.0 -14.46 7.05 Favored Glycine 0 N--CA 1.475 1.272 0 CA-C-N 116.11 -0.496 . . . . 72.340000000000003 112.396 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -77.56 172.83 12.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.75 0.82 . . . . 71.129999999999995 110.311 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 9.7 m-85 -108.62 130.01 55.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.283 0.633 . . . . 71.120000000000005 111.394 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG22 HG21 ' A' ' 24' ' ' ILE . 16.1 m -97.97 168.25 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.553 1.141 . . . . 72.519999999999996 109.029 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -120.35 106.76 12.17 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.787 -0.82 . . . . 63.310000000000002 108.787 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.19 92.37 3.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.41 -0.959 . . . . 64.400000000000006 108.41 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.78 124.77 36.74 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-N 115.063 -0.971 . . . . 75.230000000000004 108.86 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.734 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -62.86 97.61 0.11 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.663 -1.606 . . . . 74.340000000000003 106.663 172.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.62 98.59 0.38 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.388 -0.824 . . . . 74.129999999999995 109.98 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -144.09 107.38 4.56 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.345 1.058 . . . . 71.140000000000001 108.249 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 123.164 0.585 . . . . 73.140000000000001 110.33 -179.326 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.094 0 CA-C-O 121.566 0.698 . . . . 75.430000000000007 110.531 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.537 ' HD2' ' HB3' ' A' ' 85' ' ' GLU . 90.6 mtm-85 -132.94 171.08 14.42 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.777 0.831 . . . . 73.010000000000005 109.803 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.672 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 47.8 mt -116.82 124.4 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.566 -1.272 . . . . 74.140000000000001 107.566 176.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -88.74 140.21 29.68 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 118.419 0.554 . . . . 74.430000000000007 109.658 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.59 135.97 7.34 Favored Glycine 0 C--O 1.218 -0.886 0 N-CA-C 111.998 -0.441 . . . . 71.439999999999998 111.998 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -91.18 116.88 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.369 0.668 . . . . 74.439999999999998 109.266 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.484 HG12 ' SD ' ' A' ' 22' ' ' MET . 91.1 t -55.12 103.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.585 1.154 . . . . 75.400000000000006 110.4 175.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.413 HD13 HG22 ' A' ' 23' ' ' ILE . 93.9 mt -75.21 -57.05 4.13 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 122.88 0.472 . . . . 74.439999999999998 110.22 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.3 p -163.95 164.08 23.34 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.415 -0.811 . . . . 72.409999999999997 110.271 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.97 134.93 34.09 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.147 -0.686 . . . . 74.25 109.147 168.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.481 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 1.7 tmt_? -98.53 106.98 19.33 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 105.424 -2.065 . . . . 74.150000000000006 105.424 165.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.569 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 11.5 ptm180 -78.82 136.04 37.23 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.04 0.448 . . . . 74.230000000000004 110.586 -171.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 m -67.55 154.88 40.41 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.069 -0.969 . . . . 53.539999999999999 110.311 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -58.99 -42.27 89.64 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.62 0.768 . . . . 74.510000000000005 110.555 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -102.47 108.87 20.33 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.002 -0.999 . . . . 72.409999999999997 108.762 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -69.32 88.33 0.45 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.348 1.059 . . . . 74.010000000000005 109.555 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -134.62 -77.13 0.46 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.161 -1.052 . . . . 71.519999999999996 108.161 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -159.21 -172.96 3.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.458 1.103 . . . . 75.400000000000006 108.422 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 16.5 m120 63.05 34.61 13.69 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.682 0.793 . . . . 65.25 110.816 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.645 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 52.1 t30 -71.4 149.61 45.8 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-N 114.551 -1.204 . . . . 71.549999999999997 110.302 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 39.8 t -93.53 144.14 10.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.606 -0.887 . . . . 74.540000000000006 108.606 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.484 ' SD ' HG12 ' A' ' 7' ' ' VAL . 42.8 ttp -133.56 121.64 22.4 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.179 -0.675 . . . . 74.349999999999994 109.179 174.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 8' ' ' LEU . 41.1 mm -79.78 126.42 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.577 1.151 . . . . 74.230000000000004 108.832 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -126.08 152.07 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.581 1.153 . . . . 74.340000000000003 109.588 -171.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -116.22 92.66 36.68 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.756 0.822 . . . . 71.109999999999999 109.515 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.07 131.54 33.0 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.441 1.427 . . . . 74.310000000000002 109.876 172.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.437 HD11 ' HE2' ' A' ' 83' ' ' TYR . 91.1 mt -63.96 -31.51 72.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.584 0.754 . . . . 74.5 111.764 -171.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.16 -28.58 67.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.539 0.735 . . . . 73.099999999999994 111.122 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.66 144.19 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.865 0.866 . . . . 74.439999999999998 111.772 -168.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -147.52 -25.57 0.38 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.375 1.07 . . . . 72.510000000000005 111.592 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.593 ' HB2' ' HG2' ' A' ' 34' ' ' GLU . 15.7 m -109.88 169.84 8.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.403 0.681 . . . . 73.409999999999997 111.186 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 78.8 ttt180 -65.96 -42.83 89.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.954 0.902 . . . . 74.209999999999994 111.082 -177.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.99 -30.87 62.71 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.813 0.695 . . . . 72.439999999999998 110.892 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 31' ' ' SER . 20.0 mm-40 -65.92 -30.8 71.44 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.752 0.658 . . . . 74.200000000000003 110.491 173.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -81.66 -33.21 31.45 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.772 0.829 . . . . 72.129999999999995 110.851 175.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -75.44 -24.96 57.09 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.107 0.963 . . . . 75.430000000000007 111.203 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 34' ' ' GLU . 22.0 pttp -75.07 -1.51 23.23 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 122.205 0.202 . . . . 74.010000000000005 111.111 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.1 11.5 25.64 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.319 0.648 . . . . 74.439999999999998 112.53 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mm -69.24 126.28 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.414 -0.587 . . . . 74.310000000000002 109.414 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.38 57.74 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.179 -0.464 . . . . 63.43 113.242 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.07 139.14 37.03 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.017 0.527 . . . . 75.510000000000005 110.301 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -90.1 113.68 25.46 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.275 1.03 . . . . 72.109999999999999 108.75 -173.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -98.04 114.31 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.222 0.609 . . . . 74.420000000000002 109.517 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.476 HD21 ' HG2' ' A' ' 54' ' ' LYS . 42.4 mt -101.04 99.99 10.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.23 -1.026 . . . . 72.140000000000001 108.23 176.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.479 ' CD1' HG12 ' A' ' 84' ' ' VAL . 32.6 t90 -103.27 131.63 50.17 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.959 -0.756 . . . . 73.140000000000001 108.959 174.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -91.99 126.61 37.15 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.151 -1.055 . . . . 75.349999999999994 108.151 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.9 p -73.17 141.43 81.03 Favored Pre-proline 0 C--O 1.244 0.816 0 N-CA-C 109.381 -0.6 . . . . 62.299999999999997 109.381 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.69 -23.55 33.5 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.471 2.78 . . . . 72.310000000000002 113.877 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.4 m -64.17 -54.78 28.24 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.646 0.779 . . . . 75.510000000000005 110.928 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.18 32.32 0.1 Allowed Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.351 -0.386 . . . . 74.530000000000001 113.614 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -114.69 173.53 6.43 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.607 0.763 . . . . 73.340000000000003 109.542 173.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.0 105.05 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.446 -0.946 . . . . 74.219999999999999 108.446 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.475 HD23 ' HB2' ' A' ' 73' ' ' LYS . 21.2 mt -83.34 110.23 17.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.236 -1.024 . . . . 75.200000000000003 108.236 172.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HG2' HD21 ' A' ' 44' ' ' LEU . 51.7 mtpt -94.46 139.74 30.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.003 -0.74 . . . . 73.439999999999998 109.003 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.65 -171.28 19.36 Favored Glycine 0 N--CA 1.463 0.493 0 O-C-N 123.455 0.472 . . . . 52.140000000000001 112.297 -173.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -151.94 133.99 15.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.957 0.503 . . . . 72.540000000000006 110.052 -178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.429 HG22 ' HB ' ' A' ' 67' ' ' VAL . 73.6 mt -69.32 98.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.729 -0.841 . . . . 74.0 108.729 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.37 -33.44 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.183 0.593 . . . . 64.450000000000003 111.019 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -148.78 167.61 25.14 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.349 -0.982 . . . . 75.439999999999998 108.349 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 m -103.01 170.63 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.394 0.678 . . . . 65.430000000000007 109.229 172.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -132.57 122.57 24.97 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.522 -0.918 . . . . 73.099999999999994 108.522 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.67 -153.95 52.4 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.92 0.763 . . . . 73.540000000000006 113.072 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.528 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 73.6 p -116.76 -11.47 10.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.193 0.997 . . . . 73.510000000000005 111.193 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -98.73 52.94 1.0 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.229 0.537 . . . . 71.530000000000001 112.091 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.38 -0.4 33.3 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 117.312 1.685 . . . . 65.329999999999998 117.312 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.46 124.85 28.85 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.91 0.855 . . . . 63.530000000000001 109.582 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 57' ' ' ILE . 34.7 m -103.25 160.12 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.371 0.668 . . . . 64.430000000000007 109.918 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -119.79 104.29 10.09 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.703 1.201 . . . . 71.239999999999995 108.499 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.12 127.41 54.14 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.447 0.699 . . . . 75.310000000000002 110.864 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -89.61 111.5 22.46 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.59 1.156 . . . . 72.120000000000005 109.611 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 73.7 m-85 -92.08 166.33 12.72 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.056 0.542 . . . . 74.519999999999996 111.047 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.503 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 7.8 pt-20 -67.29 -39.05 85.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.937 0.895 . . . . 74.150000000000006 110.466 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.503 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 14.4 mmmm -118.8 -69.16 0.87 Allowed 'General case' 0 C--N 1.345 0.375 0 C-N-CA 124.089 0.956 . . . . 73.209999999999994 109.398 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.645 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 71.93 57.86 5.57 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 123.924 0.765 . . . . 75.430000000000007 111.231 -173.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.33 124.51 89.99 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.758 0.823 . . . . 74.420000000000002 111.22 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.59 174.57 8.24 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.335 2.69 . . . . 73.340000000000003 112.71 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.33 172.1 13.13 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.341 -0.704 . . . . 72.010000000000005 111.341 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -86.48 68.91 10.34 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.508 1.147 . . . . 75.340000000000003 109.618 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.09 17.51 17.72 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.468 -1.242 . . . . 63.32 109.714 175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.2 mt -76.41 121.88 23.7 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.92 0.888 . . . . 71.230000000000004 109.486 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.48 -6.98 14.14 Favored Glycine 0 N--CA 1.469 0.849 0 N-CA-C 111.966 -0.454 . . . . 73.329999999999998 111.966 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.58 155.64 29.55 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.814 0.846 . . . . 75.510000000000005 109.86 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.437 ' HE2' HD11 ' A' ' 27' ' ' LEU . 62.1 m-85 -91.33 133.09 35.73 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.94 0.496 . . . . 73.510000000000005 111.448 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG12 ' CD1' ' A' ' 45' ' ' TRP . 6.7 m -100.01 149.39 5.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 N-CA-C 107.632 -1.248 . . . . 72.519999999999996 107.632 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 2' ' ' ARG . 8.5 mm-40 -111.34 106.73 15.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.053 -1.091 . . . . 74.530000000000001 108.053 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.672 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 62.2 mt -96.94 104.63 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.444 0.697 . . . . 74.219999999999999 109.235 -173.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.9 t -95.31 134.75 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.221 1.008 . . . . 72.5 110.103 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.61 123.78 47.01 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.302 -1.37 . . . . 64.310000000000002 107.302 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -159.47 -39.2 0.06 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.992 0.917 . . . . 73.340000000000003 109.142 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -77.89 97.8 5.41 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.308 -0.86 . . . . 72.299999999999997 109.067 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 . . . . . 0 CA--C 1.562 1.426 0 CA-C-O 118.066 -0.968 . . . . 72.329999999999998 109.294 177.633 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 120.613 0.244 . . . . 71.200000000000003 110.467 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -119.88 130.12 54.7 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 106.845 -1.539 . . . . 73.310000000000002 106.845 168.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 28' ' ' ASP . 50.9 mt -94.67 125.86 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.275 -0.639 . . . . 74.400000000000006 109.275 -175.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -88.67 133.29 34.25 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.466 -0.939 . . . . 71.310000000000002 108.466 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.98 166.19 22.13 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.361 0.413 . . . . 71.299999999999997 112.13 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.61 135.2 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.193 0.997 . . . . 75.319999999999993 109.173 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.76 114.53 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.568 0.747 . . . . 75.329999999999998 110.292 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 25' ' ' LYS . 89.6 mt -81.79 -61.2 1.99 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.358 0.663 . . . . 75.430000000000007 110.843 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.2 t -152.46 160.5 43.26 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.849 -0.614 . . . . 73.409999999999997 110.37 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -91.02 157.55 17.2 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.361 0.601 . . . . 74.310000000000002 111.182 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.491 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.6 tpp180 -136.28 109.95 8.06 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.263 -1.754 . . . . 73.530000000000001 106.263 163.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -72.41 159.38 34.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.01 0.434 . . . . 64.099999999999994 110.704 -169.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.625 ' HB3' ' HB3' ' A' ' 17' ' ' GLN . 20.0 m -70.65 167.83 17.79 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.25 -0.886 . . . . 75.120000000000005 111.793 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -67.47 -72.01 0.18 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.122 0.969 . . . . 74.340000000000003 113.209 -167.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -132.52 -64.23 0.76 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.882 -0.784 . . . . 74.420000000000002 108.882 -170.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -142.1 92.27 2.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.801 -1.555 . . . . 72.439999999999998 106.801 167.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 13' ' ' SER . 6.3 tp-100 -144.94 135.17 24.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.717 0.807 . . . . 74.099999999999994 108.836 -172.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -93.7 -13.98 26.86 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.953 0.501 . . . . 74.450000000000003 111.565 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 19.9 m120 -74.19 80.01 1.79 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.462 -0.57 . . . . 75.439999999999998 109.462 171.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -81.55 135.57 35.58 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.044 -0.98 . . . . 72.010000000000005 109.31 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.538 HG21 ' HG2' ' A' ' 70' ' ' ARG . 5.1 t -96.96 150.62 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 108.464 -0.939 . . . . 71.409999999999997 108.464 -176.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -154.79 140.88 18.43 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.758 0.313 . . . . 72.299999999999997 110.77 168.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 8' ' ' LEU . 45.4 mm -77.17 120.48 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.307 -0.861 . . . . 72.299999999999997 108.682 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.4 mt -115.45 147.83 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.35 1.06 . . . . 75.5 108.84 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HB2' HD11 ' A' ' 8' ' ' LEU . 86.6 tttt -108.13 101.8 43.3 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 123.821 0.848 . . . . 74.519999999999996 109.424 171.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.58 115.97 3.03 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 122.067 1.845 . . . . 62.409999999999997 110.067 165.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.38 -34.07 71.97 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.159 0.984 . . . . 72.319999999999993 112.132 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HB3' HG22 ' A' ' 3' ' ' ILE . 22.2 t70 -69.31 -27.73 65.64 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.253 1.021 . . . . 73.129999999999995 111.899 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.582 HG11 ' HB2' ' A' ' 34' ' ' GLU . 25.9 t -113.09 119.06 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.235 1.014 . . . . 72.209999999999994 111.24 -170.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -120.36 -5.52 9.87 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.116 0.566 . . . . 73.450000000000003 111.893 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.42 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 69.2 m -111.18 152.86 26.57 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.038 0.535 . . . . 64.319999999999993 110.347 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 55.6 ttt85 -64.27 -35.36 80.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 73.439999999999998 111.826 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.62 -38.72 84.3 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.951 0.5 . . . . 73.040000000000006 110.7 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.582 ' HB2' HG11 ' A' ' 29' ' ' VAL . 33.8 mt-10 -67.39 -31.77 72.22 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.114 -0.948 . . . . 73.120000000000005 110.07 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.22 -23.05 32.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.977 0.911 . . . . 72.120000000000005 111.218 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.4 t -79.42 -27.6 41.73 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.769 0.828 . . . . 64.349999999999994 110.086 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -80.16 -9.19 59.7 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.329 -0.396 . . . . 74.450000000000003 110.758 170.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.438 HD13 HG22 ' A' ' 29' ' ' VAL . 47.2 mt -89.61 -3.45 58.27 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.139 0.576 . . . . 64.519999999999996 111.987 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.622 HD12 HG13 ' A' ' 60' ' ' VAL . 49.7 mm -63.65 107.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.242 -0.651 . . . . 64.409999999999997 109.242 174.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.1 5.4 30.62 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.323 -0.71 . . . . 74.239999999999995 114.145 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.437 ' HD2' HD21 ' A' ' 88' ' ' LEU . 28.9 mmt180 -84.72 159.72 20.46 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.364 1.082 . . . . 74.430000000000007 111.373 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 54' ' ' LYS . 61.0 tp -90.83 117.19 29.25 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.29 1.036 . . . . 75.510000000000005 109.331 -175.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 t -107.35 117.14 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.204 -0.665 . . . . 73.040000000000006 109.204 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -101.15 104.44 15.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.641 0.776 . . . . 75.219999999999999 109.529 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -91.75 141.95 28.12 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.554 -0.536 . . . . 73.200000000000003 109.554 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -103.08 108.95 20.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.962 -1.017 . . . . 75.230000000000004 108.87 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.2 p -60.3 160.82 15.57 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.731 0.813 . . . . 74.409999999999997 111.036 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.9 -21.67 71.65 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.937 2.424 . . . . 71.349999999999994 112.613 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.3 m -77.51 -6.96 55.44 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.017 0.927 . . . . 64.200000000000003 111.765 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.65 3.64 77.29 Favored Glycine 0 C--N 1.35 1.342 0 C-N-CA 123.197 0.427 . . . . 72.329999999999998 112.863 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -85.77 156.47 20.59 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.007 0.923 . . . . 74.030000000000001 108.898 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.8 mt -117.62 114.35 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.594 0.358 . . . . 74.430000000000007 110.367 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.504 HD12 ' HB2' ' A' ' 73' ' ' LYS . 31.5 mt -92.25 150.58 20.8 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.723 -0.843 . . . . 74.25 108.723 173.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HB3' HD11 ' A' ' 42' ' ' LEU . 23.5 mtmm -98.22 156.15 16.83 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.717 -0.475 . . . . 75.530000000000001 109.717 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.8 -174.97 29.21 Favored Glycine 0 C--O 1.239 0.441 0 N-CA-C 111.036 -0.825 . . . . 75.129999999999995 111.036 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -152.87 136.17 15.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 111.758 0.281 . . . . 70.239999999999995 111.758 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.402 HD13 HD13 ' A' ' 86' ' ' ILE . 78.2 mt -69.2 102.82 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.622 0 O-C-N 124.038 0.836 . . . . 74.109999999999999 108.895 171.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -84.29 -28.35 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.329 -0.851 . . . . 74.530000000000001 110.711 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -164.03 165.32 22.55 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.811 0.844 . . . . 74.099999999999994 109.396 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.622 HG13 HD12 ' A' ' 39' ' ' ILE . 35.4 m -92.8 169.41 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.508 0.723 . . . . 75.299999999999997 110.522 174.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -127.6 104.59 7.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.295 1.038 . . . . 73.340000000000003 109.223 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.49 -153.01 52.89 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.851 -0.613 . . . . 61.32 113.154 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 32.5 p -111.83 -0.63 15.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.789 0.836 . . . . 72.319999999999993 111.831 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -83.78 5.88 23.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.47 0.708 . . . . 74.340000000000003 112.425 -168.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.28 -16.37 57.61 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-O 119.909 -0.384 . . . . 75.299999999999997 113.063 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.68 122.55 14.41 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.613 0.765 . . . . 75.230000000000004 110.018 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.84 175.06 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.955 0.902 . . . . 74.540000000000006 110.632 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -128.5 111.39 13.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.278 1.031 . . . . 73.019999999999996 108.592 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.8 133.02 56.52 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.381 0.672 . . . . 64.409999999999997 110.774 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.538 ' HG2' HG21 ' A' ' 21' ' ' VAL . 97.0 mtt180 -103.75 128.85 51.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.947 0.899 . . . . 75.120000000000005 109.095 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 85.9 m-85 -106.11 134.6 48.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.494 0.717 . . . . 73.219999999999999 110.743 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 20.8 pt-20 -51.58 -48.09 63.3 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 124.89 1.369 . . . . 75.219999999999999 112.552 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.558 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 13.4 mmmm -92.93 -39.5 11.11 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.152 0.581 . . . . 74.329999999999998 109.478 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.99 55.0 28.11 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 124.284 0.99 . . . . 64.409999999999997 113.908 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.62 124.09 89.25 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.054 0.541 . . . . 74.519999999999996 110.591 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.14 150.67 33.67 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.107 2.538 . . . . 72.409999999999997 112.129 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.09 -151.79 14.6 Favored Glycine 0 C--N 1.344 0.972 0 N-CA-C 111.33 -0.708 . . . . 73.540000000000006 111.33 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -113.03 73.89 0.84 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.218 1.009 . . . . 75.129999999999995 108.882 172.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.27 -9.76 59.37 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.383 -1.28 . . . . 75.340000000000003 112.617 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.6 mt -61.24 115.1 3.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.621 0.768 . . . . 75.329999999999998 110.716 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.68 -18.87 49.29 Favored Glycine 0 N--CA 1.473 1.148 0 CA-C-N 116.465 -0.334 . . . . 73.329999999999998 112.826 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.08 163.49 27.06 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.698 0.799 . . . . 75.099999999999994 110.442 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -105.05 148.71 26.48 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.751 0.786 . . . . 75.209999999999994 112.279 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.14 164.45 17.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 114.35 -1.295 . . . . 75.310000000000002 108.269 171.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.13 107.66 11.0 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.008 -0.738 . . . . 74.420000000000002 109.008 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.402 HD13 HD13 ' A' ' 57' ' ' ILE . 57.4 mt -82.72 92.23 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.0 -1.111 . . . . 74.340000000000003 108.0 177.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.2 t -79.53 141.82 14.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 114.421 -1.263 . . . . 75.010000000000005 108.837 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.437 HD21 ' HD2' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -60.06 112.0 1.72 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 107.66 -1.237 . . . . 75.25 107.66 171.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.88 119.75 20.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.556 -0.905 . . . . 74.239999999999995 108.556 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -145.98 128.93 16.45 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.644 0.378 . . . . 74.519999999999996 110.972 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 68.6 m80 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.044 -0.979 . . . . 72.450000000000003 108.576 173.584 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 110.053 -0.351 . . . . 54.310000000000002 110.053 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -124.07 138.21 54.47 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.647 -1.242 . . . . 75.450000000000003 107.647 167.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.24 139.85 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.464 0.706 . . . . 71.439999999999998 109.142 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -88.14 119.16 28.26 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.283 -1.006 . . . . 63.509999999999998 108.283 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -116.98 168.84 12.89 Favored Glycine 0 C--N 1.34 0.802 0 O-C-N 123.673 0.608 . . . . 72.319999999999993 111.583 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.43 130.29 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.958 0.903 . . . . 53.409999999999997 109.175 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.2 t -68.11 104.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.095 0.958 . . . . 74.140000000000001 109.348 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 25' ' ' LYS . 83.1 mt -84.29 -55.13 4.34 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.462 0.305 . . . . 73.230000000000004 110.807 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m -154.22 170.27 21.65 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.524 0.564 . . . . 64.400000000000006 112.524 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -122.58 157.56 31.86 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.053 1.341 . . . . 74.010000000000005 109.193 170.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.535 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.7 tpt180 -137.75 115.6 11.49 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.656 -1.238 . . . . 75.099999999999994 107.656 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -85.61 117.51 24.55 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.327 0.491 . . . . 74.230000000000004 112.327 -168.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.3 m -86.26 148.17 25.75 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.501 -0.926 . . . . 75.219999999999999 108.501 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -74.39 87.19 2.03 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.819 0.448 . . . . 74.150000000000006 111.347 -173.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 51.91 -76.7 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.044 2.138 . . . . 74.340000000000003 115.245 165.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -61.86 -45.87 91.92 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.812 0.845 . . . . 74.409999999999997 111.32 -177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -85.57 46.62 1.32 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.93 0.492 . . . . 62.240000000000002 110.066 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.31 86.86 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.378 1.071 . . . . 72.219999999999999 111.762 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -130.29 39.71 3.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.674 -1.602 . . . . 74.219999999999999 106.674 172.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -51.58 126.58 17.89 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 113.986 -1.461 . . . . 72.200000000000003 110.315 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 85.8 t -86.41 145.0 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.32 -0.993 . . . . 74.120000000000005 108.32 -171.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.3 ttt -137.56 109.49 7.17 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.791 -1.559 . . . . 64.209999999999994 106.791 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.432 HG21 HD13 ' A' ' 8' ' ' LEU . 45.5 mm -81.14 120.32 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 107.119 -1.437 . . . . 72.5 107.119 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -127.65 146.64 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.49 1.116 . . . . 64.420000000000002 108.319 -175.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.519 ' HB2' HD11 ' A' ' 8' ' ' LEU . 41.1 ttmt -118.68 112.84 36.66 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 109.292 -0.632 . . . . 71.010000000000005 109.292 168.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.427 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 17.2 Cg_exo -62.65 126.2 17.76 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.057 1.838 . . . . 73.030000000000001 110.229 168.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.76 -27.45 69.29 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.715 0.806 . . . . 74.430000000000007 111.7 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.76 -27.13 66.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.41 1.084 . . . . 75.209999999999994 111.868 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 34' ' ' GLU . 71.6 t -106.72 128.0 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.964 0.906 . . . . 72.329999999999998 111.823 -169.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -127.9 5.01 5.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.53 1.132 . . . . 73.340000000000003 110.839 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -132.48 157.79 43.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.477 0.711 . . . . 71.239999999999995 110.53 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 68.9 ttt180 -64.13 -42.92 96.62 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.769 0.827 . . . . 75.200000000000003 111.101 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.54 -38.88 92.53 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.867 0.73 . . . . 75.140000000000001 111.148 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.578 ' HB2' HG11 ' A' ' 29' ' ' VAL . 41.0 mt-10 -64.94 -34.02 77.42 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 124.117 0.886 . . . . 72.310000000000002 110.448 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 29' ' ' VAL . . . -82.08 -26.39 33.69 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.098 0.959 . . . . 74.040000000000006 111.537 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 t -82.06 -23.81 35.62 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.907 0.883 . . . . 74.439999999999998 110.931 -172.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.73 1.29 39.46 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.59 0.356 . . . . 75.420000000000002 110.834 170.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 75.7 mt -102.22 11.88 37.54 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.431 0.693 . . . . 73.510000000000005 111.343 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 60' ' ' VAL . 49.9 mm -73.99 130.82 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 109.49 -0.559 . . . . 62.219999999999999 109.49 174.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.23 1.39 75.55 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.029 -0.532 . . . . 71.540000000000006 112.532 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.587 ' HG3' ' HA ' ' A' ' 88' ' ' LEU . 5.6 mpt_? -81.64 138.58 35.29 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.079 0.552 . . . . 74.439999999999998 109.98 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.2 tp -90.37 113.56 25.47 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.63 -0.878 . . . . 74.120000000000005 108.63 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 t -98.09 116.05 39.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 123.427 0.691 . . . . 64.450000000000003 109.254 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.3 mt -102.01 129.19 48.24 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.464 1.106 . . . . 75.409999999999997 108.549 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -142.38 127.38 18.4 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.14 0.576 . . . . 74.019999999999996 109.484 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -89.76 115.24 26.97 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.123 -0.695 . . . . 74.519999999999996 109.123 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -64.71 158.45 68.5 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.823 0.849 . . . . 75.519999999999996 111.006 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -59.33 -20.17 54.38 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.465 2.776 . . . . 72.450000000000003 113.432 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.6 m -75.15 -3.28 31.93 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.89 0.876 . . . . 64.430000000000007 112.234 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.87 9.76 80.23 Favored Glycine 0 C--N 1.353 1.525 0 C-N-CA 123.069 0.366 . . . . 62.5 112.936 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -96.16 132.16 41.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.583 0.753 . . . . 74.310000000000002 110.001 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.1 mt -85.55 101.87 10.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-O 121.3 0.571 . . . . 75.409999999999997 109.613 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 75' ' ' LEU . 13.5 mt -80.97 128.49 33.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.462 -0.79 . . . . 71.099999999999994 108.879 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -117.43 132.47 56.56 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.106 0.963 . . . . 54.530000000000001 109.123 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.95 -177.79 28.6 Favored Glycine 0 C--N 1.336 0.55 0 O-C-N 123.635 0.584 . . . . 52.43 112.177 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -151.77 136.67 17.23 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.115 0.413 . . . . 74.420000000000002 112.115 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.407 HG23 ' HB ' ' A' ' 67' ' ' VAL . 64.7 mt -67.94 103.62 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.935 0.894 . . . . 74.150000000000006 109.568 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.27 -30.83 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.532 -0.758 . . . . 73.450000000000003 111.547 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -163.95 160.45 21.98 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.62 0.768 . . . . 71.439999999999998 109.254 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 39' ' ' ILE . 20.2 m -101.18 170.48 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.847 0.859 . . . . 74.219999999999999 111.065 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -131.3 103.14 6.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.06 0.944 . . . . 75.400000000000006 109.021 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.66 -166.85 26.08 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.74 -0.664 . . . . 72.25 114.452 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 75.7 p -90.77 8.56 34.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.382 1.073 . . . . 65.439999999999998 111.333 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -79.84 -2.72 44.71 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.871 0.869 . . . . 72.420000000000002 111.783 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.24 -4.89 61.23 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-O 120.103 -0.276 . . . . 71.409999999999997 113.645 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.96 112.28 5.51 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 123.429 0.692 . . . . 73.349999999999994 109.635 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' HB ' HG23 ' A' ' 57' ' ' ILE . 29.1 m -100.19 143.77 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.04 0.936 . . . . 75.109999999999999 109.153 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -101.72 103.07 13.82 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.322 -0.992 . . . . 74.140000000000001 108.322 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.82 120.28 41.58 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.556 0.742 . . . . 74.019999999999996 109.935 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -88.8 106.31 18.29 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.973 0.509 . . . . 73.340000000000003 109.699 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -88.15 120.99 30.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.632 -0.877 . . . . 74.140000000000001 108.632 170.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.42 -20.71 60.66 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.134 0.492 . . . . 73.010000000000005 109.876 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -76.68 -77.64 0.14 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.641 0.777 . . . . 74.230000000000004 109.197 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.1 45.01 63.42 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.646 0.591 . . . . 53.109999999999999 114.395 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.431 ' HB2' HD22 ' A' ' 53' ' ' LEU . 81.7 mt -73.15 157.08 88.88 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.759 0.824 . . . . 74.549999999999997 111.195 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.08 124.08 14.51 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 123.402 2.735 . . . . 75.439999999999998 113.273 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.09 87.74 0.08 OUTLIER Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.776 -1.33 . . . . 74.349999999999994 109.776 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -73.92 71.43 1.54 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.092 0.957 . . . . 71.239999999999995 109.846 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.05 29.01 8.16 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.445 1.098 . . . . 75.019999999999996 110.685 -169.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 mt -52.46 118.46 3.6 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.5 0.72 . . . . 74.019999999999996 110.378 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.07 -10.51 15.17 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 112.01 -0.436 . . . . 63.539999999999999 112.01 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -77.23 169.56 18.11 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.876 0.87 . . . . 71.439999999999998 109.678 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 63.0 m-85 -112.26 127.47 55.98 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.639 0.376 . . . . 75.430000000000007 111.952 -170.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 m -100.38 162.72 3.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-N 115.171 -0.922 . . . . 74.540000000000006 109.824 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -111.62 108.99 18.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.905 0.882 . . . . 74.140000000000001 108.681 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.1 mt -92.18 92.9 3.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.1 -1.074 . . . . 73.230000000000004 108.1 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.81 134.03 27.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.082 -0.963 . . . . 74.140000000000001 109.09 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.587 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 4.4 mm? -60.61 126.79 28.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.751 0.82 . . . . 74.430000000000007 110.608 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.93 139.17 22.33 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.534 -0.913 . . . . 74.310000000000002 108.534 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -126.58 150.87 48.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.012 0.925 . . . . 71.120000000000005 110.382 -173.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 . . . . . 0 C--O 1.249 1.035 0 C-N-CA 123.899 0.879 . . . . 55.039999999999999 108.786 173.338 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 mmt . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.666 -0.494 . . . . 64.129999999999995 109.666 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -147.71 158.45 44.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.997 0.919 . . . . 74.219999999999999 110.364 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 mt -132.57 128.83 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.686 -1.227 . . . . 73.140000000000001 107.686 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -87.79 128.18 35.33 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.941 -0.763 . . . . 74.010000000000005 108.941 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 25' ' ' LYS . . . -124.74 142.44 13.94 Favored Glycine 0 C--N 1.34 0.799 0 O-C-N 123.914 0.759 . . . . 73.0 111.486 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -92.76 131.04 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.511 0.655 . . . . 72.409999999999997 109.906 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.8 97.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.951 0.9 . . . . 75.549999999999997 109.251 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.461 HD22 ' HE2' ' A' ' 25' ' ' LYS . 81.5 mt -77.34 -53.45 7.67 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.673 -0.492 . . . . 71.299999999999997 109.673 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -165.11 179.19 6.49 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.847 0.356 . . . . 71.019999999999996 111.411 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -129.96 134.8 47.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.793 1.237 . . . . 73.430000000000007 108.298 174.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -111.03 113.21 25.58 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.072 -1.455 . . . . 73.310000000000002 107.072 163.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.561 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 32.4 ptt180 -73.82 145.61 44.83 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.909 -1.145 . . . . 74.409999999999997 107.909 173.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 m -56.9 148.12 21.83 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.659 0.784 . . . . 72.329999999999998 110.496 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -86.92 -56.32 3.44 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.933 -0.766 . . . . 65.219999999999999 108.933 -176.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.47 -23.11 61.0 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.481 -0.782 . . . . 62.5 111.071 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -125.0 -179.55 4.6 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.299 1.04 . . . . 74.099999999999994 109.311 -176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.59 13.86 3.73 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.758 0.823 . . . . 75.109999999999999 110.446 169.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -124.94 168.82 12.76 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.737 1.215 . . . . 73.420000000000002 109.053 169.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 m120 59.43 40.03 21.29 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 124.449 1.093 . . . . 74.140000000000001 109.436 -176.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 12' ' ' ARG . 23.2 m-80 -78.55 149.49 33.04 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.826 -1.079 . . . . 74.209999999999994 110.001 -172.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.448 HG23 ' HG2' ' A' ' 70' ' ' ARG . 42.6 t -87.77 144.13 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.696 0.799 . . . . 55.149999999999999 109.56 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.6 ttt -131.15 117.16 18.68 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.168 -1.049 . . . . 71.120000000000005 108.168 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.453 HG22 HD13 ' A' ' 8' ' ' LEU . 28.0 mm -77.29 111.44 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.625 -0.879 . . . . 75.010000000000005 108.625 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.1 mt -112.74 145.6 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.403 1.081 . . . . 74.010000000000005 109.302 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HE2' HD22 ' A' ' 8' ' ' LEU . 22.6 ttmm -111.65 87.55 8.29 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.347 1.059 . . . . 72.030000000000001 109.012 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HD3' HG23 ' A' ' 67' ' ' VAL . 32.2 Cg_endo -62.23 107.48 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.95 1.767 . . . . 74.329999999999998 110.212 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.13 -32.48 73.87 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.507 1.123 . . . . 71.329999999999998 112.073 -174.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.89 -26.11 68.63 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.335 1.054 . . . . 73.230000000000004 111.464 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 34' ' ' GLU . 66.2 t -112.43 137.57 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 125.195 1.398 . . . . 73.319999999999993 111.489 -171.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -134.84 8.66 3.55 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.657 1.183 . . . . 72.010000000000005 110.504 170.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.5 m -124.37 147.27 48.34 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.773 0.829 . . . . 75.129999999999995 110.609 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.474 ' HD2' HG22 ' A' ' 63' ' ' THR . 71.2 ttt180 -67.81 -34.02 75.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.691 0.796 . . . . 75.329999999999998 111.193 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -67.1 -43.0 83.64 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.485 0.714 . . . . 62.140000000000001 110.485 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HB2' HG12 ' A' ' 29' ' ' VAL . 27.2 mm-40 -72.77 -22.91 60.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.165 -0.925 . . . . 72.310000000000002 110.961 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.96 -32.58 30.67 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.554 0.742 . . . . 73.540000000000006 110.165 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.0 t -75.71 -24.47 56.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.573 0.749 . . . . 74.329999999999998 111.385 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -81.39 -2.29 48.79 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 122.311 -0.243 . . . . 71.420000000000002 111.224 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.3 mt -88.68 -12.15 43.21 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 123.331 0.652 . . . . 75.030000000000001 111.185 175.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.587 HD11 HG12 ' A' ' 60' ' ' VAL . 42.1 mm -65.79 104.57 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.084 0 C-N-CA 123.183 0.593 . . . . 75.310000000000002 110.174 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.13 -6.34 10.95 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.447 -0.641 . . . . 71.239999999999995 112.93 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -84.11 155.32 22.69 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 117.756 0.778 . . . . 75.430000000000007 111.257 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 54' ' ' LYS . 58.8 tp -93.14 117.26 29.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.49 1.116 . . . . 71.25 109.983 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.34 135.33 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.359 -0.608 . . . . 71.230000000000004 109.359 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.7 mt -118.37 105.15 11.42 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.392 1.077 . . . . 73.340000000000003 108.128 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 44.8 t90 -110.23 128.4 55.48 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.644 -0.873 . . . . 61.140000000000001 108.644 171.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -98.25 117.43 32.62 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.674 -0.861 . . . . 64.450000000000003 108.674 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.3 p -74.56 162.36 73.99 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 124.024 0.93 . . . . 74.540000000000006 111.29 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.19 -14.55 45.75 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.973 2.448 . . . . 75.239999999999995 112.465 171.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -73.3 -19.38 61.05 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.707 1.203 . . . . 71.030000000000001 111.879 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.06 5.33 60.9 Favored Glycine 0 C--N 1.356 1.693 0 C-N-CA 123.437 0.542 . . . . 70.200000000000003 112.733 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -94.24 118.32 31.41 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.88 0.872 . . . . 71.150000000000006 109.817 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.85 97.2 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.017 -1.105 . . . . 72.230000000000004 108.017 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 mt -73.64 123.2 23.57 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.958 -1.127 . . . . 74.219999999999999 107.958 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.0 mtmm -104.26 140.53 37.73 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.32 -0.622 . . . . 74.530000000000001 109.32 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.93 173.42 25.42 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 116.207 -0.451 . . . . 75.329999999999998 112.112 -178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -127.57 131.77 49.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.071 -0.715 . . . . 72.400000000000006 109.071 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.485 HG23 HD12 ' A' ' 39' ' ' ILE . 62.8 mt -67.61 99.89 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 108.499 -0.926 . . . . 71.340000000000003 108.499 171.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.76 -34.31 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 115.256 -0.883 . . . . 73.420000000000002 111.24 -176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -154.2 157.11 38.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.786 -0.82 . . . . 73.230000000000004 108.786 -173.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.587 HG12 HD11 ' A' ' 39' ' ' ILE . 27.2 m -91.71 168.82 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.659 0.784 . . . . 74.519999999999996 110.05 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.455 ' HB2' ' HG3' ' A' ' 68' ' ' ARG . 82.9 t60 -132.81 103.28 6.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.964 -1.125 . . . . 73.329999999999998 107.964 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.2 -162.76 49.0 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.379 -0.373 . . . . 53.310000000000002 113.181 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 32' ' ' ARG . 73.5 p -110.96 -24.01 10.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.591 0.756 . . . . 64.329999999999998 112.18 -172.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -91.83 46.7 1.29 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.803 0.668 . . . . 71.310000000000002 112.803 -170.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.74 55.75 10.87 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.771 -0.65 . . . . 62.399999999999999 114.056 170.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.39 141.99 49.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.214 -1.032 . . . . 64.310000000000002 108.214 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 57' ' ' ILE . 22.1 m -130.85 171.94 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.141 0.977 . . . . 74.420000000000002 109.894 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.455 ' HG3' ' HB2' ' A' ' 61' ' ' HIS . 73.0 mtm180 -134.35 109.1 8.57 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.218 1.007 . . . . 71.340000000000003 109.091 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.89 127.25 53.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.257 -0.883 . . . . 65.439999999999998 110.278 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HG2' HG23 ' A' ' 21' ' ' VAL . 33.8 mtm180 -90.27 110.06 21.13 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.254 -0.647 . . . . 75.239999999999995 109.254 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.29 142.11 29.6 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.236 1.014 . . . . 74.439999999999998 110.173 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 11.0 pt-20 -50.04 -45.36 52.13 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.568 1.547 . . . . 73.099999999999994 111.885 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.531 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 32.8 mmtp -96.48 -46.94 6.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.371 -0.831 . . . . 74.420000000000002 108.854 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.6 45.69 92.93 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 124.589 1.181 . . . . 74.450000000000003 112.87 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.0 140.58 86.0 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.147 0.579 . . . . 65.239999999999995 110.696 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.16 123.93 13.04 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.153 2.569 . . . . 74.040000000000006 111.88 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -110.65 131.91 10.66 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.934 -0.575 . . . . 70.439999999999998 111.94 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -83.24 3.9 29.21 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.038 0.935 . . . . 72.120000000000005 110.297 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.409 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -94.43 29.86 2.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.693 1.197 . . . . 71.450000000000003 112.014 -177.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.7 mt -53.11 108.68 0.35 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 122.7 0.4 . . . . 73.049999999999997 110.54 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.58 -10.63 7.59 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 123.836 0.731 . . . . 72.450000000000003 112.53 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.91 163.58 27.74 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.309 1.044 . . . . 72.239999999999995 111.64 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -96.71 124.63 40.75 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.526 0.73 . . . . 74.439999999999998 110.64 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 m -99.67 149.11 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.872 1.269 . . . . 72.109999999999999 107.748 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -108.73 107.36 17.78 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.839 -0.801 . . . . 75.25 108.839 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.57 90.9 3.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.097 -1.446 . . . . 73.439999999999998 107.097 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.69 150.68 3.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 114.816 -1.084 . . . . 75.129999999999995 109.079 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.16 167.63 9.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.22 0.608 . . . . 72.049999999999997 110.854 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -68.01 82.72 0.22 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.867 0.867 . . . . 75.099999999999994 110.83 -169.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -66.76 -40.85 88.39 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.106 0.962 . . . . 73.450000000000003 110.924 -176.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 84.7 t60 . . . . . 0 CA--C 1.56 1.354 0 O-C-N 124.875 1.359 . . . . 74.430000000000007 109.907 -176.482 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 25.7 mmt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.213 -0.292 . . . . 75.120000000000005 110.213 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.619 ' HG2' HG22 ' A' ' 87' ' ' VAL . 61.4 mtt180 -128.19 118.34 23.17 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.256 -1.387 . . . . 63.119999999999997 107.256 163.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.46 HD13 HH11 ' A' ' 41' ' ' ARG . 61.5 mt -109.29 128.75 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.07 -1.085 . . . . 71.239999999999995 108.07 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -86.73 121.47 29.28 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.146 -0.687 . . . . 74.540000000000006 109.146 -170.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -127.44 169.63 19.22 Favored Glycine 0 C--N 1.341 0.847 0 O-C-N 124.003 0.814 . . . . 74.310000000000002 111.66 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.1 t -133.27 133.69 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.262 1.025 . . . . 72.040000000000006 109.167 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.97 102.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.539 0.736 . . . . 72.439999999999998 109.846 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 25' ' ' LYS . 86.7 mt -70.85 -53.86 13.65 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.688 -0.687 . . . . 73.510000000000005 109.471 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 t -158.61 168.83 25.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.759 -0.655 . . . . 73.329999999999998 111.113 -176.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -107.74 142.97 36.93 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.289 1.036 . . . . 73.0 108.752 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -132.78 133.26 43.19 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.205 -1.406 . . . . 75.329999999999998 107.205 169.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -74.03 153.31 39.74 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.742 -0.836 . . . . 75.019999999999996 108.742 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.7 t -65.02 -77.27 0.06 Allowed 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.126 -1.064 . . . . 71.239999999999995 108.126 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.3 tttm 51.33 52.31 15.08 Favored 'General case' 0 C--N 1.366 1.314 0 N-CA-C 108.053 -1.092 . . . . 75.540000000000006 108.053 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -162.76 -58.85 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.239 -1.346 . . . . 74.400000000000006 109.424 -161.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -123.16 -61.64 1.4 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.867 0.867 . . . . 71.230000000000004 109.027 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -127.25 -167.68 1.77 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.369 1.068 . . . . 72.209999999999994 110.597 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -97.64 9.31 42.85 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.093 0.957 . . . . 74.439999999999998 110.199 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.457 ' ND2' ' HA ' ' A' ' 72' ' ' GLU . 2.0 m-20 -66.21 155.13 37.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.452 1.101 . . . . 73.329999999999998 110.673 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.51 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 21.7 t-20 -98.67 127.25 44.53 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.288 -0.634 . . . . 71.129999999999995 109.288 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.529 HG23 ' HG2' ' A' ' 70' ' ' ARG . 22.0 t -89.27 104.68 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 106.451 -1.685 . . . . 74.340000000000003 106.451 172.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 47.7 ttm -93.27 130.15 39.09 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 122.681 0.392 . . . . 73.510000000000005 110.758 -171.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.443 HG23 HD13 ' A' ' 8' ' ' LEU . 32.9 mm -81.04 102.18 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.448 -0.945 . . . . 73.219999999999999 108.448 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -109.07 147.25 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.281 1.032 . . . . 74.150000000000006 109.009 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HB2' HD11 ' A' ' 8' ' ' LEU . 39.5 ttmt -118.35 102.37 50.41 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 108.622 -0.881 . . . . 74.230000000000004 108.622 167.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 18.1 Cg_endo -61.96 111.27 1.18 Allowed 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 121.545 1.497 . . . . 75.540000000000006 109.287 167.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.4 mt -55.39 -32.09 62.36 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.221 1.008 . . . . 70.400000000000006 112.266 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.14 -30.12 68.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.131 0.972 . . . . 72.409999999999997 111.718 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' A' ' 34' ' ' GLU . 93.6 t -107.1 117.89 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.195 0.998 . . . . 74.420000000000002 110.13 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -121.19 4.63 10.33 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.36 0.664 . . . . 75.209999999999994 111.522 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.517 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 6.0 m -130.24 145.36 51.74 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.272 0.629 . . . . 70.209999999999994 109.69 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.653 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 73.3 ttt180 -59.09 -46.65 87.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.769 0.827 . . . . 73.519999999999996 111.302 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.25 -39.97 84.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 123.924 0.765 . . . . 73.209999999999994 111.719 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.518 ' HB2' HG12 ' A' ' 29' ' ' VAL . 47.4 mt-10 -59.99 -49.79 76.29 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.172 0.92 . . . . 64.439999999999998 109.647 176.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.53 -24.02 61.88 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.128 0.971 . . . . 74.329999999999998 111.947 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -73.29 -39.19 65.53 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.749 0.82 . . . . 71.25 110.68 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -77.74 -10.36 59.49 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.412 -0.358 . . . . 75.019999999999996 110.976 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.604 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 55.6 mt -97.74 26.71 4.87 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.486 1.115 . . . . 73.400000000000006 111.625 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.626 HD11 HG11 ' A' ' 60' ' ' VAL . 45.2 mm -85.76 135.98 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 109.191 -0.67 . . . . 73.340000000000003 109.191 172.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.55 -7.24 39.25 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.579 -0.567 . . . . 75.310000000000002 113.517 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.604 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 16.5 ptt180 -80.59 154.17 27.6 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.223 0.511 . . . . 72.209999999999994 110.372 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' ' 54' ' ' LYS . 60.8 tp -90.93 146.59 23.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.127 0.971 . . . . 75.120000000000005 109.408 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.514 HG23 HG21 ' A' ' 86' ' ' ILE . 47.4 t -122.19 125.82 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.851 0.86 . . . . 73.510000000000005 109.279 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.0 mt -103.79 100.26 10.06 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.855 -0.795 . . . . 74.519999999999996 108.855 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -104.52 147.95 27.03 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.934 0.894 . . . . 75.420000000000002 109.439 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HZ1' ' HB3' ' A' ' 46' ' ' LYS . 5.9 ttpm? -99.63 109.05 21.57 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.348 -0.982 . . . . 74.319999999999993 108.348 175.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.4 p -68.93 154.13 95.31 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.805 0.842 . . . . 74.420000000000002 111.045 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HG3' ' HB3' ' A' ' 79' ' ' ALA . 46.2 Cg_exo -59.98 -13.29 22.33 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.391 2.727 . . . . 74.349999999999994 113.506 172.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -81.37 -5.01 57.41 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.782 0.833 . . . . 73.540000000000006 111.606 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.08 -10.56 71.72 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-O 119.986 -0.341 . . . . 73.519999999999996 113.429 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -82.35 154.46 25.26 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.657 0.783 . . . . 75.200000000000003 110.373 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -102.29 103.64 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.383 -0.969 . . . . 74.239999999999995 108.383 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.7 mt -82.43 153.41 25.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.367 -0.833 . . . . 75.430000000000007 110.892 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HB3' HD13 ' A' ' 42' ' ' LEU . 59.0 mtpt -117.03 117.0 28.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.529 -1.214 . . . . 74.510000000000005 108.02 -176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -128.2 132.82 7.5 Favored Glycine 0 CA--C 1.503 -0.672 0 N-CA-C 111.549 -0.62 . . . . 73.019999999999996 111.549 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -101.66 128.18 48.07 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 117.439 0.62 . . . . 74.450000000000003 109.86 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 78.9 mt -66.8 106.94 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 124.211 0.944 . . . . 75.430000000000007 109.373 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -84.31 -30.3 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.032 0.933 . . . . 73.140000000000001 111.162 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -168.4 167.27 11.98 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.126 0.571 . . . . 75.120000000000005 110.209 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.626 HG11 HD11 ' A' ' 39' ' ' ILE . 23.9 m -91.37 169.96 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.322 1.049 . . . . 73.140000000000001 111.292 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -141.57 105.56 4.77 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.84 1.256 . . . . 70.239999999999995 108.558 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.22 173.52 49.74 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.729 -0.214 . . . . 64.340000000000003 112.64 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.653 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 63.2 p -93.0 6.93 46.16 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.707 0.803 . . . . 74.319999999999993 111.372 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -93.67 14.96 17.46 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.185 0.994 . . . . 75.430000000000007 111.874 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.18 -4.65 70.5 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-O 119.722 -0.488 . . . . 65.200000000000003 113.959 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.97 143.89 55.42 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.379 0.672 . . . . 70.129999999999995 110.332 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.449 HG12 HG12 ' A' ' 60' ' ' VAL . 14.0 m -126.49 169.91 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.678 1.191 . . . . 72.340000000000003 110.989 -175.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -128.13 107.64 9.97 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.221 1.008 . . . . 74.25 109.327 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.5 125.86 51.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.787 0.835 . . . . 72.310000000000002 110.141 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.529 ' HG2' HG23 ' A' ' 21' ' ' VAL . 88.3 mtt180 -89.0 104.51 17.05 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.246 -0.65 . . . . 70.299999999999997 109.246 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.77 135.42 34.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.013 0.925 . . . . 75.209999999999994 109.173 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.457 ' HA ' ' ND2' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -55.94 -31.16 62.69 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.408 1.083 . . . . 64.230000000000004 112.075 -174.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -107.44 -63.11 1.34 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.082 0.953 . . . . 73.549999999999997 109.357 173.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 67.57 56.9 9.96 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.206 -0.907 . . . . 41.240000000000002 111.421 -171.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 97.0 mt -68.36 132.78 91.35 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.25 1.02 . . . . 75.420000000000002 111.257 -170.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 3.9 Cg_exo -76.48 176.35 10.19 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 123.216 2.611 . . . . 75.219999999999999 112.979 -170.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.02 177.69 15.03 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.766 -0.652 . . . . 72.430000000000007 111.595 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.8 76.46 7.98 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.894 0.854 . . . . 74.549999999999997 109.567 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.441 ' HB3' ' HG3' ' A' ' 48' ' ' PRO . . . -119.75 28.03 8.37 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.982 -1.008 . . . . 73.25 110.201 172.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.08 109.14 4.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.343 -0.614 . . . . 73.409999999999997 109.343 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.15 -5.86 21.72 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-O 119.649 -0.529 . . . . 74.340000000000003 112.331 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.05 143.42 56.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.504 0.722 . . . . 71.530000000000001 110.074 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -93.69 123.99 37.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.693 0.797 . . . . 74.299999999999997 110.87 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 m -100.69 144.04 13.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.472 -0.785 . . . . 72.439999999999998 109.065 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.95 108.04 19.01 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.426 -0.953 . . . . 74.420000000000002 108.426 170.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.514 HG21 HG23 ' A' ' 43' ' ' VAL . 38.8 mt -89.04 97.97 7.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 115.067 -0.969 . . . . 74.310000000000002 108.858 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.619 HG22 ' HG2' ' A' ' 2' ' ' ARG . 13.0 t -89.89 131.39 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.675 -0.693 . . . . 74.420000000000002 110.316 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -116.72 121.8 42.65 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.822 -1.547 . . . . 73.510000000000005 106.822 172.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -90.82 147.96 22.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.887 0.875 . . . . 74.129999999999995 109.378 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -112.15 138.04 49.38 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.011 0.524 . . . . 72.310000000000002 109.709 175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 79.4 t60 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 108.095 -1.076 . . . . 72.530000000000001 108.095 178.659 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 109.366 -0.605 . . . . 73.349999999999994 109.366 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.407 ' HG2' ' HB3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -128.92 148.05 50.89 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.124 0.97 . . . . 74.430000000000007 109.074 177.421 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.507 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 56.6 mt -105.55 128.95 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.739 -1.208 . . . . 74.120000000000005 107.739 170.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -88.65 124.27 33.92 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.165 0.507 . . . . 74.439999999999998 110.009 -174.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -121.54 135.23 10.42 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.702 -0.681 . . . . 75.230000000000004 111.876 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.7 t -90.22 132.82 33.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 117.737 0.769 . . . . 74.549999999999997 109.988 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.85 103.06 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.721 0 O-C-N 124.504 1.127 . . . . 71.140000000000001 109.482 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' A' ' 25' ' ' LYS . 71.8 mt -78.32 -56.09 4.73 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.547 0.529 . . . . 75.420000000000002 109.776 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 m -152.85 170.21 20.9 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.453 0.644 . . . . 75.299999999999997 111.712 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -117.81 147.46 43.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.589 1.156 . . . . 74.25 108.152 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 65.7 ttt180 -135.37 116.03 13.86 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 110.103 -0.332 . . . . 74.420000000000002 110.103 178.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -79.95 117.76 21.09 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 109.047 -0.723 . . . . 74.530000000000001 109.047 174.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.9 p -66.59 130.32 42.81 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.337 0.655 . . . . 72.340000000000003 110.34 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -84.03 61.64 6.57 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.722 0.772 . . . . 74.540000000000006 109.648 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -111.57 173.84 6.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.95 -1.023 . . . . 74.129999999999995 109.693 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.421 ' N ' HD21 ' A' ' 16' ' ' ASN . 0.8 OUTLIER -79.18 -38.92 34.7 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.192 -0.458 . . . . 75.010000000000005 109.845 176.053 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -171.51 91.0 0.13 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.943 0.897 . . . . 72.439999999999998 109.35 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -144.75 176.99 9.03 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.92 0.888 . . . . 61.399999999999999 110.482 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.8 161.5 30.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.251 0.621 . . . . 75.319999999999993 111.33 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -89.71 153.29 20.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.064 0.546 . . . . 73.219999999999999 110.221 -176.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 50.3 t -102.5 152.33 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.31 1.044 . . . . 72.540000000000006 108.867 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.1 ttt -150.04 129.78 13.24 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.399 -0.593 . . . . 73.400000000000006 109.399 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 8' ' ' LEU . 49.6 mm -93.41 111.53 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.132 0.973 . . . . 74.109999999999999 109.363 -177.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.7 mt -125.71 149.3 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.087 0.955 . . . . 74.439999999999998 108.769 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HB2' HD11 ' A' ' 8' ' ' LEU . 36.5 ttpt -133.19 116.83 14.44 Favored Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 109.994 -0.373 . . . . 74.329999999999998 109.994 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.7 Cg_exo -68.3 125.96 13.64 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 122.535 2.157 . . . . 73.25 110.528 173.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.6 mt -70.64 -30.25 66.83 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.86 0.464 . . . . 75.109999999999999 111.555 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.47 -19.11 62.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.365 0.666 . . . . 74.230000000000004 111.067 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.559 HG11 ' HB2' ' A' ' 34' ' ' GLU . 49.1 t -108.96 147.62 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.709 1.204 . . . . 63.439999999999998 109.678 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.04 -0.69 0.88 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.368 0.667 . . . . 73.140000000000001 112.358 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 m -128.04 147.39 50.51 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.575 0.75 . . . . 72.140000000000001 110.509 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 68.8 ttt180 -64.35 -34.62 78.58 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.474 0.71 . . . . 72.109999999999999 112.139 -176.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.11 -39.23 78.15 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.455 0.702 . . . . 75.25 111.49 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.559 ' HB2' HG11 ' A' ' 29' ' ' VAL . 29.5 mt-10 -69.88 -45.24 68.11 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.001 -0.999 . . . . 74.299999999999997 109.977 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.81 -30.08 69.85 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.044 0.538 . . . . 64.230000000000004 111.227 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 t -75.23 -30.5 60.57 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.099 0.96 . . . . 75.549999999999997 111.626 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.531 ' HZ1' ' HB2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -84.81 -1.27 56.2 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 120.293 0.092 . . . . 73.010000000000005 111.157 173.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 34' ' ' GLU . 73.6 mt -91.76 -9.26 44.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.121 0.568 . . . . 73.209999999999994 111.632 174.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.495 HD12 HG11 ' A' ' 60' ' ' VAL . 42.8 mm -63.11 119.65 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 123.439 0.462 . . . . 73.549999999999997 110.306 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.35 -0.71 46.72 Favored Glycine 0 N--CA 1.466 0.673 0 CA-C-O 119.716 -0.491 . . . . 70.319999999999993 113.167 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -88.93 160.81 16.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.382 0.591 . . . . 75.5 111.053 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 55' ' ' GLY . 36.5 tp -90.28 144.37 25.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.998 -1.001 . . . . 64.299999999999997 109.794 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.9 t -124.96 115.75 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.922 0.889 . . . . 72.239999999999995 108.668 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.07 105.9 16.31 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.902 -0.777 . . . . 75.019999999999996 108.902 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.402 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 36.1 t90 -109.06 143.18 38.73 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.033 -0.729 . . . . 73.329999999999998 109.033 175.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -97.97 118.99 35.8 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.811 -0.811 . . . . 74.329999999999998 108.811 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.0 p -78.98 153.38 77.55 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.106 0.562 . . . . 74.219999999999999 109.83 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.84 -7.84 19.64 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.788 2.325 . . . . 73.420000000000002 112.434 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -71.25 -17.51 62.48 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 124.568 1.147 . . . . 70.010000000000005 110.983 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.58 16.23 46.81 Favored Glycine 0 C--N 1.356 1.666 0 C-N-CA 123.042 0.353 . . . . 52.409999999999997 113.131 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -109.85 149.32 30.03 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.709 0.804 . . . . 74.530000000000001 109.892 -176.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -93.75 98.51 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.617 -1.253 . . . . 71.549999999999997 107.617 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.402 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 54.6 mt -78.2 125.96 30.11 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.269 -0.641 . . . . 72.239999999999995 109.269 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -96.46 127.52 42.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.388 -0.823 . . . . 73.420000000000002 109.335 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -127.08 177.57 17.31 Favored Glycine 0 CA--C 1.504 -0.649 0 CA-C-N 114.862 -1.063 . . . . 50.420000000000002 110.738 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -149.38 135.28 18.82 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.7 -0.482 . . . . 74.120000000000005 109.7 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.484 HG23 HD13 ' A' ' 39' ' ' ILE . 78.5 mt -67.96 95.71 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 O-C-N 124.531 1.144 . . . . 74.25 108.826 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.41 -24.8 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.291 -0.868 . . . . 71.540000000000006 110.688 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -150.99 164.13 37.13 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.846 -0.616 . . . . 72.430000000000007 109.454 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.495 HG11 HD12 ' A' ' 39' ' ' ILE . 32.9 m -92.09 168.39 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.778 -0.823 . . . . 64.109999999999999 108.778 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -142.05 103.65 4.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.834 -0.802 . . . . 75.420000000000002 108.834 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.91 -171.4 45.31 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 115.477 -0.783 . . . . 72.409999999999997 113.551 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 51.7 p -94.67 0.12 54.81 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.944 0.897 . . . . 72.239999999999995 111.43 176.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -81.12 2.04 29.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.457 1.103 . . . . 74.010000000000005 111.784 -173.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' HA3' HG12 ' A' ' 29' ' ' VAL . . . 78.44 6.74 88.06 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.261 0.351 . . . . 65.109999999999999 113.074 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.95 147.89 48.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.032 0.533 . . . . 74.099999999999994 110.138 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' HB ' HG22 ' A' ' 57' ' ' ILE . 30.5 m -121.69 140.53 45.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.678 0.791 . . . . 75.519999999999996 110.77 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -98.75 104.48 16.53 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.085 -1.08 . . . . 74.310000000000002 108.085 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.7 126.32 52.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.505 0.722 . . . . 70.239999999999995 110.147 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -101.56 126.14 48.32 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.854 0.462 . . . . 74.219999999999999 110.105 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.533 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 11.0 m-85 -93.37 126.34 38.45 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.025 0.93 . . . . 72.140000000000001 110.398 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.477 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 12.1 pt-20 -61.23 -28.83 69.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.273 1.029 . . . . 74.200000000000003 111.827 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.477 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 14.4 mmmm -101.07 -68.23 0.82 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.76 -0.83 . . . . 74.409999999999997 108.76 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.04 56.43 18.41 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.832 -0.622 . . . . 64.409999999999997 112.805 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.9 mt -68.7 156.55 90.72 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.7 0.8 . . . . 75.209999999999994 110.913 173.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.28 139.23 81.99 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.921 2.414 . . . . 71.109999999999999 112.695 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.72 140.62 2.96 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.633 -0.712 . . . . 74.519999999999996 112.207 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -121.11 97.09 5.36 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.919 0.888 . . . . 74.409999999999997 109.375 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.16 30.14 7.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.767 1.227 . . . . 71.430000000000007 110.899 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.4 mt -45.27 113.65 0.61 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.695 0.798 . . . . 75.209999999999994 112.242 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.41 -15.55 20.08 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-N 116.419 -0.355 . . . . 72.439999999999998 113.288 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.88 158.97 31.44 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.163 0.985 . . . . 65.109999999999999 111.908 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -100.83 127.3 47.34 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.806 0.842 . . . . 75.25 110.862 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 m -100.42 158.6 3.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 108.739 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.407 ' HB3' ' HG2' ' A' ' 2' ' ' ARG . 35.3 mt-10 -103.96 108.13 19.33 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.99 0.516 . . . . 73.340000000000003 109.869 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.507 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 74.7 mt -86.68 94.11 4.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.612 -1.255 . . . . 71.420000000000002 107.612 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 t -89.63 137.31 21.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 114.633 -1.167 . . . . 73.329999999999998 109.164 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.31 107.07 1.87 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.201 -1.407 . . . . 72.420000000000002 107.201 169.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . 37.2 tt0 -84.3 119.57 25.23 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.709 -0.848 . . . . 71.219999999999999 108.709 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -70.18 96.42 1.09 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.343 -0.614 . . . . 74.340000000000003 109.343 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 . . . . . 0 C--O 1.248 0.982 0 N-CA-C 108.098 -1.075 . . . . 74.019999999999996 108.098 169.583 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 121.382 0.611 . . . . 61.009999999999998 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -116.06 133.98 55.45 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.934 1.294 . . . . 74.349999999999994 108.405 175.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 61.3 mt -95.65 136.4 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.483 -0.932 . . . . 74.319999999999993 108.483 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.644 ' HB3' ' HZ1' ' A' ' 4' ' ' LYS . 6.1 ttpm? -88.36 126.82 35.39 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.214 0.605 . . . . 74.329999999999998 109.749 -171.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -129.95 175.49 19.11 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 123.624 0.578 . . . . 64.200000000000003 112.115 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.4 t -140.13 132.03 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.528 1.131 . . . . 65.430000000000007 109.627 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.83 107.4 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.131 0.973 . . . . 72.129999999999995 110.308 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.55 HD11 HG23 ' A' ' 23' ' ' ILE . 86.6 mt -79.99 -55.27 5.08 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.36 0.664 . . . . 74.219999999999999 110.004 176.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 p -158.71 173.25 16.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.616 -0.72 . . . . 63.450000000000003 111.254 -173.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.485 ' HE1' ' HE1' ' A' ' 22' ' ' MET . 17.2 m-85 -122.89 159.72 27.61 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.632 0.773 . . . . 72.209999999999994 109.058 172.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -136.09 107.42 6.84 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.462 -1.31 . . . . 64.299999999999997 107.462 161.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -97.29 131.82 43.63 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.384 0.611 . . . . 75.329999999999998 111.43 -172.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.7 t -83.72 108.74 16.97 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.993 -1.003 . . . . 54.130000000000003 108.415 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -80.56 -13.63 58.91 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.78 0.432 . . . . 70.430000000000007 111.3 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.46 -14.44 55.06 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.959 0.903 . . . . 71.400000000000006 111.137 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -171.89 97.04 0.17 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.129 -1.063 . . . . 75.010000000000005 108.129 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -83.38 62.55 6.79 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.801 1.286 . . . . 72.299999999999997 110.254 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -141.93 152.31 43.42 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 126.406 1.883 . . . . 74.430000000000007 106.195 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.9 m120 60.64 31.8 20.24 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.495 0.718 . . . . 64.129999999999995 110.915 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.588 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 36.1 t30 -58.57 145.06 40.74 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.782 0.833 . . . . 74.230000000000004 111.237 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.535 HG11 ' HG3' ' A' ' 68' ' ' ARG . 90.3 t -88.28 134.02 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 122.974 0.51 . . . . 72.230000000000004 109.658 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.485 ' HE1' ' HE1' ' A' ' 10' ' ' TYR . 43.1 ttm -130.85 112.88 13.41 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.23 -1.396 . . . . 75.510000000000005 107.23 170.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.55 HG23 HD11 ' A' ' 8' ' ' LEU . 50.8 mm -78.52 111.71 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.079 -1.082 . . . . 73.219999999999999 108.079 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 84' ' ' VAL . 84.6 mt -109.98 137.48 42.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 C-N-CA 124.221 1.008 . . . . 74.450000000000003 109.427 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HB2' HD12 ' A' ' 8' ' ' LEU . 81.9 tttt -96.96 104.0 17.09 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.624 -0.88 . . . . 75.129999999999995 108.624 166.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.504 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 3.3 Cg_exo -68.68 112.27 2.82 Favored 'Trans proline' 0 C--N 1.369 1.622 0 N-CA-C 107.802 -1.653 . . . . 72.209999999999994 107.802 168.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.66 -27.27 69.11 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.588 0.755 . . . . 73.299999999999997 112.576 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.43 -28.31 64.95 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.606 0.762 . . . . 71.209999999999994 111.238 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 34' ' ' GLU . 88.7 t -98.5 145.61 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.98 1.312 . . . . 74.340000000000003 109.785 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -158.12 33.0 0.25 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.272 0.558 . . . . 65.219999999999999 109.734 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.5 m -150.19 141.22 22.97 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.403 0.681 . . . . 73.010000000000005 110.116 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.609 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 59.2 ttt180 -62.71 -32.65 73.79 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.353 0.661 . . . . 74.540000000000006 110.971 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -52.15 -51.81 55.62 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.93 0.769 . . . . 72.319999999999993 110.271 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.441 ' HB2' HG13 ' A' ' 29' ' ' VAL . 44.0 mt-10 -60.24 -52.49 65.06 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 114.577 -1.192 . . . . 74.209999999999994 110.361 177.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.12 70.56 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.666 0.787 . . . . 62.140000000000001 112.193 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.5 t -76.91 -28.62 55.37 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.9 0.88 . . . . 65.450000000000003 111.321 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -94.3 2.52 55.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.733 0.413 . . . . 75.239999999999995 110.922 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.558 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 46.6 mt -113.11 24.2 12.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.473 1.109 . . . . 75.150000000000006 110.678 175.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.76 132.13 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.938 -0.764 . . . . 72.120000000000005 108.938 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.02 -14.74 19.09 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.866 -0.408 . . . . 75.230000000000004 113.333 171.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 15.1 ptt180 -75.62 155.77 35.55 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.143 0.471 . . . . 73.530000000000001 110.449 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.8 tp -89.78 154.34 19.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.144 0.977 . . . . 70.019999999999996 109.959 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 86' ' ' ILE . 36.4 t -132.73 144.39 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.331 1.052 . . . . 70.230000000000004 108.418 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -127.53 117.99 23.12 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.7 -0.852 . . . . 75.409999999999997 108.7 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -130.3 132.36 45.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.64 0.776 . . . . 73.040000000000006 109.385 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -83.8 118.88 24.22 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.972 -0.751 . . . . 61.149999999999999 108.972 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.7 p -66.8 163.13 45.84 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.808 0.843 . . . . 73.340000000000003 111.437 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.36 -13.3 37.5 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.282 1.988 . . . . 74.540000000000006 112.123 167.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -85.2 -8.8 58.41 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.251 1.02 . . . . 64.439999999999998 110.878 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.56 -21.12 47.55 Favored Glycine 0 C--N 1.352 1.434 0 C-N-CA 123.013 0.339 . . . . 62.299999999999997 113.593 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -76.59 132.36 39.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.516 0.727 . . . . 71.319999999999993 111.049 -176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -78.33 102.15 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.936 -0.764 . . . . 75.129999999999995 108.936 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.51 135.43 39.32 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.038 -0.983 . . . . 75.299999999999997 109.862 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -96.31 133.52 40.56 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.971 -0.751 . . . . 73.209999999999994 108.971 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -131.25 169.84 21.61 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 110.821 -0.912 . . . . 72.5 110.821 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -145.15 134.86 23.46 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.171 -0.677 . . . . 73.400000000000006 109.171 177.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.471 HG22 ' HB ' ' A' ' 67' ' ' VAL . 93.7 mt -72.27 102.45 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 114.908 -1.042 . . . . 74.439999999999998 109.308 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.72 -19.33 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 115.056 -0.975 . . . . 74.140000000000001 111.521 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -153.89 168.43 26.38 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 122.562 0.345 . . . . 74.530000000000001 110.165 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.52 169.79 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 123.532 0.733 . . . . 72.450000000000003 110.359 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -141.32 104.09 4.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.683 0.793 . . . . 73.340000000000003 109.203 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.3 -172.39 34.59 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 115.934 -0.575 . . . . 71.049999999999997 113.519 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.609 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 17.5 p -91.4 2.93 56.05 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.197 0.999 . . . . 73.329999999999998 111.728 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -84.75 -3.34 58.54 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.43 1.092 . . . . 75.219999999999999 112.132 -171.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.14 -1.71 88.59 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.966 -0.352 . . . . 74.140000000000001 113.264 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.63 135.44 55.93 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 109.28 -0.637 . . . . 72.430000000000007 109.28 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 57' ' ' ILE . 29.2 m -111.63 157.14 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.996 0.918 . . . . 75.219999999999999 110.889 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.535 ' HG3' HG11 ' A' ' 21' ' ' VAL . 41.3 ttm180 -106.52 109.27 21.14 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.002 0.921 . . . . 75.439999999999998 109.226 174.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.05 121.85 45.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.421 0.688 . . . . 73.030000000000001 110.267 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -88.07 111.24 21.33 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.276 -0.639 . . . . 71.430000000000007 109.276 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.414 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 39.2 m-85 -87.26 147.14 25.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.606 0.762 . . . . 75.150000000000006 110.758 175.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -49.66 -47.47 50.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.157 1.383 . . . . 75.400000000000006 111.822 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -108.7 -57.73 2.1 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.211 1.004 . . . . 75.219999999999999 108.411 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.588 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 63.42 57.16 15.97 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 114.598 -1.183 . . . . 61.340000000000003 111.661 -175.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.485 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 39.0 mt -67.56 115.49 27.5 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 109.653 -0.499 . . . . 74.200000000000003 109.653 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 12.4 Cg_exo -68.44 164.59 32.13 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 123.337 2.691 . . . . 75.510000000000005 111.949 -173.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 170.72 168.6 32.7 Favored Glycine 0 C--N 1.329 0.176 0 N-CA-C 111.139 -0.784 . . . . 75.209999999999994 111.139 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -85.6 28.71 0.74 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.299 0.639 . . . . 73.420000000000002 111.798 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.78 23.73 1.14 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.587 1.155 . . . . 72.430000000000007 111.404 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.61 113.76 3.53 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.682 0.793 . . . . 74.519999999999996 109.578 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.66 -5.67 14.32 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.948 -0.569 . . . . 61.240000000000002 112.487 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -80.44 152.73 28.64 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.508 0.723 . . . . 70.019999999999996 111.201 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -85.82 145.26 27.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.848 0.459 . . . . 74.450000000000003 111.765 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.48 HG23 HD13 ' A' ' 24' ' ' ILE . 18.2 m -116.73 157.7 17.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 C-N-CA 124.144 0.978 . . . . 71.239999999999995 108.97 171.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -113.69 109.94 19.39 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.323 -0.621 . . . . 65.319999999999993 109.323 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 69.3 mt -89.13 98.04 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.57 0.748 . . . . 73.439999999999998 109.443 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.9 t -79.69 136.41 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.496 -0.775 . . . . 72.239999999999995 109.703 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -78.52 99.98 6.72 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 108.438 -0.949 . . . . 75.400000000000006 108.438 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -137.21 135.46 37.28 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.015 0.926 . . . . 74.340000000000003 109.402 172.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -81.33 -21.98 38.8 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.394 -0.821 . . . . 70.510000000000005 109.605 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 . . . . . 0 CA--C 1.549 0.928 0 C-N-CA 125.242 1.417 . . . . 74.349999999999994 110.94 178.85 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ttt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.12 -0.326 . . . . 64.140000000000001 110.12 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 39.1 ptt180 -101.51 128.57 47.69 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.021 0.439 . . . . 74.319999999999993 110.998 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 56.8 mt -101.07 145.28 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 108.016 -1.105 . . . . 65.340000000000003 108.016 174.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 27' ' ' LEU . 20.5 ptmt -90.29 124.73 35.14 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.413 -0.588 . . . . 74.200000000000003 109.413 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -123.59 150.98 16.95 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 111.273 -0.731 . . . . 74.150000000000006 111.273 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.7 t -99.05 135.5 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.015 0.908 . . . . 73.299999999999997 110.802 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.82 104.07 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.876 1.27 . . . . 75.099999999999994 109.057 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.556 HD21 ' HG2' ' A' ' 25' ' ' LYS . 59.4 mt -82.28 -60.74 2.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.671 -0.492 . . . . 75.450000000000003 109.671 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -153.45 169.77 22.35 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.357 0.663 . . . . 73.349999999999994 111.701 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -122.82 143.09 50.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.508 1.123 . . . . 73.400000000000006 108.611 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.419 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 41.6 ttm180 -136.53 117.5 14.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.958 0.903 . . . . 73.109999999999999 108.893 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -73.75 145.05 45.4 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 109.623 -0.51 . . . . 74.239999999999995 109.623 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.6 p -111.5 -24.55 10.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.641 0.776 . . . . 74.319999999999993 109.797 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -156.91 150.59 24.53 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.411 0.684 . . . . 70.120000000000005 110.575 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -60.59 -48.84 80.01 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.169 1.387 . . . . 75.230000000000004 111.818 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.88 171.41 14.46 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.607 0.363 . . . . 73.420000000000002 111.444 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -57.14 97.62 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.782 1.233 . . . . 70.340000000000003 111.23 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -148.76 155.95 41.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.46 1.104 . . . . 74.409999999999997 109.343 -173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -66.29 90.61 0.15 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 120.825 0.345 . . . . 73.400000000000006 110.092 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -84.87 156.5 21.25 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.542 -0.911 . . . . 72.439999999999998 108.542 173.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 21.9 t -87.36 146.81 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.522 0.729 . . . . 63.310000000000002 109.208 -172.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -138.54 112.79 8.68 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.159 -1.423 . . . . 71.319999999999993 107.159 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.515 HG23 HD13 ' A' ' 8' ' ' LEU . 24.7 mm -75.06 112.43 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.272 -1.01 . . . . 72.510000000000005 108.272 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -122.62 162.63 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.703 1.201 . . . . 74.140000000000001 107.832 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.556 ' HG2' HD21 ' A' ' 8' ' ' LEU . 20.3 ptmt -145.94 131.05 9.09 Favored Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 109.511 -0.552 . . . . 71.230000000000004 109.511 163.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.51 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 9.8 Cg_exo -69.94 127.94 15.15 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 121.967 1.778 . . . . 74.409999999999997 110.562 171.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.44 HD11 ' HE2' ' A' ' 4' ' ' LYS . 64.6 mt -60.68 -37.0 80.15 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.327 0.651 . . . . 74.120000000000005 112.107 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -74.4 -29.26 61.45 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.971 -0.558 . . . . 75.239999999999995 110.8 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 45.8 t -87.39 97.78 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.914 0.864 . . . . 63.200000000000003 109.98 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -101.04 -6.63 24.15 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.815 1.246 . . . . 73.040000000000006 110.169 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 m -117.44 147.13 42.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.923 0.889 . . . . 74.549999999999997 110.352 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.573 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 75.6 ttt-85 -65.16 -34.75 79.12 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.035 0.534 . . . . 64.150000000000006 111.576 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -59.67 -43.62 93.91 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.538 0.685 . . . . 72.420000000000002 109.759 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HB2' HG11 ' A' ' 29' ' ' VAL . 21.2 mm-40 -68.86 -31.67 70.78 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.724 -1.125 . . . . 73.439999999999998 111.062 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.56 -35.0 58.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.53 0.732 . . . . 72.140000000000001 111.766 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -79.91 -25.63 40.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.395 1.078 . . . . 73.219999999999999 111.152 -168.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 63.3 pttt -77.61 -13.63 59.86 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.419 -0.355 . . . . 75.430000000000007 110.848 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.537 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 96.1 mt -89.05 8.34 30.28 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.777 0.831 . . . . 62.549999999999997 111.834 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.459 HD13 HG11 ' A' ' 60' ' ' VAL . 33.1 mm -65.87 103.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.272 -1.01 . . . . 72.430000000000007 108.272 172.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.61 0.8 17.96 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.52 -0.6 . . . . 60.140000000000001 113.446 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.786 ' HD3' HG22 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -74.37 156.24 37.28 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.747 0.773 . . . . 75.109999999999999 110.585 177.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 tp -94.43 143.88 26.04 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.172 0.589 . . . . 74.150000000000006 109.894 176.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.93 125.79 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.992 -1.114 . . . . 75.329999999999998 107.992 172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -115.01 109.5 18.19 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.735 -1.209 . . . . 73.209999999999994 107.735 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.3 t90 -131.74 117.51 18.69 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.251 -0.648 . . . . 75.239999999999995 109.251 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -86.46 105.86 17.07 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.653 0.781 . . . . 75.239999999999995 109.048 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.6 p -64.22 153.73 84.86 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 124.318 1.047 . . . . 61.43 112.459 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.33 -8.07 17.7 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.075 2.517 . . . . 73.219999999999999 112.622 168.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -61.63 -27.52 68.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.881 0.872 . . . . 73.349999999999994 110.693 167.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.42 24.85 13.18 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 115.253 -0.885 . . . . 54.149999999999999 111.901 -175.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -124.08 139.49 53.89 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.791 0.836 . . . . 74.019999999999996 110.554 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -85.18 95.1 4.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.235 -1.024 . . . . 75.129999999999995 108.235 173.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.443 HD23 ' HB2' ' A' ' 73' ' ' LYS . 28.6 mt -75.4 111.37 10.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.937 -0.764 . . . . 75.400000000000006 108.937 177.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -97.26 135.1 39.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.464 0.706 . . . . 71.010000000000005 109.662 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.46 170.98 24.51 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.581 0.551 . . . . 54.310000000000002 113.069 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -152.85 141.99 21.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.819 0.848 . . . . 75.25 109.66 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 29.9 mt -70.38 122.43 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 123.418 0.449 . . . . 75.400000000000006 110.284 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.3 m -87.25 -34.1 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.416 0.686 . . . . 70.349999999999994 110.08 172.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -167.36 150.52 6.26 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.337 0.655 . . . . 74.430000000000007 109.878 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.459 HG11 HD13 ' A' ' 39' ' ' ILE . 16.6 m -90.44 169.69 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.175 0.59 . . . . 73.329999999999998 109.639 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -135.59 101.88 4.93 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.833 -0.803 . . . . 73.409999999999997 108.833 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.79 -171.7 25.87 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 115.386 0.914 . . . . 43.409999999999997 115.386 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.573 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 40.3 p -93.81 12.1 26.95 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.646 1.179 . . . . 71.109999999999999 111.8 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -74.15 -17.76 60.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.816 0.846 . . . . 73.120000000000005 110.642 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.14 -4.95 78.24 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.515 -0.634 . . . . 74.349999999999994 111.515 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.89 141.69 51.18 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.605 0.762 . . . . 75.230000000000004 110.945 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.478 HG21 ' NH2' ' A' ' 41' ' ' ARG . 27.4 m -135.7 152.47 31.24 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 C-N-CA 124.539 1.135 . . . . 72.200000000000003 109.691 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -107.27 102.7 11.99 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.006 -1.109 . . . . 73.409999999999997 108.006 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -107.24 116.03 31.21 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.237 -0.892 . . . . 73.25 108.948 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -89.1 131.81 35.08 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.566 -0.531 . . . . 75.230000000000004 109.566 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -101.62 135.49 43.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.402 1.081 . . . . 74.230000000000004 109.432 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -54.62 -44.39 73.1 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.482 1.114 . . . . 74.540000000000006 111.15 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.443 ' HB2' HD23 ' A' ' 53' ' ' LEU . 73.3 mmtt -77.86 -42.49 33.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.507 -0.77 . . . . 74.530000000000001 109.293 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.55 33.7 72.93 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 124.137 0.898 . . . . 64.5 114.101 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.427 HD11 HD21 ' A' ' 53' ' ' LEU . 43.6 mt -69.71 121.57 82.98 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.067 0.547 . . . . 74.329999999999998 110.782 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.39 123.38 8.15 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.601 2.201 . . . . 74.319999999999993 110.969 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -135.17 142.78 14.25 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.916 -0.474 . . . . 74.329999999999998 111.916 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -88.38 70.28 9.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.159 -1.052 . . . . 74.439999999999998 108.159 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.39 28.58 7.93 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.139 -1.391 . . . . 74.409999999999997 110.315 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.29 104.05 1.4 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.841 -0.618 . . . . 74.209999999999994 110.209 -174.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.81 -1.76 8.57 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.019 -0.537 . . . . 62.310000000000002 113.015 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.81 174.16 10.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.38 0.672 . . . . 75.109999999999999 111.318 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 85.8 m-85 -115.62 129.86 56.65 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.209 0.603 . . . . 74.450000000000003 111.344 -173.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.6 m -99.71 156.52 3.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 124.383 1.073 . . . . 72.109999999999999 109.583 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -103.9 109.86 21.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.282 0.633 . . . . 73.329999999999998 109.513 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.786 HG22 ' HD3' ' A' ' 41' ' ' ARG . 82.1 mt -91.51 93.06 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.239 1.015 . . . . 75.400000000000006 108.91 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.99 105.98 12.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 115.257 -0.883 . . . . 74.239999999999995 109.896 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -73.7 102.35 3.93 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.403 -1.703 . . . . 73.540000000000006 106.403 166.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.09 161.91 27.07 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.413 -0.812 . . . . 73.409999999999997 111.508 -174.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -64.74 157.46 27.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.555 -1.202 . . . . 72.0 111.127 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 . . . . . 0 N--CA 1.484 1.238 0 C-N-CA 123.724 0.81 . . . . 72.5 109.782 -178.207 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 121.598 0.713 . . . . 74.299999999999997 110.067 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.21 155.05 35.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.863 -1.062 . . . . 73.420000000000002 109.648 172.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 mt -106.11 118.68 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.017 -1.105 . . . . 74.230000000000004 108.017 170.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HG3' HD11 ' A' ' 27' ' ' LEU . 17.4 ptpt -88.01 149.27 24.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.401 -0.592 . . . . 73.209999999999994 109.401 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -147.01 177.65 25.16 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 123.522 0.514 . . . . 63.32 112.082 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.6 t -113.03 132.66 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.893 0.877 . . . . 64.140000000000001 110.167 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.8 t -66.83 118.2 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.576 0.75 . . . . 74.329999999999998 109.636 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 25' ' ' LYS . 88.8 mt -90.64 -51.64 5.29 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.973 0.509 . . . . 75.420000000000002 109.918 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.427 ' HG ' ' HB ' ' A' ' 23' ' ' ILE . 69.1 p -164.77 163.02 21.41 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.098 -0.501 . . . . 64.450000000000003 111.551 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -111.32 157.29 20.35 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.782 0.833 . . . . 75.5 108.953 171.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -137.3 106.82 6.14 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 108.893 -0.78 . . . . 72.439999999999998 108.893 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.541 ' HD3' ' HD3' ' A' ' 76' ' ' PRO . 32.2 mmm180 -80.05 121.93 26.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.933 -1.136 . . . . 75.299999999999997 107.933 170.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 t -137.69 137.52 38.45 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.897 -0.779 . . . . 62.329999999999998 108.897 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.44 146.92 42.85 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.356 1.063 . . . . 74.010000000000005 111.374 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -65.56 116.2 6.57 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.086 0.554 . . . . 73.5 112.41 -173.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -159.01 -81.86 0.05 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.276 1.03 . . . . 71.319999999999993 109.009 174.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.14 140.77 3.65 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 107.983 -1.117 . . . . 63.350000000000001 107.983 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.0 m80 68.36 26.01 6.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.161 1.384 . . . . 73.439999999999998 112.303 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -102.14 178.44 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.315 0.646 . . . . 74.120000000000005 112.5 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 54.49 63.85 2.01 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.691 1.196 . . . . 73.230000000000004 110.524 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.42 140.71 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.967 -1.015 . . . . 72.540000000000006 108.867 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.5 ttt -132.29 116.52 17.0 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.027 -1.101 . . . . 74.349999999999994 108.027 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.486 HG22 HD13 ' A' ' 8' ' ' LEU . 31.2 mm -83.98 120.41 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.563 0.745 . . . . 73.239999999999995 109.028 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.418 HD12 HG23 ' A' ' 84' ' ' VAL . 87.2 mt -126.12 152.67 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.654 1.182 . . . . 74.239999999999995 108.262 -176.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HZ2' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -125.81 102.69 28.32 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.104 -1.073 . . . . 73.310000000000002 108.104 170.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.556 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 24.3 Cg_exo -61.05 143.0 99.0 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.756 2.304 . . . . 71.319999999999993 112.064 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.437 HD11 ' HG3' ' A' ' 4' ' ' LYS . 88.9 mt -67.99 -43.11 79.66 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.394 0.677 . . . . 74.030000000000001 111.541 -177.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.56 -25.99 66.07 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.812 0.845 . . . . 63.109999999999999 111.597 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 55.6 t -105.29 116.3 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.273 1.029 . . . . 73.219999999999999 110.981 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -128.64 13.64 6.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.389 0.676 . . . . 74.329999999999998 110.68 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.1 t -145.6 164.45 31.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.557 0.743 . . . . 64.329999999999998 110.525 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.606 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 74.5 ttt180 -59.26 -51.04 71.66 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.404 1.082 . . . . 73.430000000000007 112.141 -170.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -75.08 -29.08 60.57 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.406 -0.815 . . . . 74.129999999999995 110.82 -169.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' HB2' HG11 ' A' ' 29' ' ' VAL . 42.4 mt-10 -64.86 -30.81 71.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.538 -0.756 . . . . 75.25 109.917 173.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.74 -32.74 23.31 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.011 0.924 . . . . 73.109999999999999 111.169 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.0 m -78.04 -16.45 58.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.35 0.66 . . . . 61.340000000000003 111.898 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.585 ' HB3' ' HZ3' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -82.31 -16.11 50.53 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.807 0.337 . . . . 75.010000000000005 110.495 171.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.13 5.93 42.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.126 0.57 . . . . 74.439999999999998 112.033 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.542 HD11 HG11 ' A' ' 60' ' ' VAL . 46.5 mm -68.54 104.68 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.741 -0.837 . . . . 75.019999999999996 108.741 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.79 -4.79 11.63 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.787 -0.642 . . . . 53.520000000000003 113.143 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HD2' HD12 ' A' ' 88' ' ' LEU . 24.1 mmt180 -84.58 149.77 25.66 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.82 0.81 . . . . 72.329999999999998 110.604 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 55' ' ' GLY . 48.0 tp -89.78 138.12 31.75 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 124.177 0.991 . . . . 75.129999999999995 108.754 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.69 138.01 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.852 -0.795 . . . . 74.450000000000003 108.852 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.4 132.95 52.67 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.269 -1.012 . . . . 73.140000000000001 108.269 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -138.93 128.69 24.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.075 0.55 . . . . 74.530000000000001 109.571 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 17.6 tppt? -78.98 120.89 24.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.718 0.807 . . . . 74.129999999999995 109.354 174.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 7.6 m -83.83 138.16 40.59 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 115.259 -0.882 . . . . 74.120000000000005 109.23 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.07 -17.77 39.97 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.225 2.617 . . . . 62.32 113.619 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -82.81 13.05 4.12 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.586 0.755 . . . . 74.329999999999998 111.89 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.95 41.27 49.31 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 112.539 -0.224 . . . . 72.0 112.539 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 75.3 mmtt -124.12 169.61 11.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.947 0.899 . . . . 75.349999999999994 109.403 -178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -131.85 107.83 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.216 -1.031 . . . . 74.200000000000003 108.216 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' A' ' 73' ' ' LYS . 22.6 mt -83.45 124.89 31.14 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.88 -0.6 . . . . 73.5 109.399 176.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -105.1 130.44 53.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.429 -0.952 . . . . 73.200000000000003 108.429 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.417 ' O ' HD11 ' A' ' 42' ' ' LEU . . . -145.28 -179.6 21.69 Favored Glycine 0 N--CA 1.464 0.562 0 O-C-N 123.31 0.381 . . . . 74.340000000000003 112.304 -175.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -152.56 133.32 13.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.875 0.337 . . . . 75.049999999999997 110.819 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.536 HD12 HD11 ' A' ' 86' ' ' ILE . 68.3 mt -67.87 103.92 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 124.08 0.862 . . . . 75.140000000000001 109.524 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.2 m -89.58 -35.24 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.287 0.635 . . . . 75.099999999999994 111.517 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -164.41 149.82 10.29 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.37 -0.604 . . . . 71.120000000000005 109.37 -175.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 39' ' ' ILE . 13.9 m -94.78 171.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.473 0.709 . . . . 65.25 110.853 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -128.46 113.96 16.19 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.887 0.875 . . . . 73.230000000000004 109.651 174.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.76 -154.97 50.64 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 123.902 0.751 . . . . 72.310000000000002 113.549 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.606 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 22.7 p -105.04 7.56 34.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.56 1.144 . . . . 74.129999999999995 111.826 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -85.75 2.42 45.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.407 0.683 . . . . 75.430000000000007 112.832 -171.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.35 71.52 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.142 -0.255 . . . . 74.209999999999994 113.423 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.4 117.86 17.66 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.427 0.691 . . . . 74.219999999999999 110.077 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.5 ' HB ' HG21 ' A' ' 57' ' ' ILE . 34.6 m -102.18 150.84 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.755 0.822 . . . . 64.409999999999997 110.719 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -103.12 104.52 14.68 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.641 -1.244 . . . . 73.150000000000006 107.641 171.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.13 118.04 35.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.11 -1.07 . . . . 73.230000000000004 108.11 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.8 mtm105 -89.98 118.21 29.37 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.566 -0.531 . . . . 74.310000000000002 109.566 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -98.19 132.06 44.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.9 0.88 . . . . 73.420000000000002 109.809 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -52.88 -41.94 64.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.947 1.299 . . . . 64.129999999999995 112.264 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.525 ' HB2' HD21 ' A' ' 53' ' ' LEU . 43.6 mmtm -90.06 -47.8 7.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.128 0.971 . . . . 74.239999999999995 109.281 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.12 38.39 94.3 Favored Glycine 0 C--N 1.356 1.686 0 O-C-N 123.887 0.742 . . . . 71.310000000000002 114.331 175.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.06 131.37 92.27 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 122.934 0.493 . . . . 73.129999999999995 110.68 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.541 ' HD3' ' HD3' ' A' ' 12' ' ' ARG . 86.9 Cg_endo -75.7 176.24 10.25 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.801 2.334 . . . . 73.120000000000005 111.919 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.18 157.81 19.0 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.174 -0.466 . . . . 71.430000000000007 112.31 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -94.19 26.37 3.33 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.607 0.718 . . . . 75.219999999999999 110.555 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.48 28.63 1.08 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.432 1.093 . . . . 72.150000000000006 111.033 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -61.76 109.36 1.2 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.746 0.818 . . . . 73.299999999999997 110.036 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.94 -14.79 7.05 Favored Glycine 0 C--N 1.347 1.144 0 O-C-N 123.31 0.381 . . . . 61.219999999999999 113.011 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.12 160.39 31.28 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.661 0.784 . . . . 74.310000000000002 111.287 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 13.0 m-85 -87.32 131.67 34.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.614 0.766 . . . . 74.340000000000003 111.69 -177.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.418 HG23 HD12 ' A' ' 24' ' ' ILE . 16.6 m -104.5 151.14 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.452 -0.944 . . . . 74.030000000000001 108.452 167.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -108.97 108.72 19.57 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.085 -0.709 . . . . 55.420000000000002 109.085 171.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.536 HD11 HD12 ' A' ' 57' ' ' ILE . 59.6 mt -85.88 91.39 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.721 -1.214 . . . . 74.409999999999997 107.721 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.2 t -75.62 147.47 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.69 -1.141 . . . . 65.219999999999999 109.83 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD12 ' HD2' ' A' ' 41' ' ' ARG . 4.5 mm? -69.59 -169.12 0.21 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.552 0.741 . . . . 62.219999999999999 110.735 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -62.65 90.06 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.045 0.538 . . . . 75.230000000000004 111.922 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -71.05 89.08 0.8 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.743 -1.117 . . . . 72.519999999999996 109.219 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 115.231 -0.895 . . . . 72.239999999999995 108.897 177.639 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 121.459 0.647 . . . . 71.530000000000001 109.58 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.442 ' HD2' HG23 ' A' ' 87' ' ' VAL . 34.2 mtm-85 -132.88 130.78 40.15 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.789 1.236 . . . . 74.450000000000003 107.894 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.679 HD13 HD23 ' A' ' 38' ' ' LEU . 25.9 mt -101.1 134.96 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 109.713 -0.477 . . . . 71.439999999999998 109.713 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -89.69 121.52 31.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.577 0.751 . . . . 73.010000000000005 109.417 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -114.57 167.86 12.42 Favored Glycine 0 N--CA 1.48 1.611 0 CA-C-O 119.698 -0.501 . . . . 64.5 113.055 -175.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.2 t -124.13 122.9 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.973 0.909 . . . . 75.340000000000003 109.571 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.2 t -69.76 97.85 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.26 0.624 . . . . 74.530000000000001 109.777 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 25' ' ' LYS . 67.6 mt -75.83 -47.84 23.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.212 0.605 . . . . 73.5 110.853 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.7 m -151.43 152.45 33.07 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.7 0.8 . . . . 73.129999999999995 110.927 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.32 142.11 35.66 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.664 0.786 . . . . 74.450000000000003 109.44 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -130.96 103.85 6.78 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 105.286 -2.116 . . . . 74.140000000000001 105.286 159.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -89.12 146.41 24.82 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.262 -0.644 . . . . 75.540000000000006 109.262 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 t -136.24 142.93 44.07 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.559 -0.746 . . . . 74.120000000000005 110.089 -171.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -151.16 -5.46 0.28 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 124.382 1.073 . . . . 71.439999999999998 110.06 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.49 -59.56 4.18 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.608 0.763 . . . . 64.109999999999999 110.909 -172.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -105.93 -62.62 1.35 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.24 -1.022 . . . . 71.019999999999996 108.24 173.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -96.58 140.94 30.46 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.161 -0.927 . . . . 62.530000000000001 109.47 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -95.3 68.54 3.06 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.085 0.945 . . . . 74.049999999999997 109.816 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -124.07 124.87 43.47 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.582 -0.735 . . . . 72.519999999999996 111.382 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.461 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 4.5 t30 -75.55 93.23 2.98 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 106.91 -1.515 . . . . 62.140000000000001 106.91 164.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' A' ' 70' ' ' ARG . 14.6 t -88.08 148.89 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.067 -1.457 . . . . 75.5 107.067 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.6 ptp -153.34 144.96 23.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.669 0.271 . . . . 74.540000000000006 110.678 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.07 119.81 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.179 -1.045 . . . . 72.010000000000005 108.179 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.484 HD13 HG22 ' A' ' 84' ' ' VAL . 89.2 mt -121.25 123.03 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.951 0.9 . . . . 64.209999999999994 109.644 -175.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HB2' HD12 ' A' ' 8' ' ' LEU . 87.9 tttt -99.64 109.26 54.78 Favored Pre-proline 0 N--CA 1.482 1.173 0 CA-C-N 119.172 0.896 . . . . 75.439999999999998 109.859 172.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 20.4 Cg_exo -67.46 138.12 45.09 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.799 2.333 . . . . 72.420000000000002 112.39 171.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.33 -39.04 89.08 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.657 1.183 . . . . 74.409999999999997 111.82 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -77.72 -28.22 50.78 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.642 0.777 . . . . 70.510000000000005 112.097 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 54.7 t -92.02 113.52 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.789 0.836 . . . . 63.229999999999997 110.67 -170.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' ' 30' ' ' ASN . 0.8 OUTLIER -101.17 -30.21 11.68 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.917 0.887 . . . . 73.150000000000006 111.066 -174.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.8 p -119.99 166.72 12.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.948 0.499 . . . . 71.430000000000007 111.331 -172.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 67.7 ttt180 -61.97 -37.55 85.2 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.845 0.858 . . . . 74.239999999999995 111.022 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.87 -45.3 93.2 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.014 0.526 . . . . 71.439999999999998 111.137 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 41.5 mt-10 -66.87 -22.09 65.99 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.384 -0.825 . . . . 74.019999999999996 111.215 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.62 -28.25 28.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.617 0.767 . . . . 73.230000000000004 110.877 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -79.29 -24.2 43.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.217 0.607 . . . . 72.450000000000003 111.517 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.466 ' HB3' ' HZ3' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -61.63 -20.47 63.41 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.165 0.439 . . . . 64.329999999999998 110.622 169.447 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.679 HD23 HD13 ' A' ' 3' ' ' ILE . 88.9 mt -88.36 -1.15 57.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.761 0.824 . . . . 72.549999999999997 112.913 -175.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.6 HD12 HG13 ' A' ' 60' ' ' VAL . 38.6 mm -72.3 103.91 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.475 0.579 . . . . 73.439999999999998 109.553 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.7 -4.54 17.01 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.696 -0.684 . . . . 74.310000000000002 113.025 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HA ' HD21 ' A' ' 88' ' ' LEU . 27.6 mmt180 -75.52 153.54 37.4 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.774 0.787 . . . . 74.540000000000006 109.759 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.429 HD11 ' O ' ' A' ' 55' ' ' GLY . 56.2 tp -89.33 146.01 24.98 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.047 -1.094 . . . . 74.140000000000001 108.047 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.2 t -126.24 115.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.951 -0.759 . . . . 74.030000000000001 108.951 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.3 mt -100.36 106.19 17.78 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.917 0.887 . . . . 72.420000000000002 108.718 176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 53.9 t90 -123.72 130.64 52.95 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.903 0.881 . . . . 72.340000000000003 108.866 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 34.8 ttpt -88.0 113.88 24.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.369 0.667 . . . . 74.329999999999998 109.271 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.0 p -65.96 152.4 93.58 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.55 0.74 . . . . 73.099999999999994 111.501 176.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.8 -7.98 22.44 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.516 2.144 . . . . 74.099999999999994 112.039 170.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 t -71.17 -29.69 65.51 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.59 0.756 . . . . 74.129999999999995 110.302 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.59 -34.46 2.67 Favored Glycine 0 C--N 1.354 1.581 0 C-N-CA 122.951 0.31 . . . . 63.450000000000003 113.311 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -73.13 157.17 37.76 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.509 0.724 . . . . 73.400000000000006 111.483 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 70.5 mt -95.82 104.12 15.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.537 -1.283 . . . . 73.109999999999999 107.537 167.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 75' ' ' LEU . 26.9 mt -74.78 136.31 41.69 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.717 -0.674 . . . . 74.530000000000001 110.363 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -103.93 128.45 51.44 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.868 0.867 . . . . 65.319999999999993 109.004 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.429 ' O ' HD11 ' A' ' 42' ' ' LEU . . . -135.38 176.94 19.78 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 123.896 0.747 . . . . 44.420000000000002 112.03 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -146.63 129.59 16.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.492 -0.559 . . . . 75.129999999999995 109.492 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.437 HG21 ' HB ' ' A' ' 67' ' ' VAL . 80.9 mt -67.81 97.22 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.583 -0.895 . . . . 75.299999999999997 108.583 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.92 -31.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.09 -0.959 . . . . 71.239999999999995 111.143 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -158.57 162.88 37.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.61 0.764 . . . . 74.040000000000006 109.03 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.6 HG13 HD12 ' A' ' 39' ' ' ILE . 34.1 m -92.3 168.62 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.501 0.721 . . . . 74.219999999999999 110.382 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -137.22 103.8 5.22 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.285 -0.635 . . . . 71.519999999999996 109.285 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.6 178.66 50.37 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 116.028 -0.533 . . . . 74.109999999999999 113.651 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.567 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 71.7 p -97.76 1.19 48.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.963 0.905 . . . . 71.430000000000007 111.692 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.03 12.18 8.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.669 0.787 . . . . 65.099999999999994 112.014 -176.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.85 -12.16 70.21 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 120.083 -0.287 . . . . 55.409999999999997 113.435 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.32 143.2 56.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.959 0.504 . . . . 73.530000000000001 110.722 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 35.9 m -118.87 -171.91 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.527 1.531 . . . . 75.420000000000002 109.339 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -145.63 108.4 4.51 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.05 -0.722 . . . . 72.099999999999994 109.05 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.03 125.32 50.87 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.874 0.87 . . . . 74.420000000000002 111.125 -176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.509 ' HG2' HG23 ' A' ' 21' ' ' VAL . 97.2 mtt180 -91.13 115.1 27.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.762 0.825 . . . . 74.140000000000001 110.139 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.406 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 14.9 m-85 -89.19 119.94 30.12 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.886 -0.783 . . . . 75.349999999999994 108.886 172.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.44 -19.74 62.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.5 0.72 . . . . 73.310000000000002 112.2 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.433 ' HB3' ' HZ3' ' A' ' 73' ' ' LYS . 3.3 mmmp? -69.79 -55.9 8.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.061 0.945 . . . . 75.230000000000004 110.541 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.461 ' HA2' ' HB2' ' A' ' 20' ' ' ASN . . . 81.0 46.33 7.14 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 114.6 0.6 . . . . 74.519999999999996 114.6 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.486 ' HB2' HD11 ' A' ' 53' ' ' LEU . 31.5 mt -96.77 143.3 25.89 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 117.659 0.73 . . . . 73.329999999999998 110.668 171.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -90.08 -174.84 0.87 Allowed 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.435 2.756 . . . . 72.439999999999998 113.44 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 146.87 153.47 5.91 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.039 -0.982 . . . . 73.340000000000003 111.46 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -99.8 87.46 3.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.236 0.614 . . . . 74.450000000000003 109.483 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.04 31.33 6.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.818 0.847 . . . . 70.120000000000005 111.041 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.09 105.53 0.33 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.924 -0.398 . . . . 75.519999999999996 109.924 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.27 3.61 18.99 Favored Glycine 0 C--N 1.35 1.333 0 C-N-CA 123.929 0.776 . . . . 53.119999999999997 112.548 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -86.82 163.55 17.16 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.967 0.507 . . . . 74.430000000000007 110.428 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 97.0 m-85 -109.55 125.55 52.64 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.12 0.568 . . . . 73.030000000000001 111.513 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 24' ' ' ILE . 18.8 m -100.99 162.35 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.165 0.986 . . . . 74.340000000000003 111.008 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -103.98 110.25 22.32 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.033 0.933 . . . . 74.019999999999996 109.69 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.0 mt -87.82 91.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 107.372 -1.344 . . . . 73.329999999999998 107.372 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.442 HG23 ' HD2' ' A' ' 2' ' ' ARG . 21.9 t -98.27 151.83 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.781 1.233 . . . . 74.400000000000006 109.632 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.452 HD21 ' HA ' ' A' ' 41' ' ' ARG . 2.0 tm? -159.11 116.6 2.77 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.611 -0.885 . . . . 73.219999999999999 108.611 169.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -67.69 103.53 1.42 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.629 -0.878 . . . . 73.430000000000007 108.629 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -67.57 103.15 1.28 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.841 0.713 . . . . 73.140000000000001 110.682 -173.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 . . . . . 0 CA--C 1.55 0.961 0 C-N-CA 124.631 1.172 . . . . 65.340000000000003 109.283 174.311 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 109.21 -0.663 . . . . 74.519999999999996 109.21 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.479 ' HG3' ' HB3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -152.64 158.05 41.85 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.378 0.671 . . . . 74.010000000000005 109.702 170.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.51 HG23 ' HB2' ' A' ' 28' ' ' ASP . 80.3 mt -95.56 135.72 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.767 0.827 . . . . 75.349999999999994 109.7 -175.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.413 ' HE2' ' CD2' ' A' ' 83' ' ' TYR . 85.6 tttt -90.25 138.49 31.48 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.691 -0.855 . . . . 75.219999999999999 108.691 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.69 -179.79 16.97 Favored Glycine 0 N--CA 1.469 0.847 0 N-CA-C 111.606 -0.598 . . . . 52.100000000000001 111.606 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.17 130.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.847 0.859 . . . . 75.129999999999995 109.641 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.408 HG21 ' HE1' ' A' ' 22' ' ' MET . 48.7 t -67.18 100.87 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.599 1.159 . . . . 73.549999999999997 109.743 175.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 25' ' ' LYS . 67.0 mt -82.52 -56.66 3.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.822 0.449 . . . . 74.319999999999993 111.565 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 m -147.21 135.23 21.41 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.671 0.389 . . . . 71.319999999999993 111.352 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -80.98 122.63 27.53 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.516 -0.92 . . . . 73.219999999999999 108.516 168.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.606 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 37.0 mmt180 -117.39 107.24 14.12 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.592 -0.892 . . . . 75.519999999999996 108.592 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -84.24 114.28 21.71 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.886 0.474 . . . . 73.430000000000007 109.903 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.7 m -73.47 -74.88 0.16 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.411 0.684 . . . . 63.310000000000002 110.441 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 18' ' ' HIS . 68.2 mttm -140.86 161.34 38.05 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.076 0.55 . . . . 74.5 110.076 176.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -68.05 -48.59 65.19 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.083 0.953 . . . . 62.329999999999998 111.311 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -82.73 79.12 9.22 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.35 -0.841 . . . . 70.120000000000005 111.718 -167.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 64.57 2.0 1.5 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.396 1.478 . . . . 75.409999999999997 114.501 165.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . 93.2 m-70 -82.83 127.55 33.57 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.063 -0.718 . . . . 74.150000000000006 109.063 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 72' ' ' GLU . 7.6 m120 -63.61 117.74 7.22 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.859 0.724 . . . . 73.439999999999998 111.031 -169.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.419 ' OD1' ' HA2' ' A' ' 74' ' ' GLY . 2.9 p-10 -69.05 150.19 47.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.449 0.7 . . . . 62.520000000000003 109.137 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 11' ' ' ARG . 10.7 t -87.95 157.17 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.221 -1.029 . . . . 74.150000000000006 108.221 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.408 ' HE1' HG21 ' A' ' 7' ' ' VAL . 36.6 ttp -141.71 114.18 8.3 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.263 -1.384 . . . . 75.530000000000001 107.263 169.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.6 mm -67.42 124.45 22.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 N-CA-C 108.108 -1.071 . . . . 72.120000000000005 108.108 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.421 HG23 HG21 ' A' ' 84' ' ' VAL . 96.3 mt -134.27 137.06 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.948 -1.13 . . . . 74.530000000000001 107.948 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.589 ' HZ1' ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -102.11 113.43 65.86 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.727 -0.842 . . . . 75.420000000000002 108.727 169.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 15.8 Cg_exo -68.3 119.8 6.79 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.585 1.523 . . . . 75.299999999999997 110.177 169.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.88 -35.99 81.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.485 0.714 . . . . 71.319999999999993 111.602 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HB2' HG23 ' A' ' 3' ' ' ILE . 7.8 m-20 -76.45 -28.95 56.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.755 0.422 . . . . 74.530000000000001 111.23 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 50.0 t -115.56 102.27 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.475 0.71 . . . . 74.219999999999999 110.459 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.517 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 26.3 p30 -110.15 2.14 19.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.036 0.934 . . . . 74.010000000000005 111.425 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.9 m -97.83 156.14 16.72 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.65 0.78 . . . . 55.219999999999999 110.477 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 31.7 ttt180 -74.54 -42.8 58.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.2 0.6 . . . . 75.409999999999997 110.918 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.53 -40.43 92.91 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.788 0.835 . . . . 74.219999999999999 110.987 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.451 ' HB2' HG11 ' A' ' 29' ' ' VAL . 5.9 mm-40 -70.83 -28.57 64.7 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.268 -0.878 . . . . 65.510000000000005 110.243 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.26 43.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.561 0.744 . . . . 55.439999999999998 111.192 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.8 t -78.78 -23.54 45.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.915 0.886 . . . . 72.239999999999995 110.018 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -92.75 2.12 56.91 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.642 0.377 . . . . 75.329999999999998 111.124 171.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.478 HD22 HD13 ' A' ' 3' ' ' ILE . 43.2 mt -85.94 -11.23 53.65 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.092 0.557 . . . . 74.0 111.137 170.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.489 HD12 HG11 ' A' ' 60' ' ' VAL . 42.7 mm -63.38 126.64 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 109.214 -0.661 . . . . 72.129999999999995 109.214 177.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.64 7.67 66.48 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.612 -0.549 . . . . 73.010000000000005 113.426 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -96.1 150.86 20.03 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 117.851 0.826 . . . . 74.5 111.202 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 89' ' ' GLU . 43.8 tp -91.17 115.95 28.42 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.758 -1.11 . . . . 75.099999999999994 109.897 -171.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.404 HG23 HG12 ' A' ' 86' ' ' ILE . 62.0 t -97.38 115.04 36.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.29 -0.633 . . . . 63.549999999999997 109.29 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.9 mt -93.7 101.88 14.03 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.153 0.981 . . . . 75.430000000000007 108.419 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.409 ' CD1' HG12 ' A' ' 84' ' ' VAL . 31.2 t90 -104.38 131.21 51.99 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.399 -0.963 . . . . 72.239999999999995 108.399 172.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -96.03 114.67 26.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.16 -1.422 . . . . 74.340000000000003 107.16 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.1 p -57.95 155.74 22.44 Favored Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 124.115 0.966 . . . . 74.439999999999998 111.026 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.78 -25.25 50.75 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.126 2.551 . . . . 74.129999999999995 112.82 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -58.55 -38.15 77.21 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.921 1.288 . . . . 74.109999999999999 111.505 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.68 -8.91 11.73 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 115.635 -0.711 . . . . 72.209999999999994 112.015 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -82.05 153.54 26.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.602 1.161 . . . . 73.549999999999997 110.141 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.7 mt -110.12 109.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.816 0.446 . . . . 74.430000000000007 110.203 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.559 HD23 HD12 ' A' ' 75' ' ' LEU . 57.3 mt -80.54 142.26 34.31 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.991 0.916 . . . . 72.519999999999996 110.319 174.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HE2' HD11 ' A' ' 42' ' ' LEU . 13.9 mmmm -96.24 128.73 43.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.886 0.874 . . . . 75.310000000000002 109.513 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.05 173.31 22.48 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 111.459 -0.656 . . . . 55.130000000000003 111.459 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -152.61 132.06 12.94 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.991 0.396 . . . . 74.019999999999996 110.709 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.4 HD11 HD12 ' A' ' 86' ' ' ILE . 65.5 mt -68.22 104.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 123.878 0.736 . . . . 54.549999999999997 109.692 176.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.79 -38.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.182 -0.463 . . . . 72.299999999999997 110.132 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -136.23 176.89 8.28 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.835 0.854 . . . . 75.409999999999997 110.532 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 39' ' ' ILE . 31.0 m -123.45 169.99 14.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 124.529 1.132 . . . . 74.450000000000003 109.651 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -144.61 105.31 4.14 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.303 -0.999 . . . . 73.040000000000006 108.303 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.17 168.73 42.2 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.182 -0.463 . . . . 71.409999999999997 113.587 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 59.8 p -93.78 2.28 56.27 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.04 0.936 . . . . 71.019999999999996 110.987 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -84.54 7.92 18.37 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.094 0.958 . . . . 75.510000000000005 112.476 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 30' ' ' ASN . . . 69.12 63.91 3.23 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 112.004 -0.438 . . . . 61.409999999999997 112.004 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.67 113.45 15.39 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.232 -1.395 . . . . 74.310000000000002 107.232 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.42 167.17 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.087 0.955 . . . . 74.010000000000005 110.42 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -123.13 102.56 8.04 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.173 0.989 . . . . 75.430000000000007 108.786 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.29 116.91 32.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.776 0.83 . . . . 53.420000000000002 110.397 -176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 22.1 mtm180 -91.33 119.75 31.62 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 122.338 0.255 . . . . 73.200000000000003 111.254 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -93.29 129.3 39.42 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.339 1.056 . . . . 71.510000000000005 110.756 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HA ' ' ND2' ' A' ' 19' ' ' ASN . 10.4 pt-20 -74.27 -31.04 62.38 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.908 -1.042 . . . . 75.420000000000002 112.649 -173.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.62 -31.71 24.1 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.547 0.339 . . . . 73.010000000000005 110.883 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.419 ' HA2' ' OD1' ' A' ' 20' ' ' ASN . . . 61.87 37.1 93.79 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 115.595 0.998 . . . . 73.230000000000004 115.595 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.559 HD12 HD23 ' A' ' 53' ' ' LEU . 79.7 mt -85.04 150.02 54.36 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 122.565 0.346 . . . . 73.5 110.466 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.99 -176.04 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.1 2.533 . . . . 74.510000000000005 112.516 174.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.83 -39.7 0.02 OUTLIER Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.556 -0.747 . . . . 64.239999999999995 112.403 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 56.55 30.4 17.18 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 123.047 1.403 . . . . 74.310000000000002 109.402 -171.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.82 31.47 5.81 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.935 -1.484 . . . . 60.299999999999997 110.564 -169.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -56.01 111.79 1.03 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.661 -0.496 . . . . 65.420000000000002 109.661 172.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.58 -7.26 18.0 Favored Glycine 0 N--CA 1.476 1.342 0 C-N-CA 123.233 0.444 . . . . 71.209999999999994 112.447 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.07 169.86 17.57 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.925 0.89 . . . . 70.109999999999999 108.664 175.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.413 ' CD2' ' HE2' ' A' ' 4' ' ' LYS . 92.7 m-85 -115.36 135.24 54.33 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.097 0.408 . . . . 74.549999999999997 111.173 -171.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG21 HG23 ' A' ' 24' ' ' ILE . 13.8 m -101.28 168.34 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.973 0.909 . . . . 75.209999999999994 109.249 174.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 2' ' ' ARG . 49.3 mt-10 -132.43 107.13 8.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.043 -0.725 . . . . 73.109999999999999 109.043 173.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.404 HG12 HG23 ' A' ' 43' ' ' VAL . 46.7 mt -85.21 94.45 3.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 125.227 1.411 . . . . 75.510000000000005 109.258 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.62 150.14 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.421 0.688 . . . . 72.530000000000001 109.599 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.07 120.35 15.64 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 107.065 -1.457 . . . . 74.439999999999998 107.065 169.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 8.5 pt-20 -66.69 -37.7 85.26 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.448 0.536 . . . . 75.120000000000005 112.448 -173.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -68.23 -24.43 64.91 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.203 0.601 . . . . 74.329999999999998 110.743 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 . . . . . 0 C--O 1.254 1.29 0 N-CA-C 108.756 -0.831 . . . . 73.549999999999997 108.756 172.584 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.581 -0.526 . . . . 72.230000000000004 109.581 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -108.03 134.49 50.84 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.994 0.918 . . . . 74.519999999999996 108.651 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.71 124.75 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.635 0.774 . . . . 75.099999999999994 109.061 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -88.52 127.67 35.54 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.938 -0.764 . . . . 75.25 108.938 -176.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.62 -168.95 12.26 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 116.373 -0.376 . . . . 61.32 112.299 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -144.3 135.38 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.026 1.33 . . . . 61.140000000000001 109.695 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.5 t -72.61 115.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.833 0.853 . . . . 71.420000000000002 109.62 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 25' ' ' LYS . 84.3 mt -89.69 -47.81 7.69 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 123.461 0.476 . . . . 75.510000000000005 110.541 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.2 m -152.02 154.82 36.75 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.919 0.488 . . . . 71.439999999999998 111.535 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -110.47 137.85 47.63 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.397 1.079 . . . . 70.510000000000005 108.691 171.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.416 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 87.9 mtt180 -127.1 108.88 11.31 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.706 -1.22 . . . . 73.439999999999998 107.706 172.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -73.56 150.5 41.42 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.309 0.644 . . . . 73.140000000000001 111.849 -168.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 p -64.13 101.02 0.37 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.119 0.968 . . . . 65.439999999999998 110.235 175.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -161.21 158.19 26.94 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.694 0.797 . . . . 72.530000000000001 110.132 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 72.31 -81.74 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.024 1.73 . . . . 63.009999999999998 110.972 175.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -96.84 161.03 14.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.703 1.201 . . . . 72.349999999999994 108.082 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -72.69 87.3 1.25 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.722 0.772 . . . . 73.200000000000003 110.404 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -149.16 157.1 43.1 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.212 1.405 . . . . 71.310000000000002 108.67 174.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 72' ' ' GLU . 7.0 t-20 -94.66 -169.27 1.99 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.964 -0.754 . . . . 64.109999999999999 108.964 176.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.69 112.35 4.75 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.133 0.424 . . . . 74.519999999999996 110.327 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.418 HG11 ' HD3' ' A' ' 68' ' ' ARG . 84.3 t -90.39 106.09 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.565 0.746 . . . . 70.420000000000002 109.019 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.7 ttm -100.46 124.75 46.39 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.294 -0.632 . . . . 74.420000000000002 109.294 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -82.02 115.54 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 107.786 -1.19 . . . . 74.230000000000004 107.786 172.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.401 ' HB ' HG22 ' A' ' 67' ' ' VAL . 69.4 mt -109.24 150.41 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.799 0.84 . . . . 72.209999999999994 109.938 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.518 ' HB2' HD11 ' A' ' 8' ' ' LEU . 59.5 tttp -119.49 96.97 50.06 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 125.007 1.323 . . . . 73.140000000000001 108.962 175.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.7 106.64 0.94 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.083 1.855 . . . . 74.230000000000004 110.164 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.1 mt -53.08 -38.43 62.53 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.793 1.237 . . . . 72.209999999999994 113.324 -172.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.73 -27.11 58.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.978 0.511 . . . . 62.509999999999998 111.631 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -100.98 107.73 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.32 0.648 . . . . 74.530000000000001 111.529 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -91.62 -19.26 22.9 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.369 1.068 . . . . 73.299999999999997 111.875 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -104.53 133.42 49.42 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 122.025 -0.422 . . . . 73.540000000000006 111.05 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 49.1 ttt180 -58.97 -43.93 91.46 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.375 1.07 . . . . 73.0 111.553 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.7 -40.5 97.33 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.006 0.922 . . . . 60.340000000000003 111.524 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.69 -33.51 75.05 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.479 -0.782 . . . . 65.439999999999998 111.14 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.93 -25.77 60.15 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 122.996 0.518 . . . . 74.109999999999999 111.637 171.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -74.99 -34.11 61.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.763 0.825 . . . . 60.229999999999997 111.924 -172.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -68.93 -22.42 64.14 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 120.922 0.391 . . . . 74.450000000000003 110.39 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.55 1.74 52.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.051 0.94 . . . . 74.030000000000001 112.449 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.423 HD11 HG11 ' A' ' 60' ' ' VAL . 31.7 mm -66.53 135.79 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 118.394 0.543 . . . . 74.140000000000001 110.729 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.16 -8.58 31.16 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.683 -0.689 . . . . 65.239999999999995 113.367 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -80.26 153.44 28.5 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.362 0.581 . . . . 73.120000000000005 110.959 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 54' ' ' LYS . 59.5 tp -90.28 146.75 23.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.471 -0.786 . . . . 75.230000000000004 109.257 -174.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.437 HG23 HG12 ' A' ' 86' ' ' ILE . 40.1 t -116.95 131.83 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.83 -0.804 . . . . 73.450000000000003 108.83 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -113.14 105.73 13.8 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.603 -1.258 . . . . 71.040000000000006 107.603 175.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -125.28 124.3 41.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.33 0.652 . . . . 73.409999999999997 109.468 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HE3' ' HA2' ' A' ' 50' ' ' GLY . 45.9 tttp -81.22 122.52 27.5 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.99 -0.744 . . . . 72.239999999999995 108.99 176.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 82.2 p -65.39 152.62 91.75 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.034 0.534 . . . . 75.030000000000001 110.346 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.47 -12.9 30.0 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.268 1.979 . . . . 74.420000000000002 112.145 173.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.6 m -70.27 -42.78 71.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.417 1.087 . . . . 75.409999999999997 110.726 170.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.459 ' HA2' ' HE3' ' A' ' 46' ' ' LYS . . . 135.06 -22.78 3.56 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 116.104 -0.498 . . . . 61.32 113.126 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -74.09 122.51 22.81 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.605 0.762 . . . . 73.409999999999997 110.292 -174.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 72.3 mt -78.83 106.95 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.593 -0.892 . . . . 70.319999999999993 108.593 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.73 155.34 20.39 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.409 1.084 . . . . 74.420000000000002 109.791 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB3' HD13 ' A' ' 42' ' ' LEU . 47.1 mtpt -123.7 145.46 48.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.934 0.894 . . . . 74.319999999999993 109.229 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.76 132.61 3.04 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-O 119.824 -0.431 . . . . 74.519999999999996 112.903 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -93.05 128.77 39.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.285 0.543 . . . . 74.219999999999999 109.976 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 67' ' ' VAL . 92.2 mt -72.13 116.52 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.618 0.767 . . . . 72.439999999999998 109.411 174.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -112.92 -3.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.727 0.811 . . . . 71.129999999999995 112.284 -172.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -165.57 161.47 18.48 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.909 0.484 . . . . 73.349999999999994 110.48 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 16.0 m -91.5 168.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.781 0.832 . . . . 74.010000000000005 109.732 168.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -143.94 105.07 4.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.076 -0.511 . . . . 74.150000000000006 109.767 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.19 176.31 38.17 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 123.377 0.423 . . . . 62.229999999999997 113.841 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.508 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 30.1 p -91.04 10.1 28.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.394 1.077 . . . . 70.030000000000001 111.059 177.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -91.75 12.37 21.53 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.907 0.883 . . . . 74.420000000000002 111.749 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.07 12.03 75.23 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 113.984 0.354 . . . . 64.010000000000005 113.984 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.55 162.26 27.25 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.174 0.59 . . . . 75.510000000000005 109.728 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 15.2 m -132.18 177.92 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.098 0.959 . . . . 72.030000000000001 110.521 -178.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' HD3' HG11 ' A' ' 21' ' ' VAL . 7.4 tmm_? -138.59 116.45 11.56 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.25 -1.389 . . . . 72.400000000000006 107.25 -175.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -116.41 146.05 42.8 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.715 0.806 . . . . 53.0 111.496 -176.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -99.25 100.83 11.98 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.235 1.014 . . . . 73.519999999999996 109.311 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -77.24 124.17 27.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.321 0.648 . . . . 74.230000000000004 110.984 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.508 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 9.9 pt-20 -62.1 -35.9 80.1 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.05 0.94 . . . . 64.420000000000002 111.122 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.508 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 74.5 mmtt -99.65 -65.38 0.97 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.595 0.758 . . . . 75.420000000000002 109.017 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.0 52.97 36.22 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 124.131 0.894 . . . . 61.420000000000002 114.61 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.51 137.33 93.33 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.35 0.66 . . . . 74.400000000000006 110.563 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.52 169.74 15.11 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.024 2.482 . . . . 64.209999999999994 112.845 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.73 161.67 22.69 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 115.266 -0.879 . . . . 73.129999999999995 110.905 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -91.0 38.8 0.97 Allowed 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.301 1.048 . . . . 75.25 109.306 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.21 29.8 4.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.647 1.179 . . . . 73.209999999999994 110.538 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.12 107.9 0.96 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.703 -0.851 . . . . 74.019999999999996 108.703 169.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.46 -12.14 16.16 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 116.279 -0.419 . . . . 61.030000000000001 112.645 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -77.62 152.82 33.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.842 0.457 . . . . 73.299999999999997 110.693 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -87.8 135.58 33.32 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.193 0.997 . . . . 75.129999999999995 112.349 -169.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.5 152.69 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.947 0.899 . . . . 72.239999999999995 109.138 171.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -114.14 108.72 17.35 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.19 -1.041 . . . . 72.209999999999994 108.19 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.437 HG12 HG23 ' A' ' 43' ' ' VAL . 61.9 mt -96.22 119.25 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.358 0.663 . . . . 72.230000000000004 109.62 -174.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.7 t -113.44 142.83 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 123.348 0.659 . . . . 73.239999999999995 111.183 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.08 -178.66 6.25 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.119 0.968 . . . . 74.420000000000002 111.845 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -68.42 136.22 52.95 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.231 -0.895 . . . . 71.140000000000001 112.046 -170.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -105.19 -54.34 2.5 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.61 0.764 . . . . 72.340000000000003 109.388 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 . . . . . 0 C--O 1.256 1.425 0 C-N-CA 124.018 0.927 . . . . 73.319999999999993 108.823 177.82 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.0 mtm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 121.205 0.526 . . . . 74.310000000000002 109.584 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.6 mtm180 -140.85 141.67 34.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.346 1.058 . . . . 73.340000000000003 108.51 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.618 HD13 HD21 ' A' ' 38' ' ' LEU . 73.4 mt -129.97 130.45 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.596 0.758 . . . . 74.120000000000005 109.164 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.406 ' HG3' HD13 ' A' ' 27' ' ' LEU . 19.6 ptmt -88.54 130.07 35.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.765 -0.828 . . . . 71.400000000000006 108.765 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -128.18 140.64 11.93 Favored Glycine 0 C--O 1.217 -0.954 0 CA-C-N 116.459 -0.337 . . . . 75.329999999999998 112.363 -175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.7 t -91.93 121.98 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.01 0.524 . . . . 75.430000000000007 111.086 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.52 97.48 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.378 1.071 . . . . 73.219999999999999 109.65 172.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' A' ' 25' ' ' LYS . 88.1 mt -72.91 -48.83 33.7 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.52 -0.764 . . . . 74.310000000000002 110.036 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.46 ' HA ' HD21 ' A' ' 80' ' ' LEU . 70.0 p -162.37 168.05 22.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.869 -0.605 . . . . 71.420000000000002 110.932 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -105.13 123.77 48.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.927 -1.138 . . . . 72.150000000000006 107.927 169.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -118.42 107.46 13.85 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.734 -1.209 . . . . 74.310000000000002 107.734 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HG3' ' HB3' ' A' ' 20' ' ' ASN . 55.1 ttp180 -85.14 154.12 22.23 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.072 0.463 . . . . 74.230000000000004 110.08 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -130.25 -173.68 3.12 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.573 0.749 . . . . 74.030000000000001 109.142 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.1 110.02 4.31 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.385 -0.969 . . . . 74.129999999999995 108.385 175.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.05 -33.22 67.01 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.702 0.801 . . . . 72.099999999999994 111.993 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -69.03 -23.9 64.12 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.611 0.765 . . . . 73.109999999999999 111.188 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -88.59 -68.95 0.73 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.919 -0.771 . . . . 72.420000000000002 108.919 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -149.31 150.03 31.86 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.759 1.224 . . . . 74.5 109.001 173.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -66.65 174.64 2.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.209 0.603 . . . . 73.340000000000003 111.784 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.522 ' HB3' ' HG3' ' A' ' 12' ' ' ARG . 8.8 p30 -61.24 143.61 55.29 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.087 -0.96 . . . . 73.530000000000001 112.015 -174.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t -106.88 121.24 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 114.266 -1.334 . . . . 74.319999999999993 109.251 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 45.7 ttm -89.52 123.78 33.93 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.507 -0.923 . . . . 72.519999999999996 108.507 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.7 116.02 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.31 -0.996 . . . . 70.450000000000003 108.31 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 84' ' ' VAL . 84.8 mt -120.46 150.67 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.036 0.935 . . . . 73.329999999999998 109.647 -172.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HB2' HD11 ' A' ' 8' ' ' LEU . 78.9 tttt -123.45 91.73 49.48 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.496 0.719 . . . . 75.310000000000002 109.416 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HD2' ' HA ' ' A' ' 66' ' ' ALA . 36.9 Cg_endo -63.72 110.4 1.27 Allowed 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 122.751 2.301 . . . . 60.100000000000001 111.272 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.406 HD13 ' HG3' ' A' ' 4' ' ' LYS . 85.8 mt -62.18 -37.72 86.35 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.639 1.176 . . . . 63.520000000000003 112.875 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -65.86 -26.25 67.56 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.265 0.626 . . . . 75.510000000000005 111.546 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.595 HG11 ' HB2' ' A' ' 34' ' ' GLU . 40.3 t -100.32 131.59 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.197 0.999 . . . . 75.409999999999997 110.96 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -130.32 -3.48 4.37 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.664 0.785 . . . . 62.329999999999998 111.451 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.8 m -123.28 154.48 38.79 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.447 0.699 . . . . 74.150000000000006 110.563 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.573 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 63.0 ttt180 -64.95 -30.84 71.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.134 0.974 . . . . 72.299999999999997 111.634 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -69.48 -39.66 77.55 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.889 0.876 . . . . 65.420000000000002 110.146 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.595 ' HB2' HG11 ' A' ' 29' ' ' VAL . 36.5 mt-10 -70.42 -38.61 74.61 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.667 -1.151 . . . . 75.209999999999994 109.526 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.36 -30.81 69.84 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.645 0.778 . . . . 75.420000000000002 111.228 174.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 t -74.15 -30.82 62.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.397 0.679 . . . . 72.409999999999997 110.041 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -90.78 4.1 52.57 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.743 0.417 . . . . 73.409999999999997 110.98 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.618 HD21 HD13 ' A' ' 3' ' ' ILE . 34.3 mt -87.83 -18.31 29.57 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.618 0.367 . . . . 74.519999999999996 110.415 165.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.539 HD12 HG21 ' A' ' 57' ' ' ILE . 50.2 mm -59.86 106.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.195 0.598 . . . . 74.540000000000006 109.393 174.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.19 -29.35 4.6 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 116.052 -0.522 . . . . 53.149999999999999 112.527 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 153.94 39.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.208 0.603 . . . . 74.209999999999994 111.901 -173.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.544 HD11 ' HE2' ' A' ' 54' ' ' LYS . 60.9 tp -90.41 123.73 34.38 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.42 1.088 . . . . 72.349999999999994 109.674 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.8 115.18 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 109.412 -0.588 . . . . 75.340000000000003 109.412 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt -104.36 110.12 22.24 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.557 1.143 . . . . 71.340000000000003 108.732 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -124.49 127.73 47.91 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.307 -0.627 . . . . 75.239999999999995 109.307 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -88.12 106.7 18.34 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.367 -0.975 . . . . 64.150000000000006 108.367 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.9 p -64.31 157.37 71.53 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.046 0.938 . . . . 72.209999999999994 112.406 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.92 -23.78 73.88 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.842 2.361 . . . . 62.100000000000001 112.074 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.1 t -61.91 -23.27 66.22 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.538 1.135 . . . . 62.329999999999998 111.343 173.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.86 19.18 34.94 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.712 -0.676 . . . . 74.310000000000002 112.64 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.0 143.02 40.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.554 0.742 . . . . 75.340000000000003 110.105 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.5 mt -89.08 102.09 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.724 -0.843 . . . . 72.109999999999999 108.724 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 75' ' ' LEU . 26.3 mt -82.71 138.09 34.2 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.142 0.577 . . . . 75.329999999999998 110.369 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HE2' HD11 ' A' ' 42' ' ' LEU . 13.4 mmmm -96.09 132.92 40.97 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.572 -0.899 . . . . 74.140000000000001 108.572 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.18 172.94 22.7 Favored Glycine 0 C--N 1.332 0.353 0 O-C-N 123.618 0.574 . . . . 73.129999999999995 112.075 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -151.81 131.71 13.34 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.122 0.569 . . . . 74.140000000000001 109.843 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.539 HG21 HD12 ' A' ' 39' ' ' ILE . 73.0 mt -70.8 108.93 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 109.137 -0.69 . . . . 63.240000000000002 109.137 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.75 -14.94 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.182 0.993 . . . . 74.219999999999999 111.225 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 23.7 tpp180 -149.29 148.82 30.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.327 0.651 . . . . 74.140000000000001 109.371 -173.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 m -98.74 171.41 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.335 0.654 . . . . 74.129999999999995 109.988 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -124.13 103.64 8.39 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.386 -0.968 . . . . 72.450000000000003 108.386 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.94 -134.1 52.3 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 124.144 0.903 . . . . 75.519999999999996 113.602 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.573 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 69.3 p -119.62 -4.55 10.28 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.741 0.816 . . . . 62.020000000000003 111.993 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -73.93 -7.81 53.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.069 0.548 . . . . 75.140000000000001 112.017 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.51 -10.98 70.71 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 119.649 -0.528 . . . . 73.140000000000001 113.209 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.541 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . . . -60.68 149.68 34.5 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.999 0.52 . . . . 63.109999999999999 109.652 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.519 HG22 ' HD3' ' A' ' 26' ' ' PRO . 35.1 m -131.13 178.97 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 121.921 0.867 . . . . 72.329999999999998 111.96 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 97.8 mtt180 -133.86 118.99 18.59 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.259 1.424 . . . . 74.530000000000001 108.379 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.72 133.57 55.85 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.968 0.507 . . . . 71.129999999999995 110.715 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -88.7 123.21 32.92 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.182 0.593 . . . . 74.150000000000006 109.633 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -105.23 133.41 50.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.716 0.806 . . . . 75.409999999999997 109.46 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -61.13 -37.02 81.32 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.678 0.791 . . . . 75.319999999999993 111.852 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -98.08 -61.03 1.44 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.82 0.848 . . . . 74.109999999999999 108.974 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.422 ' HA3' ' OD1' ' A' ' 20' ' ' ASN . . . 60.91 54.68 34.91 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 124.083 0.864 . . . . 73.209999999999994 112.93 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 53' ' ' LEU . 51.6 mt -68.46 115.92 34.77 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.24 1.016 . . . . 74.409999999999997 110.513 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.7 179.84 5.85 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 123.283 2.656 . . . . 52.140000000000001 112.332 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.81 176.94 25.07 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 110.723 -0.951 . . . . 75.219999999999999 110.723 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -77.39 70.02 3.73 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 122.038 0.923 . . . . 71.310000000000002 109.086 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.73 13.6 11.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.811 -1.086 . . . . 73.299999999999997 111.922 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.46 HD21 ' HA ' ' A' ' 9' ' ' SER . 60.9 mt -74.27 103.21 4.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.464 -0.939 . . . . 72.120000000000005 108.464 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.4 -18.2 6.89 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 112.116 -0.394 . . . . 52.219999999999999 112.116 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.96 169.93 16.99 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.986 0.514 . . . . 71.200000000000003 111.336 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -108.28 155.9 19.98 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.232 0.613 . . . . 73.549999999999997 111.043 -170.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 24' ' ' ILE . 20.2 m -122.15 160.28 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.462 1.105 . . . . 74.530000000000001 108.773 174.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -106.02 108.5 20.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.177 -0.675 . . . . 71.129999999999995 109.177 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 2' ' ' ARG . 77.9 mt -93.93 92.12 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.336 -1.357 . . . . 65.400000000000006 107.336 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.483 HG13 ' HG3' ' A' ' 89' ' ' GLU . 21.4 t -96.66 127.6 48.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.247 1.019 . . . . 73.450000000000003 110.266 -172.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.33 104.56 13.04 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.915 -1.143 . . . . 74.140000000000001 107.915 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.483 ' HG3' HG13 ' A' ' 87' ' ' VAL . 36.8 mt-10 -110.23 147.72 33.24 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.043 0.937 . . . . 73.510000000000005 109.172 175.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -102.29 98.44 8.57 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.179 0.592 . . . . 73.109999999999999 109.634 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 123.949 0.9 . . . . 71.140000000000001 109.502 172.391 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 47.1 mtm-85 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 108.375 -0.972 . . . . 63.41 108.375 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 63.6 mt -97.12 132.57 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.656 0.782 . . . . 74.44 109.358 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -89.42 129.61 35.9 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.289 -0.634 . . . . 73.52 109.289 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.58 164.99 25.12 Favored Glycine 0 C--N 1.345 1.03 0 O-C-N 123.253 0.346 . . . . 43.33 112.929 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.57 120.65 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.993 0.917 . . . . 73.21 109.253 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.493 HG13 ' HB2' ' A' ' 22' ' ' MET . 23.7 t -68.9 102.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 109.687 -0.486 . . . . 72.02 109.687 173.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 25' ' ' LYS . 56.4 mt -70.23 -37.3 74.97 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.761 0.824 . . . . 72.14 110.321 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -156.96 158.13 36.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.87 -0.604 . . . . 74.14 111.603 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.96 162.15 18.22 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.955 0.902 . . . . 74.13 109.113 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.563 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 22.7 mtm180 . . . . . 0 C--O 1.248 1.017 0 N-CA-C 107.666 -1.235 . . . . 71.3 107.666 171.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 109.791 -0.448 . . . . 74.22 109.791 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.571 HG22 ' HG2' ' A' ' 70' ' ' ARG . 16.7 t -90.32 149.39 4.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.546 -0.909 . . . . 72.22 108.546 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.493 ' HB2' HG13 ' A' ' 7' ' ' VAL . 21.5 ptp -149.26 140.91 23.49 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.02 0.438 . . . . 73.34 111.309 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -86.34 97.97 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.249 -1.389 . . . . 61.35 107.249 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.01 133.18 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.747 0.819 . . . . 70.21 108.973 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HB2' HD11 ' A' ' 8' ' ' LEU . 33.7 ttpt -107.56 97.0 17.97 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.107 -1.071 . . . . 75.11 108.107 170.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 11.5 Cg_exo -68.5 122.39 9.38 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.986 1.791 . . . . 44.54 110.74 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.63 -29.56 66.6 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.255 1.022 . . . . 64.54 112.008 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HB3' HG23 ' A' ' 3' ' ' ILE . 35.7 t70 -88.46 -28.5 20.82 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.859 0.864 . . . . 64.03 112.157 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 89.4 t -104.82 99.71 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.391 0.676 . . . . 73.51 109.808 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -119.41 12.13 12.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.396 0.678 . . . . 63.33 110.359 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.1 m -122.43 149.07 44.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.819 0.847 . . . . 70.2 110.613 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 53.8 ttt180 -63.88 -36.91 85.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.237 1.015 . . . . 73.32 111.357 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -65.29 -48.69 72.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.523 0.729 . . . . 72.2 110.532 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HB2' HG13 ' A' ' 29' ' ' VAL . 50.2 mt-10 -63.21 -30.37 71.53 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.74 -1.118 . . . . 71.12 110.976 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.73 -36.2 37.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.692 0.797 . . . . 41.14 111.512 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -73.39 -27.49 61.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.73 0.812 . . . . 52.15 110.915 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -82.11 -1.19 47.92 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.094 -0.503 . . . . 61.4 111.363 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 29' ' ' VAL . 93.4 mt -98.59 1.95 46.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.574 0.75 . . . . 75.2 112.144 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.651 HD11 HG13 ' A' ' 60' ' ' VAL . 51.2 mm -67.94 109.58 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.361 0.528 . . . . 75.11 110.278 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.95 -15.82 18.65 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.566 -0.743 . . . . 75.42 112.551 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.9 152.87 43.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.905 0.482 . . . . 74.12 111.228 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 54' ' ' LYS . 26.6 tp -94.86 114.61 26.49 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 124.389 1.056 . . . . 74.3 109.668 -167.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.72 131.43 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.23 -0.656 . . . . 71.51 109.23 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.4 mt -107.66 101.31 10.63 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.66 -0.867 . . . . 61.45 108.66 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.411 ' HH2' ' HA3' ' A' ' 77' ' ' GLY . 34.5 t90 -100.22 140.8 33.94 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.916 0.486 . . . . 74.11 109.807 175.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -91.74 101.05 13.66 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.203 1.001 . . . . 75.51 108.775 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.3 p -65.0 150.58 95.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.035 0.534 . . . . 71.41 111.149 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.54 -19.37 36.47 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.409 2.739 . . . . 72.43 113.049 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.4 t -71.78 -8.59 55.17 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.056 0.942 . . . . 72.43 112.347 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.19 32.81 30.71 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.492 -0.243 . . . . 72.4 112.492 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -128.02 146.11 50.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.863 0.865 . . . . 54.14 108.864 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -99.43 100.09 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.844 -0.799 . . . . 75.52 108.844 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 75' ' ' LEU . 21.5 mt -74.99 137.28 41.45 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.156 -0.929 . . . . 73.15 109.034 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.574 ' HB3' HD11 ' A' ' 42' ' ' LEU . 24.0 mtmm -96.92 139.31 33.14 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.128 -0.693 . . . . 74.31 109.128 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -140.82 177.4 20.88 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 116.198 -0.456 . . . . 73.51 112.717 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -139.3 126.73 21.57 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.515 -0.55 . . . . 75.4 109.515 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.489 HG22 HD13 ' A' ' 39' ' ' ILE . 63.1 mt -68.75 103.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.041 -0.725 . . . . 61.24 109.041 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.456 HG11 ' HD3' ' A' ' 70' ' ' ARG . 27.6 m -83.84 -35.24 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.59 -0.732 . . . . 64.5 110.98 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -163.99 153.73 14.53 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.625 0.77 . . . . 65.21 109.584 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.651 HG13 HD11 ' A' ' 39' ' ' ILE . 12.2 m -91.55 170.46 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.289 0.636 . . . . 72.33 110.043 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -122.79 103.66 8.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.951 -1.129 . . . . 74.12 107.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.12 -150.63 51.71 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 124.335 1.022 . . . . 43.11 114.292 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.567 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 55.2 p -98.47 -9.91 24.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.664 0.786 . . . . 72.3 111.81 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.12 -12.52 19.95 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.735 0.814 . . . . 74.01 112.86 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.32 -1.34 87.56 Favored Glycine 0 C--N 1.349 1.25 0 N-CA-C 112.393 -0.283 . . . . 35.51 112.393 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.48 119.37 10.92 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.47 0.708 . . . . 72.0 110.162 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.407 ' HB ' HG23 ' A' ' 57' ' ' ILE . 29.6 m -101.65 148.27 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 122.661 0.384 . . . . 72.44 110.289 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -113.71 113.7 25.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.379 -0.6 . . . . 65.43 109.379 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.63 134.3 55.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.968 -0.56 . . . . 53.23 111.433 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 21' ' ' VAL . 67.9 mtp85 -102.57 123.31 46.06 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.162 0.985 . . . . 72.2 109.005 174.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.439 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 12.5 m-85 -99.04 126.9 44.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.178 0.591 . . . . 74.43 111.156 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 54' ' ' LYS . 22.1 pt-20 -50.28 -38.06 39.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.376 1.471 . . . . 71.45 113.652 -172.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -75.39 -24.85 57.24 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.259 0.624 . . . . 62.15 111.54 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.83 24.76 68.58 Favored Glycine 0 C--N 1.348 1.195 0 O-C-N 123.633 0.583 . . . . 64.2 114.432 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.506 ' HB2' HD11 ' A' ' 53' ' ' LEU . 84.4 mt -86.59 136.31 35.09 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 123.088 0.555 . . . . 61.02 110.6 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 11.4 Cg_exo -71.08 174.32 10.82 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.561 2.84 . . . . 63.1 112.098 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.411 ' HA3' ' HH2' ' A' ' 45' ' ' TRP . . . -158.85 -65.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.1 -0.5 . . . . 72.04 112.549 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 60.28 31.79 20.55 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 123.062 1.411 . . . . 74.02 110.272 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.33 31.61 0.81 Allowed 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 114.107 -1.406 . . . . 61.54 111.291 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -35.68 111.1 0.12 Allowed 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 126.289 1.835 . . . . 74.42 114.194 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.41 -4.25 26.54 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.9 -0.591 . . . . 54.34 113.102 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.81 157.93 35.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.331 0.652 . . . . 54.02 111.611 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -102.06 141.4 34.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.274 0.559 . . . . 73.04 112.127 -172.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.9 m -116.29 166.61 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.209 1.003 . . . . 73.23 110.326 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -128.71 109.15 11.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.506 -0.553 . . . . 74.01 109.506 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 61.3 mt -82.37 100.1 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.241 1.016 . . . . 73.34 109.346 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.5 t -72.76 117.64 16.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.229 0 N-CA-C 109.098 -0.705 . . . . 71.11 109.098 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 C--N 1.35 0.61 0 N-CA-C 107.351 -1.352 . . . . 64.13 107.351 172.879 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 108.818 -0.808 . . . . 64.15 108.818 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 74.2 mt -112.34 133.73 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.121 -1.066 . . . . 71.33 108.121 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -88.14 133.36 34.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.525 -0.546 . . . . 71.03 109.525 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -122.24 165.53 15.01 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 110.891 -0.883 . . . . 54.42 110.891 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.3 t -111.54 128.38 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 123.691 0.796 . . . . 74.24 109.313 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.69 93.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.446 1.099 . . . . 73.42 108.813 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 25' ' ' LYS . 64.7 mt -71.27 -51.19 25.9 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.343 -0.39 . . . . 73.33 110.062 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 p -159.48 156.18 27.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.737 -0.665 . . . . 74.33 110.875 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -92.5 104.88 17.15 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.243 -1.021 . . . . 74.32 108.243 169.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 109.004 -0.739 . . . . 71.04 109.004 178.608 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.694 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 29.1 t-20 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.358 0.599 . . . . 62.44 109.904 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.495 HG22 ' HD2' ' A' ' 70' ' ' ARG . 58.9 t -101.52 151.15 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.465 1.106 . . . . 65.21 109.313 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 44.6 ttm -130.86 122.65 27.43 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.404 -0.961 . . . . 70.04 108.404 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 8' ' ' LEU . 47.9 mm -81.96 118.26 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.975 -1.121 . . . . 73.32 107.975 172.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -122.12 153.32 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.271 1.029 . . . . 71.44 108.738 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HB2' HD11 ' A' ' 8' ' ' LEU . 57.6 tttp -122.76 110.5 31.67 Favored Pre-proline 0 N--CA 1.473 0.698 0 N-CA-C 109.131 -0.692 . . . . 75.11 109.131 168.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 65' ' ' GLY . 27.2 Cg_exo -59.65 125.76 18.73 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.234 1.956 . . . . 71.22 110.192 167.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.83 -33.22 74.79 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.656 0.782 . . . . 45.44 111.327 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.55 -28.02 69.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.942 0.897 . . . . 63.23 111.449 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 35' ' ' ALA . 78.6 t -109.47 131.61 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.228 1.011 . . . . 72.0 111.4 -170.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -128.89 15.67 6.34 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.214 1.006 . . . . 71.33 110.525 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 m -143.75 154.06 43.07 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.335 0.654 . . . . 74.2 111.145 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.581 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 52.1 ttt180 -61.01 -50.28 74.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.259 1.024 . . . . 73.11 111.89 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.42 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 47.6 mt-10 -74.45 -30.45 61.88 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.58 0.352 . . . . 75.2 111.061 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -67.21 -25.4 66.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.069 0.548 . . . . 75.15 110.919 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.488 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -87.13 -30.63 20.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.546 0.738 . . . . 74.2 110.307 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 10.0 t -85.92 -6.97 58.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.068 0.947 . . . . 63.34 111.606 -172.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -82.82 -19.31 37.87 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.414 -0.587 . . . . 70.23 109.414 167.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.0 mt -87.82 6.31 35.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.631 0.772 . . . . 71.22 111.478 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 57' ' ' ILE . 42.5 mm -63.03 119.26 6.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 109.663 -0.495 . . . . 75.2 109.663 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.59 -4.53 40.02 Favored Glycine 0 C--O 1.239 0.46 0 CA-C-N 116.159 -0.473 . . . . 30.12 112.93 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -80.11 150.61 30.19 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 109.067 -0.716 . . . . 74.22 109.067 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.581 HD21 ' HD2' ' A' ' 54' ' ' LYS . 27.1 tp -89.86 159.55 16.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.208 -0.905 . . . . 34.54 109.024 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 86' ' ' ILE . 90.4 t -128.32 114.53 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 107.509 -1.293 . . . . 65.01 107.509 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.32 108.75 21.52 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.705 1.202 . . . . 71.04 108.846 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -144.87 123.47 12.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.325 0.65 . . . . 74.53 109.823 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 27.1 ttpp -88.11 135.89 33.22 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.944 0.498 . . . . 61.21 109.73 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.9 p -73.75 158.28 86.32 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.856 0.863 . . . . 70.23 110.765 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.21 -8.1 19.32 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.433 2.089 . . . . 71.34 112.444 167.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -72.89 -21.71 60.87 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.644 0.777 . . . . 72.24 111.271 168.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.05 -19.44 37.85 Favored Glycine 0 C--N 1.352 1.439 0 C-N-CA 123.038 0.352 . . . . 72.34 113.442 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 134.42 34.76 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.275 0.63 . . . . 73.31 109.923 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 62.2 mt -78.3 123.72 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.481 -0.563 . . . . 41.02 109.481 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.556 HD22 ' HB2' ' A' ' 73' ' ' LYS . 10.6 mt -102.97 131.05 50.21 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.28 -1.007 . . . . 64.23 108.28 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.581 ' HD2' HD21 ' A' ' 42' ' ' LEU . 32.1 mtmm -111.77 132.25 54.78 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.067 -0.716 . . . . 71.03 109.067 173.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.46 151.37 20.55 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 111.026 -0.829 . . . . 43.52 111.026 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -115.34 135.04 54.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.266 1.033 . . . . 72.22 110.708 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.492 HG22 HD13 ' A' ' 39' ' ' ILE . 56.7 mt -67.78 96.25 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.597 -0.89 . . . . 61.13 108.597 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 m -86.75 -31.4 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.012 0.525 . . . . 73.44 111.171 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -154.42 179.37 9.07 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 107.988 -1.116 . . . . 74.23 107.988 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.412 HG13 HD11 ' A' ' 39' ' ' ILE . 35.3 m -128.64 161.87 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.364 0.666 . . . . 64.4 109.959 170.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 21.8 t-80 -144.53 103.39 3.94 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.125 -0.695 . . . . 74.45 109.125 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.47 145.59 9.29 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 112.521 -0.232 . . . . 61.2 112.521 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.581 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 43.8 p -90.16 11.94 19.43 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.246 1.018 . . . . 62.35 111.928 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -106.58 17.08 23.77 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.03 0.932 . . . . 74.11 110.98 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' HD2' ' A' ' 26' ' ' PRO . . . 76.63 36.18 38.61 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.097 -0.501 . . . . 75.11 113.909 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . -89.75 123.68 33.97 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.641 -0.874 . . . . 51.52 108.641 172.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.473 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.5 m -102.06 152.86 5.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-O 121.898 0.856 . . . . 71.23 111.35 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -101.62 103.66 14.49 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.551 1.54 . . . . 65.42 108.331 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.61 117.11 33.24 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.162 0.585 . . . . 74.23 110.762 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.495 ' HD2' HG22 ' A' ' 21' ' ' VAL . 12.5 mmm-85 -89.44 102.62 15.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.326 1.05 . . . . 73.21 109.916 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.2 136.08 34.1 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.423 0.689 . . . . 55.32 110.976 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.532 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 14.3 pt-20 -57.33 -52.4 65.51 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.681 1.193 . . . . 42.14 111.039 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HB2' HD22 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -92.92 -54.04 3.91 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.332 -0.988 . . . . 70.44 108.332 -179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.694 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 60.77 50.01 72.25 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 124.823 1.327 . . . . 50.25 112.894 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.414 ' HB2' HD11 ' A' ' 53' ' ' LEU . 35.9 mt -67.74 111.71 8.38 Favored Pre-proline 0 C--N 1.351 0.633 0 C-N-CA 123.271 0.628 . . . . 75.41 110.102 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.58 173.42 9.53 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.009 2.473 . . . . 62.55 111.218 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 165.32 -168.31 39.3 Favored Glycine 0 C--O 1.238 0.383 0 N-CA-C 111.315 -0.714 . . . . 51.21 111.315 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -94.8 67.38 3.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.192 0.996 . . . . 75.11 109.232 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.09 26.5 9.22 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.689 -1.141 . . . . 62.43 109.714 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.58 119.26 12.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.516 0.727 . . . . 71.04 110.698 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.01 -2.12 38.25 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.982 -0.554 . . . . 32.32 112.558 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.55 162.84 27.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.439 0.696 . . . . 73.43 109.943 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.53 131.92 45.21 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.386 0.674 . . . . 74.15 111.034 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.26 159.24 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.598 1.159 . . . . 61.45 108.608 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.2 106.5 14.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.522 -0.918 . . . . 74.34 108.522 170.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.496 HG12 HG22 ' A' ' 43' ' ' VAL . 71.7 mt -83.42 108.73 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.383 -0.969 . . . . 72.13 108.383 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.73 143.87 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.946 0.898 . . . . 63.44 110.015 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 CA--C 1.55 0.979 0 N-CA-C 108.837 -0.801 . . . . 73.3 108.837 174.556 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 108.648 -0.871 . . . . 73.52 108.648 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 28' ' ' ASP . 53.0 mt -97.18 134.49 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 122.976 0.51 . . . . 70.41 110.476 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -89.27 121.61 31.72 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.005 0.922 . . . . 64.14 108.778 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -119.82 176.34 16.12 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-O 119.753 -0.471 . . . . 64.04 112.054 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.44 126.99 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.77 0.828 . . . . 75.22 109.653 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.43 99.4 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.618 0.767 . . . . 63.51 109.3 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 25' ' ' LYS . 66.5 mt -71.59 -48.04 50.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.438 0.695 . . . . 62.12 110.033 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -157.02 159.96 38.51 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.451 -0.795 . . . . 71.53 110.487 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -99.65 159.22 15.21 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.245 -1.021 . . . . 63.44 108.245 167.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.57 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 108.129 -1.063 . . . . 73.33 108.129 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.505 HD22 ' HA3' ' A' ' 74' ' ' GLY . 14.6 p-10 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 108.966 -0.753 . . . . 71.23 108.966 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.572 HG11 ' HE ' ' A' ' 68' ' ' ARG . 11.7 t -98.26 162.88 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.545 -0.909 . . . . 75.23 108.545 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.0 ttm -147.18 124.0 11.25 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.63 -1.248 . . . . 72.35 107.63 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.65 118.3 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 123.876 0.735 . . . . 44.41 109.278 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.8 mt -129.15 158.08 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.256 1.022 . . . . 72.32 108.386 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 8' ' ' LEU . 27.7 ttpp -141.41 108.44 6.16 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 109.671 -0.492 . . . . 71.05 109.671 170.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 14.2 Cg_endo -56.54 143.16 89.15 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 123.887 3.058 . . . . 73.53 112.864 171.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.7 mt -80.44 -38.15 30.62 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.348 1.059 . . . . 72.34 110.467 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' HB3' HG23 ' A' ' 3' ' ' ILE . 26.2 t70 -67.96 -27.64 66.77 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.135 -0.939 . . . . 61.31 111.593 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.474 HG21 HD11 ' A' ' 38' ' ' LEU . 76.5 t -110.79 120.06 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.194 0.998 . . . . 72.43 110.477 -176.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -127.67 21.64 6.47 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.695 0.798 . . . . 63.21 110.556 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.3 p -140.28 158.62 43.75 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.718 0.807 . . . . 71.4 110.676 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.649 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 48.3 ttt85 -65.96 -50.32 64.76 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.833 0.853 . . . . 74.01 112.775 -169.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -30.21 57.62 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.652 0.595 . . . . 70.41 111.163 -171.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HA ' ' HD2' ' A' ' 37' ' ' LYS . 42.7 mm-40 -69.1 -20.29 64.07 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.25 -0.432 . . . . 72.42 111.318 170.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.2 -26.22 20.23 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.736 0.814 . . . . 60.12 110.575 170.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -80.84 -12.59 59.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.789 0.835 . . . . 75.5 110.692 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 34' ' ' GLU . 15.0 ptmt -85.46 -16.39 39.8 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.126 0.489 . . . . 70.14 109.776 170.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 HG21 ' A' ' 29' ' ' VAL . 43.2 mt -81.98 -8.5 59.67 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.27 0.628 . . . . 73.31 111.149 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.534 HD13 HG22 ' A' ' 57' ' ' ILE . 43.1 mm -59.92 130.22 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.494 -0.558 . . . . 75.11 109.494 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.94 -19.06 56.12 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-O 119.872 -0.405 . . . . 61.54 112.844 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 87' ' ' VAL . 94.3 mtt180 -78.32 156.65 29.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.989 0.516 . . . . 75.31 111.309 -176.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 54' ' ' LYS . 21.6 tp -90.99 128.88 36.99 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.531 0.732 . . . . 64.23 109.517 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 86' ' ' ILE . 56.5 t -99.28 115.12 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.054 -0.721 . . . . 62.23 109.054 172.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.17 122.62 34.83 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.397 -0.964 . . . . 75.14 108.397 173.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 37.6 t90 -135.86 132.22 36.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.24 -0.652 . . . . 61.5 109.24 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -90.61 122.66 33.59 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.292 -1.003 . . . . 63.11 108.292 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.8 p -83.86 159.51 60.24 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.095 0.558 . . . . 70.1 111.078 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.39 -14.91 44.21 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.337 2.025 . . . . 72.21 111.764 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.1 t -68.99 -23.2 64.08 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.895 0.878 . . . . 63.31 111.124 173.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.99 20.29 26.39 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 116.324 -0.398 . . . . 74.12 112.78 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -111.15 137.13 49.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.763 0.825 . . . . 71.32 110.128 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.3 mt -86.07 93.48 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.063 -1.088 . . . . 71.44 108.063 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 73' ' ' LYS . 51.1 mt -80.59 133.14 35.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.04 -0.982 . . . . 71.24 109.766 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB3' HD11 ' A' ' 42' ' ' LEU . 30.6 mtmm -116.01 138.58 51.08 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.092 -0.707 . . . . 51.23 109.092 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -140.02 176.16 21.43 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-N 115.602 -0.726 . . . . 74.42 111.312 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -135.76 133.85 38.4 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.565 0.682 . . . . 72.11 109.826 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.534 HG22 HD13 ' A' ' 39' ' ' ILE . 58.1 mt -73.84 108.32 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.384 -0.599 . . . . 54.51 109.384 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.33 -20.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.708 0.803 . . . . 71.22 111.464 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -158.45 162.66 37.55 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.524 -0.547 . . . . 72.25 109.524 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 39' ' ' ILE . 33.8 m -108.34 169.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.663 0.785 . . . . 64.3 109.731 171.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -125.26 104.59 8.57 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.034 -0.728 . . . . 65.1 109.034 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.56 -140.31 44.44 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 123.971 0.794 . . . . 72.04 113.331 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 63.5 p -115.34 4.26 14.37 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.794 0.838 . . . . 54.4 111.716 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -82.38 1.55 36.72 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.253 0.621 . . . . 63.43 112.13 -171.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.41 0.88 87.87 Favored Glycine 0 C--N 1.355 1.611 0 CA-C-O 120.069 -0.295 . . . . 62.2 112.966 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.88 121.51 16.18 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.322 0.649 . . . . 73.54 110.177 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.2 141.42 18.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.426 0.632 . . . . 62.54 110.824 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.572 ' HE ' HG11 ' A' ' 21' ' ' VAL . 64.7 ttt180 -103.8 104.32 14.31 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.879 0.872 . . . . 61.5 108.95 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.37 136.23 52.1 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.289 0.636 . . . . 70.04 110.592 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HG2' HG22 ' A' ' 21' ' ' VAL . 72.0 mtp180 -106.32 117.24 33.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.809 0.444 . . . . 61.55 110.005 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -92.41 143.69 26.12 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.933 0.893 . . . . 72.41 111.129 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 15.8 pt-20 -60.6 -30.98 70.17 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.49 1.116 . . . . 74.14 111.601 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.545 ' HB2' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -119.69 -72.73 0.67 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.744 -0.836 . . . . 71.23 108.744 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.505 ' HA3' HD22 ' A' ' 20' ' ' ASN . . . 66.57 57.26 10.39 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 111.759 -0.537 . . . . 73.12 111.759 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.12 123.17 85.65 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.824 0.85 . . . . 74.22 110.584 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.13 151.45 38.97 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 123.843 3.028 . . . . 73.3 113.489 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.56 171.52 37.47 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.395 -0.821 . . . . 54.54 111.106 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -87.39 69.01 9.88 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.773 0.797 . . . . 74.34 109.399 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -119.51 27.93 8.47 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.046 -0.979 . . . . 62.33 110.369 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.08 135.91 47.98 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.572 0.349 . . . . 72.33 110.385 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.17 -6.47 63.79 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.01 -0.541 . . . . 74.21 112.574 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.91 155.61 35.03 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.233 0.613 . . . . 55.52 109.44 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 97.3 m-85 -102.09 145.04 29.91 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.135 0.493 . . . . 63.11 112.147 -169.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.79 165.42 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.298 -0.865 . . . . 74.31 109.901 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -128.74 110.35 12.1 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.463 0.705 . . . . 73.02 109.118 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 43' ' ' VAL . 59.0 mt -84.22 113.18 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.094 0.958 . . . . 43.41 109.073 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 27.5 t -87.58 146.31 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.38 1.072 . . . . 51.23 110.022 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 N--CA 1.486 1.326 0 C-N-CA 124.138 0.975 . . . . 75.11 110.856 -179.149 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.513 ' HG2' HG22 ' A' ' 87' ' ' VAL . 73.6 mtt180 . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 109.188 -0.671 . . . . 72.22 109.188 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 48.4 mt -98.81 131.35 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.78 0.832 . . . . 73.43 108.85 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.11 120.58 29.61 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.788 -0.819 . . . . 74.23 108.788 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -125.24 170.71 17.17 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.861 -0.496 . . . . 61.14 111.861 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.7 t -126.54 138.95 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.239 1.016 . . . . 74.24 109.513 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.39 114.29 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.44 1.096 . . . . 62.12 110.12 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 23' ' ' ILE . 42.4 mt -92.61 -55.68 3.3 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.729 0.412 . . . . 55.22 110.479 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -153.87 152.33 30.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.837 0.455 . . . . 64.3 111.949 -174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -110.09 128.74 55.62 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.047 0.939 . . . . 72.14 108.574 170.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 106.058 -1.83 . . . . 65.53 106.058 171.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.43 ' OD1' ' HB2' ' A' ' 71' ' ' PHE . 3.5 p-10 . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 121.467 0.651 . . . . 74.22 110.789 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.444 HG22 ' HD3' ' A' ' 70' ' ' ARG . 47.3 t -88.07 143.5 11.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.885 -1.524 . . . . 73.43 106.885 159.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.4 ttt -137.26 113.58 10.04 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.46 -0.941 . . . . 73.24 108.46 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 8' ' ' LEU . 46.0 mm -80.37 119.83 30.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.104 -1.073 . . . . 70.21 108.104 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.479 HG21 HG21 ' A' ' 84' ' ' VAL . 98.0 mt -129.87 143.99 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.187 0.995 . . . . 71.43 108.398 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HB2' HD11 ' A' ' 8' ' ' LEU . 64.4 tttp -116.06 111.22 42.94 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 109.01 -0.737 . . . . 62.12 109.01 167.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 16.4 Cg_exo -66.33 131.27 26.07 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.12 1.88 . . . . 65.12 110.729 167.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.38 -31.91 72.64 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.016 0.926 . . . . 74.23 111.885 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.82 -29.88 64.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.791 0.836 . . . . 53.42 111.55 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 34' ' ' GLU . 72.0 t -103.1 107.73 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.0 0.92 . . . . 70.01 110.677 -170.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -124.45 17.8 8.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.486 1.114 . . . . 72.14 109.839 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.3 t -139.62 156.32 46.92 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.366 1.067 . . . . 73.25 109.97 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -67.68 -37.67 82.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.308 0.643 . . . . 73.21 110.903 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.66 -45.09 95.45 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.929 0.891 . . . . 71.23 111.594 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HB2' HG13 ' A' ' 29' ' ' VAL . 42.1 mt-10 -65.17 -32.72 74.55 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.888 -1.051 . . . . 74.41 110.553 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.0 -28.76 49.28 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.901 0.88 . . . . 54.42 111.36 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -75.69 -25.96 57.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.146 0.978 . . . . 72.41 111.474 -173.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -84.43 -3.19 58.2 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.098 0.407 . . . . 45.31 112.098 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.541 HD11 HG21 ' A' ' 29' ' ' VAL . 29.9 mt -90.52 -2.87 57.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.814 0.445 . . . . 73.34 111.428 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -66.2 117.57 7.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.087 0.555 . . . . 72.51 109.835 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.97 1.98 57.14 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.152 -0.931 . . . . 61.03 113.202 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -87.62 161.0 17.95 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.327 1.063 . . . . 73.1 111.055 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.4 tp -90.1 139.25 30.81 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.338 1.055 . . . . 73.54 108.314 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 t -126.7 122.21 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.552 -0.907 . . . . 72.42 108.552 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.19 102.25 11.67 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.947 0.899 . . . . 63.45 109.745 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.479 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 29.4 t90 -95.47 144.22 26.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.248 -0.649 . . . . 75.24 109.248 170.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -103.36 100.33 10.21 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.603 1.161 . . . . 64.22 108.162 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.7 p -64.62 150.38 94.04 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.583 0.753 . . . . 74.53 111.246 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.88 -5.35 15.39 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.646 2.231 . . . . 73.41 112.289 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.5 t -70.72 -19.54 62.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.705 1.202 . . . . 64.33 111.163 169.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.51 36.08 8.96 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.887 -0.597 . . . . 35.55 112.068 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -127.67 131.99 49.75 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.025 0.93 . . . . 74.3 109.014 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -90.26 93.11 4.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.661 -1.237 . . . . 73.52 107.661 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 75' ' ' LEU . 34.9 mt -74.86 137.35 41.76 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.819 -1.082 . . . . 75.34 109.508 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -98.0 137.65 36.5 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.003 0.921 . . . . 44.4 108.92 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.56 176.31 22.41 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 123.687 0.617 . . . . 72.2 111.635 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.3 ttmt -147.37 129.98 15.95 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.907 0.353 . . . . 75.14 110.752 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.4 mt -73.04 105.03 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.874 -1.057 . . . . 73.23 109.175 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 m -84.55 -36.14 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.821 -0.627 . . . . 54.54 110.816 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -148.22 -174.74 4.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.676 0.79 . . . . 74.15 111.203 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -114.31 170.53 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.235 1.014 . . . . 73.32 110.125 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -136.89 101.63 4.64 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.378 -0.971 . . . . 71.22 108.378 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.76 -172.56 10.17 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.268 -0.878 . . . . 65.31 115.181 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.3 p -91.22 11.93 21.82 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.808 1.243 . . . . 75.15 110.853 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.84 -25.35 60.03 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.937 1.295 . . . . 72.41 109.718 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.4 -2.43 65.23 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.653 -0.703 . . . . 42.35 112.788 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.4 129.76 40.91 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.028 0.531 . . . . 44.24 109.898 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.9 m -102.0 149.9 6.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 C-N-CA 123.665 0.786 . . . . 74.43 110.805 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -99.76 102.63 14.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.013 -1.449 . . . . 72.45 107.506 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.57 157.53 17.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.002 0.521 . . . . 71.21 110.743 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.444 ' HD3' HG22 ' A' ' 21' ' ' VAL . 10.0 mmm180 -131.65 99.7 4.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.366 1.066 . . . . 72.53 109.703 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.43 ' HB2' ' OD1' ' A' ' 20' ' ' ASN . 16.7 m-85 -88.97 138.51 31.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.181 0.593 . . . . 74.44 109.818 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.17 -43.23 99.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.83 1.252 . . . . 73.13 112.43 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -87.64 -53.4 4.81 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.613 -0.721 . . . . 64.1 111.808 -167.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.73 35.66 39.68 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-O 120.006 -0.33 . . . . 61.33 113.428 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.646 ' HB2' HD11 ' A' ' 53' ' ' LEU . 41.4 mt -69.42 126.52 92.7 Favored Pre-proline 0 C--N 1.353 0.728 0 C-N-CA 122.409 0.284 . . . . 71.1 110.44 177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.56 158.94 46.99 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.866 2.377 . . . . 75.2 110.918 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.3 115.1 0.35 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.243 -1.143 . . . . 64.43 110.243 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -65.95 75.97 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.089 1.355 . . . . 74.41 111.059 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.479 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -120.83 28.41 7.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.056 1.342 . . . . 75.52 109.468 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.3 mt -64.5 103.65 0.69 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 108.59 -0.893 . . . . 72.14 108.59 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.06 -5.52 8.93 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 116.154 -0.476 . . . . 51.12 113.109 -172.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -76.02 172.28 13.03 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.956 0.902 . . . . 73.51 108.905 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -107.51 143.62 35.65 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.526 0.679 . . . . 72.1 111.419 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG21 HG21 ' A' ' 24' ' ' ILE . 19.6 m -113.24 164.29 9.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-N 114.319 -1.31 . . . . 75.24 108.405 172.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -127.76 109.74 11.94 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.936 0.494 . . . . 71.35 109.921 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 54.6 mt -82.59 92.66 2.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.078 -1.082 . . . . 55.21 108.078 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 2' ' ' ARG . 96.4 t -77.48 128.79 37.97 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 CA-C-N 113.917 -1.492 . . . . 70.35 110.105 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 108.167 -1.049 . . . . 74.12 108.167 174.117 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HG2' ' HA ' ' A' ' 87' ' ' VAL . 59.9 mtm-85 . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.414 -0.587 . . . . 71.24 109.414 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 55.9 mt -121.92 137.32 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.866 0.866 . . . . 74.52 109.41 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -89.09 131.86 35.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.297 -0.631 . . . . 63.41 109.297 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -137.97 137.52 8.9 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-O 120.169 -0.24 . . . . 64.23 112.983 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t -98.97 117.08 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.808 0.843 . . . . 74.43 110.261 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.98 106.76 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.529 1.132 . . . . 73.42 110.669 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.7 -50.56 15.01 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.37 0.668 . . . . 74.22 110.05 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -154.35 172.05 18.32 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.1 -0.954 . . . . 51.55 110.684 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -120.33 122.61 41.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.963 -1.125 . . . . 71.53 107.963 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.51 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 1.8 tpm_? . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 106.777 -1.564 . . . . 70.52 106.777 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 36.8 t30 . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.326 0.584 . . . . 72.13 110.477 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.606 HG22 ' HG2' ' A' ' 70' ' ' ARG . 67.7 t -105.74 155.39 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 125.89 1.676 . . . . 74.51 109.785 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 44.3 ttm -137.73 127.47 25.36 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.662 -0.866 . . . . 71.44 108.662 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -88.01 110.57 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.47 -0.937 . . . . 72.34 108.47 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 84' ' ' VAL . 79.7 mt -117.39 149.21 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.364 1.066 . . . . 75.02 109.051 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -123.95 97.67 40.66 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 108.082 -1.081 . . . . 71.14 108.082 174.067 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.801 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 36.9 Cg_exo -60.85 125.62 17.64 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.919 2.412 . . . . 55.34 112.639 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.16 -42.33 89.14 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.623 0.769 . . . . 74.31 112.541 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.47 0.76 55.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.641 0.776 . . . . 73.22 111.983 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.801 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 59.4 t -114.3 107.89 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.296 1.038 . . . . 40.01 108.355 174.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -121.9 6.48 9.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.404 0.682 . . . . 74.02 111.77 -173.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 m -127.68 142.65 51.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.855 0.862 . . . . 70.41 108.875 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.533 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 57.3 ttt180 -57.4 -34.78 69.25 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.007 0.923 . . . . 74.51 111.27 175.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -60.26 -42.65 95.79 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.663 0.785 . . . . 62.51 111.825 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.657 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.5 mt-10 -64.44 -44.33 91.51 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.163 -0.926 . . . . 71.24 109.376 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.9 -26.01 66.66 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.438 -0.801 . . . . 72.21 111.55 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -73.56 -33.93 64.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.35 1.06 . . . . 74.15 110.777 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -85.86 -2.94 58.75 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.791 0.293 . . . . 75.24 111.791 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 29' ' ' VAL . 50.5 mt -86.19 -1.58 57.57 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 119.232 -0.413 . . . . 54.5 112.06 174.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 57' ' ' ILE . 43.2 mm -64.22 122.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.672 -0.862 . . . . 70.11 108.672 172.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.06 -4.94 55.93 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.508 -0.315 . . . . 73.02 113.163 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -84.8 148.09 26.5 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.197 0.499 . . . . 74.02 109.729 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.3 tp -88.83 141.5 28.45 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.4 1.08 . . . . 74.31 108.507 -173.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.51 126.02 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.4 -0.593 . . . . 72.42 109.4 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.1 mt -111.49 105.66 14.32 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.078 0.951 . . . . 73.22 109.421 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.46 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 47.3 t90 -110.47 133.27 53.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.306 0.642 . . . . 70.41 109.374 174.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -92.59 111.98 23.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.791 -1.188 . . . . 73.42 107.791 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.5 p -68.47 152.51 96.57 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.238 0.615 . . . . 74.03 111.338 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.41 -18.12 57.43 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.972 2.448 . . . . 52.32 111.917 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.6 m -61.55 -21.07 63.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.156 1.383 . . . . 63.0 111.988 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.71 20.35 44.29 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 116.352 -0.385 . . . . 24.52 112.425 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -108.29 146.98 32.09 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.875 0.87 . . . . 72.41 109.192 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -101.36 93.43 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.669 -1.234 . . . . 71.12 107.669 172.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.6 mt -77.88 130.28 36.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.938 -1.028 . . . . 74.22 109.103 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -107.3 146.62 31.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.277 0.631 . . . . 73.02 109.32 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.32 -171.31 21.12 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.214 -0.903 . . . . 62.24 111.497 -175.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -152.22 135.34 15.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.001 0.401 . . . . 63.4 110.954 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.457 HG22 HD13 ' A' ' 39' ' ' ILE . 70.6 mt -69.83 110.64 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 O-C-N 124.095 0.872 . . . . 63.14 108.686 175.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.44 -8.54 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.513 0.725 . . . . 65.54 111.291 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.408 ' HB3' ' HD3' ' A' ' 68' ' ' ARG . 18.6 tpp180 -158.48 150.79 21.76 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.73 -0.471 . . . . 75.24 109.73 -174.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.418 HG13 HD11 ' A' ' 39' ' ' ILE . 23.7 m -98.62 159.46 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.436 0.694 . . . . 64.23 109.537 173.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.414 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 59.7 t-80 -144.44 104.48 4.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.126 0.57 . . . . 70.15 109.808 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.91 168.94 40.49 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 121.336 0.409 . . . . 72.21 113.655 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.533 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 21.4 p -85.0 -9.22 58.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.482 1.113 . . . . 74.33 112.29 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -81.87 5.95 17.29 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.509 0.724 . . . . 61.42 112.686 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.439 ' HA3' HG12 ' A' ' 29' ' ' VAL . . . 84.84 9.11 81.56 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 119.518 -0.601 . . . . 75.45 113.802 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . . . -67.18 133.9 50.67 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 122.656 0.383 . . . . 71.21 110.201 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.3 150.06 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.547 0.739 . . . . 51.22 111.231 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 59' ' ' ARG . 60.2 ttt180 -103.0 105.21 15.48 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.546 1.138 . . . . 72.21 108.369 171.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.84 120.24 41.92 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.453 0.701 . . . . 71.52 109.936 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.606 ' HG2' HG22 ' A' ' 21' ' ' VAL . 41.2 mtm105 -88.92 118.81 28.9 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.174 -0.676 . . . . 70.02 109.174 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -90.78 122.94 33.95 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.336 0.654 . . . . 74.51 109.773 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.0 -39.3 74.43 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.223 1.009 . . . . 74.4 111.873 -173.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -76.81 -55.06 5.82 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.251 -0.886 . . . . 73.24 109.528 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 61.26 34.55 88.55 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 114.6 -1.182 . . . . 74.25 113.865 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 96.0 mt -69.66 137.83 88.21 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.588 0.755 . . . . 64.3 110.353 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 12.8 Cg_exo -68.76 143.85 57.39 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.96 2.44 . . . . 74.52 112.445 -174.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.76 104.02 0.17 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.722 -0.951 . . . . 63.11 110.722 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -73.68 91.18 1.87 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.733 0.813 . . . . 73.15 110.025 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -115.83 30.77 7.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.717 1.207 . . . . 74.34 109.91 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.1 mt -43.9 103.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.323 1.049 . . . . 63.12 112.259 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.15 4.75 20.38 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.814 -0.63 . . . . 33.44 113.913 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -91.36 168.11 11.8 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.055 0.942 . . . . 71.35 110.901 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -100.15 154.6 18.31 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.722 0.809 . . . . 74.43 112.627 -172.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 24' ' ' ILE . 18.5 m -131.18 158.21 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.92 1.288 . . . . 73.02 109.062 176.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.97 108.25 17.52 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.058 -0.719 . . . . 75.24 109.058 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 68.1 mt -89.14 94.09 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.976 -1.12 . . . . 71.21 107.976 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.435 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . 48.6 t -74.01 133.48 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.143 -0.935 . . . . 74.35 109.043 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 tm? . . . . . 0 CA--C 1.549 0.913 0 N-CA-C 108.743 -0.836 . . . . 72.43 108.743 176.536 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.466 -0.568 . . . . 65.23 109.466 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.503 HD12 HH11 ' A' ' 41' ' ' ARG . 65.7 mt -111.84 124.06 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.91 -1.144 . . . . 73.33 107.91 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 7.1 ptpp? -88.35 127.29 35.48 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.314 0.578 . . . . 63.42 110.912 -173.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -123.76 160.45 18.31 Favored Glycine 0 C--O 1.218 -0.872 0 CA-C-N 115.59 -0.732 . . . . 62.2 111.834 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.14 129.56 50.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 123.542 0.737 . . . . 73.31 109.379 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.505 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 60.4 t -66.93 99.87 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.954 0.902 . . . . 62.1 109.459 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.748 HD11 ' HG2' ' A' ' 25' ' ' LYS . 72.2 mt -74.46 -59.32 2.78 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.776 -0.453 . . . . 74.22 109.776 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.4 t -166.08 162.07 17.6 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.923 -0.581 . . . . 75.1 111.355 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB3' HD21 ' A' ' 20' ' ' ASN . 62.4 m-85 -115.87 145.35 42.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.965 1.306 . . . . 70.33 108.892 171.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 107.426 -1.324 . . . . 64.52 107.426 173.667 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.508 HD21 ' HB3' ' A' ' 10' ' ' TYR . 44.6 t-20 . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 109.223 -0.658 . . . . 75.35 109.223 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.8 t -88.44 105.1 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.448 -0.945 . . . . 54.31 108.448 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.42 ' HE3' HG22 ' A' ' 7' ' ' VAL . 24.8 ttt -98.83 136.46 38.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.268 -1.333 . . . . 72.01 109.11 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.511 HG22 HD12 ' A' ' 8' ' ' LEU . 27.7 mm -104.48 131.0 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 108.238 -1.023 . . . . 70.13 108.238 174.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.9 mt -124.97 150.31 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.941 0.897 . . . . 74.13 109.239 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.748 ' HG2' HD11 ' A' ' 8' ' ' LEU . 1.1 mmmm -120.37 98.59 48.52 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 123.115 0.566 . . . . 61.55 110.404 170.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 23.8 Cg_exo -63.07 135.88 53.42 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.116 1.877 . . . . 72.32 110.377 169.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.5 mt -60.73 -30.99 70.31 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.31 0.576 . . . . 71.24 111.149 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.23 -27.17 61.44 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.334 1.453 . . . . 73.14 111.79 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 34' ' ' GLU . 94.6 t -115.93 121.09 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.9 0.88 . . . . 61.14 110.427 -170.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -135.29 14.68 3.5 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.671 0.788 . . . . 73.5 111.26 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 m -137.67 151.27 48.08 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.845 0.858 . . . . 54.02 109.781 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.65 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 50.0 ttt180 -60.37 -38.82 85.1 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.253 1.021 . . . . 75.21 112.184 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.57 -40.1 95.78 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.049 0.54 . . . . 73.34 111.44 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.508 ' HB2' HG13 ' A' ' 29' ' ' VAL . 48.0 mt-10 -64.73 -35.64 81.71 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.9 0.75 . . . . 63.42 110.828 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.79 -30.6 51.38 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.987 0.915 . . . . 63.21 111.274 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -73.19 -31.63 64.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.065 0.946 . . . . 72.41 111.25 -173.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -79.28 -11.71 59.94 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 120.831 0.348 . . . . 54.21 110.899 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.587 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 51.5 mt -109.73 23.62 14.16 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.205 1.002 . . . . 74.31 111.561 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.5 mm -75.47 135.39 27.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.565 -0.531 . . . . 71.11 109.565 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.6 -9.3 44.55 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-O 119.103 -0.831 . . . . 65.5 113.061 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.587 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 79.1 mtm180 -62.11 149.11 42.25 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.334 0.654 . . . . 73.21 112.408 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 tp -91.64 120.68 32.62 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.369 1.068 . . . . 62.41 109.262 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.0 t -100.21 137.28 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 122.911 0.484 . . . . 60.32 110.031 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.7 mt -131.34 120.13 22.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.787 1.235 . . . . 74.02 107.761 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.42 ' HE1' ' HB3' ' A' ' 82' ' ' ASP . 47.4 t90 -130.28 128.44 41.57 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.435 -0.579 . . . . 74.13 109.435 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -84.43 110.84 18.94 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.347 -0.612 . . . . 63.42 109.347 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.8 t -77.2 153.72 82.23 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 124.255 1.022 . . . . 63.43 109.537 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.3 -8.55 14.85 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.137 2.558 . . . . 75.1 114.686 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.9 p -70.9 -15.32 62.61 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.262 0.625 . . . . 74.31 111.506 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.23 -10.53 63.54 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 123.719 0.676 . . . . 43.15 112.388 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.57 132.41 35.11 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.627 0.771 . . . . 74.45 110.755 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.8 106.5 13.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.944 -0.761 . . . . 54.25 108.944 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.8 117.93 16.15 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.726 -0.842 . . . . 74.34 108.726 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -109.16 146.67 33.74 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 123.021 0.528 . . . . 55.51 110.424 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.82 -171.75 27.2 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 114.825 -1.079 . . . . 32.5 110.999 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.73 134.18 20.81 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.057 0.428 . . . . 74.03 111.086 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 41' ' ' ARG . 78.1 mt -67.5 106.87 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.509 0 O-C-N 124.41 1.069 . . . . 62.04 109.402 175.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.545 HG11 ' HE ' ' A' ' 70' ' ' ARG . 27.6 m -91.52 -31.74 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.567 0.747 . . . . 54.13 111.559 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -155.76 176.29 12.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.863 -0.791 . . . . 71.3 108.863 -173.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.2 m -92.51 170.06 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 170.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -136.17 103.4 5.31 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.267 -1.012 . . . . 72.31 108.267 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.7 -149.04 42.71 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.657 -0.702 . . . . 22.14 113.24 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.65 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -117.97 -17.37 9.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.472 0.709 . . . . 70.3 112.105 -171.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 25.29 2.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.497 0.719 . . . . 61.13 112.232 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.22 18.13 78.66 Favored Glycine 0 C--N 1.346 1.13 0 N-CA-C 114.97 0.748 . . . . 73.41 114.97 167.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.12 38.19 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.582 -0.896 . . . . 61.31 108.582 171.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.8 m -102.43 139.46 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.046 0.451 . . . . 65.0 109.973 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -99.58 105.53 17.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.118 0.967 . . . . 74.23 108.747 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.51 121.58 44.7 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.832 0.853 . . . . 70.35 110.817 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HE ' HG11 ' A' ' 58' ' ' VAL . 39.1 mtm180 -89.33 113.12 24.36 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.979 -0.748 . . . . 63.3 108.979 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -81.5 136.15 35.62 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.337 1.055 . . . . 72.52 110.329 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.66 -24.78 36.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.404 0.682 . . . . 70.13 110.904 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -77.39 -54.77 6.05 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.485 -0.78 . . . . 70.43 109.685 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.04 25.1 63.82 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 124.042 0.838 . . . . 71.03 114.263 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.63 158.46 78.5 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.949 0.9 . . . . 73.43 110.848 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.58 150.6 51.32 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.996 2.464 . . . . 73.13 112.733 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.24 -71.96 0.3 Allowed Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.915 -0.584 . . . . 73.12 112.43 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 76.02 -40.43 0.4 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 126.075 1.75 . . . . 75.02 112.604 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.81 30.07 0.11 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.126 0.97 . . . . 44.15 112.661 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.18 149.42 28.32 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.216 1.006 . . . . 72.25 110.707 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' H ' ' HB ' ' A' ' 7' ' ' VAL . . . 87.72 4.12 79.8 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 116.601 -0.272 . . . . 73.51 113.076 -169.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.42 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 35.0 t70 -85.38 170.9 12.28 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.76 0.824 . . . . 73.33 110.176 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.69 133.24 36.2 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.516 0.674 . . . . 73.1 112.169 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 11.4 m -100.71 159.34 3.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 114.452 -1.249 . . . . 72.32 108.946 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -109.19 108.9 19.71 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.473 -0.936 . . . . 72.43 108.473 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.9 95.13 4.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.584 -0.895 . . . . 75.42 108.584 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.22 136.73 24.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 115.246 -0.888 . . . . 75.22 109.593 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 108.642 -0.873 . . . . 60.23 108.642 178.714 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 . . . . . 0 CA--C 1.537 0.468 0 N-CA-C 107.421 -1.326 . . . . 75.33 107.421 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 mt -98.55 155.69 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.411 1.084 . . . . 65.15 108.96 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.553 ' HG3' HD12 ' A' ' 27' ' ' LEU . 19.1 ptmt -114.36 140.92 48.26 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.865 -0.791 . . . . 75.03 108.865 173.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -139.32 164.57 25.9 Favored Glycine 0 C--O 1.216 -0.995 0 N-CA-C 111.647 -0.581 . . . . 23.31 111.647 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.37 131.38 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.348 0.659 . . . . 75.23 109.926 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.1 93.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.304 -0.998 . . . . 72.1 108.304 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 25' ' ' LYS . 79.8 mt -68.4 -59.31 3.27 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 110.131 -0.322 . . . . 73.32 110.131 -176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 t -154.38 155.67 35.46 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.074 -0.512 . . . . 72.4 110.722 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -95.78 138.81 32.91 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.458 -0.941 . . . . 73.44 108.458 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 108.585 -0.894 . . . . 71.23 108.585 173.393 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.0 m120 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.025 -0.731 . . . . 63.03 109.025 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 70' ' ' ARG . 62.2 t -88.12 145.9 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 108.282 -1.007 . . . . 72.31 108.282 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.3 ttt -136.22 111.51 9.09 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.485 -1.302 . . . . 62.21 107.485 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 mm -78.51 119.13 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 114.98 -1.009 . . . . 63.31 108.387 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.469 HG21 HG21 ' A' ' 84' ' ' VAL . 81.5 mt -130.93 153.12 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.488 1.115 . . . . 73.4 108.089 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HB2' HD11 ' A' ' 8' ' ' LEU . 87.5 tttt -127.33 121.88 22.69 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 108.912 -0.773 . . . . 73.4 108.912 164.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -69.87 140.23 41.74 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.768 2.312 . . . . 70.25 110.768 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.553 HD12 ' HG3' ' A' ' 4' ' ' LYS . 92.7 mt -69.84 -29.78 67.11 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.384 0.673 . . . . 73.54 111.276 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.08 -22.23 60.62 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.996 -1.002 . . . . 64.44 111.303 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' A' ' 34' ' ' GLU . 57.9 t -110.23 123.96 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.335 1.054 . . . . 63.32 110.746 -174.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -135.16 11.13 3.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.845 0.858 . . . . 64.3 110.429 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.442 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 27.5 m -131.09 165.33 23.49 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.426 0.69 . . . . 74.0 111.126 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -68.93 -43.73 74.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.703 1.201 . . . . 73.43 110.97 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -70.65 -32.54 69.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.746 0.818 . . . . 72.02 110.763 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.563 ' HB2' HG13 ' A' ' 29' ' ' VAL . 44.7 mt-10 -68.51 -30.89 69.81 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.78 -0.645 . . . . 73.45 110.5 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.38 -32.04 33.04 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.578 0.751 . . . . 72.35 110.728 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -75.18 -23.77 57.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.869 0.868 . . . . 72.35 111.382 -174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -80.23 -13.67 59.04 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 120.73 0.3 . . . . 70.01 110.968 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.9 mt -90.32 3.87 52.42 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 122.961 0.504 . . . . 75.04 112.084 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.481 HD13 HG22 ' A' ' 57' ' ' ILE . 48.9 mm -65.63 124.36 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 108.819 -0.808 . . . . 71.53 108.819 171.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.06 9.56 62.08 Favored Glycine 0 N--CA 1.475 1.288 0 CA-C-O 119.967 -0.351 . . . . 74.4 113.371 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.714 ' HG3' ' HA ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -89.85 146.72 24.23 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.691 0.796 . . . . 74.31 110.673 178.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.8 tp -93.98 115.41 27.75 Favored 'General case' 0 C--N 1.345 0.398 0 O-C-N 124.037 0.835 . . . . 64.31 109.41 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.9 t -98.99 120.43 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 109.629 -0.508 . . . . 75.31 109.629 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt -105.9 128.05 53.53 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.765 1.226 . . . . 63.34 109.077 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -147.33 119.27 8.15 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.377 -0.601 . . . . 72.43 109.377 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 28.3 ttpp -82.06 112.27 18.97 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.194 -0.669 . . . . 73.13 109.194 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.0 p -64.7 155.51 81.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.781 0.832 . . . . 61.23 110.94 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.71 -9.09 19.57 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.988 2.459 . . . . 73.35 112.523 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 t -74.67 -10.12 59.23 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.927 0.891 . . . . 61.31 111.347 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.47 -12.37 63.18 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 123.633 0.635 . . . . 60.14 113.188 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -83.51 126.66 33.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.564 0.746 . . . . 65.4 109.563 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 63.1 mt -79.57 96.74 2.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 107.31 -1.367 . . . . 60.03 107.31 168.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 73' ' ' LYS . 50.3 mt -73.62 126.43 30.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.094 -0.957 . . . . 73.33 108.953 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -106.65 139.82 40.49 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.991 -0.744 . . . . 72.02 108.991 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.24 -179.64 28.02 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 123.51 0.506 . . . . 40.24 111.939 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 31.0 ttmt -149.38 137.32 20.47 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.949 0.404 . . . . 73.32 111.073 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.481 HG22 HD13 ' A' ' 39' ' ' ILE . 67.3 mt -74.85 103.49 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 114.77 -1.105 . . . . 74.24 109.643 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.21 -18.59 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 114.965 -1.016 . . . . 60.24 111.345 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 20.8 ttm180 -160.13 160.67 33.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.084 0.554 . . . . 62.32 109.755 -175.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 m -95.1 171.05 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.496 0.718 . . . . 73.02 109.469 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -128.36 103.03 6.92 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.795 -0.817 . . . . 73.2 108.795 173.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.35 -150.52 46.96 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 124.291 0.994 . . . . 41.54 114.089 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -109.54 7.08 24.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.473 1.109 . . . . 75.11 110.89 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -67.23 -28.05 67.74 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.171 0.588 . . . . 72.23 111.047 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.17 3.3 58.92 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.639 -0.709 . . . . 65.15 111.903 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.44 130.21 42.19 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.515 -0.55 . . . . 73.55 109.515 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.6 m -102.37 153.97 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.581 0.752 . . . . 74.22 110.573 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HD2' ' HB3' ' A' ' 59' ' ' ARG . 17.8 ttm180 -111.84 103.31 11.56 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.491 -0.929 . . . . 54.21 108.491 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.84 116.58 30.91 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.449 0.699 . . . . 44.54 109.813 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.423 ' HG2' HG22 ' A' ' 21' ' ' VAL . 43.3 mtm180 -90.24 118.01 29.43 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.69 -0.856 . . . . 71.11 108.69 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -91.37 128.41 37.19 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.488 0.715 . . . . 72.51 109.801 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.12 -32.97 68.64 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.629 1.172 . . . . 72.21 112.468 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.505 ' HB2' HD22 ' A' ' 53' ' ' LEU . 70.9 mmtt -90.5 -37.94 13.55 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.132 0.573 . . . . 71.42 109.565 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.17 35.73 34.6 Favored Glycine 0 C--N 1.36 1.871 0 O-C-N 124.503 1.127 . . . . 75.04 114.315 174.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -76.28 133.15 71.95 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 122.992 0.517 . . . . 72.43 110.622 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.23 120.17 6.41 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.772 1.648 . . . . 75.51 110.404 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.12 -15.2 31.3 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.523 -0.762 . . . . 73.21 111.868 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 67.68 12.74 9.0 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.765 1.226 . . . . 62.11 111.35 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.12 32.47 2.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.836 1.254 . . . . 44.3 111.833 -168.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -51.79 108.02 0.24 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.522 0.729 . . . . 71.2 111.413 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.0 -14.46 7.05 Favored Glycine 0 N--CA 1.475 1.272 0 CA-C-N 116.11 -0.496 . . . . 72.34 112.396 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -77.56 172.83 12.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.75 0.82 . . . . 71.13 110.311 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 9.7 m-85 -108.62 130.01 55.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.283 0.633 . . . . 71.12 111.394 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 24' ' ' ILE . 16.1 m -97.97 168.25 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.553 1.141 . . . . 61.43 109.029 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -120.35 106.76 12.17 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.787 -0.82 . . . . 45.11 108.787 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.19 92.37 3.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.41 -0.959 . . . . 64.4 108.41 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.78 124.77 36.74 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-N 115.063 -0.971 . . . . 75.23 108.86 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.714 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.239 0.533 0 N-CA-C 106.663 -1.606 . . . . 72.41 106.663 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.544 ' HD2' ' HB3' ' A' ' 85' ' ' GLU . 90.6 mtm-85 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.803 -0.443 . . . . 73.01 109.803 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.682 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 47.8 mt -116.82 124.4 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.566 -1.272 . . . . 53.21 107.566 176.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -88.74 140.21 29.68 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 118.419 0.554 . . . . 74.43 109.658 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.59 135.97 7.34 Favored Glycine 0 C--O 1.218 -0.886 0 N-CA-C 111.998 -0.441 . . . . 71.44 111.998 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -91.18 116.88 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.369 0.668 . . . . 44.22 109.266 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.485 HG13 ' SD ' ' A' ' 22' ' ' MET . 91.1 t -55.12 103.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.585 1.154 . . . . 75.4 110.4 175.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 23' ' ' ILE . 93.9 mt -75.21 -57.05 4.13 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 122.88 0.472 . . . . 70.14 110.22 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.409 ' HA ' HD22 ' A' ' 80' ' ' LEU . 71.3 p -163.95 164.08 23.34 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.415 -0.811 . . . . 64.2 110.271 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.97 134.93 34.09 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.147 -0.686 . . . . 74.25 109.147 168.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 1.7 tmt_? . . . . . 0 C--O 1.241 0.648 0 N-CA-C 105.424 -2.065 . . . . 73.02 105.424 165.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.656 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 52.1 t30 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 120.886 0.374 . . . . 71.55 110.302 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 39.8 t -93.53 144.14 10.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.606 -0.887 . . . . 74.54 108.606 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.485 ' SD ' HG13 ' A' ' 7' ' ' VAL . 42.8 ttp -133.56 121.64 22.4 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.179 -0.675 . . . . 74.35 109.179 174.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 8' ' ' LEU . 41.1 mm -79.78 126.42 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.577 1.151 . . . . 70.14 108.832 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -126.08 152.07 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.581 1.153 . . . . 74.1 109.588 -171.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 64' ' ' LYS . 4.5 tppp? -116.22 92.66 36.68 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.756 0.822 . . . . 71.11 109.515 173.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.07 131.54 33.0 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.441 1.427 . . . . 62.13 109.876 172.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.449 HD11 ' HE2' ' A' ' 83' ' ' TYR . 91.1 mt -63.96 -31.51 72.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.584 0.754 . . . . 63.21 111.764 -171.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.16 -28.58 67.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.539 0.735 . . . . 73.1 111.122 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.421 HG12 ' HA2' ' A' ' 65' ' ' GLY . 89.1 t -96.66 144.19 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.865 0.866 . . . . 64.4 111.772 -168.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -147.52 -25.57 0.38 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.375 1.07 . . . . 61.12 111.592 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.608 ' HB2' ' HG2' ' A' ' 34' ' ' GLU . 15.7 m -109.88 169.84 8.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.403 0.681 . . . . 73.41 111.186 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.511 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 78.8 ttt180 -65.96 -42.83 89.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.954 0.902 . . . . 74.21 111.082 -177.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.99 -30.87 62.71 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.813 0.695 . . . . 72.44 110.892 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HG2' ' HB2' ' A' ' 31' ' ' SER . 20.0 mm-40 -65.92 -30.8 71.44 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.752 0.658 . . . . 70.5 110.491 173.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.66 -33.21 31.45 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.772 0.829 . . . . 65.33 110.851 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -75.44 -24.96 57.09 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.107 0.963 . . . . 75.43 111.203 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 34' ' ' GLU . 22.0 pttp -75.07 -1.51 23.23 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 122.205 0.202 . . . . 74.01 111.111 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.1 11.5 25.64 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.319 0.648 . . . . 74.44 112.53 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mm -69.24 126.28 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.414 -0.587 . . . . 65.12 109.414 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.38 57.74 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.179 -0.464 . . . . 53.25 113.242 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.07 139.14 37.03 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.017 0.527 . . . . 75.51 110.301 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -90.1 113.68 25.46 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.275 1.03 . . . . 63.05 108.75 -173.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -98.04 114.31 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.222 0.609 . . . . 74.42 109.517 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.464 HD22 ' HG2' ' A' ' 54' ' ' LYS . 42.4 mt -101.04 99.99 10.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.23 -1.026 . . . . 72.14 108.23 176.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.5 ' CD1' HG12 ' A' ' 84' ' ' VAL . 32.6 t90 -103.27 131.63 50.17 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.959 -0.756 . . . . 73.14 108.959 174.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -91.99 126.61 37.15 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.151 -1.055 . . . . 75.35 108.151 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.9 p -73.17 141.43 81.03 Favored Pre-proline 0 C--O 1.244 0.816 0 N-CA-C 109.381 -0.6 . . . . 53.11 109.381 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.69 -23.55 33.5 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.471 2.78 . . . . 72.31 113.877 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.4 m -64.17 -54.78 28.24 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.646 0.779 . . . . 75.51 110.928 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.18 32.32 0.1 Allowed Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.351 -0.386 . . . . 74.53 113.614 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -114.69 173.53 6.43 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.607 0.763 . . . . 73.34 109.542 173.225 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.0 105.05 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.446 -0.946 . . . . 74.22 108.446 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 73' ' ' LYS . 21.2 mt -83.34 110.23 17.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.236 -1.024 . . . . 74.33 108.236 172.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.464 ' HG2' HD22 ' A' ' 44' ' ' LEU . 51.7 mtpt -94.46 139.74 30.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.003 -0.74 . . . . 70.43 109.003 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.65 -171.28 19.36 Favored Glycine 0 N--CA 1.463 0.493 0 O-C-N 123.455 0.472 . . . . 44.03 112.297 -173.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -151.94 133.99 15.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.957 0.503 . . . . 71.31 110.052 -178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 67' ' ' VAL . 73.6 mt -69.32 98.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.729 -0.841 . . . . 71.24 108.729 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.37 -33.44 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.183 0.593 . . . . 64.45 111.019 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -148.78 167.61 25.14 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.349 -0.982 . . . . 62.22 108.349 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 m -103.01 170.63 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.394 0.678 . . . . 65.43 109.229 172.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -132.57 122.57 24.97 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.522 -0.918 . . . . 73.1 108.522 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.67 -153.95 52.4 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.92 0.763 . . . . 53.22 113.072 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.511 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 73.6 p -116.76 -11.47 10.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.193 0.997 . . . . 71.44 111.193 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 73.0 mmtt -98.73 52.94 1.0 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.229 0.537 . . . . 64.14 112.091 -172.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.421 ' HA2' HG12 ' A' ' 29' ' ' VAL . . . 71.38 -0.4 33.3 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 117.312 1.685 . . . . 61.13 117.312 163.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.46 124.85 28.85 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.91 0.855 . . . . 61.21 109.582 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.7 m -103.25 160.12 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.371 0.668 . . . . 64.43 109.918 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -119.79 104.29 10.09 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.703 1.201 . . . . 64.24 108.499 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.12 127.41 54.14 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.447 0.699 . . . . 72.13 110.864 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' HD2' HG22 ' A' ' 21' ' ' VAL . 7.8 mmm180 -89.61 111.5 22.46 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.59 1.156 . . . . 70.41 109.611 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -92.08 166.33 12.72 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.056 0.542 . . . . 72.22 111.047 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 7.8 pt-20 -67.29 -39.05 85.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.937 0.895 . . . . 74.15 110.466 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 14.4 mmmm -118.8 -69.16 0.87 Allowed 'General case' 0 C--N 1.345 0.375 0 C-N-CA 124.089 0.956 . . . . 55.12 109.398 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.656 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 71.93 57.86 5.57 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 123.924 0.765 . . . . 53.24 111.231 -173.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.33 124.51 89.99 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.758 0.823 . . . . 74.22 111.22 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.59 174.57 8.24 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.335 2.69 . . . . 73.34 112.71 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.33 172.1 13.13 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.341 -0.704 . . . . 53.05 111.341 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -86.48 68.91 10.34 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.508 1.147 . . . . 75.34 109.618 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.09 17.51 17.72 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.468 -1.242 . . . . 63.32 109.714 175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 9' ' ' SER . 41.2 mt -76.41 121.88 23.7 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.92 0.888 . . . . 63.43 109.486 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.48 -6.98 14.14 Favored Glycine 0 N--CA 1.469 0.849 0 N-CA-C 111.966 -0.454 . . . . 73.33 111.966 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.58 155.64 29.55 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.814 0.846 . . . . 65.45 109.86 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.449 ' HE2' HD11 ' A' ' 27' ' ' LEU . 62.1 m-85 -91.33 133.09 35.73 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.94 0.496 . . . . 73.51 111.448 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 45' ' ' TRP . 6.7 m -100.01 149.39 5.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 N-CA-C 107.632 -1.248 . . . . 72.15 107.632 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.544 ' HB3' ' HD2' ' A' ' 2' ' ' ARG . 8.5 mm-40 -111.34 106.73 15.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.053 -1.091 . . . . 73.34 108.053 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.682 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 62.2 mt -96.94 104.63 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.444 0.697 . . . . 71.41 109.235 -173.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.9 t -95.31 134.75 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.221 1.008 . . . . 61.22 110.103 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 107.302 -1.37 . . . . 64.31 107.302 168.777 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 106.845 -1.539 . . . . 54.3 106.845 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 28' ' ' ASP . 50.9 mt -94.67 125.86 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.275 -0.639 . . . . 63.23 109.275 -175.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -88.67 133.29 34.25 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.466 -0.939 . . . . 71.31 108.466 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.98 166.19 22.13 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.361 0.413 . . . . 71.3 112.13 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.61 135.2 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.193 0.997 . . . . 70.21 109.173 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.76 114.53 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.568 0.747 . . . . 74.31 110.292 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 25' ' ' LYS . 89.6 mt -81.79 -61.2 1.99 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.358 0.663 . . . . 75.43 110.843 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.2 t -152.46 160.5 43.26 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.849 -0.614 . . . . 71.32 110.37 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -91.02 157.55 17.2 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.361 0.601 . . . . 74.31 111.182 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.486 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.6 tpp180 . . . . . 0 C--O 1.238 0.495 0 N-CA-C 106.263 -1.754 . . . . 61.55 106.263 163.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 . . . . . 0 C--O 1.241 0.629 0 N-CA-C 109.31 -0.626 . . . . 72.01 109.31 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 70' ' ' ARG . 5.1 t -96.96 150.62 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 108.464 -0.939 . . . . 63.22 108.464 -176.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -154.79 140.88 18.43 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.758 0.313 . . . . 72.3 110.77 168.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 8' ' ' LEU . 45.4 mm -77.17 120.48 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.307 -0.861 . . . . 72.3 108.682 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.4 mt -115.45 147.83 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.35 1.06 . . . . 61.35 108.84 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 8' ' ' LEU . 86.6 tttt -108.13 101.8 43.3 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 123.821 0.848 . . . . 74.52 109.424 171.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' HG22 ' A' ' 67' ' ' VAL . 17.7 Cg_endo -60.58 115.97 3.03 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 122.067 1.845 . . . . 62.41 110.067 165.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.38 -34.07 71.97 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.159 0.984 . . . . 72.24 112.132 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 3' ' ' ILE . 22.2 t70 -69.31 -27.73 65.64 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.253 1.021 . . . . 73.12 111.899 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 34' ' ' GLU . 25.9 t -113.09 119.06 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.235 1.014 . . . . 55.3 111.24 -170.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -120.36 -5.52 9.87 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.116 0.566 . . . . 72.32 111.893 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 69.2 m -111.18 152.86 26.57 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.038 0.535 . . . . 64.32 110.347 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.589 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 55.6 ttt85 -64.27 -35.36 80.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 73.13 111.826 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.62 -38.72 84.3 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.951 0.5 . . . . 73.04 110.7 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HB2' HG13 ' A' ' 29' ' ' VAL . 33.8 mt-10 -67.39 -31.77 72.22 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.114 -0.948 . . . . 72.3 110.07 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.22 -23.05 32.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.977 0.911 . . . . 71.52 111.218 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.4 t -79.42 -27.6 41.73 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.769 0.828 . . . . 64.35 110.086 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -80.16 -9.19 59.7 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.329 -0.396 . . . . 74.45 110.758 170.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.432 HD21 HD12 ' A' ' 3' ' ' ILE . 47.2 mt -89.61 -3.45 58.27 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.139 0.576 . . . . 64.52 111.987 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.683 HD11 HG13 ' A' ' 60' ' ' VAL . 49.7 mm -63.65 107.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.242 -0.651 . . . . 64.41 109.242 174.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.1 5.4 30.62 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.323 -0.71 . . . . 72.32 114.145 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.436 ' HD2' HD22 ' A' ' 88' ' ' LEU . 28.9 mmt180 -84.72 159.72 20.46 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.364 1.082 . . . . 74.43 111.373 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 54' ' ' LYS . 61.0 tp -90.83 117.19 29.25 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.29 1.036 . . . . 75.51 109.331 -175.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 t -107.35 117.14 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.204 -0.665 . . . . 63.31 109.204 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -101.15 104.44 15.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.641 0.776 . . . . 75.22 109.529 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -91.75 141.95 28.12 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.554 -0.536 . . . . 73.2 109.554 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -103.08 108.95 20.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.962 -1.017 . . . . 73.35 108.87 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.2 p -60.3 160.82 15.57 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.731 0.813 . . . . 74.41 111.036 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.9 -21.67 71.65 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.937 2.424 . . . . 71.35 112.613 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.3 m -77.51 -6.96 55.44 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.017 0.927 . . . . 64.2 111.765 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.65 3.64 77.29 Favored Glycine 0 C--N 1.35 1.342 0 C-N-CA 123.197 0.427 . . . . 64.55 112.863 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -85.77 156.47 20.59 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.007 0.923 . . . . 74.03 108.898 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.8 mt -117.62 114.35 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.594 0.358 . . . . 62.25 110.367 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 73' ' ' LYS . 31.5 mt -92.25 150.58 20.8 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.723 -0.843 . . . . 74.25 108.723 173.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB3' HD11 ' A' ' 42' ' ' LEU . 23.5 mtmm -98.22 156.15 16.83 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.717 -0.475 . . . . 75.53 109.717 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.8 -174.97 29.21 Favored Glycine 0 C--O 1.239 0.441 0 N-CA-C 111.036 -0.825 . . . . 50.33 111.036 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -152.87 136.17 15.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 111.758 0.281 . . . . 70.24 111.758 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.411 HD11 HD13 ' A' ' 86' ' ' ILE . 78.2 mt -69.2 102.82 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.622 0 O-C-N 124.038 0.836 . . . . 70.54 108.895 171.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -84.29 -28.35 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.329 -0.851 . . . . 74.53 110.711 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -164.03 165.32 22.55 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.811 0.844 . . . . 74.1 109.396 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.683 HG13 HD11 ' A' ' 39' ' ' ILE . 35.4 m -92.8 169.41 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.508 0.723 . . . . 75.3 110.522 174.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -127.6 104.59 7.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.295 1.038 . . . . 73.34 109.223 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.49 -153.01 52.89 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.851 -0.613 . . . . 61.32 113.154 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 32.5 p -111.83 -0.63 15.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.789 0.836 . . . . 72.32 111.831 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -83.78 5.88 23.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.47 0.708 . . . . 72.32 112.425 -168.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.28 -16.37 57.61 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-O 119.909 -0.384 . . . . 75.3 113.063 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.68 122.55 14.41 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.613 0.765 . . . . 42.24 110.018 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.4 HG22 ' HD3' ' A' ' 26' ' ' PRO . 35.9 m -102.84 175.06 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.955 0.902 . . . . 74.54 110.632 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -128.5 111.39 13.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.278 1.031 . . . . 65.14 108.592 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.8 133.02 56.52 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.381 0.672 . . . . 63.11 110.774 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.553 ' HG2' HG22 ' A' ' 21' ' ' VAL . 97.0 mtt180 -103.75 128.85 51.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.947 0.899 . . . . 75.12 109.095 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -106.11 134.6 48.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.494 0.717 . . . . 73.04 110.743 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.566 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 20.8 pt-20 -51.58 -48.09 63.3 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 124.89 1.369 . . . . 72.33 112.552 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.566 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 13.4 mmmm -92.93 -39.5 11.11 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.152 0.581 . . . . 73.2 109.478 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.99 55.0 28.11 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 124.284 0.99 . . . . 64.41 113.908 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.62 124.09 89.25 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.054 0.541 . . . . 74.52 110.591 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.14 150.67 33.67 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.107 2.538 . . . . 60.14 112.129 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.09 -151.79 14.6 Favored Glycine 0 C--N 1.344 0.972 0 N-CA-C 111.33 -0.708 . . . . 73.54 111.33 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -113.03 73.89 0.84 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.218 1.009 . . . . 73.43 108.882 172.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.27 -9.76 59.37 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.383 -1.28 . . . . 75.34 112.617 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.6 mt -61.24 115.1 3.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.621 0.768 . . . . 75.33 110.716 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.68 -18.87 49.29 Favored Glycine 0 N--CA 1.473 1.148 0 CA-C-N 116.465 -0.334 . . . . 73.33 112.826 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.08 163.49 27.06 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.698 0.799 . . . . 62.11 110.442 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -105.05 148.71 26.48 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.751 0.786 . . . . 55.22 112.279 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.14 164.45 17.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 114.35 -1.295 . . . . 75.31 108.269 171.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.13 107.66 11.0 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.008 -0.738 . . . . 62.31 109.008 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.411 HD13 HD11 ' A' ' 57' ' ' ILE . 57.4 mt -82.72 92.23 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.0 -1.111 . . . . 74.34 108.0 177.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.2 t -79.53 141.82 14.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 114.421 -1.263 . . . . 73.42 108.837 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' HD2' ' A' ' 41' ' ' ARG . 1.0 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 107.66 -1.237 . . . . 53.22 107.66 171.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 107.647 -1.242 . . . . 75.45 107.647 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.24 139.85 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.464 0.706 . . . . 71.44 109.142 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -88.14 119.16 28.26 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.283 -1.006 . . . . 51.21 108.283 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -116.98 168.84 12.89 Favored Glycine 0 C--N 1.34 0.802 0 O-C-N 123.673 0.608 . . . . 64.33 111.583 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.43 130.29 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.958 0.903 . . . . 53.21 109.175 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.2 t -68.11 104.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.095 0.958 . . . . 74.14 109.348 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 25' ' ' LYS . 83.1 mt -84.29 -55.13 4.34 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.462 0.305 . . . . 73.23 110.807 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m -154.22 170.27 21.65 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.524 0.564 . . . . 62.34 112.524 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -122.58 157.56 31.86 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.053 1.341 . . . . 71.3 109.193 170.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.55 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.7 tpt180 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 107.656 -1.238 . . . . 75.1 107.656 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 110.315 -0.254 . . . . 65.31 110.315 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 85.8 t -86.41 145.0 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.32 -0.993 . . . . 63.55 108.32 -171.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.3 ttt -137.56 109.49 7.17 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.791 -1.559 . . . . 62.44 106.791 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.448 HG22 HD12 ' A' ' 8' ' ' LEU . 45.5 mm -81.14 120.32 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 107.119 -1.437 . . . . 64.23 107.119 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.409 HG21 HG21 ' A' ' 84' ' ' VAL . 85.5 mt -127.65 146.64 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.49 1.116 . . . . 63.03 108.319 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HB2' HD11 ' A' ' 8' ' ' LEU . 41.1 ttmt -118.68 112.84 36.66 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 109.292 -0.632 . . . . 71.01 109.292 168.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 17.2 Cg_exo -62.65 126.2 17.76 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.057 1.838 . . . . 63.24 110.229 168.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.76 -27.45 69.29 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.715 0.806 . . . . 71.54 111.7 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.76 -27.13 66.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.41 1.084 . . . . 75.21 111.868 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 34' ' ' GLU . 71.6 t -106.72 128.0 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.964 0.906 . . . . 72.33 111.823 -169.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -127.9 5.01 5.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.53 1.132 . . . . 61.2 110.839 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -132.48 157.79 43.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.477 0.711 . . . . 71.24 110.53 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 68.9 ttt180 -64.13 -42.92 96.62 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.769 0.827 . . . . 65.01 111.101 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.54 -38.88 92.53 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.867 0.73 . . . . 75.14 111.148 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HB2' HG13 ' A' ' 29' ' ' VAL . 41.0 mt-10 -64.94 -34.02 77.42 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 124.117 0.886 . . . . 72.31 110.448 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.497 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -82.08 -26.39 33.69 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.098 0.959 . . . . 52.33 111.537 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 t -82.06 -23.81 35.62 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.907 0.883 . . . . 61.11 110.931 -172.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.73 1.29 39.46 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.59 0.356 . . . . 75.42 110.834 170.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 75.7 mt -102.22 11.88 37.54 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.431 0.693 . . . . 54.53 111.343 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.543 HD11 HG13 ' A' ' 60' ' ' VAL . 49.9 mm -73.99 130.82 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 109.49 -0.559 . . . . 62.22 109.49 174.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.23 1.39 75.55 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.029 -0.532 . . . . 65.4 112.532 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.581 ' HG3' ' HA ' ' A' ' 88' ' ' LEU . 5.6 mpt_? -81.64 138.58 35.29 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.079 0.552 . . . . 74.44 109.98 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 55' ' ' GLY . 67.2 tp -90.37 113.56 25.47 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.63 -0.878 . . . . 74.12 108.63 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 t -98.09 116.05 39.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 123.427 0.691 . . . . 64.45 109.254 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.3 mt -102.01 129.19 48.24 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.464 1.106 . . . . 62.22 108.549 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -142.38 127.38 18.4 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.14 0.576 . . . . 74.02 109.484 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -89.76 115.24 26.97 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.123 -0.695 . . . . 74.52 109.123 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -64.71 158.45 68.5 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.823 0.849 . . . . 75.52 111.006 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -59.33 -20.17 54.38 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.465 2.776 . . . . 61.13 113.432 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.6 m -75.15 -3.28 31.93 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.89 0.876 . . . . 64.43 112.234 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.87 9.76 80.23 Favored Glycine 0 C--N 1.353 1.525 0 C-N-CA 123.069 0.366 . . . . 51.13 112.936 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -96.16 132.16 41.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.583 0.753 . . . . 74.31 110.001 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.1 mt -85.55 101.87 10.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-O 121.3 0.571 . . . . 72.1 109.613 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 75' ' ' LEU . 13.5 mt -80.97 128.49 33.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.462 -0.79 . . . . 71.1 108.879 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -117.43 132.47 56.56 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.106 0.963 . . . . 54.53 109.123 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -154.95 -177.79 28.6 Favored Glycine 0 C--N 1.336 0.55 0 O-C-N 123.635 0.584 . . . . 52.43 112.177 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -151.77 136.67 17.23 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.115 0.413 . . . . 74.42 112.115 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 39' ' ' ILE . 64.7 mt -67.94 103.62 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.935 0.894 . . . . 74.15 109.568 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.27 -30.83 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.532 -0.758 . . . . 73.45 111.547 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -163.95 160.45 21.98 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.62 0.768 . . . . 71.44 109.254 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.543 HG13 HD11 ' A' ' 39' ' ' ILE . 20.2 m -101.18 170.48 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.847 0.859 . . . . 73.01 111.065 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -131.3 103.14 6.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.06 0.944 . . . . 75.4 109.021 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.66 -166.85 26.08 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.74 -0.664 . . . . 72.25 114.452 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.429 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 75.7 p -90.77 8.56 34.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.382 1.073 . . . . 65.44 111.333 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -79.84 -2.72 44.71 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.871 0.869 . . . . 72.42 111.783 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.24 -4.89 61.23 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-O 120.103 -0.276 . . . . 52.53 113.645 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.96 112.28 5.51 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 123.429 0.692 . . . . 73.35 109.635 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 m -100.19 143.77 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.04 0.936 . . . . 75.11 109.153 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -101.72 103.07 13.82 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.322 -0.992 . . . . 63.33 108.322 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.82 120.28 41.58 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.556 0.742 . . . . 74.02 109.935 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -88.8 106.31 18.29 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.973 0.509 . . . . 73.34 109.699 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -88.15 120.99 30.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.632 -0.877 . . . . 74.14 108.632 170.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.42 -20.71 60.66 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.134 0.492 . . . . 70.22 109.876 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -76.68 -77.64 0.14 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.641 0.777 . . . . 73.43 109.197 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.1 45.01 63.42 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.646 0.591 . . . . 53.11 114.395 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.44 ' HB2' HD21 ' A' ' 53' ' ' LEU . 81.7 mt -73.15 157.08 88.88 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.759 0.824 . . . . 74.42 111.195 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.08 124.08 14.51 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 123.402 2.735 . . . . 75.44 113.273 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.09 87.74 0.08 OUTLIER Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.776 -1.33 . . . . 74.35 109.776 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -73.92 71.43 1.54 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.092 0.957 . . . . 65.21 109.846 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.05 29.01 8.16 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.445 1.098 . . . . 75.02 110.685 -169.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 mt -52.46 118.46 3.6 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.5 0.72 . . . . 64.25 110.378 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.07 -10.51 15.17 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 112.01 -0.436 . . . . 63.13 112.01 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -77.23 169.56 18.11 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.876 0.87 . . . . 70.44 109.678 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 63.0 m-85 -112.26 127.47 55.98 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.639 0.376 . . . . 75.43 111.952 -170.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 24' ' ' ILE . 15.2 m -100.38 162.72 3.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-N 115.171 -0.922 . . . . 72.0 109.824 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -111.62 108.99 18.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.905 0.882 . . . . 74.14 108.681 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.1 mt -92.18 92.9 3.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.1 -1.074 . . . . 72.05 108.1 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.81 134.03 27.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.082 -0.963 . . . . 64.44 109.09 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.581 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 4.4 mm? . . . . . 0 C--O 1.241 0.615 0 C-N-CA 123.751 0.82 . . . . 62.55 110.608 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.751 0.31 . . . . 64.14 110.364 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 40.1 mt -132.57 128.83 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.686 -1.227 . . . . 73.14 107.686 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -87.79 128.18 35.33 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.941 -0.763 . . . . 74.01 108.941 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 25' ' ' LYS . . . -124.74 142.44 13.94 Favored Glycine 0 C--N 1.34 0.799 0 O-C-N 123.914 0.759 . . . . 60.2 111.486 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -92.76 131.04 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.511 0.655 . . . . 72.41 109.906 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.8 97.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.951 0.9 . . . . 63.32 109.251 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.478 HD21 ' HE2' ' A' ' 25' ' ' LYS . 81.5 mt -77.34 -53.45 7.67 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.673 -0.492 . . . . 71.3 109.673 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -165.11 179.19 6.49 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.847 0.356 . . . . 60.51 111.411 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -129.96 134.8 47.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.793 1.237 . . . . 73.43 108.298 174.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.407 ' HD3' HD11 ' A' ' 23' ' ' ILE . 2.6 mpt_? . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.072 -1.455 . . . . 73.31 107.072 163.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 110.001 -0.37 . . . . 62.34 110.001 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 70' ' ' ARG . 42.6 t -87.77 144.13 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.696 0.799 . . . . 55.15 109.56 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.6 ttt -131.15 117.16 18.68 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.168 -1.049 . . . . 71.12 108.168 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.459 HG22 HD12 ' A' ' 8' ' ' LEU . 28.0 mm -77.29 111.44 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.625 -0.879 . . . . 71.54 108.625 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.1 mt -112.74 145.6 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.403 1.081 . . . . 70.41 109.302 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HE2' HD21 ' A' ' 8' ' ' LEU . 22.6 ttmm -111.65 87.55 8.29 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.347 1.059 . . . . 72.03 109.012 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' HG22 ' A' ' 67' ' ' VAL . 32.2 Cg_endo -62.23 107.48 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.95 1.767 . . . . 73.03 110.212 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.13 -32.48 73.87 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.507 1.123 . . . . 62.42 112.073 -174.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.89 -26.11 68.63 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.335 1.054 . . . . 64.33 111.464 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.496 HG13 ' HB2' ' A' ' 34' ' ' GLU . 66.2 t -112.43 137.57 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 125.195 1.398 . . . . 72.54 111.489 -171.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -134.84 8.66 3.55 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.657 1.183 . . . . 72.01 110.504 170.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.5 m -124.37 147.27 48.34 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.773 0.829 . . . . 62.43 110.609 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.486 ' HD2' HG22 ' A' ' 63' ' ' THR . 71.2 ttt180 -67.81 -34.02 75.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.691 0.796 . . . . 75.33 111.193 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -67.1 -43.0 83.64 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.485 0.714 . . . . 62.14 110.485 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.496 ' HB2' HG13 ' A' ' 29' ' ' VAL . 27.2 mm-40 -72.77 -22.91 60.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.165 -0.925 . . . . 72.31 110.961 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.96 -32.58 30.67 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.554 0.742 . . . . 71.35 110.165 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.0 t -75.71 -24.47 56.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.573 0.749 . . . . 71.11 111.385 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -81.39 -2.29 48.79 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 122.311 -0.243 . . . . 71.42 111.224 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.402 HD12 HG11 ' A' ' 67' ' ' VAL . 53.3 mt -88.68 -12.15 43.21 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 123.331 0.652 . . . . 72.03 111.185 175.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.624 HD11 HG13 ' A' ' 60' ' ' VAL . 42.1 mm -65.79 104.57 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.084 0 C-N-CA 123.183 0.593 . . . . 75.31 110.174 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.13 -6.34 10.95 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.447 -0.641 . . . . 63.42 112.93 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -84.11 155.32 22.69 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 117.756 0.778 . . . . 75.43 111.257 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 54' ' ' LYS . 58.8 tp -93.14 117.26 29.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.49 1.116 . . . . 65.41 109.983 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.34 135.33 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.359 -0.608 . . . . 61.32 109.359 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.7 mt -118.37 105.15 11.42 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.392 1.077 . . . . 73.34 108.128 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 44.8 t90 -110.23 128.4 55.48 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.644 -0.873 . . . . 53.4 108.644 171.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -98.25 117.43 32.62 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.674 -0.861 . . . . 64.24 108.674 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.3 p -74.56 162.36 73.99 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 124.024 0.93 . . . . 74.54 111.29 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.19 -14.55 45.75 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.973 2.448 . . . . 75.24 112.465 171.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -73.3 -19.38 61.05 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.707 1.203 . . . . 53.41 111.879 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.06 5.33 60.9 Favored Glycine 0 C--N 1.356 1.693 0 C-N-CA 123.437 0.542 . . . . 70.2 112.733 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -94.24 118.32 31.41 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.88 0.872 . . . . 62.42 109.817 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.85 97.2 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.017 -1.105 . . . . 72.23 108.017 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 mt -73.64 123.2 23.57 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.958 -1.127 . . . . 73.44 107.958 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.552 ' HB3' HD11 ' A' ' 42' ' ' LEU . 31.0 mtmm -104.26 140.53 37.73 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.32 -0.622 . . . . 72.05 109.32 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.93 173.42 25.42 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 116.207 -0.451 . . . . 75.33 112.112 -178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -127.57 131.77 49.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.071 -0.715 . . . . 72.4 109.071 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.563 HG22 HD13 ' A' ' 39' ' ' ILE . 62.8 mt -67.61 99.89 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 108.499 -0.926 . . . . 71.34 108.499 171.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.76 -34.31 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 115.256 -0.883 . . . . 73.42 111.24 -176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -154.2 157.11 38.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.786 -0.82 . . . . 71.05 108.786 -173.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.624 HG13 HD11 ' A' ' 39' ' ' ILE . 27.2 m -91.71 168.82 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.659 0.784 . . . . 74.52 110.05 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 68' ' ' ARG . 82.9 t60 -132.81 103.28 6.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.964 -1.125 . . . . 73.33 107.964 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.2 -162.76 49.0 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.379 -0.373 . . . . 53.31 113.181 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.486 HG22 ' HD2' ' A' ' 32' ' ' ARG . 73.5 p -110.96 -24.01 10.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.591 0.756 . . . . 64.33 112.18 -172.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -91.83 46.7 1.29 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.803 0.668 . . . . 63.22 112.803 -170.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA2' HG12 ' A' ' 29' ' ' VAL . . . 68.74 55.75 10.87 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.771 -0.65 . . . . 62.4 114.056 170.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.39 141.99 49.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.214 -1.032 . . . . 64.31 108.214 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 26' ' ' PRO . 22.1 m -130.85 171.94 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.141 0.977 . . . . 71.23 109.894 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HG3' ' HB2' ' A' ' 61' ' ' HIS . 73.0 mtm180 -134.35 109.1 8.57 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.218 1.007 . . . . 71.34 109.091 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.89 127.25 53.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.257 -0.883 . . . . 52.32 110.278 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HG2' HG22 ' A' ' 21' ' ' VAL . 33.8 mtm180 -90.27 110.06 21.13 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.254 -0.647 . . . . 75.24 109.254 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.29 142.11 29.6 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.236 1.014 . . . . 71.04 110.173 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.526 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 11.0 pt-20 -50.04 -45.36 52.13 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.568 1.547 . . . . 73.1 111.885 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.526 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 32.8 mmtp -96.48 -46.94 6.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.371 -0.831 . . . . 74.42 108.854 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.6 45.69 92.93 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 124.589 1.181 . . . . 50.2 112.87 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.0 140.58 86.0 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.147 0.579 . . . . 54.22 110.696 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.16 123.93 13.04 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.153 2.569 . . . . 73.3 111.88 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -110.65 131.91 10.66 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.934 -0.575 . . . . 70.44 111.94 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -83.24 3.9 29.21 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.038 0.935 . . . . 70.23 110.297 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -94.43 29.86 2.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.693 1.197 . . . . 71.45 112.014 -177.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.7 mt -53.11 108.68 0.35 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 122.7 0.4 . . . . 73.05 110.54 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.58 -10.63 7.59 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 123.836 0.731 . . . . 72.45 112.53 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.91 163.58 27.74 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.309 1.044 . . . . 72.24 111.64 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -96.71 124.63 40.75 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.526 0.73 . . . . 74.44 110.64 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 m -99.67 149.11 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.872 1.269 . . . . 72.11 107.748 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -108.73 107.36 17.78 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.839 -0.801 . . . . 72.42 108.839 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 53.6 mt -89.57 90.9 3.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.097 -1.446 . . . . 73.34 107.097 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.69 150.68 3.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 114.816 -1.084 . . . . 75.13 109.079 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.472 0.658 0 C-N-CA 123.22 0.608 . . . . 64.12 110.854 174.793 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.638 ' HG2' HG22 ' A' ' 87' ' ' VAL . 61.4 mtt180 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 107.256 -1.387 . . . . 63.12 107.256 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.479 HD12 HH11 ' A' ' 41' ' ' ARG . 61.5 mt -109.29 128.75 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.07 -1.085 . . . . 54.53 108.07 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -86.73 121.47 29.28 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.146 -0.687 . . . . 70.21 109.146 -170.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -127.44 169.63 19.22 Favored Glycine 0 C--N 1.341 0.847 0 O-C-N 124.003 0.814 . . . . 74.31 111.66 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.1 t -133.27 133.69 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.262 1.025 . . . . 53.31 109.167 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.97 102.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.539 0.736 . . . . 72.44 109.846 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 25' ' ' LYS . 86.7 mt -70.85 -53.86 13.65 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.688 -0.687 . . . . 73.51 109.471 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 t -158.61 168.83 25.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.759 -0.655 . . . . 71.34 111.113 -176.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -107.74 142.97 36.93 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.289 1.036 . . . . 73.0 108.752 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 . . . . . 0 C--O 1.22 -0.493 0 N-CA-C 107.205 -1.406 . . . . 73.13 107.205 169.632 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.527 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 5.9 t30 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.288 -0.634 . . . . 71.13 109.288 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 70' ' ' ARG . 22.0 t -89.27 104.68 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 106.451 -1.685 . . . . 74.34 106.451 172.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 47.7 ttm -93.27 130.15 39.09 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 122.681 0.392 . . . . 73.51 110.758 -171.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.455 HG22 HD12 ' A' ' 8' ' ' LEU . 32.9 mm -81.04 102.18 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.448 -0.945 . . . . 71.4 108.448 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -109.07 147.25 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.281 1.032 . . . . 62.25 109.009 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HB2' HD11 ' A' ' 8' ' ' LEU . 39.5 ttmt -118.35 102.37 50.41 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 108.622 -0.881 . . . . 65.3 108.622 167.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 18.1 Cg_endo -61.96 111.27 1.18 Allowed 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 121.545 1.497 . . . . 75.54 109.287 167.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.4 mt -55.39 -32.09 62.36 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.221 1.008 . . . . 54.33 112.266 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.14 -30.12 68.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.131 0.972 . . . . 61.32 111.718 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 34' ' ' GLU . 93.6 t -107.1 117.89 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.195 0.998 . . . . 74.42 110.13 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -121.19 4.63 10.33 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.36 0.664 . . . . 54.11 111.522 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.516 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 6.0 m -130.24 145.36 51.74 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.272 0.629 . . . . 70.21 109.69 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.666 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 73.3 ttt180 -59.09 -46.65 87.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.769 0.827 . . . . 64.52 111.302 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.25 -39.97 84.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 123.924 0.765 . . . . 73.21 111.719 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HB2' HG13 ' A' ' 29' ' ' VAL . 47.4 mt-10 -59.99 -49.79 76.29 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.172 0.92 . . . . 64.44 109.647 176.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -71.53 -24.02 61.88 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.128 0.971 . . . . 74.33 111.947 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -73.29 -39.19 65.53 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.749 0.82 . . . . 71.25 110.68 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -77.74 -10.36 59.49 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.412 -0.358 . . . . 71.11 110.976 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.61 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 55.6 mt -97.74 26.71 4.87 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.486 1.115 . . . . 73.4 111.625 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.663 HD11 HG13 ' A' ' 60' ' ' VAL . 45.2 mm -85.76 135.98 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 109.191 -0.67 . . . . 71.32 109.191 172.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.55 -7.24 39.25 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.579 -0.567 . . . . 75.31 113.517 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.61 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 16.5 ptt180 -80.59 154.17 27.6 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.223 0.511 . . . . 72.21 110.372 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 54' ' ' LYS . 60.8 tp -90.93 146.59 23.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.127 0.971 . . . . 75.12 109.408 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.548 HG22 HG23 ' A' ' 86' ' ' ILE . 47.4 t -122.19 125.82 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.851 0.86 . . . . 71.52 109.279 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.0 mt -103.79 100.26 10.06 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.855 -0.795 . . . . 74.52 108.855 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.432 ' HE1' ' HB3' ' A' ' 82' ' ' ASP . 32.7 t90 -104.52 147.95 27.03 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.934 0.894 . . . . 75.42 109.439 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -99.63 109.05 21.57 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.348 -0.982 . . . . 74.1 108.348 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.4 p -68.93 154.13 95.31 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.805 0.842 . . . . 73.42 111.045 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HG3' ' HB2' ' A' ' 79' ' ' ALA . 46.2 Cg_exo -59.98 -13.29 22.33 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.391 2.727 . . . . 74.35 113.506 172.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -81.37 -5.01 57.41 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.782 0.833 . . . . 71.44 111.606 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.08 -10.56 71.72 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-O 119.986 -0.341 . . . . 51.43 113.429 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -82.35 154.46 25.26 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.657 0.783 . . . . 62.31 110.373 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -102.29 103.64 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.383 -0.969 . . . . 71.24 108.383 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 74' ' ' GLY . 56.7 mt -82.43 153.41 25.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.367 -0.833 . . . . 73.42 110.892 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HB3' HD11 ' A' ' 42' ' ' LEU . 59.0 mtpt -117.03 117.0 28.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.529 -1.214 . . . . 34.25 108.02 -176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -128.2 132.82 7.5 Favored Glycine 0 CA--C 1.503 -0.672 0 N-CA-C 111.549 -0.62 . . . . 73.02 111.549 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -101.66 128.18 48.07 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 117.439 0.62 . . . . 74.45 109.86 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.411 HD12 ' HG3' ' A' ' 41' ' ' ARG . 78.9 mt -66.8 106.94 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 124.211 0.944 . . . . 71.31 109.373 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -84.31 -30.3 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.032 0.933 . . . . 71.22 111.162 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -168.4 167.27 11.98 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.126 0.571 . . . . 75.12 110.209 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.663 HG13 HD11 ' A' ' 39' ' ' ILE . 23.9 m -91.37 169.96 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.322 1.049 . . . . 50.24 111.292 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -141.57 105.56 4.77 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.84 1.256 . . . . 70.24 108.558 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.22 173.52 49.74 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.729 -0.214 . . . . 64.34 112.64 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.666 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 63.2 p -93.0 6.93 46.16 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.707 0.803 . . . . 74.32 111.372 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -93.67 14.96 17.46 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.185 0.994 . . . . 75.14 111.874 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.18 -4.65 70.5 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-O 119.722 -0.488 . . . . 65.2 113.959 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.97 143.89 55.42 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.379 0.672 . . . . 70.13 110.332 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 60' ' ' VAL . 14.0 m -126.49 169.91 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.678 1.191 . . . . 72.34 110.989 -175.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -128.13 107.64 9.97 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.221 1.008 . . . . 74.25 109.327 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.5 125.86 51.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.787 0.835 . . . . 44.41 110.141 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.555 ' HG2' HG22 ' A' ' 21' ' ' VAL . 88.3 mtt180 -89.0 104.51 17.05 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.246 -0.65 . . . . 70.3 109.246 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.77 135.42 34.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.013 0.925 . . . . 73.54 109.173 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -31.16 62.69 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.408 1.083 . . . . 64.23 112.075 -174.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -107.44 -63.11 1.34 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.082 0.953 . . . . 72.41 109.357 173.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 67.57 56.9 9.96 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.206 -0.907 . . . . 23.13 111.421 -171.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 97.0 mt -68.36 132.78 91.35 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.25 1.02 . . . . 72.11 111.257 -170.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 3.9 Cg_exo -76.48 176.35 10.19 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 123.216 2.611 . . . . 74.41 112.979 -170.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.02 177.69 15.03 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.766 -0.652 . . . . 72.43 111.595 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.8 76.46 7.98 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.894 0.854 . . . . 74.55 109.567 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . . . -119.75 28.03 8.37 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.982 -1.008 . . . . 73.25 110.201 172.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.08 109.14 4.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.343 -0.614 . . . . 73.12 109.343 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.15 -5.86 21.72 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-O 119.649 -0.529 . . . . 72.42 112.331 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 13.2 t70 -67.05 143.42 56.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.504 0.722 . . . . 71.53 110.074 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -93.69 123.99 37.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.693 0.797 . . . . 74.3 110.87 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 m -100.69 144.04 13.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.472 -0.785 . . . . 72.44 109.065 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.95 108.04 19.01 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.426 -0.953 . . . . 74.42 108.426 170.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.548 HG23 HG22 ' A' ' 43' ' ' VAL . 38.8 mt -89.04 97.97 7.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 115.067 -0.969 . . . . 73.1 108.858 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.638 HG22 ' HG2' ' A' ' 2' ' ' ARG . 13.0 t -89.89 131.39 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.675 -0.693 . . . . 74.42 110.316 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 106.822 -1.547 . . . . 72.45 106.822 172.553 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.429 ' HG2' ' HB3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.074 -0.713 . . . . 70.02 109.074 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 56.6 mt -105.55 128.95 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.739 -1.208 . . . . 73.12 107.739 170.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -88.65 124.27 33.92 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.165 0.507 . . . . 72.23 110.009 -174.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -121.54 135.23 10.42 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.702 -0.681 . . . . 75.23 111.876 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.7 t -90.22 132.82 33.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 117.737 0.769 . . . . 74.55 109.988 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.85 103.06 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.721 0 O-C-N 124.504 1.127 . . . . 71.14 109.482 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 25' ' ' LYS . 71.8 mt -78.32 -56.09 4.73 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.547 0.529 . . . . 75.42 109.776 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 m -152.85 170.21 20.9 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.453 0.644 . . . . 71.35 111.712 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -117.81 147.46 43.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.589 1.156 . . . . 71.53 108.152 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 65.7 ttt180 . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 110.103 -0.332 . . . . 74.42 110.103 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 110.221 -0.289 . . . . 73.22 110.221 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 50.3 t -102.5 152.33 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.31 1.044 . . . . 72.24 108.867 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.1 ttt -150.04 129.78 13.24 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.399 -0.593 . . . . 73.4 109.399 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.431 HG22 ' HB2' ' A' ' 8' ' ' LEU . 49.6 mm -93.41 111.53 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.132 0.973 . . . . 63.14 109.363 -177.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.7 mt -125.71 149.3 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.087 0.955 . . . . 55.13 108.769 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.527 ' HB2' HD11 ' A' ' 8' ' ' LEU . 36.5 ttpt -133.19 116.83 14.44 Favored Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 109.994 -0.373 . . . . 74.03 109.994 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.7 Cg_exo -68.3 125.96 13.64 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 122.535 2.157 . . . . 61.03 110.528 173.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.6 mt -70.64 -30.25 66.83 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.86 0.464 . . . . 70.32 111.555 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.47 -19.11 62.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.365 0.666 . . . . 74.23 111.067 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.64 HG13 ' HB2' ' A' ' 34' ' ' GLU . 49.1 t -108.96 147.62 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.709 1.204 . . . . 63.44 109.678 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -145.04 -0.69 0.88 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.368 0.667 . . . . 73.14 112.358 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 m -128.04 147.39 50.51 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.575 0.75 . . . . 72.14 110.509 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 68.8 ttt180 -64.35 -34.62 78.58 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.474 0.71 . . . . 72.11 112.139 -176.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.11 -39.23 78.15 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.455 0.702 . . . . 75.25 111.49 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.64 ' HB2' HG13 ' A' ' 29' ' ' VAL . 29.5 mt-10 -69.88 -45.24 68.11 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.001 -0.999 . . . . 73.42 109.977 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.81 -30.08 69.85 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.044 0.538 . . . . 64.23 111.227 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 t -75.23 -30.5 60.57 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.099 0.96 . . . . 75.55 111.626 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -1.27 56.2 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 120.293 0.092 . . . . 73.01 111.157 173.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 34' ' ' GLU . 73.6 mt -91.76 -9.26 44.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.121 0.568 . . . . 52.33 111.632 174.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.527 HD13 HG22 ' A' ' 57' ' ' ILE . 42.8 mm -63.11 119.65 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 123.439 0.462 . . . . 73.55 110.306 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.35 -0.71 46.72 Favored Glycine 0 N--CA 1.466 0.673 0 CA-C-O 119.716 -0.491 . . . . 70.32 113.167 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -88.93 160.81 16.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.382 0.591 . . . . 61.55 111.053 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 55' ' ' GLY . 36.5 tp -90.28 144.37 25.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.998 -1.001 . . . . 64.3 109.794 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.9 t -124.96 115.75 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.922 0.889 . . . . 72.14 108.668 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.07 105.9 16.31 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.902 -0.777 . . . . 72.32 108.902 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.442 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 36.1 t90 -109.06 143.18 38.73 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.033 -0.729 . . . . 73.33 109.033 175.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -97.97 118.99 35.8 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.811 -0.811 . . . . 74.33 108.811 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.0 p -78.98 153.38 77.55 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.106 0.562 . . . . 65.45 109.83 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.84 -7.84 19.64 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.788 2.325 . . . . 73.42 112.434 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -71.25 -17.51 62.48 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 124.568 1.147 . . . . 70.01 110.983 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.58 16.23 46.81 Favored Glycine 0 C--N 1.356 1.666 0 C-N-CA 123.042 0.353 . . . . 45.43 113.131 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -109.85 149.32 30.03 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.709 0.804 . . . . 74.53 109.892 -176.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -93.75 98.51 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.617 -1.253 . . . . 61.14 107.617 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.442 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 54.6 mt -78.2 125.96 30.11 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.269 -0.641 . . . . 70.24 109.269 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -96.46 127.52 42.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.388 -0.823 . . . . 64.33 109.335 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -127.08 177.57 17.31 Favored Glycine 0 CA--C 1.504 -0.649 0 CA-C-N 114.862 -1.063 . . . . 41.25 110.738 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -149.38 135.28 18.82 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.7 -0.482 . . . . 62.24 109.7 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.527 HG22 HD13 ' A' ' 39' ' ' ILE . 78.5 mt -67.96 95.71 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 O-C-N 124.531 1.144 . . . . 74.25 108.826 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.41 -24.8 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.291 -0.868 . . . . 65.13 110.688 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -150.99 164.13 37.13 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.846 -0.616 . . . . 64.24 109.454 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 39' ' ' ILE . 32.9 m -92.09 168.39 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.778 -0.823 . . . . 64.11 108.778 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -142.05 103.65 4.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.834 -0.802 . . . . 75.42 108.834 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.91 -171.4 45.31 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 115.477 -0.783 . . . . 54.13 113.551 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 51.7 p -94.67 0.12 54.81 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.944 0.897 . . . . 64.12 111.43 176.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -81.12 2.04 29.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.457 1.103 . . . . 70.35 111.784 -173.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.494 ' HA3' HG12 ' A' ' 29' ' ' VAL . . . 78.44 6.74 88.06 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.261 0.351 . . . . 55.35 113.074 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.95 147.89 48.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.032 0.533 . . . . 54.43 110.138 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.452 ' HB ' HG23 ' A' ' 57' ' ' ILE . 30.5 m -121.69 140.53 45.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.678 0.791 . . . . 71.11 110.77 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -98.75 104.48 16.53 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.085 -1.08 . . . . 74.31 108.085 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.7 126.32 52.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.505 0.722 . . . . 70.24 110.147 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -101.56 126.14 48.32 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.854 0.462 . . . . 74.22 110.105 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.523 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 11.0 m-85 -93.37 126.34 38.45 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.025 0.93 . . . . 72.14 110.398 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 12.1 pt-20 -61.23 -28.83 69.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.273 1.029 . . . . 74.2 111.827 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.484 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 14.4 mmmm -101.07 -68.23 0.82 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.76 -0.83 . . . . 74.41 108.76 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.04 56.43 18.41 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.832 -0.622 . . . . 64.41 112.805 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.402 HD12 HD21 ' A' ' 53' ' ' LEU . 71.9 mt -68.7 156.55 90.72 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.7 0.8 . . . . 72.22 110.913 173.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.28 139.23 81.99 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.921 2.414 . . . . 45.44 112.695 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.72 140.62 2.96 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.633 -0.712 . . . . 74.01 112.207 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -121.11 97.09 5.36 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.919 0.888 . . . . 74.41 109.375 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.16 30.14 7.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.767 1.227 . . . . 62.11 110.899 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.4 mt -45.27 113.65 0.61 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.695 0.798 . . . . 62.32 112.242 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.41 -15.55 20.08 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-N 116.419 -0.355 . . . . 70.52 113.288 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.88 158.97 31.44 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.163 0.985 . . . . 65.04 111.908 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -100.83 127.3 47.34 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.806 0.842 . . . . 75.25 110.862 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 m -100.42 158.6 3.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 C-N-CA 124.129 0.972 . . . . 74.23 108.739 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 2' ' ' ARG . 35.3 mt-10 -103.96 108.13 19.33 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.99 0.516 . . . . 63.02 109.869 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 74.7 mt -86.68 94.11 4.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.612 -1.255 . . . . 61.14 107.612 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.418 HG22 ' HG3' ' A' ' 2' ' ' ARG . 31.5 t -89.63 137.31 21.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 114.633 -1.167 . . . . 52.25 109.164 -177.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 107.201 -1.407 . . . . 63.32 107.201 169.62 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HG2' HG22 ' A' ' 87' ' ' VAL . 82.3 mtm180 . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 108.405 -0.961 . . . . 74.35 108.405 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.446 HD12 HH11 ' A' ' 41' ' ' ARG . 61.3 mt -95.65 136.4 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.483 -0.932 . . . . 64.23 108.483 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -88.36 126.82 35.39 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.214 0.605 . . . . 74.2 109.749 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -129.95 175.49 19.11 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 123.624 0.578 . . . . 64.2 112.115 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.4 t -140.13 132.03 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.528 1.131 . . . . 65.43 109.627 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.83 107.4 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.131 0.973 . . . . 72.13 110.308 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 23' ' ' ILE . 86.6 mt -79.99 -55.27 5.08 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.36 0.664 . . . . 73.04 110.004 176.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 p -158.71 173.25 16.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.616 -0.72 . . . . 62.23 111.254 -173.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.89 159.72 27.61 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.632 0.773 . . . . 63.33 109.058 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 . . . . . 0 C--O 1.242 0.686 0 N-CA-C 107.462 -1.31 . . . . 63.22 107.462 161.692 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.592 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 36.1 t30 . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.47 0.176 . . . . 72.34 111.237 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.574 HG13 ' HG3' ' A' ' 68' ' ' ARG . 90.3 t -88.28 134.02 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 122.974 0.51 . . . . 44.24 109.658 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 43.1 ttm -130.85 112.88 13.41 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.23 -1.396 . . . . 75.51 107.23 170.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 8' ' ' LEU . 50.8 mm -78.52 111.71 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.079 -1.082 . . . . 63.51 108.079 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.51 HD13 HG21 ' A' ' 84' ' ' VAL . 84.6 mt -109.98 137.48 42.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 C-N-CA 124.221 1.008 . . . . 74.45 109.427 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB2' HD11 ' A' ' 8' ' ' LEU . 81.9 tttt -96.96 104.0 17.09 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.624 -0.88 . . . . 75.13 108.624 166.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 3.3 Cg_exo -68.68 112.27 2.82 Favored 'Trans proline' 0 C--N 1.369 1.622 0 N-CA-C 107.802 -1.653 . . . . 72.21 107.802 168.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.66 -27.27 69.11 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.588 0.755 . . . . 62.0 112.576 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.43 -28.31 64.95 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.606 0.762 . . . . 71.21 111.238 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 34' ' ' GLU . 88.7 t -98.5 145.61 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.98 1.312 . . . . 74.34 109.785 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.12 33.0 0.25 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.272 0.558 . . . . 55.24 109.734 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.5 m -150.19 141.22 22.97 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.403 0.681 . . . . 73.01 110.116 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.649 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 59.2 ttt180 -62.71 -32.65 73.79 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.353 0.661 . . . . 70.42 110.971 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -52.15 -51.81 55.62 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.93 0.769 . . . . 70.31 110.271 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.454 ' HB2' HG13 ' A' ' 29' ' ' VAL . 44.0 mt-10 -60.24 -52.49 65.06 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 114.577 -1.192 . . . . 74.21 110.361 177.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.12 70.56 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.666 0.787 . . . . 62.14 112.193 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.5 t -76.91 -28.62 55.37 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.9 0.88 . . . . 61.25 111.321 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -94.3 2.52 55.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.733 0.413 . . . . 75.24 110.922 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.561 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 46.6 mt -113.11 24.2 12.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.473 1.109 . . . . 75.15 110.678 175.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.76 132.13 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.938 -0.764 . . . . 72.12 108.938 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.02 -14.74 19.09 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.866 -0.408 . . . . 75.23 113.333 171.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.561 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 15.1 ptt180 -75.62 155.77 35.55 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.143 0.471 . . . . 73.31 110.449 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 55' ' ' GLY . 24.8 tp -89.78 154.34 19.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.144 0.977 . . . . 64.14 109.959 -173.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 86' ' ' ILE . 36.4 t -132.73 144.39 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.331 1.052 . . . . 64.13 108.418 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -127.53 117.99 23.12 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.7 -0.852 . . . . 75.41 108.7 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -130.3 132.36 45.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.64 0.776 . . . . 73.04 109.385 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -83.8 118.88 24.22 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.972 -0.751 . . . . 61.15 108.972 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.7 p -66.8 163.13 45.84 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.808 0.843 . . . . 61.31 111.437 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.36 -13.3 37.5 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.282 1.988 . . . . 64.55 112.123 167.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -85.2 -8.8 58.41 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.251 1.02 . . . . 64.44 110.878 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.56 -21.12 47.55 Favored Glycine 0 C--N 1.352 1.434 0 C-N-CA 123.013 0.339 . . . . 62.3 113.593 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -76.59 132.36 39.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.516 0.727 . . . . 44.25 111.049 -176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -78.33 102.15 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.936 -0.764 . . . . 74.12 108.936 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.51 135.43 39.32 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.038 -0.983 . . . . 74.03 109.862 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -96.31 133.52 40.56 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.971 -0.751 . . . . 72.4 108.971 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -131.25 169.84 21.61 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 110.821 -0.912 . . . . 53.32 110.821 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -145.15 134.86 23.46 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.171 -0.677 . . . . 73.31 109.171 177.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.512 HD12 ' HG3' ' A' ' 41' ' ' ARG . 93.7 mt -72.27 102.45 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 114.908 -1.042 . . . . 71.45 109.308 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.72 -19.33 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 115.056 -0.975 . . . . 55.03 111.521 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -153.89 168.43 26.38 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 122.562 0.345 . . . . 74.53 110.165 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.52 169.79 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 123.532 0.733 . . . . 72.45 110.359 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -141.32 104.09 4.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.683 0.793 . . . . 73.24 109.203 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.3 -172.39 34.59 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 115.934 -0.575 . . . . 64.01 113.519 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 17.5 p -91.4 2.93 56.05 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.197 0.999 . . . . 70.11 111.728 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -84.75 -3.34 58.54 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.43 1.092 . . . . 73.15 112.132 -171.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.14 -1.71 88.59 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.966 -0.352 . . . . 74.14 113.264 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.63 135.44 55.93 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 109.28 -0.637 . . . . 72.12 109.28 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.464 ' HB ' HG23 ' A' ' 57' ' ' ILE . 29.2 m -111.63 157.14 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.996 0.918 . . . . 75.22 110.889 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.574 ' HG3' HG13 ' A' ' 21' ' ' VAL . 41.3 ttm180 -106.52 109.27 21.14 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.002 0.921 . . . . 75.11 109.226 174.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.05 121.85 45.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.421 0.688 . . . . 73.03 110.267 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -88.07 111.24 21.33 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.276 -0.639 . . . . 71.43 109.276 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.411 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 39.2 m-85 -87.26 147.14 25.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.606 0.762 . . . . 71.54 110.758 175.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -49.66 -47.47 50.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.157 1.383 . . . . 72.25 111.822 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -108.7 -57.73 2.1 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.211 1.004 . . . . 75.22 108.411 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 63.42 57.16 15.97 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 114.598 -1.183 . . . . 53.4 111.661 -175.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 39.0 mt -67.56 115.49 27.5 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 109.653 -0.499 . . . . 64.33 109.653 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 12.4 Cg_exo -68.44 164.59 32.13 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 123.337 2.691 . . . . 73.12 111.949 -173.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 170.72 168.6 32.7 Favored Glycine 0 C--N 1.329 0.176 0 N-CA-C 111.139 -0.784 . . . . 75.21 111.139 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -85.6 28.71 0.74 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.299 0.639 . . . . 70.54 111.798 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.78 23.73 1.14 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.587 1.155 . . . . 71.33 111.404 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.61 113.76 3.53 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.682 0.793 . . . . 73.0 109.578 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.66 -5.67 14.32 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.948 -0.569 . . . . 21.24 112.487 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -80.44 152.73 28.64 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.508 0.723 . . . . 70.02 111.201 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -85.82 145.26 27.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.848 0.459 . . . . 73.33 111.765 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 24' ' ' ILE . 18.2 m -116.73 157.7 17.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 C-N-CA 124.144 0.978 . . . . 71.24 108.97 171.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -113.69 109.94 19.39 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.323 -0.621 . . . . 65.32 109.323 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 69.3 mt -89.13 98.04 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.57 0.748 . . . . 63.13 109.443 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 2' ' ' ARG . 59.9 t -79.69 136.41 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.496 -0.775 . . . . 72.24 109.703 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? . . . . . 0 CA--C 1.551 0.994 0 N-CA-C 108.438 -0.949 . . . . 61.5 108.438 175.967 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 39.1 ptt180 . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 121.021 0.439 . . . . 73.22 110.998 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 56.8 mt -101.07 145.28 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 108.016 -1.105 . . . . 65.34 108.016 174.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.454 ' HE2' HD12 ' A' ' 27' ' ' LEU . 20.5 ptmt -90.29 124.73 35.14 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.413 -0.588 . . . . 63.01 109.413 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -123.59 150.98 16.95 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 111.273 -0.731 . . . . 74.15 111.273 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.7 t -99.05 135.5 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.015 0.908 . . . . 72.34 110.802 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.82 104.07 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.876 1.27 . . . . 75.1 109.057 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.563 HD21 ' HG2' ' A' ' 25' ' ' LYS . 59.4 mt -82.28 -60.74 2.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.671 -0.492 . . . . 75.45 109.671 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -153.45 169.77 22.35 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.357 0.663 . . . . 34.32 111.701 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -122.82 143.09 50.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.508 1.123 . . . . 73.4 108.611 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.42 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 41.6 ttm180 . . . . . 0 CA--C 1.532 0.281 0 C-N-CA 123.958 0.903 . . . . 73.11 108.893 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.542 -0.911 . . . . 72.44 108.542 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 21.9 t -87.36 146.81 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.522 0.729 . . . . 63.31 109.208 -172.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -138.54 112.79 8.68 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.159 -1.423 . . . . 71.32 107.159 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 8' ' ' LEU . 24.7 mm -75.06 112.43 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.272 -1.01 . . . . 72.51 108.272 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -122.62 162.63 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.703 1.201 . . . . 65.44 107.832 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG2' HD21 ' A' ' 8' ' ' LEU . 20.3 ptmt -145.94 131.05 9.09 Favored Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 109.511 -0.552 . . . . 71.23 109.511 163.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.481 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 9.8 Cg_exo -69.94 127.94 15.15 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 121.967 1.778 . . . . 72.25 110.562 171.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.454 HD12 ' HE2' ' A' ' 4' ' ' LYS . 64.6 mt -60.68 -37.0 80.15 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.327 0.651 . . . . 53.34 112.107 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -74.4 -29.26 61.45 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.971 -0.558 . . . . 64.13 110.8 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 34' ' ' GLU . 45.8 t -87.39 97.78 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.914 0.864 . . . . 63.2 109.98 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -101.04 -6.63 24.15 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.815 1.246 . . . . 73.04 110.169 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 m -117.44 147.13 42.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.923 0.889 . . . . 74.55 110.352 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.58 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 75.6 ttt-85 -65.16 -34.75 79.12 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.035 0.534 . . . . 64.15 111.576 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -59.67 -43.62 93.91 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.538 0.685 . . . . 65.11 109.759 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.524 ' HB2' HG13 ' A' ' 29' ' ' VAL . 21.2 mm-40 -68.86 -31.67 70.78 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.724 -1.125 . . . . 73.44 111.062 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.56 -35.0 58.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.53 0.732 . . . . 50.43 111.766 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -79.91 -25.63 40.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.395 1.078 . . . . 65.32 111.152 -168.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 63.3 pttt -77.61 -13.63 59.86 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.419 -0.355 . . . . 72.23 110.848 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.555 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 96.1 mt -89.05 8.34 30.28 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.777 0.831 . . . . 62.55 111.834 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.472 HD11 HG13 ' A' ' 60' ' ' VAL . 33.1 mm -65.87 103.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.272 -1.01 . . . . 61.13 108.272 172.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.61 0.8 17.96 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.52 -0.6 . . . . 60.14 113.446 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.782 ' HD3' HG23 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -74.37 156.24 37.28 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.747 0.773 . . . . 43.15 110.585 177.402 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 tp -94.43 143.88 26.04 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.172 0.589 . . . . 74.15 109.894 176.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.93 125.79 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.992 -1.114 . . . . 75.33 107.992 172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -115.01 109.5 18.19 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.735 -1.209 . . . . 73.21 107.735 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.3 t90 -131.74 117.51 18.69 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.251 -0.648 . . . . 75.24 109.251 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -86.46 105.86 17.07 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.653 0.781 . . . . 74.05 109.048 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.6 p -64.22 153.73 84.86 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 124.318 1.047 . . . . 61.43 112.459 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.33 -8.07 17.7 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.075 2.517 . . . . 65.34 112.622 168.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -61.63 -27.52 68.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.881 0.872 . . . . 73.35 110.693 167.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.42 24.85 13.18 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 115.253 -0.885 . . . . 22.44 111.901 -175.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -124.08 139.49 53.89 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.791 0.836 . . . . 70.11 110.554 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -85.18 95.1 4.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.235 -1.024 . . . . 75.13 108.235 173.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.445 HD22 ' HB2' ' A' ' 73' ' ' LYS . 28.6 mt -75.4 111.37 10.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.937 -0.764 . . . . 74.42 108.937 177.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -97.26 135.1 39.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.464 0.706 . . . . 71.01 109.662 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.46 170.98 24.51 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.581 0.551 . . . . 54.31 113.069 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -152.85 141.99 21.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.819 0.848 . . . . 75.25 109.66 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 29.9 mt -70.38 122.43 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 123.418 0.449 . . . . 75.4 110.284 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.3 m -87.25 -34.1 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.416 0.686 . . . . 70.05 110.08 172.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -167.36 150.52 6.26 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.337 0.655 . . . . 73.44 109.878 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.472 HG13 HD11 ' A' ' 39' ' ' ILE . 16.6 m -90.44 169.69 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.175 0.59 . . . . 73.33 109.639 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -135.59 101.88 4.93 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.833 -0.803 . . . . 73.41 108.833 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.79 -171.7 25.87 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 115.386 0.914 . . . . 43.41 115.386 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 40.3 p -93.81 12.1 26.95 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.646 1.179 . . . . 61.32 111.8 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -74.15 -17.76 60.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.816 0.846 . . . . 73.12 110.642 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.14 -4.95 78.24 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.515 -0.634 . . . . 72.1 111.515 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.89 141.69 51.18 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.605 0.762 . . . . 64.25 110.945 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.481 HG21 ' NH2' ' A' ' 41' ' ' ARG . 27.4 m -135.7 152.47 31.24 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 C-N-CA 124.539 1.135 . . . . 64.21 109.691 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -107.27 102.7 11.99 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.006 -1.109 . . . . 73.41 108.006 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -107.24 116.03 31.21 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.237 -0.892 . . . . 73.25 108.948 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -89.1 131.81 35.08 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.566 -0.531 . . . . 75.23 109.566 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -101.62 135.49 43.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.402 1.081 . . . . 74.23 109.432 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -54.62 -44.39 73.1 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.482 1.114 . . . . 74.54 111.15 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.445 ' HB2' HD22 ' A' ' 53' ' ' LEU . 73.3 mmtt -77.86 -42.49 33.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.507 -0.77 . . . . 74.53 109.293 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.55 33.7 72.93 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 124.137 0.898 . . . . 64.5 114.101 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.441 HD12 HD21 ' A' ' 53' ' ' LEU . 43.6 mt -69.71 121.57 82.98 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.067 0.547 . . . . 73.51 110.782 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.39 123.38 8.15 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.601 2.201 . . . . 74.32 110.969 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -135.17 142.78 14.25 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.916 -0.474 . . . . 72.25 111.916 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -88.38 70.28 9.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.159 -1.052 . . . . 74.44 108.159 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.39 28.58 7.93 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.139 -1.391 . . . . 74.41 110.315 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.29 104.05 1.4 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.841 -0.618 . . . . 74.21 110.209 -174.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.81 -1.76 8.57 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.019 -0.537 . . . . 60.31 113.015 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.81 174.16 10.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.38 0.672 . . . . 75.11 111.318 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 85.8 m-85 -115.62 129.86 56.65 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.209 0.603 . . . . 61.31 111.344 -173.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.6 m -99.71 156.52 3.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 124.383 1.073 . . . . 72.11 109.583 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -103.9 109.86 21.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.282 0.633 . . . . 73.33 109.513 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.782 HG23 ' HD3' ' A' ' 41' ' ' ARG . 82.1 mt -91.51 93.06 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.239 1.015 . . . . 71.43 108.91 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.99 105.98 12.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 115.257 -0.883 . . . . 74.24 109.896 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 106.403 -1.703 . . . . 63.12 106.403 166.918 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.648 -0.501 . . . . 73.21 109.648 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 mt -106.11 118.68 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.017 -1.105 . . . . 70.4 108.017 170.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.447 ' HG3' HD12 ' A' ' 27' ' ' LEU . 17.4 ptpt -88.01 149.27 24.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.401 -0.592 . . . . 73.21 109.401 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -147.01 177.65 25.16 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 123.522 0.514 . . . . 63.32 112.082 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.6 t -113.03 132.66 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.893 0.877 . . . . 64.14 110.167 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.8 t -66.83 118.2 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.576 0.75 . . . . 74.33 109.636 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.525 HD12 HG22 ' A' ' 23' ' ' ILE . 88.8 mt -90.64 -51.64 5.29 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.973 0.509 . . . . 74.54 109.918 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.1 p -164.77 163.02 21.41 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.098 -0.501 . . . . 64.45 111.551 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -111.32 157.29 20.35 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.782 0.833 . . . . 61.24 108.953 171.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 . . . . . 0 C--O 1.245 0.829 0 N-CA-C 108.893 -0.78 . . . . 72.31 108.893 173.266 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 121.634 0.731 . . . . 73.23 110.524 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.42 140.71 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.967 -1.015 . . . . 72.5 108.867 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.5 ttt -132.29 116.52 17.0 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.027 -1.101 . . . . 74.35 108.027 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.525 HG22 HD12 ' A' ' 8' ' ' LEU . 31.2 mm -83.98 120.41 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.563 0.745 . . . . 52.3 109.028 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 84' ' ' VAL . 87.2 mt -126.12 152.67 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.654 1.182 . . . . 74.2 108.262 -176.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.523 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -125.81 102.69 28.32 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.104 -1.073 . . . . 73.31 108.104 170.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.538 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 24.3 Cg_exo -61.05 143.0 99.0 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.756 2.304 . . . . 71.32 112.064 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.447 HD12 ' HG3' ' A' ' 4' ' ' LYS . 88.9 mt -67.99 -43.11 79.66 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.394 0.677 . . . . 74.03 111.541 -177.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.56 -25.99 66.07 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.812 0.845 . . . . 62.34 111.597 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 55.6 t -105.29 116.3 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.273 1.029 . . . . 52.42 110.981 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -128.64 13.64 6.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.389 0.676 . . . . 74.33 110.68 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.1 t -145.6 164.45 31.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.557 0.743 . . . . 64.33 110.525 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.611 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 74.5 ttt180 -59.26 -51.04 71.66 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.404 1.082 . . . . 71.42 112.141 -170.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -75.08 -29.08 60.57 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.406 -0.815 . . . . 71.31 110.82 -169.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 29' ' ' VAL . 42.4 mt-10 -64.86 -30.81 71.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.538 -0.756 . . . . 73.42 109.917 173.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.74 -32.74 23.31 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.011 0.924 . . . . 73.11 111.169 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.0 m -78.04 -16.45 58.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.35 0.66 . . . . 51.43 111.898 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -82.31 -16.11 50.53 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.807 0.337 . . . . 75.01 110.495 171.423 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.13 5.93 42.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.126 0.57 . . . . 74.44 112.033 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.579 HD11 HG13 ' A' ' 60' ' ' VAL . 46.5 mm -68.54 104.68 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.741 -0.837 . . . . 65.13 108.741 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.79 -4.79 11.63 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.787 -0.642 . . . . 53.52 113.143 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HD2' HD13 ' A' ' 88' ' ' LEU . 24.1 mmt180 -84.58 149.77 25.66 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.82 0.81 . . . . 64.34 110.604 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 55' ' ' GLY . 48.0 tp -89.78 138.12 31.75 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 124.177 0.991 . . . . 72.42 108.754 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 86' ' ' ILE . 16.3 t -119.69 138.01 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.852 -0.795 . . . . 74.45 108.852 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.4 132.95 52.67 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.269 -1.012 . . . . 72.35 108.269 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -138.93 128.69 24.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.075 0.55 . . . . 74.53 109.571 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 17.6 tppt? -78.98 120.89 24.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.718 0.807 . . . . 73.31 109.354 174.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 7.6 m -83.83 138.16 40.59 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 115.259 -0.882 . . . . 74.12 109.23 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.07 -17.77 39.97 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.225 2.617 . . . . 61.05 113.619 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -82.81 13.05 4.12 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.586 0.755 . . . . 74.33 111.89 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.95 41.27 49.31 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 112.539 -0.224 . . . . 72.0 112.539 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 75.3 mmtt -124.12 169.61 11.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.947 0.899 . . . . 71.2 109.403 -178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -131.85 107.83 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.216 -1.031 . . . . 53.4 108.216 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.556 HD22 ' HB2' ' A' ' 73' ' ' LYS . 22.6 mt -83.45 124.89 31.14 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.88 -0.6 . . . . 71.33 109.399 176.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -105.1 130.44 53.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.429 -0.952 . . . . 73.2 108.429 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.438 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -145.28 -179.6 21.69 Favored Glycine 0 N--CA 1.464 0.562 0 O-C-N 123.31 0.381 . . . . 74.34 112.304 -175.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -152.56 133.32 13.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.875 0.337 . . . . 64.51 110.819 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.562 HD11 HD13 ' A' ' 86' ' ' ILE . 68.3 mt -67.87 103.92 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 124.08 0.862 . . . . 73.3 109.524 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.2 m -89.58 -35.24 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.287 0.635 . . . . 73.21 111.517 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -164.41 149.82 10.29 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.37 -0.604 . . . . 71.12 109.37 -175.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.579 HG13 HD11 ' A' ' 39' ' ' ILE . 13.9 m -94.78 171.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.473 0.709 . . . . 55.11 110.853 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -128.46 113.96 16.19 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.887 0.875 . . . . 73.23 109.651 174.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.76 -154.97 50.64 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 123.902 0.751 . . . . 64.21 113.549 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.611 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 22.7 p -105.04 7.56 34.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.56 1.144 . . . . 74.13 111.826 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -85.75 2.42 45.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.407 0.683 . . . . 72.33 112.832 -171.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.35 71.52 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.142 -0.255 . . . . 51.41 113.423 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.4 117.86 17.66 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.427 0.691 . . . . 73.32 110.077 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.6 m -102.18 150.84 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.755 0.822 . . . . 64.41 110.719 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -103.12 104.52 14.68 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.641 -1.244 . . . . 73.15 107.641 171.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.13 118.04 35.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.11 -1.07 . . . . 65.4 108.11 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.8 mtm105 -89.98 118.21 29.37 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.566 -0.531 . . . . 72.24 109.566 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -98.19 132.06 44.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.9 0.88 . . . . 72.11 109.809 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -52.88 -41.94 64.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.947 1.299 . . . . 64.13 112.264 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HB2' HD22 ' A' ' 53' ' ' LEU . 43.6 mmtm -90.06 -47.8 7.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.128 0.971 . . . . 74.24 109.281 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.12 38.39 94.3 Favored Glycine 0 C--N 1.356 1.686 0 O-C-N 123.887 0.742 . . . . 50.02 114.331 175.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.06 131.37 92.27 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 122.934 0.493 . . . . 72.52 110.68 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.7 176.24 10.25 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.801 2.334 . . . . 73.12 111.919 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.18 157.81 19.0 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.174 -0.466 . . . . 61.33 112.31 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -94.19 26.37 3.33 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.607 0.718 . . . . 64.4 110.555 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.48 28.63 1.08 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.432 1.093 . . . . 53.33 111.033 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -61.76 109.36 1.2 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.746 0.818 . . . . 73.3 110.036 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.94 -14.79 7.05 Favored Glycine 0 C--N 1.347 1.144 0 O-C-N 123.31 0.381 . . . . 54.3 113.011 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.12 160.39 31.28 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.661 0.784 . . . . 74.31 111.287 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 13.0 m-85 -87.32 131.67 34.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.614 0.766 . . . . 74.34 111.69 -177.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 24' ' ' ILE . 16.6 m -104.5 151.14 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.452 -0.944 . . . . 73.0 108.452 167.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -108.97 108.72 19.57 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.085 -0.709 . . . . 52.14 109.085 171.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.562 HD13 HD11 ' A' ' 57' ' ' ILE . 59.6 mt -85.88 91.39 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.721 -1.214 . . . . 74.25 107.721 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.2 t -75.62 147.47 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.69 -1.141 . . . . 65.22 109.83 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.478 HD13 ' HD2' ' A' ' 41' ' ' ARG . 4.5 mm? . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 123.552 0.741 . . . . 54.32 110.735 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.46 ' HD2' HG22 ' A' ' 87' ' ' VAL . 34.2 mtm-85 . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 107.894 -1.15 . . . . 74.45 107.894 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.701 HD12 HD21 ' A' ' 38' ' ' LEU . 25.9 mt -101.1 134.96 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 109.713 -0.477 . . . . 64.43 109.713 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -89.69 121.52 31.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.577 0.751 . . . . 71.4 109.417 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -114.57 167.86 12.42 Favored Glycine 0 N--CA 1.48 1.611 0 CA-C-O 119.698 -0.501 . . . . 60.44 113.055 -175.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.2 t -124.13 122.9 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.973 0.909 . . . . 75.14 109.571 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.2 t -69.76 97.85 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.26 0.624 . . . . 54.54 109.777 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 25' ' ' LYS . 67.6 mt -75.83 -47.84 23.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.212 0.605 . . . . 73.5 110.853 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.7 m -151.43 152.45 33.07 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.7 0.8 . . . . 73.13 110.927 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.32 142.11 35.66 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.664 0.786 . . . . 74.1 109.44 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 105.286 -2.116 . . . . 73.5 105.286 159.52 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 24.5 t-20 . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 106.91 -1.515 . . . . 62.14 106.91 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 70' ' ' ARG . 14.6 t -88.08 148.89 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.067 -1.457 . . . . 54.24 107.067 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.6 ptp -153.34 144.96 23.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.669 0.271 . . . . 74.54 110.678 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.07 119.81 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.179 -1.045 . . . . 50.32 108.179 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.511 HD13 HG21 ' A' ' 84' ' ' VAL . 89.2 mt -121.25 123.03 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.951 0.9 . . . . 64.21 109.644 -175.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.594 ' HB2' HD11 ' A' ' 8' ' ' LEU . 87.9 tttt -99.64 109.26 54.78 Favored Pre-proline 0 N--CA 1.482 1.173 0 CA-C-N 119.172 0.896 . . . . 71.22 109.859 172.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.642 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 20.4 Cg_exo -67.46 138.12 45.09 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.799 2.333 . . . . 72.42 112.39 171.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.33 -39.04 89.08 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.657 1.183 . . . . 74.41 111.82 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -77.72 -28.22 50.78 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.642 0.777 . . . . 70.51 112.097 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 34' ' ' GLU . 54.7 t -92.02 113.52 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.789 0.836 . . . . 61.05 110.67 -170.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -101.17 -30.21 11.68 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.917 0.887 . . . . 72.53 111.066 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.8 p -119.99 166.72 12.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.948 0.499 . . . . 54.21 111.331 -172.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 67.7 ttt180 -61.97 -37.55 85.2 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.845 0.858 . . . . 74.24 111.022 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.87 -45.3 93.2 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.014 0.526 . . . . 70.34 111.137 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HB2' HG13 ' A' ' 29' ' ' VAL . 41.5 mt-10 -66.87 -22.09 65.99 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.384 -0.825 . . . . 71.45 111.215 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.62 -28.25 28.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.617 0.767 . . . . 73.23 110.877 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -79.29 -24.2 43.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.217 0.607 . . . . 72.45 111.517 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -61.63 -20.47 63.41 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.165 0.439 . . . . 60.42 110.622 169.447 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.701 HD21 HD12 ' A' ' 3' ' ' ILE . 88.9 mt -88.36 -1.15 57.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.761 0.824 . . . . 72.55 112.913 -175.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.659 HD11 HG13 ' A' ' 60' ' ' VAL . 38.6 mm -72.3 103.91 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.475 0.579 . . . . 72.3 109.553 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.7 -4.54 17.01 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.696 -0.684 . . . . 74.31 113.025 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HA ' HD23 ' A' ' 88' ' ' LEU . 27.6 mmt180 -75.52 153.54 37.4 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.774 0.787 . . . . 74.54 109.759 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 55' ' ' GLY . 56.2 tp -89.33 146.01 24.98 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.047 -1.094 . . . . 63.45 108.047 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.2 t -126.24 115.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.951 -0.759 . . . . 74.03 108.951 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.3 mt -100.36 106.19 17.78 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.917 0.887 . . . . 72.22 108.718 176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 53.9 t90 -123.72 130.64 52.95 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.903 0.881 . . . . 72.34 108.866 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -88.0 113.88 24.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.369 0.667 . . . . 74.33 109.271 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.0 p -65.96 152.4 93.58 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.55 0.74 . . . . 73.1 111.501 176.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.8 -7.98 22.44 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.516 2.144 . . . . 55.53 112.039 170.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 t -71.17 -29.69 65.51 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.59 0.756 . . . . 74.13 110.302 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.59 -34.46 2.67 Favored Glycine 0 C--N 1.354 1.581 0 C-N-CA 122.951 0.31 . . . . 63.45 113.311 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -73.13 157.17 37.76 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.509 0.724 . . . . 72.44 111.483 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.82 104.12 15.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.537 -1.283 . . . . 51.24 107.537 167.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 75' ' ' LEU . 26.9 mt -74.78 136.31 41.69 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.717 -0.674 . . . . 74.53 110.363 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -103.93 128.45 51.44 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.868 0.867 . . . . 43.31 109.004 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -135.38 176.94 19.78 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 123.896 0.747 . . . . 43.45 112.03 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -146.63 129.59 16.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.492 -0.559 . . . . 74.34 109.492 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.431 HG23 ' HB ' ' A' ' 67' ' ' VAL . 80.9 mt -67.81 97.22 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.583 -0.895 . . . . 75.3 108.583 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.92 -31.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.09 -0.959 . . . . 54.35 111.143 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -158.57 162.88 37.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.61 0.764 . . . . 74.04 109.03 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.659 HG13 HD11 ' A' ' 39' ' ' ILE . 34.1 m -92.3 168.62 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.501 0.721 . . . . 73.15 110.382 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -137.22 103.8 5.22 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.285 -0.635 . . . . 61.32 109.285 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.6 178.66 50.37 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 116.028 -0.533 . . . . 71.05 113.651 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 71.7 p -97.76 1.19 48.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.963 0.905 . . . . 71.43 111.692 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.03 12.18 8.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.669 0.787 . . . . 61.51 112.014 -176.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.85 -12.16 70.21 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 120.083 -0.287 . . . . 51.14 113.435 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.32 143.2 56.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.959 0.504 . . . . 54.31 110.722 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 35.9 m -118.87 -171.91 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.527 1.531 . . . . 75.42 109.339 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -145.63 108.4 4.51 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.05 -0.722 . . . . 65.34 109.05 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.03 125.32 50.87 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.874 0.87 . . . . 74.42 111.125 -176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.514 ' HG2' HG22 ' A' ' 21' ' ' VAL . 97.2 mtt180 -91.13 115.1 27.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.762 0.825 . . . . 73.53 110.139 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.4 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 14.9 m-85 -89.19 119.94 30.12 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.886 -0.783 . . . . 75.35 108.886 172.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.44 -19.74 62.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.5 0.72 . . . . 70.22 112.2 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -69.79 -55.9 8.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.061 0.945 . . . . 73.21 110.541 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 20' ' ' ASN . . . 81.0 46.33 7.14 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 114.6 0.6 . . . . 74.52 114.6 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.514 ' HB2' HD11 ' A' ' 53' ' ' LEU . 31.5 mt -96.77 143.3 25.89 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 117.659 0.73 . . . . 73.33 110.668 171.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -90.08 -174.84 0.87 Allowed 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.435 2.756 . . . . 72.44 113.44 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 146.87 153.47 5.91 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.039 -0.982 . . . . 73.34 111.46 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -99.8 87.46 3.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.236 0.614 . . . . 73.33 109.483 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.04 31.33 6.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.818 0.847 . . . . 43.53 111.041 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.09 105.53 0.33 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.924 -0.398 . . . . 75.52 109.924 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.27 3.61 18.99 Favored Glycine 0 C--N 1.35 1.333 0 C-N-CA 123.929 0.776 . . . . 53.12 112.548 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -86.82 163.55 17.16 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.967 0.507 . . . . 74.43 110.428 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 97.0 m-85 -109.55 125.55 52.64 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.12 0.568 . . . . 71.05 111.513 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.511 HG21 HD13 ' A' ' 24' ' ' ILE . 18.8 m -100.99 162.35 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.165 0.986 . . . . 74.34 111.008 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -103.98 110.25 22.32 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.033 0.933 . . . . 74.02 109.69 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.0 mt -87.82 91.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 107.372 -1.344 . . . . 72.13 107.372 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.46 HG22 ' HD2' ' A' ' 2' ' ' ARG . 21.9 t -98.27 151.83 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.781 1.233 . . . . 51.45 109.632 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 41' ' ' ARG . 2.0 tm? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 108.611 -0.885 . . . . 72.5 108.611 169.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.498 ' HG3' ' HB3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 109.702 -0.481 . . . . 74.01 109.702 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.509 HG23 ' HB2' ' A' ' 28' ' ' ASP . 80.3 mt -95.56 135.72 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.767 0.827 . . . . 71.4 109.7 -175.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HE2' ' CD2' ' A' ' 83' ' ' TYR . 85.6 tttt -90.25 138.49 31.48 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.691 -0.855 . . . . 74.52 108.691 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.69 -179.79 16.97 Favored Glycine 0 N--CA 1.469 0.847 0 N-CA-C 111.606 -0.598 . . . . 50.42 111.606 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.17 130.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.847 0.859 . . . . 65.12 109.641 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.18 100.87 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.599 1.159 . . . . 54.11 109.743 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 25' ' ' LYS . 67.0 mt -82.52 -56.66 3.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.822 0.449 . . . . 71.21 111.565 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 m -147.21 135.23 21.41 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.671 0.389 . . . . 64.24 111.352 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -80.98 122.63 27.53 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.516 -0.92 . . . . 73.22 108.516 168.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.659 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 37.0 mmt180 . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 108.592 -0.892 . . . . 75.52 108.592 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.446 ' OD1' ' HA2' ' A' ' 74' ' ' GLY . 2.9 p-10 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 109.137 -0.69 . . . . 62.52 109.137 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.659 ' HB ' ' HB2' ' A' ' 11' ' ' ARG . 10.7 t -87.95 157.17 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.221 -1.029 . . . . 74.01 108.221 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 36.6 ttp -141.71 114.18 8.3 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.263 -1.384 . . . . 74.42 107.263 169.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.6 mm -67.42 124.45 22.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 N-CA-C 108.108 -1.071 . . . . 64.35 108.108 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.462 HG21 HG21 ' A' ' 84' ' ' VAL . 96.3 mt -134.27 137.06 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.948 -1.13 . . . . 72.25 107.948 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.512 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -102.11 113.43 65.86 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.727 -0.842 . . . . 75.42 108.727 169.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.621 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 15.8 Cg_exo -68.3 119.8 6.79 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.585 1.523 . . . . 71.21 110.177 169.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.88 -35.99 81.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.485 0.714 . . . . 65.42 111.602 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 3' ' ' ILE . 7.8 m-20 -76.45 -28.95 56.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.755 0.422 . . . . 74.53 111.23 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 50.0 t -115.56 102.27 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.475 0.71 . . . . 74.12 110.459 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.525 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 26.3 p30 -110.15 2.14 19.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.036 0.934 . . . . 74.01 111.425 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.9 m -97.83 156.14 16.72 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.65 0.78 . . . . 52.13 110.477 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 31.7 ttt180 -74.54 -42.8 58.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.2 0.6 . . . . 73.51 110.918 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.53 -40.43 92.91 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.788 0.835 . . . . 74.22 110.987 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HB2' HG13 ' A' ' 29' ' ' VAL . 5.9 mm-40 -70.83 -28.57 64.7 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.268 -0.878 . . . . 65.51 110.243 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.26 43.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.561 0.744 . . . . 44.25 111.192 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.8 t -78.78 -23.54 45.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.915 0.886 . . . . 72.12 110.018 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -92.75 2.12 56.91 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.642 0.377 . . . . 74.11 111.124 171.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD21 HD12 ' A' ' 3' ' ' ILE . 43.2 mt -85.94 -11.23 53.65 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.092 0.557 . . . . 73.24 111.137 170.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.531 HD11 HG13 ' A' ' 60' ' ' VAL . 42.7 mm -63.38 126.64 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 109.214 -0.661 . . . . 71.04 109.214 177.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.64 7.67 66.48 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.612 -0.549 . . . . 72.33 113.426 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -96.1 150.86 20.03 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 117.851 0.826 . . . . 73.31 111.202 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.44 HD11 ' HE2' ' A' ' 54' ' ' LYS . 43.8 tp -91.17 115.95 28.42 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.758 -1.11 . . . . 75.1 109.897 -171.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 86' ' ' ILE . 62.0 t -97.38 115.04 36.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.29 -0.633 . . . . 41.42 109.29 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.9 mt -93.7 101.88 14.03 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.153 0.981 . . . . 75.43 108.419 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.403 ' CD1' HG12 ' A' ' 84' ' ' VAL . 31.2 t90 -104.38 131.21 51.99 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.399 -0.963 . . . . 72.24 108.399 172.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -96.03 114.67 26.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.16 -1.422 . . . . 73.01 107.16 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.1 p -57.95 155.74 22.44 Favored Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 124.115 0.966 . . . . 74.44 111.026 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.78 -25.25 50.75 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.126 2.551 . . . . 53.5 112.82 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -58.55 -38.15 77.21 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.921 1.288 . . . . 72.1 111.505 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.68 -8.91 11.73 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 115.635 -0.711 . . . . 72.21 112.015 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -82.05 153.54 26.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.602 1.161 . . . . 73.55 110.141 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.7 mt -110.12 109.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.816 0.446 . . . . 74.43 110.203 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.571 HD21 HD12 ' A' ' 75' ' ' LEU . 57.3 mt -80.54 142.26 34.31 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.991 0.916 . . . . 62.15 110.319 174.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 42' ' ' LEU . 13.9 mmmm -96.24 128.73 43.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.886 0.874 . . . . 71.11 109.513 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.05 173.31 22.48 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 111.459 -0.656 . . . . 55.13 111.459 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -152.61 132.06 12.94 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.991 0.396 . . . . 74.02 110.709 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.464 HG22 HD13 ' A' ' 39' ' ' ILE . 65.5 mt -68.22 104.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 123.878 0.736 . . . . 43.13 109.692 176.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.79 -38.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.182 -0.463 . . . . 71.11 110.132 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -136.23 176.89 8.28 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.835 0.854 . . . . 75.41 110.532 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.531 HG13 HD11 ' A' ' 39' ' ' ILE . 31.0 m -123.45 169.99 14.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 124.529 1.132 . . . . 74.45 109.651 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -144.61 105.31 4.14 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.303 -0.999 . . . . 72.15 108.303 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.17 168.73 42.2 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.182 -0.463 . . . . 71.41 113.587 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 59.8 p -93.78 2.28 56.27 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.04 0.936 . . . . 63.13 110.987 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -84.54 7.92 18.37 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.094 0.958 . . . . 72.05 112.476 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 30' ' ' ASN . . . 69.12 63.91 3.23 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 112.004 -0.438 . . . . 61.41 112.004 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.67 113.45 15.39 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.232 -1.395 . . . . 74.01 107.232 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.42 167.17 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.087 0.955 . . . . 74.01 110.42 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -123.13 102.56 8.04 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.173 0.989 . . . . 75.1 108.786 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.29 116.91 32.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.776 0.83 . . . . 53.42 110.397 -176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 22.1 mtm180 -91.33 119.75 31.62 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 122.338 0.255 . . . . 73.2 111.254 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -93.29 129.3 39.42 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.339 1.056 . . . . 71.51 110.756 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.27 -31.04 62.38 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.908 -1.042 . . . . 75.42 112.649 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.62 -31.71 24.1 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.547 0.339 . . . . 64.52 110.883 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.446 ' HA2' ' OD1' ' A' ' 20' ' ' ASN . . . 61.87 37.1 93.79 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 115.595 0.998 . . . . 73.23 115.595 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD12 HD21 ' A' ' 53' ' ' LEU . 79.7 mt -85.04 150.02 54.36 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 122.565 0.346 . . . . 73.22 110.466 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.99 -176.04 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.1 2.533 . . . . 55.31 112.516 174.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.83 -39.7 0.02 OUTLIER Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.556 -0.747 . . . . 63.24 112.403 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 56.55 30.4 17.18 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 123.047 1.403 . . . . 62.21 109.402 -171.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.82 31.47 5.81 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.935 -1.484 . . . . 54.25 110.564 -169.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -56.01 111.79 1.03 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.661 -0.496 . . . . 60.52 109.661 172.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.58 -7.26 18.0 Favored Glycine 0 N--CA 1.476 1.342 0 C-N-CA 123.233 0.444 . . . . 71.21 112.447 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.07 169.86 17.57 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.925 0.89 . . . . 70.11 108.664 175.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CD2' ' HE2' ' A' ' 4' ' ' LYS . 92.7 m-85 -115.36 135.24 54.33 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.097 0.408 . . . . 64.23 111.173 -171.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 24' ' ' ILE . 13.8 m -101.28 168.34 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.973 0.909 . . . . 70.53 109.249 174.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 2' ' ' ARG . 49.3 mt-10 -132.43 107.13 8.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.043 -0.725 . . . . 73.11 109.043 173.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.422 HD13 HD11 ' A' ' 57' ' ' ILE . 46.7 mt -85.21 94.45 3.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 125.227 1.411 . . . . 75.51 109.258 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.62 150.14 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.421 0.688 . . . . 72.53 109.599 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.553 1.095 0 N-CA-C 107.065 -1.457 . . . . 74.44 107.065 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 108.651 -0.87 . . . . 74.52 108.651 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.71 124.75 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.635 0.774 . . . . 63.25 109.061 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -88.52 127.67 35.54 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.938 -0.764 . . . . 75.25 108.938 -176.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.62 -168.95 12.26 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 116.373 -0.376 . . . . 61.32 112.299 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -144.3 135.38 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.026 1.33 . . . . 61.14 109.695 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.5 t -72.61 115.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.833 0.853 . . . . 71.42 109.62 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 25' ' ' LYS . 84.3 mt -89.69 -47.81 7.69 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 123.461 0.476 . . . . 74.42 110.541 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.2 m -152.02 154.82 36.75 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.919 0.488 . . . . 33.41 111.535 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -110.47 137.85 47.63 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.397 1.079 . . . . 70.51 108.691 171.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.422 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 87.9 mtt180 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 107.706 -1.22 . . . . 72.3 107.706 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 120.682 0.277 . . . . 74.52 110.327 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' HD3' ' A' ' 68' ' ' ARG . 84.3 t -90.39 106.09 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.565 0.746 . . . . 62.44 109.019 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.7 ttm -100.46 124.75 46.39 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.294 -0.632 . . . . 74.42 109.294 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -82.02 115.54 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 107.786 -1.19 . . . . 72.45 107.786 172.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.414 ' HB ' HG23 ' A' ' 67' ' ' VAL . 69.4 mt -109.24 150.41 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.799 0.84 . . . . 65.2 109.938 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 8' ' ' LEU . 59.5 tttp -119.49 96.97 50.06 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 125.007 1.323 . . . . 64.32 108.962 175.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.7 106.64 0.94 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.083 1.855 . . . . 74.23 110.164 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.1 mt -53.08 -38.43 62.53 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.793 1.237 . . . . 72.21 113.324 -172.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.73 -27.11 58.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.978 0.511 . . . . 62.51 111.631 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -100.98 107.73 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.32 0.648 . . . . 64.02 111.529 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -91.62 -19.26 22.9 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.369 1.068 . . . . 73.23 111.875 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -104.53 133.42 49.42 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 122.025 -0.422 . . . . 64.22 111.05 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 49.1 ttt180 -58.97 -43.93 91.46 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.375 1.07 . . . . 62.22 111.553 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.7 -40.5 97.33 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.006 0.922 . . . . 60.34 111.524 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.69 -33.51 75.05 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.479 -0.782 . . . . 42.5 111.14 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.93 -25.77 60.15 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 122.996 0.518 . . . . 61.21 111.637 171.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -74.99 -34.11 61.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.763 0.825 . . . . 60.21 111.924 -172.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -68.93 -22.42 64.14 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 120.922 0.391 . . . . 71.42 110.39 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.55 1.74 52.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.051 0.94 . . . . 61.22 112.449 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.462 HD11 HG13 ' A' ' 60' ' ' VAL . 31.7 mm -66.53 135.79 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 118.394 0.543 . . . . 64.24 110.729 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.16 -8.58 31.16 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.683 -0.689 . . . . 65.24 113.367 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -80.26 153.44 28.5 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.362 0.581 . . . . 73.12 110.959 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 54' ' ' LYS . 59.5 tp -90.28 146.75 23.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.471 -0.786 . . . . 72.31 109.257 -174.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.431 HG22 HG12 ' A' ' 86' ' ' ILE . 40.1 t -116.95 131.83 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.83 -0.804 . . . . 70.13 108.83 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -113.14 105.73 13.8 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.603 -1.258 . . . . 65.52 107.603 175.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -125.28 124.3 41.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.33 0.652 . . . . 73.41 109.468 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HE3' ' HA2' ' A' ' 50' ' ' GLY . 45.9 tttp -81.22 122.52 27.5 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.99 -0.744 . . . . 70.14 108.99 176.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 82.2 p -65.39 152.62 91.75 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.034 0.534 . . . . 75.03 110.346 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.47 -12.9 30.0 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.268 1.979 . . . . 74.42 112.145 173.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.6 m -70.27 -42.78 71.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.417 1.087 . . . . 75.41 110.726 170.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.464 ' HA2' ' HE3' ' A' ' 46' ' ' LYS . . . 135.06 -22.78 3.56 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 116.104 -0.498 . . . . 33.01 113.126 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -74.09 122.51 22.81 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.605 0.762 . . . . 71.43 110.292 -174.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 72.3 mt -78.83 106.95 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.593 -0.892 . . . . 65.55 108.593 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.401 HD13 ' H ' ' A' ' 75' ' ' LEU . 13.2 mt -86.73 155.34 20.39 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.409 1.084 . . . . 72.21 109.791 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' HD11 ' A' ' 42' ' ' LEU . 47.1 mtpt -123.7 145.46 48.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.934 0.894 . . . . 72.34 109.229 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.76 132.61 3.04 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-O 119.824 -0.431 . . . . 74.52 112.903 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -93.05 128.77 39.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.285 0.543 . . . . 74.03 109.976 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.2 mt -72.13 116.52 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.618 0.767 . . . . 72.44 109.411 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -112.92 -3.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.727 0.811 . . . . 71.13 112.284 -172.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -165.57 161.47 18.48 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.909 0.484 . . . . 73.35 110.48 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.462 HG13 HD11 ' A' ' 39' ' ' ILE . 16.0 m -91.5 168.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.781 0.832 . . . . 74.01 109.732 168.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -143.94 105.07 4.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.076 -0.511 . . . . 74.15 109.767 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.19 176.31 38.17 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 123.377 0.423 . . . . 62.23 113.841 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 30.1 p -91.04 10.1 28.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.394 1.077 . . . . 70.03 111.059 177.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -91.75 12.37 21.53 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.907 0.883 . . . . 73.54 111.749 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.07 12.03 75.23 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 113.984 0.354 . . . . 53.23 113.984 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.55 162.26 27.25 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.174 0.59 . . . . 73.43 109.728 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 15.2 m -132.18 177.92 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.098 0.959 . . . . 61.11 110.521 -178.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.454 ' HD3' HG13 ' A' ' 21' ' ' VAL . 7.4 tmm_? -138.59 116.45 11.56 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.25 -1.389 . . . . 72.4 107.25 -175.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.41 146.05 42.8 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.715 0.806 . . . . 53.0 111.496 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -99.25 100.83 11.98 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.235 1.014 . . . . 73.52 109.311 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -77.24 124.17 27.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.321 0.648 . . . . 74.12 110.984 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 9.9 pt-20 -62.1 -35.9 80.1 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.05 0.94 . . . . 60.21 111.122 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.506 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 74.5 mmtt -99.65 -65.38 0.97 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.595 0.758 . . . . 75.42 109.017 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.0 52.97 36.22 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 124.131 0.894 . . . . 61.42 114.61 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.401 ' H ' HD13 ' A' ' 53' ' ' LEU . 85.5 mt -67.51 137.33 93.33 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.35 0.66 . . . . 64.13 110.563 175.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.52 169.74 15.11 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.024 2.482 . . . . 64.21 112.845 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.73 161.67 22.69 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 115.266 -0.879 . . . . 73.13 110.905 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -91.0 38.8 0.97 Allowed 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.301 1.048 . . . . 75.25 109.306 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.21 29.8 4.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.647 1.179 . . . . 63.23 110.538 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.12 107.9 0.96 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.703 -0.851 . . . . 74.02 108.703 169.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.46 -12.14 16.16 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 116.279 -0.419 . . . . 61.03 112.645 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -77.62 152.82 33.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.842 0.457 . . . . 73.3 110.693 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -87.8 135.58 33.32 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.193 0.997 . . . . 71.23 112.349 -169.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.5 152.69 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.947 0.899 . . . . 55.32 109.138 171.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -114.14 108.72 17.35 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.19 -1.041 . . . . 72.21 108.19 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.431 HG12 HG22 ' A' ' 43' ' ' VAL . 61.9 mt -96.22 119.25 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.358 0.663 . . . . 71.05 109.62 -174.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.7 t -113.44 142.83 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 123.348 0.659 . . . . 71.35 111.183 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 CA--C 1.549 0.939 0 C-N-CA 124.119 0.968 . . . . 74.42 111.845 176.431 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.6 mtm180 . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.51 -0.922 . . . . 73.34 108.51 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.626 HD12 HD21 ' A' ' 38' ' ' LEU . 73.4 mt -129.97 130.45 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.596 0.758 . . . . 74.12 109.164 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.412 ' HG3' HD12 ' A' ' 27' ' ' LEU . 19.6 ptmt -88.54 130.07 35.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.765 -0.828 . . . . 71.4 108.765 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -128.18 140.64 11.93 Favored Glycine 0 C--O 1.217 -0.954 0 CA-C-N 116.459 -0.337 . . . . 71.31 112.363 -175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.7 t -91.93 121.98 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.01 0.524 . . . . 75.43 111.086 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.52 97.48 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.378 1.071 . . . . 71.41 109.65 172.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 25' ' ' LYS . 88.1 mt -72.91 -48.83 33.7 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.52 -0.764 . . . . 65.33 110.036 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.463 ' HA ' HD22 ' A' ' 80' ' ' LEU . 70.0 p -162.37 168.05 22.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.869 -0.605 . . . . 71.42 110.932 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -105.13 123.77 48.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.927 -1.138 . . . . 72.15 107.927 169.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 107.734 -1.209 . . . . 74.24 107.734 176.752 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.436 ' OD1' ' HA3' ' A' ' 74' ' ' GLY . 8.8 p30 . . . . . 0 C--O 1.243 0.738 0 CA-C-O 121.802 0.811 . . . . 73.53 112.015 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t -106.88 121.24 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 114.266 -1.334 . . . . 74.32 109.251 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 45.7 ttm -89.52 123.78 33.93 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.507 -0.923 . . . . 54.54 108.507 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.7 116.02 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.31 -0.996 . . . . 61.44 108.31 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.6 HD13 HG21 ' A' ' 84' ' ' VAL . 84.8 mt -120.46 150.67 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.036 0.935 . . . . 73.33 109.647 -172.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HB2' HD11 ' A' ' 8' ' ' LEU . 78.9 tttt -123.45 91.73 49.48 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.496 0.719 . . . . 75.31 109.416 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' A' ' 66' ' ' ALA . 36.9 Cg_endo -63.72 110.4 1.27 Allowed 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 122.751 2.301 . . . . 60.1 111.272 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.412 HD12 ' HG3' ' A' ' 4' ' ' LYS . 85.8 mt -62.18 -37.72 86.35 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.639 1.176 . . . . 63.52 112.875 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -65.86 -26.25 67.56 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.265 0.626 . . . . 75.51 111.546 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.685 HG13 ' HB2' ' A' ' 34' ' ' GLU . 40.3 t -100.32 131.59 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.197 0.999 . . . . 74.22 110.96 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -130.32 -3.48 4.37 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.664 0.785 . . . . 62.33 111.451 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.8 m -123.28 154.48 38.79 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.447 0.699 . . . . 72.15 110.563 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.566 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 63.0 ttt180 -64.95 -30.84 71.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.134 0.974 . . . . 64.31 111.634 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -69.48 -39.66 77.55 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.889 0.876 . . . . 63.0 110.146 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.685 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.5 mt-10 -70.42 -38.61 74.61 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.667 -1.151 . . . . 73.52 109.526 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.36 -30.81 69.84 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.645 0.778 . . . . 72.54 111.228 174.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 t -74.15 -30.82 62.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.397 0.679 . . . . 72.41 110.041 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -90.78 4.1 52.57 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.743 0.417 . . . . 53.45 110.98 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.626 HD21 HD12 ' A' ' 3' ' ' ILE . 34.3 mt -87.83 -18.31 29.57 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.618 0.367 . . . . 74.24 110.415 165.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.565 HD13 HG22 ' A' ' 57' ' ' ILE . 50.2 mm -59.86 106.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.195 0.598 . . . . 73.53 109.393 174.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.19 -29.35 4.6 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 116.052 -0.522 . . . . 15.54 112.527 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 153.94 39.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.208 0.603 . . . . 74.21 111.901 -173.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.58 HD11 ' HE2' ' A' ' 54' ' ' LYS . 60.9 tp -90.41 123.73 34.38 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.42 1.088 . . . . 65.11 109.674 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.8 115.18 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 109.412 -0.588 . . . . 75.34 109.412 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt -104.36 110.12 22.24 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.557 1.143 . . . . 52.24 108.732 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -124.49 127.73 47.91 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.307 -0.627 . . . . 64.32 109.307 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -88.12 106.7 18.34 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.367 -0.975 . . . . 62.21 108.367 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.9 p -64.31 157.37 71.53 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.046 0.938 . . . . 62.45 112.406 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.92 -23.78 73.88 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.842 2.361 . . . . 62.1 112.074 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.1 t -61.91 -23.27 66.22 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.538 1.135 . . . . 62.33 111.343 173.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.86 19.18 34.94 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.712 -0.676 . . . . 60.24 112.64 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.0 143.02 40.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.554 0.742 . . . . 73.01 110.105 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.5 mt -89.08 102.09 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.724 -0.843 . . . . 72.01 108.724 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 75' ' ' LEU . 26.3 mt -82.71 138.09 34.2 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.142 0.577 . . . . 75.21 110.369 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.58 ' HE2' HD11 ' A' ' 42' ' ' LEU . 13.4 mmmm -96.09 132.92 40.97 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.572 -0.899 . . . . 73.12 108.572 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.18 172.94 22.7 Favored Glycine 0 C--N 1.332 0.353 0 O-C-N 123.618 0.574 . . . . 65.33 112.075 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -151.81 131.71 13.34 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.122 0.569 . . . . 74.14 109.843 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.565 HG22 HD13 ' A' ' 39' ' ' ILE . 73.0 mt -70.8 108.93 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 109.137 -0.69 . . . . 54.11 109.137 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.75 -14.94 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.182 0.993 . . . . 63.1 111.225 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 23.7 tpp180 -149.29 148.82 30.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.327 0.651 . . . . 71.41 109.371 -173.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 39' ' ' ILE . 21.2 m -98.74 171.41 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.335 0.654 . . . . 74.13 109.988 173.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -124.13 103.64 8.39 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.386 -0.968 . . . . 72.45 108.386 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.94 -134.1 52.3 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 124.144 0.903 . . . . 75.52 113.602 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.566 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 69.3 p -119.62 -4.55 10.28 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.741 0.816 . . . . 54.33 111.993 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -73.93 -7.81 53.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.069 0.548 . . . . 75.14 112.017 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.51 -10.98 70.71 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 119.649 -0.528 . . . . 53.34 113.209 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . . . -60.68 149.68 34.5 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.999 0.52 . . . . 52.23 109.652 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.542 HG22 ' HD3' ' A' ' 26' ' ' PRO . 35.1 m -131.13 178.97 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 121.921 0.867 . . . . 72.33 111.96 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 97.8 mtt180 -133.86 118.99 18.59 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.259 1.424 . . . . 74.53 108.379 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.72 133.57 55.85 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.968 0.507 . . . . 64.44 110.715 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -88.7 123.21 32.92 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.182 0.593 . . . . 74.15 109.633 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -105.23 133.41 50.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.716 0.806 . . . . 75.41 109.46 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -61.13 -37.02 81.32 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.678 0.791 . . . . 74.12 111.852 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -98.08 -61.03 1.44 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.82 0.848 . . . . 74.11 108.974 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.436 ' HA3' ' OD1' ' A' ' 20' ' ' ASN . . . 60.91 54.68 34.91 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 124.083 0.864 . . . . 73.21 112.93 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.496 ' HB2' HD11 ' A' ' 53' ' ' LEU . 51.6 mt -68.46 115.92 34.77 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.24 1.016 . . . . 63.02 110.513 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.7 179.84 5.85 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 123.283 2.656 . . . . 52.14 112.332 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.81 176.94 25.07 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 110.723 -0.951 . . . . 44.42 110.723 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -77.39 70.02 3.73 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 122.038 0.923 . . . . 71.31 109.086 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.73 13.6 11.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.811 -1.086 . . . . 73.3 111.922 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 9' ' ' SER . 60.9 mt -74.27 103.21 4.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.464 -0.939 . . . . 72.12 108.464 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.4 -18.2 6.89 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 112.116 -0.394 . . . . 52.22 112.116 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.96 169.93 16.99 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.986 0.514 . . . . 64.31 111.336 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -108.28 155.9 19.98 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.232 0.613 . . . . 73.24 111.043 -170.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.6 HG21 HD13 ' A' ' 24' ' ' ILE . 20.2 m -122.15 160.28 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.462 1.105 . . . . 65.53 108.773 174.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -106.02 108.5 20.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.177 -0.675 . . . . 43.14 109.177 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' ARG . 77.9 mt -93.93 92.12 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.336 -1.357 . . . . 34.41 107.336 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.66 127.6 48.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.247 1.019 . . . . 73.45 110.266 -172.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 C--O 1.238 0.465 0 N-CA-C 107.915 -1.143 . . . . 72.24 107.915 173.961 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 110.48 -0.193 . . . . 72.41 110.48 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 47.1 mtm-85 -125.12 127.56 47.06 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.375 -0.972 . . . . 63.41 108.375 170.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 63.6 mt -97.12 132.57 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.656 0.782 . . . . 74.44 109.358 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -89.42 129.61 35.9 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.289 -0.634 . . . . 73.52 109.289 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.58 164.99 25.12 Favored Glycine 0 C--N 1.345 1.03 0 O-C-N 123.253 0.346 . . . . 43.33 112.929 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.57 120.65 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.993 0.917 . . . . 73.21 109.253 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.493 HG13 ' HB2' ' A' ' 22' ' ' MET . 23.7 t -68.9 102.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 109.687 -0.486 . . . . 72.02 109.687 173.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 25' ' ' LYS . 56.4 mt -70.23 -37.3 74.97 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.761 0.824 . . . . 72.14 110.321 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -156.96 158.13 36.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.87 -0.604 . . . . 74.14 111.603 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.96 162.15 18.22 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.955 0.902 . . . . 74.13 109.113 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.563 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 22.7 mtm180 -135.4 128.31 31.34 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.666 -1.235 . . . . 71.3 107.666 171.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -73.98 121.34 20.86 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.28 -0.637 . . . . 65.23 109.28 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -69.54 101.06 1.52 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.678 -0.692 . . . . 63.54 109.948 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -88.62 -2.37 58.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.692 -1.14 . . . . 73.51 110.566 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -76.79 173.49 11.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.112 0.965 . . . . 74.1 110.111 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -64.02 -44.93 91.08 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.008 0.432 . . . . 75.53 109.902 172.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -76.51 89.17 3.26 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.302 -0.863 . . . . 64.05 108.806 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -70.67 87.97 0.69 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.577 0.703 . . . . 61.35 109.555 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -127.42 105.69 8.69 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.334 -0.987 . . . . 63.34 108.334 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.653 ' H ' ' HA2' ' A' ' 74' ' ' GLY . 4.3 p-10 -63.11 118.84 8.46 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 123.681 0.613 . . . . 74.22 109.791 -171.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.571 HG22 ' HG2' ' A' ' 70' ' ' ARG . 16.7 t -90.32 149.39 4.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.546 -0.909 . . . . 72.22 108.546 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.493 ' HB2' HG13 ' A' ' 7' ' ' VAL . 21.5 ptp -149.26 140.91 23.49 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.02 0.438 . . . . 73.34 111.309 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -86.34 97.97 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.249 -1.389 . . . . 61.35 107.249 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.01 133.18 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.747 0.819 . . . . 70.21 108.973 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HB2' HD11 ' A' ' 8' ' ' LEU . 33.7 ttpt -107.56 97.0 17.97 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.107 -1.071 . . . . 75.11 108.107 170.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 11.5 Cg_exo -68.5 122.39 9.38 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.986 1.791 . . . . 44.54 110.74 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.63 -29.56 66.6 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.255 1.022 . . . . 64.54 112.008 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HB3' HG23 ' A' ' 3' ' ' ILE . 35.7 t70 -88.46 -28.5 20.82 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.859 0.864 . . . . 64.03 112.157 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 89.4 t -104.82 99.71 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.391 0.676 . . . . 73.51 109.808 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -119.41 12.13 12.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.396 0.678 . . . . 63.33 110.359 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.1 m -122.43 149.07 44.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.819 0.847 . . . . 70.2 110.613 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 53.8 ttt180 -63.88 -36.91 85.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.237 1.015 . . . . 73.32 111.357 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -65.29 -48.69 72.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.523 0.729 . . . . 72.2 110.532 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HB2' HG13 ' A' ' 29' ' ' VAL . 50.2 mt-10 -63.21 -30.37 71.53 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.74 -1.118 . . . . 71.12 110.976 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.73 -36.2 37.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.692 0.797 . . . . 41.14 111.512 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -73.39 -27.49 61.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.73 0.812 . . . . 52.15 110.915 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -82.11 -1.19 47.92 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.094 -0.503 . . . . 61.4 111.363 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 29' ' ' VAL . 93.4 mt -98.59 1.95 46.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.574 0.75 . . . . 75.2 112.144 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.651 HD11 HG13 ' A' ' 60' ' ' VAL . 51.2 mm -67.94 109.58 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.361 0.528 . . . . 75.11 110.278 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.95 -15.82 18.65 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.566 -0.743 . . . . 75.42 112.551 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.587 ' HG3' ' H ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -70.9 152.87 43.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.905 0.482 . . . . 74.12 111.228 -177.181 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 54' ' ' LYS . 26.6 tp -94.86 114.61 26.49 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 124.389 1.056 . . . . 74.3 109.668 -167.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.72 131.43 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.23 -0.656 . . . . 71.51 109.23 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.4 mt -107.66 101.31 10.63 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.66 -0.867 . . . . 61.45 108.66 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.411 ' HH2' ' HA3' ' A' ' 77' ' ' GLY . 34.5 t90 -100.22 140.8 33.94 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.916 0.486 . . . . 74.11 109.807 175.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -91.74 101.05 13.66 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.203 1.001 . . . . 75.51 108.775 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.3 p -65.0 150.58 95.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.035 0.534 . . . . 71.41 111.149 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.54 -19.37 36.47 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.409 2.739 . . . . 72.43 113.049 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.4 t -71.78 -8.59 55.17 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.056 0.942 . . . . 72.43 112.347 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.19 32.81 30.71 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.492 -0.243 . . . . 72.4 112.492 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -128.02 146.11 50.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.863 0.865 . . . . 54.14 108.864 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -99.43 100.09 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.844 -0.799 . . . . 75.52 108.844 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 75' ' ' LEU . 21.5 mt -74.99 137.28 41.45 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.156 -0.929 . . . . 73.15 109.034 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.574 ' HB3' HD11 ' A' ' 42' ' ' LEU . 24.0 mtmm -96.92 139.31 33.14 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.128 -0.693 . . . . 74.31 109.128 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -140.82 177.4 20.88 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 116.198 -0.456 . . . . 73.51 112.717 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -139.3 126.73 21.57 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.515 -0.55 . . . . 75.4 109.515 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.489 HG22 HD13 ' A' ' 39' ' ' ILE . 63.1 mt -68.75 103.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.041 -0.725 . . . . 61.24 109.041 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.456 HG11 ' HD3' ' A' ' 70' ' ' ARG . 27.6 m -83.84 -35.24 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.59 -0.732 . . . . 64.5 110.98 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -163.99 153.73 14.53 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.625 0.77 . . . . 65.21 109.584 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.651 HG13 HD11 ' A' ' 39' ' ' ILE . 12.2 m -91.55 170.46 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.289 0.636 . . . . 72.33 110.043 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -122.79 103.66 8.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.951 -1.129 . . . . 74.12 107.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.12 -150.63 51.71 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 124.335 1.022 . . . . 43.11 114.292 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.567 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 55.2 p -98.47 -9.91 24.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.664 0.786 . . . . 72.3 111.81 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.12 -12.52 19.95 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.735 0.814 . . . . 74.01 112.86 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.32 -1.34 87.56 Favored Glycine 0 C--N 1.349 1.25 0 N-CA-C 112.393 -0.283 . . . . 35.51 112.393 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.48 119.37 10.92 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.47 0.708 . . . . 72.0 110.162 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' HB ' HG23 ' A' ' 57' ' ' ILE . 29.6 m -101.65 148.27 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 122.661 0.384 . . . . 72.44 110.289 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -113.71 113.7 25.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.379 -0.6 . . . . 65.43 109.379 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.63 134.3 55.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.968 -0.56 . . . . 53.23 111.433 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 21' ' ' VAL . 67.9 mtp85 -102.57 123.31 46.06 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.162 0.985 . . . . 72.2 109.005 174.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.439 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 12.5 m-85 -99.04 126.9 44.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.178 0.591 . . . . 74.43 111.156 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 54' ' ' LYS . 22.1 pt-20 -50.28 -38.06 39.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.376 1.471 . . . . 71.45 113.652 -172.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -75.39 -24.85 57.24 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.259 0.624 . . . . 62.15 111.54 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.653 ' HA2' ' H ' ' A' ' 20' ' ' ASN . . . 63.83 24.76 68.58 Favored Glycine 0 C--N 1.348 1.195 0 O-C-N 123.633 0.583 . . . . 64.2 114.432 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.506 ' HB2' HD11 ' A' ' 53' ' ' LEU . 84.4 mt -86.59 136.31 35.09 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 123.088 0.555 . . . . 61.02 110.6 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 11.4 Cg_exo -71.08 174.32 10.82 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.561 2.84 . . . . 63.1 112.098 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.411 ' HA3' ' HH2' ' A' ' 45' ' ' TRP . . . -158.85 -65.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.1 -0.5 . . . . 72.04 112.549 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 60.28 31.79 20.55 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 123.062 1.411 . . . . 74.02 110.272 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.33 31.61 0.81 Allowed 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 114.107 -1.406 . . . . 61.54 111.291 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -35.68 111.1 0.12 Allowed 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 126.289 1.835 . . . . 74.42 114.194 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.41 -4.25 26.54 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.9 -0.591 . . . . 54.34 113.102 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.81 157.93 35.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.331 0.652 . . . . 54.02 111.611 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -102.06 141.4 34.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.274 0.559 . . . . 73.04 112.127 -172.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.9 m -116.29 166.61 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.209 1.003 . . . . 73.23 110.326 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -128.71 109.15 11.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.506 -0.553 . . . . 74.01 109.506 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 61.3 mt -82.37 100.1 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.241 1.016 . . . . 73.34 109.346 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.5 t -72.76 117.64 16.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.229 0 N-CA-C 109.098 -0.705 . . . . 71.11 109.098 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -63.34 86.61 0.03 OUTLIER 'General case' 0 C--N 1.35 0.61 0 N-CA-C 107.351 -1.352 . . . . 64.13 107.351 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.587 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -75.86 -62.99 1.41 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.421 -1.263 . . . . 72.55 110.035 -179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 58.29 81.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.567 1.167 . . . . 72.34 110.732 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 119.051 -0.499 . . . . 64.13 110.046 173.344 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mmt . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 109.762 -0.458 . . . . 71.31 109.762 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -150.05 141.69 23.56 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.637 1.175 . . . . 64.15 108.818 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 74.2 mt -112.34 133.73 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.121 -1.066 . . . . 71.33 108.121 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -88.14 133.36 34.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.525 -0.546 . . . . 71.03 109.525 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -122.24 165.53 15.01 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 110.891 -0.883 . . . . 54.42 110.891 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.3 t -111.54 128.38 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 123.691 0.796 . . . . 74.24 109.313 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.69 93.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.446 1.099 . . . . 73.42 108.813 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 25' ' ' LYS . 64.7 mt -71.27 -51.19 25.9 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.343 -0.39 . . . . 73.33 110.062 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 p -159.48 156.18 27.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.737 -0.665 . . . . 74.33 110.875 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -92.5 104.88 17.15 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.243 -1.021 . . . . 74.32 108.243 169.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -83.35 112.35 19.83 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.004 -0.739 . . . . 71.04 109.004 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -74.08 148.4 41.9 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.818 -0.438 . . . . 73.11 109.818 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -137.87 157.69 45.88 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.023 0.929 . . . . 74.22 109.337 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -78.22 77.16 4.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.743 0.782 . . . . 70.05 109.815 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -65.54 131.26 45.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.132 -1.394 . . . . 73.53 111.452 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -64.01 -51.48 64.04 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.271 0.628 . . . . 64.43 109.954 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -118.37 -65.68 1.15 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.445 -0.946 . . . . 71.55 108.445 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -160.43 118.02 2.51 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 123.191 0.307 . . . . 74.53 111.174 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -154.69 136.91 14.82 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.636 1.575 . . . . 73.44 107.854 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.694 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 29.1 t-20 -138.53 141.24 39.32 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.358 0.599 . . . . 62.44 109.904 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.495 HG22 ' HD2' ' A' ' 70' ' ' ARG . 58.9 t -101.52 151.15 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.465 1.106 . . . . 65.21 109.313 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 44.6 ttm -130.86 122.65 27.43 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.404 -0.961 . . . . 70.04 108.404 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 8' ' ' LEU . 47.9 mm -81.96 118.26 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.975 -1.121 . . . . 73.32 107.975 172.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -122.12 153.32 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.271 1.029 . . . . 71.44 108.738 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HB2' HD11 ' A' ' 8' ' ' LEU . 57.6 tttp -122.76 110.5 31.67 Favored Pre-proline 0 N--CA 1.473 0.698 0 N-CA-C 109.131 -0.692 . . . . 75.11 109.131 168.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 65' ' ' GLY . 27.2 Cg_exo -59.65 125.76 18.73 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.234 1.956 . . . . 71.22 110.192 167.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.83 -33.22 74.79 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.656 0.782 . . . . 45.44 111.327 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.55 -28.02 69.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.942 0.897 . . . . 63.23 111.449 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 35' ' ' ALA . 78.6 t -109.47 131.61 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.228 1.011 . . . . 72.0 111.4 -170.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -128.89 15.67 6.34 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.214 1.006 . . . . 71.33 110.525 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 m -143.75 154.06 43.07 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.335 0.654 . . . . 74.2 111.145 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.581 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 52.1 ttt180 -61.01 -50.28 74.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.259 1.024 . . . . 73.11 111.89 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.42 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 47.6 mt-10 -74.45 -30.45 61.88 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.58 0.352 . . . . 75.2 111.061 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -67.21 -25.4 66.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.069 0.548 . . . . 75.15 110.919 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.488 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -87.13 -30.63 20.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.546 0.738 . . . . 74.2 110.307 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 10.0 t -85.92 -6.97 58.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.068 0.947 . . . . 63.34 111.606 -172.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -82.82 -19.31 37.87 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.414 -0.587 . . . . 70.23 109.414 167.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.0 mt -87.82 6.31 35.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.631 0.772 . . . . 71.22 111.478 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 57' ' ' ILE . 42.5 mm -63.03 119.26 6.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 109.663 -0.495 . . . . 75.2 109.663 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.59 -4.53 40.02 Favored Glycine 0 C--O 1.239 0.46 0 CA-C-N 116.159 -0.473 . . . . 30.12 112.93 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -80.11 150.61 30.19 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 109.067 -0.716 . . . . 74.22 109.067 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.581 HD21 ' HD2' ' A' ' 54' ' ' LYS . 27.1 tp -89.86 159.55 16.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.208 -0.905 . . . . 34.54 109.024 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 86' ' ' ILE . 90.4 t -128.32 114.53 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 107.509 -1.293 . . . . 65.01 107.509 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.32 108.75 21.52 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.705 1.202 . . . . 71.04 108.846 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -144.87 123.47 12.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.325 0.65 . . . . 74.53 109.823 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 27.1 ttpp -88.11 135.89 33.22 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.944 0.498 . . . . 61.21 109.73 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.9 p -73.75 158.28 86.32 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.856 0.863 . . . . 70.23 110.765 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.21 -8.1 19.32 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.433 2.089 . . . . 71.34 112.444 167.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -72.89 -21.71 60.87 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.644 0.777 . . . . 72.24 111.271 168.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.05 -19.44 37.85 Favored Glycine 0 C--N 1.352 1.439 0 C-N-CA 123.038 0.352 . . . . 72.34 113.442 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 134.42 34.76 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.275 0.63 . . . . 73.31 109.923 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 62.2 mt -78.3 123.72 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.481 -0.563 . . . . 41.02 109.481 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.556 HD22 ' HB2' ' A' ' 73' ' ' LYS . 10.6 mt -102.97 131.05 50.21 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.28 -1.007 . . . . 64.23 108.28 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.581 ' HD2' HD21 ' A' ' 42' ' ' LEU . 32.1 mtmm -111.77 132.25 54.78 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.067 -0.716 . . . . 71.03 109.067 173.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.46 151.37 20.55 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 111.026 -0.829 . . . . 43.52 111.026 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -115.34 135.04 54.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.266 1.033 . . . . 72.22 110.708 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.492 HG22 HD13 ' A' ' 39' ' ' ILE . 56.7 mt -67.78 96.25 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.597 -0.89 . . . . 61.13 108.597 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 m -86.75 -31.4 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.012 0.525 . . . . 73.44 111.171 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -154.42 179.37 9.07 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 107.988 -1.116 . . . . 74.23 107.988 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.412 HG13 HD11 ' A' ' 39' ' ' ILE . 35.3 m -128.64 161.87 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.364 0.666 . . . . 64.4 109.959 170.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 21.8 t-80 -144.53 103.39 3.94 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.125 -0.695 . . . . 74.45 109.125 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.47 145.59 9.29 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 112.521 -0.232 . . . . 61.2 112.521 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.581 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 43.8 p -90.16 11.94 19.43 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.246 1.018 . . . . 62.35 111.928 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -106.58 17.08 23.77 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.03 0.932 . . . . 74.11 110.98 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' HD2' ' A' ' 26' ' ' PRO . . . 76.63 36.18 38.61 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.097 -0.501 . . . . 75.11 113.909 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . -89.75 123.68 33.97 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.641 -0.874 . . . . 51.52 108.641 172.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.473 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.5 m -102.06 152.86 5.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-O 121.898 0.856 . . . . 71.23 111.35 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -101.62 103.66 14.49 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.551 1.54 . . . . 65.42 108.331 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.61 117.11 33.24 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.162 0.585 . . . . 74.23 110.762 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.495 ' HD2' HG22 ' A' ' 21' ' ' VAL . 12.5 mmm-85 -89.44 102.62 15.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.326 1.05 . . . . 73.21 109.916 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.2 136.08 34.1 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.423 0.689 . . . . 55.32 110.976 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.532 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 14.3 pt-20 -57.33 -52.4 65.51 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.681 1.193 . . . . 42.14 111.039 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HB2' HD22 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -92.92 -54.04 3.91 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.332 -0.988 . . . . 70.44 108.332 -179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.694 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 60.77 50.01 72.25 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 124.823 1.327 . . . . 50.25 112.894 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.414 ' HB2' HD11 ' A' ' 53' ' ' LEU . 35.9 mt -67.74 111.71 8.38 Favored Pre-proline 0 C--N 1.351 0.633 0 C-N-CA 123.271 0.628 . . . . 75.41 110.102 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.58 173.42 9.53 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.009 2.473 . . . . 62.55 111.218 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 165.32 -168.31 39.3 Favored Glycine 0 C--O 1.238 0.383 0 N-CA-C 111.315 -0.714 . . . . 51.21 111.315 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -94.8 67.38 3.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.192 0.996 . . . . 75.11 109.232 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.09 26.5 9.22 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.689 -1.141 . . . . 62.43 109.714 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.58 119.26 12.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.516 0.727 . . . . 71.04 110.698 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.01 -2.12 38.25 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.982 -0.554 . . . . 32.32 112.558 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.55 162.84 27.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.439 0.696 . . . . 73.43 109.943 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.53 131.92 45.21 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.386 0.674 . . . . 74.15 111.034 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.26 159.24 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.598 1.159 . . . . 61.45 108.608 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.2 106.5 14.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.522 -0.918 . . . . 74.34 108.522 170.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.496 HG12 HG22 ' A' ' 43' ' ' VAL . 71.7 mt -83.42 108.73 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.383 -0.969 . . . . 72.13 108.383 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.73 143.87 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.946 0.898 . . . . 63.44 110.015 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.78 132.92 54.71 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 108.837 -0.801 . . . . 73.3 108.837 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -139.04 127.82 23.42 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.817 -1.179 . . . . 75.21 107.817 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -157.79 18.79 0.26 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.221 0.609 . . . . 72.13 110.718 -172.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 124.51 1.124 . . . . 74.31 110.097 -178.48 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.0 mtp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.869 0.366 . . . . 63.45 110.513 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 -128.52 139.35 52.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.172 0.989 . . . . 73.52 108.648 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 28' ' ' ASP . 53.0 mt -97.18 134.49 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 122.976 0.51 . . . . 70.41 110.476 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -89.27 121.61 31.72 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.005 0.922 . . . . 64.14 108.778 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -119.82 176.34 16.12 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-O 119.753 -0.471 . . . . 64.04 112.054 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.44 126.99 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.77 0.828 . . . . 75.22 109.653 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.43 99.4 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.618 0.767 . . . . 63.51 109.3 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 25' ' ' LYS . 66.5 mt -71.59 -48.04 50.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.438 0.695 . . . . 62.12 110.033 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -157.02 159.96 38.51 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.451 -0.795 . . . . 71.53 110.487 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -99.65 159.22 15.21 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.245 -1.021 . . . . 63.44 108.245 167.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.57 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -136.98 106.6 6.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.129 -1.063 . . . . 73.33 108.129 176.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.03 146.85 43.42 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.782 0.433 . . . . 73.13 110.46 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -96.09 151.47 19.44 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.438 0.695 . . . . 65.32 109.482 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -57.59 -33.37 68.13 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.733 0.813 . . . . 73.12 111.003 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.96 136.45 33.01 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.1 -1.445 . . . . 70.01 107.1 171.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -53.62 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.477 1.511 . . . . 74.22 113.099 -169.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 44.83 37.9 2.58 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.59 1.556 . . . . 73.32 113.255 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -74.07 -38.07 64.04 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.078 -0.965 . . . . 72.05 109.736 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -156.05 70.51 0.69 Allowed 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.607 -1.257 . . . . 62.24 107.607 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.505 HD22 ' HA3' ' A' ' 74' ' ' GLY . 14.6 p-10 -76.63 160.74 29.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.169 -0.923 . . . . 71.23 108.966 176.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.572 HG11 ' HE ' ' A' ' 68' ' ' ARG . 11.7 t -98.26 162.88 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.545 -0.909 . . . . 75.23 108.545 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.0 ttm -147.18 124.0 11.25 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.63 -1.248 . . . . 72.35 107.63 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.65 118.3 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 123.876 0.735 . . . . 44.41 109.278 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.8 mt -129.15 158.08 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.256 1.022 . . . . 72.32 108.386 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 8' ' ' LEU . 27.7 ttpp -141.41 108.44 6.16 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 109.671 -0.492 . . . . 71.05 109.671 170.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 14.2 Cg_endo -56.54 143.16 89.15 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 123.887 3.058 . . . . 73.53 112.864 171.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.7 mt -80.44 -38.15 30.62 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.348 1.059 . . . . 72.34 110.467 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' HB3' HG23 ' A' ' 3' ' ' ILE . 26.2 t70 -67.96 -27.64 66.77 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.135 -0.939 . . . . 61.31 111.593 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.474 HG21 HD11 ' A' ' 38' ' ' LEU . 76.5 t -110.79 120.06 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.194 0.998 . . . . 72.43 110.477 -176.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -127.67 21.64 6.47 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.695 0.798 . . . . 63.21 110.556 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.3 p -140.28 158.62 43.75 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.718 0.807 . . . . 71.4 110.676 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.649 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 48.3 ttt85 -65.96 -50.32 64.76 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.833 0.853 . . . . 74.01 112.775 -169.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -30.21 57.62 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.652 0.595 . . . . 70.41 111.163 -171.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HA ' ' HD2' ' A' ' 37' ' ' LYS . 42.7 mm-40 -69.1 -20.29 64.07 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.25 -0.432 . . . . 72.42 111.318 170.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.2 -26.22 20.23 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.736 0.814 . . . . 60.12 110.575 170.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -80.84 -12.59 59.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.789 0.835 . . . . 75.5 110.692 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 34' ' ' GLU . 15.0 ptmt -85.46 -16.39 39.8 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.126 0.489 . . . . 70.14 109.776 170.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 HG21 ' A' ' 29' ' ' VAL . 43.2 mt -81.98 -8.5 59.67 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.27 0.628 . . . . 73.31 111.149 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.534 HD13 HG22 ' A' ' 57' ' ' ILE . 43.1 mm -59.92 130.22 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.494 -0.558 . . . . 75.11 109.494 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.94 -19.06 56.12 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-O 119.872 -0.405 . . . . 61.54 112.844 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 87' ' ' VAL . 94.3 mtt180 -78.32 156.65 29.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.989 0.516 . . . . 75.31 111.309 -176.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.808 ' HB2' ' HA ' ' A' ' 90' ' ' HIS . 21.6 tp -90.99 128.88 36.99 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.531 0.732 . . . . 64.23 109.517 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 86' ' ' ILE . 56.5 t -99.28 115.12 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.054 -0.721 . . . . 62.23 109.054 172.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.17 122.62 34.83 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.397 -0.964 . . . . 75.14 108.397 173.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 37.6 t90 -135.86 132.22 36.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.24 -0.652 . . . . 61.5 109.24 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -90.61 122.66 33.59 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.292 -1.003 . . . . 63.11 108.292 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.8 p -83.86 159.51 60.24 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.095 0.558 . . . . 70.1 111.078 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.39 -14.91 44.21 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.337 2.025 . . . . 72.21 111.764 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.1 t -68.99 -23.2 64.08 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.895 0.878 . . . . 63.31 111.124 173.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.99 20.29 26.39 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 116.324 -0.398 . . . . 74.12 112.78 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -111.15 137.13 49.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.763 0.825 . . . . 71.32 110.128 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.3 mt -86.07 93.48 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.063 -1.088 . . . . 71.44 108.063 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 73' ' ' LYS . 51.1 mt -80.59 133.14 35.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.04 -0.982 . . . . 71.24 109.766 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB3' HD11 ' A' ' 42' ' ' LEU . 30.6 mtmm -116.01 138.58 51.08 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.092 -0.707 . . . . 51.23 109.092 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -140.02 176.16 21.43 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-N 115.602 -0.726 . . . . 74.42 111.312 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -135.76 133.85 38.4 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.565 0.682 . . . . 72.11 109.826 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.534 HG22 HD13 ' A' ' 39' ' ' ILE . 58.1 mt -73.84 108.32 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.384 -0.599 . . . . 54.51 109.384 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.33 -20.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.708 0.803 . . . . 71.22 111.464 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -158.45 162.66 37.55 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.524 -0.547 . . . . 72.25 109.524 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 39' ' ' ILE . 33.8 m -108.34 169.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.663 0.785 . . . . 64.3 109.731 171.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -125.26 104.59 8.57 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.034 -0.728 . . . . 65.1 109.034 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.56 -140.31 44.44 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 123.971 0.794 . . . . 72.04 113.331 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 63.5 p -115.34 4.26 14.37 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.794 0.838 . . . . 54.4 111.716 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -82.38 1.55 36.72 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.253 0.621 . . . . 63.43 112.13 -171.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.41 0.88 87.87 Favored Glycine 0 C--N 1.355 1.611 0 CA-C-O 120.069 -0.295 . . . . 62.2 112.966 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.88 121.51 16.18 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.322 0.649 . . . . 73.54 110.177 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.2 141.42 18.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.426 0.632 . . . . 62.54 110.824 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.572 ' HE ' HG11 ' A' ' 21' ' ' VAL . 64.7 ttt180 -103.8 104.32 14.31 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.879 0.872 . . . . 61.5 108.95 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.37 136.23 52.1 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.289 0.636 . . . . 70.04 110.592 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HG2' HG22 ' A' ' 21' ' ' VAL . 72.0 mtp180 -106.32 117.24 33.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.809 0.444 . . . . 61.55 110.005 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -92.41 143.69 26.12 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.933 0.893 . . . . 72.41 111.129 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 15.8 pt-20 -60.6 -30.98 70.17 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.49 1.116 . . . . 74.14 111.601 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' HB2' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -119.69 -72.73 0.67 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.744 -0.836 . . . . 71.23 108.744 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.505 ' HA3' HD22 ' A' ' 20' ' ' ASN . . . 66.57 57.26 10.39 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 111.759 -0.537 . . . . 73.12 111.759 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.12 123.17 85.65 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.824 0.85 . . . . 74.22 110.584 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.13 151.45 38.97 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 123.843 3.028 . . . . 73.3 113.489 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.56 171.52 37.47 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.395 -0.821 . . . . 54.54 111.106 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -87.39 69.01 9.88 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.773 0.797 . . . . 74.34 109.399 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -119.51 27.93 8.47 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.046 -0.979 . . . . 62.33 110.369 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.08 135.91 47.98 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.572 0.349 . . . . 72.33 110.385 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.17 -6.47 63.79 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.01 -0.541 . . . . 74.21 112.574 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.91 155.61 35.03 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.233 0.613 . . . . 55.52 109.44 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 97.3 m-85 -102.09 145.04 29.91 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.135 0.493 . . . . 63.11 112.147 -169.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.79 165.42 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.298 -0.865 . . . . 74.31 109.901 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -128.74 110.35 12.1 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.463 0.705 . . . . 73.02 109.118 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 43' ' ' VAL . 59.0 mt -84.22 113.18 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.094 0.958 . . . . 43.41 109.073 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 27.5 t -87.58 146.31 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.38 1.072 . . . . 51.23 110.022 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -57.02 -48.68 77.9 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.138 0.975 . . . . 75.11 110.856 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.32 -177.49 6.5 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.112 0.965 . . . . 72.23 110.452 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.808 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . 37.9 p-80 -137.88 -68.27 0.47 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.504 0.322 . . . . 71.41 110.944 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 . . . . . 0 C--O 1.246 0.907 0 N-CA-C 108.115 -1.069 . . . . 74.21 108.115 -178.4 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 120.939 0.4 . . . . 73.2 110.227 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.513 ' HG2' HG22 ' A' ' 87' ' ' VAL . 73.6 mtt180 -103.49 123.54 47.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.93 0.892 . . . . 72.22 109.188 173.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 48.4 mt -98.81 131.35 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.78 0.832 . . . . 73.43 108.85 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.11 120.58 29.61 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.788 -0.819 . . . . 74.23 108.788 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -125.24 170.71 17.17 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.861 -0.496 . . . . 61.14 111.861 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.7 t -126.54 138.95 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.239 1.016 . . . . 74.24 109.513 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.39 114.29 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.44 1.096 . . . . 62.12 110.12 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 23' ' ' ILE . 42.4 mt -92.61 -55.68 3.3 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.729 0.412 . . . . 55.22 110.479 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -153.87 152.33 30.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.837 0.455 . . . . 64.3 111.949 -174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -110.09 128.74 55.62 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.047 0.939 . . . . 72.14 108.574 170.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.79 106.19 9.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.058 -1.83 . . . . 65.53 106.058 171.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -76.91 125.41 29.26 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.252 0.478 . . . . 65.14 109.796 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.444 ' H ' ' HA ' ' A' ' 20' ' ' ASN . 33.5 t -73.6 119.42 17.8 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.303 1.041 . . . . 64.41 110.795 -174.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -68.87 106.63 2.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.845 0.858 . . . . 42.13 110.186 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.575 ' HG3' ' H ' ' A' ' 17' ' ' GLN . 11.2 tp10 -163.84 164.94 23.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.607 0.763 . . . . 63.03 109.763 -176.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.87 -35.78 79.13 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.607 -0.516 . . . . 70.2 109.607 171.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.575 ' H ' ' HG3' ' A' ' 15' ' ' GLU . 33.8 tt0 -88.2 113.01 23.39 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.504 -0.924 . . . . 72.12 108.504 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -57.62 119.78 7.18 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 124.091 0.869 . . . . 65.22 109.972 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -153.02 171.36 18.5 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.962 -1.125 . . . . 63.22 107.962 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.444 ' HA ' ' H ' ' A' ' 13' ' ' SER . 3.5 p-10 -149.0 150.21 32.44 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.467 0.651 . . . . 74.22 110.789 174.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.444 HG22 ' HD3' ' A' ' 70' ' ' ARG . 47.3 t -88.07 143.5 11.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.885 -1.524 . . . . 73.43 106.885 159.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.4 ttt -137.26 113.58 10.04 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.46 -0.941 . . . . 73.24 108.46 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 8' ' ' LEU . 46.0 mm -80.37 119.83 30.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.104 -1.073 . . . . 70.21 108.104 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.479 HG21 HG21 ' A' ' 84' ' ' VAL . 98.0 mt -129.87 143.99 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.187 0.995 . . . . 71.43 108.398 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HB2' HD11 ' A' ' 8' ' ' LEU . 64.4 tttp -116.06 111.22 42.94 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 109.01 -0.737 . . . . 62.12 109.01 167.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 16.4 Cg_exo -66.33 131.27 26.07 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.12 1.88 . . . . 65.12 110.729 167.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.38 -31.91 72.64 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.016 0.926 . . . . 74.23 111.885 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.82 -29.88 64.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.791 0.836 . . . . 53.42 111.55 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 34' ' ' GLU . 72.0 t -103.1 107.73 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.0 0.92 . . . . 70.01 110.677 -170.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -124.45 17.8 8.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.486 1.114 . . . . 72.14 109.839 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.3 t -139.62 156.32 46.92 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.366 1.067 . . . . 73.25 109.97 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -67.68 -37.67 82.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.308 0.643 . . . . 73.21 110.903 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.66 -45.09 95.45 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.929 0.891 . . . . 71.23 111.594 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HB2' HG13 ' A' ' 29' ' ' VAL . 42.1 mt-10 -65.17 -32.72 74.55 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.888 -1.051 . . . . 74.41 110.553 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.0 -28.76 49.28 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.901 0.88 . . . . 54.42 111.36 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -75.69 -25.96 57.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.146 0.978 . . . . 72.41 111.474 -173.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -84.43 -3.19 58.2 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.098 0.407 . . . . 45.31 112.098 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.541 HD11 HG21 ' A' ' 29' ' ' VAL . 29.9 mt -90.52 -2.87 57.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.814 0.445 . . . . 73.34 111.428 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -66.2 117.57 7.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.087 0.555 . . . . 72.51 109.835 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.97 1.98 57.14 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.152 -0.931 . . . . 61.03 113.202 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -87.62 161.0 17.95 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.327 1.063 . . . . 73.1 111.055 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.4 tp -90.1 139.25 30.81 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.338 1.055 . . . . 73.54 108.314 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 t -126.7 122.21 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.552 -0.907 . . . . 72.42 108.552 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.19 102.25 11.67 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.947 0.899 . . . . 63.45 109.745 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.479 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 29.4 t90 -95.47 144.22 26.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.248 -0.649 . . . . 75.24 109.248 170.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -103.36 100.33 10.21 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.603 1.161 . . . . 64.22 108.162 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.7 p -64.62 150.38 94.04 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.583 0.753 . . . . 74.53 111.246 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.88 -5.35 15.39 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.646 2.231 . . . . 73.41 112.289 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.5 t -70.72 -19.54 62.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.705 1.202 . . . . 64.33 111.163 169.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.51 36.08 8.96 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.887 -0.597 . . . . 35.55 112.068 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -127.67 131.99 49.75 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.025 0.93 . . . . 74.3 109.014 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -90.26 93.11 4.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.661 -1.237 . . . . 73.52 107.661 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 75' ' ' LEU . 34.9 mt -74.86 137.35 41.76 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.819 -1.082 . . . . 75.34 109.508 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -98.0 137.65 36.5 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.003 0.921 . . . . 44.4 108.92 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.56 176.31 22.41 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 123.687 0.617 . . . . 72.2 111.635 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.3 ttmt -147.37 129.98 15.95 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.907 0.353 . . . . 75.14 110.752 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.4 mt -73.04 105.03 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.874 -1.057 . . . . 73.23 109.175 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 m -84.55 -36.14 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.821 -0.627 . . . . 54.54 110.816 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -148.22 -174.74 4.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.676 0.79 . . . . 74.15 111.203 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -114.31 170.53 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.235 1.014 . . . . 73.32 110.125 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -136.89 101.63 4.64 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.378 -0.971 . . . . 71.22 108.378 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.76 -172.56 10.17 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.268 -0.878 . . . . 65.31 115.181 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.3 p -91.22 11.93 21.82 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.808 1.243 . . . . 75.15 110.853 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.84 -25.35 60.03 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.937 1.295 . . . . 72.41 109.718 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.4 -2.43 65.23 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.653 -0.703 . . . . 42.35 112.788 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.4 129.76 40.91 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.028 0.531 . . . . 44.24 109.898 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.9 m -102.0 149.9 6.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 C-N-CA 123.665 0.786 . . . . 74.43 110.805 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -99.76 102.63 14.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.013 -1.449 . . . . 72.45 107.506 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.57 157.53 17.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.002 0.521 . . . . 71.21 110.743 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.444 ' HD3' HG22 ' A' ' 21' ' ' VAL . 10.0 mmm180 -131.65 99.7 4.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.366 1.066 . . . . 72.53 109.703 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.43 ' HB2' ' OD1' ' A' ' 20' ' ' ASN . 16.7 m-85 -88.97 138.51 31.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.181 0.593 . . . . 74.44 109.818 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.17 -43.23 99.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.83 1.252 . . . . 73.13 112.43 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -87.64 -53.4 4.81 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.613 -0.721 . . . . 64.1 111.808 -167.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.73 35.66 39.68 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-O 120.006 -0.33 . . . . 61.33 113.428 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.646 ' HB2' HD11 ' A' ' 53' ' ' LEU . 41.4 mt -69.42 126.52 92.7 Favored Pre-proline 0 C--N 1.353 0.728 0 C-N-CA 122.409 0.284 . . . . 71.1 110.44 177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.56 158.94 46.99 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.866 2.377 . . . . 75.2 110.918 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.3 115.1 0.35 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.243 -1.143 . . . . 64.43 110.243 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -65.95 75.97 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.089 1.355 . . . . 74.41 111.059 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.479 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -120.83 28.41 7.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.056 1.342 . . . . 75.52 109.468 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.3 mt -64.5 103.65 0.69 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 108.59 -0.893 . . . . 72.14 108.59 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.06 -5.52 8.93 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 116.154 -0.476 . . . . 51.12 113.109 -172.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -76.02 172.28 13.03 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.956 0.902 . . . . 73.51 108.905 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -107.51 143.62 35.65 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.526 0.679 . . . . 72.1 111.419 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG21 HG21 ' A' ' 24' ' ' ILE . 19.6 m -113.24 164.29 9.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-N 114.319 -1.31 . . . . 75.24 108.405 172.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -127.76 109.74 11.94 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.936 0.494 . . . . 71.35 109.921 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 54.6 mt -82.59 92.66 2.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.078 -1.082 . . . . 55.21 108.078 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 2' ' ' ARG . 96.4 t -77.48 128.79 37.97 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 CA-C-N 113.917 -1.492 . . . . 70.35 110.105 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.25 137.63 57.7 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 108.167 -1.049 . . . . 74.12 108.167 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -58.48 134.15 56.42 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.273 1.029 . . . . 71.32 113.13 -173.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -107.2 92.96 4.29 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.94 0.896 . . . . 60.33 108.9 173.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 . . . . . 0 C--O 1.249 1.05 0 N-CA-C 108.357 -0.979 . . . . 65.11 108.357 -179.762 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 ttm . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.338 -0.615 . . . . 74.51 109.338 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HG2' ' HA ' ' A' ' 87' ' ' VAL . 59.9 mtm-85 -134.71 153.84 51.82 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.365 1.066 . . . . 71.24 109.414 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 55.9 mt -121.92 137.32 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.866 0.866 . . . . 74.52 109.41 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -89.09 131.86 35.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.297 -0.631 . . . . 63.41 109.297 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -137.97 137.52 8.9 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-O 120.169 -0.24 . . . . 64.23 112.983 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t -98.97 117.08 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.808 0.843 . . . . 74.43 110.261 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.98 106.76 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.529 1.132 . . . . 73.42 110.669 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.7 -50.56 15.01 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.37 0.668 . . . . 74.22 110.05 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -154.35 172.05 18.32 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.1 -0.954 . . . . 51.55 110.684 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -120.33 122.61 41.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.963 -1.125 . . . . 71.53 107.963 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.51 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 1.8 tpm_? -101.83 104.2 14.94 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 106.777 -1.564 . . . . 70.52 106.777 174.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 66.6 mtp85 -100.32 115.38 29.83 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.15 0.5 . . . . 74.15 111.994 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.6 t -67.84 134.24 50.56 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 108.103 -1.073 . . . . 74.12 108.103 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -58.02 117.27 4.15 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 124.107 0.88 . . . . 75.41 110.357 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 60.37 20.18 9.78 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.473 1.109 . . . . 64.11 113.074 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.0 t30 68.09 30.54 5.83 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.351 1.06 . . . . 75.24 110.695 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -58.1 -64.41 0.92 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.124 0.97 . . . . 74.23 111.864 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -99.35 25.8 6.61 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.156 0.582 . . . . 72.34 109.761 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 73.17 134.99 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.244 1.817 . . . . 73.12 112.146 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 36.8 t30 -73.54 137.7 44.54 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 123.395 0.678 . . . . 72.13 110.477 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.606 HG22 ' HG2' ' A' ' 70' ' ' ARG . 67.7 t -105.74 155.39 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 125.89 1.676 . . . . 74.51 109.785 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 44.3 ttm -137.73 127.47 25.36 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.662 -0.866 . . . . 71.44 108.662 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -88.01 110.57 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.47 -0.937 . . . . 72.34 108.47 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 84' ' ' VAL . 79.7 mt -117.39 149.21 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.364 1.066 . . . . 75.02 109.051 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -123.95 97.67 40.66 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 108.082 -1.081 . . . . 71.14 108.082 174.067 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.801 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 36.9 Cg_exo -60.85 125.62 17.64 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.919 2.412 . . . . 55.34 112.639 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.16 -42.33 89.14 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.623 0.769 . . . . 74.31 112.541 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.47 0.76 55.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.641 0.776 . . . . 73.22 111.983 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.801 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 59.4 t -114.3 107.89 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.296 1.038 . . . . 40.01 108.355 174.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -121.9 6.48 9.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.404 0.682 . . . . 74.02 111.77 -173.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 m -127.68 142.65 51.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.855 0.862 . . . . 70.41 108.875 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.533 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 57.3 ttt180 -57.4 -34.78 69.25 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.007 0.923 . . . . 74.51 111.27 175.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -60.26 -42.65 95.79 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.663 0.785 . . . . 62.51 111.825 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.657 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.5 mt-10 -64.44 -44.33 91.51 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.163 -0.926 . . . . 71.24 109.376 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.9 -26.01 66.66 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.438 -0.801 . . . . 72.21 111.55 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -73.56 -33.93 64.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.35 1.06 . . . . 74.15 110.777 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -85.86 -2.94 58.75 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.791 0.293 . . . . 75.24 111.791 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 29' ' ' VAL . 50.5 mt -86.19 -1.58 57.57 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 119.232 -0.413 . . . . 54.5 112.06 174.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 57' ' ' ILE . 43.2 mm -64.22 122.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.672 -0.862 . . . . 70.11 108.672 172.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.06 -4.94 55.93 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.508 -0.315 . . . . 73.02 113.163 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -84.8 148.09 26.5 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.197 0.499 . . . . 74.02 109.729 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.3 tp -88.83 141.5 28.45 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.4 1.08 . . . . 74.31 108.507 -173.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.51 126.02 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.4 -0.593 . . . . 72.42 109.4 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.1 mt -111.49 105.66 14.32 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.078 0.951 . . . . 73.22 109.421 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.46 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 47.3 t90 -110.47 133.27 53.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.306 0.642 . . . . 70.41 109.374 174.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -92.59 111.98 23.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.791 -1.188 . . . . 73.42 107.791 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.5 p -68.47 152.51 96.57 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.238 0.615 . . . . 74.03 111.338 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.41 -18.12 57.43 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.972 2.448 . . . . 52.32 111.917 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.6 m -61.55 -21.07 63.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.156 1.383 . . . . 63.0 111.988 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.71 20.35 44.29 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 116.352 -0.385 . . . . 24.52 112.425 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -108.29 146.98 32.09 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.875 0.87 . . . . 72.41 109.192 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -101.36 93.43 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.669 -1.234 . . . . 71.12 107.669 172.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.6 mt -77.88 130.28 36.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.938 -1.028 . . . . 74.22 109.103 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -107.3 146.62 31.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.277 0.631 . . . . 73.02 109.32 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.32 -171.31 21.12 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.214 -0.903 . . . . 62.24 111.497 -175.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -152.22 135.34 15.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.001 0.401 . . . . 63.4 110.954 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.457 HG22 HD13 ' A' ' 39' ' ' ILE . 70.6 mt -69.83 110.64 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 O-C-N 124.095 0.872 . . . . 63.14 108.686 175.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.44 -8.54 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.513 0.725 . . . . 65.54 111.291 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.408 ' HB3' ' HD3' ' A' ' 68' ' ' ARG . 18.6 tpp180 -158.48 150.79 21.76 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.73 -0.471 . . . . 75.24 109.73 -174.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.418 HG13 HD11 ' A' ' 39' ' ' ILE . 23.7 m -98.62 159.46 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.436 0.694 . . . . 64.23 109.537 173.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.414 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 59.7 t-80 -144.44 104.48 4.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.126 0.57 . . . . 70.15 109.808 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.91 168.94 40.49 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 121.336 0.409 . . . . 72.21 113.655 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.533 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 21.4 p -85.0 -9.22 58.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.482 1.113 . . . . 74.33 112.29 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -81.87 5.95 17.29 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.509 0.724 . . . . 61.42 112.686 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' HA3' HG12 ' A' ' 29' ' ' VAL . . . 84.84 9.11 81.56 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 119.518 -0.601 . . . . 75.45 113.802 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . . . -67.18 133.9 50.67 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 122.656 0.383 . . . . 71.21 110.201 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.3 150.06 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.547 0.739 . . . . 51.22 111.231 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 59' ' ' ARG . 60.2 ttt180 -103.0 105.21 15.48 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.546 1.138 . . . . 72.21 108.369 171.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.84 120.24 41.92 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.453 0.701 . . . . 71.52 109.936 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.606 ' HG2' HG22 ' A' ' 21' ' ' VAL . 41.2 mtm105 -88.92 118.81 28.9 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.174 -0.676 . . . . 70.02 109.174 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -90.78 122.94 33.95 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.336 0.654 . . . . 74.51 109.773 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.0 -39.3 74.43 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.223 1.009 . . . . 74.4 111.873 -173.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -76.81 -55.06 5.82 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.251 -0.886 . . . . 73.24 109.528 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 61.26 34.55 88.55 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 114.6 -1.182 . . . . 74.25 113.865 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 96.0 mt -69.66 137.83 88.21 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.588 0.755 . . . . 64.3 110.353 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 12.8 Cg_exo -68.76 143.85 57.39 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.96 2.44 . . . . 74.52 112.445 -174.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.76 104.02 0.17 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.722 -0.951 . . . . 63.11 110.722 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -73.68 91.18 1.87 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.733 0.813 . . . . 73.15 110.025 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -115.83 30.77 7.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.717 1.207 . . . . 74.34 109.91 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.1 mt -43.9 103.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.323 1.049 . . . . 63.12 112.259 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.15 4.75 20.38 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.814 -0.63 . . . . 33.44 113.913 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -91.36 168.11 11.8 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.055 0.942 . . . . 71.35 110.901 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -100.15 154.6 18.31 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.722 0.809 . . . . 74.43 112.627 -172.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 24' ' ' ILE . 18.5 m -131.18 158.21 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.92 1.288 . . . . 73.02 109.062 176.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.97 108.25 17.52 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.058 -0.719 . . . . 75.24 109.058 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 68.1 mt -89.14 94.09 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.976 -1.12 . . . . 71.21 107.976 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.435 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . 48.6 t -74.01 133.48 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.143 -0.935 . . . . 74.35 109.043 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -61.34 127.64 32.48 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.743 -0.836 . . . . 72.43 108.743 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.53 144.38 21.7 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.237 -1.023 . . . . 71.51 108.237 -174.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -152.94 136.24 15.76 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.314 0.645 . . . . 72.0 109.79 -177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 42.3 t60 . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 118.59 -0.719 . . . . 62.13 110.04 -177.825 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.968 -0.382 . . . . 73.42 109.968 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -99.7 135.26 41.39 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.525 0.73 . . . . 65.23 109.466 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.503 HD12 HH11 ' A' ' 41' ' ' ARG . 65.7 mt -111.84 124.06 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.91 -1.144 . . . . 73.33 107.91 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 7.1 ptpp? -88.35 127.29 35.48 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.314 0.578 . . . . 63.42 110.912 -173.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -123.76 160.45 18.31 Favored Glycine 0 C--O 1.218 -0.872 0 CA-C-N 115.59 -0.732 . . . . 62.2 111.834 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.14 129.56 50.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 123.542 0.737 . . . . 73.31 109.379 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.505 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 60.4 t -66.93 99.87 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.954 0.902 . . . . 62.1 109.459 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.748 HD11 ' HG2' ' A' ' 25' ' ' LYS . 72.2 mt -74.46 -59.32 2.78 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.776 -0.453 . . . . 74.22 109.776 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.4 t -166.08 162.07 17.6 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.923 -0.581 . . . . 75.1 111.355 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB3' HD21 ' A' ' 20' ' ' ASN . 62.4 m-85 -115.87 145.35 42.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.965 1.306 . . . . 70.33 108.892 171.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -136.27 106.17 6.26 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.426 -1.324 . . . . 64.52 107.426 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -75.46 136.67 40.67 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.723 -0.473 . . . . 73.11 109.723 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.2 t -77.73 145.23 36.66 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.653 0.381 . . . . 63.41 110.706 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -72.06 -26.44 62.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.885 0.874 . . . . 54.45 110.263 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -68.99 -59.57 2.96 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.049 0.94 . . . . 74.13 109.29 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 2.8 m-20 -129.56 116.34 18.76 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.184 0.994 . . . . 62.33 108.894 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -56.06 -44.53 78.99 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.469 1.108 . . . . 74.1 111.398 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -74.85 -28.59 60.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.92 -1.036 . . . . 71.52 111.696 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 16' ' ' ASN . 16.2 t-20 -82.16 84.12 7.14 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.543 -0.91 . . . . 73.3 108.543 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.508 HD21 ' HB3' ' A' ' 10' ' ' TYR . 44.6 t-20 -97.2 127.7 43.41 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.618 -1.174 . . . . 75.35 109.223 -174.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.8 t -88.44 105.1 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.448 -0.945 . . . . 54.31 108.448 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.42 ' HE3' HG22 ' A' ' 7' ' ' VAL . 24.8 ttt -98.83 136.46 38.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.268 -1.333 . . . . 72.01 109.11 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.511 HG22 HD12 ' A' ' 8' ' ' LEU . 27.7 mm -104.48 131.0 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 108.238 -1.023 . . . . 70.13 108.238 174.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.9 mt -124.97 150.31 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.941 0.897 . . . . 74.13 109.239 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.748 ' HG2' HD11 ' A' ' 8' ' ' LEU . 1.1 mmmm -120.37 98.59 48.52 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 123.115 0.566 . . . . 61.55 110.404 170.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 23.8 Cg_exo -63.07 135.88 53.42 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.116 1.877 . . . . 72.32 110.377 169.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.5 mt -60.73 -30.99 70.31 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.31 0.576 . . . . 71.24 111.149 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.23 -27.17 61.44 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.334 1.453 . . . . 73.14 111.79 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 34' ' ' GLU . 94.6 t -115.93 121.09 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.9 0.88 . . . . 61.14 110.427 -170.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -135.29 14.68 3.5 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.671 0.788 . . . . 73.5 111.26 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 m -137.67 151.27 48.08 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.845 0.858 . . . . 54.02 109.781 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.65 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 50.0 ttt180 -60.37 -38.82 85.1 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.253 1.021 . . . . 75.21 112.184 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.57 -40.1 95.78 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.049 0.54 . . . . 73.34 111.44 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.508 ' HB2' HG13 ' A' ' 29' ' ' VAL . 48.0 mt-10 -64.73 -35.64 81.71 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.9 0.75 . . . . 63.42 110.828 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.79 -30.6 51.38 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.987 0.915 . . . . 63.21 111.274 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -73.19 -31.63 64.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.065 0.946 . . . . 72.41 111.25 -173.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -79.28 -11.71 59.94 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 120.831 0.348 . . . . 54.21 110.899 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.587 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 51.5 mt -109.73 23.62 14.16 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.205 1.002 . . . . 74.31 111.561 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.5 mm -75.47 135.39 27.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.565 -0.531 . . . . 71.11 109.565 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.6 -9.3 44.55 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-O 119.103 -0.831 . . . . 65.5 113.061 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.587 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 79.1 mtm180 -62.11 149.11 42.25 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.334 0.654 . . . . 73.21 112.408 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 tp -91.64 120.68 32.62 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.369 1.068 . . . . 62.41 109.262 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.0 t -100.21 137.28 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 122.911 0.484 . . . . 60.32 110.031 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.7 mt -131.34 120.13 22.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.787 1.235 . . . . 74.02 107.761 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.42 ' HE1' ' HB3' ' A' ' 82' ' ' ASP . 47.4 t90 -130.28 128.44 41.57 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.435 -0.579 . . . . 74.13 109.435 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -84.43 110.84 18.94 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.347 -0.612 . . . . 63.42 109.347 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.8 t -77.2 153.72 82.23 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 124.255 1.022 . . . . 63.43 109.537 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.3 -8.55 14.85 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.137 2.558 . . . . 75.1 114.686 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.9 p -70.9 -15.32 62.61 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.262 0.625 . . . . 74.31 111.506 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.23 -10.53 63.54 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 123.719 0.676 . . . . 43.15 112.388 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.57 132.41 35.11 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.627 0.771 . . . . 74.45 110.755 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.8 106.5 13.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.944 -0.761 . . . . 54.25 108.944 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.8 117.93 16.15 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.726 -0.842 . . . . 74.34 108.726 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -109.16 146.67 33.74 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 123.021 0.528 . . . . 55.51 110.424 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.82 -171.75 27.2 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 114.825 -1.079 . . . . 32.5 110.999 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.73 134.18 20.81 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.057 0.428 . . . . 74.03 111.086 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 41' ' ' ARG . 78.1 mt -67.5 106.87 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.509 0 O-C-N 124.41 1.069 . . . . 62.04 109.402 175.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.545 HG11 ' HE ' ' A' ' 70' ' ' ARG . 27.6 m -91.52 -31.74 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.567 0.747 . . . . 54.13 111.559 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -155.76 176.29 12.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.863 -0.791 . . . . 71.3 108.863 -173.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.2 m -92.51 170.06 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 170.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -136.17 103.4 5.31 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.267 -1.012 . . . . 72.31 108.267 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.7 -149.04 42.71 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.657 -0.702 . . . . 22.14 113.24 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.65 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -117.97 -17.37 9.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.472 0.709 . . . . 70.3 112.105 -171.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 25.29 2.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.497 0.719 . . . . 61.13 112.232 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.22 18.13 78.66 Favored Glycine 0 C--N 1.346 1.13 0 N-CA-C 114.97 0.748 . . . . 73.41 114.97 167.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.12 38.19 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.582 -0.896 . . . . 61.31 108.582 171.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.8 m -102.43 139.46 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.046 0.451 . . . . 65.0 109.973 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -99.58 105.53 17.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.118 0.967 . . . . 74.23 108.747 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.51 121.58 44.7 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.832 0.853 . . . . 70.35 110.817 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HE ' HG11 ' A' ' 58' ' ' VAL . 39.1 mtm180 -89.33 113.12 24.36 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.979 -0.748 . . . . 63.3 108.979 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -81.5 136.15 35.62 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.337 1.055 . . . . 72.52 110.329 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.66 -24.78 36.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.404 0.682 . . . . 70.13 110.904 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -77.39 -54.77 6.05 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.485 -0.78 . . . . 70.43 109.685 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.04 25.1 63.82 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 124.042 0.838 . . . . 71.03 114.263 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.63 158.46 78.5 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.949 0.9 . . . . 73.43 110.848 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.58 150.6 51.32 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.996 2.464 . . . . 73.13 112.733 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.24 -71.96 0.3 Allowed Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.915 -0.584 . . . . 73.12 112.43 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 76.02 -40.43 0.4 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 126.075 1.75 . . . . 75.02 112.604 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.81 30.07 0.11 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.126 0.97 . . . . 44.15 112.661 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.18 149.42 28.32 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.216 1.006 . . . . 72.25 110.707 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' H ' ' HB ' ' A' ' 7' ' ' VAL . . . 87.72 4.12 79.8 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 116.601 -0.272 . . . . 73.51 113.076 -169.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.42 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 35.0 t70 -85.38 170.9 12.28 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.76 0.824 . . . . 73.33 110.176 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.69 133.24 36.2 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.516 0.674 . . . . 73.1 112.169 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 11.4 m -100.71 159.34 3.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 114.452 -1.249 . . . . 72.32 108.946 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -109.19 108.9 19.71 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.473 -0.936 . . . . 72.43 108.473 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.9 95.13 4.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.584 -0.895 . . . . 75.42 108.584 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.22 136.73 24.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 115.246 -0.888 . . . . 75.22 109.593 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.64 96.4 0.27 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.642 -0.873 . . . . 60.23 108.642 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.75 141.87 58.18 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.799 0.84 . . . . 74.14 110.592 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 32.8 m170 61.75 66.46 0.84 Allowed 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.743 1.217 . . . . 62.4 109.902 -173.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 34.3 p80 . . . . . 0 C--O 1.253 1.284 0 CA-C-N 114.998 -1.001 . . . . 72.11 109.748 174.996 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 121.168 0.509 . . . . 72.12 110.383 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -133.27 118.94 19.16 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.421 -1.326 . . . . 75.33 107.421 173.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 mt -98.55 155.69 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.411 1.084 . . . . 65.15 108.96 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.553 ' HG3' HD12 ' A' ' 27' ' ' LEU . 19.1 ptmt -114.36 140.92 48.26 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.865 -0.791 . . . . 75.03 108.865 173.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -139.32 164.57 25.9 Favored Glycine 0 C--O 1.216 -0.995 0 N-CA-C 111.647 -0.581 . . . . 23.31 111.647 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.37 131.38 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.348 0.659 . . . . 75.23 109.926 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.1 93.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.304 -0.998 . . . . 72.1 108.304 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 25' ' ' LYS . 79.8 mt -68.4 -59.31 3.27 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 110.131 -0.322 . . . . 73.32 110.131 -176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 t -154.38 155.67 35.46 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.074 -0.512 . . . . 72.4 110.722 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -95.78 138.81 32.91 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.458 -0.941 . . . . 73.44 108.458 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -130.06 107.11 9.08 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.585 -0.894 . . . . 71.23 108.585 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -76.18 138.85 40.95 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 110.111 -0.329 . . . . 64.25 110.111 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.502 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 62.9 m -86.28 131.98 34.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.348 0.659 . . . . 73.35 109.766 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -65.36 -30.19 70.99 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.226 1.01 . . . . 72.32 112.474 -175.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -98.62 -62.77 1.19 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.706 0.803 . . . . 75.23 109.128 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.56 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 11.7 m120 -75.5 88.69 2.67 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.791 -0.64 . . . . 74.14 110.354 -176.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -61.98 -24.42 67.01 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.733 0.813 . . . . 75.02 112.37 -175.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -110.09 -42.09 4.28 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.452 0.701 . . . . 53.34 111.046 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.56 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 53.7 t30 -78.11 72.45 4.64 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.758 0.789 . . . . 72.14 108.923 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -89.63 159.72 17.01 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.981 -1.009 . . . . 63.03 109.025 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 70' ' ' ARG . 62.2 t -88.12 145.9 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 108.282 -1.007 . . . . 72.31 108.282 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.3 ttt -136.22 111.51 9.09 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.485 -1.302 . . . . 62.21 107.485 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 mm -78.51 119.13 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 114.98 -1.009 . . . . 63.31 108.387 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.469 HG21 HG21 ' A' ' 84' ' ' VAL . 81.5 mt -130.93 153.12 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.488 1.115 . . . . 73.4 108.089 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HB2' HD11 ' A' ' 8' ' ' LEU . 87.5 tttt -127.33 121.88 22.69 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 108.912 -0.773 . . . . 73.4 108.912 164.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -69.87 140.23 41.74 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.768 2.312 . . . . 70.25 110.768 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.553 HD12 ' HG3' ' A' ' 4' ' ' LYS . 92.7 mt -69.84 -29.78 67.11 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.384 0.673 . . . . 73.54 111.276 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.08 -22.23 60.62 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.996 -1.002 . . . . 64.44 111.303 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' A' ' 34' ' ' GLU . 57.9 t -110.23 123.96 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.335 1.054 . . . . 63.32 110.746 -174.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -135.16 11.13 3.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.845 0.858 . . . . 64.3 110.429 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.442 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 27.5 m -131.09 165.33 23.49 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.426 0.69 . . . . 74.0 111.126 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -68.93 -43.73 74.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.703 1.201 . . . . 73.43 110.97 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -70.65 -32.54 69.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.746 0.818 . . . . 72.02 110.763 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.563 ' HB2' HG13 ' A' ' 29' ' ' VAL . 44.7 mt-10 -68.51 -30.89 69.81 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.78 -0.645 . . . . 73.45 110.5 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.38 -32.04 33.04 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.578 0.751 . . . . 72.35 110.728 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -75.18 -23.77 57.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.869 0.868 . . . . 72.35 111.382 -174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -80.23 -13.67 59.04 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 120.73 0.3 . . . . 70.01 110.968 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.9 mt -90.32 3.87 52.42 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 122.961 0.504 . . . . 75.04 112.084 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.481 HD13 HG22 ' A' ' 57' ' ' ILE . 48.9 mm -65.63 124.36 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 108.819 -0.808 . . . . 71.53 108.819 171.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.06 9.56 62.08 Favored Glycine 0 N--CA 1.475 1.288 0 CA-C-O 119.967 -0.351 . . . . 74.4 113.371 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.714 ' HG3' ' HA ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -89.85 146.72 24.23 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.691 0.796 . . . . 74.31 110.673 178.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.8 tp -93.98 115.41 27.75 Favored 'General case' 0 C--N 1.345 0.398 0 O-C-N 124.037 0.835 . . . . 64.31 109.41 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.9 t -98.99 120.43 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 109.629 -0.508 . . . . 75.31 109.629 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt -105.9 128.05 53.53 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.765 1.226 . . . . 63.34 109.077 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -147.33 119.27 8.15 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.377 -0.601 . . . . 72.43 109.377 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 28.3 ttpp -82.06 112.27 18.97 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.194 -0.669 . . . . 73.13 109.194 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.0 p -64.7 155.51 81.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.781 0.832 . . . . 61.23 110.94 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.71 -9.09 19.57 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.988 2.459 . . . . 73.35 112.523 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 t -74.67 -10.12 59.23 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.927 0.891 . . . . 61.31 111.347 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.47 -12.37 63.18 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 123.633 0.635 . . . . 60.14 113.188 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -83.51 126.66 33.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.564 0.746 . . . . 65.4 109.563 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 63.1 mt -79.57 96.74 2.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 107.31 -1.367 . . . . 60.03 107.31 168.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 73' ' ' LYS . 50.3 mt -73.62 126.43 30.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.094 -0.957 . . . . 73.33 108.953 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -106.65 139.82 40.49 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.991 -0.744 . . . . 72.02 108.991 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.24 -179.64 28.02 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 123.51 0.506 . . . . 40.24 111.939 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 31.0 ttmt -149.38 137.32 20.47 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.949 0.404 . . . . 73.32 111.073 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.481 HG22 HD13 ' A' ' 39' ' ' ILE . 67.3 mt -74.85 103.49 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 114.77 -1.105 . . . . 74.24 109.643 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.21 -18.59 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 114.965 -1.016 . . . . 60.24 111.345 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 20.8 ttm180 -160.13 160.67 33.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.084 0.554 . . . . 62.32 109.755 -175.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 m -95.1 171.05 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.496 0.718 . . . . 73.02 109.469 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -128.36 103.03 6.92 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.795 -0.817 . . . . 73.2 108.795 173.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.35 -150.52 46.96 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 124.291 0.994 . . . . 41.54 114.089 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -109.54 7.08 24.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.473 1.109 . . . . 75.11 110.89 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -67.23 -28.05 67.74 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.171 0.588 . . . . 72.23 111.047 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.17 3.3 58.92 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.639 -0.709 . . . . 65.15 111.903 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.44 130.21 42.19 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.515 -0.55 . . . . 73.55 109.515 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.6 m -102.37 153.97 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.581 0.752 . . . . 74.22 110.573 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HD2' ' HB3' ' A' ' 59' ' ' ARG . 17.8 ttm180 -111.84 103.31 11.56 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.491 -0.929 . . . . 54.21 108.491 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.84 116.58 30.91 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.449 0.699 . . . . 44.54 109.813 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.423 ' HG2' HG22 ' A' ' 21' ' ' VAL . 43.3 mtm180 -90.24 118.01 29.43 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.69 -0.856 . . . . 71.11 108.69 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -91.37 128.41 37.19 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.488 0.715 . . . . 72.51 109.801 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.12 -32.97 68.64 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.629 1.172 . . . . 72.21 112.468 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.505 ' HB2' HD22 ' A' ' 53' ' ' LEU . 70.9 mmtt -90.5 -37.94 13.55 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.132 0.573 . . . . 71.42 109.565 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.17 35.73 34.6 Favored Glycine 0 C--N 1.36 1.871 0 O-C-N 124.503 1.127 . . . . 75.04 114.315 174.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -76.28 133.15 71.95 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 122.992 0.517 . . . . 72.43 110.622 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.23 120.17 6.41 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.772 1.648 . . . . 75.51 110.404 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.12 -15.2 31.3 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.523 -0.762 . . . . 73.21 111.868 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 67.68 12.74 9.0 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.765 1.226 . . . . 62.11 111.35 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.12 32.47 2.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.836 1.254 . . . . 44.3 111.833 -168.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -51.79 108.02 0.24 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.522 0.729 . . . . 71.2 111.413 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.0 -14.46 7.05 Favored Glycine 0 N--CA 1.475 1.272 0 CA-C-N 116.11 -0.496 . . . . 72.34 112.396 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -77.56 172.83 12.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.75 0.82 . . . . 71.13 110.311 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 9.7 m-85 -108.62 130.01 55.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.283 0.633 . . . . 71.12 111.394 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 24' ' ' ILE . 16.1 m -97.97 168.25 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.553 1.141 . . . . 61.43 109.029 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -120.35 106.76 12.17 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.787 -0.82 . . . . 45.11 108.787 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.19 92.37 3.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.41 -0.959 . . . . 64.4 108.41 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.78 124.77 36.74 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-N 115.063 -0.971 . . . . 75.23 108.86 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.714 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -62.86 97.61 0.11 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.663 -1.606 . . . . 72.41 106.663 172.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.62 98.59 0.38 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.388 -0.824 . . . . 74.13 109.98 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -144.09 107.38 4.56 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.345 1.058 . . . . 71.14 108.249 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 123.164 0.585 . . . . 73.14 110.33 -179.326 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.434 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.094 0 CA-C-O 121.566 0.698 . . . . 73.5 110.531 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.544 ' HD2' ' HB3' ' A' ' 85' ' ' GLU . 90.6 mtm-85 -132.94 171.08 14.42 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.777 0.831 . . . . 73.01 109.803 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.682 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 47.8 mt -116.82 124.4 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.566 -1.272 . . . . 53.21 107.566 176.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -88.74 140.21 29.68 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 118.419 0.554 . . . . 74.43 109.658 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.59 135.97 7.34 Favored Glycine 0 C--O 1.218 -0.886 0 N-CA-C 111.998 -0.441 . . . . 71.44 111.998 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -91.18 116.88 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.369 0.668 . . . . 44.22 109.266 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.485 HG13 ' SD ' ' A' ' 22' ' ' MET . 91.1 t -55.12 103.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.585 1.154 . . . . 75.4 110.4 175.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 23' ' ' ILE . 93.9 mt -75.21 -57.05 4.13 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 122.88 0.472 . . . . 70.14 110.22 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.409 ' HA ' HD22 ' A' ' 80' ' ' LEU . 71.3 p -163.95 164.08 23.34 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.415 -0.811 . . . . 64.2 110.271 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.97 134.93 34.09 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.147 -0.686 . . . . 74.25 109.147 168.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 1.7 tmt_? -98.53 106.98 19.33 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 105.424 -2.065 . . . . 73.02 105.424 165.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.56 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 11.5 ptm180 -78.82 136.04 37.23 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.04 0.448 . . . . 74.23 110.586 -171.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 m -67.55 154.88 40.41 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.069 -0.969 . . . . 53.54 110.311 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -58.99 -42.27 89.64 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.62 0.768 . . . . 74.42 110.555 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -102.47 108.87 20.33 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.002 -0.999 . . . . 72.41 108.762 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -69.32 88.33 0.45 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.348 1.059 . . . . 74.01 109.555 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -134.62 -77.13 0.46 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.161 -1.052 . . . . 71.52 108.161 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -159.21 -172.96 3.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.458 1.103 . . . . 75.4 108.422 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 89.8 m-20 63.05 34.61 13.69 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.682 0.793 . . . . 65.25 110.816 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.656 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 52.1 t30 -71.4 149.61 45.8 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-N 114.551 -1.204 . . . . 71.55 110.302 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 39.8 t -93.53 144.14 10.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.606 -0.887 . . . . 74.54 108.606 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.485 ' SD ' HG13 ' A' ' 7' ' ' VAL . 42.8 ttp -133.56 121.64 22.4 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.179 -0.675 . . . . 74.35 109.179 174.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 8' ' ' LEU . 41.1 mm -79.78 126.42 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.577 1.151 . . . . 70.14 108.832 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -126.08 152.07 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.581 1.153 . . . . 74.1 109.588 -171.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 64' ' ' LYS . 4.5 tppp? -116.22 92.66 36.68 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.756 0.822 . . . . 71.11 109.515 173.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.07 131.54 33.0 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.441 1.427 . . . . 62.13 109.876 172.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.449 HD11 ' HE2' ' A' ' 83' ' ' TYR . 91.1 mt -63.96 -31.51 72.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.584 0.754 . . . . 63.21 111.764 -171.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.16 -28.58 67.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.539 0.735 . . . . 73.1 111.122 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.421 HG12 ' HA2' ' A' ' 65' ' ' GLY . 89.1 t -96.66 144.19 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.865 0.866 . . . . 64.4 111.772 -168.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -147.52 -25.57 0.38 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.375 1.07 . . . . 61.12 111.592 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.608 ' HB2' ' HG2' ' A' ' 34' ' ' GLU . 15.7 m -109.88 169.84 8.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.403 0.681 . . . . 73.41 111.186 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.511 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 78.8 ttt180 -65.96 -42.83 89.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.954 0.902 . . . . 74.21 111.082 -177.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.99 -30.87 62.71 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.813 0.695 . . . . 72.44 110.892 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HG2' ' HB2' ' A' ' 31' ' ' SER . 20.0 mm-40 -65.92 -30.8 71.44 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.752 0.658 . . . . 70.5 110.491 173.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.66 -33.21 31.45 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.772 0.829 . . . . 65.33 110.851 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -75.44 -24.96 57.09 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.107 0.963 . . . . 75.43 111.203 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 34' ' ' GLU . 22.0 pttp -75.07 -1.51 23.23 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 122.205 0.202 . . . . 74.01 111.111 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.1 11.5 25.64 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.319 0.648 . . . . 74.44 112.53 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mm -69.24 126.28 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.414 -0.587 . . . . 65.12 109.414 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.38 57.74 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.179 -0.464 . . . . 53.25 113.242 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.07 139.14 37.03 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.017 0.527 . . . . 75.51 110.301 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -90.1 113.68 25.46 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.275 1.03 . . . . 63.05 108.75 -173.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -98.04 114.31 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.222 0.609 . . . . 74.42 109.517 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.464 HD22 ' HG2' ' A' ' 54' ' ' LYS . 42.4 mt -101.04 99.99 10.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.23 -1.026 . . . . 72.14 108.23 176.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.5 ' CD1' HG12 ' A' ' 84' ' ' VAL . 32.6 t90 -103.27 131.63 50.17 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.959 -0.756 . . . . 73.14 108.959 174.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -91.99 126.61 37.15 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.151 -1.055 . . . . 75.35 108.151 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.9 p -73.17 141.43 81.03 Favored Pre-proline 0 C--O 1.244 0.816 0 N-CA-C 109.381 -0.6 . . . . 53.11 109.381 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.69 -23.55 33.5 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.471 2.78 . . . . 72.31 113.877 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.4 m -64.17 -54.78 28.24 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.646 0.779 . . . . 75.51 110.928 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.18 32.32 0.1 Allowed Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.351 -0.386 . . . . 74.53 113.614 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -114.69 173.53 6.43 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.607 0.763 . . . . 73.34 109.542 173.225 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.0 105.05 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.446 -0.946 . . . . 74.22 108.446 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 73' ' ' LYS . 21.2 mt -83.34 110.23 17.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.236 -1.024 . . . . 74.33 108.236 172.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' HG2' HD22 ' A' ' 44' ' ' LEU . 51.7 mtpt -94.46 139.74 30.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.003 -0.74 . . . . 70.43 109.003 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.65 -171.28 19.36 Favored Glycine 0 N--CA 1.463 0.493 0 O-C-N 123.455 0.472 . . . . 44.03 112.297 -173.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -151.94 133.99 15.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.957 0.503 . . . . 71.31 110.052 -178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 67' ' ' VAL . 73.6 mt -69.32 98.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.729 -0.841 . . . . 71.24 108.729 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.37 -33.44 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.183 0.593 . . . . 64.45 111.019 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -148.78 167.61 25.14 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.349 -0.982 . . . . 62.22 108.349 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 m -103.01 170.63 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.394 0.678 . . . . 65.43 109.229 172.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -132.57 122.57 24.97 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.522 -0.918 . . . . 73.1 108.522 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.67 -153.95 52.4 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.92 0.763 . . . . 53.22 113.072 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.511 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 73.6 p -116.76 -11.47 10.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.193 0.997 . . . . 71.44 111.193 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 73.0 mmtt -98.73 52.94 1.0 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.229 0.537 . . . . 64.14 112.091 -172.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.421 ' HA2' HG12 ' A' ' 29' ' ' VAL . . . 71.38 -0.4 33.3 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 117.312 1.685 . . . . 61.13 117.312 163.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.46 124.85 28.85 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.91 0.855 . . . . 61.21 109.582 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.7 m -103.25 160.12 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.371 0.668 . . . . 64.43 109.918 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -119.79 104.29 10.09 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.703 1.201 . . . . 64.24 108.499 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.12 127.41 54.14 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.447 0.699 . . . . 72.13 110.864 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' HD2' HG22 ' A' ' 21' ' ' VAL . 7.8 mmm180 -89.61 111.5 22.46 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.59 1.156 . . . . 70.41 109.611 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 73.7 m-85 -92.08 166.33 12.72 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.056 0.542 . . . . 72.22 111.047 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 7.8 pt-20 -67.29 -39.05 85.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.937 0.895 . . . . 74.15 110.466 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 14.4 mmmm -118.8 -69.16 0.87 Allowed 'General case' 0 C--N 1.345 0.375 0 C-N-CA 124.089 0.956 . . . . 55.12 109.398 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.656 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 71.93 57.86 5.57 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 123.924 0.765 . . . . 53.24 111.231 -173.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.33 124.51 89.99 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.758 0.823 . . . . 74.22 111.22 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.59 174.57 8.24 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.335 2.69 . . . . 73.34 112.71 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.33 172.1 13.13 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.341 -0.704 . . . . 53.05 111.341 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -86.48 68.91 10.34 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.508 1.147 . . . . 75.34 109.618 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.09 17.51 17.72 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.468 -1.242 . . . . 63.32 109.714 175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 9' ' ' SER . 41.2 mt -76.41 121.88 23.7 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.92 0.888 . . . . 63.43 109.486 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.48 -6.98 14.14 Favored Glycine 0 N--CA 1.469 0.849 0 N-CA-C 111.966 -0.454 . . . . 73.33 111.966 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.58 155.64 29.55 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.814 0.846 . . . . 65.45 109.86 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.449 ' HE2' HD11 ' A' ' 27' ' ' LEU . 62.1 m-85 -91.33 133.09 35.73 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.94 0.496 . . . . 73.51 111.448 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 45' ' ' TRP . 6.7 m -100.01 149.39 5.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 N-CA-C 107.632 -1.248 . . . . 72.15 107.632 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.544 ' HB3' ' HD2' ' A' ' 2' ' ' ARG . 8.5 mm-40 -111.34 106.73 15.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.053 -1.091 . . . . 73.34 108.053 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.682 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 62.2 mt -96.94 104.63 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.444 0.697 . . . . 71.41 109.235 -173.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.9 t -95.31 134.75 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.221 1.008 . . . . 61.22 110.103 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.61 123.78 47.01 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.302 -1.37 . . . . 64.31 107.302 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -159.47 -39.2 0.06 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.992 0.917 . . . . 73.34 109.142 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -77.89 97.8 5.41 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.308 -0.86 . . . . 72.3 109.067 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 . . . . . 0 CA--C 1.562 1.426 0 CA-C-O 118.066 -0.968 . . . . 72.33 109.294 177.633 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 120.613 0.244 . . . . 70.03 110.467 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -119.88 130.12 54.7 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 106.845 -1.539 . . . . 54.3 106.845 168.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 28' ' ' ASP . 50.9 mt -94.67 125.86 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.275 -0.639 . . . . 63.23 109.275 -175.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -88.67 133.29 34.25 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.466 -0.939 . . . . 71.31 108.466 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.98 166.19 22.13 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.361 0.413 . . . . 71.3 112.13 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.61 135.2 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.193 0.997 . . . . 70.21 109.173 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.76 114.53 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.568 0.747 . . . . 74.31 110.292 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 25' ' ' LYS . 89.6 mt -81.79 -61.2 1.99 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.358 0.663 . . . . 75.43 110.843 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.2 t -152.46 160.5 43.26 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.849 -0.614 . . . . 71.32 110.37 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -91.02 157.55 17.2 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.361 0.601 . . . . 74.31 111.182 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.486 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.6 tpp180 -136.28 109.95 8.06 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.263 -1.754 . . . . 61.55 106.263 163.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -72.41 159.38 34.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.01 0.434 . . . . 61.52 110.704 -169.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.642 ' HB3' ' HB3' ' A' ' 17' ' ' GLN . 20.0 m -70.65 167.83 17.79 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.25 -0.886 . . . . 63.54 111.793 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -67.47 -72.01 0.18 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.122 0.969 . . . . 74.34 113.209 -167.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -132.52 -64.23 0.76 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.882 -0.784 . . . . 74.42 108.882 -170.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -142.1 92.27 2.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.801 -1.555 . . . . 72.44 106.801 167.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.642 ' HB3' ' HB3' ' A' ' 13' ' ' SER . 6.3 tp-100 -144.94 135.17 24.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.717 0.807 . . . . 63.31 108.836 -172.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -93.7 -13.98 26.86 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.953 0.501 . . . . 74.45 111.565 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 50.7 m-80 -74.19 80.01 1.79 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.462 -0.57 . . . . 72.22 109.462 171.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -81.55 135.57 35.58 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.044 -0.98 . . . . 72.01 109.31 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 70' ' ' ARG . 5.1 t -96.96 150.62 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 108.464 -0.939 . . . . 63.22 108.464 -176.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -154.79 140.88 18.43 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.758 0.313 . . . . 72.3 110.77 168.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 8' ' ' LEU . 45.4 mm -77.17 120.48 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.307 -0.861 . . . . 72.3 108.682 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.4 mt -115.45 147.83 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.35 1.06 . . . . 61.35 108.84 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 8' ' ' LEU . 86.6 tttt -108.13 101.8 43.3 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 123.821 0.848 . . . . 74.52 109.424 171.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' HG22 ' A' ' 67' ' ' VAL . 17.7 Cg_endo -60.58 115.97 3.03 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 122.067 1.845 . . . . 62.41 110.067 165.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.38 -34.07 71.97 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.159 0.984 . . . . 72.24 112.132 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 3' ' ' ILE . 22.2 t70 -69.31 -27.73 65.64 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.253 1.021 . . . . 73.12 111.899 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 34' ' ' GLU . 25.9 t -113.09 119.06 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.235 1.014 . . . . 55.3 111.24 -170.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -120.36 -5.52 9.87 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.116 0.566 . . . . 72.32 111.893 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 69.2 m -111.18 152.86 26.57 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.038 0.535 . . . . 64.32 110.347 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.589 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 55.6 ttt85 -64.27 -35.36 80.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 73.13 111.826 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.62 -38.72 84.3 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.951 0.5 . . . . 73.04 110.7 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HB2' HG13 ' A' ' 29' ' ' VAL . 33.8 mt-10 -67.39 -31.77 72.22 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.114 -0.948 . . . . 72.3 110.07 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.22 -23.05 32.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.977 0.911 . . . . 71.52 111.218 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.4 t -79.42 -27.6 41.73 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.769 0.828 . . . . 64.35 110.086 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -80.16 -9.19 59.7 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.329 -0.396 . . . . 74.45 110.758 170.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.432 HD21 HD12 ' A' ' 3' ' ' ILE . 47.2 mt -89.61 -3.45 58.27 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.139 0.576 . . . . 64.52 111.987 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.683 HD11 HG13 ' A' ' 60' ' ' VAL . 49.7 mm -63.65 107.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.242 -0.651 . . . . 64.41 109.242 174.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.1 5.4 30.62 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.323 -0.71 . . . . 72.32 114.145 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.436 ' HD2' HD22 ' A' ' 88' ' ' LEU . 28.9 mmt180 -84.72 159.72 20.46 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.364 1.082 . . . . 74.43 111.373 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 54' ' ' LYS . 61.0 tp -90.83 117.19 29.25 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.29 1.036 . . . . 75.51 109.331 -175.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 t -107.35 117.14 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.204 -0.665 . . . . 63.31 109.204 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -101.15 104.44 15.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.641 0.776 . . . . 75.22 109.529 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -91.75 141.95 28.12 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.554 -0.536 . . . . 73.2 109.554 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -103.08 108.95 20.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.962 -1.017 . . . . 73.35 108.87 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.2 p -60.3 160.82 15.57 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.731 0.813 . . . . 74.41 111.036 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.9 -21.67 71.65 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.937 2.424 . . . . 71.35 112.613 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.3 m -77.51 -6.96 55.44 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.017 0.927 . . . . 64.2 111.765 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.65 3.64 77.29 Favored Glycine 0 C--N 1.35 1.342 0 C-N-CA 123.197 0.427 . . . . 64.55 112.863 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -85.77 156.47 20.59 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.007 0.923 . . . . 74.03 108.898 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.8 mt -117.62 114.35 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.594 0.358 . . . . 62.25 110.367 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 73' ' ' LYS . 31.5 mt -92.25 150.58 20.8 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.723 -0.843 . . . . 74.25 108.723 173.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB3' HD11 ' A' ' 42' ' ' LEU . 23.5 mtmm -98.22 156.15 16.83 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.717 -0.475 . . . . 75.53 109.717 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.8 -174.97 29.21 Favored Glycine 0 C--O 1.239 0.441 0 N-CA-C 111.036 -0.825 . . . . 50.33 111.036 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -152.87 136.17 15.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 111.758 0.281 . . . . 70.24 111.758 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.411 HD11 HD13 ' A' ' 86' ' ' ILE . 78.2 mt -69.2 102.82 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.622 0 O-C-N 124.038 0.836 . . . . 70.54 108.895 171.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -84.29 -28.35 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.329 -0.851 . . . . 74.53 110.711 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -164.03 165.32 22.55 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.811 0.844 . . . . 74.1 109.396 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.683 HG13 HD11 ' A' ' 39' ' ' ILE . 35.4 m -92.8 169.41 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.508 0.723 . . . . 75.3 110.522 174.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -127.6 104.59 7.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.295 1.038 . . . . 73.34 109.223 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.49 -153.01 52.89 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.851 -0.613 . . . . 61.32 113.154 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 32.5 p -111.83 -0.63 15.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.789 0.836 . . . . 72.32 111.831 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -83.78 5.88 23.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.47 0.708 . . . . 72.32 112.425 -168.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.28 -16.37 57.61 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-O 119.909 -0.384 . . . . 75.3 113.063 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.68 122.55 14.41 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.613 0.765 . . . . 42.24 110.018 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.4 HG22 ' HD3' ' A' ' 26' ' ' PRO . 35.9 m -102.84 175.06 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.955 0.902 . . . . 74.54 110.632 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -128.5 111.39 13.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.278 1.031 . . . . 65.14 108.592 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.8 133.02 56.52 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.381 0.672 . . . . 63.11 110.774 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.553 ' HG2' HG22 ' A' ' 21' ' ' VAL . 97.0 mtt180 -103.75 128.85 51.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.947 0.899 . . . . 75.12 109.095 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 85.9 m-85 -106.11 134.6 48.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.494 0.717 . . . . 73.04 110.743 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.566 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 20.8 pt-20 -51.58 -48.09 63.3 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 124.89 1.369 . . . . 72.33 112.552 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.566 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 13.4 mmmm -92.93 -39.5 11.11 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.152 0.581 . . . . 73.2 109.478 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.99 55.0 28.11 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 124.284 0.99 . . . . 64.41 113.908 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.62 124.09 89.25 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.054 0.541 . . . . 74.52 110.591 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.14 150.67 33.67 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.107 2.538 . . . . 60.14 112.129 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.09 -151.79 14.6 Favored Glycine 0 C--N 1.344 0.972 0 N-CA-C 111.33 -0.708 . . . . 73.54 111.33 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -113.03 73.89 0.84 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.218 1.009 . . . . 73.43 108.882 172.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.27 -9.76 59.37 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.383 -1.28 . . . . 75.34 112.617 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.6 mt -61.24 115.1 3.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.621 0.768 . . . . 75.33 110.716 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.68 -18.87 49.29 Favored Glycine 0 N--CA 1.473 1.148 0 CA-C-N 116.465 -0.334 . . . . 73.33 112.826 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.08 163.49 27.06 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.698 0.799 . . . . 62.11 110.442 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -105.05 148.71 26.48 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.751 0.786 . . . . 55.22 112.279 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.14 164.45 17.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 114.35 -1.295 . . . . 75.31 108.269 171.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.13 107.66 11.0 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.008 -0.738 . . . . 62.31 109.008 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.411 HD13 HD11 ' A' ' 57' ' ' ILE . 57.4 mt -82.72 92.23 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.0 -1.111 . . . . 74.34 108.0 177.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.2 t -79.53 141.82 14.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 114.421 -1.263 . . . . 73.42 108.837 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' HD2' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -60.06 112.0 1.72 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 107.66 -1.237 . . . . 53.22 107.66 171.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.88 119.75 20.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.556 -0.905 . . . . 73.22 108.556 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -145.98 128.93 16.45 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.644 0.378 . . . . 72.03 110.972 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 68.6 m80 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.044 -0.979 . . . . 72.45 108.576 173.584 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 110.053 -0.351 . . . . 52.44 110.053 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -124.07 138.21 54.47 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.647 -1.242 . . . . 75.45 107.647 167.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.24 139.85 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.464 0.706 . . . . 71.44 109.142 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -88.14 119.16 28.26 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.283 -1.006 . . . . 51.21 108.283 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -116.98 168.84 12.89 Favored Glycine 0 C--N 1.34 0.802 0 O-C-N 123.673 0.608 . . . . 64.33 111.583 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.43 130.29 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.958 0.903 . . . . 53.21 109.175 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.2 t -68.11 104.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.095 0.958 . . . . 74.14 109.348 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 25' ' ' LYS . 83.1 mt -84.29 -55.13 4.34 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.462 0.305 . . . . 73.23 110.807 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m -154.22 170.27 21.65 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.524 0.564 . . . . 62.34 112.524 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -122.58 157.56 31.86 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.053 1.341 . . . . 71.3 109.193 170.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.55 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.7 tpt180 -137.75 115.6 11.49 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.656 -1.238 . . . . 75.1 107.656 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -85.61 117.51 24.55 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.327 0.491 . . . . 51.22 112.327 -168.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.3 m -86.26 148.17 25.75 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.501 -0.926 . . . . 50.42 108.501 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -74.39 87.19 2.03 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.819 0.448 . . . . 65.32 111.347 -173.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 51.91 -76.7 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.044 2.138 . . . . 74.34 115.245 165.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -61.86 -45.87 91.92 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.812 0.845 . . . . 72.35 111.32 -177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -85.57 46.62 1.32 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.93 0.492 . . . . 61.11 110.066 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.31 86.86 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.378 1.071 . . . . 61.13 111.762 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -130.29 39.71 3.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.674 -1.602 . . . . 65.11 106.674 172.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -51.58 126.58 17.89 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 113.986 -1.461 . . . . 65.31 110.315 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 85.8 t -86.41 145.0 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.32 -0.993 . . . . 63.55 108.32 -171.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.3 ttt -137.56 109.49 7.17 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.791 -1.559 . . . . 62.44 106.791 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.448 HG22 HD12 ' A' ' 8' ' ' LEU . 45.5 mm -81.14 120.32 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 107.119 -1.437 . . . . 64.23 107.119 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.409 HG21 HG21 ' A' ' 84' ' ' VAL . 85.5 mt -127.65 146.64 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.49 1.116 . . . . 63.03 108.319 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HB2' HD11 ' A' ' 8' ' ' LEU . 41.1 ttmt -118.68 112.84 36.66 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 109.292 -0.632 . . . . 71.01 109.292 168.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 17.2 Cg_exo -62.65 126.2 17.76 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.057 1.838 . . . . 63.24 110.229 168.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.76 -27.45 69.29 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.715 0.806 . . . . 71.54 111.7 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.76 -27.13 66.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.41 1.084 . . . . 75.21 111.868 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 34' ' ' GLU . 71.6 t -106.72 128.0 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.964 0.906 . . . . 72.33 111.823 -169.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -127.9 5.01 5.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.53 1.132 . . . . 61.2 110.839 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -132.48 157.79 43.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.477 0.711 . . . . 71.24 110.53 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 68.9 ttt180 -64.13 -42.92 96.62 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.769 0.827 . . . . 65.01 111.101 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.54 -38.88 92.53 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.867 0.73 . . . . 75.14 111.148 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HB2' HG13 ' A' ' 29' ' ' VAL . 41.0 mt-10 -64.94 -34.02 77.42 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 124.117 0.886 . . . . 72.31 110.448 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.497 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -82.08 -26.39 33.69 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.098 0.959 . . . . 52.33 111.537 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 t -82.06 -23.81 35.62 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.907 0.883 . . . . 61.11 110.931 -172.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.73 1.29 39.46 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.59 0.356 . . . . 75.42 110.834 170.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 75.7 mt -102.22 11.88 37.54 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.431 0.693 . . . . 54.53 111.343 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.543 HD11 HG13 ' A' ' 60' ' ' VAL . 49.9 mm -73.99 130.82 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 109.49 -0.559 . . . . 62.22 109.49 174.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.23 1.39 75.55 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.029 -0.532 . . . . 65.4 112.532 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.581 ' HG3' ' HA ' ' A' ' 88' ' ' LEU . 5.6 mpt_? -81.64 138.58 35.29 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.079 0.552 . . . . 74.44 109.98 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 55' ' ' GLY . 67.2 tp -90.37 113.56 25.47 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.63 -0.878 . . . . 74.12 108.63 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 t -98.09 116.05 39.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 123.427 0.691 . . . . 64.45 109.254 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.3 mt -102.01 129.19 48.24 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.464 1.106 . . . . 62.22 108.549 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -142.38 127.38 18.4 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.14 0.576 . . . . 74.02 109.484 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -89.76 115.24 26.97 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.123 -0.695 . . . . 74.52 109.123 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -64.71 158.45 68.5 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.823 0.849 . . . . 75.52 111.006 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -59.33 -20.17 54.38 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.465 2.776 . . . . 61.13 113.432 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.6 m -75.15 -3.28 31.93 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.89 0.876 . . . . 64.43 112.234 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.87 9.76 80.23 Favored Glycine 0 C--N 1.353 1.525 0 C-N-CA 123.069 0.366 . . . . 51.13 112.936 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -96.16 132.16 41.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.583 0.753 . . . . 74.31 110.001 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.1 mt -85.55 101.87 10.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-O 121.3 0.571 . . . . 72.1 109.613 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 75' ' ' LEU . 13.5 mt -80.97 128.49 33.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.462 -0.79 . . . . 71.1 108.879 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -117.43 132.47 56.56 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.106 0.963 . . . . 54.53 109.123 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -154.95 -177.79 28.6 Favored Glycine 0 C--N 1.336 0.55 0 O-C-N 123.635 0.584 . . . . 52.43 112.177 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -151.77 136.67 17.23 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.115 0.413 . . . . 74.42 112.115 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 39' ' ' ILE . 64.7 mt -67.94 103.62 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.935 0.894 . . . . 74.15 109.568 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.27 -30.83 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.532 -0.758 . . . . 73.45 111.547 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -163.95 160.45 21.98 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.62 0.768 . . . . 71.44 109.254 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.543 HG13 HD11 ' A' ' 39' ' ' ILE . 20.2 m -101.18 170.48 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.847 0.859 . . . . 73.01 111.065 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -131.3 103.14 6.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.06 0.944 . . . . 75.4 109.021 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.66 -166.85 26.08 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.74 -0.664 . . . . 72.25 114.452 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.429 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 75.7 p -90.77 8.56 34.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.382 1.073 . . . . 65.44 111.333 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -79.84 -2.72 44.71 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.871 0.869 . . . . 72.42 111.783 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.24 -4.89 61.23 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-O 120.103 -0.276 . . . . 52.53 113.645 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.96 112.28 5.51 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 123.429 0.692 . . . . 73.35 109.635 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 m -100.19 143.77 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.04 0.936 . . . . 75.11 109.153 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -101.72 103.07 13.82 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.322 -0.992 . . . . 63.33 108.322 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.82 120.28 41.58 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.556 0.742 . . . . 74.02 109.935 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -88.8 106.31 18.29 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.973 0.509 . . . . 73.34 109.699 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -88.15 120.99 30.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.632 -0.877 . . . . 74.14 108.632 170.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.42 -20.71 60.66 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.134 0.492 . . . . 70.22 109.876 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -76.68 -77.64 0.14 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.641 0.777 . . . . 73.43 109.197 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.1 45.01 63.42 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.646 0.591 . . . . 53.11 114.395 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.44 ' HB2' HD21 ' A' ' 53' ' ' LEU . 81.7 mt -73.15 157.08 88.88 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.759 0.824 . . . . 74.42 111.195 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.08 124.08 14.51 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 123.402 2.735 . . . . 75.44 113.273 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.09 87.74 0.08 OUTLIER Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.776 -1.33 . . . . 74.35 109.776 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -73.92 71.43 1.54 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.092 0.957 . . . . 65.21 109.846 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.05 29.01 8.16 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.445 1.098 . . . . 75.02 110.685 -169.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 mt -52.46 118.46 3.6 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.5 0.72 . . . . 64.25 110.378 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.07 -10.51 15.17 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 112.01 -0.436 . . . . 63.13 112.01 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -77.23 169.56 18.11 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.876 0.87 . . . . 70.44 109.678 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 63.0 m-85 -112.26 127.47 55.98 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.639 0.376 . . . . 75.43 111.952 -170.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 24' ' ' ILE . 15.2 m -100.38 162.72 3.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-N 115.171 -0.922 . . . . 72.0 109.824 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -111.62 108.99 18.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.905 0.882 . . . . 74.14 108.681 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.1 mt -92.18 92.9 3.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.1 -1.074 . . . . 72.05 108.1 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.81 134.03 27.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.082 -0.963 . . . . 64.44 109.09 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.581 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 4.4 mm? -60.61 126.79 28.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.751 0.82 . . . . 62.55 110.608 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.93 139.17 22.33 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.534 -0.913 . . . . 74.31 108.534 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -126.58 150.87 48.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.012 0.925 . . . . 71.12 110.382 -173.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 . . . . . 0 C--O 1.249 1.035 0 C-N-CA 123.899 0.879 . . . . 55.04 108.786 173.338 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 mmt . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.666 -0.494 . . . . 64.13 109.666 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -147.71 158.45 44.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.997 0.919 . . . . 64.14 110.364 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 40.1 mt -132.57 128.83 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.686 -1.227 . . . . 73.14 107.686 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -87.79 128.18 35.33 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.941 -0.763 . . . . 74.01 108.941 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 25' ' ' LYS . . . -124.74 142.44 13.94 Favored Glycine 0 C--N 1.34 0.799 0 O-C-N 123.914 0.759 . . . . 60.2 111.486 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -92.76 131.04 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.511 0.655 . . . . 72.41 109.906 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.8 97.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.951 0.9 . . . . 63.32 109.251 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.478 HD21 ' HE2' ' A' ' 25' ' ' LYS . 81.5 mt -77.34 -53.45 7.67 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.673 -0.492 . . . . 71.3 109.673 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -165.11 179.19 6.49 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.847 0.356 . . . . 60.51 111.411 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -129.96 134.8 47.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.793 1.237 . . . . 73.43 108.298 174.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.407 ' HD3' HD11 ' A' ' 23' ' ' ILE . 2.6 mpt_? -111.03 113.21 25.58 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.072 -1.455 . . . . 73.31 107.072 163.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 32.4 ptt180 -73.82 145.61 44.83 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.909 -1.145 . . . . 74.41 107.909 173.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 m -56.9 148.12 21.83 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.659 0.784 . . . . 72.33 110.496 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -86.92 -56.32 3.44 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.933 -0.766 . . . . 65.22 108.933 -176.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.47 -23.11 61.0 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.481 -0.782 . . . . 53.05 111.071 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -125.0 -179.55 4.6 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.299 1.04 . . . . 72.35 109.311 -176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.59 13.86 3.73 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.758 0.823 . . . . 75.11 110.446 169.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -124.94 168.82 12.76 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.737 1.215 . . . . 73.23 109.053 169.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 m120 59.43 40.03 21.29 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 124.449 1.093 . . . . 74.14 109.436 -176.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 12' ' ' ARG . 23.2 m-80 -78.55 149.49 33.04 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.826 -1.079 . . . . 62.34 110.001 -172.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 70' ' ' ARG . 42.6 t -87.77 144.13 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.696 0.799 . . . . 55.15 109.56 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.6 ttt -131.15 117.16 18.68 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.168 -1.049 . . . . 71.12 108.168 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.459 HG22 HD12 ' A' ' 8' ' ' LEU . 28.0 mm -77.29 111.44 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.625 -0.879 . . . . 71.54 108.625 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.1 mt -112.74 145.6 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.403 1.081 . . . . 70.41 109.302 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HE2' HD21 ' A' ' 8' ' ' LEU . 22.6 ttmm -111.65 87.55 8.29 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.347 1.059 . . . . 72.03 109.012 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' HG22 ' A' ' 67' ' ' VAL . 32.2 Cg_endo -62.23 107.48 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.95 1.767 . . . . 73.03 110.212 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.13 -32.48 73.87 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.507 1.123 . . . . 62.42 112.073 -174.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.89 -26.11 68.63 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.335 1.054 . . . . 64.33 111.464 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.496 HG13 ' HB2' ' A' ' 34' ' ' GLU . 66.2 t -112.43 137.57 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 125.195 1.398 . . . . 72.54 111.489 -171.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -134.84 8.66 3.55 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.657 1.183 . . . . 72.01 110.504 170.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.5 m -124.37 147.27 48.34 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.773 0.829 . . . . 62.43 110.609 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.486 ' HD2' HG22 ' A' ' 63' ' ' THR . 71.2 ttt180 -67.81 -34.02 75.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.691 0.796 . . . . 75.33 111.193 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -67.1 -43.0 83.64 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.485 0.714 . . . . 62.14 110.485 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.496 ' HB2' HG13 ' A' ' 29' ' ' VAL . 27.2 mm-40 -72.77 -22.91 60.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.165 -0.925 . . . . 72.31 110.961 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.96 -32.58 30.67 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.554 0.742 . . . . 71.35 110.165 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.0 t -75.71 -24.47 56.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.573 0.749 . . . . 71.11 111.385 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -81.39 -2.29 48.79 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 122.311 -0.243 . . . . 71.42 111.224 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.402 HD12 HG11 ' A' ' 67' ' ' VAL . 53.3 mt -88.68 -12.15 43.21 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 123.331 0.652 . . . . 72.03 111.185 175.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.624 HD11 HG13 ' A' ' 60' ' ' VAL . 42.1 mm -65.79 104.57 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.084 0 C-N-CA 123.183 0.593 . . . . 75.31 110.174 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.13 -6.34 10.95 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.447 -0.641 . . . . 63.42 112.93 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -84.11 155.32 22.69 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 117.756 0.778 . . . . 75.43 111.257 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 54' ' ' LYS . 58.8 tp -93.14 117.26 29.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.49 1.116 . . . . 65.41 109.983 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.34 135.33 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.359 -0.608 . . . . 61.32 109.359 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.7 mt -118.37 105.15 11.42 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.392 1.077 . . . . 73.34 108.128 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 44.8 t90 -110.23 128.4 55.48 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.644 -0.873 . . . . 53.4 108.644 171.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -98.25 117.43 32.62 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.674 -0.861 . . . . 64.24 108.674 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.3 p -74.56 162.36 73.99 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 124.024 0.93 . . . . 74.54 111.29 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.19 -14.55 45.75 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.973 2.448 . . . . 75.24 112.465 171.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -73.3 -19.38 61.05 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.707 1.203 . . . . 53.41 111.879 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.06 5.33 60.9 Favored Glycine 0 C--N 1.356 1.693 0 C-N-CA 123.437 0.542 . . . . 70.2 112.733 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -94.24 118.32 31.41 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.88 0.872 . . . . 62.42 109.817 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.85 97.2 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.017 -1.105 . . . . 72.23 108.017 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 mt -73.64 123.2 23.57 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.958 -1.127 . . . . 73.44 107.958 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.552 ' HB3' HD11 ' A' ' 42' ' ' LEU . 31.0 mtmm -104.26 140.53 37.73 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.32 -0.622 . . . . 72.05 109.32 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.93 173.42 25.42 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 116.207 -0.451 . . . . 75.33 112.112 -178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -127.57 131.77 49.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.071 -0.715 . . . . 72.4 109.071 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.563 HG22 HD13 ' A' ' 39' ' ' ILE . 62.8 mt -67.61 99.89 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 108.499 -0.926 . . . . 71.34 108.499 171.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.76 -34.31 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 115.256 -0.883 . . . . 73.42 111.24 -176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -154.2 157.11 38.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.786 -0.82 . . . . 71.05 108.786 -173.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.624 HG13 HD11 ' A' ' 39' ' ' ILE . 27.2 m -91.71 168.82 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.659 0.784 . . . . 74.52 110.05 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 68' ' ' ARG . 82.9 t60 -132.81 103.28 6.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.964 -1.125 . . . . 73.33 107.964 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.2 -162.76 49.0 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.379 -0.373 . . . . 53.31 113.181 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.486 HG22 ' HD2' ' A' ' 32' ' ' ARG . 73.5 p -110.96 -24.01 10.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.591 0.756 . . . . 64.33 112.18 -172.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -91.83 46.7 1.29 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.803 0.668 . . . . 63.22 112.803 -170.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA2' HG12 ' A' ' 29' ' ' VAL . . . 68.74 55.75 10.87 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.771 -0.65 . . . . 62.4 114.056 170.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.39 141.99 49.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.214 -1.032 . . . . 64.31 108.214 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 26' ' ' PRO . 22.1 m -130.85 171.94 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.141 0.977 . . . . 71.23 109.894 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HG3' ' HB2' ' A' ' 61' ' ' HIS . 73.0 mtm180 -134.35 109.1 8.57 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.218 1.007 . . . . 71.34 109.091 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.89 127.25 53.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.257 -0.883 . . . . 52.32 110.278 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HG2' HG22 ' A' ' 21' ' ' VAL . 33.8 mtm180 -90.27 110.06 21.13 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.254 -0.647 . . . . 75.24 109.254 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.29 142.11 29.6 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.236 1.014 . . . . 71.04 110.173 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 11.0 pt-20 -50.04 -45.36 52.13 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.568 1.547 . . . . 73.1 111.885 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.526 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 32.8 mmtp -96.48 -46.94 6.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.371 -0.831 . . . . 74.42 108.854 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.6 45.69 92.93 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 124.589 1.181 . . . . 50.2 112.87 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.0 140.58 86.0 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.147 0.579 . . . . 54.22 110.696 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.16 123.93 13.04 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.153 2.569 . . . . 73.3 111.88 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -110.65 131.91 10.66 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.934 -0.575 . . . . 70.44 111.94 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -83.24 3.9 29.21 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.038 0.935 . . . . 70.23 110.297 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -94.43 29.86 2.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.693 1.197 . . . . 71.45 112.014 -177.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.7 mt -53.11 108.68 0.35 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 122.7 0.4 . . . . 73.05 110.54 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.58 -10.63 7.59 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 123.836 0.731 . . . . 72.45 112.53 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.91 163.58 27.74 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.309 1.044 . . . . 72.24 111.64 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -96.71 124.63 40.75 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.526 0.73 . . . . 74.44 110.64 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 m -99.67 149.11 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.872 1.269 . . . . 72.11 107.748 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -108.73 107.36 17.78 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.839 -0.801 . . . . 72.42 108.839 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 53.6 mt -89.57 90.9 3.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.097 -1.446 . . . . 73.34 107.097 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.69 150.68 3.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 114.816 -1.084 . . . . 75.13 109.079 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.16 167.63 9.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.22 0.608 . . . . 64.12 110.854 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -68.01 82.72 0.22 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.867 0.867 . . . . 75.1 110.83 -169.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -66.76 -40.85 88.39 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.106 0.962 . . . . 72.43 110.924 -176.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 84.7 t60 . . . . . 0 CA--C 1.56 1.354 0 O-C-N 124.875 1.359 . . . . 74.43 109.907 -176.482 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 25.7 mmt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.213 -0.292 . . . . 73.24 110.213 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.638 ' HG2' HG22 ' A' ' 87' ' ' VAL . 61.4 mtt180 -128.19 118.34 23.17 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.256 -1.387 . . . . 63.12 107.256 163.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.479 HD12 HH11 ' A' ' 41' ' ' ARG . 61.5 mt -109.29 128.75 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.07 -1.085 . . . . 54.53 108.07 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -86.73 121.47 29.28 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.146 -0.687 . . . . 70.21 109.146 -170.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -127.44 169.63 19.22 Favored Glycine 0 C--N 1.341 0.847 0 O-C-N 124.003 0.814 . . . . 74.31 111.66 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.1 t -133.27 133.69 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.262 1.025 . . . . 53.31 109.167 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.97 102.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.539 0.736 . . . . 72.44 109.846 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 25' ' ' LYS . 86.7 mt -70.85 -53.86 13.65 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.688 -0.687 . . . . 73.51 109.471 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 t -158.61 168.83 25.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.759 -0.655 . . . . 71.34 111.113 -176.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -107.74 142.97 36.93 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.289 1.036 . . . . 73.0 108.752 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -132.78 133.26 43.19 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.205 -1.406 . . . . 73.13 107.205 169.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -74.03 153.31 39.74 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.742 -0.836 . . . . 74.22 108.742 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.7 t -65.02 -77.27 0.06 Allowed 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.126 -1.064 . . . . 70.15 108.126 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.3 tttm 51.33 52.31 15.08 Favored 'General case' 0 C--N 1.366 1.314 0 N-CA-C 108.053 -1.092 . . . . 75.54 108.053 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -162.76 -58.85 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.239 -1.346 . . . . 74.4 109.424 -161.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -123.16 -61.64 1.4 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.867 0.867 . . . . 62.24 109.027 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -127.25 -167.68 1.77 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.369 1.068 . . . . 72.21 110.597 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -97.64 9.31 42.85 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.093 0.957 . . . . 73.42 110.199 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' A' ' 72' ' ' GLU . 2.0 m-20 -66.21 155.13 37.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.452 1.101 . . . . 71.44 110.673 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.527 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 5.9 t30 -98.67 127.25 44.53 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.288 -0.634 . . . . 71.13 109.288 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 70' ' ' ARG . 22.0 t -89.27 104.68 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 106.451 -1.685 . . . . 74.34 106.451 172.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 47.7 ttm -93.27 130.15 39.09 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 122.681 0.392 . . . . 73.51 110.758 -171.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.455 HG22 HD12 ' A' ' 8' ' ' LEU . 32.9 mm -81.04 102.18 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.448 -0.945 . . . . 71.4 108.448 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -109.07 147.25 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.281 1.032 . . . . 62.25 109.009 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HB2' HD11 ' A' ' 8' ' ' LEU . 39.5 ttmt -118.35 102.37 50.41 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 108.622 -0.881 . . . . 65.3 108.622 167.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 18.1 Cg_endo -61.96 111.27 1.18 Allowed 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 121.545 1.497 . . . . 75.54 109.287 167.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.4 mt -55.39 -32.09 62.36 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.221 1.008 . . . . 54.33 112.266 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.14 -30.12 68.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.131 0.972 . . . . 61.32 111.718 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 34' ' ' GLU . 93.6 t -107.1 117.89 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.195 0.998 . . . . 74.42 110.13 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -121.19 4.63 10.33 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.36 0.664 . . . . 54.11 111.522 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.516 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 6.0 m -130.24 145.36 51.74 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.272 0.629 . . . . 70.21 109.69 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.666 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 73.3 ttt180 -59.09 -46.65 87.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.769 0.827 . . . . 64.52 111.302 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.25 -39.97 84.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 123.924 0.765 . . . . 73.21 111.719 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HB2' HG13 ' A' ' 29' ' ' VAL . 47.4 mt-10 -59.99 -49.79 76.29 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.172 0.92 . . . . 64.44 109.647 176.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -71.53 -24.02 61.88 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.128 0.971 . . . . 74.33 111.947 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -73.29 -39.19 65.53 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.749 0.82 . . . . 71.25 110.68 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -77.74 -10.36 59.49 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.412 -0.358 . . . . 71.11 110.976 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.61 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 55.6 mt -97.74 26.71 4.87 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.486 1.115 . . . . 73.4 111.625 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.663 HD11 HG13 ' A' ' 60' ' ' VAL . 45.2 mm -85.76 135.98 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 109.191 -0.67 . . . . 71.32 109.191 172.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.55 -7.24 39.25 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.579 -0.567 . . . . 75.31 113.517 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.61 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 16.5 ptt180 -80.59 154.17 27.6 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.223 0.511 . . . . 72.21 110.372 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 54' ' ' LYS . 60.8 tp -90.93 146.59 23.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.127 0.971 . . . . 75.12 109.408 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.548 HG22 HG23 ' A' ' 86' ' ' ILE . 47.4 t -122.19 125.82 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.851 0.86 . . . . 71.52 109.279 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.0 mt -103.79 100.26 10.06 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.855 -0.795 . . . . 74.52 108.855 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.432 ' HE1' ' HB3' ' A' ' 82' ' ' ASP . 32.7 t90 -104.52 147.95 27.03 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.934 0.894 . . . . 75.42 109.439 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -99.63 109.05 21.57 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.348 -0.982 . . . . 74.1 108.348 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.4 p -68.93 154.13 95.31 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.805 0.842 . . . . 73.42 111.045 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HG3' ' HB2' ' A' ' 79' ' ' ALA . 46.2 Cg_exo -59.98 -13.29 22.33 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.391 2.727 . . . . 74.35 113.506 172.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -81.37 -5.01 57.41 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.782 0.833 . . . . 71.44 111.606 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.08 -10.56 71.72 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-O 119.986 -0.341 . . . . 51.43 113.429 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -82.35 154.46 25.26 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.657 0.783 . . . . 62.31 110.373 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -102.29 103.64 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.383 -0.969 . . . . 71.24 108.383 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 74' ' ' GLY . 56.7 mt -82.43 153.41 25.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.367 -0.833 . . . . 73.42 110.892 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HB3' HD11 ' A' ' 42' ' ' LEU . 59.0 mtpt -117.03 117.0 28.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.529 -1.214 . . . . 34.25 108.02 -176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -128.2 132.82 7.5 Favored Glycine 0 CA--C 1.503 -0.672 0 N-CA-C 111.549 -0.62 . . . . 73.02 111.549 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -101.66 128.18 48.07 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 117.439 0.62 . . . . 74.45 109.86 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.411 HD12 ' HG3' ' A' ' 41' ' ' ARG . 78.9 mt -66.8 106.94 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 124.211 0.944 . . . . 71.31 109.373 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -84.31 -30.3 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.032 0.933 . . . . 71.22 111.162 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -168.4 167.27 11.98 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.126 0.571 . . . . 75.12 110.209 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.663 HG13 HD11 ' A' ' 39' ' ' ILE . 23.9 m -91.37 169.96 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.322 1.049 . . . . 50.24 111.292 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -141.57 105.56 4.77 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.84 1.256 . . . . 70.24 108.558 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.22 173.52 49.74 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.729 -0.214 . . . . 64.34 112.64 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.666 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 63.2 p -93.0 6.93 46.16 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.707 0.803 . . . . 74.32 111.372 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -93.67 14.96 17.46 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.185 0.994 . . . . 75.14 111.874 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.18 -4.65 70.5 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-O 119.722 -0.488 . . . . 65.2 113.959 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.97 143.89 55.42 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.379 0.672 . . . . 70.13 110.332 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 60' ' ' VAL . 14.0 m -126.49 169.91 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.678 1.191 . . . . 72.34 110.989 -175.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -128.13 107.64 9.97 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.221 1.008 . . . . 74.25 109.327 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.5 125.86 51.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.787 0.835 . . . . 44.41 110.141 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.555 ' HG2' HG22 ' A' ' 21' ' ' VAL . 88.3 mtt180 -89.0 104.51 17.05 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.246 -0.65 . . . . 70.3 109.246 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.77 135.42 34.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.013 0.925 . . . . 73.54 109.173 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HA ' ' ND2' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -55.94 -31.16 62.69 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.408 1.083 . . . . 64.23 112.075 -174.635 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -107.44 -63.11 1.34 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.082 0.953 . . . . 72.41 109.357 173.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 67.57 56.9 9.96 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.206 -0.907 . . . . 23.13 111.421 -171.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 97.0 mt -68.36 132.78 91.35 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.25 1.02 . . . . 72.11 111.257 -170.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 3.9 Cg_exo -76.48 176.35 10.19 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 123.216 2.611 . . . . 74.41 112.979 -170.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.02 177.69 15.03 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.766 -0.652 . . . . 72.43 111.595 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.8 76.46 7.98 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.894 0.854 . . . . 74.55 109.567 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . . . -119.75 28.03 8.37 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.982 -1.008 . . . . 73.25 110.201 172.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.08 109.14 4.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.343 -0.614 . . . . 73.12 109.343 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.15 -5.86 21.72 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-O 119.649 -0.529 . . . . 72.42 112.331 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 13.2 t70 -67.05 143.42 56.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.504 0.722 . . . . 71.53 110.074 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -93.69 123.99 37.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.693 0.797 . . . . 74.3 110.87 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 m -100.69 144.04 13.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.472 -0.785 . . . . 72.44 109.065 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.95 108.04 19.01 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.426 -0.953 . . . . 74.42 108.426 170.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.548 HG23 HG22 ' A' ' 43' ' ' VAL . 38.8 mt -89.04 97.97 7.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 115.067 -0.969 . . . . 73.1 108.858 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.638 HG22 ' HG2' ' A' ' 2' ' ' ARG . 13.0 t -89.89 131.39 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.675 -0.693 . . . . 74.42 110.316 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -116.72 121.8 42.65 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.822 -1.547 . . . . 72.45 106.822 172.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -90.82 147.96 22.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.887 0.875 . . . . 72.43 109.378 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -112.15 138.04 49.38 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.011 0.524 . . . . 72.31 109.709 175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 79.4 t60 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 108.095 -1.076 . . . . 72.53 108.095 178.659 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 109.366 -0.605 . . . . 70.33 109.366 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.429 ' HG2' ' HB3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -128.92 148.05 50.89 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.124 0.97 . . . . 70.02 109.074 177.421 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 56.6 mt -105.55 128.95 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.739 -1.208 . . . . 73.12 107.739 170.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -88.65 124.27 33.92 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.165 0.507 . . . . 72.23 110.009 -174.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -121.54 135.23 10.42 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.702 -0.681 . . . . 75.23 111.876 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.7 t -90.22 132.82 33.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 117.737 0.769 . . . . 74.55 109.988 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.85 103.06 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.721 0 O-C-N 124.504 1.127 . . . . 71.14 109.482 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 25' ' ' LYS . 71.8 mt -78.32 -56.09 4.73 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.547 0.529 . . . . 75.42 109.776 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 m -152.85 170.21 20.9 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.453 0.644 . . . . 71.35 111.712 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -117.81 147.46 43.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.589 1.156 . . . . 71.53 108.152 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 65.7 ttt180 -135.37 116.03 13.86 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 110.103 -0.332 . . . . 74.42 110.103 178.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -79.95 117.76 21.09 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 109.047 -0.723 . . . . 71.41 109.047 174.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.9 p -66.59 130.32 42.81 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.337 0.655 . . . . 43.43 110.34 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -84.03 61.64 6.57 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.722 0.772 . . . . 74.54 109.648 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -111.57 173.84 6.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.95 -1.023 . . . . 74.13 109.693 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -79.18 -38.92 34.7 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.192 -0.458 . . . . 75.01 109.845 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -171.51 91.0 0.13 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.943 0.897 . . . . 72.44 109.35 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -144.75 176.99 9.03 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.92 0.888 . . . . 61.4 110.482 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.8 161.5 30.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.251 0.621 . . . . 72.42 111.33 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -89.71 153.29 20.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.064 0.546 . . . . 73.22 110.221 -176.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 50.3 t -102.5 152.33 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.31 1.044 . . . . 72.24 108.867 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.1 ttt -150.04 129.78 13.24 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.399 -0.593 . . . . 73.4 109.399 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.431 HG22 ' HB2' ' A' ' 8' ' ' LEU . 49.6 mm -93.41 111.53 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.132 0.973 . . . . 63.14 109.363 -177.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.7 mt -125.71 149.3 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.087 0.955 . . . . 55.13 108.769 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.527 ' HB2' HD11 ' A' ' 8' ' ' LEU . 36.5 ttpt -133.19 116.83 14.44 Favored Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 109.994 -0.373 . . . . 74.03 109.994 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.7 Cg_exo -68.3 125.96 13.64 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 122.535 2.157 . . . . 61.03 110.528 173.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.6 mt -70.64 -30.25 66.83 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.86 0.464 . . . . 70.32 111.555 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.47 -19.11 62.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.365 0.666 . . . . 74.23 111.067 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.64 HG13 ' HB2' ' A' ' 34' ' ' GLU . 49.1 t -108.96 147.62 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.709 1.204 . . . . 63.44 109.678 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -145.04 -0.69 0.88 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.368 0.667 . . . . 73.14 112.358 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 m -128.04 147.39 50.51 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.575 0.75 . . . . 72.14 110.509 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 68.8 ttt180 -64.35 -34.62 78.58 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.474 0.71 . . . . 72.11 112.139 -176.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.11 -39.23 78.15 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.455 0.702 . . . . 75.25 111.49 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.64 ' HB2' HG13 ' A' ' 29' ' ' VAL . 29.5 mt-10 -69.88 -45.24 68.11 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.001 -0.999 . . . . 73.42 109.977 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.81 -30.08 69.85 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.044 0.538 . . . . 64.23 111.227 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 t -75.23 -30.5 60.57 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.099 0.96 . . . . 75.55 111.626 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -1.27 56.2 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 120.293 0.092 . . . . 73.01 111.157 173.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 34' ' ' GLU . 73.6 mt -91.76 -9.26 44.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.121 0.568 . . . . 52.33 111.632 174.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.527 HD13 HG22 ' A' ' 57' ' ' ILE . 42.8 mm -63.11 119.65 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 123.439 0.462 . . . . 73.55 110.306 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.35 -0.71 46.72 Favored Glycine 0 N--CA 1.466 0.673 0 CA-C-O 119.716 -0.491 . . . . 70.32 113.167 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -88.93 160.81 16.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.382 0.591 . . . . 61.55 111.053 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 55' ' ' GLY . 36.5 tp -90.28 144.37 25.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.998 -1.001 . . . . 64.3 109.794 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.9 t -124.96 115.75 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.922 0.889 . . . . 72.14 108.668 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.07 105.9 16.31 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.902 -0.777 . . . . 72.32 108.902 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.442 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 36.1 t90 -109.06 143.18 38.73 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.033 -0.729 . . . . 73.33 109.033 175.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -97.97 118.99 35.8 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.811 -0.811 . . . . 74.33 108.811 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.0 p -78.98 153.38 77.55 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.106 0.562 . . . . 65.45 109.83 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.84 -7.84 19.64 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.788 2.325 . . . . 73.42 112.434 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -71.25 -17.51 62.48 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 124.568 1.147 . . . . 70.01 110.983 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.58 16.23 46.81 Favored Glycine 0 C--N 1.356 1.666 0 C-N-CA 123.042 0.353 . . . . 45.43 113.131 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -109.85 149.32 30.03 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.709 0.804 . . . . 74.53 109.892 -176.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -93.75 98.51 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.617 -1.253 . . . . 61.14 107.617 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.442 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 54.6 mt -78.2 125.96 30.11 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.269 -0.641 . . . . 70.24 109.269 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -96.46 127.52 42.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.388 -0.823 . . . . 64.33 109.335 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -127.08 177.57 17.31 Favored Glycine 0 CA--C 1.504 -0.649 0 CA-C-N 114.862 -1.063 . . . . 41.25 110.738 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -149.38 135.28 18.82 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.7 -0.482 . . . . 62.24 109.7 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.527 HG22 HD13 ' A' ' 39' ' ' ILE . 78.5 mt -67.96 95.71 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 O-C-N 124.531 1.144 . . . . 74.25 108.826 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.41 -24.8 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.291 -0.868 . . . . 65.13 110.688 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -150.99 164.13 37.13 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.846 -0.616 . . . . 64.24 109.454 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 39' ' ' ILE . 32.9 m -92.09 168.39 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.778 -0.823 . . . . 64.11 108.778 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -142.05 103.65 4.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.834 -0.802 . . . . 75.42 108.834 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.91 -171.4 45.31 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 115.477 -0.783 . . . . 54.13 113.551 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 51.7 p -94.67 0.12 54.81 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.944 0.897 . . . . 64.12 111.43 176.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -81.12 2.04 29.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.457 1.103 . . . . 70.35 111.784 -173.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.494 ' HA3' HG12 ' A' ' 29' ' ' VAL . . . 78.44 6.74 88.06 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.261 0.351 . . . . 55.35 113.074 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.95 147.89 48.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.032 0.533 . . . . 54.43 110.138 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.452 ' HB ' HG23 ' A' ' 57' ' ' ILE . 30.5 m -121.69 140.53 45.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.678 0.791 . . . . 71.11 110.77 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -98.75 104.48 16.53 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.085 -1.08 . . . . 74.31 108.085 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.7 126.32 52.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.505 0.722 . . . . 70.24 110.147 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -101.56 126.14 48.32 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.854 0.462 . . . . 74.22 110.105 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.523 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 11.0 m-85 -93.37 126.34 38.45 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.025 0.93 . . . . 72.14 110.398 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 12.1 pt-20 -61.23 -28.83 69.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.273 1.029 . . . . 74.2 111.827 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.484 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 14.4 mmmm -101.07 -68.23 0.82 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.76 -0.83 . . . . 74.41 108.76 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.04 56.43 18.41 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.832 -0.622 . . . . 64.41 112.805 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.402 HD12 HD21 ' A' ' 53' ' ' LEU . 71.9 mt -68.7 156.55 90.72 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.7 0.8 . . . . 72.22 110.913 173.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.28 139.23 81.99 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.921 2.414 . . . . 45.44 112.695 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.72 140.62 2.96 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.633 -0.712 . . . . 74.01 112.207 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -121.11 97.09 5.36 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.919 0.888 . . . . 74.41 109.375 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.16 30.14 7.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.767 1.227 . . . . 62.11 110.899 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.4 mt -45.27 113.65 0.61 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.695 0.798 . . . . 62.32 112.242 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.41 -15.55 20.08 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-N 116.419 -0.355 . . . . 70.52 113.288 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.88 158.97 31.44 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.163 0.985 . . . . 65.04 111.908 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -100.83 127.3 47.34 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.806 0.842 . . . . 75.25 110.862 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 m -100.42 158.6 3.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 C-N-CA 124.129 0.972 . . . . 74.23 108.739 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 2' ' ' ARG . 35.3 mt-10 -103.96 108.13 19.33 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.99 0.516 . . . . 63.02 109.869 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 74.7 mt -86.68 94.11 4.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.612 -1.255 . . . . 61.14 107.612 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.418 HG22 ' HG3' ' A' ' 2' ' ' ARG . 31.5 t -89.63 137.31 21.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 114.633 -1.167 . . . . 52.25 109.164 -177.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.31 107.07 1.87 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.201 -1.407 . . . . 63.32 107.201 169.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . 37.2 tt0 -84.3 119.57 25.23 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.709 -0.848 . . . . 71.22 108.709 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -70.18 96.42 1.09 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.343 -0.614 . . . . 74.34 109.343 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 . . . . . 0 C--O 1.248 0.982 0 N-CA-C 108.098 -1.075 . . . . 74.02 108.098 169.583 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 121.382 0.611 . . . . 60.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HG2' HG22 ' A' ' 87' ' ' VAL . 82.3 mtm180 -116.06 133.98 55.45 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.934 1.294 . . . . 74.35 108.405 175.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.446 HD12 HH11 ' A' ' 41' ' ' ARG . 61.3 mt -95.65 136.4 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.483 -0.932 . . . . 64.23 108.483 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -88.36 126.82 35.39 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.214 0.605 . . . . 74.2 109.749 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -129.95 175.49 19.11 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 123.624 0.578 . . . . 64.2 112.115 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.4 t -140.13 132.03 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.528 1.131 . . . . 65.43 109.627 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.83 107.4 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.131 0.973 . . . . 72.13 110.308 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 23' ' ' ILE . 86.6 mt -79.99 -55.27 5.08 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.36 0.664 . . . . 73.04 110.004 176.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 p -158.71 173.25 16.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.616 -0.72 . . . . 62.23 111.254 -173.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.89 159.72 27.61 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.632 0.773 . . . . 63.33 109.058 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -136.09 107.42 6.84 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.462 -1.31 . . . . 63.22 107.462 161.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -97.29 131.82 43.63 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.384 0.611 . . . . 70.45 111.43 -172.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.7 t -83.72 108.74 16.97 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.993 -1.003 . . . . 44.12 108.415 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -80.56 -13.63 58.91 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.78 0.432 . . . . 70.43 111.3 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.46 -14.44 55.06 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.959 0.903 . . . . 70.11 111.137 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -171.89 97.04 0.17 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.129 -1.063 . . . . 54.21 108.129 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -83.38 62.55 6.79 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.801 1.286 . . . . 72.3 110.254 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -141.93 152.31 43.42 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 126.406 1.883 . . . . 74.43 106.195 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.9 m120 60.64 31.8 20.24 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.495 0.718 . . . . 64.13 110.915 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.592 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 36.1 t30 -58.57 145.06 40.74 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.782 0.833 . . . . 72.34 111.237 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.574 HG13 ' HG3' ' A' ' 68' ' ' ARG . 90.3 t -88.28 134.02 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 122.974 0.51 . . . . 44.24 109.658 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 43.1 ttm -130.85 112.88 13.41 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.23 -1.396 . . . . 75.51 107.23 170.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 8' ' ' LEU . 50.8 mm -78.52 111.71 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.079 -1.082 . . . . 63.51 108.079 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.51 HD13 HG21 ' A' ' 84' ' ' VAL . 84.6 mt -109.98 137.48 42.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 C-N-CA 124.221 1.008 . . . . 74.45 109.427 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB2' HD11 ' A' ' 8' ' ' LEU . 81.9 tttt -96.96 104.0 17.09 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.624 -0.88 . . . . 75.13 108.624 166.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 3.3 Cg_exo -68.68 112.27 2.82 Favored 'Trans proline' 0 C--N 1.369 1.622 0 N-CA-C 107.802 -1.653 . . . . 72.21 107.802 168.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.66 -27.27 69.11 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.588 0.755 . . . . 62.0 112.576 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.43 -28.31 64.95 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.606 0.762 . . . . 71.21 111.238 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 34' ' ' GLU . 88.7 t -98.5 145.61 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.98 1.312 . . . . 74.34 109.785 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.12 33.0 0.25 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.272 0.558 . . . . 55.24 109.734 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.5 m -150.19 141.22 22.97 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.403 0.681 . . . . 73.01 110.116 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.649 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 59.2 ttt180 -62.71 -32.65 73.79 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.353 0.661 . . . . 70.42 110.971 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -52.15 -51.81 55.62 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.93 0.769 . . . . 70.31 110.271 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' HB2' HG13 ' A' ' 29' ' ' VAL . 44.0 mt-10 -60.24 -52.49 65.06 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 114.577 -1.192 . . . . 74.21 110.361 177.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.12 70.56 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.666 0.787 . . . . 62.14 112.193 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.5 t -76.91 -28.62 55.37 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.9 0.88 . . . . 61.25 111.321 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -94.3 2.52 55.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.733 0.413 . . . . 75.24 110.922 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.561 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 46.6 mt -113.11 24.2 12.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.473 1.109 . . . . 75.15 110.678 175.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.76 132.13 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.938 -0.764 . . . . 72.12 108.938 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.02 -14.74 19.09 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.866 -0.408 . . . . 75.23 113.333 171.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.561 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 15.1 ptt180 -75.62 155.77 35.55 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.143 0.471 . . . . 73.31 110.449 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 55' ' ' GLY . 24.8 tp -89.78 154.34 19.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.144 0.977 . . . . 64.14 109.959 -173.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 86' ' ' ILE . 36.4 t -132.73 144.39 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.331 1.052 . . . . 64.13 108.418 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -127.53 117.99 23.12 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.7 -0.852 . . . . 75.41 108.7 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -130.3 132.36 45.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.64 0.776 . . . . 73.04 109.385 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -83.8 118.88 24.22 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.972 -0.751 . . . . 61.15 108.972 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.7 p -66.8 163.13 45.84 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.808 0.843 . . . . 61.31 111.437 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.36 -13.3 37.5 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.282 1.988 . . . . 64.55 112.123 167.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -85.2 -8.8 58.41 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.251 1.02 . . . . 64.44 110.878 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.56 -21.12 47.55 Favored Glycine 0 C--N 1.352 1.434 0 C-N-CA 123.013 0.339 . . . . 62.3 113.593 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -76.59 132.36 39.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.516 0.727 . . . . 44.25 111.049 -176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -78.33 102.15 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.936 -0.764 . . . . 74.12 108.936 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.51 135.43 39.32 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.038 -0.983 . . . . 74.03 109.862 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -96.31 133.52 40.56 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.971 -0.751 . . . . 72.4 108.971 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -131.25 169.84 21.61 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 110.821 -0.912 . . . . 53.32 110.821 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -145.15 134.86 23.46 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.171 -0.677 . . . . 73.31 109.171 177.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.512 HD12 ' HG3' ' A' ' 41' ' ' ARG . 93.7 mt -72.27 102.45 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 114.908 -1.042 . . . . 71.45 109.308 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.72 -19.33 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 115.056 -0.975 . . . . 55.03 111.521 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -153.89 168.43 26.38 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 122.562 0.345 . . . . 74.53 110.165 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.52 169.79 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 123.532 0.733 . . . . 72.45 110.359 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -141.32 104.09 4.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.683 0.793 . . . . 73.24 109.203 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.3 -172.39 34.59 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 115.934 -0.575 . . . . 64.01 113.519 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 17.5 p -91.4 2.93 56.05 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.197 0.999 . . . . 70.11 111.728 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -84.75 -3.34 58.54 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.43 1.092 . . . . 73.15 112.132 -171.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.14 -1.71 88.59 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.966 -0.352 . . . . 74.14 113.264 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.63 135.44 55.93 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 109.28 -0.637 . . . . 72.12 109.28 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.464 ' HB ' HG23 ' A' ' 57' ' ' ILE . 29.2 m -111.63 157.14 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.996 0.918 . . . . 75.22 110.889 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.574 ' HG3' HG13 ' A' ' 21' ' ' VAL . 41.3 ttm180 -106.52 109.27 21.14 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.002 0.921 . . . . 75.11 109.226 174.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.05 121.85 45.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.421 0.688 . . . . 73.03 110.267 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -88.07 111.24 21.33 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.276 -0.639 . . . . 71.43 109.276 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.411 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 39.2 m-85 -87.26 147.14 25.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.606 0.762 . . . . 71.54 110.758 175.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -49.66 -47.47 50.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.157 1.383 . . . . 72.25 111.822 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -108.7 -57.73 2.1 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.211 1.004 . . . . 75.22 108.411 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 63.42 57.16 15.97 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 114.598 -1.183 . . . . 53.4 111.661 -175.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 39.0 mt -67.56 115.49 27.5 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 109.653 -0.499 . . . . 64.33 109.653 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 12.4 Cg_exo -68.44 164.59 32.13 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 123.337 2.691 . . . . 73.12 111.949 -173.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 170.72 168.6 32.7 Favored Glycine 0 C--N 1.329 0.176 0 N-CA-C 111.139 -0.784 . . . . 75.21 111.139 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -85.6 28.71 0.74 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.299 0.639 . . . . 70.54 111.798 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.78 23.73 1.14 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.587 1.155 . . . . 71.33 111.404 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.61 113.76 3.53 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.682 0.793 . . . . 73.0 109.578 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.66 -5.67 14.32 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.948 -0.569 . . . . 21.24 112.487 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -80.44 152.73 28.64 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.508 0.723 . . . . 70.02 111.201 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -85.82 145.26 27.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.848 0.459 . . . . 73.33 111.765 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 24' ' ' ILE . 18.2 m -116.73 157.7 17.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 C-N-CA 124.144 0.978 . . . . 71.24 108.97 171.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -113.69 109.94 19.39 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.323 -0.621 . . . . 65.32 109.323 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 69.3 mt -89.13 98.04 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.57 0.748 . . . . 63.13 109.443 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 2' ' ' ARG . 59.9 t -79.69 136.41 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.496 -0.775 . . . . 72.24 109.703 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -78.52 99.98 6.72 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 108.438 -0.949 . . . . 61.5 108.438 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -137.21 135.46 37.28 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.015 0.926 . . . . 74.34 109.402 172.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -81.33 -21.98 38.8 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.394 -0.821 . . . . 65.05 109.605 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 . . . . . 0 CA--C 1.549 0.928 0 C-N-CA 125.242 1.417 . . . . 72.55 110.94 178.85 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ttt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.12 -0.326 . . . . 64.14 110.12 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 39.1 ptt180 -101.51 128.57 47.69 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.021 0.439 . . . . 73.22 110.998 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 56.8 mt -101.07 145.28 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 108.016 -1.105 . . . . 65.34 108.016 174.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.454 ' HE2' HD12 ' A' ' 27' ' ' LEU . 20.5 ptmt -90.29 124.73 35.14 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.413 -0.588 . . . . 63.01 109.413 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -123.59 150.98 16.95 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 111.273 -0.731 . . . . 74.15 111.273 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.7 t -99.05 135.5 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.015 0.908 . . . . 72.34 110.802 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.82 104.07 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.876 1.27 . . . . 75.1 109.057 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.563 HD21 ' HG2' ' A' ' 25' ' ' LYS . 59.4 mt -82.28 -60.74 2.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.671 -0.492 . . . . 75.45 109.671 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -153.45 169.77 22.35 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.357 0.663 . . . . 34.32 111.701 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -122.82 143.09 50.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.508 1.123 . . . . 73.4 108.611 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.42 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 41.6 ttm180 -136.53 117.5 14.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.958 0.903 . . . . 73.11 108.893 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -73.75 145.05 45.4 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 109.623 -0.51 . . . . 64.11 109.623 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.6 p -111.5 -24.55 10.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.641 0.776 . . . . 74.32 109.797 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -156.91 150.59 24.53 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.411 0.684 . . . . 63.1 110.575 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -60.59 -48.84 80.01 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.169 1.387 . . . . 63.51 111.818 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.88 171.41 14.46 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.607 0.363 . . . . 64.4 111.444 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -57.14 97.62 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.782 1.233 . . . . 70.34 111.23 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -148.76 155.95 41.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.46 1.104 . . . . 72.01 109.343 -173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -66.29 90.61 0.15 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 120.825 0.345 . . . . 73.4 110.092 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -84.87 156.5 21.25 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.542 -0.911 . . . . 72.44 108.542 173.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 21.9 t -87.36 146.81 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.522 0.729 . . . . 63.31 109.208 -172.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -138.54 112.79 8.68 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.159 -1.423 . . . . 71.32 107.159 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 8' ' ' LEU . 24.7 mm -75.06 112.43 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.272 -1.01 . . . . 72.51 108.272 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -122.62 162.63 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.703 1.201 . . . . 65.44 107.832 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG2' HD21 ' A' ' 8' ' ' LEU . 20.3 ptmt -145.94 131.05 9.09 Favored Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 109.511 -0.552 . . . . 71.23 109.511 163.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.481 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 9.8 Cg_exo -69.94 127.94 15.15 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 121.967 1.778 . . . . 72.25 110.562 171.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.454 HD12 ' HE2' ' A' ' 4' ' ' LYS . 64.6 mt -60.68 -37.0 80.15 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.327 0.651 . . . . 53.34 112.107 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -74.4 -29.26 61.45 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.971 -0.558 . . . . 64.13 110.8 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 34' ' ' GLU . 45.8 t -87.39 97.78 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.914 0.864 . . . . 63.2 109.98 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -101.04 -6.63 24.15 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.815 1.246 . . . . 73.04 110.169 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 m -117.44 147.13 42.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.923 0.889 . . . . 74.55 110.352 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.58 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 75.6 ttt-85 -65.16 -34.75 79.12 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.035 0.534 . . . . 64.15 111.576 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -59.67 -43.62 93.91 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.538 0.685 . . . . 65.11 109.759 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.524 ' HB2' HG13 ' A' ' 29' ' ' VAL . 21.2 mm-40 -68.86 -31.67 70.78 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.724 -1.125 . . . . 73.44 111.062 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.56 -35.0 58.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.53 0.732 . . . . 50.43 111.766 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -79.91 -25.63 40.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.395 1.078 . . . . 65.32 111.152 -168.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 63.3 pttt -77.61 -13.63 59.86 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.419 -0.355 . . . . 72.23 110.848 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.555 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 96.1 mt -89.05 8.34 30.28 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.777 0.831 . . . . 62.55 111.834 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.472 HD11 HG13 ' A' ' 60' ' ' VAL . 33.1 mm -65.87 103.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.272 -1.01 . . . . 61.13 108.272 172.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.61 0.8 17.96 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.52 -0.6 . . . . 60.14 113.446 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.782 ' HD3' HG23 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -74.37 156.24 37.28 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.747 0.773 . . . . 43.15 110.585 177.402 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 tp -94.43 143.88 26.04 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.172 0.589 . . . . 74.15 109.894 176.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.93 125.79 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.992 -1.114 . . . . 75.33 107.992 172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -115.01 109.5 18.19 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.735 -1.209 . . . . 73.21 107.735 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.3 t90 -131.74 117.51 18.69 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.251 -0.648 . . . . 75.24 109.251 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -86.46 105.86 17.07 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.653 0.781 . . . . 74.05 109.048 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.6 p -64.22 153.73 84.86 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 124.318 1.047 . . . . 61.43 112.459 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.33 -8.07 17.7 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.075 2.517 . . . . 65.34 112.622 168.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -61.63 -27.52 68.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.881 0.872 . . . . 73.35 110.693 167.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.42 24.85 13.18 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 115.253 -0.885 . . . . 22.44 111.901 -175.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -124.08 139.49 53.89 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.791 0.836 . . . . 70.11 110.554 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -85.18 95.1 4.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.235 -1.024 . . . . 75.13 108.235 173.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.445 HD22 ' HB2' ' A' ' 73' ' ' LYS . 28.6 mt -75.4 111.37 10.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.937 -0.764 . . . . 74.42 108.937 177.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -97.26 135.1 39.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.464 0.706 . . . . 71.01 109.662 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.46 170.98 24.51 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.581 0.551 . . . . 54.31 113.069 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -152.85 141.99 21.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.819 0.848 . . . . 75.25 109.66 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 29.9 mt -70.38 122.43 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 123.418 0.449 . . . . 75.4 110.284 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.3 m -87.25 -34.1 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.416 0.686 . . . . 70.05 110.08 172.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -167.36 150.52 6.26 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.337 0.655 . . . . 73.44 109.878 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.472 HG13 HD11 ' A' ' 39' ' ' ILE . 16.6 m -90.44 169.69 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.175 0.59 . . . . 73.33 109.639 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -135.59 101.88 4.93 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.833 -0.803 . . . . 73.41 108.833 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.79 -171.7 25.87 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 115.386 0.914 . . . . 43.41 115.386 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 40.3 p -93.81 12.1 26.95 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.646 1.179 . . . . 61.32 111.8 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -74.15 -17.76 60.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.816 0.846 . . . . 73.12 110.642 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.14 -4.95 78.24 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.515 -0.634 . . . . 72.1 111.515 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.89 141.69 51.18 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.605 0.762 . . . . 64.25 110.945 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.481 HG21 ' NH2' ' A' ' 41' ' ' ARG . 27.4 m -135.7 152.47 31.24 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 C-N-CA 124.539 1.135 . . . . 64.21 109.691 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -107.27 102.7 11.99 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.006 -1.109 . . . . 73.41 108.006 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -107.24 116.03 31.21 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.237 -0.892 . . . . 73.25 108.948 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -89.1 131.81 35.08 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.566 -0.531 . . . . 75.23 109.566 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -101.62 135.49 43.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.402 1.081 . . . . 74.23 109.432 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -54.62 -44.39 73.1 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.482 1.114 . . . . 74.54 111.15 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.445 ' HB2' HD22 ' A' ' 53' ' ' LEU . 73.3 mmtt -77.86 -42.49 33.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.507 -0.77 . . . . 74.53 109.293 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.55 33.7 72.93 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 124.137 0.898 . . . . 64.5 114.101 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.441 HD12 HD21 ' A' ' 53' ' ' LEU . 43.6 mt -69.71 121.57 82.98 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.067 0.547 . . . . 73.51 110.782 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.39 123.38 8.15 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.601 2.201 . . . . 74.32 110.969 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -135.17 142.78 14.25 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.916 -0.474 . . . . 72.25 111.916 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -88.38 70.28 9.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.159 -1.052 . . . . 74.44 108.159 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.39 28.58 7.93 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.139 -1.391 . . . . 74.41 110.315 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.29 104.05 1.4 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.841 -0.618 . . . . 74.21 110.209 -174.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.81 -1.76 8.57 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.019 -0.537 . . . . 60.31 113.015 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.81 174.16 10.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.38 0.672 . . . . 75.11 111.318 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 85.8 m-85 -115.62 129.86 56.65 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.209 0.603 . . . . 61.31 111.344 -173.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.6 m -99.71 156.52 3.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 124.383 1.073 . . . . 72.11 109.583 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -103.9 109.86 21.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.282 0.633 . . . . 73.33 109.513 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.782 HG23 ' HD3' ' A' ' 41' ' ' ARG . 82.1 mt -91.51 93.06 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.239 1.015 . . . . 71.43 108.91 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.99 105.98 12.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 115.257 -0.883 . . . . 74.24 109.896 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -73.7 102.35 3.93 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.403 -1.703 . . . . 63.12 106.403 166.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.09 161.91 27.07 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.413 -0.812 . . . . 73.41 111.508 -174.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -64.74 157.46 27.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.555 -1.202 . . . . 72.0 111.127 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 . . . . . 0 N--CA 1.484 1.238 0 C-N-CA 123.724 0.81 . . . . 72.5 109.782 -178.207 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 121.598 0.713 . . . . 73.11 110.067 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.21 155.05 35.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.863 -1.062 . . . . 73.21 109.648 172.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 mt -106.11 118.68 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.017 -1.105 . . . . 70.4 108.017 170.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.447 ' HG3' HD12 ' A' ' 27' ' ' LEU . 17.4 ptpt -88.01 149.27 24.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.401 -0.592 . . . . 73.21 109.401 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -147.01 177.65 25.16 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 123.522 0.514 . . . . 63.32 112.082 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.6 t -113.03 132.66 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.893 0.877 . . . . 64.14 110.167 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.8 t -66.83 118.2 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.576 0.75 . . . . 74.33 109.636 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.525 HD12 HG22 ' A' ' 23' ' ' ILE . 88.8 mt -90.64 -51.64 5.29 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.973 0.509 . . . . 74.54 109.918 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.1 p -164.77 163.02 21.41 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.098 -0.501 . . . . 64.45 111.551 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -111.32 157.29 20.35 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.782 0.833 . . . . 61.24 108.953 171.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -137.3 106.82 6.14 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 108.893 -0.78 . . . . 72.31 108.893 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' HD3' ' HD3' ' A' ' 76' ' ' PRO . 32.2 mmm180 -80.05 121.93 26.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.933 -1.136 . . . . 70.51 107.933 170.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 t -137.69 137.52 38.45 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.897 -0.779 . . . . 53.21 108.897 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.44 146.92 42.85 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.356 1.063 . . . . 64.33 111.374 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -65.56 116.2 6.57 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.086 0.554 . . . . 71.5 112.41 -173.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -159.01 -81.86 0.05 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.276 1.03 . . . . 71.32 109.009 174.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.14 140.77 3.65 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 107.983 -1.117 . . . . 53.31 107.983 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.0 m80 68.36 26.01 6.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.161 1.384 . . . . 64.24 112.303 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -102.14 178.44 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.315 0.646 . . . . 71.31 112.5 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 54.49 63.85 2.01 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.691 1.196 . . . . 73.23 110.524 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.42 140.71 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.967 -1.015 . . . . 72.5 108.867 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.5 ttt -132.29 116.52 17.0 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.027 -1.101 . . . . 74.35 108.027 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.525 HG22 HD12 ' A' ' 8' ' ' LEU . 31.2 mm -83.98 120.41 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.563 0.745 . . . . 52.3 109.028 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 84' ' ' VAL . 87.2 mt -126.12 152.67 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.654 1.182 . . . . 74.2 108.262 -176.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.523 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -125.81 102.69 28.32 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.104 -1.073 . . . . 73.31 108.104 170.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.538 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 24.3 Cg_exo -61.05 143.0 99.0 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.756 2.304 . . . . 71.32 112.064 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.447 HD12 ' HG3' ' A' ' 4' ' ' LYS . 88.9 mt -67.99 -43.11 79.66 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.394 0.677 . . . . 74.03 111.541 -177.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.56 -25.99 66.07 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.812 0.845 . . . . 62.34 111.597 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 55.6 t -105.29 116.3 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.273 1.029 . . . . 52.42 110.981 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -128.64 13.64 6.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.389 0.676 . . . . 74.33 110.68 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.1 t -145.6 164.45 31.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.557 0.743 . . . . 64.33 110.525 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.611 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 74.5 ttt180 -59.26 -51.04 71.66 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.404 1.082 . . . . 71.42 112.141 -170.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -75.08 -29.08 60.57 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.406 -0.815 . . . . 71.31 110.82 -169.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 29' ' ' VAL . 42.4 mt-10 -64.86 -30.81 71.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.538 -0.756 . . . . 73.42 109.917 173.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.74 -32.74 23.31 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.011 0.924 . . . . 73.11 111.169 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.0 m -78.04 -16.45 58.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.35 0.66 . . . . 51.43 111.898 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -82.31 -16.11 50.53 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.807 0.337 . . . . 75.01 110.495 171.423 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.13 5.93 42.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.126 0.57 . . . . 74.44 112.033 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.579 HD11 HG13 ' A' ' 60' ' ' VAL . 46.5 mm -68.54 104.68 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.741 -0.837 . . . . 65.13 108.741 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.79 -4.79 11.63 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.787 -0.642 . . . . 53.52 113.143 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HD2' HD13 ' A' ' 88' ' ' LEU . 24.1 mmt180 -84.58 149.77 25.66 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.82 0.81 . . . . 64.34 110.604 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 55' ' ' GLY . 48.0 tp -89.78 138.12 31.75 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 124.177 0.991 . . . . 72.42 108.754 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 86' ' ' ILE . 16.3 t -119.69 138.01 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.852 -0.795 . . . . 74.45 108.852 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.4 132.95 52.67 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.269 -1.012 . . . . 72.35 108.269 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -138.93 128.69 24.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.075 0.55 . . . . 74.53 109.571 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 17.6 tppt? -78.98 120.89 24.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.718 0.807 . . . . 73.31 109.354 174.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 7.6 m -83.83 138.16 40.59 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 115.259 -0.882 . . . . 74.12 109.23 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.07 -17.77 39.97 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.225 2.617 . . . . 61.05 113.619 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -82.81 13.05 4.12 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.586 0.755 . . . . 74.33 111.89 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.95 41.27 49.31 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 112.539 -0.224 . . . . 72.0 112.539 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 75.3 mmtt -124.12 169.61 11.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.947 0.899 . . . . 71.2 109.403 -178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -131.85 107.83 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.216 -1.031 . . . . 53.4 108.216 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.556 HD22 ' HB2' ' A' ' 73' ' ' LYS . 22.6 mt -83.45 124.89 31.14 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.88 -0.6 . . . . 71.33 109.399 176.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -105.1 130.44 53.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.429 -0.952 . . . . 73.2 108.429 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.438 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -145.28 -179.6 21.69 Favored Glycine 0 N--CA 1.464 0.562 0 O-C-N 123.31 0.381 . . . . 74.34 112.304 -175.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -152.56 133.32 13.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.875 0.337 . . . . 64.51 110.819 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.562 HD11 HD13 ' A' ' 86' ' ' ILE . 68.3 mt -67.87 103.92 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 124.08 0.862 . . . . 73.3 109.524 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.2 m -89.58 -35.24 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.287 0.635 . . . . 73.21 111.517 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -164.41 149.82 10.29 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.37 -0.604 . . . . 71.12 109.37 -175.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.579 HG13 HD11 ' A' ' 39' ' ' ILE . 13.9 m -94.78 171.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.473 0.709 . . . . 55.11 110.853 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -128.46 113.96 16.19 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.887 0.875 . . . . 73.23 109.651 174.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.76 -154.97 50.64 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 123.902 0.751 . . . . 64.21 113.549 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.611 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 22.7 p -105.04 7.56 34.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.56 1.144 . . . . 74.13 111.826 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -85.75 2.42 45.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.407 0.683 . . . . 72.33 112.832 -171.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.35 71.52 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.142 -0.255 . . . . 51.41 113.423 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.4 117.86 17.66 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.427 0.691 . . . . 73.32 110.077 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.6 m -102.18 150.84 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.755 0.822 . . . . 64.41 110.719 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -103.12 104.52 14.68 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.641 -1.244 . . . . 73.15 107.641 171.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.13 118.04 35.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.11 -1.07 . . . . 65.4 108.11 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.8 mtm105 -89.98 118.21 29.37 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.566 -0.531 . . . . 72.24 109.566 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -98.19 132.06 44.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.9 0.88 . . . . 72.11 109.809 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -52.88 -41.94 64.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.947 1.299 . . . . 64.13 112.264 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HB2' HD22 ' A' ' 53' ' ' LEU . 43.6 mmtm -90.06 -47.8 7.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.128 0.971 . . . . 74.24 109.281 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.12 38.39 94.3 Favored Glycine 0 C--N 1.356 1.686 0 O-C-N 123.887 0.742 . . . . 50.02 114.331 175.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.06 131.37 92.27 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 122.934 0.493 . . . . 72.52 110.68 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' HD3' ' HD3' ' A' ' 12' ' ' ARG . 86.9 Cg_endo -75.7 176.24 10.25 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.801 2.334 . . . . 73.12 111.919 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.18 157.81 19.0 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.174 -0.466 . . . . 61.33 112.31 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -94.19 26.37 3.33 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.607 0.718 . . . . 64.4 110.555 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.48 28.63 1.08 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.432 1.093 . . . . 53.33 111.033 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -61.76 109.36 1.2 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.746 0.818 . . . . 73.3 110.036 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.94 -14.79 7.05 Favored Glycine 0 C--N 1.347 1.144 0 O-C-N 123.31 0.381 . . . . 54.3 113.011 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.12 160.39 31.28 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.661 0.784 . . . . 74.31 111.287 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 13.0 m-85 -87.32 131.67 34.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.614 0.766 . . . . 74.34 111.69 -177.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 24' ' ' ILE . 16.6 m -104.5 151.14 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.452 -0.944 . . . . 73.0 108.452 167.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -108.97 108.72 19.57 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.085 -0.709 . . . . 52.14 109.085 171.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.562 HD13 HD11 ' A' ' 57' ' ' ILE . 59.6 mt -85.88 91.39 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.721 -1.214 . . . . 74.25 107.721 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.2 t -75.62 147.47 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.69 -1.141 . . . . 65.22 109.83 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.478 HD13 ' HD2' ' A' ' 41' ' ' ARG . 4.5 mm? -69.59 -169.12 0.21 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.552 0.741 . . . . 54.32 110.735 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -62.65 90.06 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.045 0.538 . . . . 75.23 111.922 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -71.05 89.08 0.8 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.743 -1.117 . . . . 71.52 109.219 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 115.231 -0.895 . . . . 72.24 108.897 177.639 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 121.459 0.647 . . . . 51.44 109.58 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.46 ' HD2' HG22 ' A' ' 87' ' ' VAL . 34.2 mtm-85 -132.88 130.78 40.15 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.789 1.236 . . . . 74.45 107.894 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.701 HD12 HD21 ' A' ' 38' ' ' LEU . 25.9 mt -101.1 134.96 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 109.713 -0.477 . . . . 64.43 109.713 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -89.69 121.52 31.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.577 0.751 . . . . 71.4 109.417 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -114.57 167.86 12.42 Favored Glycine 0 N--CA 1.48 1.611 0 CA-C-O 119.698 -0.501 . . . . 60.44 113.055 -175.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.2 t -124.13 122.9 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.973 0.909 . . . . 75.14 109.571 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.2 t -69.76 97.85 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.26 0.624 . . . . 54.54 109.777 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 25' ' ' LYS . 67.6 mt -75.83 -47.84 23.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.212 0.605 . . . . 73.5 110.853 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.7 m -151.43 152.45 33.07 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.7 0.8 . . . . 73.13 110.927 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.32 142.11 35.66 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.664 0.786 . . . . 74.1 109.44 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -130.96 103.85 6.78 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 105.286 -2.116 . . . . 73.5 105.286 159.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -89.12 146.41 24.82 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.262 -0.644 . . . . 74.23 109.262 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 t -136.24 142.93 44.07 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.559 -0.746 . . . . 44.33 110.089 -171.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -151.16 -5.46 0.28 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 124.382 1.073 . . . . 60.14 110.06 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.49 -59.56 4.18 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.608 0.763 . . . . 64.11 110.909 -172.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -105.93 -62.62 1.35 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.24 -1.022 . . . . 53.12 108.24 173.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -96.58 140.94 30.46 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.161 -0.927 . . . . 62.31 109.47 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -95.3 68.54 3.06 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.085 0.945 . . . . 74.05 109.816 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -124.07 124.87 43.47 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.582 -0.735 . . . . 72.52 111.382 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 4.5 t30 -75.55 93.23 2.98 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 106.91 -1.515 . . . . 62.14 106.91 164.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 70' ' ' ARG . 14.6 t -88.08 148.89 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.067 -1.457 . . . . 54.24 107.067 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.6 ptp -153.34 144.96 23.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.669 0.271 . . . . 74.54 110.678 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.07 119.81 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.179 -1.045 . . . . 50.32 108.179 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.511 HD13 HG21 ' A' ' 84' ' ' VAL . 89.2 mt -121.25 123.03 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.951 0.9 . . . . 64.21 109.644 -175.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.594 ' HB2' HD11 ' A' ' 8' ' ' LEU . 87.9 tttt -99.64 109.26 54.78 Favored Pre-proline 0 N--CA 1.482 1.173 0 CA-C-N 119.172 0.896 . . . . 71.22 109.859 172.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.642 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 20.4 Cg_exo -67.46 138.12 45.09 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.799 2.333 . . . . 72.42 112.39 171.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.33 -39.04 89.08 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.657 1.183 . . . . 74.41 111.82 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -77.72 -28.22 50.78 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.642 0.777 . . . . 70.51 112.097 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 34' ' ' GLU . 54.7 t -92.02 113.52 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.789 0.836 . . . . 61.05 110.67 -170.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -101.17 -30.21 11.68 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.917 0.887 . . . . 72.53 111.066 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.8 p -119.99 166.72 12.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.948 0.499 . . . . 54.21 111.331 -172.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 67.7 ttt180 -61.97 -37.55 85.2 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.845 0.858 . . . . 74.24 111.022 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.87 -45.3 93.2 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.014 0.526 . . . . 70.34 111.137 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HB2' HG13 ' A' ' 29' ' ' VAL . 41.5 mt-10 -66.87 -22.09 65.99 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.384 -0.825 . . . . 71.45 111.215 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.62 -28.25 28.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.617 0.767 . . . . 73.23 110.877 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -79.29 -24.2 43.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.217 0.607 . . . . 72.45 111.517 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -61.63 -20.47 63.41 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.165 0.439 . . . . 60.42 110.622 169.447 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.701 HD21 HD12 ' A' ' 3' ' ' ILE . 88.9 mt -88.36 -1.15 57.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.761 0.824 . . . . 72.55 112.913 -175.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.659 HD11 HG13 ' A' ' 60' ' ' VAL . 38.6 mm -72.3 103.91 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.475 0.579 . . . . 72.3 109.553 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.7 -4.54 17.01 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.696 -0.684 . . . . 74.31 113.025 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HA ' HD23 ' A' ' 88' ' ' LEU . 27.6 mmt180 -75.52 153.54 37.4 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.774 0.787 . . . . 74.54 109.759 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 55' ' ' GLY . 56.2 tp -89.33 146.01 24.98 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.047 -1.094 . . . . 63.45 108.047 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.2 t -126.24 115.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.951 -0.759 . . . . 74.03 108.951 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.3 mt -100.36 106.19 17.78 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.917 0.887 . . . . 72.22 108.718 176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 53.9 t90 -123.72 130.64 52.95 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.903 0.881 . . . . 72.34 108.866 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -88.0 113.88 24.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.369 0.667 . . . . 74.33 109.271 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.0 p -65.96 152.4 93.58 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.55 0.74 . . . . 73.1 111.501 176.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.8 -7.98 22.44 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.516 2.144 . . . . 55.53 112.039 170.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 t -71.17 -29.69 65.51 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.59 0.756 . . . . 74.13 110.302 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.59 -34.46 2.67 Favored Glycine 0 C--N 1.354 1.581 0 C-N-CA 122.951 0.31 . . . . 63.45 113.311 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -73.13 157.17 37.76 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.509 0.724 . . . . 72.44 111.483 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.82 104.12 15.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.537 -1.283 . . . . 51.24 107.537 167.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 75' ' ' LEU . 26.9 mt -74.78 136.31 41.69 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.717 -0.674 . . . . 74.53 110.363 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -103.93 128.45 51.44 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.868 0.867 . . . . 43.31 109.004 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.439 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -135.38 176.94 19.78 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 123.896 0.747 . . . . 43.45 112.03 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -146.63 129.59 16.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.492 -0.559 . . . . 74.34 109.492 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.431 HG23 ' HB ' ' A' ' 67' ' ' VAL . 80.9 mt -67.81 97.22 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.583 -0.895 . . . . 75.3 108.583 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.92 -31.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.09 -0.959 . . . . 54.35 111.143 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -158.57 162.88 37.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.61 0.764 . . . . 74.04 109.03 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.659 HG13 HD11 ' A' ' 39' ' ' ILE . 34.1 m -92.3 168.62 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.501 0.721 . . . . 73.15 110.382 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -137.22 103.8 5.22 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.285 -0.635 . . . . 61.32 109.285 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.6 178.66 50.37 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 116.028 -0.533 . . . . 71.05 113.651 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 71.7 p -97.76 1.19 48.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.963 0.905 . . . . 71.43 111.692 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.03 12.18 8.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.669 0.787 . . . . 61.51 112.014 -176.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.85 -12.16 70.21 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 120.083 -0.287 . . . . 51.14 113.435 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.32 143.2 56.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.959 0.504 . . . . 54.31 110.722 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 35.9 m -118.87 -171.91 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.527 1.531 . . . . 75.42 109.339 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -145.63 108.4 4.51 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.05 -0.722 . . . . 65.34 109.05 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.03 125.32 50.87 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.874 0.87 . . . . 74.42 111.125 -176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.514 ' HG2' HG22 ' A' ' 21' ' ' VAL . 97.2 mtt180 -91.13 115.1 27.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.762 0.825 . . . . 73.53 110.139 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.4 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 14.9 m-85 -89.19 119.94 30.12 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.886 -0.783 . . . . 75.35 108.886 172.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.44 -19.74 62.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.5 0.72 . . . . 70.22 112.2 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -69.79 -55.9 8.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.061 0.945 . . . . 73.21 110.541 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 20' ' ' ASN . . . 81.0 46.33 7.14 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 114.6 0.6 . . . . 74.52 114.6 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.514 ' HB2' HD11 ' A' ' 53' ' ' LEU . 31.5 mt -96.77 143.3 25.89 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 117.659 0.73 . . . . 73.33 110.668 171.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -90.08 -174.84 0.87 Allowed 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.435 2.756 . . . . 72.44 113.44 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 146.87 153.47 5.91 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.039 -0.982 . . . . 73.34 111.46 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -99.8 87.46 3.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.236 0.614 . . . . 73.33 109.483 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.04 31.33 6.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.818 0.847 . . . . 43.53 111.041 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.09 105.53 0.33 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.924 -0.398 . . . . 75.52 109.924 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.27 3.61 18.99 Favored Glycine 0 C--N 1.35 1.333 0 C-N-CA 123.929 0.776 . . . . 53.12 112.548 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -86.82 163.55 17.16 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.967 0.507 . . . . 74.43 110.428 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 97.0 m-85 -109.55 125.55 52.64 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.12 0.568 . . . . 71.05 111.513 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.511 HG21 HD13 ' A' ' 24' ' ' ILE . 18.8 m -100.99 162.35 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.165 0.986 . . . . 74.34 111.008 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -103.98 110.25 22.32 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.033 0.933 . . . . 74.02 109.69 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.0 mt -87.82 91.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 107.372 -1.344 . . . . 72.13 107.372 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.46 HG22 ' HD2' ' A' ' 2' ' ' ARG . 21.9 t -98.27 151.83 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.781 1.233 . . . . 51.45 109.632 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 41' ' ' ARG . 2.0 tm? -159.11 116.6 2.77 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.611 -0.885 . . . . 72.5 108.611 169.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -67.69 103.53 1.42 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.629 -0.878 . . . . 73.31 108.629 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -67.57 103.15 1.28 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.841 0.713 . . . . 70.04 110.682 -173.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 . . . . . 0 CA--C 1.55 0.961 0 C-N-CA 124.631 1.172 . . . . 65.31 109.283 174.311 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 109.21 -0.663 . . . . 61.23 109.21 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.498 ' HG3' ' HB3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -152.64 158.05 41.85 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.378 0.671 . . . . 74.01 109.702 170.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.509 HG23 ' HB2' ' A' ' 28' ' ' ASP . 80.3 mt -95.56 135.72 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.767 0.827 . . . . 71.4 109.7 -175.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HE2' ' CD2' ' A' ' 83' ' ' TYR . 85.6 tttt -90.25 138.49 31.48 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.691 -0.855 . . . . 74.52 108.691 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.69 -179.79 16.97 Favored Glycine 0 N--CA 1.469 0.847 0 N-CA-C 111.606 -0.598 . . . . 50.42 111.606 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.17 130.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.847 0.859 . . . . 65.12 109.641 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.18 100.87 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.599 1.159 . . . . 54.11 109.743 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 25' ' ' LYS . 67.0 mt -82.52 -56.66 3.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.822 0.449 . . . . 71.21 111.565 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 m -147.21 135.23 21.41 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.671 0.389 . . . . 64.24 111.352 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -80.98 122.63 27.53 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.516 -0.92 . . . . 73.22 108.516 168.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.659 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 37.0 mmt180 -117.39 107.24 14.12 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.592 -0.892 . . . . 75.52 108.592 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -84.24 114.28 21.71 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.886 0.474 . . . . 73.43 109.903 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.7 m -73.47 -74.88 0.16 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.411 0.684 . . . . 63.31 110.441 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 18' ' ' HIS . 68.2 mttm -140.86 161.34 38.05 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.076 0.55 . . . . 74.5 110.076 176.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -68.05 -48.59 65.19 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.083 0.953 . . . . 62.33 111.311 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -82.73 79.12 9.22 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.35 -0.841 . . . . 70.12 111.718 -167.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 64.57 2.0 1.5 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.396 1.478 . . . . 72.12 114.501 165.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . 59.9 m80 -82.83 127.55 33.57 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.063 -0.718 . . . . 71.13 109.063 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -63.61 117.74 7.22 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.859 0.724 . . . . 71.03 111.031 -169.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.446 ' OD1' ' HA2' ' A' ' 74' ' ' GLY . 2.9 p-10 -69.05 150.19 47.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.449 0.7 . . . . 62.52 109.137 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.659 ' HB ' ' HB2' ' A' ' 11' ' ' ARG . 10.7 t -87.95 157.17 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.221 -1.029 . . . . 74.01 108.221 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 36.6 ttp -141.71 114.18 8.3 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.263 -1.384 . . . . 74.42 107.263 169.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.6 mm -67.42 124.45 22.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 N-CA-C 108.108 -1.071 . . . . 64.35 108.108 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.462 HG21 HG21 ' A' ' 84' ' ' VAL . 96.3 mt -134.27 137.06 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.948 -1.13 . . . . 72.25 107.948 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.512 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -102.11 113.43 65.86 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.727 -0.842 . . . . 75.42 108.727 169.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.621 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 15.8 Cg_exo -68.3 119.8 6.79 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.585 1.523 . . . . 71.21 110.177 169.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.88 -35.99 81.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.485 0.714 . . . . 65.42 111.602 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 3' ' ' ILE . 7.8 m-20 -76.45 -28.95 56.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.755 0.422 . . . . 74.53 111.23 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 50.0 t -115.56 102.27 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.475 0.71 . . . . 74.12 110.459 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.525 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 26.3 p30 -110.15 2.14 19.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.036 0.934 . . . . 74.01 111.425 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.9 m -97.83 156.14 16.72 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.65 0.78 . . . . 52.13 110.477 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 31.7 ttt180 -74.54 -42.8 58.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.2 0.6 . . . . 73.51 110.918 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.53 -40.43 92.91 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.788 0.835 . . . . 74.22 110.987 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HB2' HG13 ' A' ' 29' ' ' VAL . 5.9 mm-40 -70.83 -28.57 64.7 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.268 -0.878 . . . . 65.51 110.243 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.26 43.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.561 0.744 . . . . 44.25 111.192 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.8 t -78.78 -23.54 45.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.915 0.886 . . . . 72.12 110.018 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -92.75 2.12 56.91 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.642 0.377 . . . . 74.11 111.124 171.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD21 HD12 ' A' ' 3' ' ' ILE . 43.2 mt -85.94 -11.23 53.65 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.092 0.557 . . . . 73.24 111.137 170.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.531 HD11 HG13 ' A' ' 60' ' ' VAL . 42.7 mm -63.38 126.64 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 109.214 -0.661 . . . . 71.04 109.214 177.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.64 7.67 66.48 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.612 -0.549 . . . . 72.33 113.426 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -96.1 150.86 20.03 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 117.851 0.826 . . . . 73.31 111.202 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 89' ' ' GLU . 43.8 tp -91.17 115.95 28.42 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.758 -1.11 . . . . 75.1 109.897 -171.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 86' ' ' ILE . 62.0 t -97.38 115.04 36.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.29 -0.633 . . . . 41.42 109.29 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.9 mt -93.7 101.88 14.03 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.153 0.981 . . . . 75.43 108.419 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.403 ' CD1' HG12 ' A' ' 84' ' ' VAL . 31.2 t90 -104.38 131.21 51.99 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.399 -0.963 . . . . 72.24 108.399 172.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -96.03 114.67 26.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.16 -1.422 . . . . 73.01 107.16 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.1 p -57.95 155.74 22.44 Favored Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 124.115 0.966 . . . . 74.44 111.026 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.78 -25.25 50.75 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.126 2.551 . . . . 53.5 112.82 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -58.55 -38.15 77.21 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.921 1.288 . . . . 72.1 111.505 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.68 -8.91 11.73 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 115.635 -0.711 . . . . 72.21 112.015 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -82.05 153.54 26.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.602 1.161 . . . . 73.55 110.141 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.7 mt -110.12 109.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.816 0.446 . . . . 74.43 110.203 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.571 HD21 HD12 ' A' ' 75' ' ' LEU . 57.3 mt -80.54 142.26 34.31 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.991 0.916 . . . . 62.15 110.319 174.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 42' ' ' LEU . 13.9 mmmm -96.24 128.73 43.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.886 0.874 . . . . 71.11 109.513 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.05 173.31 22.48 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 111.459 -0.656 . . . . 55.13 111.459 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -152.61 132.06 12.94 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.991 0.396 . . . . 74.02 110.709 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.464 HG22 HD13 ' A' ' 39' ' ' ILE . 65.5 mt -68.22 104.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 123.878 0.736 . . . . 43.13 109.692 176.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.79 -38.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.182 -0.463 . . . . 71.11 110.132 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -136.23 176.89 8.28 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.835 0.854 . . . . 75.41 110.532 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.531 HG13 HD11 ' A' ' 39' ' ' ILE . 31.0 m -123.45 169.99 14.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 124.529 1.132 . . . . 74.45 109.651 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -144.61 105.31 4.14 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.303 -0.999 . . . . 72.15 108.303 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.17 168.73 42.2 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.182 -0.463 . . . . 71.41 113.587 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 59.8 p -93.78 2.28 56.27 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.04 0.936 . . . . 63.13 110.987 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -84.54 7.92 18.37 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.094 0.958 . . . . 72.05 112.476 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 30' ' ' ASN . . . 69.12 63.91 3.23 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 112.004 -0.438 . . . . 61.41 112.004 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.67 113.45 15.39 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.232 -1.395 . . . . 74.01 107.232 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.42 167.17 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.087 0.955 . . . . 74.01 110.42 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -123.13 102.56 8.04 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.173 0.989 . . . . 75.1 108.786 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.29 116.91 32.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.776 0.83 . . . . 53.42 110.397 -176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 22.1 mtm180 -91.33 119.75 31.62 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 122.338 0.255 . . . . 73.2 111.254 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -93.29 129.3 39.42 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.339 1.056 . . . . 71.51 110.756 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.27 -31.04 62.38 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.908 -1.042 . . . . 75.42 112.649 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.62 -31.71 24.1 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.547 0.339 . . . . 64.52 110.883 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.446 ' HA2' ' OD1' ' A' ' 20' ' ' ASN . . . 61.87 37.1 93.79 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 115.595 0.998 . . . . 73.23 115.595 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD12 HD21 ' A' ' 53' ' ' LEU . 79.7 mt -85.04 150.02 54.36 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 122.565 0.346 . . . . 73.22 110.466 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.99 -176.04 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.1 2.533 . . . . 55.31 112.516 174.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.83 -39.7 0.02 OUTLIER Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.556 -0.747 . . . . 63.24 112.403 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 56.55 30.4 17.18 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 123.047 1.403 . . . . 62.21 109.402 -171.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.82 31.47 5.81 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.935 -1.484 . . . . 54.25 110.564 -169.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -56.01 111.79 1.03 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.661 -0.496 . . . . 60.52 109.661 172.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.58 -7.26 18.0 Favored Glycine 0 N--CA 1.476 1.342 0 C-N-CA 123.233 0.444 . . . . 71.21 112.447 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.07 169.86 17.57 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.925 0.89 . . . . 70.11 108.664 175.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CD2' ' HE2' ' A' ' 4' ' ' LYS . 92.7 m-85 -115.36 135.24 54.33 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.097 0.408 . . . . 64.23 111.173 -171.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 24' ' ' ILE . 13.8 m -101.28 168.34 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.973 0.909 . . . . 70.53 109.249 174.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 2' ' ' ARG . 49.3 mt-10 -132.43 107.13 8.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.043 -0.725 . . . . 73.11 109.043 173.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.422 HD13 HD11 ' A' ' 57' ' ' ILE . 46.7 mt -85.21 94.45 3.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 125.227 1.411 . . . . 75.51 109.258 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.62 150.14 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.421 0.688 . . . . 72.53 109.599 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.07 120.35 15.64 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 107.065 -1.457 . . . . 74.44 107.065 169.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 8.5 pt-20 -66.69 -37.7 85.26 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.448 0.536 . . . . 63.2 112.448 -173.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -68.23 -24.43 64.91 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.203 0.601 . . . . 73.13 110.743 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 . . . . . 0 C--O 1.254 1.29 0 N-CA-C 108.756 -0.831 . . . . 73.55 108.756 172.584 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.581 -0.526 . . . . 72.23 109.581 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -108.03 134.49 50.84 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.994 0.918 . . . . 74.52 108.651 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.71 124.75 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.635 0.774 . . . . 63.25 109.061 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -88.52 127.67 35.54 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.938 -0.764 . . . . 75.25 108.938 -176.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.62 -168.95 12.26 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 116.373 -0.376 . . . . 61.32 112.299 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -144.3 135.38 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.026 1.33 . . . . 61.14 109.695 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.5 t -72.61 115.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.833 0.853 . . . . 71.42 109.62 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 25' ' ' LYS . 84.3 mt -89.69 -47.81 7.69 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 123.461 0.476 . . . . 74.42 110.541 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.2 m -152.02 154.82 36.75 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.919 0.488 . . . . 33.41 111.535 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -110.47 137.85 47.63 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.397 1.079 . . . . 70.51 108.691 171.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.422 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 87.9 mtt180 -127.1 108.88 11.31 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.706 -1.22 . . . . 72.3 107.706 172.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -73.56 150.5 41.42 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.309 0.644 . . . . 70.23 111.849 -168.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 p -64.13 101.02 0.37 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.119 0.968 . . . . 62.03 110.235 175.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -161.21 158.19 26.94 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.694 0.797 . . . . 72.53 110.132 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 72.31 -81.74 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.024 1.73 . . . . 54.44 110.972 175.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -96.84 161.03 14.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.703 1.201 . . . . 72.35 108.082 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -72.69 87.3 1.25 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.722 0.772 . . . . 73.2 110.404 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -149.16 157.1 43.1 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.212 1.405 . . . . 71.31 108.67 174.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' A' ' 72' ' ' GLU . 7.0 t-20 -94.66 -169.27 1.99 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.964 -0.754 . . . . 64.11 108.964 176.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.69 112.35 4.75 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.133 0.424 . . . . 74.52 110.327 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' HD3' ' A' ' 68' ' ' ARG . 84.3 t -90.39 106.09 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.565 0.746 . . . . 62.44 109.019 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.7 ttm -100.46 124.75 46.39 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.294 -0.632 . . . . 74.42 109.294 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -82.02 115.54 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 107.786 -1.19 . . . . 72.45 107.786 172.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.414 ' HB ' HG23 ' A' ' 67' ' ' VAL . 69.4 mt -109.24 150.41 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.799 0.84 . . . . 65.2 109.938 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 8' ' ' LEU . 59.5 tttp -119.49 96.97 50.06 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 125.007 1.323 . . . . 64.32 108.962 175.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.7 106.64 0.94 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.083 1.855 . . . . 74.23 110.164 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.1 mt -53.08 -38.43 62.53 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.793 1.237 . . . . 72.21 113.324 -172.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.73 -27.11 58.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.978 0.511 . . . . 62.51 111.631 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -100.98 107.73 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.32 0.648 . . . . 64.02 111.529 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -91.62 -19.26 22.9 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.369 1.068 . . . . 73.23 111.875 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -104.53 133.42 49.42 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 122.025 -0.422 . . . . 64.22 111.05 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 49.1 ttt180 -58.97 -43.93 91.46 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.375 1.07 . . . . 62.22 111.553 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.7 -40.5 97.33 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.006 0.922 . . . . 60.34 111.524 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.69 -33.51 75.05 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.479 -0.782 . . . . 42.5 111.14 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.93 -25.77 60.15 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 122.996 0.518 . . . . 61.21 111.637 171.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -74.99 -34.11 61.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.763 0.825 . . . . 60.21 111.924 -172.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -68.93 -22.42 64.14 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 120.922 0.391 . . . . 71.42 110.39 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.55 1.74 52.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.051 0.94 . . . . 61.22 112.449 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.462 HD11 HG13 ' A' ' 60' ' ' VAL . 31.7 mm -66.53 135.79 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 118.394 0.543 . . . . 64.24 110.729 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.16 -8.58 31.16 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.683 -0.689 . . . . 65.24 113.367 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -80.26 153.44 28.5 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.362 0.581 . . . . 73.12 110.959 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 54' ' ' LYS . 59.5 tp -90.28 146.75 23.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.471 -0.786 . . . . 72.31 109.257 -174.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.431 HG22 HG12 ' A' ' 86' ' ' ILE . 40.1 t -116.95 131.83 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.83 -0.804 . . . . 70.13 108.83 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -113.14 105.73 13.8 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.603 -1.258 . . . . 65.52 107.603 175.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -125.28 124.3 41.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.33 0.652 . . . . 73.41 109.468 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HE3' ' HA2' ' A' ' 50' ' ' GLY . 45.9 tttp -81.22 122.52 27.5 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.99 -0.744 . . . . 70.14 108.99 176.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 82.2 p -65.39 152.62 91.75 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.034 0.534 . . . . 75.03 110.346 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.47 -12.9 30.0 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.268 1.979 . . . . 74.42 112.145 173.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.6 m -70.27 -42.78 71.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.417 1.087 . . . . 75.41 110.726 170.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.464 ' HA2' ' HE3' ' A' ' 46' ' ' LYS . . . 135.06 -22.78 3.56 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 116.104 -0.498 . . . . 33.01 113.126 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -74.09 122.51 22.81 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.605 0.762 . . . . 71.43 110.292 -174.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 72.3 mt -78.83 106.95 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.593 -0.892 . . . . 65.55 108.593 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.401 HD13 ' H ' ' A' ' 75' ' ' LEU . 13.2 mt -86.73 155.34 20.39 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.409 1.084 . . . . 72.21 109.791 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' HD11 ' A' ' 42' ' ' LEU . 47.1 mtpt -123.7 145.46 48.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.934 0.894 . . . . 72.34 109.229 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.76 132.61 3.04 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-O 119.824 -0.431 . . . . 74.52 112.903 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -93.05 128.77 39.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.285 0.543 . . . . 74.03 109.976 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.2 mt -72.13 116.52 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.618 0.767 . . . . 72.44 109.411 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -112.92 -3.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.727 0.811 . . . . 71.13 112.284 -172.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -165.57 161.47 18.48 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.909 0.484 . . . . 73.35 110.48 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.462 HG13 HD11 ' A' ' 39' ' ' ILE . 16.0 m -91.5 168.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.781 0.832 . . . . 74.01 109.732 168.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -143.94 105.07 4.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.076 -0.511 . . . . 74.15 109.767 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.19 176.31 38.17 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 123.377 0.423 . . . . 62.23 113.841 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 30.1 p -91.04 10.1 28.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.394 1.077 . . . . 70.03 111.059 177.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -91.75 12.37 21.53 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.907 0.883 . . . . 73.54 111.749 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.07 12.03 75.23 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 113.984 0.354 . . . . 53.23 113.984 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.55 162.26 27.25 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.174 0.59 . . . . 73.43 109.728 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 15.2 m -132.18 177.92 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.098 0.959 . . . . 61.11 110.521 -178.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.454 ' HD3' HG13 ' A' ' 21' ' ' VAL . 7.4 tmm_? -138.59 116.45 11.56 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.25 -1.389 . . . . 72.4 107.25 -175.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.41 146.05 42.8 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.715 0.806 . . . . 53.0 111.496 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -99.25 100.83 11.98 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.235 1.014 . . . . 73.52 109.311 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -77.24 124.17 27.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.321 0.648 . . . . 74.12 110.984 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 9.9 pt-20 -62.1 -35.9 80.1 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.05 0.94 . . . . 60.21 111.122 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 74.5 mmtt -99.65 -65.38 0.97 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.595 0.758 . . . . 75.42 109.017 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.0 52.97 36.22 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 124.131 0.894 . . . . 61.42 114.61 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.401 ' H ' HD13 ' A' ' 53' ' ' LEU . 85.5 mt -67.51 137.33 93.33 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.35 0.66 . . . . 64.13 110.563 175.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.52 169.74 15.11 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.024 2.482 . . . . 64.21 112.845 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.73 161.67 22.69 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 115.266 -0.879 . . . . 73.13 110.905 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -91.0 38.8 0.97 Allowed 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.301 1.048 . . . . 75.25 109.306 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.21 29.8 4.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.647 1.179 . . . . 63.23 110.538 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.12 107.9 0.96 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.703 -0.851 . . . . 74.02 108.703 169.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.46 -12.14 16.16 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 116.279 -0.419 . . . . 61.03 112.645 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -77.62 152.82 33.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.842 0.457 . . . . 73.3 110.693 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -87.8 135.58 33.32 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.193 0.997 . . . . 71.23 112.349 -169.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.5 152.69 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.947 0.899 . . . . 55.32 109.138 171.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -114.14 108.72 17.35 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.19 -1.041 . . . . 72.21 108.19 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.431 HG12 HG22 ' A' ' 43' ' ' VAL . 61.9 mt -96.22 119.25 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.358 0.663 . . . . 71.05 109.62 -174.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.7 t -113.44 142.83 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 123.348 0.659 . . . . 71.35 111.183 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.08 -178.66 6.25 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.119 0.968 . . . . 74.42 111.845 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -68.42 136.22 52.95 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.231 -0.895 . . . . 71.04 112.046 -170.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -105.19 -54.34 2.5 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.61 0.764 . . . . 61.24 109.388 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 . . . . . 0 C--O 1.256 1.425 0 C-N-CA 124.018 0.927 . . . . 70.02 108.823 177.82 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.0 mtm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 121.205 0.526 . . . . 74.31 109.584 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.6 mtm180 -140.85 141.67 34.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.346 1.058 . . . . 73.34 108.51 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.626 HD12 HD21 ' A' ' 38' ' ' LEU . 73.4 mt -129.97 130.45 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.596 0.758 . . . . 74.12 109.164 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.412 ' HG3' HD12 ' A' ' 27' ' ' LEU . 19.6 ptmt -88.54 130.07 35.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.765 -0.828 . . . . 71.4 108.765 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -128.18 140.64 11.93 Favored Glycine 0 C--O 1.217 -0.954 0 CA-C-N 116.459 -0.337 . . . . 71.31 112.363 -175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.7 t -91.93 121.98 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.01 0.524 . . . . 75.43 111.086 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.52 97.48 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.378 1.071 . . . . 71.41 109.65 172.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 25' ' ' LYS . 88.1 mt -72.91 -48.83 33.7 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.52 -0.764 . . . . 65.33 110.036 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.463 ' HA ' HD22 ' A' ' 80' ' ' LEU . 70.0 p -162.37 168.05 22.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.869 -0.605 . . . . 71.42 110.932 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -105.13 123.77 48.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.927 -1.138 . . . . 72.15 107.927 169.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -118.42 107.46 13.85 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.734 -1.209 . . . . 74.24 107.734 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.527 ' HG3' ' HB3' ' A' ' 20' ' ' ASN . 55.1 ttp180 -85.14 154.12 22.23 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.072 0.463 . . . . 74.23 110.08 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -130.25 -173.68 3.12 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.573 0.749 . . . . 71.2 109.142 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.1 110.02 4.31 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.385 -0.969 . . . . 71.11 108.385 175.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.05 -33.22 67.01 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.702 0.801 . . . . 64.45 111.993 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -69.03 -23.9 64.12 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.611 0.765 . . . . 73.11 111.188 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -88.59 -68.95 0.73 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.919 -0.771 . . . . 63.53 108.919 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -149.31 150.03 31.86 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.759 1.224 . . . . 74.5 109.001 173.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -66.65 174.64 2.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.209 0.603 . . . . 72.41 111.784 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.527 ' HB3' ' HG3' ' A' ' 12' ' ' ARG . 8.8 p30 -61.24 143.61 55.29 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.087 -0.96 . . . . 73.53 112.015 -174.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t -106.88 121.24 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 114.266 -1.334 . . . . 74.32 109.251 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 45.7 ttm -89.52 123.78 33.93 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.507 -0.923 . . . . 54.54 108.507 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.7 116.02 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.31 -0.996 . . . . 61.44 108.31 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.6 HD13 HG21 ' A' ' 84' ' ' VAL . 84.8 mt -120.46 150.67 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.036 0.935 . . . . 73.33 109.647 -172.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HB2' HD11 ' A' ' 8' ' ' LEU . 78.9 tttt -123.45 91.73 49.48 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.496 0.719 . . . . 75.31 109.416 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' A' ' 66' ' ' ALA . 36.9 Cg_endo -63.72 110.4 1.27 Allowed 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 122.751 2.301 . . . . 60.1 111.272 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.412 HD12 ' HG3' ' A' ' 4' ' ' LYS . 85.8 mt -62.18 -37.72 86.35 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.639 1.176 . . . . 63.52 112.875 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -65.86 -26.25 67.56 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.265 0.626 . . . . 75.51 111.546 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.685 HG13 ' HB2' ' A' ' 34' ' ' GLU . 40.3 t -100.32 131.59 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.197 0.999 . . . . 74.22 110.96 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -130.32 -3.48 4.37 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.664 0.785 . . . . 62.33 111.451 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.8 m -123.28 154.48 38.79 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.447 0.699 . . . . 72.15 110.563 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.566 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 63.0 ttt180 -64.95 -30.84 71.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.134 0.974 . . . . 64.31 111.634 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -69.48 -39.66 77.55 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.889 0.876 . . . . 63.0 110.146 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.685 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.5 mt-10 -70.42 -38.61 74.61 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.667 -1.151 . . . . 73.52 109.526 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.36 -30.81 69.84 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.645 0.778 . . . . 72.54 111.228 174.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 t -74.15 -30.82 62.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.397 0.679 . . . . 72.41 110.041 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -90.78 4.1 52.57 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.743 0.417 . . . . 53.45 110.98 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.626 HD21 HD12 ' A' ' 3' ' ' ILE . 34.3 mt -87.83 -18.31 29.57 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.618 0.367 . . . . 74.24 110.415 165.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.565 HD13 HG22 ' A' ' 57' ' ' ILE . 50.2 mm -59.86 106.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.195 0.598 . . . . 73.53 109.393 174.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.19 -29.35 4.6 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 116.052 -0.522 . . . . 15.54 112.527 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 153.94 39.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.208 0.603 . . . . 74.21 111.901 -173.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.58 HD11 ' HE2' ' A' ' 54' ' ' LYS . 60.9 tp -90.41 123.73 34.38 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.42 1.088 . . . . 65.11 109.674 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.8 115.18 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 109.412 -0.588 . . . . 75.34 109.412 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt -104.36 110.12 22.24 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.557 1.143 . . . . 52.24 108.732 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -124.49 127.73 47.91 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.307 -0.627 . . . . 64.32 109.307 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -88.12 106.7 18.34 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.367 -0.975 . . . . 62.21 108.367 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.9 p -64.31 157.37 71.53 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.046 0.938 . . . . 62.45 112.406 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.92 -23.78 73.88 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.842 2.361 . . . . 62.1 112.074 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.1 t -61.91 -23.27 66.22 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.538 1.135 . . . . 62.33 111.343 173.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.86 19.18 34.94 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.712 -0.676 . . . . 60.24 112.64 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.0 143.02 40.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.554 0.742 . . . . 73.01 110.105 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.5 mt -89.08 102.09 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.724 -0.843 . . . . 72.01 108.724 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 75' ' ' LEU . 26.3 mt -82.71 138.09 34.2 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.142 0.577 . . . . 75.21 110.369 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.58 ' HE2' HD11 ' A' ' 42' ' ' LEU . 13.4 mmmm -96.09 132.92 40.97 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.572 -0.899 . . . . 73.12 108.572 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.18 172.94 22.7 Favored Glycine 0 C--N 1.332 0.353 0 O-C-N 123.618 0.574 . . . . 65.33 112.075 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -151.81 131.71 13.34 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.122 0.569 . . . . 74.14 109.843 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.565 HG22 HD13 ' A' ' 39' ' ' ILE . 73.0 mt -70.8 108.93 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 109.137 -0.69 . . . . 54.11 109.137 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.75 -14.94 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.182 0.993 . . . . 63.1 111.225 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 23.7 tpp180 -149.29 148.82 30.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.327 0.651 . . . . 71.41 109.371 -173.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 39' ' ' ILE . 21.2 m -98.74 171.41 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.335 0.654 . . . . 74.13 109.988 173.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -124.13 103.64 8.39 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.386 -0.968 . . . . 72.45 108.386 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.94 -134.1 52.3 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 124.144 0.903 . . . . 75.52 113.602 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.566 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 69.3 p -119.62 -4.55 10.28 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.741 0.816 . . . . 54.33 111.993 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -73.93 -7.81 53.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.069 0.548 . . . . 75.14 112.017 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.51 -10.98 70.71 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 119.649 -0.528 . . . . 53.34 113.209 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . . . -60.68 149.68 34.5 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.999 0.52 . . . . 52.23 109.652 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.542 HG22 ' HD3' ' A' ' 26' ' ' PRO . 35.1 m -131.13 178.97 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 121.921 0.867 . . . . 72.33 111.96 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 97.8 mtt180 -133.86 118.99 18.59 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.259 1.424 . . . . 74.53 108.379 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.72 133.57 55.85 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.968 0.507 . . . . 64.44 110.715 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -88.7 123.21 32.92 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.182 0.593 . . . . 74.15 109.633 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -105.23 133.41 50.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.716 0.806 . . . . 75.41 109.46 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -61.13 -37.02 81.32 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.678 0.791 . . . . 74.12 111.852 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -98.08 -61.03 1.44 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.82 0.848 . . . . 74.11 108.974 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.436 ' HA3' ' OD1' ' A' ' 20' ' ' ASN . . . 60.91 54.68 34.91 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 124.083 0.864 . . . . 73.21 112.93 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.496 ' HB2' HD11 ' A' ' 53' ' ' LEU . 51.6 mt -68.46 115.92 34.77 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.24 1.016 . . . . 63.02 110.513 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.7 179.84 5.85 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 123.283 2.656 . . . . 52.14 112.332 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.81 176.94 25.07 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 110.723 -0.951 . . . . 44.42 110.723 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -77.39 70.02 3.73 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 122.038 0.923 . . . . 71.31 109.086 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.73 13.6 11.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.811 -1.086 . . . . 73.3 111.922 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 9' ' ' SER . 60.9 mt -74.27 103.21 4.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.464 -0.939 . . . . 72.12 108.464 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.4 -18.2 6.89 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 112.116 -0.394 . . . . 52.22 112.116 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.96 169.93 16.99 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.986 0.514 . . . . 64.31 111.336 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -108.28 155.9 19.98 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.232 0.613 . . . . 73.24 111.043 -170.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.6 HG21 HD13 ' A' ' 24' ' ' ILE . 20.2 m -122.15 160.28 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.462 1.105 . . . . 65.53 108.773 174.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -106.02 108.5 20.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.177 -0.675 . . . . 43.14 109.177 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' ARG . 77.9 mt -93.93 92.12 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.336 -1.357 . . . . 34.41 107.336 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.507 HG12 ' HG3' ' A' ' 89' ' ' GLU . 21.4 t -96.66 127.6 48.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.247 1.019 . . . . 73.45 110.266 -172.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.33 104.56 13.04 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.915 -1.143 . . . . 72.24 107.915 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.507 ' HG3' HG12 ' A' ' 87' ' ' VAL . 36.8 mt-10 -110.23 147.72 33.24 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.043 0.937 . . . . 73.51 109.172 175.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -102.29 98.44 8.57 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.179 0.592 . . . . 73.11 109.634 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 123.949 0.9 . . . . 71.14 109.502 172.391 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 47.1 mtm-85 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 108.375 -0.972 . . . . 63.409999999999997 108.375 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 63.6 mt -97.12 132.57 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.656 0.782 . . . . 74.439999999999998 109.358 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -89.42 129.61 35.9 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.289 -0.634 . . . . 73.519999999999996 109.289 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.58 164.99 25.12 Favored Glycine 0 C--N 1.345 1.03 0 O-C-N 123.253 0.346 . . . . 43.329999999999998 112.929 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.57 120.65 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.993 0.917 . . . . 73.209999999999994 109.253 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.493 HG13 ' HB2' ' A' ' 22' ' ' MET . 23.7 t -68.9 102.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 109.687 -0.486 . . . . 72.019999999999996 109.687 173.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 25' ' ' LYS . 56.4 mt -70.23 -37.3 74.97 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.761 0.824 . . . . 72.140000000000001 110.321 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -156.96 158.13 36.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.87 -0.604 . . . . 74.140000000000001 111.603 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.96 162.15 18.22 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.955 0.902 . . . . 74.129999999999995 109.113 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.563 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 22.7 mtm180 . . . . . 0 C--O 1.248 1.017 0 N-CA-C 107.666 -1.235 . . . . 71.299999999999997 107.666 171.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 109.791 -0.448 . . . . 74.219999999999999 109.791 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.571 HG22 ' HG2' ' A' ' 70' ' ' ARG . 16.7 t -90.32 149.39 4.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.546 -0.909 . . . . 72.219999999999999 108.546 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.493 ' HB2' HG13 ' A' ' 7' ' ' VAL . 21.5 ptp -149.26 140.91 23.49 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.02 0.438 . . . . 73.340000000000003 111.309 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -86.34 97.97 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.249 -1.389 . . . . 61.350000000000001 107.249 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.01 133.18 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.747 0.819 . . . . 70.209999999999994 108.973 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HB2' HD11 ' A' ' 8' ' ' LEU . 33.7 ttpt -107.56 97.0 17.97 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.107 -1.071 . . . . 75.109999999999999 108.107 170.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 11.5 Cg_exo -68.5 122.39 9.38 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.986 1.791 . . . . 44.539999999999999 110.74 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.63 -29.56 66.6 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.255 1.022 . . . . 64.540000000000006 112.008 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HB3' HG23 ' A' ' 3' ' ' ILE . 35.7 t70 -88.46 -28.5 20.82 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.859 0.864 . . . . 64.030000000000001 112.157 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 89.4 t -104.82 99.71 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.391 0.676 . . . . 73.510000000000005 109.808 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -119.41 12.13 12.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.396 0.678 . . . . 63.329999999999998 110.359 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.1 m -122.43 149.07 44.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.819 0.847 . . . . 70.200000000000003 110.613 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 53.8 ttt180 -63.88 -36.91 85.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.237 1.015 . . . . 73.319999999999993 111.357 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -65.29 -48.69 72.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.523 0.729 . . . . 72.200000000000003 110.532 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HB2' HG13 ' A' ' 29' ' ' VAL . 50.2 mt-10 -63.21 -30.37 71.53 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.74 -1.118 . . . . 71.120000000000005 110.976 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.73 -36.2 37.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.692 0.797 . . . . 41.140000000000001 111.512 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -73.39 -27.49 61.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.73 0.812 . . . . 52.149999999999999 110.915 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -82.11 -1.19 47.92 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.094 -0.503 . . . . 61.399999999999999 111.363 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 29' ' ' VAL . 93.4 mt -98.59 1.95 46.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.574 0.75 . . . . 75.200000000000003 112.144 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.651 HD11 HG13 ' A' ' 60' ' ' VAL . 51.2 mm -67.94 109.58 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.361 0.528 . . . . 75.109999999999999 110.278 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.95 -15.82 18.65 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.566 -0.743 . . . . 75.420000000000002 112.551 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.9 152.87 43.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.905 0.482 . . . . 74.120000000000005 111.228 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 54' ' ' LYS . 26.6 tp -94.86 114.61 26.49 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 124.389 1.056 . . . . 74.299999999999997 109.668 -167.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.72 131.43 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.23 -0.656 . . . . 71.510000000000005 109.23 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.4 mt -107.66 101.31 10.63 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.66 -0.867 . . . . 61.450000000000003 108.66 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.411 ' HH2' ' HA3' ' A' ' 77' ' ' GLY . 34.5 t90 -100.22 140.8 33.94 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.916 0.486 . . . . 74.109999999999999 109.807 175.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -91.74 101.05 13.66 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.203 1.001 . . . . 75.510000000000005 108.775 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.3 p -65.0 150.58 95.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.035 0.534 . . . . 71.409999999999997 111.149 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.54 -19.37 36.47 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.409 2.739 . . . . 72.430000000000007 113.049 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.4 t -71.78 -8.59 55.17 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.056 0.942 . . . . 72.430000000000007 112.347 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.19 32.81 30.71 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.492 -0.243 . . . . 72.400000000000006 112.492 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -128.02 146.11 50.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.863 0.865 . . . . 54.140000000000001 108.864 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -99.43 100.09 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.844 -0.799 . . . . 75.519999999999996 108.844 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 75' ' ' LEU . 21.5 mt -74.99 137.28 41.45 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.156 -0.929 . . . . 73.150000000000006 109.034 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.574 ' HB3' HD11 ' A' ' 42' ' ' LEU . 24.0 mtmm -96.92 139.31 33.14 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.128 -0.693 . . . . 74.310000000000002 109.128 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -140.82 177.4 20.88 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 116.198 -0.456 . . . . 73.510000000000005 112.717 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -139.3 126.73 21.57 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.515 -0.55 . . . . 75.400000000000006 109.515 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.489 HG22 HD13 ' A' ' 39' ' ' ILE . 63.1 mt -68.75 103.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.041 -0.725 . . . . 61.240000000000002 109.041 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.456 HG11 ' HD3' ' A' ' 70' ' ' ARG . 27.6 m -83.84 -35.24 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.59 -0.732 . . . . 64.5 110.98 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -163.99 153.73 14.53 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.625 0.77 . . . . 65.209999999999994 109.584 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.651 HG13 HD11 ' A' ' 39' ' ' ILE . 12.2 m -91.55 170.46 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.289 0.636 . . . . 72.329999999999998 110.043 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -122.79 103.66 8.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.951 -1.129 . . . . 74.120000000000005 107.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.12 -150.63 51.71 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 124.335 1.022 . . . . 43.109999999999999 114.292 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.567 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 55.2 p -98.47 -9.91 24.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.664 0.786 . . . . 72.299999999999997 111.81 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.12 -12.52 19.95 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.735 0.814 . . . . 74.010000000000005 112.86 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.32 -1.34 87.56 Favored Glycine 0 C--N 1.349 1.25 0 N-CA-C 112.393 -0.283 . . . . 35.509999999999998 112.393 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.48 119.37 10.92 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.47 0.708 . . . . 72.0 110.162 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.407 ' HB ' HG23 ' A' ' 57' ' ' ILE . 29.6 m -101.65 148.27 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 122.661 0.384 . . . . 72.439999999999998 110.289 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -113.71 113.7 25.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.379 -0.6 . . . . 65.430000000000007 109.379 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.63 134.3 55.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.968 -0.56 . . . . 53.229999999999997 111.433 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 21' ' ' VAL . 67.9 mtp85 -102.57 123.31 46.06 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.162 0.985 . . . . 72.200000000000003 109.005 174.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.439 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 12.5 m-85 -99.04 126.9 44.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.178 0.591 . . . . 74.430000000000007 111.156 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 54' ' ' LYS . 22.1 pt-20 -50.28 -38.06 39.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.376 1.471 . . . . 71.450000000000003 113.652 -172.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -75.39 -24.85 57.24 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.259 0.624 . . . . 62.149999999999999 111.54 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.83 24.76 68.58 Favored Glycine 0 C--N 1.348 1.195 0 O-C-N 123.633 0.583 . . . . 64.200000000000003 114.432 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.506 ' HB2' HD11 ' A' ' 53' ' ' LEU . 84.4 mt -86.59 136.31 35.09 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 123.088 0.555 . . . . 61.020000000000003 110.6 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 11.4 Cg_exo -71.08 174.32 10.82 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.561 2.84 . . . . 63.100000000000001 112.098 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.411 ' HA3' ' HH2' ' A' ' 45' ' ' TRP . . . -158.85 -65.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.1 -0.5 . . . . 72.040000000000006 112.549 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 60.28 31.79 20.55 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 123.062 1.411 . . . . 74.019999999999996 110.272 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.33 31.61 0.81 Allowed 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 114.107 -1.406 . . . . 61.539999999999999 111.291 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -35.68 111.1 0.12 Allowed 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 126.289 1.835 . . . . 74.420000000000002 114.194 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.41 -4.25 26.54 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.9 -0.591 . . . . 54.340000000000003 113.102 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.81 157.93 35.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.331 0.652 . . . . 54.020000000000003 111.611 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -102.06 141.4 34.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.274 0.559 . . . . 73.040000000000006 112.127 -172.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.9 m -116.29 166.61 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.209 1.003 . . . . 73.230000000000004 110.326 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -128.71 109.15 11.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.506 -0.553 . . . . 74.010000000000005 109.506 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 61.3 mt -82.37 100.1 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.241 1.016 . . . . 73.340000000000003 109.346 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.5 t -72.76 117.64 16.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.229 0 N-CA-C 109.098 -0.705 . . . . 71.109999999999999 109.098 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 C--N 1.35 0.61 0 N-CA-C 107.351 -1.352 . . . . 64.129999999999995 107.351 172.879 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 108.818 -0.808 . . . . 64.150000000000006 108.818 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 74.2 mt -112.34 133.73 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.121 -1.066 . . . . 71.329999999999998 108.121 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -88.14 133.36 34.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.525 -0.546 . . . . 71.030000000000001 109.525 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -122.24 165.53 15.01 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 110.891 -0.883 . . . . 54.420000000000002 110.891 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.3 t -111.54 128.38 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 123.691 0.796 . . . . 74.239999999999995 109.313 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.69 93.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.446 1.099 . . . . 73.420000000000002 108.813 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 25' ' ' LYS . 64.7 mt -71.27 -51.19 25.9 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.343 -0.39 . . . . 73.329999999999998 110.062 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 p -159.48 156.18 27.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.737 -0.665 . . . . 74.329999999999998 110.875 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -92.5 104.88 17.15 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.243 -1.021 . . . . 74.319999999999993 108.243 169.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 109.004 -0.739 . . . . 71.040000000000006 109.004 178.608 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.694 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 29.1 t-20 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.358 0.599 . . . . 62.439999999999998 109.904 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.495 HG22 ' HD2' ' A' ' 70' ' ' ARG . 58.9 t -101.52 151.15 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.465 1.106 . . . . 65.209999999999994 109.313 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 44.6 ttm -130.86 122.65 27.43 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.404 -0.961 . . . . 70.040000000000006 108.404 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 8' ' ' LEU . 47.9 mm -81.96 118.26 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.975 -1.121 . . . . 73.319999999999993 107.975 172.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -122.12 153.32 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.271 1.029 . . . . 71.439999999999998 108.738 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HB2' HD11 ' A' ' 8' ' ' LEU . 57.6 tttp -122.76 110.5 31.67 Favored Pre-proline 0 N--CA 1.473 0.698 0 N-CA-C 109.131 -0.692 . . . . 75.109999999999999 109.131 168.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 65' ' ' GLY . 27.2 Cg_exo -59.65 125.76 18.73 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.234 1.956 . . . . 71.219999999999999 110.192 167.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.83 -33.22 74.79 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.656 0.782 . . . . 45.439999999999998 111.327 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.55 -28.02 69.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.942 0.897 . . . . 63.229999999999997 111.449 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 35' ' ' ALA . 78.6 t -109.47 131.61 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.228 1.011 . . . . 72.0 111.4 -170.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -128.89 15.67 6.34 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.214 1.006 . . . . 71.329999999999998 110.525 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 m -143.75 154.06 43.07 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.335 0.654 . . . . 74.200000000000003 111.145 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.581 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 52.1 ttt180 -61.01 -50.28 74.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.259 1.024 . . . . 73.109999999999999 111.89 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.42 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 47.6 mt-10 -74.45 -30.45 61.88 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.58 0.352 . . . . 75.200000000000003 111.061 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -67.21 -25.4 66.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.069 0.548 . . . . 75.150000000000006 110.919 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.488 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -87.13 -30.63 20.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.546 0.738 . . . . 74.200000000000003 110.307 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 10.0 t -85.92 -6.97 58.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.068 0.947 . . . . 63.340000000000003 111.606 -172.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -82.82 -19.31 37.87 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.414 -0.587 . . . . 70.230000000000004 109.414 167.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.0 mt -87.82 6.31 35.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.631 0.772 . . . . 71.219999999999999 111.478 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 57' ' ' ILE . 42.5 mm -63.03 119.26 6.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 109.663 -0.495 . . . . 75.200000000000003 109.663 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.59 -4.53 40.02 Favored Glycine 0 C--O 1.239 0.46 0 CA-C-N 116.159 -0.473 . . . . 30.120000000000001 112.93 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -80.11 150.61 30.19 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 109.067 -0.716 . . . . 74.219999999999999 109.067 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.581 HD21 ' HD2' ' A' ' 54' ' ' LYS . 27.1 tp -89.86 159.55 16.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.208 -0.905 . . . . 34.539999999999999 109.024 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 86' ' ' ILE . 90.4 t -128.32 114.53 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 107.509 -1.293 . . . . 65.010000000000005 107.509 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.32 108.75 21.52 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.705 1.202 . . . . 71.040000000000006 108.846 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -144.87 123.47 12.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.325 0.65 . . . . 74.530000000000001 109.823 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 27.1 ttpp -88.11 135.89 33.22 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.944 0.498 . . . . 61.210000000000001 109.73 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.9 p -73.75 158.28 86.32 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.856 0.863 . . . . 70.230000000000004 110.765 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.21 -8.1 19.32 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.433 2.089 . . . . 71.340000000000003 112.444 167.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -72.89 -21.71 60.87 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.644 0.777 . . . . 72.239999999999995 111.271 168.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.05 -19.44 37.85 Favored Glycine 0 C--N 1.352 1.439 0 C-N-CA 123.038 0.352 . . . . 72.340000000000003 113.442 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 134.42 34.76 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.275 0.63 . . . . 73.310000000000002 109.923 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 62.2 mt -78.3 123.72 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.481 -0.563 . . . . 41.020000000000003 109.481 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.556 HD22 ' HB2' ' A' ' 73' ' ' LYS . 10.6 mt -102.97 131.05 50.21 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.28 -1.007 . . . . 64.230000000000004 108.28 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.581 ' HD2' HD21 ' A' ' 42' ' ' LEU . 32.1 mtmm -111.77 132.25 54.78 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.067 -0.716 . . . . 71.030000000000001 109.067 173.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.46 151.37 20.55 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 111.026 -0.829 . . . . 43.520000000000003 111.026 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -115.34 135.04 54.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.266 1.033 . . . . 72.219999999999999 110.708 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.492 HG22 HD13 ' A' ' 39' ' ' ILE . 56.7 mt -67.78 96.25 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.597 -0.89 . . . . 61.130000000000003 108.597 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 m -86.75 -31.4 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.012 0.525 . . . . 73.439999999999998 111.171 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -154.42 179.37 9.07 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 107.988 -1.116 . . . . 74.230000000000004 107.988 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.412 HG13 HD11 ' A' ' 39' ' ' ILE . 35.3 m -128.64 161.87 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.364 0.666 . . . . 64.400000000000006 109.959 170.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 21.8 t-80 -144.53 103.39 3.94 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.125 -0.695 . . . . 74.450000000000003 109.125 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.47 145.59 9.29 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 112.521 -0.232 . . . . 61.200000000000003 112.521 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.581 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 43.8 p -90.16 11.94 19.43 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.246 1.018 . . . . 62.350000000000001 111.928 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -106.58 17.08 23.77 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.03 0.932 . . . . 74.109999999999999 110.98 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' HD2' ' A' ' 26' ' ' PRO . . . 76.63 36.18 38.61 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.097 -0.501 . . . . 75.109999999999999 113.909 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . -89.75 123.68 33.97 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.641 -0.874 . . . . 51.520000000000003 108.641 172.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.473 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.5 m -102.06 152.86 5.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-O 121.898 0.856 . . . . 71.230000000000004 111.35 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -101.62 103.66 14.49 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.551 1.54 . . . . 65.420000000000002 108.331 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.61 117.11 33.24 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.162 0.585 . . . . 74.230000000000004 110.762 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.495 ' HD2' HG22 ' A' ' 21' ' ' VAL . 12.5 mmm-85 -89.44 102.62 15.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.326 1.05 . . . . 73.209999999999994 109.916 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.2 136.08 34.1 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.423 0.689 . . . . 55.32 110.976 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.532 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 14.3 pt-20 -57.33 -52.4 65.51 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.681 1.193 . . . . 42.140000000000001 111.039 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HB2' HD22 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -92.92 -54.04 3.91 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.332 -0.988 . . . . 70.439999999999998 108.332 -179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.694 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 60.77 50.01 72.25 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 124.823 1.327 . . . . 50.25 112.894 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.414 ' HB2' HD11 ' A' ' 53' ' ' LEU . 35.9 mt -67.74 111.71 8.38 Favored Pre-proline 0 C--N 1.351 0.633 0 C-N-CA 123.271 0.628 . . . . 75.409999999999997 110.102 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.58 173.42 9.53 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.009 2.473 . . . . 62.549999999999997 111.218 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 165.32 -168.31 39.3 Favored Glycine 0 C--O 1.238 0.383 0 N-CA-C 111.315 -0.714 . . . . 51.210000000000001 111.315 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -94.8 67.38 3.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.192 0.996 . . . . 75.109999999999999 109.232 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.09 26.5 9.22 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.689 -1.141 . . . . 62.43 109.714 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.58 119.26 12.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.516 0.727 . . . . 71.040000000000006 110.698 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.01 -2.12 38.25 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.982 -0.554 . . . . 32.32 112.558 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.55 162.84 27.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.439 0.696 . . . . 73.430000000000007 109.943 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.53 131.92 45.21 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.386 0.674 . . . . 74.150000000000006 111.034 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.26 159.24 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.598 1.159 . . . . 61.450000000000003 108.608 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.2 106.5 14.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.522 -0.918 . . . . 74.340000000000003 108.522 170.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.496 HG12 HG22 ' A' ' 43' ' ' VAL . 71.7 mt -83.42 108.73 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.383 -0.969 . . . . 72.129999999999995 108.383 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.73 143.87 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.946 0.898 . . . . 63.439999999999998 110.015 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 CA--C 1.55 0.979 0 N-CA-C 108.837 -0.801 . . . . 73.299999999999997 108.837 174.556 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 108.648 -0.871 . . . . 73.519999999999996 108.648 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 28' ' ' ASP . 53.0 mt -97.18 134.49 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 122.976 0.51 . . . . 70.409999999999997 110.476 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -89.27 121.61 31.72 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.005 0.922 . . . . 64.140000000000001 108.778 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -119.82 176.34 16.12 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-O 119.753 -0.471 . . . . 64.040000000000006 112.054 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.44 126.99 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.77 0.828 . . . . 75.219999999999999 109.653 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.43 99.4 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.618 0.767 . . . . 63.509999999999998 109.3 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 25' ' ' LYS . 66.5 mt -71.59 -48.04 50.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.438 0.695 . . . . 62.119999999999997 110.033 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -157.02 159.96 38.51 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.451 -0.795 . . . . 71.530000000000001 110.487 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -99.65 159.22 15.21 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.245 -1.021 . . . . 63.439999999999998 108.245 167.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.57 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 108.129 -1.063 . . . . 73.329999999999998 108.129 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.501 HD21 ' HA3' ' A' ' 74' ' ' GLY . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 108.966 -0.753 . . . . 71.230000000000004 108.966 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.572 HG11 ' HE ' ' A' ' 68' ' ' ARG . 11.7 t -98.26 162.88 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.545 -0.909 . . . . 75.230000000000004 108.545 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.0 ttm -147.18 124.0 11.25 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.63 -1.248 . . . . 72.349999999999994 107.63 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.65 118.3 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 123.876 0.735 . . . . 44.409999999999997 109.278 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.8 mt -129.15 158.08 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.256 1.022 . . . . 72.319999999999993 108.386 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 8' ' ' LEU . 27.7 ttpp -141.41 108.44 6.16 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 109.671 -0.492 . . . . 71.049999999999997 109.671 170.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 14.2 Cg_endo -56.54 143.16 89.15 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 123.887 3.058 . . . . 73.530000000000001 112.864 171.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.7 mt -80.44 -38.15 30.62 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.348 1.059 . . . . 72.340000000000003 110.467 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' HB3' HG23 ' A' ' 3' ' ' ILE . 26.2 t70 -67.96 -27.64 66.77 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.135 -0.939 . . . . 61.310000000000002 111.593 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.474 HG21 HD11 ' A' ' 38' ' ' LEU . 76.5 t -110.79 120.06 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.194 0.998 . . . . 72.430000000000007 110.477 -176.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -127.67 21.64 6.47 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.695 0.798 . . . . 63.210000000000001 110.556 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.3 p -140.28 158.62 43.75 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.718 0.807 . . . . 71.400000000000006 110.676 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.649 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 48.3 ttt85 -65.96 -50.32 64.76 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.833 0.853 . . . . 74.010000000000005 112.775 -169.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -30.21 57.62 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.652 0.595 . . . . 70.409999999999997 111.163 -171.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HA ' ' HD2' ' A' ' 37' ' ' LYS . 42.7 mm-40 -69.1 -20.29 64.07 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.25 -0.432 . . . . 72.420000000000002 111.318 170.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.2 -26.22 20.23 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.736 0.814 . . . . 60.119999999999997 110.575 170.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -80.84 -12.59 59.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.789 0.835 . . . . 75.5 110.692 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 34' ' ' GLU . 15.0 ptmt -85.46 -16.39 39.8 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.126 0.489 . . . . 70.140000000000001 109.776 170.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 HG21 ' A' ' 29' ' ' VAL . 43.2 mt -81.98 -8.5 59.67 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.27 0.628 . . . . 73.310000000000002 111.149 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.534 HD13 HG22 ' A' ' 57' ' ' ILE . 43.1 mm -59.92 130.22 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.494 -0.558 . . . . 75.109999999999999 109.494 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.94 -19.06 56.12 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-O 119.872 -0.405 . . . . 61.539999999999999 112.844 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 87' ' ' VAL . 94.3 mtt180 -78.32 156.65 29.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.989 0.516 . . . . 75.310000000000002 111.309 -176.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 54' ' ' LYS . 21.6 tp -90.99 128.88 36.99 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.531 0.732 . . . . 64.230000000000004 109.517 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 86' ' ' ILE . 56.5 t -99.28 115.12 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.054 -0.721 . . . . 62.229999999999997 109.054 172.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.17 122.62 34.83 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.397 -0.964 . . . . 75.140000000000001 108.397 173.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 37.6 t90 -135.86 132.22 36.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.24 -0.652 . . . . 61.5 109.24 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -90.61 122.66 33.59 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.292 -1.003 . . . . 63.109999999999999 108.292 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.8 p -83.86 159.51 60.24 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.095 0.558 . . . . 70.099999999999994 111.078 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.39 -14.91 44.21 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.337 2.025 . . . . 72.209999999999994 111.764 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.1 t -68.99 -23.2 64.08 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.895 0.878 . . . . 63.310000000000002 111.124 173.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.99 20.29 26.39 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 116.324 -0.398 . . . . 74.120000000000005 112.78 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -111.15 137.13 49.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.763 0.825 . . . . 71.319999999999993 110.128 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.3 mt -86.07 93.48 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.063 -1.088 . . . . 71.439999999999998 108.063 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 73' ' ' LYS . 51.1 mt -80.59 133.14 35.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.04 -0.982 . . . . 71.239999999999995 109.766 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB3' HD11 ' A' ' 42' ' ' LEU . 30.6 mtmm -116.01 138.58 51.08 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.092 -0.707 . . . . 51.229999999999997 109.092 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -140.02 176.16 21.43 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-N 115.602 -0.726 . . . . 74.420000000000002 111.312 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -135.76 133.85 38.4 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.565 0.682 . . . . 72.109999999999999 109.826 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.534 HG22 HD13 ' A' ' 39' ' ' ILE . 58.1 mt -73.84 108.32 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.384 -0.599 . . . . 54.509999999999998 109.384 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.33 -20.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.708 0.803 . . . . 71.219999999999999 111.464 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -158.45 162.66 37.55 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.524 -0.547 . . . . 72.25 109.524 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 39' ' ' ILE . 33.8 m -108.34 169.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.663 0.785 . . . . 64.299999999999997 109.731 171.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -125.26 104.59 8.57 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.034 -0.728 . . . . 65.099999999999994 109.034 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.56 -140.31 44.44 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 123.971 0.794 . . . . 72.040000000000006 113.331 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 63.5 p -115.34 4.26 14.37 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.794 0.838 . . . . 54.399999999999999 111.716 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -82.38 1.55 36.72 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.253 0.621 . . . . 63.43 112.13 -171.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.41 0.88 87.87 Favored Glycine 0 C--N 1.355 1.611 0 CA-C-O 120.069 -0.295 . . . . 62.200000000000003 112.966 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.88 121.51 16.18 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.322 0.649 . . . . 73.540000000000006 110.177 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.2 141.42 18.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.426 0.632 . . . . 62.539999999999999 110.824 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.572 ' HE ' HG11 ' A' ' 21' ' ' VAL . 64.7 ttt180 -103.8 104.32 14.31 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.879 0.872 . . . . 61.5 108.95 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.37 136.23 52.1 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.289 0.636 . . . . 70.040000000000006 110.592 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HG2' HG22 ' A' ' 21' ' ' VAL . 72.0 mtp180 -106.32 117.24 33.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.809 0.444 . . . . 61.549999999999997 110.005 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -92.41 143.69 26.12 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.933 0.893 . . . . 72.409999999999997 111.129 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 15.8 pt-20 -60.6 -30.98 70.17 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.49 1.116 . . . . 74.140000000000001 111.601 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.545 ' HB2' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -119.69 -72.73 0.67 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.744 -0.836 . . . . 71.230000000000004 108.744 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.501 ' HA3' HD21 ' A' ' 20' ' ' ASN . . . 66.57 57.26 10.39 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 111.759 -0.537 . . . . 73.120000000000005 111.759 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.12 123.17 85.65 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.824 0.85 . . . . 74.219999999999999 110.584 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.13 151.45 38.97 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 123.843 3.028 . . . . 73.299999999999997 113.489 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.56 171.52 37.47 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.395 -0.821 . . . . 54.539999999999999 111.106 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -87.39 69.01 9.88 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.773 0.797 . . . . 74.340000000000003 109.399 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -119.51 27.93 8.47 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.046 -0.979 . . . . 62.329999999999998 110.369 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.08 135.91 47.98 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.572 0.349 . . . . 72.329999999999998 110.385 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.17 -6.47 63.79 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.01 -0.541 . . . . 74.209999999999994 112.574 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.91 155.61 35.03 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.233 0.613 . . . . 55.520000000000003 109.44 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 97.3 m-85 -102.09 145.04 29.91 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.135 0.493 . . . . 63.109999999999999 112.147 -169.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.79 165.42 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.298 -0.865 . . . . 74.310000000000002 109.901 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -128.74 110.35 12.1 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.463 0.705 . . . . 73.019999999999996 109.118 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 43' ' ' VAL . 59.0 mt -84.22 113.18 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.094 0.958 . . . . 43.409999999999997 109.073 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 27.5 t -87.58 146.31 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.38 1.072 . . . . 51.229999999999997 110.022 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 N--CA 1.486 1.326 0 C-N-CA 124.138 0.975 . . . . 75.109999999999999 110.856 -179.149 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.513 ' HG2' HG22 ' A' ' 87' ' ' VAL . 73.6 mtt180 . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 109.188 -0.671 . . . . 72.219999999999999 109.188 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 48.4 mt -98.81 131.35 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.78 0.832 . . . . 73.430000000000007 108.85 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.11 120.58 29.61 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.788 -0.819 . . . . 74.230000000000004 108.788 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -125.24 170.71 17.17 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.861 -0.496 . . . . 61.140000000000001 111.861 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.7 t -126.54 138.95 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.239 1.016 . . . . 74.239999999999995 109.513 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.39 114.29 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.44 1.096 . . . . 62.119999999999997 110.12 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 23' ' ' ILE . 42.4 mt -92.61 -55.68 3.3 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.729 0.412 . . . . 55.219999999999999 110.479 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -153.87 152.33 30.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.837 0.455 . . . . 64.299999999999997 111.949 -174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -110.09 128.74 55.62 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.047 0.939 . . . . 72.140000000000001 108.574 170.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 106.058 -1.83 . . . . 65.530000000000001 106.058 171.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.43 ' OD1' ' HB2' ' A' ' 71' ' ' PHE . 3.5 p-10 . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 121.467 0.651 . . . . 74.219999999999999 110.789 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.444 HG22 ' HD3' ' A' ' 70' ' ' ARG . 47.3 t -88.07 143.5 11.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.885 -1.524 . . . . 73.430000000000007 106.885 159.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.4 ttt -137.26 113.58 10.04 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.46 -0.941 . . . . 73.239999999999995 108.46 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 8' ' ' LEU . 46.0 mm -80.37 119.83 30.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.104 -1.073 . . . . 70.209999999999994 108.104 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.479 HG21 HG21 ' A' ' 84' ' ' VAL . 98.0 mt -129.87 143.99 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.187 0.995 . . . . 71.430000000000007 108.398 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HB2' HD11 ' A' ' 8' ' ' LEU . 64.4 tttp -116.06 111.22 42.94 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 109.01 -0.737 . . . . 62.119999999999997 109.01 167.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 16.4 Cg_exo -66.33 131.27 26.07 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.12 1.88 . . . . 65.120000000000005 110.729 167.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.38 -31.91 72.64 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.016 0.926 . . . . 74.230000000000004 111.885 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.82 -29.88 64.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.791 0.836 . . . . 53.420000000000002 111.55 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 34' ' ' GLU . 72.0 t -103.1 107.73 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.0 0.92 . . . . 70.010000000000005 110.677 -170.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -124.45 17.8 8.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.486 1.114 . . . . 72.140000000000001 109.839 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.3 t -139.62 156.32 46.92 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.366 1.067 . . . . 73.25 109.97 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -67.68 -37.67 82.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.308 0.643 . . . . 73.209999999999994 110.903 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.66 -45.09 95.45 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.929 0.891 . . . . 71.230000000000004 111.594 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HB2' HG13 ' A' ' 29' ' ' VAL . 42.1 mt-10 -65.17 -32.72 74.55 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.888 -1.051 . . . . 74.409999999999997 110.553 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.0 -28.76 49.28 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.901 0.88 . . . . 54.420000000000002 111.36 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -75.69 -25.96 57.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.146 0.978 . . . . 72.409999999999997 111.474 -173.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -84.43 -3.19 58.2 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.098 0.407 . . . . 45.310000000000002 112.098 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.541 HD11 HG21 ' A' ' 29' ' ' VAL . 29.9 mt -90.52 -2.87 57.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.814 0.445 . . . . 73.340000000000003 111.428 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -66.2 117.57 7.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.087 0.555 . . . . 72.510000000000005 109.835 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.97 1.98 57.14 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.152 -0.931 . . . . 61.030000000000001 113.202 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -87.62 161.0 17.95 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.327 1.063 . . . . 73.099999999999994 111.055 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.4 tp -90.1 139.25 30.81 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.338 1.055 . . . . 73.540000000000006 108.314 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 t -126.7 122.21 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.552 -0.907 . . . . 72.420000000000002 108.552 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.19 102.25 11.67 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.947 0.899 . . . . 63.450000000000003 109.745 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.479 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 29.4 t90 -95.47 144.22 26.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.248 -0.649 . . . . 75.239999999999995 109.248 170.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -103.36 100.33 10.21 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.603 1.161 . . . . 64.219999999999999 108.162 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.7 p -64.62 150.38 94.04 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.583 0.753 . . . . 74.530000000000001 111.246 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.88 -5.35 15.39 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.646 2.231 . . . . 73.409999999999997 112.289 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.5 t -70.72 -19.54 62.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.705 1.202 . . . . 64.329999999999998 111.163 169.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.51 36.08 8.96 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.887 -0.597 . . . . 35.549999999999997 112.068 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -127.67 131.99 49.75 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.025 0.93 . . . . 74.299999999999997 109.014 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -90.26 93.11 4.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.661 -1.237 . . . . 73.519999999999996 107.661 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 75' ' ' LEU . 34.9 mt -74.86 137.35 41.76 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.819 -1.082 . . . . 75.340000000000003 109.508 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -98.0 137.65 36.5 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.003 0.921 . . . . 44.399999999999999 108.92 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.56 176.31 22.41 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 123.687 0.617 . . . . 72.200000000000003 111.635 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.3 ttmt -147.37 129.98 15.95 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.907 0.353 . . . . 75.140000000000001 110.752 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.4 mt -73.04 105.03 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.874 -1.057 . . . . 73.230000000000004 109.175 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 m -84.55 -36.14 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.821 -0.627 . . . . 54.539999999999999 110.816 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -148.22 -174.74 4.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.676 0.79 . . . . 74.150000000000006 111.203 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -114.31 170.53 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.235 1.014 . . . . 73.319999999999993 110.125 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -136.89 101.63 4.64 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.378 -0.971 . . . . 71.219999999999999 108.378 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.76 -172.56 10.17 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.268 -0.878 . . . . 65.310000000000002 115.181 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.3 p -91.22 11.93 21.82 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.808 1.243 . . . . 75.150000000000006 110.853 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.84 -25.35 60.03 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.937 1.295 . . . . 72.409999999999997 109.718 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.4 -2.43 65.23 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.653 -0.703 . . . . 42.350000000000001 112.788 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.4 129.76 40.91 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.028 0.531 . . . . 44.240000000000002 109.898 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.9 m -102.0 149.9 6.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 C-N-CA 123.665 0.786 . . . . 74.430000000000007 110.805 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -99.76 102.63 14.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.013 -1.449 . . . . 72.450000000000003 107.506 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.57 157.53 17.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.002 0.521 . . . . 71.209999999999994 110.743 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.444 ' HD3' HG22 ' A' ' 21' ' ' VAL . 10.0 mmm180 -131.65 99.7 4.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.366 1.066 . . . . 72.530000000000001 109.703 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.43 ' HB2' ' OD1' ' A' ' 20' ' ' ASN . 16.7 m-85 -88.97 138.51 31.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.181 0.593 . . . . 74.439999999999998 109.818 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.17 -43.23 99.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.83 1.252 . . . . 73.129999999999995 112.43 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -87.64 -53.4 4.81 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.613 -0.721 . . . . 64.099999999999994 111.808 -167.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.73 35.66 39.68 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-O 120.006 -0.33 . . . . 61.329999999999998 113.428 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.646 ' HB2' HD11 ' A' ' 53' ' ' LEU . 41.4 mt -69.42 126.52 92.7 Favored Pre-proline 0 C--N 1.353 0.728 0 C-N-CA 122.409 0.284 . . . . 71.099999999999994 110.44 177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.56 158.94 46.99 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.866 2.377 . . . . 75.200000000000003 110.918 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.3 115.1 0.35 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.243 -1.143 . . . . 64.430000000000007 110.243 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -65.95 75.97 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.089 1.355 . . . . 74.409999999999997 111.059 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.479 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -120.83 28.41 7.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.056 1.342 . . . . 75.519999999999996 109.468 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.3 mt -64.5 103.65 0.69 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 108.59 -0.893 . . . . 72.140000000000001 108.59 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.06 -5.52 8.93 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 116.154 -0.476 . . . . 51.119999999999997 113.109 -172.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -76.02 172.28 13.03 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.956 0.902 . . . . 73.510000000000005 108.905 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -107.51 143.62 35.65 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.526 0.679 . . . . 72.099999999999994 111.419 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG21 HG21 ' A' ' 24' ' ' ILE . 19.6 m -113.24 164.29 9.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-N 114.319 -1.31 . . . . 75.239999999999995 108.405 172.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -127.76 109.74 11.94 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.936 0.494 . . . . 71.349999999999994 109.921 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 54.6 mt -82.59 92.66 2.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.078 -1.082 . . . . 55.210000000000001 108.078 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 2' ' ' ARG . 96.4 t -77.48 128.79 37.97 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 CA-C-N 113.917 -1.492 . . . . 70.349999999999994 110.105 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 108.167 -1.049 . . . . 74.120000000000005 108.167 174.117 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HG2' ' HA ' ' A' ' 87' ' ' VAL . 59.9 mtm-85 . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.414 -0.587 . . . . 71.239999999999995 109.414 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 55.9 mt -121.92 137.32 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.866 0.866 . . . . 74.519999999999996 109.41 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -89.09 131.86 35.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.297 -0.631 . . . . 63.409999999999997 109.297 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -137.97 137.52 8.9 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-O 120.169 -0.24 . . . . 64.230000000000004 112.983 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t -98.97 117.08 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.808 0.843 . . . . 74.430000000000007 110.261 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.98 106.76 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.529 1.132 . . . . 73.420000000000002 110.669 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.7 -50.56 15.01 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.37 0.668 . . . . 74.219999999999999 110.05 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -154.35 172.05 18.32 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.1 -0.954 . . . . 51.549999999999997 110.684 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -120.33 122.61 41.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.963 -1.125 . . . . 71.530000000000001 107.963 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.51 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 1.8 tpm_? . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 106.777 -1.564 . . . . 70.519999999999996 106.777 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 36.8 t30 . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.326 0.584 . . . . 72.129999999999995 110.477 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.606 HG22 ' HG2' ' A' ' 70' ' ' ARG . 67.7 t -105.74 155.39 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 125.89 1.676 . . . . 74.510000000000005 109.785 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 44.3 ttm -137.73 127.47 25.36 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.662 -0.866 . . . . 71.439999999999998 108.662 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -88.01 110.57 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.47 -0.937 . . . . 72.340000000000003 108.47 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 84' ' ' VAL . 79.7 mt -117.39 149.21 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.364 1.066 . . . . 75.019999999999996 109.051 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -123.95 97.67 40.66 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 108.082 -1.081 . . . . 71.140000000000001 108.082 174.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.801 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 36.9 Cg_exo -60.85 125.62 17.64 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.919 2.412 . . . . 55.340000000000003 112.639 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.16 -42.33 89.14 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.623 0.769 . . . . 74.310000000000002 112.541 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.47 0.76 55.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.641 0.776 . . . . 73.219999999999999 111.983 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.801 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 59.4 t -114.3 107.89 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.296 1.038 . . . . 40.009999999999998 108.355 174.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -121.9 6.48 9.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.404 0.682 . . . . 74.019999999999996 111.77 -173.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 m -127.68 142.65 51.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.855 0.862 . . . . 70.409999999999997 108.875 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.533 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 57.3 ttt180 -57.4 -34.78 69.25 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.007 0.923 . . . . 74.510000000000005 111.27 175.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -60.26 -42.65 95.79 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.663 0.785 . . . . 62.509999999999998 111.825 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.657 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.5 mt-10 -64.44 -44.33 91.51 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.163 -0.926 . . . . 71.239999999999995 109.376 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.9 -26.01 66.66 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.438 -0.801 . . . . 72.209999999999994 111.55 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -73.56 -33.93 64.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.35 1.06 . . . . 74.150000000000006 110.777 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -85.86 -2.94 58.75 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.791 0.293 . . . . 75.239999999999995 111.791 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 29' ' ' VAL . 50.5 mt -86.19 -1.58 57.57 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 119.232 -0.413 . . . . 54.5 112.06 174.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 57' ' ' ILE . 43.2 mm -64.22 122.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.672 -0.862 . . . . 70.109999999999999 108.672 172.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.06 -4.94 55.93 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.508 -0.315 . . . . 73.019999999999996 113.163 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -84.8 148.09 26.5 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.197 0.499 . . . . 74.019999999999996 109.729 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.3 tp -88.83 141.5 28.45 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.4 1.08 . . . . 74.310000000000002 108.507 -173.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.51 126.02 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.4 -0.593 . . . . 72.420000000000002 109.4 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.1 mt -111.49 105.66 14.32 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.078 0.951 . . . . 73.219999999999999 109.421 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.46 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 47.3 t90 -110.47 133.27 53.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.306 0.642 . . . . 70.409999999999997 109.374 174.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -92.59 111.98 23.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.791 -1.188 . . . . 73.420000000000002 107.791 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.5 p -68.47 152.51 96.57 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.238 0.615 . . . . 74.030000000000001 111.338 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.41 -18.12 57.43 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.972 2.448 . . . . 52.32 111.917 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.6 m -61.55 -21.07 63.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.156 1.383 . . . . 63.0 111.988 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.71 20.35 44.29 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 116.352 -0.385 . . . . 24.52 112.425 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -108.29 146.98 32.09 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.875 0.87 . . . . 72.409999999999997 109.192 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -101.36 93.43 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.669 -1.234 . . . . 71.120000000000005 107.669 172.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.6 mt -77.88 130.28 36.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.938 -1.028 . . . . 74.219999999999999 109.103 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -107.3 146.62 31.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.277 0.631 . . . . 73.019999999999996 109.32 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.32 -171.31 21.12 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.214 -0.903 . . . . 62.240000000000002 111.497 -175.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -152.22 135.34 15.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.001 0.401 . . . . 63.399999999999999 110.954 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.457 HG22 HD13 ' A' ' 39' ' ' ILE . 70.6 mt -69.83 110.64 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 O-C-N 124.095 0.872 . . . . 63.140000000000001 108.686 175.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.44 -8.54 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.513 0.725 . . . . 65.540000000000006 111.291 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.408 ' HB3' ' HD3' ' A' ' 68' ' ' ARG . 18.6 tpp180 -158.48 150.79 21.76 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.73 -0.471 . . . . 75.239999999999995 109.73 -174.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.418 HG13 HD11 ' A' ' 39' ' ' ILE . 23.7 m -98.62 159.46 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.436 0.694 . . . . 64.230000000000004 109.537 173.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.414 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 59.7 t-80 -144.44 104.48 4.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.126 0.57 . . . . 70.150000000000006 109.808 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.91 168.94 40.49 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 121.336 0.409 . . . . 72.209999999999994 113.655 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.533 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 21.4 p -85.0 -9.22 58.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.482 1.113 . . . . 74.329999999999998 112.29 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -81.87 5.95 17.29 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.509 0.724 . . . . 61.420000000000002 112.686 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.439 ' HA3' HG12 ' A' ' 29' ' ' VAL . . . 84.84 9.11 81.56 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 119.518 -0.601 . . . . 75.450000000000003 113.802 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . . . -67.18 133.9 50.67 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 122.656 0.383 . . . . 71.209999999999994 110.201 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.3 150.06 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.547 0.739 . . . . 51.219999999999999 111.231 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 59' ' ' ARG . 60.2 ttt180 -103.0 105.21 15.48 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.546 1.138 . . . . 72.209999999999994 108.369 171.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.84 120.24 41.92 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.453 0.701 . . . . 71.519999999999996 109.936 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.606 ' HG2' HG22 ' A' ' 21' ' ' VAL . 41.2 mtm105 -88.92 118.81 28.9 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.174 -0.676 . . . . 70.019999999999996 109.174 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -90.78 122.94 33.95 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.336 0.654 . . . . 74.510000000000005 109.773 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.0 -39.3 74.43 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.223 1.009 . . . . 74.400000000000006 111.873 -173.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -76.81 -55.06 5.82 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.251 -0.886 . . . . 73.239999999999995 109.528 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 61.26 34.55 88.55 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 114.6 -1.182 . . . . 74.25 113.865 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 96.0 mt -69.66 137.83 88.21 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.588 0.755 . . . . 64.299999999999997 110.353 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 12.8 Cg_exo -68.76 143.85 57.39 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.96 2.44 . . . . 74.519999999999996 112.445 -174.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.76 104.02 0.17 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.722 -0.951 . . . . 63.109999999999999 110.722 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -73.68 91.18 1.87 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.733 0.813 . . . . 73.150000000000006 110.025 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -115.83 30.77 7.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.717 1.207 . . . . 74.340000000000003 109.91 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.1 mt -43.9 103.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.323 1.049 . . . . 63.119999999999997 112.259 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.15 4.75 20.38 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.814 -0.63 . . . . 33.439999999999998 113.913 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -91.36 168.11 11.8 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.055 0.942 . . . . 71.349999999999994 110.901 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -100.15 154.6 18.31 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.722 0.809 . . . . 74.430000000000007 112.627 -172.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 24' ' ' ILE . 18.5 m -131.18 158.21 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.92 1.288 . . . . 73.019999999999996 109.062 176.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.97 108.25 17.52 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.058 -0.719 . . . . 75.239999999999995 109.058 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 68.1 mt -89.14 94.09 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.976 -1.12 . . . . 71.209999999999994 107.976 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.435 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . 48.6 t -74.01 133.48 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.143 -0.935 . . . . 74.349999999999994 109.043 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 tm? . . . . . 0 CA--C 1.549 0.913 0 N-CA-C 108.743 -0.836 . . . . 72.430000000000007 108.743 176.536 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.466 -0.568 . . . . 65.230000000000004 109.466 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.503 HD12 HH11 ' A' ' 41' ' ' ARG . 65.7 mt -111.84 124.06 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.91 -1.144 . . . . 73.329999999999998 107.91 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 7.1 ptpp? -88.35 127.29 35.48 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.314 0.578 . . . . 63.420000000000002 110.912 -173.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -123.76 160.45 18.31 Favored Glycine 0 C--O 1.218 -0.872 0 CA-C-N 115.59 -0.732 . . . . 62.200000000000003 111.834 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.14 129.56 50.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 123.542 0.737 . . . . 73.310000000000002 109.379 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.505 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 60.4 t -66.93 99.87 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.954 0.902 . . . . 62.100000000000001 109.459 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.748 HD11 ' HG2' ' A' ' 25' ' ' LYS . 72.2 mt -74.46 -59.32 2.78 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.776 -0.453 . . . . 74.219999999999999 109.776 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.4 t -166.08 162.07 17.6 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.923 -0.581 . . . . 75.099999999999994 111.355 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB3' HD21 ' A' ' 20' ' ' ASN . 62.4 m-85 -115.87 145.35 42.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.965 1.306 . . . . 70.329999999999998 108.892 171.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 107.426 -1.324 . . . . 64.519999999999996 107.426 173.667 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.508 HD21 ' HB3' ' A' ' 10' ' ' TYR . 44.6 t-20 . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 109.223 -0.658 . . . . 75.349999999999994 109.223 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.8 t -88.44 105.1 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.448 -0.945 . . . . 54.310000000000002 108.448 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.42 ' HE3' HG22 ' A' ' 7' ' ' VAL . 24.8 ttt -98.83 136.46 38.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.268 -1.333 . . . . 72.010000000000005 109.11 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.511 HG22 HD12 ' A' ' 8' ' ' LEU . 27.7 mm -104.48 131.0 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 108.238 -1.023 . . . . 70.129999999999995 108.238 174.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.9 mt -124.97 150.31 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.941 0.897 . . . . 74.129999999999995 109.239 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.748 ' HG2' HD11 ' A' ' 8' ' ' LEU . 1.1 mmmm -120.37 98.59 48.52 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 123.115 0.566 . . . . 61.549999999999997 110.404 170.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 23.8 Cg_exo -63.07 135.88 53.42 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.116 1.877 . . . . 72.319999999999993 110.377 169.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.5 mt -60.73 -30.99 70.31 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.31 0.576 . . . . 71.239999999999995 111.149 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.23 -27.17 61.44 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.334 1.453 . . . . 73.140000000000001 111.79 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 34' ' ' GLU . 94.6 t -115.93 121.09 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.9 0.88 . . . . 61.140000000000001 110.427 -170.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -135.29 14.68 3.5 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.671 0.788 . . . . 73.5 111.26 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 m -137.67 151.27 48.08 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.845 0.858 . . . . 54.020000000000003 109.781 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.65 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 50.0 ttt180 -60.37 -38.82 85.1 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.253 1.021 . . . . 75.209999999999994 112.184 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.57 -40.1 95.78 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.049 0.54 . . . . 73.340000000000003 111.44 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.508 ' HB2' HG13 ' A' ' 29' ' ' VAL . 48.0 mt-10 -64.73 -35.64 81.71 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.9 0.75 . . . . 63.420000000000002 110.828 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.79 -30.6 51.38 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.987 0.915 . . . . 63.210000000000001 111.274 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -73.19 -31.63 64.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.065 0.946 . . . . 72.409999999999997 111.25 -173.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -79.28 -11.71 59.94 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 120.831 0.348 . . . . 54.210000000000001 110.899 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.587 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 51.5 mt -109.73 23.62 14.16 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.205 1.002 . . . . 74.310000000000002 111.561 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.5 mm -75.47 135.39 27.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.565 -0.531 . . . . 71.109999999999999 109.565 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.6 -9.3 44.55 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-O 119.103 -0.831 . . . . 65.5 113.061 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.587 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 79.1 mtm180 -62.11 149.11 42.25 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.334 0.654 . . . . 73.209999999999994 112.408 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 tp -91.64 120.68 32.62 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.369 1.068 . . . . 62.409999999999997 109.262 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.0 t -100.21 137.28 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 122.911 0.484 . . . . 60.32 110.031 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.7 mt -131.34 120.13 22.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.787 1.235 . . . . 74.019999999999996 107.761 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.42 ' HE1' ' HB3' ' A' ' 82' ' ' ASP . 47.4 t90 -130.28 128.44 41.57 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.435 -0.579 . . . . 74.129999999999995 109.435 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -84.43 110.84 18.94 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.347 -0.612 . . . . 63.420000000000002 109.347 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.8 t -77.2 153.72 82.23 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 124.255 1.022 . . . . 63.43 109.537 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.3 -8.55 14.85 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.137 2.558 . . . . 75.099999999999994 114.686 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.9 p -70.9 -15.32 62.61 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.262 0.625 . . . . 74.310000000000002 111.506 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.23 -10.53 63.54 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 123.719 0.676 . . . . 43.149999999999999 112.388 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.57 132.41 35.11 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.627 0.771 . . . . 74.450000000000003 110.755 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.8 106.5 13.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.944 -0.761 . . . . 54.25 108.944 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.8 117.93 16.15 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.726 -0.842 . . . . 74.340000000000003 108.726 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -109.16 146.67 33.74 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 123.021 0.528 . . . . 55.509999999999998 110.424 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.82 -171.75 27.2 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 114.825 -1.079 . . . . 32.5 110.999 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.73 134.18 20.81 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.057 0.428 . . . . 74.030000000000001 111.086 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 41' ' ' ARG . 78.1 mt -67.5 106.87 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.509 0 O-C-N 124.41 1.069 . . . . 62.039999999999999 109.402 175.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.545 HG11 ' HE ' ' A' ' 70' ' ' ARG . 27.6 m -91.52 -31.74 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.567 0.747 . . . . 54.130000000000003 111.559 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -155.76 176.29 12.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.863 -0.791 . . . . 71.299999999999997 108.863 -173.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.2 m -92.51 170.06 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 109.092 -0.707 . . . . 74.329999999999998 109.092 170.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -136.17 103.4 5.31 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.267 -1.012 . . . . 72.310000000000002 108.267 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.7 -149.04 42.71 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.657 -0.702 . . . . 22.140000000000001 113.24 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.65 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -117.97 -17.37 9.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.472 0.709 . . . . 70.299999999999997 112.105 -171.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 25.29 2.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.497 0.719 . . . . 61.130000000000003 112.232 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.22 18.13 78.66 Favored Glycine 0 C--N 1.346 1.13 0 N-CA-C 114.97 0.748 . . . . 73.409999999999997 114.97 167.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.12 38.19 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.582 -0.896 . . . . 61.310000000000002 108.582 171.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.8 m -102.43 139.46 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.046 0.451 . . . . 65.0 109.973 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -99.58 105.53 17.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.118 0.967 . . . . 74.230000000000004 108.747 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.51 121.58 44.7 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.832 0.853 . . . . 70.349999999999994 110.817 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HE ' HG11 ' A' ' 58' ' ' VAL . 39.1 mtm180 -89.33 113.12 24.36 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.979 -0.748 . . . . 63.299999999999997 108.979 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -81.5 136.15 35.62 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.337 1.055 . . . . 72.519999999999996 110.329 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.66 -24.78 36.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.404 0.682 . . . . 70.129999999999995 110.904 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -77.39 -54.77 6.05 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.485 -0.78 . . . . 70.430000000000007 109.685 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.04 25.1 63.82 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 124.042 0.838 . . . . 71.030000000000001 114.263 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.63 158.46 78.5 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.949 0.9 . . . . 73.430000000000007 110.848 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.58 150.6 51.32 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.996 2.464 . . . . 73.129999999999995 112.733 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.24 -71.96 0.3 Allowed Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.915 -0.584 . . . . 73.120000000000005 112.43 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 76.02 -40.43 0.4 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 126.075 1.75 . . . . 75.019999999999996 112.604 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.81 30.07 0.11 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.126 0.97 . . . . 44.149999999999999 112.661 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.18 149.42 28.32 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.216 1.006 . . . . 72.25 110.707 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' H ' ' HB ' ' A' ' 7' ' ' VAL . . . 87.72 4.12 79.8 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 116.601 -0.272 . . . . 73.510000000000005 113.076 -169.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.42 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 35.0 t70 -85.38 170.9 12.28 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.76 0.824 . . . . 73.329999999999998 110.176 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.69 133.24 36.2 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.516 0.674 . . . . 73.099999999999994 112.169 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 11.4 m -100.71 159.34 3.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 114.452 -1.249 . . . . 72.319999999999993 108.946 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -109.19 108.9 19.71 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.473 -0.936 . . . . 72.430000000000007 108.473 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.9 95.13 4.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.584 -0.895 . . . . 75.420000000000002 108.584 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.22 136.73 24.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 115.246 -0.888 . . . . 75.219999999999999 109.593 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 108.642 -0.873 . . . . 60.229999999999997 108.642 178.714 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 . . . . . 0 CA--C 1.537 0.468 0 N-CA-C 107.421 -1.326 . . . . 75.329999999999998 107.421 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 mt -98.55 155.69 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.411 1.084 . . . . 65.150000000000006 108.96 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.553 ' HG3' HD12 ' A' ' 27' ' ' LEU . 19.1 ptmt -114.36 140.92 48.26 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.865 -0.791 . . . . 75.030000000000001 108.865 173.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -139.32 164.57 25.9 Favored Glycine 0 C--O 1.216 -0.995 0 N-CA-C 111.647 -0.581 . . . . 23.309999999999999 111.647 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.37 131.38 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.348 0.659 . . . . 75.230000000000004 109.926 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.1 93.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.304 -0.998 . . . . 72.099999999999994 108.304 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 25' ' ' LYS . 79.8 mt -68.4 -59.31 3.27 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 110.131 -0.322 . . . . 73.319999999999993 110.131 -176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 t -154.38 155.67 35.46 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.074 -0.512 . . . . 72.400000000000006 110.722 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -95.78 138.81 32.91 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.458 -0.941 . . . . 73.439999999999998 108.458 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 108.585 -0.894 . . . . 71.230000000000004 108.585 173.393 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.025 -0.731 . . . . 63.030000000000001 109.025 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 70' ' ' ARG . 62.2 t -88.12 145.9 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 108.282 -1.007 . . . . 72.310000000000002 108.282 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.3 ttt -136.22 111.51 9.09 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.485 -1.302 . . . . 62.210000000000001 107.485 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 mm -78.51 119.13 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 114.98 -1.009 . . . . 63.310000000000002 108.387 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.469 HG21 HG21 ' A' ' 84' ' ' VAL . 81.5 mt -130.93 153.12 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.488 1.115 . . . . 73.400000000000006 108.089 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HB2' HD11 ' A' ' 8' ' ' LEU . 87.5 tttt -127.33 121.88 22.69 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 108.912 -0.773 . . . . 73.400000000000006 108.912 164.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -69.87 140.23 41.74 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.768 2.312 . . . . 70.25 110.768 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.553 HD12 ' HG3' ' A' ' 4' ' ' LYS . 92.7 mt -69.84 -29.78 67.11 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.384 0.673 . . . . 73.540000000000006 111.276 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.08 -22.23 60.62 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.996 -1.002 . . . . 64.439999999999998 111.303 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' A' ' 34' ' ' GLU . 57.9 t -110.23 123.96 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.335 1.054 . . . . 63.32 110.746 -174.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -135.16 11.13 3.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.845 0.858 . . . . 64.299999999999997 110.429 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.442 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 27.5 m -131.09 165.33 23.49 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.426 0.69 . . . . 74.0 111.126 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -68.93 -43.73 74.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.703 1.201 . . . . 73.430000000000007 110.97 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -70.65 -32.54 69.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.746 0.818 . . . . 72.019999999999996 110.763 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.563 ' HB2' HG13 ' A' ' 29' ' ' VAL . 44.7 mt-10 -68.51 -30.89 69.81 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.78 -0.645 . . . . 73.450000000000003 110.5 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.38 -32.04 33.04 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.578 0.751 . . . . 72.349999999999994 110.728 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -75.18 -23.77 57.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.869 0.868 . . . . 72.349999999999994 111.382 -174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -80.23 -13.67 59.04 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 120.73 0.3 . . . . 70.010000000000005 110.968 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.9 mt -90.32 3.87 52.42 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 122.961 0.504 . . . . 75.040000000000006 112.084 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.481 HD13 HG22 ' A' ' 57' ' ' ILE . 48.9 mm -65.63 124.36 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 108.819 -0.808 . . . . 71.530000000000001 108.819 171.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.06 9.56 62.08 Favored Glycine 0 N--CA 1.475 1.288 0 CA-C-O 119.967 -0.351 . . . . 74.400000000000006 113.371 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.714 ' HG3' ' HA ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -89.85 146.72 24.23 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.691 0.796 . . . . 74.310000000000002 110.673 178.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.8 tp -93.98 115.41 27.75 Favored 'General case' 0 C--N 1.345 0.398 0 O-C-N 124.037 0.835 . . . . 64.310000000000002 109.41 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.9 t -98.99 120.43 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 109.629 -0.508 . . . . 75.310000000000002 109.629 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt -105.9 128.05 53.53 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.765 1.226 . . . . 63.340000000000003 109.077 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -147.33 119.27 8.15 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.377 -0.601 . . . . 72.430000000000007 109.377 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 28.3 ttpp -82.06 112.27 18.97 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.194 -0.669 . . . . 73.129999999999995 109.194 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.0 p -64.7 155.51 81.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.781 0.832 . . . . 61.229999999999997 110.94 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.71 -9.09 19.57 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.988 2.459 . . . . 73.349999999999994 112.523 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 t -74.67 -10.12 59.23 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.927 0.891 . . . . 61.310000000000002 111.347 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.47 -12.37 63.18 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 123.633 0.635 . . . . 60.140000000000001 113.188 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -83.51 126.66 33.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.564 0.746 . . . . 65.400000000000006 109.563 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 63.1 mt -79.57 96.74 2.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 107.31 -1.367 . . . . 60.030000000000001 107.31 168.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 73' ' ' LYS . 50.3 mt -73.62 126.43 30.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.094 -0.957 . . . . 73.329999999999998 108.953 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -106.65 139.82 40.49 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.991 -0.744 . . . . 72.019999999999996 108.991 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.24 -179.64 28.02 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 123.51 0.506 . . . . 40.240000000000002 111.939 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 31.0 ttmt -149.38 137.32 20.47 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.949 0.404 . . . . 73.319999999999993 111.073 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.481 HG22 HD13 ' A' ' 39' ' ' ILE . 67.3 mt -74.85 103.49 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 114.77 -1.105 . . . . 74.239999999999995 109.643 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.21 -18.59 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 114.965 -1.016 . . . . 60.240000000000002 111.345 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 20.8 ttm180 -160.13 160.67 33.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.084 0.554 . . . . 62.32 109.755 -175.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 m -95.1 171.05 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.496 0.718 . . . . 73.019999999999996 109.469 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -128.36 103.03 6.92 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.795 -0.817 . . . . 73.200000000000003 108.795 173.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.35 -150.52 46.96 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 124.291 0.994 . . . . 41.539999999999999 114.089 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -109.54 7.08 24.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.473 1.109 . . . . 75.109999999999999 110.89 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -67.23 -28.05 67.74 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.171 0.588 . . . . 72.230000000000004 111.047 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.17 3.3 58.92 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.639 -0.709 . . . . 65.150000000000006 111.903 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.44 130.21 42.19 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.515 -0.55 . . . . 73.549999999999997 109.515 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.6 m -102.37 153.97 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.581 0.752 . . . . 74.219999999999999 110.573 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HD2' ' HB3' ' A' ' 59' ' ' ARG . 17.8 ttm180 -111.84 103.31 11.56 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.491 -0.929 . . . . 54.210000000000001 108.491 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.84 116.58 30.91 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.449 0.699 . . . . 44.539999999999999 109.813 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.423 ' HG2' HG22 ' A' ' 21' ' ' VAL . 43.3 mtm180 -90.24 118.01 29.43 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.69 -0.856 . . . . 71.109999999999999 108.69 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -91.37 128.41 37.19 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.488 0.715 . . . . 72.510000000000005 109.801 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.12 -32.97 68.64 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.629 1.172 . . . . 72.209999999999994 112.468 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.505 ' HB2' HD22 ' A' ' 53' ' ' LEU . 70.9 mmtt -90.5 -37.94 13.55 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.132 0.573 . . . . 71.420000000000002 109.565 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.17 35.73 34.6 Favored Glycine 0 C--N 1.36 1.871 0 O-C-N 124.503 1.127 . . . . 75.040000000000006 114.315 174.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -76.28 133.15 71.95 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 122.992 0.517 . . . . 72.430000000000007 110.622 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.23 120.17 6.41 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.772 1.648 . . . . 75.510000000000005 110.404 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.12 -15.2 31.3 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.523 -0.762 . . . . 73.209999999999994 111.868 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 67.68 12.74 9.0 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.765 1.226 . . . . 62.109999999999999 111.35 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.12 32.47 2.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.836 1.254 . . . . 44.299999999999997 111.833 -168.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -51.79 108.02 0.24 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.522 0.729 . . . . 71.200000000000003 111.413 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.0 -14.46 7.05 Favored Glycine 0 N--CA 1.475 1.272 0 CA-C-N 116.11 -0.496 . . . . 72.340000000000003 112.396 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -77.56 172.83 12.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.75 0.82 . . . . 71.129999999999995 110.311 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 9.7 m-85 -108.62 130.01 55.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.283 0.633 . . . . 71.120000000000005 111.394 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 24' ' ' ILE . 16.1 m -97.97 168.25 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.553 1.141 . . . . 61.43 109.029 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -120.35 106.76 12.17 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.787 -0.82 . . . . 45.109999999999999 108.787 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.19 92.37 3.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.41 -0.959 . . . . 64.400000000000006 108.41 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.78 124.77 36.74 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-N 115.063 -0.971 . . . . 75.230000000000004 108.86 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.714 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.239 0.533 0 N-CA-C 106.663 -1.606 . . . . 72.409999999999997 106.663 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.544 ' HD2' ' HB3' ' A' ' 85' ' ' GLU . 90.6 mtm-85 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.803 -0.443 . . . . 73.010000000000005 109.803 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.682 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 47.8 mt -116.82 124.4 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.566 -1.272 . . . . 53.210000000000001 107.566 176.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -88.74 140.21 29.68 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 118.419 0.554 . . . . 74.430000000000007 109.658 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.59 135.97 7.34 Favored Glycine 0 C--O 1.218 -0.886 0 N-CA-C 111.998 -0.441 . . . . 71.439999999999998 111.998 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -91.18 116.88 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.369 0.668 . . . . 44.219999999999999 109.266 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.485 HG13 ' SD ' ' A' ' 22' ' ' MET . 91.1 t -55.12 103.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.585 1.154 . . . . 75.400000000000006 110.4 175.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 23' ' ' ILE . 93.9 mt -75.21 -57.05 4.13 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 122.88 0.472 . . . . 70.140000000000001 110.22 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.409 ' HA ' HD22 ' A' ' 80' ' ' LEU . 71.3 p -163.95 164.08 23.34 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.415 -0.811 . . . . 64.200000000000003 110.271 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.97 134.93 34.09 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.147 -0.686 . . . . 74.25 109.147 168.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 1.7 tmt_? . . . . . 0 C--O 1.241 0.648 0 N-CA-C 105.424 -2.065 . . . . 73.019999999999996 105.424 165.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.656 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 52.1 t30 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 120.886 0.374 . . . . 71.549999999999997 110.302 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 39.8 t -93.53 144.14 10.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.606 -0.887 . . . . 74.540000000000006 108.606 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.485 ' SD ' HG13 ' A' ' 7' ' ' VAL . 42.8 ttp -133.56 121.64 22.4 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.179 -0.675 . . . . 74.349999999999994 109.179 174.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 8' ' ' LEU . 41.1 mm -79.78 126.42 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.577 1.151 . . . . 70.140000000000001 108.832 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -126.08 152.07 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.581 1.153 . . . . 74.099999999999994 109.588 -171.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 64' ' ' LYS . 4.5 tppp? -116.22 92.66 36.68 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.756 0.822 . . . . 71.109999999999999 109.515 173.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.07 131.54 33.0 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.441 1.427 . . . . 62.130000000000003 109.876 172.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.449 HD11 ' HE2' ' A' ' 83' ' ' TYR . 91.1 mt -63.96 -31.51 72.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.584 0.754 . . . . 63.210000000000001 111.764 -171.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.16 -28.58 67.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.539 0.735 . . . . 73.099999999999994 111.122 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.421 HG12 ' HA2' ' A' ' 65' ' ' GLY . 89.1 t -96.66 144.19 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.865 0.866 . . . . 64.400000000000006 111.772 -168.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -147.52 -25.57 0.38 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.375 1.07 . . . . 61.119999999999997 111.592 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.608 ' HB2' ' HG2' ' A' ' 34' ' ' GLU . 15.7 m -109.88 169.84 8.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.403 0.681 . . . . 73.409999999999997 111.186 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.511 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 78.8 ttt180 -65.96 -42.83 89.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.954 0.902 . . . . 74.209999999999994 111.082 -177.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.99 -30.87 62.71 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.813 0.695 . . . . 72.439999999999998 110.892 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HG2' ' HB2' ' A' ' 31' ' ' SER . 20.0 mm-40 -65.92 -30.8 71.44 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.752 0.658 . . . . 70.5 110.491 173.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.66 -33.21 31.45 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.772 0.829 . . . . 65.329999999999998 110.851 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -75.44 -24.96 57.09 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.107 0.963 . . . . 75.430000000000007 111.203 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 34' ' ' GLU . 22.0 pttp -75.07 -1.51 23.23 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 122.205 0.202 . . . . 74.010000000000005 111.111 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.1 11.5 25.64 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.319 0.648 . . . . 74.439999999999998 112.53 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mm -69.24 126.28 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.414 -0.587 . . . . 65.120000000000005 109.414 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.38 57.74 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.179 -0.464 . . . . 53.25 113.242 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.07 139.14 37.03 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.017 0.527 . . . . 75.510000000000005 110.301 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -90.1 113.68 25.46 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.275 1.03 . . . . 63.049999999999997 108.75 -173.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -98.04 114.31 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.222 0.609 . . . . 74.420000000000002 109.517 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.464 HD22 ' HG2' ' A' ' 54' ' ' LYS . 42.4 mt -101.04 99.99 10.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.23 -1.026 . . . . 72.140000000000001 108.23 176.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.5 ' CD1' HG12 ' A' ' 84' ' ' VAL . 32.6 t90 -103.27 131.63 50.17 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.959 -0.756 . . . . 73.140000000000001 108.959 174.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -91.99 126.61 37.15 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.151 -1.055 . . . . 75.349999999999994 108.151 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.9 p -73.17 141.43 81.03 Favored Pre-proline 0 C--O 1.244 0.816 0 N-CA-C 109.381 -0.6 . . . . 53.109999999999999 109.381 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.69 -23.55 33.5 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.471 2.78 . . . . 72.310000000000002 113.877 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.4 m -64.17 -54.78 28.24 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.646 0.779 . . . . 75.510000000000005 110.928 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.18 32.32 0.1 Allowed Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.351 -0.386 . . . . 74.530000000000001 113.614 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -114.69 173.53 6.43 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.607 0.763 . . . . 73.340000000000003 109.542 173.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.0 105.05 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.446 -0.946 . . . . 74.219999999999999 108.446 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 73' ' ' LYS . 21.2 mt -83.34 110.23 17.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.236 -1.024 . . . . 74.329999999999998 108.236 172.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.464 ' HG2' HD22 ' A' ' 44' ' ' LEU . 51.7 mtpt -94.46 139.74 30.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.003 -0.74 . . . . 70.430000000000007 109.003 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.65 -171.28 19.36 Favored Glycine 0 N--CA 1.463 0.493 0 O-C-N 123.455 0.472 . . . . 44.030000000000001 112.297 -173.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -151.94 133.99 15.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.957 0.503 . . . . 71.310000000000002 110.052 -178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 67' ' ' VAL . 73.6 mt -69.32 98.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.729 -0.841 . . . . 71.239999999999995 108.729 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.37 -33.44 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.183 0.593 . . . . 64.450000000000003 111.019 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -148.78 167.61 25.14 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.349 -0.982 . . . . 62.219999999999999 108.349 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 m -103.01 170.63 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.394 0.678 . . . . 65.430000000000007 109.229 172.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -132.57 122.57 24.97 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.522 -0.918 . . . . 73.099999999999994 108.522 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.67 -153.95 52.4 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.92 0.763 . . . . 53.219999999999999 113.072 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.511 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 73.6 p -116.76 -11.47 10.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.193 0.997 . . . . 71.439999999999998 111.193 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 73.0 mmtt -98.73 52.94 1.0 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.229 0.537 . . . . 64.140000000000001 112.091 -172.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.421 ' HA2' HG12 ' A' ' 29' ' ' VAL . . . 71.38 -0.4 33.3 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 117.312 1.685 . . . . 61.130000000000003 117.312 163.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.46 124.85 28.85 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.91 0.855 . . . . 61.210000000000001 109.582 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.7 m -103.25 160.12 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.371 0.668 . . . . 64.430000000000007 109.918 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -119.79 104.29 10.09 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.703 1.201 . . . . 64.239999999999995 108.499 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.12 127.41 54.14 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.447 0.699 . . . . 72.129999999999995 110.864 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' HD2' HG22 ' A' ' 21' ' ' VAL . 7.8 mmm180 -89.61 111.5 22.46 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.59 1.156 . . . . 70.409999999999997 109.611 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -92.08 166.33 12.72 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.056 0.542 . . . . 72.219999999999999 111.047 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 7.8 pt-20 -67.29 -39.05 85.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.937 0.895 . . . . 74.150000000000006 110.466 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 14.4 mmmm -118.8 -69.16 0.87 Allowed 'General case' 0 C--N 1.345 0.375 0 C-N-CA 124.089 0.956 . . . . 55.119999999999997 109.398 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.656 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 71.93 57.86 5.57 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 123.924 0.765 . . . . 53.240000000000002 111.231 -173.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.33 124.51 89.99 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.758 0.823 . . . . 74.219999999999999 111.22 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.59 174.57 8.24 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.335 2.69 . . . . 73.340000000000003 112.71 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.33 172.1 13.13 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.341 -0.704 . . . . 53.049999999999997 111.341 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -86.48 68.91 10.34 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.508 1.147 . . . . 75.340000000000003 109.618 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.09 17.51 17.72 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.468 -1.242 . . . . 63.32 109.714 175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 9' ' ' SER . 41.2 mt -76.41 121.88 23.7 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.92 0.888 . . . . 63.43 109.486 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.48 -6.98 14.14 Favored Glycine 0 N--CA 1.469 0.849 0 N-CA-C 111.966 -0.454 . . . . 73.329999999999998 111.966 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.58 155.64 29.55 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.814 0.846 . . . . 65.450000000000003 109.86 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.449 ' HE2' HD11 ' A' ' 27' ' ' LEU . 62.1 m-85 -91.33 133.09 35.73 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.94 0.496 . . . . 73.510000000000005 111.448 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 45' ' ' TRP . 6.7 m -100.01 149.39 5.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 N-CA-C 107.632 -1.248 . . . . 72.150000000000006 107.632 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.544 ' HB3' ' HD2' ' A' ' 2' ' ' ARG . 8.5 mm-40 -111.34 106.73 15.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.053 -1.091 . . . . 73.340000000000003 108.053 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.682 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 62.2 mt -96.94 104.63 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.444 0.697 . . . . 71.409999999999997 109.235 -173.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.9 t -95.31 134.75 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.221 1.008 . . . . 61.219999999999999 110.103 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 107.302 -1.37 . . . . 64.310000000000002 107.302 168.777 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 106.845 -1.539 . . . . 54.299999999999997 106.845 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 28' ' ' ASP . 50.9 mt -94.67 125.86 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.275 -0.639 . . . . 63.229999999999997 109.275 -175.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -88.67 133.29 34.25 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.466 -0.939 . . . . 71.310000000000002 108.466 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.98 166.19 22.13 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.361 0.413 . . . . 71.299999999999997 112.13 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.61 135.2 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.193 0.997 . . . . 70.209999999999994 109.173 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.76 114.53 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.568 0.747 . . . . 74.310000000000002 110.292 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 25' ' ' LYS . 89.6 mt -81.79 -61.2 1.99 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.358 0.663 . . . . 75.430000000000007 110.843 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.2 t -152.46 160.5 43.26 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.849 -0.614 . . . . 71.319999999999993 110.37 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -91.02 157.55 17.2 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.361 0.601 . . . . 74.310000000000002 111.182 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.486 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.6 tpp180 . . . . . 0 C--O 1.238 0.495 0 N-CA-C 106.263 -1.754 . . . . 61.549999999999997 106.263 163.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 . . . . . 0 C--O 1.241 0.629 0 N-CA-C 109.31 -0.626 . . . . 72.010000000000005 109.31 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 70' ' ' ARG . 5.1 t -96.96 150.62 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 108.464 -0.939 . . . . 63.219999999999999 108.464 -176.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -154.79 140.88 18.43 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.758 0.313 . . . . 72.299999999999997 110.77 168.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 8' ' ' LEU . 45.4 mm -77.17 120.48 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.307 -0.861 . . . . 72.299999999999997 108.682 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.4 mt -115.45 147.83 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.35 1.06 . . . . 61.350000000000001 108.84 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 8' ' ' LEU . 86.6 tttt -108.13 101.8 43.3 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 123.821 0.848 . . . . 74.519999999999996 109.424 171.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' HG22 ' A' ' 67' ' ' VAL . 17.7 Cg_endo -60.58 115.97 3.03 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 122.067 1.845 . . . . 62.409999999999997 110.067 165.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.38 -34.07 71.97 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.159 0.984 . . . . 72.239999999999995 112.132 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 3' ' ' ILE . 22.2 t70 -69.31 -27.73 65.64 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.253 1.021 . . . . 73.120000000000005 111.899 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 34' ' ' GLU . 25.9 t -113.09 119.06 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.235 1.014 . . . . 55.299999999999997 111.24 -170.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -120.36 -5.52 9.87 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.116 0.566 . . . . 72.319999999999993 111.893 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 69.2 m -111.18 152.86 26.57 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.038 0.535 . . . . 64.319999999999993 110.347 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.589 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 55.6 ttt85 -64.27 -35.36 80.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 73.129999999999995 111.826 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.62 -38.72 84.3 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.951 0.5 . . . . 73.040000000000006 110.7 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HB2' HG13 ' A' ' 29' ' ' VAL . 33.8 mt-10 -67.39 -31.77 72.22 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.114 -0.948 . . . . 72.299999999999997 110.07 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.22 -23.05 32.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.977 0.911 . . . . 71.519999999999996 111.218 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.4 t -79.42 -27.6 41.73 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.769 0.828 . . . . 64.349999999999994 110.086 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -80.16 -9.19 59.7 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.329 -0.396 . . . . 74.450000000000003 110.758 170.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.432 HD21 HD12 ' A' ' 3' ' ' ILE . 47.2 mt -89.61 -3.45 58.27 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.139 0.576 . . . . 64.519999999999996 111.987 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.683 HD11 HG13 ' A' ' 60' ' ' VAL . 49.7 mm -63.65 107.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.242 -0.651 . . . . 64.409999999999997 109.242 174.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.1 5.4 30.62 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.323 -0.71 . . . . 72.319999999999993 114.145 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.436 ' HD2' HD22 ' A' ' 88' ' ' LEU . 28.9 mmt180 -84.72 159.72 20.46 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.364 1.082 . . . . 74.430000000000007 111.373 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 54' ' ' LYS . 61.0 tp -90.83 117.19 29.25 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.29 1.036 . . . . 75.510000000000005 109.331 -175.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 t -107.35 117.14 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.204 -0.665 . . . . 63.310000000000002 109.204 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -101.15 104.44 15.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.641 0.776 . . . . 75.219999999999999 109.529 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -91.75 141.95 28.12 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.554 -0.536 . . . . 73.200000000000003 109.554 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -103.08 108.95 20.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.962 -1.017 . . . . 73.349999999999994 108.87 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.2 p -60.3 160.82 15.57 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.731 0.813 . . . . 74.409999999999997 111.036 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.9 -21.67 71.65 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.937 2.424 . . . . 71.349999999999994 112.613 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.3 m -77.51 -6.96 55.44 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.017 0.927 . . . . 64.200000000000003 111.765 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.65 3.64 77.29 Favored Glycine 0 C--N 1.35 1.342 0 C-N-CA 123.197 0.427 . . . . 64.549999999999997 112.863 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -85.77 156.47 20.59 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.007 0.923 . . . . 74.030000000000001 108.898 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.8 mt -117.62 114.35 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.594 0.358 . . . . 62.25 110.367 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 73' ' ' LYS . 31.5 mt -92.25 150.58 20.8 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.723 -0.843 . . . . 74.25 108.723 173.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB3' HD11 ' A' ' 42' ' ' LEU . 23.5 mtmm -98.22 156.15 16.83 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.717 -0.475 . . . . 75.530000000000001 109.717 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.8 -174.97 29.21 Favored Glycine 0 C--O 1.239 0.441 0 N-CA-C 111.036 -0.825 . . . . 50.329999999999998 111.036 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -152.87 136.17 15.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 111.758 0.281 . . . . 70.239999999999995 111.758 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.411 HD11 HD13 ' A' ' 86' ' ' ILE . 78.2 mt -69.2 102.82 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.622 0 O-C-N 124.038 0.836 . . . . 70.540000000000006 108.895 171.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -84.29 -28.35 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.329 -0.851 . . . . 74.530000000000001 110.711 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -164.03 165.32 22.55 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.811 0.844 . . . . 74.099999999999994 109.396 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.683 HG13 HD11 ' A' ' 39' ' ' ILE . 35.4 m -92.8 169.41 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.508 0.723 . . . . 75.299999999999997 110.522 174.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -127.6 104.59 7.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.295 1.038 . . . . 73.340000000000003 109.223 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.49 -153.01 52.89 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.851 -0.613 . . . . 61.32 113.154 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 32.5 p -111.83 -0.63 15.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.789 0.836 . . . . 72.319999999999993 111.831 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -83.78 5.88 23.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.47 0.708 . . . . 72.319999999999993 112.425 -168.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.28 -16.37 57.61 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-O 119.909 -0.384 . . . . 75.299999999999997 113.063 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.68 122.55 14.41 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.613 0.765 . . . . 42.240000000000002 110.018 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.4 HG22 ' HD3' ' A' ' 26' ' ' PRO . 35.9 m -102.84 175.06 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.955 0.902 . . . . 74.540000000000006 110.632 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -128.5 111.39 13.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.278 1.031 . . . . 65.140000000000001 108.592 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.8 133.02 56.52 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.381 0.672 . . . . 63.109999999999999 110.774 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.553 ' HG2' HG22 ' A' ' 21' ' ' VAL . 97.0 mtt180 -103.75 128.85 51.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.947 0.899 . . . . 75.120000000000005 109.095 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -106.11 134.6 48.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.494 0.717 . . . . 73.040000000000006 110.743 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.566 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 20.8 pt-20 -51.58 -48.09 63.3 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 124.89 1.369 . . . . 72.329999999999998 112.552 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.566 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 13.4 mmmm -92.93 -39.5 11.11 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.152 0.581 . . . . 73.200000000000003 109.478 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.99 55.0 28.11 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 124.284 0.99 . . . . 64.409999999999997 113.908 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.62 124.09 89.25 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.054 0.541 . . . . 74.519999999999996 110.591 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.14 150.67 33.67 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.107 2.538 . . . . 60.140000000000001 112.129 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.09 -151.79 14.6 Favored Glycine 0 C--N 1.344 0.972 0 N-CA-C 111.33 -0.708 . . . . 73.540000000000006 111.33 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -113.03 73.89 0.84 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.218 1.009 . . . . 73.430000000000007 108.882 172.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.27 -9.76 59.37 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.383 -1.28 . . . . 75.340000000000003 112.617 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.6 mt -61.24 115.1 3.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.621 0.768 . . . . 75.329999999999998 110.716 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.68 -18.87 49.29 Favored Glycine 0 N--CA 1.473 1.148 0 CA-C-N 116.465 -0.334 . . . . 73.329999999999998 112.826 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.08 163.49 27.06 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.698 0.799 . . . . 62.109999999999999 110.442 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -105.05 148.71 26.48 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.751 0.786 . . . . 55.219999999999999 112.279 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.14 164.45 17.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 114.35 -1.295 . . . . 75.310000000000002 108.269 171.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.13 107.66 11.0 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.008 -0.738 . . . . 62.310000000000002 109.008 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.411 HD13 HD11 ' A' ' 57' ' ' ILE . 57.4 mt -82.72 92.23 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.0 -1.111 . . . . 74.340000000000003 108.0 177.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.2 t -79.53 141.82 14.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 114.421 -1.263 . . . . 73.420000000000002 108.837 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' HD2' ' A' ' 41' ' ' ARG . 1.0 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 107.66 -1.237 . . . . 53.219999999999999 107.66 171.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 107.647 -1.242 . . . . 75.450000000000003 107.647 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.24 139.85 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.464 0.706 . . . . 71.439999999999998 109.142 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -88.14 119.16 28.26 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.283 -1.006 . . . . 51.210000000000001 108.283 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -116.98 168.84 12.89 Favored Glycine 0 C--N 1.34 0.802 0 O-C-N 123.673 0.608 . . . . 64.329999999999998 111.583 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.43 130.29 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.958 0.903 . . . . 53.210000000000001 109.175 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.2 t -68.11 104.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.095 0.958 . . . . 74.140000000000001 109.348 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 25' ' ' LYS . 83.1 mt -84.29 -55.13 4.34 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.462 0.305 . . . . 73.230000000000004 110.807 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m -154.22 170.27 21.65 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.524 0.564 . . . . 62.340000000000003 112.524 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -122.58 157.56 31.86 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.053 1.341 . . . . 71.299999999999997 109.193 170.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.55 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.7 tpt180 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 107.656 -1.238 . . . . 75.099999999999994 107.656 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 110.315 -0.254 . . . . 65.310000000000002 110.315 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 85.8 t -86.41 145.0 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.32 -0.993 . . . . 63.549999999999997 108.32 -171.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.3 ttt -137.56 109.49 7.17 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.791 -1.559 . . . . 62.439999999999998 106.791 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.448 HG22 HD12 ' A' ' 8' ' ' LEU . 45.5 mm -81.14 120.32 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 107.119 -1.437 . . . . 64.230000000000004 107.119 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.409 HG21 HG21 ' A' ' 84' ' ' VAL . 85.5 mt -127.65 146.64 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.49 1.116 . . . . 63.030000000000001 108.319 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HB2' HD11 ' A' ' 8' ' ' LEU . 41.1 ttmt -118.68 112.84 36.66 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 109.292 -0.632 . . . . 71.010000000000005 109.292 168.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 17.2 Cg_exo -62.65 126.2 17.76 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.057 1.838 . . . . 63.240000000000002 110.229 168.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.76 -27.45 69.29 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.715 0.806 . . . . 71.540000000000006 111.7 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.76 -27.13 66.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.41 1.084 . . . . 75.209999999999994 111.868 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 34' ' ' GLU . 71.6 t -106.72 128.0 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.964 0.906 . . . . 72.329999999999998 111.823 -169.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -127.9 5.01 5.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.53 1.132 . . . . 61.200000000000003 110.839 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -132.48 157.79 43.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.477 0.711 . . . . 71.239999999999995 110.53 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 68.9 ttt180 -64.13 -42.92 96.62 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.769 0.827 . . . . 65.010000000000005 111.101 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.54 -38.88 92.53 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.867 0.73 . . . . 75.140000000000001 111.148 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HB2' HG13 ' A' ' 29' ' ' VAL . 41.0 mt-10 -64.94 -34.02 77.42 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 124.117 0.886 . . . . 72.310000000000002 110.448 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.497 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -82.08 -26.39 33.69 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.098 0.959 . . . . 52.329999999999998 111.537 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 t -82.06 -23.81 35.62 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.907 0.883 . . . . 61.109999999999999 110.931 -172.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.73 1.29 39.46 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.59 0.356 . . . . 75.420000000000002 110.834 170.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 75.7 mt -102.22 11.88 37.54 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.431 0.693 . . . . 54.530000000000001 111.343 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.543 HD11 HG13 ' A' ' 60' ' ' VAL . 49.9 mm -73.99 130.82 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 109.49 -0.559 . . . . 62.219999999999999 109.49 174.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.23 1.39 75.55 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.029 -0.532 . . . . 65.400000000000006 112.532 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.581 ' HG3' ' HA ' ' A' ' 88' ' ' LEU . 5.6 mpt_? -81.64 138.58 35.29 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.079 0.552 . . . . 74.439999999999998 109.98 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 55' ' ' GLY . 67.2 tp -90.37 113.56 25.47 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.63 -0.878 . . . . 74.120000000000005 108.63 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 t -98.09 116.05 39.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 123.427 0.691 . . . . 64.450000000000003 109.254 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.3 mt -102.01 129.19 48.24 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.464 1.106 . . . . 62.219999999999999 108.549 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -142.38 127.38 18.4 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.14 0.576 . . . . 74.019999999999996 109.484 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -89.76 115.24 26.97 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.123 -0.695 . . . . 74.519999999999996 109.123 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -64.71 158.45 68.5 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.823 0.849 . . . . 75.519999999999996 111.006 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -59.33 -20.17 54.38 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.465 2.776 . . . . 61.130000000000003 113.432 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.6 m -75.15 -3.28 31.93 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.89 0.876 . . . . 64.430000000000007 112.234 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.87 9.76 80.23 Favored Glycine 0 C--N 1.353 1.525 0 C-N-CA 123.069 0.366 . . . . 51.130000000000003 112.936 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -96.16 132.16 41.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.583 0.753 . . . . 74.310000000000002 110.001 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.1 mt -85.55 101.87 10.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-O 121.3 0.571 . . . . 72.099999999999994 109.613 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 75' ' ' LEU . 13.5 mt -80.97 128.49 33.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.462 -0.79 . . . . 71.099999999999994 108.879 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -117.43 132.47 56.56 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.106 0.963 . . . . 54.530000000000001 109.123 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -154.95 -177.79 28.6 Favored Glycine 0 C--N 1.336 0.55 0 O-C-N 123.635 0.584 . . . . 52.43 112.177 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -151.77 136.67 17.23 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.115 0.413 . . . . 74.420000000000002 112.115 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 39' ' ' ILE . 64.7 mt -67.94 103.62 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.935 0.894 . . . . 74.150000000000006 109.568 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.27 -30.83 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.532 -0.758 . . . . 73.450000000000003 111.547 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -163.95 160.45 21.98 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.62 0.768 . . . . 71.439999999999998 109.254 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.543 HG13 HD11 ' A' ' 39' ' ' ILE . 20.2 m -101.18 170.48 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.847 0.859 . . . . 73.010000000000005 111.065 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -131.3 103.14 6.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.06 0.944 . . . . 75.400000000000006 109.021 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.66 -166.85 26.08 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.74 -0.664 . . . . 72.25 114.452 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.429 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 75.7 p -90.77 8.56 34.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.382 1.073 . . . . 65.439999999999998 111.333 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -79.84 -2.72 44.71 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.871 0.869 . . . . 72.420000000000002 111.783 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.24 -4.89 61.23 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-O 120.103 -0.276 . . . . 52.530000000000001 113.645 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.96 112.28 5.51 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 123.429 0.692 . . . . 73.349999999999994 109.635 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 m -100.19 143.77 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.04 0.936 . . . . 75.109999999999999 109.153 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -101.72 103.07 13.82 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.322 -0.992 . . . . 63.329999999999998 108.322 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.82 120.28 41.58 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.556 0.742 . . . . 74.019999999999996 109.935 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -88.8 106.31 18.29 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.973 0.509 . . . . 73.340000000000003 109.699 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -88.15 120.99 30.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.632 -0.877 . . . . 74.140000000000001 108.632 170.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.42 -20.71 60.66 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.134 0.492 . . . . 70.219999999999999 109.876 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -76.68 -77.64 0.14 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.641 0.777 . . . . 73.430000000000007 109.197 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.1 45.01 63.42 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.646 0.591 . . . . 53.109999999999999 114.395 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.44 ' HB2' HD21 ' A' ' 53' ' ' LEU . 81.7 mt -73.15 157.08 88.88 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.759 0.824 . . . . 74.420000000000002 111.195 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.08 124.08 14.51 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 123.402 2.735 . . . . 75.439999999999998 113.273 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.09 87.74 0.08 OUTLIER Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.776 -1.33 . . . . 74.349999999999994 109.776 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -73.92 71.43 1.54 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.092 0.957 . . . . 65.209999999999994 109.846 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.05 29.01 8.16 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.445 1.098 . . . . 75.019999999999996 110.685 -169.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 mt -52.46 118.46 3.6 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.5 0.72 . . . . 64.25 110.378 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.07 -10.51 15.17 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 112.01 -0.436 . . . . 63.130000000000003 112.01 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -77.23 169.56 18.11 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.876 0.87 . . . . 70.439999999999998 109.678 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 63.0 m-85 -112.26 127.47 55.98 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.639 0.376 . . . . 75.430000000000007 111.952 -170.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 24' ' ' ILE . 15.2 m -100.38 162.72 3.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-N 115.171 -0.922 . . . . 72.0 109.824 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -111.62 108.99 18.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.905 0.882 . . . . 74.140000000000001 108.681 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.1 mt -92.18 92.9 3.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.1 -1.074 . . . . 72.049999999999997 108.1 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.81 134.03 27.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.082 -0.963 . . . . 64.439999999999998 109.09 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.581 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 4.4 mm? . . . . . 0 C--O 1.241 0.615 0 C-N-CA 123.751 0.82 . . . . 62.549999999999997 110.608 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.751 0.31 . . . . 64.140000000000001 110.364 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 40.1 mt -132.57 128.83 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.686 -1.227 . . . . 73.140000000000001 107.686 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -87.79 128.18 35.33 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.941 -0.763 . . . . 74.010000000000005 108.941 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 25' ' ' LYS . . . -124.74 142.44 13.94 Favored Glycine 0 C--N 1.34 0.799 0 O-C-N 123.914 0.759 . . . . 60.200000000000003 111.486 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -92.76 131.04 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.511 0.655 . . . . 72.409999999999997 109.906 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.8 97.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.951 0.9 . . . . 63.32 109.251 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.478 HD21 ' HE2' ' A' ' 25' ' ' LYS . 81.5 mt -77.34 -53.45 7.67 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.673 -0.492 . . . . 71.299999999999997 109.673 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -165.11 179.19 6.49 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.847 0.356 . . . . 60.509999999999998 111.411 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -129.96 134.8 47.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.793 1.237 . . . . 73.430000000000007 108.298 174.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.407 ' HD3' HD11 ' A' ' 23' ' ' ILE . 2.6 mpt_? . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.072 -1.455 . . . . 73.310000000000002 107.072 163.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 110.001 -0.37 . . . . 62.340000000000003 110.001 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 70' ' ' ARG . 42.6 t -87.77 144.13 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.696 0.799 . . . . 55.149999999999999 109.56 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.6 ttt -131.15 117.16 18.68 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.168 -1.049 . . . . 71.120000000000005 108.168 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.459 HG22 HD12 ' A' ' 8' ' ' LEU . 28.0 mm -77.29 111.44 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.625 -0.879 . . . . 71.540000000000006 108.625 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.1 mt -112.74 145.6 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.403 1.081 . . . . 70.409999999999997 109.302 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HE2' HD21 ' A' ' 8' ' ' LEU . 22.6 ttmm -111.65 87.55 8.29 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.347 1.059 . . . . 72.030000000000001 109.012 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' HG22 ' A' ' 67' ' ' VAL . 32.2 Cg_endo -62.23 107.48 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.95 1.767 . . . . 73.030000000000001 110.212 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.13 -32.48 73.87 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.507 1.123 . . . . 62.420000000000002 112.073 -174.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.89 -26.11 68.63 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.335 1.054 . . . . 64.329999999999998 111.464 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.496 HG13 ' HB2' ' A' ' 34' ' ' GLU . 66.2 t -112.43 137.57 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 125.195 1.398 . . . . 72.540000000000006 111.489 -171.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -134.84 8.66 3.55 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.657 1.183 . . . . 72.010000000000005 110.504 170.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.5 m -124.37 147.27 48.34 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.773 0.829 . . . . 62.43 110.609 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.486 ' HD2' HG22 ' A' ' 63' ' ' THR . 71.2 ttt180 -67.81 -34.02 75.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.691 0.796 . . . . 75.329999999999998 111.193 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -67.1 -43.0 83.64 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.485 0.714 . . . . 62.140000000000001 110.485 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.496 ' HB2' HG13 ' A' ' 29' ' ' VAL . 27.2 mm-40 -72.77 -22.91 60.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.165 -0.925 . . . . 72.310000000000002 110.961 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.96 -32.58 30.67 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.554 0.742 . . . . 71.349999999999994 110.165 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.0 t -75.71 -24.47 56.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.573 0.749 . . . . 71.109999999999999 111.385 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -81.39 -2.29 48.79 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 122.311 -0.243 . . . . 71.420000000000002 111.224 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.402 HD12 HG11 ' A' ' 67' ' ' VAL . 53.3 mt -88.68 -12.15 43.21 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 123.331 0.652 . . . . 72.030000000000001 111.185 175.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.624 HD11 HG13 ' A' ' 60' ' ' VAL . 42.1 mm -65.79 104.57 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.084 0 C-N-CA 123.183 0.593 . . . . 75.310000000000002 110.174 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.13 -6.34 10.95 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.447 -0.641 . . . . 63.420000000000002 112.93 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -84.11 155.32 22.69 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 117.756 0.778 . . . . 75.430000000000007 111.257 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 54' ' ' LYS . 58.8 tp -93.14 117.26 29.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.49 1.116 . . . . 65.409999999999997 109.983 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.34 135.33 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.359 -0.608 . . . . 61.32 109.359 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.7 mt -118.37 105.15 11.42 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.392 1.077 . . . . 73.340000000000003 108.128 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 44.8 t90 -110.23 128.4 55.48 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.644 -0.873 . . . . 53.399999999999999 108.644 171.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -98.25 117.43 32.62 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.674 -0.861 . . . . 64.239999999999995 108.674 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.3 p -74.56 162.36 73.99 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 124.024 0.93 . . . . 74.540000000000006 111.29 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.19 -14.55 45.75 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.973 2.448 . . . . 75.239999999999995 112.465 171.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -73.3 -19.38 61.05 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.707 1.203 . . . . 53.409999999999997 111.879 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.06 5.33 60.9 Favored Glycine 0 C--N 1.356 1.693 0 C-N-CA 123.437 0.542 . . . . 70.200000000000003 112.733 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -94.24 118.32 31.41 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.88 0.872 . . . . 62.420000000000002 109.817 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.85 97.2 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.017 -1.105 . . . . 72.230000000000004 108.017 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 mt -73.64 123.2 23.57 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.958 -1.127 . . . . 73.439999999999998 107.958 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.552 ' HB3' HD11 ' A' ' 42' ' ' LEU . 31.0 mtmm -104.26 140.53 37.73 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.32 -0.622 . . . . 72.049999999999997 109.32 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.93 173.42 25.42 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 116.207 -0.451 . . . . 75.329999999999998 112.112 -178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -127.57 131.77 49.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.071 -0.715 . . . . 72.400000000000006 109.071 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.563 HG22 HD13 ' A' ' 39' ' ' ILE . 62.8 mt -67.61 99.89 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 108.499 -0.926 . . . . 71.340000000000003 108.499 171.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.76 -34.31 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 115.256 -0.883 . . . . 73.420000000000002 111.24 -176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -154.2 157.11 38.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.786 -0.82 . . . . 71.049999999999997 108.786 -173.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.624 HG13 HD11 ' A' ' 39' ' ' ILE . 27.2 m -91.71 168.82 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.659 0.784 . . . . 74.519999999999996 110.05 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 68' ' ' ARG . 82.9 t60 -132.81 103.28 6.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.964 -1.125 . . . . 73.329999999999998 107.964 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.2 -162.76 49.0 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.379 -0.373 . . . . 53.310000000000002 113.181 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.486 HG22 ' HD2' ' A' ' 32' ' ' ARG . 73.5 p -110.96 -24.01 10.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.591 0.756 . . . . 64.329999999999998 112.18 -172.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -91.83 46.7 1.29 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.803 0.668 . . . . 63.219999999999999 112.803 -170.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA2' HG12 ' A' ' 29' ' ' VAL . . . 68.74 55.75 10.87 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.771 -0.65 . . . . 62.399999999999999 114.056 170.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.39 141.99 49.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.214 -1.032 . . . . 64.310000000000002 108.214 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 26' ' ' PRO . 22.1 m -130.85 171.94 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.141 0.977 . . . . 71.230000000000004 109.894 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HG3' ' HB2' ' A' ' 61' ' ' HIS . 73.0 mtm180 -134.35 109.1 8.57 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.218 1.007 . . . . 71.340000000000003 109.091 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.89 127.25 53.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.257 -0.883 . . . . 52.32 110.278 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HG2' HG22 ' A' ' 21' ' ' VAL . 33.8 mtm180 -90.27 110.06 21.13 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.254 -0.647 . . . . 75.239999999999995 109.254 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.29 142.11 29.6 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.236 1.014 . . . . 71.040000000000006 110.173 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.526 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 11.0 pt-20 -50.04 -45.36 52.13 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.568 1.547 . . . . 73.099999999999994 111.885 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.526 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 32.8 mmtp -96.48 -46.94 6.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.371 -0.831 . . . . 74.420000000000002 108.854 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.6 45.69 92.93 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 124.589 1.181 . . . . 50.200000000000003 112.87 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.0 140.58 86.0 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.147 0.579 . . . . 54.219999999999999 110.696 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.16 123.93 13.04 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.153 2.569 . . . . 73.299999999999997 111.88 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -110.65 131.91 10.66 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.934 -0.575 . . . . 70.439999999999998 111.94 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -83.24 3.9 29.21 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.038 0.935 . . . . 70.230000000000004 110.297 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -94.43 29.86 2.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.693 1.197 . . . . 71.450000000000003 112.014 -177.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.7 mt -53.11 108.68 0.35 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 122.7 0.4 . . . . 73.049999999999997 110.54 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.58 -10.63 7.59 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 123.836 0.731 . . . . 72.450000000000003 112.53 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.91 163.58 27.74 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.309 1.044 . . . . 72.239999999999995 111.64 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -96.71 124.63 40.75 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.526 0.73 . . . . 74.439999999999998 110.64 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 m -99.67 149.11 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.872 1.269 . . . . 72.109999999999999 107.748 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -108.73 107.36 17.78 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.839 -0.801 . . . . 72.420000000000002 108.839 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 53.6 mt -89.57 90.9 3.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.097 -1.446 . . . . 73.340000000000003 107.097 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.69 150.68 3.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 114.816 -1.084 . . . . 75.129999999999995 109.079 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.472 0.658 0 C-N-CA 123.22 0.608 . . . . 64.120000000000005 110.854 174.793 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.638 ' HG2' HG22 ' A' ' 87' ' ' VAL . 61.4 mtt180 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 107.256 -1.387 . . . . 63.119999999999997 107.256 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.479 HD12 HH11 ' A' ' 41' ' ' ARG . 61.5 mt -109.29 128.75 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.07 -1.085 . . . . 54.530000000000001 108.07 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -86.73 121.47 29.28 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.146 -0.687 . . . . 70.209999999999994 109.146 -170.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -127.44 169.63 19.22 Favored Glycine 0 C--N 1.341 0.847 0 O-C-N 124.003 0.814 . . . . 74.310000000000002 111.66 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.1 t -133.27 133.69 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.262 1.025 . . . . 53.310000000000002 109.167 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.97 102.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.539 0.736 . . . . 72.439999999999998 109.846 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 25' ' ' LYS . 86.7 mt -70.85 -53.86 13.65 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.688 -0.687 . . . . 73.510000000000005 109.471 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 t -158.61 168.83 25.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.759 -0.655 . . . . 71.340000000000003 111.113 -176.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.403 ' HB3' HD21 ' A' ' 20' ' ' ASN . 54.2 m-85 -107.74 142.97 36.93 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.289 1.036 . . . . 73.0 108.752 172.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 . . . . . 0 C--O 1.22 -0.493 0 N-CA-C 107.205 -1.406 . . . . 73.129999999999995 107.205 169.632 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.527 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 21.7 t-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.288 -0.634 . . . . 71.129999999999995 109.288 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 70' ' ' ARG . 22.0 t -89.27 104.68 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 106.451 -1.685 . . . . 74.340000000000003 106.451 172.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 47.7 ttm -93.27 130.15 39.09 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 122.681 0.392 . . . . 73.510000000000005 110.758 -171.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.455 HG22 HD12 ' A' ' 8' ' ' LEU . 32.9 mm -81.04 102.18 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.448 -0.945 . . . . 71.400000000000006 108.448 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -109.07 147.25 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.281 1.032 . . . . 62.25 109.009 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HB2' HD11 ' A' ' 8' ' ' LEU . 39.5 ttmt -118.35 102.37 50.41 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 108.622 -0.881 . . . . 65.299999999999997 108.622 167.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 18.1 Cg_endo -61.96 111.27 1.18 Allowed 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 121.545 1.497 . . . . 75.540000000000006 109.287 167.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.4 mt -55.39 -32.09 62.36 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.221 1.008 . . . . 54.329999999999998 112.266 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.14 -30.12 68.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.131 0.972 . . . . 61.32 111.718 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 34' ' ' GLU . 93.6 t -107.1 117.89 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.195 0.998 . . . . 74.420000000000002 110.13 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -121.19 4.63 10.33 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.36 0.664 . . . . 54.109999999999999 111.522 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.516 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 6.0 m -130.24 145.36 51.74 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.272 0.629 . . . . 70.209999999999994 109.69 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.666 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 73.3 ttt180 -59.09 -46.65 87.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.769 0.827 . . . . 64.519999999999996 111.302 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.25 -39.97 84.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 123.924 0.765 . . . . 73.209999999999994 111.719 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HB2' HG13 ' A' ' 29' ' ' VAL . 47.4 mt-10 -59.99 -49.79 76.29 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.172 0.92 . . . . 64.439999999999998 109.647 176.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -71.53 -24.02 61.88 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.128 0.971 . . . . 74.329999999999998 111.947 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -73.29 -39.19 65.53 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.749 0.82 . . . . 71.25 110.68 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -77.74 -10.36 59.49 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.412 -0.358 . . . . 71.109999999999999 110.976 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.61 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 55.6 mt -97.74 26.71 4.87 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.486 1.115 . . . . 73.400000000000006 111.625 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.663 HD11 HG13 ' A' ' 60' ' ' VAL . 45.2 mm -85.76 135.98 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 109.191 -0.67 . . . . 71.319999999999993 109.191 172.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.55 -7.24 39.25 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.579 -0.567 . . . . 75.310000000000002 113.517 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.61 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 16.5 ptt180 -80.59 154.17 27.6 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.223 0.511 . . . . 72.209999999999994 110.372 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 54' ' ' LYS . 60.8 tp -90.93 146.59 23.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.127 0.971 . . . . 75.120000000000005 109.408 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.548 HG22 HG23 ' A' ' 86' ' ' ILE . 47.4 t -122.19 125.82 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.851 0.86 . . . . 71.519999999999996 109.279 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.0 mt -103.79 100.26 10.06 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.855 -0.795 . . . . 74.519999999999996 108.855 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.432 ' HE1' ' HB3' ' A' ' 82' ' ' ASP . 32.7 t90 -104.52 147.95 27.03 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.934 0.894 . . . . 75.420000000000002 109.439 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -99.63 109.05 21.57 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.348 -0.982 . . . . 74.099999999999994 108.348 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.4 p -68.93 154.13 95.31 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.805 0.842 . . . . 73.420000000000002 111.045 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HG3' ' HB2' ' A' ' 79' ' ' ALA . 46.2 Cg_exo -59.98 -13.29 22.33 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.391 2.727 . . . . 74.349999999999994 113.506 172.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -81.37 -5.01 57.41 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.782 0.833 . . . . 71.439999999999998 111.606 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.08 -10.56 71.72 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-O 119.986 -0.341 . . . . 51.43 113.429 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -82.35 154.46 25.26 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.657 0.783 . . . . 62.310000000000002 110.373 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -102.29 103.64 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.383 -0.969 . . . . 71.239999999999995 108.383 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 74' ' ' GLY . 56.7 mt -82.43 153.41 25.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.367 -0.833 . . . . 73.420000000000002 110.892 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HB3' HD11 ' A' ' 42' ' ' LEU . 59.0 mtpt -117.03 117.0 28.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.529 -1.214 . . . . 34.25 108.02 -176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -128.2 132.82 7.5 Favored Glycine 0 CA--C 1.503 -0.672 0 N-CA-C 111.549 -0.62 . . . . 73.019999999999996 111.549 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -101.66 128.18 48.07 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 117.439 0.62 . . . . 74.450000000000003 109.86 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.411 HD12 ' HG3' ' A' ' 41' ' ' ARG . 78.9 mt -66.8 106.94 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 124.211 0.944 . . . . 71.310000000000002 109.373 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -84.31 -30.3 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.032 0.933 . . . . 71.219999999999999 111.162 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -168.4 167.27 11.98 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.126 0.571 . . . . 75.120000000000005 110.209 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.663 HG13 HD11 ' A' ' 39' ' ' ILE . 23.9 m -91.37 169.96 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.322 1.049 . . . . 50.240000000000002 111.292 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -141.57 105.56 4.77 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.84 1.256 . . . . 70.239999999999995 108.558 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.22 173.52 49.74 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.729 -0.214 . . . . 64.340000000000003 112.64 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.666 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 63.2 p -93.0 6.93 46.16 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.707 0.803 . . . . 74.319999999999993 111.372 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -93.67 14.96 17.46 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.185 0.994 . . . . 75.140000000000001 111.874 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.18 -4.65 70.5 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-O 119.722 -0.488 . . . . 65.200000000000003 113.959 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.97 143.89 55.42 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.379 0.672 . . . . 70.129999999999995 110.332 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 60' ' ' VAL . 14.0 m -126.49 169.91 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.678 1.191 . . . . 72.340000000000003 110.989 -175.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -128.13 107.64 9.97 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.221 1.008 . . . . 74.25 109.327 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.5 125.86 51.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.787 0.835 . . . . 44.409999999999997 110.141 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.555 ' HG2' HG22 ' A' ' 21' ' ' VAL . 88.3 mtt180 -89.0 104.51 17.05 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.246 -0.65 . . . . 70.299999999999997 109.246 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.77 135.42 34.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.013 0.925 . . . . 73.540000000000006 109.173 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -31.16 62.69 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.408 1.083 . . . . 64.230000000000004 112.075 -174.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -107.44 -63.11 1.34 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.082 0.953 . . . . 72.409999999999997 109.357 173.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 67.57 56.9 9.96 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.206 -0.907 . . . . 23.129999999999999 111.421 -171.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 97.0 mt -68.36 132.78 91.35 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.25 1.02 . . . . 72.109999999999999 111.257 -170.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 3.9 Cg_exo -76.48 176.35 10.19 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 123.216 2.611 . . . . 74.409999999999997 112.979 -170.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.02 177.69 15.03 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.766 -0.652 . . . . 72.430000000000007 111.595 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.8 76.46 7.98 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.894 0.854 . . . . 74.549999999999997 109.567 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . . . -119.75 28.03 8.37 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.982 -1.008 . . . . 73.25 110.201 172.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.08 109.14 4.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.343 -0.614 . . . . 73.120000000000005 109.343 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.15 -5.86 21.72 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-O 119.649 -0.529 . . . . 72.420000000000002 112.331 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 13.2 t70 -67.05 143.42 56.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.504 0.722 . . . . 71.530000000000001 110.074 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -93.69 123.99 37.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.693 0.797 . . . . 74.299999999999997 110.87 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 m -100.69 144.04 13.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.472 -0.785 . . . . 72.439999999999998 109.065 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.95 108.04 19.01 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.426 -0.953 . . . . 74.420000000000002 108.426 170.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.548 HG23 HG22 ' A' ' 43' ' ' VAL . 38.8 mt -89.04 97.97 7.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 115.067 -0.969 . . . . 73.099999999999994 108.858 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.638 HG22 ' HG2' ' A' ' 2' ' ' ARG . 13.0 t -89.89 131.39 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.675 -0.693 . . . . 74.420000000000002 110.316 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 106.822 -1.547 . . . . 72.450000000000003 106.822 172.553 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.429 ' HG2' ' HB3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.074 -0.713 . . . . 70.019999999999996 109.074 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 56.6 mt -105.55 128.95 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.739 -1.208 . . . . 73.120000000000005 107.739 170.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -88.65 124.27 33.92 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.165 0.507 . . . . 72.230000000000004 110.009 -174.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -121.54 135.23 10.42 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.702 -0.681 . . . . 75.230000000000004 111.876 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.7 t -90.22 132.82 33.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 117.737 0.769 . . . . 74.549999999999997 109.988 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.85 103.06 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.721 0 O-C-N 124.504 1.127 . . . . 71.140000000000001 109.482 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 25' ' ' LYS . 71.8 mt -78.32 -56.09 4.73 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.547 0.529 . . . . 75.420000000000002 109.776 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 m -152.85 170.21 20.9 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.453 0.644 . . . . 71.349999999999994 111.712 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -117.81 147.46 43.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.589 1.156 . . . . 71.530000000000001 108.152 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 65.7 ttt180 . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 110.103 -0.332 . . . . 74.420000000000002 110.103 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 110.221 -0.289 . . . . 73.219999999999999 110.221 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 50.3 t -102.5 152.33 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.31 1.044 . . . . 72.239999999999995 108.867 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.1 ttt -150.04 129.78 13.24 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.399 -0.593 . . . . 73.400000000000006 109.399 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.431 HG22 ' HB2' ' A' ' 8' ' ' LEU . 49.6 mm -93.41 111.53 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.132 0.973 . . . . 63.140000000000001 109.363 -177.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.7 mt -125.71 149.3 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.087 0.955 . . . . 55.130000000000003 108.769 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.527 ' HB2' HD11 ' A' ' 8' ' ' LEU . 36.5 ttpt -133.19 116.83 14.44 Favored Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 109.994 -0.373 . . . . 74.030000000000001 109.994 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.7 Cg_exo -68.3 125.96 13.64 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 122.535 2.157 . . . . 61.030000000000001 110.528 173.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.6 mt -70.64 -30.25 66.83 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.86 0.464 . . . . 70.319999999999993 111.555 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.47 -19.11 62.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.365 0.666 . . . . 74.230000000000004 111.067 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.64 HG13 ' HB2' ' A' ' 34' ' ' GLU . 49.1 t -108.96 147.62 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.709 1.204 . . . . 63.439999999999998 109.678 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.04 -0.69 0.88 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.368 0.667 . . . . 73.140000000000001 112.358 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 m -128.04 147.39 50.51 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.575 0.75 . . . . 72.140000000000001 110.509 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 68.8 ttt180 -64.35 -34.62 78.58 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.474 0.71 . . . . 72.109999999999999 112.139 -176.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.11 -39.23 78.15 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.455 0.702 . . . . 75.25 111.49 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.64 ' HB2' HG13 ' A' ' 29' ' ' VAL . 29.5 mt-10 -69.88 -45.24 68.11 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.001 -0.999 . . . . 73.420000000000002 109.977 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.81 -30.08 69.85 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.044 0.538 . . . . 64.230000000000004 111.227 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 t -75.23 -30.5 60.57 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.099 0.96 . . . . 75.549999999999997 111.626 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -1.27 56.2 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 120.293 0.092 . . . . 73.010000000000005 111.157 173.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 34' ' ' GLU . 73.6 mt -91.76 -9.26 44.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.121 0.568 . . . . 52.329999999999998 111.632 174.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.527 HD13 HG22 ' A' ' 57' ' ' ILE . 42.8 mm -63.11 119.65 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 123.439 0.462 . . . . 73.549999999999997 110.306 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.35 -0.71 46.72 Favored Glycine 0 N--CA 1.466 0.673 0 CA-C-O 119.716 -0.491 . . . . 70.319999999999993 113.167 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -88.93 160.81 16.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.382 0.591 . . . . 61.549999999999997 111.053 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 55' ' ' GLY . 36.5 tp -90.28 144.37 25.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.998 -1.001 . . . . 64.299999999999997 109.794 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.9 t -124.96 115.75 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.922 0.889 . . . . 72.140000000000001 108.668 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.07 105.9 16.31 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.902 -0.777 . . . . 72.319999999999993 108.902 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.442 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 36.1 t90 -109.06 143.18 38.73 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.033 -0.729 . . . . 73.329999999999998 109.033 175.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -97.97 118.99 35.8 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.811 -0.811 . . . . 74.329999999999998 108.811 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.0 p -78.98 153.38 77.55 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.106 0.562 . . . . 65.450000000000003 109.83 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.84 -7.84 19.64 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.788 2.325 . . . . 73.420000000000002 112.434 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -71.25 -17.51 62.48 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 124.568 1.147 . . . . 70.010000000000005 110.983 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.58 16.23 46.81 Favored Glycine 0 C--N 1.356 1.666 0 C-N-CA 123.042 0.353 . . . . 45.43 113.131 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -109.85 149.32 30.03 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.709 0.804 . . . . 74.530000000000001 109.892 -176.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -93.75 98.51 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.617 -1.253 . . . . 61.140000000000001 107.617 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.442 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 54.6 mt -78.2 125.96 30.11 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.269 -0.641 . . . . 70.239999999999995 109.269 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -96.46 127.52 42.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.388 -0.823 . . . . 64.329999999999998 109.335 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -127.08 177.57 17.31 Favored Glycine 0 CA--C 1.504 -0.649 0 CA-C-N 114.862 -1.063 . . . . 41.25 110.738 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -149.38 135.28 18.82 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.7 -0.482 . . . . 62.240000000000002 109.7 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.527 HG22 HD13 ' A' ' 39' ' ' ILE . 78.5 mt -67.96 95.71 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 O-C-N 124.531 1.144 . . . . 74.25 108.826 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.41 -24.8 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.291 -0.868 . . . . 65.129999999999995 110.688 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -150.99 164.13 37.13 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.846 -0.616 . . . . 64.239999999999995 109.454 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 39' ' ' ILE . 32.9 m -92.09 168.39 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.778 -0.823 . . . . 64.109999999999999 108.778 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -142.05 103.65 4.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.834 -0.802 . . . . 75.420000000000002 108.834 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.91 -171.4 45.31 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 115.477 -0.783 . . . . 54.130000000000003 113.551 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 51.7 p -94.67 0.12 54.81 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.944 0.897 . . . . 64.120000000000005 111.43 176.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -81.12 2.04 29.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.457 1.103 . . . . 70.349999999999994 111.784 -173.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.494 ' HA3' HG12 ' A' ' 29' ' ' VAL . . . 78.44 6.74 88.06 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.261 0.351 . . . . 55.350000000000001 113.074 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.95 147.89 48.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.032 0.533 . . . . 54.43 110.138 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.452 ' HB ' HG23 ' A' ' 57' ' ' ILE . 30.5 m -121.69 140.53 45.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.678 0.791 . . . . 71.109999999999999 110.77 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -98.75 104.48 16.53 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.085 -1.08 . . . . 74.310000000000002 108.085 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.7 126.32 52.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.505 0.722 . . . . 70.239999999999995 110.147 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -101.56 126.14 48.32 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.854 0.462 . . . . 74.219999999999999 110.105 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.523 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 11.0 m-85 -93.37 126.34 38.45 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.025 0.93 . . . . 72.140000000000001 110.398 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 12.1 pt-20 -61.23 -28.83 69.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.273 1.029 . . . . 74.200000000000003 111.827 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.484 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 14.4 mmmm -101.07 -68.23 0.82 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.76 -0.83 . . . . 74.409999999999997 108.76 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.04 56.43 18.41 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.832 -0.622 . . . . 64.409999999999997 112.805 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.402 HD12 HD21 ' A' ' 53' ' ' LEU . 71.9 mt -68.7 156.55 90.72 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.7 0.8 . . . . 72.219999999999999 110.913 173.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.28 139.23 81.99 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.921 2.414 . . . . 45.439999999999998 112.695 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.72 140.62 2.96 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.633 -0.712 . . . . 74.010000000000005 112.207 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -121.11 97.09 5.36 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.919 0.888 . . . . 74.409999999999997 109.375 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.16 30.14 7.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.767 1.227 . . . . 62.109999999999999 110.899 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.4 mt -45.27 113.65 0.61 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.695 0.798 . . . . 62.32 112.242 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.41 -15.55 20.08 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-N 116.419 -0.355 . . . . 70.519999999999996 113.288 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.88 158.97 31.44 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.163 0.985 . . . . 65.040000000000006 111.908 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -100.83 127.3 47.34 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.806 0.842 . . . . 75.25 110.862 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 m -100.42 158.6 3.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 108.739 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 2' ' ' ARG . 35.3 mt-10 -103.96 108.13 19.33 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.99 0.516 . . . . 63.020000000000003 109.869 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 74.7 mt -86.68 94.11 4.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.612 -1.255 . . . . 61.140000000000001 107.612 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.418 HG22 ' HG3' ' A' ' 2' ' ' ARG . 31.5 t -89.63 137.31 21.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 114.633 -1.167 . . . . 52.25 109.164 -177.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 107.201 -1.407 . . . . 63.32 107.201 169.62 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HG2' HG22 ' A' ' 87' ' ' VAL . 82.3 mtm180 . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 108.405 -0.961 . . . . 74.349999999999994 108.405 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.446 HD12 HH11 ' A' ' 41' ' ' ARG . 61.3 mt -95.65 136.4 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.483 -0.932 . . . . 64.230000000000004 108.483 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -88.36 126.82 35.39 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.214 0.605 . . . . 74.200000000000003 109.749 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -129.95 175.49 19.11 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 123.624 0.578 . . . . 64.200000000000003 112.115 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.4 t -140.13 132.03 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.528 1.131 . . . . 65.430000000000007 109.627 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.83 107.4 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.131 0.973 . . . . 72.129999999999995 110.308 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 23' ' ' ILE . 86.6 mt -79.99 -55.27 5.08 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.36 0.664 . . . . 73.040000000000006 110.004 176.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 p -158.71 173.25 16.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.616 -0.72 . . . . 62.229999999999997 111.254 -173.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.89 159.72 27.61 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.632 0.773 . . . . 63.329999999999998 109.058 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 . . . . . 0 C--O 1.242 0.686 0 N-CA-C 107.462 -1.31 . . . . 63.219999999999999 107.462 161.692 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.592 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 36.1 t30 . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.47 0.176 . . . . 72.340000000000003 111.237 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.574 HG13 ' HG3' ' A' ' 68' ' ' ARG . 90.3 t -88.28 134.02 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 122.974 0.51 . . . . 44.240000000000002 109.658 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 43.1 ttm -130.85 112.88 13.41 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.23 -1.396 . . . . 75.510000000000005 107.23 170.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 8' ' ' LEU . 50.8 mm -78.52 111.71 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.079 -1.082 . . . . 63.509999999999998 108.079 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.51 HD13 HG21 ' A' ' 84' ' ' VAL . 84.6 mt -109.98 137.48 42.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 C-N-CA 124.221 1.008 . . . . 74.450000000000003 109.427 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB2' HD11 ' A' ' 8' ' ' LEU . 81.9 tttt -96.96 104.0 17.09 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.624 -0.88 . . . . 75.129999999999995 108.624 166.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 3.3 Cg_exo -68.68 112.27 2.82 Favored 'Trans proline' 0 C--N 1.369 1.622 0 N-CA-C 107.802 -1.653 . . . . 72.209999999999994 107.802 168.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.66 -27.27 69.11 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.588 0.755 . . . . 62.0 112.576 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.43 -28.31 64.95 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.606 0.762 . . . . 71.209999999999994 111.238 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 34' ' ' GLU . 88.7 t -98.5 145.61 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.98 1.312 . . . . 74.340000000000003 109.785 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -158.12 33.0 0.25 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.272 0.558 . . . . 55.240000000000002 109.734 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.5 m -150.19 141.22 22.97 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.403 0.681 . . . . 73.010000000000005 110.116 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.649 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 59.2 ttt180 -62.71 -32.65 73.79 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.353 0.661 . . . . 70.420000000000002 110.971 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -52.15 -51.81 55.62 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.93 0.769 . . . . 70.310000000000002 110.271 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.454 ' HB2' HG13 ' A' ' 29' ' ' VAL . 44.0 mt-10 -60.24 -52.49 65.06 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 114.577 -1.192 . . . . 74.209999999999994 110.361 177.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.12 70.56 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.666 0.787 . . . . 62.140000000000001 112.193 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.5 t -76.91 -28.62 55.37 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.9 0.88 . . . . 61.25 111.321 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -94.3 2.52 55.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.733 0.413 . . . . 75.239999999999995 110.922 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.561 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 46.6 mt -113.11 24.2 12.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.473 1.109 . . . . 75.150000000000006 110.678 175.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.76 132.13 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.938 -0.764 . . . . 72.120000000000005 108.938 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.02 -14.74 19.09 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.866 -0.408 . . . . 75.230000000000004 113.333 171.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.561 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 15.1 ptt180 -75.62 155.77 35.55 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.143 0.471 . . . . 73.310000000000002 110.449 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 55' ' ' GLY . 24.8 tp -89.78 154.34 19.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.144 0.977 . . . . 64.140000000000001 109.959 -173.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 86' ' ' ILE . 36.4 t -132.73 144.39 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.331 1.052 . . . . 64.129999999999995 108.418 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -127.53 117.99 23.12 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.7 -0.852 . . . . 75.409999999999997 108.7 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -130.3 132.36 45.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.64 0.776 . . . . 73.040000000000006 109.385 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -83.8 118.88 24.22 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.972 -0.751 . . . . 61.149999999999999 108.972 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.7 p -66.8 163.13 45.84 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.808 0.843 . . . . 61.310000000000002 111.437 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.36 -13.3 37.5 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.282 1.988 . . . . 64.549999999999997 112.123 167.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -85.2 -8.8 58.41 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.251 1.02 . . . . 64.439999999999998 110.878 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.56 -21.12 47.55 Favored Glycine 0 C--N 1.352 1.434 0 C-N-CA 123.013 0.339 . . . . 62.299999999999997 113.593 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -76.59 132.36 39.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.516 0.727 . . . . 44.25 111.049 -176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -78.33 102.15 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.936 -0.764 . . . . 74.120000000000005 108.936 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.51 135.43 39.32 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.038 -0.983 . . . . 74.030000000000001 109.862 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -96.31 133.52 40.56 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.971 -0.751 . . . . 72.400000000000006 108.971 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -131.25 169.84 21.61 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 110.821 -0.912 . . . . 53.32 110.821 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -145.15 134.86 23.46 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.171 -0.677 . . . . 73.310000000000002 109.171 177.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.512 HD12 ' HG3' ' A' ' 41' ' ' ARG . 93.7 mt -72.27 102.45 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 114.908 -1.042 . . . . 71.450000000000003 109.308 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.72 -19.33 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 115.056 -0.975 . . . . 55.030000000000001 111.521 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -153.89 168.43 26.38 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 122.562 0.345 . . . . 74.530000000000001 110.165 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.52 169.79 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 123.532 0.733 . . . . 72.450000000000003 110.359 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -141.32 104.09 4.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.683 0.793 . . . . 73.239999999999995 109.203 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.3 -172.39 34.59 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 115.934 -0.575 . . . . 64.010000000000005 113.519 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 17.5 p -91.4 2.93 56.05 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.197 0.999 . . . . 70.109999999999999 111.728 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -84.75 -3.34 58.54 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.43 1.092 . . . . 73.150000000000006 112.132 -171.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.14 -1.71 88.59 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.966 -0.352 . . . . 74.140000000000001 113.264 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.63 135.44 55.93 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 109.28 -0.637 . . . . 72.120000000000005 109.28 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.464 ' HB ' HG23 ' A' ' 57' ' ' ILE . 29.2 m -111.63 157.14 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.996 0.918 . . . . 75.219999999999999 110.889 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.574 ' HG3' HG13 ' A' ' 21' ' ' VAL . 41.3 ttm180 -106.52 109.27 21.14 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.002 0.921 . . . . 75.109999999999999 109.226 174.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.05 121.85 45.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.421 0.688 . . . . 73.030000000000001 110.267 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -88.07 111.24 21.33 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.276 -0.639 . . . . 71.430000000000007 109.276 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.411 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 39.2 m-85 -87.26 147.14 25.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.606 0.762 . . . . 71.540000000000006 110.758 175.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -49.66 -47.47 50.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.157 1.383 . . . . 72.25 111.822 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -108.7 -57.73 2.1 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.211 1.004 . . . . 75.219999999999999 108.411 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 63.42 57.16 15.97 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 114.598 -1.183 . . . . 53.399999999999999 111.661 -175.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 39.0 mt -67.56 115.49 27.5 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 109.653 -0.499 . . . . 64.329999999999998 109.653 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 12.4 Cg_exo -68.44 164.59 32.13 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 123.337 2.691 . . . . 73.120000000000005 111.949 -173.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 170.72 168.6 32.7 Favored Glycine 0 C--N 1.329 0.176 0 N-CA-C 111.139 -0.784 . . . . 75.209999999999994 111.139 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -85.6 28.71 0.74 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.299 0.639 . . . . 70.540000000000006 111.798 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.78 23.73 1.14 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.587 1.155 . . . . 71.329999999999998 111.404 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.61 113.76 3.53 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.682 0.793 . . . . 73.0 109.578 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.66 -5.67 14.32 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.948 -0.569 . . . . 21.239999999999998 112.487 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -80.44 152.73 28.64 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.508 0.723 . . . . 70.019999999999996 111.201 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -85.82 145.26 27.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.848 0.459 . . . . 73.329999999999998 111.765 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 24' ' ' ILE . 18.2 m -116.73 157.7 17.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 C-N-CA 124.144 0.978 . . . . 71.239999999999995 108.97 171.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -113.69 109.94 19.39 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.323 -0.621 . . . . 65.319999999999993 109.323 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 69.3 mt -89.13 98.04 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.57 0.748 . . . . 63.130000000000003 109.443 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 2' ' ' ARG . 59.9 t -79.69 136.41 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.496 -0.775 . . . . 72.239999999999995 109.703 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? . . . . . 0 CA--C 1.551 0.994 0 N-CA-C 108.438 -0.949 . . . . 61.5 108.438 175.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 39.1 ptt180 . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 121.021 0.439 . . . . 73.219999999999999 110.998 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 56.8 mt -101.07 145.28 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 108.016 -1.105 . . . . 65.340000000000003 108.016 174.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.454 ' HE2' HD12 ' A' ' 27' ' ' LEU . 20.5 ptmt -90.29 124.73 35.14 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.413 -0.588 . . . . 63.009999999999998 109.413 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -123.59 150.98 16.95 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 111.273 -0.731 . . . . 74.150000000000006 111.273 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.7 t -99.05 135.5 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.015 0.908 . . . . 72.340000000000003 110.802 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.82 104.07 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.876 1.27 . . . . 75.099999999999994 109.057 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.563 HD21 ' HG2' ' A' ' 25' ' ' LYS . 59.4 mt -82.28 -60.74 2.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.671 -0.492 . . . . 75.450000000000003 109.671 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -153.45 169.77 22.35 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.357 0.663 . . . . 34.32 111.701 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -122.82 143.09 50.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.508 1.123 . . . . 73.400000000000006 108.611 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.42 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 41.6 ttm180 . . . . . 0 CA--C 1.532 0.281 0 C-N-CA 123.958 0.903 . . . . 73.109999999999999 108.893 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.542 -0.911 . . . . 72.439999999999998 108.542 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 21.9 t -87.36 146.81 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.522 0.729 . . . . 63.310000000000002 109.208 -172.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -138.54 112.79 8.68 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.159 -1.423 . . . . 71.319999999999993 107.159 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 8' ' ' LEU . 24.7 mm -75.06 112.43 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.272 -1.01 . . . . 72.510000000000005 108.272 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -122.62 162.63 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.703 1.201 . . . . 65.439999999999998 107.832 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG2' HD21 ' A' ' 8' ' ' LEU . 20.3 ptmt -145.94 131.05 9.09 Favored Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 109.511 -0.552 . . . . 71.230000000000004 109.511 163.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.481 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 9.8 Cg_exo -69.94 127.94 15.15 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 121.967 1.778 . . . . 72.25 110.562 171.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.454 HD12 ' HE2' ' A' ' 4' ' ' LYS . 64.6 mt -60.68 -37.0 80.15 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.327 0.651 . . . . 53.340000000000003 112.107 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -74.4 -29.26 61.45 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.971 -0.558 . . . . 64.129999999999995 110.8 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 34' ' ' GLU . 45.8 t -87.39 97.78 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.914 0.864 . . . . 63.200000000000003 109.98 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -101.04 -6.63 24.15 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.815 1.246 . . . . 73.040000000000006 110.169 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 m -117.44 147.13 42.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.923 0.889 . . . . 74.549999999999997 110.352 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.58 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 75.6 ttt-85 -65.16 -34.75 79.12 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.035 0.534 . . . . 64.150000000000006 111.576 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -59.67 -43.62 93.91 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.538 0.685 . . . . 65.109999999999999 109.759 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.524 ' HB2' HG13 ' A' ' 29' ' ' VAL . 21.2 mm-40 -68.86 -31.67 70.78 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.724 -1.125 . . . . 73.439999999999998 111.062 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.56 -35.0 58.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.53 0.732 . . . . 50.43 111.766 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -79.91 -25.63 40.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.395 1.078 . . . . 65.319999999999993 111.152 -168.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 63.3 pttt -77.61 -13.63 59.86 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.419 -0.355 . . . . 72.230000000000004 110.848 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.555 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 96.1 mt -89.05 8.34 30.28 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.777 0.831 . . . . 62.549999999999997 111.834 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.472 HD11 HG13 ' A' ' 60' ' ' VAL . 33.1 mm -65.87 103.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.272 -1.01 . . . . 61.130000000000003 108.272 172.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.61 0.8 17.96 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.52 -0.6 . . . . 60.140000000000001 113.446 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.782 ' HD3' HG23 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -74.37 156.24 37.28 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.747 0.773 . . . . 43.149999999999999 110.585 177.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 tp -94.43 143.88 26.04 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.172 0.589 . . . . 74.150000000000006 109.894 176.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.93 125.79 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.992 -1.114 . . . . 75.329999999999998 107.992 172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -115.01 109.5 18.19 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.735 -1.209 . . . . 73.209999999999994 107.735 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.3 t90 -131.74 117.51 18.69 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.251 -0.648 . . . . 75.239999999999995 109.251 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -86.46 105.86 17.07 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.653 0.781 . . . . 74.049999999999997 109.048 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.6 p -64.22 153.73 84.86 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 124.318 1.047 . . . . 61.43 112.459 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.33 -8.07 17.7 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.075 2.517 . . . . 65.340000000000003 112.622 168.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -61.63 -27.52 68.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.881 0.872 . . . . 73.349999999999994 110.693 167.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.42 24.85 13.18 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 115.253 -0.885 . . . . 22.440000000000001 111.901 -175.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -124.08 139.49 53.89 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.791 0.836 . . . . 70.109999999999999 110.554 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -85.18 95.1 4.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.235 -1.024 . . . . 75.129999999999995 108.235 173.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.445 HD22 ' HB2' ' A' ' 73' ' ' LYS . 28.6 mt -75.4 111.37 10.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.937 -0.764 . . . . 74.420000000000002 108.937 177.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -97.26 135.1 39.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.464 0.706 . . . . 71.010000000000005 109.662 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.46 170.98 24.51 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.581 0.551 . . . . 54.310000000000002 113.069 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -152.85 141.99 21.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.819 0.848 . . . . 75.25 109.66 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 29.9 mt -70.38 122.43 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 123.418 0.449 . . . . 75.400000000000006 110.284 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.3 m -87.25 -34.1 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.416 0.686 . . . . 70.049999999999997 110.08 172.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -167.36 150.52 6.26 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.337 0.655 . . . . 73.439999999999998 109.878 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.472 HG13 HD11 ' A' ' 39' ' ' ILE . 16.6 m -90.44 169.69 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.175 0.59 . . . . 73.329999999999998 109.639 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -135.59 101.88 4.93 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.833 -0.803 . . . . 73.409999999999997 108.833 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.79 -171.7 25.87 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 115.386 0.914 . . . . 43.409999999999997 115.386 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 40.3 p -93.81 12.1 26.95 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.646 1.179 . . . . 61.32 111.8 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -74.15 -17.76 60.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.816 0.846 . . . . 73.120000000000005 110.642 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.14 -4.95 78.24 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.515 -0.634 . . . . 72.099999999999994 111.515 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.89 141.69 51.18 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.605 0.762 . . . . 64.25 110.945 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.481 HG21 ' NH2' ' A' ' 41' ' ' ARG . 27.4 m -135.7 152.47 31.24 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 C-N-CA 124.539 1.135 . . . . 64.209999999999994 109.691 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -107.27 102.7 11.99 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.006 -1.109 . . . . 73.409999999999997 108.006 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -107.24 116.03 31.21 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.237 -0.892 . . . . 73.25 108.948 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -89.1 131.81 35.08 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.566 -0.531 . . . . 75.230000000000004 109.566 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -101.62 135.49 43.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.402 1.081 . . . . 74.230000000000004 109.432 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -54.62 -44.39 73.1 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.482 1.114 . . . . 74.540000000000006 111.15 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.445 ' HB2' HD22 ' A' ' 53' ' ' LEU . 73.3 mmtt -77.86 -42.49 33.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.507 -0.77 . . . . 74.530000000000001 109.293 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.55 33.7 72.93 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 124.137 0.898 . . . . 64.5 114.101 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.441 HD12 HD21 ' A' ' 53' ' ' LEU . 43.6 mt -69.71 121.57 82.98 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.067 0.547 . . . . 73.510000000000005 110.782 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.39 123.38 8.15 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.601 2.201 . . . . 74.319999999999993 110.969 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -135.17 142.78 14.25 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.916 -0.474 . . . . 72.25 111.916 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -88.38 70.28 9.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.159 -1.052 . . . . 74.439999999999998 108.159 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.39 28.58 7.93 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.139 -1.391 . . . . 74.409999999999997 110.315 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.29 104.05 1.4 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.841 -0.618 . . . . 74.209999999999994 110.209 -174.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.81 -1.76 8.57 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.019 -0.537 . . . . 60.310000000000002 113.015 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.81 174.16 10.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.38 0.672 . . . . 75.109999999999999 111.318 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 85.8 m-85 -115.62 129.86 56.65 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.209 0.603 . . . . 61.310000000000002 111.344 -173.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.6 m -99.71 156.52 3.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 124.383 1.073 . . . . 72.109999999999999 109.583 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -103.9 109.86 21.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.282 0.633 . . . . 73.329999999999998 109.513 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.782 HG23 ' HD3' ' A' ' 41' ' ' ARG . 82.1 mt -91.51 93.06 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.239 1.015 . . . . 71.430000000000007 108.91 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.99 105.98 12.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 115.257 -0.883 . . . . 74.239999999999995 109.896 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 106.403 -1.703 . . . . 63.119999999999997 106.403 166.918 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.648 -0.501 . . . . 73.209999999999994 109.648 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 mt -106.11 118.68 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.017 -1.105 . . . . 70.400000000000006 108.017 170.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.447 ' HG3' HD12 ' A' ' 27' ' ' LEU . 17.4 ptpt -88.01 149.27 24.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.401 -0.592 . . . . 73.209999999999994 109.401 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -147.01 177.65 25.16 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 123.522 0.514 . . . . 63.32 112.082 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.6 t -113.03 132.66 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.893 0.877 . . . . 64.140000000000001 110.167 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.8 t -66.83 118.2 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.576 0.75 . . . . 74.329999999999998 109.636 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.525 HD12 HG22 ' A' ' 23' ' ' ILE . 88.8 mt -90.64 -51.64 5.29 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.973 0.509 . . . . 74.540000000000006 109.918 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.1 p -164.77 163.02 21.41 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.098 -0.501 . . . . 64.450000000000003 111.551 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -111.32 157.29 20.35 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.782 0.833 . . . . 61.240000000000002 108.953 171.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 . . . . . 0 C--O 1.245 0.829 0 N-CA-C 108.893 -0.78 . . . . 72.310000000000002 108.893 173.266 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 121.634 0.731 . . . . 73.230000000000004 110.524 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.42 140.71 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.967 -1.015 . . . . 72.5 108.867 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.5 ttt -132.29 116.52 17.0 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.027 -1.101 . . . . 74.349999999999994 108.027 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.525 HG22 HD12 ' A' ' 8' ' ' LEU . 31.2 mm -83.98 120.41 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.563 0.745 . . . . 52.299999999999997 109.028 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 84' ' ' VAL . 87.2 mt -126.12 152.67 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.654 1.182 . . . . 74.200000000000003 108.262 -176.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.523 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -125.81 102.69 28.32 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.104 -1.073 . . . . 73.310000000000002 108.104 170.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.538 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 24.3 Cg_exo -61.05 143.0 99.0 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.756 2.304 . . . . 71.319999999999993 112.064 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.447 HD12 ' HG3' ' A' ' 4' ' ' LYS . 88.9 mt -67.99 -43.11 79.66 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.394 0.677 . . . . 74.030000000000001 111.541 -177.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.56 -25.99 66.07 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.812 0.845 . . . . 62.340000000000003 111.597 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 55.6 t -105.29 116.3 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.273 1.029 . . . . 52.420000000000002 110.981 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -128.64 13.64 6.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.389 0.676 . . . . 74.329999999999998 110.68 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.1 t -145.6 164.45 31.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.557 0.743 . . . . 64.329999999999998 110.525 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.611 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 74.5 ttt180 -59.26 -51.04 71.66 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.404 1.082 . . . . 71.420000000000002 112.141 -170.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -75.08 -29.08 60.57 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.406 -0.815 . . . . 71.310000000000002 110.82 -169.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 29' ' ' VAL . 42.4 mt-10 -64.86 -30.81 71.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.538 -0.756 . . . . 73.420000000000002 109.917 173.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.74 -32.74 23.31 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.011 0.924 . . . . 73.109999999999999 111.169 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.0 m -78.04 -16.45 58.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.35 0.66 . . . . 51.43 111.898 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -82.31 -16.11 50.53 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.807 0.337 . . . . 75.010000000000005 110.495 171.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.13 5.93 42.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.126 0.57 . . . . 74.439999999999998 112.033 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.579 HD11 HG13 ' A' ' 60' ' ' VAL . 46.5 mm -68.54 104.68 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.741 -0.837 . . . . 65.129999999999995 108.741 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.79 -4.79 11.63 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.787 -0.642 . . . . 53.520000000000003 113.143 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HD2' HD13 ' A' ' 88' ' ' LEU . 24.1 mmt180 -84.58 149.77 25.66 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.82 0.81 . . . . 64.340000000000003 110.604 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 55' ' ' GLY . 48.0 tp -89.78 138.12 31.75 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 124.177 0.991 . . . . 72.420000000000002 108.754 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 86' ' ' ILE . 16.3 t -119.69 138.01 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.852 -0.795 . . . . 74.450000000000003 108.852 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.4 132.95 52.67 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.269 -1.012 . . . . 72.349999999999994 108.269 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -138.93 128.69 24.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.075 0.55 . . . . 74.530000000000001 109.571 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 17.6 tppt? -78.98 120.89 24.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.718 0.807 . . . . 73.310000000000002 109.354 174.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 7.6 m -83.83 138.16 40.59 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 115.259 -0.882 . . . . 74.120000000000005 109.23 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.07 -17.77 39.97 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.225 2.617 . . . . 61.049999999999997 113.619 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -82.81 13.05 4.12 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.586 0.755 . . . . 74.329999999999998 111.89 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.95 41.27 49.31 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 112.539 -0.224 . . . . 72.0 112.539 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 75.3 mmtt -124.12 169.61 11.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.947 0.899 . . . . 71.200000000000003 109.403 -178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -131.85 107.83 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.216 -1.031 . . . . 53.399999999999999 108.216 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.556 HD22 ' HB2' ' A' ' 73' ' ' LYS . 22.6 mt -83.45 124.89 31.14 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.88 -0.6 . . . . 71.329999999999998 109.399 176.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -105.1 130.44 53.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.429 -0.952 . . . . 73.200000000000003 108.429 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.438 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -145.28 -179.6 21.69 Favored Glycine 0 N--CA 1.464 0.562 0 O-C-N 123.31 0.381 . . . . 74.340000000000003 112.304 -175.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -152.56 133.32 13.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.875 0.337 . . . . 64.510000000000005 110.819 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.562 HD11 HD13 ' A' ' 86' ' ' ILE . 68.3 mt -67.87 103.92 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 124.08 0.862 . . . . 73.299999999999997 109.524 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.2 m -89.58 -35.24 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.287 0.635 . . . . 73.209999999999994 111.517 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -164.41 149.82 10.29 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.37 -0.604 . . . . 71.120000000000005 109.37 -175.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.579 HG13 HD11 ' A' ' 39' ' ' ILE . 13.9 m -94.78 171.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.473 0.709 . . . . 55.109999999999999 110.853 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -128.46 113.96 16.19 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.887 0.875 . . . . 73.230000000000004 109.651 174.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.76 -154.97 50.64 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 123.902 0.751 . . . . 64.209999999999994 113.549 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.611 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 22.7 p -105.04 7.56 34.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.56 1.144 . . . . 74.129999999999995 111.826 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -85.75 2.42 45.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.407 0.683 . . . . 72.329999999999998 112.832 -171.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.35 71.52 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.142 -0.255 . . . . 51.409999999999997 113.423 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.4 117.86 17.66 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.427 0.691 . . . . 73.319999999999993 110.077 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.6 m -102.18 150.84 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.755 0.822 . . . . 64.409999999999997 110.719 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -103.12 104.52 14.68 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.641 -1.244 . . . . 73.150000000000006 107.641 171.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.13 118.04 35.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.11 -1.07 . . . . 65.400000000000006 108.11 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.8 mtm105 -89.98 118.21 29.37 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.566 -0.531 . . . . 72.239999999999995 109.566 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -98.19 132.06 44.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.9 0.88 . . . . 72.109999999999999 109.809 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -52.88 -41.94 64.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.947 1.299 . . . . 64.129999999999995 112.264 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HB2' HD22 ' A' ' 53' ' ' LEU . 43.6 mmtm -90.06 -47.8 7.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.128 0.971 . . . . 74.239999999999995 109.281 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.12 38.39 94.3 Favored Glycine 0 C--N 1.356 1.686 0 O-C-N 123.887 0.742 . . . . 50.020000000000003 114.331 175.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.06 131.37 92.27 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 122.934 0.493 . . . . 72.519999999999996 110.68 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.7 176.24 10.25 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.801 2.334 . . . . 73.120000000000005 111.919 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.18 157.81 19.0 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.174 -0.466 . . . . 61.329999999999998 112.31 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -94.19 26.37 3.33 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.607 0.718 . . . . 64.400000000000006 110.555 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.48 28.63 1.08 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.432 1.093 . . . . 53.329999999999998 111.033 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -61.76 109.36 1.2 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.746 0.818 . . . . 73.299999999999997 110.036 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.94 -14.79 7.05 Favored Glycine 0 C--N 1.347 1.144 0 O-C-N 123.31 0.381 . . . . 54.299999999999997 113.011 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.12 160.39 31.28 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.661 0.784 . . . . 74.310000000000002 111.287 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 13.0 m-85 -87.32 131.67 34.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.614 0.766 . . . . 74.340000000000003 111.69 -177.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 24' ' ' ILE . 16.6 m -104.5 151.14 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.452 -0.944 . . . . 73.0 108.452 167.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -108.97 108.72 19.57 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.085 -0.709 . . . . 52.140000000000001 109.085 171.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.562 HD13 HD11 ' A' ' 57' ' ' ILE . 59.6 mt -85.88 91.39 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.721 -1.214 . . . . 74.25 107.721 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.2 t -75.62 147.47 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.69 -1.141 . . . . 65.219999999999999 109.83 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.478 HD13 ' HD2' ' A' ' 41' ' ' ARG . 4.5 mm? . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 123.552 0.741 . . . . 54.32 110.735 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.46 ' HD2' HG22 ' A' ' 87' ' ' VAL . 34.2 mtm-85 . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 107.894 -1.15 . . . . 74.450000000000003 107.894 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.701 HD12 HD21 ' A' ' 38' ' ' LEU . 25.9 mt -101.1 134.96 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 109.713 -0.477 . . . . 64.430000000000007 109.713 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -89.69 121.52 31.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.577 0.751 . . . . 71.400000000000006 109.417 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -114.57 167.86 12.42 Favored Glycine 0 N--CA 1.48 1.611 0 CA-C-O 119.698 -0.501 . . . . 60.439999999999998 113.055 -175.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.2 t -124.13 122.9 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.973 0.909 . . . . 75.140000000000001 109.571 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.2 t -69.76 97.85 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.26 0.624 . . . . 54.539999999999999 109.777 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 25' ' ' LYS . 67.6 mt -75.83 -47.84 23.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.212 0.605 . . . . 73.5 110.853 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.7 m -151.43 152.45 33.07 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.7 0.8 . . . . 73.129999999999995 110.927 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.32 142.11 35.66 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.664 0.786 . . . . 74.099999999999994 109.44 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 105.286 -2.116 . . . . 73.5 105.286 159.52 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 4.5 t30 . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 106.91 -1.515 . . . . 62.140000000000001 106.91 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 70' ' ' ARG . 14.6 t -88.08 148.89 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.067 -1.457 . . . . 54.240000000000002 107.067 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.6 ptp -153.34 144.96 23.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.669 0.271 . . . . 74.540000000000006 110.678 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.07 119.81 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.179 -1.045 . . . . 50.32 108.179 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.511 HD13 HG21 ' A' ' 84' ' ' VAL . 89.2 mt -121.25 123.03 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.951 0.9 . . . . 64.209999999999994 109.644 -175.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.594 ' HB2' HD11 ' A' ' 8' ' ' LEU . 87.9 tttt -99.64 109.26 54.78 Favored Pre-proline 0 N--CA 1.482 1.173 0 CA-C-N 119.172 0.896 . . . . 71.219999999999999 109.859 172.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.642 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 20.4 Cg_exo -67.46 138.12 45.09 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.799 2.333 . . . . 72.420000000000002 112.39 171.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.33 -39.04 89.08 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.657 1.183 . . . . 74.409999999999997 111.82 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -77.72 -28.22 50.78 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.642 0.777 . . . . 70.510000000000005 112.097 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 34' ' ' GLU . 54.7 t -92.02 113.52 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.789 0.836 . . . . 61.049999999999997 110.67 -170.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.44 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -101.17 -30.21 11.68 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.917 0.887 . . . . 72.530000000000001 111.066 -174.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.8 p -119.99 166.72 12.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.948 0.499 . . . . 54.210000000000001 111.331 -172.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 67.7 ttt180 -61.97 -37.55 85.2 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.845 0.858 . . . . 74.239999999999995 111.022 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.87 -45.3 93.2 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.014 0.526 . . . . 70.340000000000003 111.137 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HB2' HG13 ' A' ' 29' ' ' VAL . 41.5 mt-10 -66.87 -22.09 65.99 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.384 -0.825 . . . . 71.450000000000003 111.215 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.62 -28.25 28.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.617 0.767 . . . . 73.230000000000004 110.877 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -79.29 -24.2 43.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.217 0.607 . . . . 72.450000000000003 111.517 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -61.63 -20.47 63.41 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.165 0.439 . . . . 60.420000000000002 110.622 169.447 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.701 HD21 HD12 ' A' ' 3' ' ' ILE . 88.9 mt -88.36 -1.15 57.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.761 0.824 . . . . 72.549999999999997 112.913 -175.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.659 HD11 HG13 ' A' ' 60' ' ' VAL . 38.6 mm -72.3 103.91 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.475 0.579 . . . . 72.299999999999997 109.553 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.7 -4.54 17.01 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.696 -0.684 . . . . 74.310000000000002 113.025 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HA ' HD23 ' A' ' 88' ' ' LEU . 27.6 mmt180 -75.52 153.54 37.4 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.774 0.787 . . . . 74.540000000000006 109.759 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 55' ' ' GLY . 56.2 tp -89.33 146.01 24.98 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.047 -1.094 . . . . 63.450000000000003 108.047 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.2 t -126.24 115.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.951 -0.759 . . . . 74.030000000000001 108.951 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.3 mt -100.36 106.19 17.78 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.917 0.887 . . . . 72.219999999999999 108.718 176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 53.9 t90 -123.72 130.64 52.95 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.903 0.881 . . . . 72.340000000000003 108.866 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -88.0 113.88 24.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.369 0.667 . . . . 74.329999999999998 109.271 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.0 p -65.96 152.4 93.58 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.55 0.74 . . . . 73.099999999999994 111.501 176.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.8 -7.98 22.44 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.516 2.144 . . . . 55.530000000000001 112.039 170.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 t -71.17 -29.69 65.51 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.59 0.756 . . . . 74.129999999999995 110.302 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.59 -34.46 2.67 Favored Glycine 0 C--N 1.354 1.581 0 C-N-CA 122.951 0.31 . . . . 63.450000000000003 113.311 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -73.13 157.17 37.76 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.509 0.724 . . . . 72.439999999999998 111.483 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.82 104.12 15.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.537 -1.283 . . . . 51.240000000000002 107.537 167.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 75' ' ' LEU . 26.9 mt -74.78 136.31 41.69 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.717 -0.674 . . . . 74.530000000000001 110.363 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -103.93 128.45 51.44 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.868 0.867 . . . . 43.310000000000002 109.004 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -135.38 176.94 19.78 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 123.896 0.747 . . . . 43.450000000000003 112.03 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -146.63 129.59 16.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.492 -0.559 . . . . 74.340000000000003 109.492 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.431 HG23 ' HB ' ' A' ' 67' ' ' VAL . 80.9 mt -67.81 97.22 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.583 -0.895 . . . . 75.299999999999997 108.583 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.92 -31.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.09 -0.959 . . . . 54.350000000000001 111.143 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -158.57 162.88 37.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.61 0.764 . . . . 74.040000000000006 109.03 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.659 HG13 HD11 ' A' ' 39' ' ' ILE . 34.1 m -92.3 168.62 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.501 0.721 . . . . 73.150000000000006 110.382 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -137.22 103.8 5.22 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.285 -0.635 . . . . 61.32 109.285 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.6 178.66 50.37 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 116.028 -0.533 . . . . 71.049999999999997 113.651 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 71.7 p -97.76 1.19 48.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.963 0.905 . . . . 71.430000000000007 111.692 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.03 12.18 8.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.669 0.787 . . . . 61.509999999999998 112.014 -176.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.85 -12.16 70.21 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 120.083 -0.287 . . . . 51.140000000000001 113.435 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.32 143.2 56.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.959 0.504 . . . . 54.310000000000002 110.722 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 35.9 m -118.87 -171.91 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.527 1.531 . . . . 75.420000000000002 109.339 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -145.63 108.4 4.51 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.05 -0.722 . . . . 65.340000000000003 109.05 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.03 125.32 50.87 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.874 0.87 . . . . 74.420000000000002 111.125 -176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.514 ' HG2' HG22 ' A' ' 21' ' ' VAL . 97.2 mtt180 -91.13 115.1 27.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.762 0.825 . . . . 73.530000000000001 110.139 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.4 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 14.9 m-85 -89.19 119.94 30.12 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.886 -0.783 . . . . 75.349999999999994 108.886 172.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.44 -19.74 62.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.5 0.72 . . . . 70.219999999999999 112.2 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -69.79 -55.9 8.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.061 0.945 . . . . 73.209999999999994 110.541 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 20' ' ' ASN . . . 81.0 46.33 7.14 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 114.6 0.6 . . . . 74.519999999999996 114.6 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.514 ' HB2' HD11 ' A' ' 53' ' ' LEU . 31.5 mt -96.77 143.3 25.89 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 117.659 0.73 . . . . 73.329999999999998 110.668 171.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -90.08 -174.84 0.87 Allowed 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.435 2.756 . . . . 72.439999999999998 113.44 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 146.87 153.47 5.91 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.039 -0.982 . . . . 73.340000000000003 111.46 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -99.8 87.46 3.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.236 0.614 . . . . 73.329999999999998 109.483 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.04 31.33 6.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.818 0.847 . . . . 43.530000000000001 111.041 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.09 105.53 0.33 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.924 -0.398 . . . . 75.519999999999996 109.924 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.27 3.61 18.99 Favored Glycine 0 C--N 1.35 1.333 0 C-N-CA 123.929 0.776 . . . . 53.119999999999997 112.548 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -86.82 163.55 17.16 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.967 0.507 . . . . 74.430000000000007 110.428 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 97.0 m-85 -109.55 125.55 52.64 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.12 0.568 . . . . 71.049999999999997 111.513 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.511 HG21 HD13 ' A' ' 24' ' ' ILE . 18.8 m -100.99 162.35 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.165 0.986 . . . . 74.340000000000003 111.008 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -103.98 110.25 22.32 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.033 0.933 . . . . 74.019999999999996 109.69 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.0 mt -87.82 91.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 107.372 -1.344 . . . . 72.129999999999995 107.372 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.46 HG22 ' HD2' ' A' ' 2' ' ' ARG . 21.9 t -98.27 151.83 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.781 1.233 . . . . 51.450000000000003 109.632 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 41' ' ' ARG . 2.0 tm? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 108.611 -0.885 . . . . 72.5 108.611 169.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.498 ' HG3' ' HB3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 109.702 -0.481 . . . . 74.010000000000005 109.702 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.509 HG23 ' HB2' ' A' ' 28' ' ' ASP . 80.3 mt -95.56 135.72 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.767 0.827 . . . . 71.400000000000006 109.7 -175.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HE2' ' CD2' ' A' ' 83' ' ' TYR . 85.6 tttt -90.25 138.49 31.48 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.691 -0.855 . . . . 74.519999999999996 108.691 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.69 -179.79 16.97 Favored Glycine 0 N--CA 1.469 0.847 0 N-CA-C 111.606 -0.598 . . . . 50.420000000000002 111.606 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.17 130.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.847 0.859 . . . . 65.120000000000005 109.641 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.18 100.87 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.599 1.159 . . . . 54.109999999999999 109.743 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 25' ' ' LYS . 67.0 mt -82.52 -56.66 3.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.822 0.449 . . . . 71.209999999999994 111.565 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 m -147.21 135.23 21.41 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.671 0.389 . . . . 64.239999999999995 111.352 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -80.98 122.63 27.53 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.516 -0.92 . . . . 73.219999999999999 108.516 168.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.659 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 37.0 mmt180 . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 108.592 -0.892 . . . . 75.519999999999996 108.592 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.446 ' OD1' ' HA2' ' A' ' 74' ' ' GLY . 2.9 p-10 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 109.137 -0.69 . . . . 62.520000000000003 109.137 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.659 ' HB ' ' HB2' ' A' ' 11' ' ' ARG . 10.7 t -87.95 157.17 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.221 -1.029 . . . . 74.010000000000005 108.221 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 36.6 ttp -141.71 114.18 8.3 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.263 -1.384 . . . . 74.420000000000002 107.263 169.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.6 mm -67.42 124.45 22.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 N-CA-C 108.108 -1.071 . . . . 64.349999999999994 108.108 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.462 HG21 HG21 ' A' ' 84' ' ' VAL . 96.3 mt -134.27 137.06 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.948 -1.13 . . . . 72.25 107.948 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.512 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -102.11 113.43 65.86 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.727 -0.842 . . . . 75.420000000000002 108.727 169.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.621 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 15.8 Cg_exo -68.3 119.8 6.79 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.585 1.523 . . . . 71.209999999999994 110.177 169.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.88 -35.99 81.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.485 0.714 . . . . 65.420000000000002 111.602 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 3' ' ' ILE . 7.8 m-20 -76.45 -28.95 56.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.755 0.422 . . . . 74.530000000000001 111.23 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 50.0 t -115.56 102.27 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.475 0.71 . . . . 74.120000000000005 110.459 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.525 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 26.3 p30 -110.15 2.14 19.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.036 0.934 . . . . 74.010000000000005 111.425 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.9 m -97.83 156.14 16.72 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.65 0.78 . . . . 52.130000000000003 110.477 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 31.7 ttt180 -74.54 -42.8 58.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.2 0.6 . . . . 73.510000000000005 110.918 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.53 -40.43 92.91 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.788 0.835 . . . . 74.219999999999999 110.987 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HB2' HG13 ' A' ' 29' ' ' VAL . 5.9 mm-40 -70.83 -28.57 64.7 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.268 -0.878 . . . . 65.510000000000005 110.243 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.26 43.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.561 0.744 . . . . 44.25 111.192 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.8 t -78.78 -23.54 45.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.915 0.886 . . . . 72.120000000000005 110.018 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -92.75 2.12 56.91 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.642 0.377 . . . . 74.109999999999999 111.124 171.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD21 HD12 ' A' ' 3' ' ' ILE . 43.2 mt -85.94 -11.23 53.65 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.092 0.557 . . . . 73.239999999999995 111.137 170.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.531 HD11 HG13 ' A' ' 60' ' ' VAL . 42.7 mm -63.38 126.64 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 109.214 -0.661 . . . . 71.040000000000006 109.214 177.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.64 7.67 66.48 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.612 -0.549 . . . . 72.329999999999998 113.426 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -96.1 150.86 20.03 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 117.851 0.826 . . . . 73.310000000000002 111.202 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.44 HD11 ' HE2' ' A' ' 54' ' ' LYS . 43.8 tp -91.17 115.95 28.42 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.758 -1.11 . . . . 75.099999999999994 109.897 -171.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 86' ' ' ILE . 62.0 t -97.38 115.04 36.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.29 -0.633 . . . . 41.420000000000002 109.29 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.9 mt -93.7 101.88 14.03 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.153 0.981 . . . . 75.430000000000007 108.419 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.403 ' CD1' HG12 ' A' ' 84' ' ' VAL . 31.2 t90 -104.38 131.21 51.99 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.399 -0.963 . . . . 72.239999999999995 108.399 172.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -96.03 114.67 26.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.16 -1.422 . . . . 73.010000000000005 107.16 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.1 p -57.95 155.74 22.44 Favored Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 124.115 0.966 . . . . 74.439999999999998 111.026 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.78 -25.25 50.75 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.126 2.551 . . . . 53.5 112.82 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -58.55 -38.15 77.21 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.921 1.288 . . . . 72.099999999999994 111.505 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.68 -8.91 11.73 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 115.635 -0.711 . . . . 72.209999999999994 112.015 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -82.05 153.54 26.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.602 1.161 . . . . 73.549999999999997 110.141 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.7 mt -110.12 109.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.816 0.446 . . . . 74.430000000000007 110.203 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.571 HD21 HD12 ' A' ' 75' ' ' LEU . 57.3 mt -80.54 142.26 34.31 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.991 0.916 . . . . 62.149999999999999 110.319 174.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 42' ' ' LEU . 13.9 mmmm -96.24 128.73 43.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.886 0.874 . . . . 71.109999999999999 109.513 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.05 173.31 22.48 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 111.459 -0.656 . . . . 55.130000000000003 111.459 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -152.61 132.06 12.94 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.991 0.396 . . . . 74.019999999999996 110.709 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.464 HG22 HD13 ' A' ' 39' ' ' ILE . 65.5 mt -68.22 104.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 123.878 0.736 . . . . 43.130000000000003 109.692 176.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.79 -38.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.182 -0.463 . . . . 71.109999999999999 110.132 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -136.23 176.89 8.28 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.835 0.854 . . . . 75.409999999999997 110.532 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.531 HG13 HD11 ' A' ' 39' ' ' ILE . 31.0 m -123.45 169.99 14.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 124.529 1.132 . . . . 74.450000000000003 109.651 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -144.61 105.31 4.14 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.303 -0.999 . . . . 72.150000000000006 108.303 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.17 168.73 42.2 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.182 -0.463 . . . . 71.409999999999997 113.587 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 59.8 p -93.78 2.28 56.27 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.04 0.936 . . . . 63.130000000000003 110.987 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -84.54 7.92 18.37 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.094 0.958 . . . . 72.049999999999997 112.476 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 30' ' ' ASN . . . 69.12 63.91 3.23 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 112.004 -0.438 . . . . 61.409999999999997 112.004 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.67 113.45 15.39 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.232 -1.395 . . . . 74.010000000000005 107.232 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.42 167.17 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.087 0.955 . . . . 74.010000000000005 110.42 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -123.13 102.56 8.04 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.173 0.989 . . . . 75.099999999999994 108.786 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.29 116.91 32.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.776 0.83 . . . . 53.420000000000002 110.397 -176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 22.1 mtm180 -91.33 119.75 31.62 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 122.338 0.255 . . . . 73.200000000000003 111.254 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -93.29 129.3 39.42 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.339 1.056 . . . . 71.510000000000005 110.756 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.27 -31.04 62.38 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.908 -1.042 . . . . 75.420000000000002 112.649 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.62 -31.71 24.1 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.547 0.339 . . . . 64.519999999999996 110.883 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.446 ' HA2' ' OD1' ' A' ' 20' ' ' ASN . . . 61.87 37.1 93.79 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 115.595 0.998 . . . . 73.230000000000004 115.595 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD12 HD21 ' A' ' 53' ' ' LEU . 79.7 mt -85.04 150.02 54.36 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 122.565 0.346 . . . . 73.219999999999999 110.466 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.99 -176.04 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.1 2.533 . . . . 55.310000000000002 112.516 174.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.83 -39.7 0.02 OUTLIER Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.556 -0.747 . . . . 63.240000000000002 112.403 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 56.55 30.4 17.18 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 123.047 1.403 . . . . 62.210000000000001 109.402 -171.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.82 31.47 5.81 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.935 -1.484 . . . . 54.25 110.564 -169.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -56.01 111.79 1.03 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.661 -0.496 . . . . 60.520000000000003 109.661 172.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.58 -7.26 18.0 Favored Glycine 0 N--CA 1.476 1.342 0 C-N-CA 123.233 0.444 . . . . 71.209999999999994 112.447 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.07 169.86 17.57 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.925 0.89 . . . . 70.109999999999999 108.664 175.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CD2' ' HE2' ' A' ' 4' ' ' LYS . 92.7 m-85 -115.36 135.24 54.33 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.097 0.408 . . . . 64.230000000000004 111.173 -171.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 24' ' ' ILE . 13.8 m -101.28 168.34 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.973 0.909 . . . . 70.530000000000001 109.249 174.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 2' ' ' ARG . 49.3 mt-10 -132.43 107.13 8.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.043 -0.725 . . . . 73.109999999999999 109.043 173.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.422 HD13 HD11 ' A' ' 57' ' ' ILE . 46.7 mt -85.21 94.45 3.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 125.227 1.411 . . . . 75.510000000000005 109.258 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.62 150.14 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.421 0.688 . . . . 72.530000000000001 109.599 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.553 1.095 0 N-CA-C 107.065 -1.457 . . . . 74.439999999999998 107.065 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 108.651 -0.87 . . . . 74.519999999999996 108.651 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.71 124.75 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.635 0.774 . . . . 63.25 109.061 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -88.52 127.67 35.54 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.938 -0.764 . . . . 75.25 108.938 -176.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.62 -168.95 12.26 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 116.373 -0.376 . . . . 61.32 112.299 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -144.3 135.38 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.026 1.33 . . . . 61.140000000000001 109.695 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.5 t -72.61 115.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.833 0.853 . . . . 71.420000000000002 109.62 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 25' ' ' LYS . 84.3 mt -89.69 -47.81 7.69 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 123.461 0.476 . . . . 74.420000000000002 110.541 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.2 m -152.02 154.82 36.75 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.919 0.488 . . . . 33.409999999999997 111.535 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -110.47 137.85 47.63 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.397 1.079 . . . . 70.510000000000005 108.691 171.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.422 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 87.9 mtt180 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 107.706 -1.22 . . . . 72.299999999999997 107.706 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 120.682 0.277 . . . . 74.519999999999996 110.327 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' HD3' ' A' ' 68' ' ' ARG . 84.3 t -90.39 106.09 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.565 0.746 . . . . 62.439999999999998 109.019 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.7 ttm -100.46 124.75 46.39 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.294 -0.632 . . . . 74.420000000000002 109.294 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -82.02 115.54 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 107.786 -1.19 . . . . 72.450000000000003 107.786 172.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.414 ' HB ' HG23 ' A' ' 67' ' ' VAL . 69.4 mt -109.24 150.41 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.799 0.84 . . . . 65.200000000000003 109.938 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 8' ' ' LEU . 59.5 tttp -119.49 96.97 50.06 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 125.007 1.323 . . . . 64.319999999999993 108.962 175.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.7 106.64 0.94 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.083 1.855 . . . . 74.230000000000004 110.164 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.1 mt -53.08 -38.43 62.53 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.793 1.237 . . . . 72.209999999999994 113.324 -172.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.73 -27.11 58.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.978 0.511 . . . . 62.509999999999998 111.631 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -100.98 107.73 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.32 0.648 . . . . 64.019999999999996 111.529 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -91.62 -19.26 22.9 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.369 1.068 . . . . 73.230000000000004 111.875 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -104.53 133.42 49.42 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 122.025 -0.422 . . . . 64.219999999999999 111.05 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 49.1 ttt180 -58.97 -43.93 91.46 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.375 1.07 . . . . 62.219999999999999 111.553 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.7 -40.5 97.33 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.006 0.922 . . . . 60.340000000000003 111.524 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.69 -33.51 75.05 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.479 -0.782 . . . . 42.5 111.14 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.93 -25.77 60.15 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 122.996 0.518 . . . . 61.210000000000001 111.637 171.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -74.99 -34.11 61.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.763 0.825 . . . . 60.210000000000001 111.924 -172.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -68.93 -22.42 64.14 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 120.922 0.391 . . . . 71.420000000000002 110.39 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.55 1.74 52.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.051 0.94 . . . . 61.219999999999999 112.449 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.462 HD11 HG13 ' A' ' 60' ' ' VAL . 31.7 mm -66.53 135.79 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 118.394 0.543 . . . . 64.239999999999995 110.729 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.16 -8.58 31.16 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.683 -0.689 . . . . 65.239999999999995 113.367 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -80.26 153.44 28.5 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.362 0.581 . . . . 73.120000000000005 110.959 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 54' ' ' LYS . 59.5 tp -90.28 146.75 23.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.471 -0.786 . . . . 72.310000000000002 109.257 -174.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.431 HG22 HG12 ' A' ' 86' ' ' ILE . 40.1 t -116.95 131.83 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.83 -0.804 . . . . 70.129999999999995 108.83 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -113.14 105.73 13.8 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.603 -1.258 . . . . 65.519999999999996 107.603 175.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -125.28 124.3 41.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.33 0.652 . . . . 73.409999999999997 109.468 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HE3' ' HA2' ' A' ' 50' ' ' GLY . 45.9 tttp -81.22 122.52 27.5 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.99 -0.744 . . . . 70.140000000000001 108.99 176.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 82.2 p -65.39 152.62 91.75 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.034 0.534 . . . . 75.030000000000001 110.346 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.47 -12.9 30.0 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.268 1.979 . . . . 74.420000000000002 112.145 173.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.6 m -70.27 -42.78 71.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.417 1.087 . . . . 75.409999999999997 110.726 170.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.464 ' HA2' ' HE3' ' A' ' 46' ' ' LYS . . . 135.06 -22.78 3.56 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 116.104 -0.498 . . . . 33.009999999999998 113.126 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -74.09 122.51 22.81 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.605 0.762 . . . . 71.430000000000007 110.292 -174.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 72.3 mt -78.83 106.95 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.593 -0.892 . . . . 65.549999999999997 108.593 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.401 HD13 ' H ' ' A' ' 75' ' ' LEU . 13.2 mt -86.73 155.34 20.39 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.409 1.084 . . . . 72.209999999999994 109.791 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' HD11 ' A' ' 42' ' ' LEU . 47.1 mtpt -123.7 145.46 48.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.934 0.894 . . . . 72.340000000000003 109.229 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.76 132.61 3.04 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-O 119.824 -0.431 . . . . 74.519999999999996 112.903 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -93.05 128.77 39.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.285 0.543 . . . . 74.030000000000001 109.976 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.2 mt -72.13 116.52 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.618 0.767 . . . . 72.439999999999998 109.411 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -112.92 -3.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.727 0.811 . . . . 71.129999999999995 112.284 -172.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -165.57 161.47 18.48 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.909 0.484 . . . . 73.349999999999994 110.48 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.462 HG13 HD11 ' A' ' 39' ' ' ILE . 16.0 m -91.5 168.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.781 0.832 . . . . 74.010000000000005 109.732 168.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -143.94 105.07 4.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.076 -0.511 . . . . 74.150000000000006 109.767 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.19 176.31 38.17 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 123.377 0.423 . . . . 62.229999999999997 113.841 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 30.1 p -91.04 10.1 28.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.394 1.077 . . . . 70.030000000000001 111.059 177.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -91.75 12.37 21.53 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.907 0.883 . . . . 73.540000000000006 111.749 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.07 12.03 75.23 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 113.984 0.354 . . . . 53.229999999999997 113.984 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.55 162.26 27.25 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.174 0.59 . . . . 73.430000000000007 109.728 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 15.2 m -132.18 177.92 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.098 0.959 . . . . 61.109999999999999 110.521 -178.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.454 ' HD3' HG13 ' A' ' 21' ' ' VAL . 7.4 tmm_? -138.59 116.45 11.56 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.25 -1.389 . . . . 72.400000000000006 107.25 -175.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.41 146.05 42.8 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.715 0.806 . . . . 53.0 111.496 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -99.25 100.83 11.98 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.235 1.014 . . . . 73.519999999999996 109.311 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -77.24 124.17 27.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.321 0.648 . . . . 74.120000000000005 110.984 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 9.9 pt-20 -62.1 -35.9 80.1 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.05 0.94 . . . . 60.210000000000001 111.122 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.506 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 74.5 mmtt -99.65 -65.38 0.97 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.595 0.758 . . . . 75.420000000000002 109.017 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.0 52.97 36.22 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 124.131 0.894 . . . . 61.420000000000002 114.61 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.401 ' H ' HD13 ' A' ' 53' ' ' LEU . 85.5 mt -67.51 137.33 93.33 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.35 0.66 . . . . 64.129999999999995 110.563 175.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.52 169.74 15.11 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.024 2.482 . . . . 64.209999999999994 112.845 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.73 161.67 22.69 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 115.266 -0.879 . . . . 73.129999999999995 110.905 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -91.0 38.8 0.97 Allowed 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.301 1.048 . . . . 75.25 109.306 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.21 29.8 4.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.647 1.179 . . . . 63.229999999999997 110.538 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.12 107.9 0.96 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.703 -0.851 . . . . 74.019999999999996 108.703 169.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.46 -12.14 16.16 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 116.279 -0.419 . . . . 61.030000000000001 112.645 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -77.62 152.82 33.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.842 0.457 . . . . 73.299999999999997 110.693 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -87.8 135.58 33.32 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.193 0.997 . . . . 71.230000000000004 112.349 -169.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.5 152.69 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.947 0.899 . . . . 55.32 109.138 171.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -114.14 108.72 17.35 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.19 -1.041 . . . . 72.209999999999994 108.19 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.431 HG12 HG22 ' A' ' 43' ' ' VAL . 61.9 mt -96.22 119.25 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.358 0.663 . . . . 71.049999999999997 109.62 -174.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.7 t -113.44 142.83 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 123.348 0.659 . . . . 71.349999999999994 111.183 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 CA--C 1.549 0.939 0 C-N-CA 124.119 0.968 . . . . 74.420000000000002 111.845 176.431 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.6 mtm180 . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.51 -0.922 . . . . 73.340000000000003 108.51 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.626 HD12 HD21 ' A' ' 38' ' ' LEU . 73.4 mt -129.97 130.45 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.596 0.758 . . . . 74.120000000000005 109.164 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.412 ' HG3' HD12 ' A' ' 27' ' ' LEU . 19.6 ptmt -88.54 130.07 35.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.765 -0.828 . . . . 71.400000000000006 108.765 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -128.18 140.64 11.93 Favored Glycine 0 C--O 1.217 -0.954 0 CA-C-N 116.459 -0.337 . . . . 71.310000000000002 112.363 -175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.7 t -91.93 121.98 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.01 0.524 . . . . 75.430000000000007 111.086 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.52 97.48 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.378 1.071 . . . . 71.409999999999997 109.65 172.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 25' ' ' LYS . 88.1 mt -72.91 -48.83 33.7 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.52 -0.764 . . . . 65.329999999999998 110.036 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.463 ' HA ' HD22 ' A' ' 80' ' ' LEU . 70.0 p -162.37 168.05 22.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.869 -0.605 . . . . 71.420000000000002 110.932 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -105.13 123.77 48.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.927 -1.138 . . . . 72.150000000000006 107.927 169.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 107.734 -1.209 . . . . 74.239999999999995 107.734 176.752 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.436 ' OD1' ' HA3' ' A' ' 74' ' ' GLY . 8.8 p30 . . . . . 0 C--O 1.243 0.738 0 CA-C-O 121.802 0.811 . . . . 73.530000000000001 112.015 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t -106.88 121.24 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 114.266 -1.334 . . . . 74.319999999999993 109.251 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 45.7 ttm -89.52 123.78 33.93 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.507 -0.923 . . . . 54.539999999999999 108.507 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.7 116.02 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.31 -0.996 . . . . 61.439999999999998 108.31 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.6 HD13 HG21 ' A' ' 84' ' ' VAL . 84.8 mt -120.46 150.67 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.036 0.935 . . . . 73.329999999999998 109.647 -172.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HB2' HD11 ' A' ' 8' ' ' LEU . 78.9 tttt -123.45 91.73 49.48 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.496 0.719 . . . . 75.310000000000002 109.416 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' A' ' 66' ' ' ALA . 36.9 Cg_endo -63.72 110.4 1.27 Allowed 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 122.751 2.301 . . . . 60.100000000000001 111.272 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.412 HD12 ' HG3' ' A' ' 4' ' ' LYS . 85.8 mt -62.18 -37.72 86.35 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.639 1.176 . . . . 63.520000000000003 112.875 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -65.86 -26.25 67.56 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.265 0.626 . . . . 75.510000000000005 111.546 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.685 HG13 ' HB2' ' A' ' 34' ' ' GLU . 40.3 t -100.32 131.59 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.197 0.999 . . . . 74.219999999999999 110.96 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -130.32 -3.48 4.37 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.664 0.785 . . . . 62.329999999999998 111.451 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.8 m -123.28 154.48 38.79 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.447 0.699 . . . . 72.150000000000006 110.563 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.566 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 63.0 ttt180 -64.95 -30.84 71.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.134 0.974 . . . . 64.310000000000002 111.634 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -69.48 -39.66 77.55 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.889 0.876 . . . . 63.0 110.146 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.685 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.5 mt-10 -70.42 -38.61 74.61 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.667 -1.151 . . . . 73.519999999999996 109.526 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.36 -30.81 69.84 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.645 0.778 . . . . 72.540000000000006 111.228 174.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 t -74.15 -30.82 62.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.397 0.679 . . . . 72.409999999999997 110.041 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -90.78 4.1 52.57 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.743 0.417 . . . . 53.450000000000003 110.98 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.626 HD21 HD12 ' A' ' 3' ' ' ILE . 34.3 mt -87.83 -18.31 29.57 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.618 0.367 . . . . 74.239999999999995 110.415 165.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.565 HD13 HG22 ' A' ' 57' ' ' ILE . 50.2 mm -59.86 106.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.195 0.598 . . . . 73.530000000000001 109.393 174.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.19 -29.35 4.6 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 116.052 -0.522 . . . . 15.539999999999999 112.527 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 153.94 39.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.208 0.603 . . . . 74.209999999999994 111.901 -173.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.58 HD11 ' HE2' ' A' ' 54' ' ' LYS . 60.9 tp -90.41 123.73 34.38 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.42 1.088 . . . . 65.109999999999999 109.674 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.8 115.18 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 109.412 -0.588 . . . . 75.340000000000003 109.412 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt -104.36 110.12 22.24 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.557 1.143 . . . . 52.240000000000002 108.732 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -124.49 127.73 47.91 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.307 -0.627 . . . . 64.319999999999993 109.307 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -88.12 106.7 18.34 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.367 -0.975 . . . . 62.210000000000001 108.367 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.9 p -64.31 157.37 71.53 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.046 0.938 . . . . 62.450000000000003 112.406 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.92 -23.78 73.88 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.842 2.361 . . . . 62.100000000000001 112.074 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.1 t -61.91 -23.27 66.22 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.538 1.135 . . . . 62.329999999999998 111.343 173.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.86 19.18 34.94 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.712 -0.676 . . . . 60.240000000000002 112.64 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.0 143.02 40.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.554 0.742 . . . . 73.010000000000005 110.105 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.5 mt -89.08 102.09 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.724 -0.843 . . . . 72.010000000000005 108.724 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 75' ' ' LEU . 26.3 mt -82.71 138.09 34.2 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.142 0.577 . . . . 75.209999999999994 110.369 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.58 ' HE2' HD11 ' A' ' 42' ' ' LEU . 13.4 mmmm -96.09 132.92 40.97 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.572 -0.899 . . . . 73.120000000000005 108.572 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.18 172.94 22.7 Favored Glycine 0 C--N 1.332 0.353 0 O-C-N 123.618 0.574 . . . . 65.329999999999998 112.075 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -151.81 131.71 13.34 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.122 0.569 . . . . 74.140000000000001 109.843 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.565 HG22 HD13 ' A' ' 39' ' ' ILE . 73.0 mt -70.8 108.93 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 109.137 -0.69 . . . . 54.109999999999999 109.137 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.75 -14.94 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.182 0.993 . . . . 63.100000000000001 111.225 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 23.7 tpp180 -149.29 148.82 30.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.327 0.651 . . . . 71.409999999999997 109.371 -173.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 39' ' ' ILE . 21.2 m -98.74 171.41 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.335 0.654 . . . . 74.129999999999995 109.988 173.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -124.13 103.64 8.39 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.386 -0.968 . . . . 72.450000000000003 108.386 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.94 -134.1 52.3 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 124.144 0.903 . . . . 75.519999999999996 113.602 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.566 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 69.3 p -119.62 -4.55 10.28 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.741 0.816 . . . . 54.329999999999998 111.993 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -73.93 -7.81 53.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.069 0.548 . . . . 75.140000000000001 112.017 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.51 -10.98 70.71 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 119.649 -0.528 . . . . 53.340000000000003 113.209 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . . . -60.68 149.68 34.5 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.999 0.52 . . . . 52.229999999999997 109.652 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.542 HG22 ' HD3' ' A' ' 26' ' ' PRO . 35.1 m -131.13 178.97 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 121.921 0.867 . . . . 72.329999999999998 111.96 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 97.8 mtt180 -133.86 118.99 18.59 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.259 1.424 . . . . 74.530000000000001 108.379 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.72 133.57 55.85 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.968 0.507 . . . . 64.439999999999998 110.715 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -88.7 123.21 32.92 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.182 0.593 . . . . 74.150000000000006 109.633 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -105.23 133.41 50.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.716 0.806 . . . . 75.409999999999997 109.46 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -61.13 -37.02 81.32 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.678 0.791 . . . . 74.120000000000005 111.852 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -98.08 -61.03 1.44 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.82 0.848 . . . . 74.109999999999999 108.974 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.436 ' HA3' ' OD1' ' A' ' 20' ' ' ASN . . . 60.91 54.68 34.91 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 124.083 0.864 . . . . 73.209999999999994 112.93 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.496 ' HB2' HD11 ' A' ' 53' ' ' LEU . 51.6 mt -68.46 115.92 34.77 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.24 1.016 . . . . 63.020000000000003 110.513 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.7 179.84 5.85 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 123.283 2.656 . . . . 52.140000000000001 112.332 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.81 176.94 25.07 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 110.723 -0.951 . . . . 44.420000000000002 110.723 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -77.39 70.02 3.73 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 122.038 0.923 . . . . 71.310000000000002 109.086 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.73 13.6 11.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.811 -1.086 . . . . 73.299999999999997 111.922 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 9' ' ' SER . 60.9 mt -74.27 103.21 4.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.464 -0.939 . . . . 72.120000000000005 108.464 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.4 -18.2 6.89 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 112.116 -0.394 . . . . 52.219999999999999 112.116 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.96 169.93 16.99 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.986 0.514 . . . . 64.310000000000002 111.336 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -108.28 155.9 19.98 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.232 0.613 . . . . 73.239999999999995 111.043 -170.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.6 HG21 HD13 ' A' ' 24' ' ' ILE . 20.2 m -122.15 160.28 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.462 1.105 . . . . 65.530000000000001 108.773 174.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -106.02 108.5 20.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.177 -0.675 . . . . 43.140000000000001 109.177 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' ARG . 77.9 mt -93.93 92.12 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.336 -1.357 . . . . 34.409999999999997 107.336 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.66 127.6 48.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.247 1.019 . . . . 73.450000000000003 110.266 -172.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 C--O 1.238 0.465 0 N-CA-C 107.915 -1.143 . . . . 72.239999999999995 107.915 173.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 110.48 -0.193 . . . . 72.409999999999997 110.48 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 47.1 mtm-85 -125.12 127.56 47.06 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.375 -0.972 . . . . 63.409999999999997 108.375 170.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 63.6 mt -97.12 132.57 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.656 0.782 . . . . 74.439999999999998 109.358 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -89.42 129.61 35.9 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.289 -0.634 . . . . 73.519999999999996 109.289 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.58 164.99 25.12 Favored Glycine 0 C--N 1.345 1.03 0 O-C-N 123.253 0.346 . . . . 43.329999999999998 112.929 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.57 120.65 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.993 0.917 . . . . 73.209999999999994 109.253 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.493 HG13 ' HB2' ' A' ' 22' ' ' MET . 23.7 t -68.9 102.91 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 109.687 -0.486 . . . . 72.019999999999996 109.687 173.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 25' ' ' LYS . 56.4 mt -70.23 -37.3 74.97 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.761 0.824 . . . . 72.140000000000001 110.321 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -156.96 158.13 36.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.87 -0.604 . . . . 74.140000000000001 111.603 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.96 162.15 18.22 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.955 0.902 . . . . 74.129999999999995 109.113 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.563 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 22.7 mtm180 -135.4 128.31 31.34 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.666 -1.235 . . . . 71.299999999999997 107.666 171.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -73.98 121.34 20.86 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.28 -0.637 . . . . 65.230000000000004 109.28 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -69.54 101.06 1.52 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.678 -0.692 . . . . 63.539999999999999 109.948 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -88.62 -2.37 58.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.692 -1.14 . . . . 73.510000000000005 110.566 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -76.79 173.49 11.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.112 0.965 . . . . 74.099999999999994 110.111 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -64.02 -44.93 91.08 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.008 0.432 . . . . 75.530000000000001 109.902 172.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -76.51 89.17 3.26 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.302 -0.863 . . . . 64.049999999999997 108.806 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -70.67 87.97 0.69 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.577 0.703 . . . . 61.350000000000001 109.555 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.42 105.69 8.69 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.334 -0.987 . . . . 63.340000000000003 108.334 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.653 ' H ' ' HA2' ' A' ' 74' ' ' GLY . 4.3 p-10 -63.11 118.84 8.46 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 123.681 0.613 . . . . 74.219999999999999 109.791 -171.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.571 HG22 ' HG2' ' A' ' 70' ' ' ARG . 16.7 t -90.32 149.39 4.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.546 -0.909 . . . . 72.219999999999999 108.546 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.493 ' HB2' HG13 ' A' ' 7' ' ' VAL . 21.5 ptp -149.26 140.91 23.49 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.02 0.438 . . . . 73.340000000000003 111.309 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -86.34 97.97 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.249 -1.389 . . . . 61.350000000000001 107.249 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.01 133.18 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.747 0.819 . . . . 70.209999999999994 108.973 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HB2' HD11 ' A' ' 8' ' ' LEU . 33.7 ttpt -107.56 97.0 17.97 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.107 -1.071 . . . . 75.109999999999999 108.107 170.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 11.5 Cg_exo -68.5 122.39 9.38 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.986 1.791 . . . . 44.539999999999999 110.74 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.63 -29.56 66.6 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.255 1.022 . . . . 64.540000000000006 112.008 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HB3' HG23 ' A' ' 3' ' ' ILE . 35.7 t70 -88.46 -28.5 20.82 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.859 0.864 . . . . 64.030000000000001 112.157 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 89.4 t -104.82 99.71 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.391 0.676 . . . . 73.510000000000005 109.808 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -119.41 12.13 12.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.396 0.678 . . . . 63.329999999999998 110.359 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.1 m -122.43 149.07 44.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.819 0.847 . . . . 70.200000000000003 110.613 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 53.8 ttt180 -63.88 -36.91 85.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.237 1.015 . . . . 73.319999999999993 111.357 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -65.29 -48.69 72.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.523 0.729 . . . . 72.200000000000003 110.532 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HB2' HG13 ' A' ' 29' ' ' VAL . 50.2 mt-10 -63.21 -30.37 71.53 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.74 -1.118 . . . . 71.120000000000005 110.976 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.73 -36.2 37.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.692 0.797 . . . . 41.140000000000001 111.512 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -73.39 -27.49 61.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.73 0.812 . . . . 52.149999999999999 110.915 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -82.11 -1.19 47.92 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.094 -0.503 . . . . 61.399999999999999 111.363 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 29' ' ' VAL . 93.4 mt -98.59 1.95 46.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.574 0.75 . . . . 75.200000000000003 112.144 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.651 HD11 HG13 ' A' ' 60' ' ' VAL . 51.2 mm -67.94 109.58 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.361 0.528 . . . . 75.109999999999999 110.278 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.95 -15.82 18.65 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.566 -0.743 . . . . 75.420000000000002 112.551 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.587 ' HG3' ' H ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -70.9 152.87 43.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.905 0.482 . . . . 74.120000000000005 111.228 -177.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 54' ' ' LYS . 26.6 tp -94.86 114.61 26.49 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 124.389 1.056 . . . . 74.299999999999997 109.668 -167.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.72 131.43 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.23 -0.656 . . . . 71.510000000000005 109.23 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.4 mt -107.66 101.31 10.63 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.66 -0.867 . . . . 61.450000000000003 108.66 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.411 ' HH2' ' HA3' ' A' ' 77' ' ' GLY . 34.5 t90 -100.22 140.8 33.94 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.916 0.486 . . . . 74.109999999999999 109.807 175.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -91.74 101.05 13.66 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.203 1.001 . . . . 75.510000000000005 108.775 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.3 p -65.0 150.58 95.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.035 0.534 . . . . 71.409999999999997 111.149 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.54 -19.37 36.47 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.409 2.739 . . . . 72.430000000000007 113.049 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.4 t -71.78 -8.59 55.17 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.056 0.942 . . . . 72.430000000000007 112.347 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.19 32.81 30.71 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.492 -0.243 . . . . 72.400000000000006 112.492 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -128.02 146.11 50.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.863 0.865 . . . . 54.140000000000001 108.864 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -99.43 100.09 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.844 -0.799 . . . . 75.519999999999996 108.844 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 75' ' ' LEU . 21.5 mt -74.99 137.28 41.45 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.156 -0.929 . . . . 73.150000000000006 109.034 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.574 ' HB3' HD11 ' A' ' 42' ' ' LEU . 24.0 mtmm -96.92 139.31 33.14 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.128 -0.693 . . . . 74.310000000000002 109.128 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -140.82 177.4 20.88 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 116.198 -0.456 . . . . 73.510000000000005 112.717 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -139.3 126.73 21.57 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.515 -0.55 . . . . 75.400000000000006 109.515 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.489 HG22 HD13 ' A' ' 39' ' ' ILE . 63.1 mt -68.75 103.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.041 -0.725 . . . . 61.240000000000002 109.041 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.456 HG11 ' HD3' ' A' ' 70' ' ' ARG . 27.6 m -83.84 -35.24 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.59 -0.732 . . . . 64.5 110.98 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -163.99 153.73 14.53 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.625 0.77 . . . . 65.209999999999994 109.584 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.651 HG13 HD11 ' A' ' 39' ' ' ILE . 12.2 m -91.55 170.46 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.289 0.636 . . . . 72.329999999999998 110.043 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -122.79 103.66 8.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.951 -1.129 . . . . 74.120000000000005 107.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.12 -150.63 51.71 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 124.335 1.022 . . . . 43.109999999999999 114.292 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.567 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 55.2 p -98.47 -9.91 24.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.664 0.786 . . . . 72.299999999999997 111.81 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.12 -12.52 19.95 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.735 0.814 . . . . 74.010000000000005 112.86 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.32 -1.34 87.56 Favored Glycine 0 C--N 1.349 1.25 0 N-CA-C 112.393 -0.283 . . . . 35.509999999999998 112.393 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.48 119.37 10.92 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.47 0.708 . . . . 72.0 110.162 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' HB ' HG23 ' A' ' 57' ' ' ILE . 29.6 m -101.65 148.27 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 122.661 0.384 . . . . 72.439999999999998 110.289 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -113.71 113.7 25.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.379 -0.6 . . . . 65.430000000000007 109.379 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.63 134.3 55.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.968 -0.56 . . . . 53.229999999999997 111.433 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 21' ' ' VAL . 67.9 mtp85 -102.57 123.31 46.06 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.162 0.985 . . . . 72.200000000000003 109.005 174.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.439 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 12.5 m-85 -99.04 126.9 44.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.178 0.591 . . . . 74.430000000000007 111.156 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 54' ' ' LYS . 22.1 pt-20 -50.28 -38.06 39.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.376 1.471 . . . . 71.450000000000003 113.652 -172.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -75.39 -24.85 57.24 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.259 0.624 . . . . 62.149999999999999 111.54 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.653 ' HA2' ' H ' ' A' ' 20' ' ' ASN . . . 63.83 24.76 68.58 Favored Glycine 0 C--N 1.348 1.195 0 O-C-N 123.633 0.583 . . . . 64.200000000000003 114.432 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.506 ' HB2' HD11 ' A' ' 53' ' ' LEU . 84.4 mt -86.59 136.31 35.09 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 123.088 0.555 . . . . 61.020000000000003 110.6 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 11.4 Cg_exo -71.08 174.32 10.82 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.561 2.84 . . . . 63.100000000000001 112.098 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.411 ' HA3' ' HH2' ' A' ' 45' ' ' TRP . . . -158.85 -65.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.1 -0.5 . . . . 72.040000000000006 112.549 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 60.28 31.79 20.55 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 123.062 1.411 . . . . 74.019999999999996 110.272 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.33 31.61 0.81 Allowed 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 114.107 -1.406 . . . . 61.539999999999999 111.291 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -35.68 111.1 0.12 Allowed 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 126.289 1.835 . . . . 74.420000000000002 114.194 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.41 -4.25 26.54 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.9 -0.591 . . . . 54.340000000000003 113.102 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.81 157.93 35.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.331 0.652 . . . . 54.020000000000003 111.611 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -102.06 141.4 34.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.274 0.559 . . . . 73.040000000000006 112.127 -172.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.9 m -116.29 166.61 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.209 1.003 . . . . 73.230000000000004 110.326 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -128.71 109.15 11.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.506 -0.553 . . . . 74.010000000000005 109.506 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 61.3 mt -82.37 100.1 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.241 1.016 . . . . 73.340000000000003 109.346 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.5 t -72.76 117.64 16.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.229 0 N-CA-C 109.098 -0.705 . . . . 71.109999999999999 109.098 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -63.34 86.61 0.03 OUTLIER 'General case' 0 C--N 1.35 0.61 0 N-CA-C 107.351 -1.352 . . . . 64.129999999999995 107.351 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.587 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -75.86 -62.99 1.41 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.421 -1.263 . . . . 72.549999999999997 110.035 -179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 58.29 81.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.567 1.167 . . . . 72.340000000000003 110.732 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 119.051 -0.499 . . . . 64.129999999999995 110.046 173.344 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mmt . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 109.762 -0.458 . . . . 71.310000000000002 109.762 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -150.05 141.69 23.56 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.637 1.175 . . . . 64.150000000000006 108.818 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 74.2 mt -112.34 133.73 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.121 -1.066 . . . . 71.329999999999998 108.121 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -88.14 133.36 34.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.525 -0.546 . . . . 71.030000000000001 109.525 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -122.24 165.53 15.01 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 110.891 -0.883 . . . . 54.420000000000002 110.891 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.3 t -111.54 128.38 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 123.691 0.796 . . . . 74.239999999999995 109.313 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.69 93.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.446 1.099 . . . . 73.420000000000002 108.813 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 25' ' ' LYS . 64.7 mt -71.27 -51.19 25.9 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 116.343 -0.39 . . . . 73.329999999999998 110.062 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 p -159.48 156.18 27.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.737 -0.665 . . . . 74.329999999999998 110.875 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -92.5 104.88 17.15 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.243 -1.021 . . . . 74.319999999999993 108.243 169.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -83.35 112.35 19.83 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.004 -0.739 . . . . 71.040000000000006 109.004 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -74.08 148.4 41.9 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.818 -0.438 . . . . 73.109999999999999 109.818 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -137.87 157.69 45.88 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.023 0.929 . . . . 74.219999999999999 109.337 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -78.22 77.16 4.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.743 0.782 . . . . 70.049999999999997 109.815 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -65.54 131.26 45.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.132 -1.394 . . . . 73.530000000000001 111.452 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -64.01 -51.48 64.04 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.271 0.628 . . . . 64.430000000000007 109.954 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -118.37 -65.68 1.15 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.445 -0.946 . . . . 71.549999999999997 108.445 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -160.43 118.02 2.51 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 123.191 0.307 . . . . 74.530000000000001 111.174 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -154.69 136.91 14.82 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.636 1.575 . . . . 73.439999999999998 107.854 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.694 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 29.1 t-20 -138.53 141.24 39.32 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.358 0.599 . . . . 62.439999999999998 109.904 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.495 HG22 ' HD2' ' A' ' 70' ' ' ARG . 58.9 t -101.52 151.15 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.465 1.106 . . . . 65.209999999999994 109.313 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 44.6 ttm -130.86 122.65 27.43 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.404 -0.961 . . . . 70.040000000000006 108.404 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 8' ' ' LEU . 47.9 mm -81.96 118.26 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.975 -1.121 . . . . 73.319999999999993 107.975 172.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -122.12 153.32 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.271 1.029 . . . . 71.439999999999998 108.738 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HB2' HD11 ' A' ' 8' ' ' LEU . 57.6 tttp -122.76 110.5 31.67 Favored Pre-proline 0 N--CA 1.473 0.698 0 N-CA-C 109.131 -0.692 . . . . 75.109999999999999 109.131 168.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 65' ' ' GLY . 27.2 Cg_exo -59.65 125.76 18.73 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.234 1.956 . . . . 71.219999999999999 110.192 167.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.83 -33.22 74.79 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.656 0.782 . . . . 45.439999999999998 111.327 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.55 -28.02 69.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.942 0.897 . . . . 63.229999999999997 111.449 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 35' ' ' ALA . 78.6 t -109.47 131.61 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.228 1.011 . . . . 72.0 111.4 -170.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -128.89 15.67 6.34 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.214 1.006 . . . . 71.329999999999998 110.525 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 m -143.75 154.06 43.07 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.335 0.654 . . . . 74.200000000000003 111.145 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.581 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 52.1 ttt180 -61.01 -50.28 74.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.259 1.024 . . . . 73.109999999999999 111.89 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.42 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 47.6 mt-10 -74.45 -30.45 61.88 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.58 0.352 . . . . 75.200000000000003 111.061 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -67.21 -25.4 66.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.069 0.548 . . . . 75.150000000000006 110.919 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.488 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -87.13 -30.63 20.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.546 0.738 . . . . 74.200000000000003 110.307 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 10.0 t -85.92 -6.97 58.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.068 0.947 . . . . 63.340000000000003 111.606 -172.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -82.82 -19.31 37.87 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.414 -0.587 . . . . 70.230000000000004 109.414 167.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.0 mt -87.82 6.31 35.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.631 0.772 . . . . 71.219999999999999 111.478 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 57' ' ' ILE . 42.5 mm -63.03 119.26 6.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 109.663 -0.495 . . . . 75.200000000000003 109.663 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.59 -4.53 40.02 Favored Glycine 0 C--O 1.239 0.46 0 CA-C-N 116.159 -0.473 . . . . 30.120000000000001 112.93 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -80.11 150.61 30.19 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 109.067 -0.716 . . . . 74.219999999999999 109.067 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.581 HD21 ' HD2' ' A' ' 54' ' ' LYS . 27.1 tp -89.86 159.55 16.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.208 -0.905 . . . . 34.539999999999999 109.024 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 86' ' ' ILE . 90.4 t -128.32 114.53 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 107.509 -1.293 . . . . 65.010000000000005 107.509 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.32 108.75 21.52 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.705 1.202 . . . . 71.040000000000006 108.846 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -144.87 123.47 12.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.325 0.65 . . . . 74.530000000000001 109.823 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 27.1 ttpp -88.11 135.89 33.22 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.944 0.498 . . . . 61.210000000000001 109.73 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.9 p -73.75 158.28 86.32 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.856 0.863 . . . . 70.230000000000004 110.765 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.21 -8.1 19.32 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.433 2.089 . . . . 71.340000000000003 112.444 167.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -72.89 -21.71 60.87 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.644 0.777 . . . . 72.239999999999995 111.271 168.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.05 -19.44 37.85 Favored Glycine 0 C--N 1.352 1.439 0 C-N-CA 123.038 0.352 . . . . 72.340000000000003 113.442 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 134.42 34.76 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.275 0.63 . . . . 73.310000000000002 109.923 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 62.2 mt -78.3 123.72 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.481 -0.563 . . . . 41.020000000000003 109.481 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.556 HD22 ' HB2' ' A' ' 73' ' ' LYS . 10.6 mt -102.97 131.05 50.21 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.28 -1.007 . . . . 64.230000000000004 108.28 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.581 ' HD2' HD21 ' A' ' 42' ' ' LEU . 32.1 mtmm -111.77 132.25 54.78 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.067 -0.716 . . . . 71.030000000000001 109.067 173.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.46 151.37 20.55 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 111.026 -0.829 . . . . 43.520000000000003 111.026 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -115.34 135.04 54.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.266 1.033 . . . . 72.219999999999999 110.708 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.492 HG22 HD13 ' A' ' 39' ' ' ILE . 56.7 mt -67.78 96.25 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.597 -0.89 . . . . 61.130000000000003 108.597 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 m -86.75 -31.4 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.012 0.525 . . . . 73.439999999999998 111.171 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -154.42 179.37 9.07 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 107.988 -1.116 . . . . 74.230000000000004 107.988 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.412 HG13 HD11 ' A' ' 39' ' ' ILE . 35.3 m -128.64 161.87 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.364 0.666 . . . . 64.400000000000006 109.959 170.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 21.8 t-80 -144.53 103.39 3.94 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.125 -0.695 . . . . 74.450000000000003 109.125 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.47 145.59 9.29 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 112.521 -0.232 . . . . 61.200000000000003 112.521 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.581 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 43.8 p -90.16 11.94 19.43 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.246 1.018 . . . . 62.350000000000001 111.928 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -106.58 17.08 23.77 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.03 0.932 . . . . 74.109999999999999 110.98 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' HD2' ' A' ' 26' ' ' PRO . . . 76.63 36.18 38.61 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.097 -0.501 . . . . 75.109999999999999 113.909 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . -89.75 123.68 33.97 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.641 -0.874 . . . . 51.520000000000003 108.641 172.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.473 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.5 m -102.06 152.86 5.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-O 121.898 0.856 . . . . 71.230000000000004 111.35 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -101.62 103.66 14.49 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.551 1.54 . . . . 65.420000000000002 108.331 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.61 117.11 33.24 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.162 0.585 . . . . 74.230000000000004 110.762 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.495 ' HD2' HG22 ' A' ' 21' ' ' VAL . 12.5 mmm-85 -89.44 102.62 15.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.326 1.05 . . . . 73.209999999999994 109.916 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.2 136.08 34.1 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.423 0.689 . . . . 55.32 110.976 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.532 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 14.3 pt-20 -57.33 -52.4 65.51 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.681 1.193 . . . . 42.140000000000001 111.039 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HB2' HD22 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -92.92 -54.04 3.91 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.332 -0.988 . . . . 70.439999999999998 108.332 -179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.694 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 60.77 50.01 72.25 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 124.823 1.327 . . . . 50.25 112.894 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.414 ' HB2' HD11 ' A' ' 53' ' ' LEU . 35.9 mt -67.74 111.71 8.38 Favored Pre-proline 0 C--N 1.351 0.633 0 C-N-CA 123.271 0.628 . . . . 75.409999999999997 110.102 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.58 173.42 9.53 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.009 2.473 . . . . 62.549999999999997 111.218 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 165.32 -168.31 39.3 Favored Glycine 0 C--O 1.238 0.383 0 N-CA-C 111.315 -0.714 . . . . 51.210000000000001 111.315 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -94.8 67.38 3.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.192 0.996 . . . . 75.109999999999999 109.232 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.09 26.5 9.22 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.689 -1.141 . . . . 62.43 109.714 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.58 119.26 12.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.516 0.727 . . . . 71.040000000000006 110.698 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.01 -2.12 38.25 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.982 -0.554 . . . . 32.32 112.558 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.55 162.84 27.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.439 0.696 . . . . 73.430000000000007 109.943 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.53 131.92 45.21 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.386 0.674 . . . . 74.150000000000006 111.034 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.26 159.24 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.598 1.159 . . . . 61.450000000000003 108.608 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.2 106.5 14.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.522 -0.918 . . . . 74.340000000000003 108.522 170.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.496 HG12 HG22 ' A' ' 43' ' ' VAL . 71.7 mt -83.42 108.73 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.383 -0.969 . . . . 72.129999999999995 108.383 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.73 143.87 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.946 0.898 . . . . 63.439999999999998 110.015 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.78 132.92 54.71 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 108.837 -0.801 . . . . 73.299999999999997 108.837 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -139.04 127.82 23.42 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.817 -1.179 . . . . 75.209999999999994 107.817 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -157.79 18.79 0.26 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.221 0.609 . . . . 72.129999999999995 110.718 -172.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 124.51 1.124 . . . . 74.310000000000002 110.097 -178.48 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.0 mtp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.869 0.366 . . . . 63.450000000000003 110.513 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 -128.52 139.35 52.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.172 0.989 . . . . 73.519999999999996 108.648 169.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 28' ' ' ASP . 53.0 mt -97.18 134.49 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 122.976 0.51 . . . . 70.409999999999997 110.476 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -89.27 121.61 31.72 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.005 0.922 . . . . 64.140000000000001 108.778 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -119.82 176.34 16.12 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-O 119.753 -0.471 . . . . 64.040000000000006 112.054 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.44 126.99 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.77 0.828 . . . . 75.219999999999999 109.653 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.43 99.4 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.618 0.767 . . . . 63.509999999999998 109.3 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 25' ' ' LYS . 66.5 mt -71.59 -48.04 50.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.438 0.695 . . . . 62.119999999999997 110.033 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -157.02 159.96 38.51 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.451 -0.795 . . . . 71.530000000000001 110.487 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -99.65 159.22 15.21 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.245 -1.021 . . . . 63.439999999999998 108.245 167.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.57 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -136.98 106.6 6.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.129 -1.063 . . . . 73.329999999999998 108.129 176.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.03 146.85 43.42 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.782 0.433 . . . . 73.129999999999995 110.46 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -96.09 151.47 19.44 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.438 0.695 . . . . 65.319999999999993 109.482 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -57.59 -33.37 68.13 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.733 0.813 . . . . 73.120000000000005 111.003 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.96 136.45 33.01 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.1 -1.445 . . . . 70.010000000000005 107.1 171.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -53.62 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.477 1.511 . . . . 74.219999999999999 113.099 -169.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 44.83 37.9 2.58 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.59 1.556 . . . . 73.319999999999993 113.255 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -74.07 -38.07 64.04 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.078 -0.965 . . . . 72.049999999999997 109.736 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -156.05 70.51 0.69 Allowed 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.607 -1.257 . . . . 62.240000000000002 107.607 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.501 HD21 ' HA3' ' A' ' 74' ' ' GLY . 0.1 OUTLIER -76.63 160.74 29.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.169 -0.923 . . . . 71.230000000000004 108.966 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.572 HG11 ' HE ' ' A' ' 68' ' ' ARG . 11.7 t -98.26 162.88 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.545 -0.909 . . . . 75.230000000000004 108.545 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.0 ttm -147.18 124.0 11.25 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.63 -1.248 . . . . 72.349999999999994 107.63 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.65 118.3 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 123.876 0.735 . . . . 44.409999999999997 109.278 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.8 mt -129.15 158.08 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.256 1.022 . . . . 72.319999999999993 108.386 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 8' ' ' LEU . 27.7 ttpp -141.41 108.44 6.16 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 109.671 -0.492 . . . . 71.049999999999997 109.671 170.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 14.2 Cg_endo -56.54 143.16 89.15 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 123.887 3.058 . . . . 73.530000000000001 112.864 171.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.7 mt -80.44 -38.15 30.62 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.348 1.059 . . . . 72.340000000000003 110.467 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' HB3' HG23 ' A' ' 3' ' ' ILE . 26.2 t70 -67.96 -27.64 66.77 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.135 -0.939 . . . . 61.310000000000002 111.593 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.474 HG21 HD11 ' A' ' 38' ' ' LEU . 76.5 t -110.79 120.06 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.194 0.998 . . . . 72.430000000000007 110.477 -176.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -127.67 21.64 6.47 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.695 0.798 . . . . 63.210000000000001 110.556 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.3 p -140.28 158.62 43.75 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.718 0.807 . . . . 71.400000000000006 110.676 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.649 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 48.3 ttt85 -65.96 -50.32 64.76 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.833 0.853 . . . . 74.010000000000005 112.775 -169.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -30.21 57.62 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.652 0.595 . . . . 70.409999999999997 111.163 -171.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HA ' ' HD2' ' A' ' 37' ' ' LYS . 42.7 mm-40 -69.1 -20.29 64.07 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.25 -0.432 . . . . 72.420000000000002 111.318 170.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.2 -26.22 20.23 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.736 0.814 . . . . 60.119999999999997 110.575 170.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -80.84 -12.59 59.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.789 0.835 . . . . 75.5 110.692 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 34' ' ' GLU . 15.0 ptmt -85.46 -16.39 39.8 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.126 0.489 . . . . 70.140000000000001 109.776 170.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 HG21 ' A' ' 29' ' ' VAL . 43.2 mt -81.98 -8.5 59.67 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.27 0.628 . . . . 73.310000000000002 111.149 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.534 HD13 HG22 ' A' ' 57' ' ' ILE . 43.1 mm -59.92 130.22 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.494 -0.558 . . . . 75.109999999999999 109.494 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.94 -19.06 56.12 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-O 119.872 -0.405 . . . . 61.539999999999999 112.844 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 87' ' ' VAL . 94.3 mtt180 -78.32 156.65 29.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.989 0.516 . . . . 75.310000000000002 111.309 -176.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.808 ' HB2' ' HA ' ' A' ' 90' ' ' HIS . 21.6 tp -90.99 128.88 36.99 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.531 0.732 . . . . 64.230000000000004 109.517 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 86' ' ' ILE . 56.5 t -99.28 115.12 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.054 -0.721 . . . . 62.229999999999997 109.054 172.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.17 122.62 34.83 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.397 -0.964 . . . . 75.140000000000001 108.397 173.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 37.6 t90 -135.86 132.22 36.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.24 -0.652 . . . . 61.5 109.24 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -90.61 122.66 33.59 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.292 -1.003 . . . . 63.109999999999999 108.292 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.8 p -83.86 159.51 60.24 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.095 0.558 . . . . 70.099999999999994 111.078 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.39 -14.91 44.21 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.337 2.025 . . . . 72.209999999999994 111.764 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.1 t -68.99 -23.2 64.08 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.895 0.878 . . . . 63.310000000000002 111.124 173.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.99 20.29 26.39 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 116.324 -0.398 . . . . 74.120000000000005 112.78 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -111.15 137.13 49.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.763 0.825 . . . . 71.319999999999993 110.128 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.3 mt -86.07 93.48 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.063 -1.088 . . . . 71.439999999999998 108.063 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 73' ' ' LYS . 51.1 mt -80.59 133.14 35.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.04 -0.982 . . . . 71.239999999999995 109.766 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB3' HD11 ' A' ' 42' ' ' LEU . 30.6 mtmm -116.01 138.58 51.08 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.092 -0.707 . . . . 51.229999999999997 109.092 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -140.02 176.16 21.43 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-N 115.602 -0.726 . . . . 74.420000000000002 111.312 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -135.76 133.85 38.4 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.565 0.682 . . . . 72.109999999999999 109.826 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.534 HG22 HD13 ' A' ' 39' ' ' ILE . 58.1 mt -73.84 108.32 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.384 -0.599 . . . . 54.509999999999998 109.384 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.33 -20.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.708 0.803 . . . . 71.219999999999999 111.464 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -158.45 162.66 37.55 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.524 -0.547 . . . . 72.25 109.524 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 39' ' ' ILE . 33.8 m -108.34 169.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.663 0.785 . . . . 64.299999999999997 109.731 171.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -125.26 104.59 8.57 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.034 -0.728 . . . . 65.099999999999994 109.034 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.56 -140.31 44.44 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 123.971 0.794 . . . . 72.040000000000006 113.331 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 63.5 p -115.34 4.26 14.37 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.794 0.838 . . . . 54.399999999999999 111.716 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -82.38 1.55 36.72 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.253 0.621 . . . . 63.43 112.13 -171.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.41 0.88 87.87 Favored Glycine 0 C--N 1.355 1.611 0 CA-C-O 120.069 -0.295 . . . . 62.200000000000003 112.966 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.88 121.51 16.18 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.322 0.649 . . . . 73.540000000000006 110.177 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.2 141.42 18.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.426 0.632 . . . . 62.539999999999999 110.824 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.572 ' HE ' HG11 ' A' ' 21' ' ' VAL . 64.7 ttt180 -103.8 104.32 14.31 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.879 0.872 . . . . 61.5 108.95 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.37 136.23 52.1 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.289 0.636 . . . . 70.040000000000006 110.592 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HG2' HG22 ' A' ' 21' ' ' VAL . 72.0 mtp180 -106.32 117.24 33.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.809 0.444 . . . . 61.549999999999997 110.005 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -92.41 143.69 26.12 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.933 0.893 . . . . 72.409999999999997 111.129 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 15.8 pt-20 -60.6 -30.98 70.17 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.49 1.116 . . . . 74.140000000000001 111.601 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' HB2' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -119.69 -72.73 0.67 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.744 -0.836 . . . . 71.230000000000004 108.744 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.501 ' HA3' HD21 ' A' ' 20' ' ' ASN . . . 66.57 57.26 10.39 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 111.759 -0.537 . . . . 73.120000000000005 111.759 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.12 123.17 85.65 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.824 0.85 . . . . 74.219999999999999 110.584 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.13 151.45 38.97 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 123.843 3.028 . . . . 73.299999999999997 113.489 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.56 171.52 37.47 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.395 -0.821 . . . . 54.539999999999999 111.106 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -87.39 69.01 9.88 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.773 0.797 . . . . 74.340000000000003 109.399 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -119.51 27.93 8.47 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.046 -0.979 . . . . 62.329999999999998 110.369 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.08 135.91 47.98 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.572 0.349 . . . . 72.329999999999998 110.385 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.17 -6.47 63.79 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.01 -0.541 . . . . 74.209999999999994 112.574 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.91 155.61 35.03 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.233 0.613 . . . . 55.520000000000003 109.44 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 97.3 m-85 -102.09 145.04 29.91 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.135 0.493 . . . . 63.109999999999999 112.147 -169.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.79 165.42 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.298 -0.865 . . . . 74.310000000000002 109.901 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -128.74 110.35 12.1 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.463 0.705 . . . . 73.019999999999996 109.118 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 43' ' ' VAL . 59.0 mt -84.22 113.18 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.094 0.958 . . . . 43.409999999999997 109.073 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 27.5 t -87.58 146.31 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.38 1.072 . . . . 51.229999999999997 110.022 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -57.02 -48.68 77.9 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.138 0.975 . . . . 75.109999999999999 110.856 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.32 -177.49 6.5 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.112 0.965 . . . . 72.230000000000004 110.452 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.808 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . 37.9 p-80 -137.88 -68.27 0.47 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.504 0.322 . . . . 71.409999999999997 110.944 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 . . . . . 0 C--O 1.246 0.907 0 N-CA-C 108.115 -1.069 . . . . 74.209999999999994 108.115 -178.4 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 120.939 0.4 . . . . 73.200000000000003 110.227 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.513 ' HG2' HG22 ' A' ' 87' ' ' VAL . 73.6 mtt180 -103.49 123.54 47.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.93 0.892 . . . . 72.219999999999999 109.188 173.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 48.4 mt -98.81 131.35 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.78 0.832 . . . . 73.430000000000007 108.85 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.11 120.58 29.61 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.788 -0.819 . . . . 74.230000000000004 108.788 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -125.24 170.71 17.17 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.861 -0.496 . . . . 61.140000000000001 111.861 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.7 t -126.54 138.95 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.239 1.016 . . . . 74.239999999999995 109.513 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.39 114.29 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.44 1.096 . . . . 62.119999999999997 110.12 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 23' ' ' ILE . 42.4 mt -92.61 -55.68 3.3 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.729 0.412 . . . . 55.219999999999999 110.479 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.1 m -153.87 152.33 30.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.837 0.455 . . . . 64.299999999999997 111.949 -174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -110.09 128.74 55.62 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.047 0.939 . . . . 72.140000000000001 108.574 170.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.79 106.19 9.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.058 -1.83 . . . . 65.530000000000001 106.058 171.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -76.91 125.41 29.26 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.252 0.478 . . . . 65.140000000000001 109.796 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.444 ' H ' ' HA ' ' A' ' 20' ' ' ASN . 33.5 t -73.6 119.42 17.8 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.303 1.041 . . . . 64.409999999999997 110.795 -174.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -68.87 106.63 2.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.845 0.858 . . . . 42.130000000000003 110.186 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.575 ' HG3' ' H ' ' A' ' 17' ' ' GLN . 11.2 tp10 -163.84 164.94 23.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.607 0.763 . . . . 63.030000000000001 109.763 -176.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.87 -35.78 79.13 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.607 -0.516 . . . . 70.200000000000003 109.607 171.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.575 ' H ' ' HG3' ' A' ' 15' ' ' GLU . 33.8 tt0 -88.2 113.01 23.39 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.504 -0.924 . . . . 72.120000000000005 108.504 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -57.62 119.78 7.18 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 124.091 0.869 . . . . 65.219999999999999 109.972 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -153.02 171.36 18.5 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.962 -1.125 . . . . 63.219999999999999 107.962 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.444 ' HA ' ' H ' ' A' ' 13' ' ' SER . 3.5 p-10 -149.0 150.21 32.44 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.467 0.651 . . . . 74.219999999999999 110.789 174.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.444 HG22 ' HD3' ' A' ' 70' ' ' ARG . 47.3 t -88.07 143.5 11.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.885 -1.524 . . . . 73.430000000000007 106.885 159.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.4 ttt -137.26 113.58 10.04 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.46 -0.941 . . . . 73.239999999999995 108.46 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 8' ' ' LEU . 46.0 mm -80.37 119.83 30.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.104 -1.073 . . . . 70.209999999999994 108.104 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.479 HG21 HG21 ' A' ' 84' ' ' VAL . 98.0 mt -129.87 143.99 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.187 0.995 . . . . 71.430000000000007 108.398 -175.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HB2' HD11 ' A' ' 8' ' ' LEU . 64.4 tttp -116.06 111.22 42.94 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 109.01 -0.737 . . . . 62.119999999999997 109.01 167.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 16.4 Cg_exo -66.33 131.27 26.07 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.12 1.88 . . . . 65.120000000000005 110.729 167.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.38 -31.91 72.64 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.016 0.926 . . . . 74.230000000000004 111.885 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.82 -29.88 64.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.791 0.836 . . . . 53.420000000000002 111.55 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 34' ' ' GLU . 72.0 t -103.1 107.73 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.0 0.92 . . . . 70.010000000000005 110.677 -170.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -124.45 17.8 8.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.486 1.114 . . . . 72.140000000000001 109.839 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.3 t -139.62 156.32 46.92 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.366 1.067 . . . . 73.25 109.97 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -67.68 -37.67 82.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.308 0.643 . . . . 73.209999999999994 110.903 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.66 -45.09 95.45 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.929 0.891 . . . . 71.230000000000004 111.594 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HB2' HG13 ' A' ' 29' ' ' VAL . 42.1 mt-10 -65.17 -32.72 74.55 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.888 -1.051 . . . . 74.409999999999997 110.553 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.0 -28.76 49.28 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.901 0.88 . . . . 54.420000000000002 111.36 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -75.69 -25.96 57.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.146 0.978 . . . . 72.409999999999997 111.474 -173.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -84.43 -3.19 58.2 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.098 0.407 . . . . 45.310000000000002 112.098 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.541 HD11 HG21 ' A' ' 29' ' ' VAL . 29.9 mt -90.52 -2.87 57.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.814 0.445 . . . . 73.340000000000003 111.428 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -66.2 117.57 7.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.087 0.555 . . . . 72.510000000000005 109.835 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.97 1.98 57.14 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.152 -0.931 . . . . 61.030000000000001 113.202 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -87.62 161.0 17.95 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.327 1.063 . . . . 73.099999999999994 111.055 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.4 tp -90.1 139.25 30.81 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.338 1.055 . . . . 73.540000000000006 108.314 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 t -126.7 122.21 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.552 -0.907 . . . . 72.420000000000002 108.552 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.19 102.25 11.67 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.947 0.899 . . . . 63.450000000000003 109.745 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.479 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 29.4 t90 -95.47 144.22 26.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.248 -0.649 . . . . 75.239999999999995 109.248 170.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -103.36 100.33 10.21 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.603 1.161 . . . . 64.219999999999999 108.162 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.7 p -64.62 150.38 94.04 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.583 0.753 . . . . 74.530000000000001 111.246 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.88 -5.35 15.39 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.646 2.231 . . . . 73.409999999999997 112.289 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.5 t -70.72 -19.54 62.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.705 1.202 . . . . 64.329999999999998 111.163 169.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.51 36.08 8.96 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.887 -0.597 . . . . 35.549999999999997 112.068 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -127.67 131.99 49.75 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.025 0.93 . . . . 74.299999999999997 109.014 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -90.26 93.11 4.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.661 -1.237 . . . . 73.519999999999996 107.661 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 75' ' ' LEU . 34.9 mt -74.86 137.35 41.76 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.819 -1.082 . . . . 75.340000000000003 109.508 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -98.0 137.65 36.5 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.003 0.921 . . . . 44.399999999999999 108.92 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.56 176.31 22.41 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 123.687 0.617 . . . . 72.200000000000003 111.635 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.3 ttmt -147.37 129.98 15.95 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.907 0.353 . . . . 75.140000000000001 110.752 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.4 mt -73.04 105.03 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.874 -1.057 . . . . 73.230000000000004 109.175 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 m -84.55 -36.14 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.821 -0.627 . . . . 54.539999999999999 110.816 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -148.22 -174.74 4.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.676 0.79 . . . . 74.150000000000006 111.203 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -114.31 170.53 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.235 1.014 . . . . 73.319999999999993 110.125 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -136.89 101.63 4.64 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.378 -0.971 . . . . 71.219999999999999 108.378 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.76 -172.56 10.17 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.268 -0.878 . . . . 65.310000000000002 115.181 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.3 p -91.22 11.93 21.82 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.808 1.243 . . . . 75.150000000000006 110.853 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.84 -25.35 60.03 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.937 1.295 . . . . 72.409999999999997 109.718 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.4 -2.43 65.23 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.653 -0.703 . . . . 42.350000000000001 112.788 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.4 129.76 40.91 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.028 0.531 . . . . 44.240000000000002 109.898 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.9 m -102.0 149.9 6.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 C-N-CA 123.665 0.786 . . . . 74.430000000000007 110.805 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -99.76 102.63 14.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.013 -1.449 . . . . 72.450000000000003 107.506 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.57 157.53 17.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.002 0.521 . . . . 71.209999999999994 110.743 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.444 ' HD3' HG22 ' A' ' 21' ' ' VAL . 10.0 mmm180 -131.65 99.7 4.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.366 1.066 . . . . 72.530000000000001 109.703 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.43 ' HB2' ' OD1' ' A' ' 20' ' ' ASN . 16.7 m-85 -88.97 138.51 31.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.181 0.593 . . . . 74.439999999999998 109.818 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.17 -43.23 99.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.83 1.252 . . . . 73.129999999999995 112.43 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -87.64 -53.4 4.81 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.613 -0.721 . . . . 64.099999999999994 111.808 -167.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.73 35.66 39.68 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-O 120.006 -0.33 . . . . 61.329999999999998 113.428 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.646 ' HB2' HD11 ' A' ' 53' ' ' LEU . 41.4 mt -69.42 126.52 92.7 Favored Pre-proline 0 C--N 1.353 0.728 0 C-N-CA 122.409 0.284 . . . . 71.099999999999994 110.44 177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.56 158.94 46.99 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.866 2.377 . . . . 75.200000000000003 110.918 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.3 115.1 0.35 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.243 -1.143 . . . . 64.430000000000007 110.243 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -65.95 75.97 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.089 1.355 . . . . 74.409999999999997 111.059 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.479 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -120.83 28.41 7.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.056 1.342 . . . . 75.519999999999996 109.468 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.3 mt -64.5 103.65 0.69 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 108.59 -0.893 . . . . 72.140000000000001 108.59 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.06 -5.52 8.93 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 116.154 -0.476 . . . . 51.119999999999997 113.109 -172.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -76.02 172.28 13.03 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.956 0.902 . . . . 73.510000000000005 108.905 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -107.51 143.62 35.65 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.526 0.679 . . . . 72.099999999999994 111.419 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG21 HG21 ' A' ' 24' ' ' ILE . 19.6 m -113.24 164.29 9.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-N 114.319 -1.31 . . . . 75.239999999999995 108.405 172.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -127.76 109.74 11.94 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.936 0.494 . . . . 71.349999999999994 109.921 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 54.6 mt -82.59 92.66 2.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.078 -1.082 . . . . 55.210000000000001 108.078 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 2' ' ' ARG . 96.4 t -77.48 128.79 37.97 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 CA-C-N 113.917 -1.492 . . . . 70.349999999999994 110.105 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.25 137.63 57.7 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 108.167 -1.049 . . . . 74.120000000000005 108.167 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -58.48 134.15 56.42 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.273 1.029 . . . . 71.319999999999993 113.13 -173.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -107.2 92.96 4.29 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.94 0.896 . . . . 60.329999999999998 108.9 173.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 . . . . . 0 C--O 1.249 1.05 0 N-CA-C 108.357 -0.979 . . . . 65.109999999999999 108.357 -179.762 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 ttm . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.338 -0.615 . . . . 74.510000000000005 109.338 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HG2' ' HA ' ' A' ' 87' ' ' VAL . 59.9 mtm-85 -134.71 153.84 51.82 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.365 1.066 . . . . 71.239999999999995 109.414 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 55.9 mt -121.92 137.32 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.866 0.866 . . . . 74.519999999999996 109.41 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -89.09 131.86 35.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.297 -0.631 . . . . 63.409999999999997 109.297 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -137.97 137.52 8.9 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-O 120.169 -0.24 . . . . 64.230000000000004 112.983 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t -98.97 117.08 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.808 0.843 . . . . 74.430000000000007 110.261 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.98 106.76 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.529 1.132 . . . . 73.420000000000002 110.669 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.7 -50.56 15.01 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.37 0.668 . . . . 74.219999999999999 110.05 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -154.35 172.05 18.32 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.1 -0.954 . . . . 51.549999999999997 110.684 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -120.33 122.61 41.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.963 -1.125 . . . . 71.530000000000001 107.963 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.51 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 1.8 tpm_? -101.83 104.2 14.94 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 106.777 -1.564 . . . . 70.519999999999996 106.777 174.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 66.6 mtp85 -100.32 115.38 29.83 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.15 0.5 . . . . 74.150000000000006 111.994 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.6 t -67.84 134.24 50.56 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 108.103 -1.073 . . . . 74.120000000000005 108.103 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -58.02 117.27 4.15 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 124.107 0.88 . . . . 75.409999999999997 110.357 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 60.37 20.18 9.78 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.473 1.109 . . . . 64.109999999999999 113.074 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.0 t30 68.09 30.54 5.83 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.351 1.06 . . . . 75.239999999999995 110.695 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -58.1 -64.41 0.92 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.124 0.97 . . . . 74.230000000000004 111.864 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -99.35 25.8 6.61 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.156 0.582 . . . . 72.340000000000003 109.761 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 73.17 134.99 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.244 1.817 . . . . 73.120000000000005 112.146 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 36.8 t30 -73.54 137.7 44.54 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 123.395 0.678 . . . . 72.129999999999995 110.477 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.606 HG22 ' HG2' ' A' ' 70' ' ' ARG . 67.7 t -105.74 155.39 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 125.89 1.676 . . . . 74.510000000000005 109.785 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 44.3 ttm -137.73 127.47 25.36 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.662 -0.866 . . . . 71.439999999999998 108.662 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mm -88.01 110.57 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.47 -0.937 . . . . 72.340000000000003 108.47 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 84' ' ' VAL . 79.7 mt -117.39 149.21 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.364 1.066 . . . . 75.019999999999996 109.051 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -123.95 97.67 40.66 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 108.082 -1.081 . . . . 71.140000000000001 108.082 174.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.801 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 36.9 Cg_exo -60.85 125.62 17.64 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.919 2.412 . . . . 55.340000000000003 112.639 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.16 -42.33 89.14 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.623 0.769 . . . . 74.310000000000002 112.541 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.47 0.76 55.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.641 0.776 . . . . 73.219999999999999 111.983 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.801 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 59.4 t -114.3 107.89 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.296 1.038 . . . . 40.009999999999998 108.355 174.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -121.9 6.48 9.86 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.404 0.682 . . . . 74.019999999999996 111.77 -173.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 m -127.68 142.65 51.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.855 0.862 . . . . 70.409999999999997 108.875 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.533 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 57.3 ttt180 -57.4 -34.78 69.25 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.007 0.923 . . . . 74.510000000000005 111.27 175.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -60.26 -42.65 95.79 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.663 0.785 . . . . 62.509999999999998 111.825 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.657 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.5 mt-10 -64.44 -44.33 91.51 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.163 -0.926 . . . . 71.239999999999995 109.376 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.9 -26.01 66.66 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.438 -0.801 . . . . 72.209999999999994 111.55 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -73.56 -33.93 64.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.35 1.06 . . . . 74.150000000000006 110.777 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -85.86 -2.94 58.75 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.791 0.293 . . . . 75.239999999999995 111.791 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 29' ' ' VAL . 50.5 mt -86.19 -1.58 57.57 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 119.232 -0.413 . . . . 54.5 112.06 174.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 57' ' ' ILE . 43.2 mm -64.22 122.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.672 -0.862 . . . . 70.109999999999999 108.672 172.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.06 -4.94 55.93 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 116.508 -0.315 . . . . 73.019999999999996 113.163 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -84.8 148.09 26.5 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.197 0.499 . . . . 74.019999999999996 109.729 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.3 tp -88.83 141.5 28.45 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.4 1.08 . . . . 74.310000000000002 108.507 -173.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.51 126.02 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.4 -0.593 . . . . 72.420000000000002 109.4 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.1 mt -111.49 105.66 14.32 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.078 0.951 . . . . 73.219999999999999 109.421 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.46 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 47.3 t90 -110.47 133.27 53.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.306 0.642 . . . . 70.409999999999997 109.374 174.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -92.59 111.98 23.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.791 -1.188 . . . . 73.420000000000002 107.791 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.5 p -68.47 152.51 96.57 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.238 0.615 . . . . 74.030000000000001 111.338 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.41 -18.12 57.43 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.972 2.448 . . . . 52.32 111.917 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.6 m -61.55 -21.07 63.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.156 1.383 . . . . 63.0 111.988 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.71 20.35 44.29 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 116.352 -0.385 . . . . 24.52 112.425 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -108.29 146.98 32.09 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.875 0.87 . . . . 72.409999999999997 109.192 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -101.36 93.43 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.669 -1.234 . . . . 71.120000000000005 107.669 172.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.6 mt -77.88 130.28 36.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.938 -1.028 . . . . 74.219999999999999 109.103 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -107.3 146.62 31.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.277 0.631 . . . . 73.019999999999996 109.32 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.32 -171.31 21.12 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.214 -0.903 . . . . 62.240000000000002 111.497 -175.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -152.22 135.34 15.76 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.001 0.401 . . . . 63.399999999999999 110.954 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.457 HG22 HD13 ' A' ' 39' ' ' ILE . 70.6 mt -69.83 110.64 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 O-C-N 124.095 0.872 . . . . 63.140000000000001 108.686 175.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.44 -8.54 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.513 0.725 . . . . 65.540000000000006 111.291 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.408 ' HB3' ' HD3' ' A' ' 68' ' ' ARG . 18.6 tpp180 -158.48 150.79 21.76 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.73 -0.471 . . . . 75.239999999999995 109.73 -174.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.418 HG13 HD11 ' A' ' 39' ' ' ILE . 23.7 m -98.62 159.46 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.436 0.694 . . . . 64.230000000000004 109.537 173.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.414 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 59.7 t-80 -144.44 104.48 4.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.126 0.57 . . . . 70.150000000000006 109.808 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.91 168.94 40.49 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 121.336 0.409 . . . . 72.209999999999994 113.655 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.533 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 21.4 p -85.0 -9.22 58.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.482 1.113 . . . . 74.329999999999998 112.29 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -81.87 5.95 17.29 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.509 0.724 . . . . 61.420000000000002 112.686 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' HA3' HG12 ' A' ' 29' ' ' VAL . . . 84.84 9.11 81.56 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 119.518 -0.601 . . . . 75.450000000000003 113.802 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . . . -67.18 133.9 50.67 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 122.656 0.383 . . . . 71.209999999999994 110.201 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.3 150.06 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.547 0.739 . . . . 51.219999999999999 111.231 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 59' ' ' ARG . 60.2 ttt180 -103.0 105.21 15.48 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.546 1.138 . . . . 72.209999999999994 108.369 171.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.84 120.24 41.92 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.453 0.701 . . . . 71.519999999999996 109.936 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.606 ' HG2' HG22 ' A' ' 21' ' ' VAL . 41.2 mtm105 -88.92 118.81 28.9 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.174 -0.676 . . . . 70.019999999999996 109.174 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -90.78 122.94 33.95 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.336 0.654 . . . . 74.510000000000005 109.773 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.0 -39.3 74.43 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.223 1.009 . . . . 74.400000000000006 111.873 -173.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -76.81 -55.06 5.82 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.251 -0.886 . . . . 73.239999999999995 109.528 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 61.26 34.55 88.55 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 114.6 -1.182 . . . . 74.25 113.865 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 96.0 mt -69.66 137.83 88.21 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.588 0.755 . . . . 64.299999999999997 110.353 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 12.8 Cg_exo -68.76 143.85 57.39 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.96 2.44 . . . . 74.519999999999996 112.445 -174.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.76 104.02 0.17 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.722 -0.951 . . . . 63.109999999999999 110.722 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -73.68 91.18 1.87 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.733 0.813 . . . . 73.150000000000006 110.025 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -115.83 30.77 7.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.717 1.207 . . . . 74.340000000000003 109.91 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.1 mt -43.9 103.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.323 1.049 . . . . 63.119999999999997 112.259 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.15 4.75 20.38 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.814 -0.63 . . . . 33.439999999999998 113.913 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -91.36 168.11 11.8 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.055 0.942 . . . . 71.349999999999994 110.901 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -100.15 154.6 18.31 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.722 0.809 . . . . 74.430000000000007 112.627 -172.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 24' ' ' ILE . 18.5 m -131.18 158.21 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.92 1.288 . . . . 73.019999999999996 109.062 176.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.97 108.25 17.52 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.058 -0.719 . . . . 75.239999999999995 109.058 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 68.1 mt -89.14 94.09 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.976 -1.12 . . . . 71.209999999999994 107.976 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.435 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . 48.6 t -74.01 133.48 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.143 -0.935 . . . . 74.349999999999994 109.043 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -61.34 127.64 32.48 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.743 -0.836 . . . . 72.430000000000007 108.743 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.53 144.38 21.7 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.237 -1.023 . . . . 71.510000000000005 108.237 -174.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -152.94 136.24 15.76 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.314 0.645 . . . . 72.0 109.79 -177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 42.3 t60 . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 118.59 -0.719 . . . . 62.130000000000003 110.04 -177.825 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.968 -0.382 . . . . 73.420000000000002 109.968 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -99.7 135.26 41.39 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.525 0.73 . . . . 65.230000000000004 109.466 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.503 HD12 HH11 ' A' ' 41' ' ' ARG . 65.7 mt -111.84 124.06 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.91 -1.144 . . . . 73.329999999999998 107.91 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 7.1 ptpp? -88.35 127.29 35.48 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.314 0.578 . . . . 63.420000000000002 110.912 -173.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -123.76 160.45 18.31 Favored Glycine 0 C--O 1.218 -0.872 0 CA-C-N 115.59 -0.732 . . . . 62.200000000000003 111.834 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.14 129.56 50.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 123.542 0.737 . . . . 73.310000000000002 109.379 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.505 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 60.4 t -66.93 99.87 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.954 0.902 . . . . 62.100000000000001 109.459 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.748 HD11 ' HG2' ' A' ' 25' ' ' LYS . 72.2 mt -74.46 -59.32 2.78 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.776 -0.453 . . . . 74.219999999999999 109.776 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.4 t -166.08 162.07 17.6 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.923 -0.581 . . . . 75.099999999999994 111.355 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB3' HD21 ' A' ' 20' ' ' ASN . 62.4 m-85 -115.87 145.35 42.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.965 1.306 . . . . 70.329999999999998 108.892 171.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -136.27 106.17 6.26 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.426 -1.324 . . . . 64.519999999999996 107.426 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -75.46 136.67 40.67 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.723 -0.473 . . . . 73.109999999999999 109.723 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.2 t -77.73 145.23 36.66 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.653 0.381 . . . . 63.409999999999997 110.706 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -72.06 -26.44 62.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.885 0.874 . . . . 54.450000000000003 110.263 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -68.99 -59.57 2.96 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.049 0.94 . . . . 74.129999999999995 109.29 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 2.8 m-20 -129.56 116.34 18.76 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.184 0.994 . . . . 62.329999999999998 108.894 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -56.06 -44.53 78.99 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.469 1.108 . . . . 74.099999999999994 111.398 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -74.85 -28.59 60.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.92 -1.036 . . . . 71.519999999999996 111.696 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 16' ' ' ASN . 16.2 t-20 -82.16 84.12 7.14 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.543 -0.91 . . . . 73.299999999999997 108.543 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.508 HD21 ' HB3' ' A' ' 10' ' ' TYR . 44.6 t-20 -97.2 127.7 43.41 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.618 -1.174 . . . . 75.349999999999994 109.223 -174.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.8 t -88.44 105.1 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.448 -0.945 . . . . 54.310000000000002 108.448 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.42 ' HE3' HG22 ' A' ' 7' ' ' VAL . 24.8 ttt -98.83 136.46 38.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.268 -1.333 . . . . 72.010000000000005 109.11 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.511 HG22 HD12 ' A' ' 8' ' ' LEU . 27.7 mm -104.48 131.0 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 108.238 -1.023 . . . . 70.129999999999995 108.238 174.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.9 mt -124.97 150.31 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.941 0.897 . . . . 74.129999999999995 109.239 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.748 ' HG2' HD11 ' A' ' 8' ' ' LEU . 1.1 mmmm -120.37 98.59 48.52 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 123.115 0.566 . . . . 61.549999999999997 110.404 170.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 23.8 Cg_exo -63.07 135.88 53.42 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.116 1.877 . . . . 72.319999999999993 110.377 169.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.5 mt -60.73 -30.99 70.31 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.31 0.576 . . . . 71.239999999999995 111.149 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.23 -27.17 61.44 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.334 1.453 . . . . 73.140000000000001 111.79 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 34' ' ' GLU . 94.6 t -115.93 121.09 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.9 0.88 . . . . 61.140000000000001 110.427 -170.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -135.29 14.68 3.5 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.671 0.788 . . . . 73.5 111.26 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 m -137.67 151.27 48.08 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.845 0.858 . . . . 54.020000000000003 109.781 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.65 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 50.0 ttt180 -60.37 -38.82 85.1 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.253 1.021 . . . . 75.209999999999994 112.184 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.57 -40.1 95.78 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.049 0.54 . . . . 73.340000000000003 111.44 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.508 ' HB2' HG13 ' A' ' 29' ' ' VAL . 48.0 mt-10 -64.73 -35.64 81.71 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.9 0.75 . . . . 63.420000000000002 110.828 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.79 -30.6 51.38 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.987 0.915 . . . . 63.210000000000001 111.274 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -73.19 -31.63 64.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.065 0.946 . . . . 72.409999999999997 111.25 -173.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -79.28 -11.71 59.94 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 120.831 0.348 . . . . 54.210000000000001 110.899 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.587 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 51.5 mt -109.73 23.62 14.16 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.205 1.002 . . . . 74.310000000000002 111.561 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.5 mm -75.47 135.39 27.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.565 -0.531 . . . . 71.109999999999999 109.565 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.6 -9.3 44.55 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-O 119.103 -0.831 . . . . 65.5 113.061 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.587 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 79.1 mtm180 -62.11 149.11 42.25 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.334 0.654 . . . . 73.209999999999994 112.408 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 tp -91.64 120.68 32.62 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.369 1.068 . . . . 62.409999999999997 109.262 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.0 t -100.21 137.28 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 122.911 0.484 . . . . 60.32 110.031 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.7 mt -131.34 120.13 22.7 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.787 1.235 . . . . 74.019999999999996 107.761 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.42 ' HE1' ' HB3' ' A' ' 82' ' ' ASP . 47.4 t90 -130.28 128.44 41.57 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.435 -0.579 . . . . 74.129999999999995 109.435 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -84.43 110.84 18.94 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.347 -0.612 . . . . 63.420000000000002 109.347 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.8 t -77.2 153.72 82.23 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 124.255 1.022 . . . . 63.43 109.537 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.3 -8.55 14.85 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.137 2.558 . . . . 75.099999999999994 114.686 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.9 p -70.9 -15.32 62.61 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.262 0.625 . . . . 74.310000000000002 111.506 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.23 -10.53 63.54 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 123.719 0.676 . . . . 43.149999999999999 112.388 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.57 132.41 35.11 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.627 0.771 . . . . 74.450000000000003 110.755 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.8 106.5 13.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.944 -0.761 . . . . 54.25 108.944 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.8 117.93 16.15 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.726 -0.842 . . . . 74.340000000000003 108.726 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -109.16 146.67 33.74 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 123.021 0.528 . . . . 55.509999999999998 110.424 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.82 -171.75 27.2 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 114.825 -1.079 . . . . 32.5 110.999 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.73 134.18 20.81 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.057 0.428 . . . . 74.030000000000001 111.086 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 41' ' ' ARG . 78.1 mt -67.5 106.87 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.509 0 O-C-N 124.41 1.069 . . . . 62.039999999999999 109.402 175.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.545 HG11 ' HE ' ' A' ' 70' ' ' ARG . 27.6 m -91.52 -31.74 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.567 0.747 . . . . 54.130000000000003 111.559 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -155.76 176.29 12.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.863 -0.791 . . . . 71.299999999999997 108.863 -173.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.2 m -92.51 170.06 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 109.092 -0.707 . . . . 74.329999999999998 109.092 170.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -136.17 103.4 5.31 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.267 -1.012 . . . . 72.310000000000002 108.267 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.7 -149.04 42.71 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.657 -0.702 . . . . 22.140000000000001 113.24 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.65 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -117.97 -17.37 9.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.472 0.709 . . . . 70.299999999999997 112.105 -171.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 25.29 2.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.497 0.719 . . . . 61.130000000000003 112.232 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.22 18.13 78.66 Favored Glycine 0 C--N 1.346 1.13 0 N-CA-C 114.97 0.748 . . . . 73.409999999999997 114.97 167.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.12 38.19 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.582 -0.896 . . . . 61.310000000000002 108.582 171.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.8 m -102.43 139.46 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.046 0.451 . . . . 65.0 109.973 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -99.58 105.53 17.42 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.118 0.967 . . . . 74.230000000000004 108.747 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.51 121.58 44.7 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.832 0.853 . . . . 70.349999999999994 110.817 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HE ' HG11 ' A' ' 58' ' ' VAL . 39.1 mtm180 -89.33 113.12 24.36 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.979 -0.748 . . . . 63.299999999999997 108.979 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -81.5 136.15 35.62 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.337 1.055 . . . . 72.519999999999996 110.329 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.66 -24.78 36.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.404 0.682 . . . . 70.129999999999995 110.904 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -77.39 -54.77 6.05 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.485 -0.78 . . . . 70.430000000000007 109.685 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.04 25.1 63.82 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 124.042 0.838 . . . . 71.030000000000001 114.263 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.63 158.46 78.5 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.949 0.9 . . . . 73.430000000000007 110.848 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.58 150.6 51.32 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.996 2.464 . . . . 73.129999999999995 112.733 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.24 -71.96 0.3 Allowed Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.915 -0.584 . . . . 73.120000000000005 112.43 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 76.02 -40.43 0.4 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 126.075 1.75 . . . . 75.019999999999996 112.604 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.81 30.07 0.11 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.126 0.97 . . . . 44.149999999999999 112.661 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.18 149.42 28.32 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.216 1.006 . . . . 72.25 110.707 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' H ' ' HB ' ' A' ' 7' ' ' VAL . . . 87.72 4.12 79.8 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 116.601 -0.272 . . . . 73.510000000000005 113.076 -169.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.42 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 35.0 t70 -85.38 170.9 12.28 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.76 0.824 . . . . 73.329999999999998 110.176 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.69 133.24 36.2 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.516 0.674 . . . . 73.099999999999994 112.169 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 11.4 m -100.71 159.34 3.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 114.452 -1.249 . . . . 72.319999999999993 108.946 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -109.19 108.9 19.71 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.473 -0.936 . . . . 72.430000000000007 108.473 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.9 95.13 4.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.584 -0.895 . . . . 75.420000000000002 108.584 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.22 136.73 24.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 115.246 -0.888 . . . . 75.219999999999999 109.593 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.64 96.4 0.27 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.642 -0.873 . . . . 60.229999999999997 108.642 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.75 141.87 58.18 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.799 0.84 . . . . 74.140000000000001 110.592 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 32.8 m170 61.75 66.46 0.84 Allowed 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.743 1.217 . . . . 62.399999999999999 109.902 -173.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 34.3 p80 . . . . . 0 C--O 1.253 1.284 0 CA-C-N 114.998 -1.001 . . . . 72.109999999999999 109.748 174.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 121.168 0.509 . . . . 72.120000000000005 110.383 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -133.27 118.94 19.16 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.421 -1.326 . . . . 75.329999999999998 107.421 173.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 mt -98.55 155.69 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.411 1.084 . . . . 65.150000000000006 108.96 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.553 ' HG3' HD12 ' A' ' 27' ' ' LEU . 19.1 ptmt -114.36 140.92 48.26 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.865 -0.791 . . . . 75.030000000000001 108.865 173.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -139.32 164.57 25.9 Favored Glycine 0 C--O 1.216 -0.995 0 N-CA-C 111.647 -0.581 . . . . 23.309999999999999 111.647 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.37 131.38 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.348 0.659 . . . . 75.230000000000004 109.926 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.1 93.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.304 -0.998 . . . . 72.099999999999994 108.304 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 25' ' ' LYS . 79.8 mt -68.4 -59.31 3.27 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 110.131 -0.322 . . . . 73.319999999999993 110.131 -176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 t -154.38 155.67 35.46 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.074 -0.512 . . . . 72.400000000000006 110.722 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -95.78 138.81 32.91 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.458 -0.941 . . . . 73.439999999999998 108.458 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -130.06 107.11 9.08 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.585 -0.894 . . . . 71.230000000000004 108.585 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -76.18 138.85 40.95 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 110.111 -0.329 . . . . 64.25 110.111 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.502 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 62.9 m -86.28 131.98 34.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.348 0.659 . . . . 73.349999999999994 109.766 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -65.36 -30.19 70.99 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.226 1.01 . . . . 72.319999999999993 112.474 -175.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -98.62 -62.77 1.19 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.706 0.803 . . . . 75.230000000000004 109.128 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.56 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 11.7 m120 -75.5 88.69 2.67 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.791 -0.64 . . . . 74.140000000000001 110.354 -176.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -61.98 -24.42 67.01 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.733 0.813 . . . . 75.019999999999996 112.37 -175.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -110.09 -42.09 4.28 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.452 0.701 . . . . 53.340000000000003 111.046 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.56 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 53.7 t30 -78.11 72.45 4.64 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.758 0.789 . . . . 72.140000000000001 108.923 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -89.63 159.72 17.01 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.981 -1.009 . . . . 63.030000000000001 109.025 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 70' ' ' ARG . 62.2 t -88.12 145.9 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 108.282 -1.007 . . . . 72.310000000000002 108.282 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.3 ttt -136.22 111.51 9.09 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.485 -1.302 . . . . 62.210000000000001 107.485 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 mm -78.51 119.13 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 114.98 -1.009 . . . . 63.310000000000002 108.387 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.469 HG21 HG21 ' A' ' 84' ' ' VAL . 81.5 mt -130.93 153.12 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.488 1.115 . . . . 73.400000000000006 108.089 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HB2' HD11 ' A' ' 8' ' ' LEU . 87.5 tttt -127.33 121.88 22.69 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 108.912 -0.773 . . . . 73.400000000000006 108.912 164.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -69.87 140.23 41.74 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.768 2.312 . . . . 70.25 110.768 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.553 HD12 ' HG3' ' A' ' 4' ' ' LYS . 92.7 mt -69.84 -29.78 67.11 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.384 0.673 . . . . 73.540000000000006 111.276 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.08 -22.23 60.62 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.996 -1.002 . . . . 64.439999999999998 111.303 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' A' ' 34' ' ' GLU . 57.9 t -110.23 123.96 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.335 1.054 . . . . 63.32 110.746 -174.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -135.16 11.13 3.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.845 0.858 . . . . 64.299999999999997 110.429 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.442 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 27.5 m -131.09 165.33 23.49 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.426 0.69 . . . . 74.0 111.126 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -68.93 -43.73 74.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.703 1.201 . . . . 73.430000000000007 110.97 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -70.65 -32.54 69.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.746 0.818 . . . . 72.019999999999996 110.763 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.563 ' HB2' HG13 ' A' ' 29' ' ' VAL . 44.7 mt-10 -68.51 -30.89 69.81 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.78 -0.645 . . . . 73.450000000000003 110.5 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.38 -32.04 33.04 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.578 0.751 . . . . 72.349999999999994 110.728 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -75.18 -23.77 57.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.869 0.868 . . . . 72.349999999999994 111.382 -174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -80.23 -13.67 59.04 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 120.73 0.3 . . . . 70.010000000000005 110.968 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.9 mt -90.32 3.87 52.42 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 122.961 0.504 . . . . 75.040000000000006 112.084 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.481 HD13 HG22 ' A' ' 57' ' ' ILE . 48.9 mm -65.63 124.36 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 108.819 -0.808 . . . . 71.530000000000001 108.819 171.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.06 9.56 62.08 Favored Glycine 0 N--CA 1.475 1.288 0 CA-C-O 119.967 -0.351 . . . . 74.400000000000006 113.371 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.714 ' HG3' ' HA ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -89.85 146.72 24.23 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.691 0.796 . . . . 74.310000000000002 110.673 178.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.8 tp -93.98 115.41 27.75 Favored 'General case' 0 C--N 1.345 0.398 0 O-C-N 124.037 0.835 . . . . 64.310000000000002 109.41 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.9 t -98.99 120.43 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 109.629 -0.508 . . . . 75.310000000000002 109.629 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt -105.9 128.05 53.53 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.765 1.226 . . . . 63.340000000000003 109.077 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -147.33 119.27 8.15 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.377 -0.601 . . . . 72.430000000000007 109.377 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 28.3 ttpp -82.06 112.27 18.97 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.194 -0.669 . . . . 73.129999999999995 109.194 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.0 p -64.7 155.51 81.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.781 0.832 . . . . 61.229999999999997 110.94 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.71 -9.09 19.57 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.988 2.459 . . . . 73.349999999999994 112.523 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 t -74.67 -10.12 59.23 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.927 0.891 . . . . 61.310000000000002 111.347 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.47 -12.37 63.18 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 123.633 0.635 . . . . 60.140000000000001 113.188 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -83.51 126.66 33.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.564 0.746 . . . . 65.400000000000006 109.563 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 63.1 mt -79.57 96.74 2.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 107.31 -1.367 . . . . 60.030000000000001 107.31 168.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 73' ' ' LYS . 50.3 mt -73.62 126.43 30.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.094 -0.957 . . . . 73.329999999999998 108.953 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -106.65 139.82 40.49 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.991 -0.744 . . . . 72.019999999999996 108.991 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -152.24 -179.64 28.02 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 123.51 0.506 . . . . 40.240000000000002 111.939 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 31.0 ttmt -149.38 137.32 20.47 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.949 0.404 . . . . 73.319999999999993 111.073 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.481 HG22 HD13 ' A' ' 39' ' ' ILE . 67.3 mt -74.85 103.49 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 114.77 -1.105 . . . . 74.239999999999995 109.643 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.21 -18.59 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 114.965 -1.016 . . . . 60.240000000000002 111.345 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 20.8 ttm180 -160.13 160.67 33.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.084 0.554 . . . . 62.32 109.755 -175.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 m -95.1 171.05 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.496 0.718 . . . . 73.019999999999996 109.469 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -128.36 103.03 6.92 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.795 -0.817 . . . . 73.200000000000003 108.795 173.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.35 -150.52 46.96 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 124.291 0.994 . . . . 41.539999999999999 114.089 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -109.54 7.08 24.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.473 1.109 . . . . 75.109999999999999 110.89 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -67.23 -28.05 67.74 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.171 0.588 . . . . 72.230000000000004 111.047 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.17 3.3 58.92 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.639 -0.709 . . . . 65.150000000000006 111.903 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.44 130.21 42.19 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.515 -0.55 . . . . 73.549999999999997 109.515 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.6 m -102.37 153.97 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.581 0.752 . . . . 74.219999999999999 110.573 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HD2' ' HB3' ' A' ' 59' ' ' ARG . 17.8 ttm180 -111.84 103.31 11.56 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.491 -0.929 . . . . 54.210000000000001 108.491 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.84 116.58 30.91 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.449 0.699 . . . . 44.539999999999999 109.813 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.423 ' HG2' HG22 ' A' ' 21' ' ' VAL . 43.3 mtm180 -90.24 118.01 29.43 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.69 -0.856 . . . . 71.109999999999999 108.69 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -91.37 128.41 37.19 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.488 0.715 . . . . 72.510000000000005 109.801 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.12 -32.97 68.64 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.629 1.172 . . . . 72.209999999999994 112.468 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.505 ' HB2' HD22 ' A' ' 53' ' ' LEU . 70.9 mmtt -90.5 -37.94 13.55 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.132 0.573 . . . . 71.420000000000002 109.565 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.17 35.73 34.6 Favored Glycine 0 C--N 1.36 1.871 0 O-C-N 124.503 1.127 . . . . 75.040000000000006 114.315 174.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -76.28 133.15 71.95 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 122.992 0.517 . . . . 72.430000000000007 110.622 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.23 120.17 6.41 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.772 1.648 . . . . 75.510000000000005 110.404 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.12 -15.2 31.3 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.523 -0.762 . . . . 73.209999999999994 111.868 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 67.68 12.74 9.0 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.765 1.226 . . . . 62.109999999999999 111.35 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.12 32.47 2.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.836 1.254 . . . . 44.299999999999997 111.833 -168.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -51.79 108.02 0.24 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.522 0.729 . . . . 71.200000000000003 111.413 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.0 -14.46 7.05 Favored Glycine 0 N--CA 1.475 1.272 0 CA-C-N 116.11 -0.496 . . . . 72.340000000000003 112.396 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -77.56 172.83 12.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.75 0.82 . . . . 71.129999999999995 110.311 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 9.7 m-85 -108.62 130.01 55.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.283 0.633 . . . . 71.120000000000005 111.394 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 24' ' ' ILE . 16.1 m -97.97 168.25 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.553 1.141 . . . . 61.43 109.029 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -120.35 106.76 12.17 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.787 -0.82 . . . . 45.109999999999999 108.787 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.19 92.37 3.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.41 -0.959 . . . . 64.400000000000006 108.41 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.78 124.77 36.74 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-N 115.063 -0.971 . . . . 75.230000000000004 108.86 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.714 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -62.86 97.61 0.11 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.663 -1.606 . . . . 72.409999999999997 106.663 172.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.62 98.59 0.38 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.388 -0.824 . . . . 74.129999999999995 109.98 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -144.09 107.38 4.56 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.345 1.058 . . . . 71.140000000000001 108.249 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 123.164 0.585 . . . . 73.140000000000001 110.33 -179.326 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.434 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.094 0 CA-C-O 121.566 0.698 . . . . 73.5 110.531 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.544 ' HD2' ' HB3' ' A' ' 85' ' ' GLU . 90.6 mtm-85 -132.94 171.08 14.42 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.777 0.831 . . . . 73.010000000000005 109.803 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.682 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 47.8 mt -116.82 124.4 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.566 -1.272 . . . . 53.210000000000001 107.566 176.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -88.74 140.21 29.68 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 118.419 0.554 . . . . 74.430000000000007 109.658 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.59 135.97 7.34 Favored Glycine 0 C--O 1.218 -0.886 0 N-CA-C 111.998 -0.441 . . . . 71.439999999999998 111.998 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -91.18 116.88 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.369 0.668 . . . . 44.219999999999999 109.266 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.485 HG13 ' SD ' ' A' ' 22' ' ' MET . 91.1 t -55.12 103.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.585 1.154 . . . . 75.400000000000006 110.4 175.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 23' ' ' ILE . 93.9 mt -75.21 -57.05 4.13 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 122.88 0.472 . . . . 70.140000000000001 110.22 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.409 ' HA ' HD22 ' A' ' 80' ' ' LEU . 71.3 p -163.95 164.08 23.34 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.415 -0.811 . . . . 64.200000000000003 110.271 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.97 134.93 34.09 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.147 -0.686 . . . . 74.25 109.147 168.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 1.7 tmt_? -98.53 106.98 19.33 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 105.424 -2.065 . . . . 73.019999999999996 105.424 165.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.56 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 11.5 ptm180 -78.82 136.04 37.23 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.04 0.448 . . . . 74.230000000000004 110.586 -171.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 m -67.55 154.88 40.41 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.069 -0.969 . . . . 53.539999999999999 110.311 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -58.99 -42.27 89.64 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.62 0.768 . . . . 74.420000000000002 110.555 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -102.47 108.87 20.33 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.002 -0.999 . . . . 72.409999999999997 108.762 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -69.32 88.33 0.45 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.348 1.059 . . . . 74.010000000000005 109.555 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -134.62 -77.13 0.46 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.161 -1.052 . . . . 71.519999999999996 108.161 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -159.21 -172.96 3.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.458 1.103 . . . . 75.400000000000006 108.422 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 16.5 m120 63.05 34.61 13.69 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.682 0.793 . . . . 65.25 110.816 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.656 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 52.1 t30 -71.4 149.61 45.8 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-N 114.551 -1.204 . . . . 71.549999999999997 110.302 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 39.8 t -93.53 144.14 10.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.606 -0.887 . . . . 74.540000000000006 108.606 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.485 ' SD ' HG13 ' A' ' 7' ' ' VAL . 42.8 ttp -133.56 121.64 22.4 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.179 -0.675 . . . . 74.349999999999994 109.179 174.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 8' ' ' LEU . 41.1 mm -79.78 126.42 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.577 1.151 . . . . 70.140000000000001 108.832 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -126.08 152.07 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.581 1.153 . . . . 74.099999999999994 109.588 -171.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 64' ' ' LYS . 4.5 tppp? -116.22 92.66 36.68 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.756 0.822 . . . . 71.109999999999999 109.515 173.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.07 131.54 33.0 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.441 1.427 . . . . 62.130000000000003 109.876 172.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.449 HD11 ' HE2' ' A' ' 83' ' ' TYR . 91.1 mt -63.96 -31.51 72.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.584 0.754 . . . . 63.210000000000001 111.764 -171.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.16 -28.58 67.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.539 0.735 . . . . 73.099999999999994 111.122 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.421 HG12 ' HA2' ' A' ' 65' ' ' GLY . 89.1 t -96.66 144.19 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.865 0.866 . . . . 64.400000000000006 111.772 -168.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -147.52 -25.57 0.38 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.375 1.07 . . . . 61.119999999999997 111.592 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.608 ' HB2' ' HG2' ' A' ' 34' ' ' GLU . 15.7 m -109.88 169.84 8.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.403 0.681 . . . . 73.409999999999997 111.186 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.511 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 78.8 ttt180 -65.96 -42.83 89.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.954 0.902 . . . . 74.209999999999994 111.082 -177.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.99 -30.87 62.71 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.813 0.695 . . . . 72.439999999999998 110.892 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HG2' ' HB2' ' A' ' 31' ' ' SER . 20.0 mm-40 -65.92 -30.8 71.44 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.752 0.658 . . . . 70.5 110.491 173.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.66 -33.21 31.45 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.772 0.829 . . . . 65.329999999999998 110.851 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -75.44 -24.96 57.09 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.107 0.963 . . . . 75.430000000000007 111.203 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 34' ' ' GLU . 22.0 pttp -75.07 -1.51 23.23 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 122.205 0.202 . . . . 74.010000000000005 111.111 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.1 11.5 25.64 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.319 0.648 . . . . 74.439999999999998 112.53 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mm -69.24 126.28 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.414 -0.587 . . . . 65.120000000000005 109.414 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.38 57.74 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.179 -0.464 . . . . 53.25 113.242 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.07 139.14 37.03 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.017 0.527 . . . . 75.510000000000005 110.301 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -90.1 113.68 25.46 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.275 1.03 . . . . 63.049999999999997 108.75 -173.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -98.04 114.31 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.222 0.609 . . . . 74.420000000000002 109.517 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.464 HD22 ' HG2' ' A' ' 54' ' ' LYS . 42.4 mt -101.04 99.99 10.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.23 -1.026 . . . . 72.140000000000001 108.23 176.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.5 ' CD1' HG12 ' A' ' 84' ' ' VAL . 32.6 t90 -103.27 131.63 50.17 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.959 -0.756 . . . . 73.140000000000001 108.959 174.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -91.99 126.61 37.15 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.151 -1.055 . . . . 75.349999999999994 108.151 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.9 p -73.17 141.43 81.03 Favored Pre-proline 0 C--O 1.244 0.816 0 N-CA-C 109.381 -0.6 . . . . 53.109999999999999 109.381 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.69 -23.55 33.5 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.471 2.78 . . . . 72.310000000000002 113.877 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.4 m -64.17 -54.78 28.24 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.646 0.779 . . . . 75.510000000000005 110.928 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.18 32.32 0.1 Allowed Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.351 -0.386 . . . . 74.530000000000001 113.614 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -114.69 173.53 6.43 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.607 0.763 . . . . 73.340000000000003 109.542 173.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.0 105.05 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.446 -0.946 . . . . 74.219999999999999 108.446 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 73' ' ' LYS . 21.2 mt -83.34 110.23 17.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.236 -1.024 . . . . 74.329999999999998 108.236 172.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' HG2' HD22 ' A' ' 44' ' ' LEU . 51.7 mtpt -94.46 139.74 30.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.003 -0.74 . . . . 70.430000000000007 109.003 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.65 -171.28 19.36 Favored Glycine 0 N--CA 1.463 0.493 0 O-C-N 123.455 0.472 . . . . 44.030000000000001 112.297 -173.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -151.94 133.99 15.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.957 0.503 . . . . 71.310000000000002 110.052 -178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 67' ' ' VAL . 73.6 mt -69.32 98.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.729 -0.841 . . . . 71.239999999999995 108.729 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.37 -33.44 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.183 0.593 . . . . 64.450000000000003 111.019 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -148.78 167.61 25.14 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.349 -0.982 . . . . 62.219999999999999 108.349 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 m -103.01 170.63 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.394 0.678 . . . . 65.430000000000007 109.229 172.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -132.57 122.57 24.97 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.522 -0.918 . . . . 73.099999999999994 108.522 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.67 -153.95 52.4 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.92 0.763 . . . . 53.219999999999999 113.072 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.511 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 73.6 p -116.76 -11.47 10.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.193 0.997 . . . . 71.439999999999998 111.193 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 73.0 mmtt -98.73 52.94 1.0 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.229 0.537 . . . . 64.140000000000001 112.091 -172.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.421 ' HA2' HG12 ' A' ' 29' ' ' VAL . . . 71.38 -0.4 33.3 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 117.312 1.685 . . . . 61.130000000000003 117.312 163.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.46 124.85 28.85 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.91 0.855 . . . . 61.210000000000001 109.582 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.7 m -103.25 160.12 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.371 0.668 . . . . 64.430000000000007 109.918 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -119.79 104.29 10.09 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.703 1.201 . . . . 64.239999999999995 108.499 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.12 127.41 54.14 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.447 0.699 . . . . 72.129999999999995 110.864 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' HD2' HG22 ' A' ' 21' ' ' VAL . 7.8 mmm180 -89.61 111.5 22.46 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.59 1.156 . . . . 70.409999999999997 109.611 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 73.7 m-85 -92.08 166.33 12.72 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.056 0.542 . . . . 72.219999999999999 111.047 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 7.8 pt-20 -67.29 -39.05 85.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.937 0.895 . . . . 74.150000000000006 110.466 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 14.4 mmmm -118.8 -69.16 0.87 Allowed 'General case' 0 C--N 1.345 0.375 0 C-N-CA 124.089 0.956 . . . . 55.119999999999997 109.398 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.656 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 71.93 57.86 5.57 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 123.924 0.765 . . . . 53.240000000000002 111.231 -173.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.33 124.51 89.99 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.758 0.823 . . . . 74.219999999999999 111.22 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.59 174.57 8.24 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.335 2.69 . . . . 73.340000000000003 112.71 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.33 172.1 13.13 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.341 -0.704 . . . . 53.049999999999997 111.341 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -86.48 68.91 10.34 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.508 1.147 . . . . 75.340000000000003 109.618 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.09 17.51 17.72 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.468 -1.242 . . . . 63.32 109.714 175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 9' ' ' SER . 41.2 mt -76.41 121.88 23.7 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.92 0.888 . . . . 63.43 109.486 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.48 -6.98 14.14 Favored Glycine 0 N--CA 1.469 0.849 0 N-CA-C 111.966 -0.454 . . . . 73.329999999999998 111.966 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.58 155.64 29.55 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.814 0.846 . . . . 65.450000000000003 109.86 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.449 ' HE2' HD11 ' A' ' 27' ' ' LEU . 62.1 m-85 -91.33 133.09 35.73 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.94 0.496 . . . . 73.510000000000005 111.448 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 45' ' ' TRP . 6.7 m -100.01 149.39 5.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 N-CA-C 107.632 -1.248 . . . . 72.150000000000006 107.632 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.544 ' HB3' ' HD2' ' A' ' 2' ' ' ARG . 8.5 mm-40 -111.34 106.73 15.77 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.053 -1.091 . . . . 73.340000000000003 108.053 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.682 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 62.2 mt -96.94 104.63 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.444 0.697 . . . . 71.409999999999997 109.235 -173.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.9 t -95.31 134.75 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.221 1.008 . . . . 61.219999999999999 110.103 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.61 123.78 47.01 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.302 -1.37 . . . . 64.310000000000002 107.302 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -159.47 -39.2 0.06 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.992 0.917 . . . . 73.340000000000003 109.142 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -77.89 97.8 5.41 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.308 -0.86 . . . . 72.299999999999997 109.067 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 . . . . . 0 CA--C 1.562 1.426 0 CA-C-O 118.066 -0.968 . . . . 72.329999999999998 109.294 177.633 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 120.613 0.244 . . . . 70.030000000000001 110.467 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -119.88 130.12 54.7 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 106.845 -1.539 . . . . 54.299999999999997 106.845 168.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 28' ' ' ASP . 50.9 mt -94.67 125.86 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.275 -0.639 . . . . 63.229999999999997 109.275 -175.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -88.67 133.29 34.25 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.466 -0.939 . . . . 71.310000000000002 108.466 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.98 166.19 22.13 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.361 0.413 . . . . 71.299999999999997 112.13 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.61 135.2 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.193 0.997 . . . . 70.209999999999994 109.173 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.76 114.53 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.568 0.747 . . . . 74.310000000000002 110.292 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 25' ' ' LYS . 89.6 mt -81.79 -61.2 1.99 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.358 0.663 . . . . 75.430000000000007 110.843 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.2 t -152.46 160.5 43.26 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.849 -0.614 . . . . 71.319999999999993 110.37 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -91.02 157.55 17.2 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.361 0.601 . . . . 74.310000000000002 111.182 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.486 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.6 tpp180 -136.28 109.95 8.06 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.263 -1.754 . . . . 61.549999999999997 106.263 163.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -72.41 159.38 34.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.01 0.434 . . . . 61.520000000000003 110.704 -169.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.642 ' HB3' ' HB3' ' A' ' 17' ' ' GLN . 20.0 m -70.65 167.83 17.79 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.25 -0.886 . . . . 63.539999999999999 111.793 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -67.47 -72.01 0.18 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.122 0.969 . . . . 74.340000000000003 113.209 -167.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -132.52 -64.23 0.76 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.882 -0.784 . . . . 74.420000000000002 108.882 -170.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -142.1 92.27 2.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.801 -1.555 . . . . 72.439999999999998 106.801 167.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.642 ' HB3' ' HB3' ' A' ' 13' ' ' SER . 6.3 tp-100 -144.94 135.17 24.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.717 0.807 . . . . 63.310000000000002 108.836 -172.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -93.7 -13.98 26.86 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.953 0.501 . . . . 74.450000000000003 111.565 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 19.9 m120 -74.19 80.01 1.79 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.462 -0.57 . . . . 72.219999999999999 109.462 171.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -81.55 135.57 35.58 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.044 -0.98 . . . . 72.010000000000005 109.31 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 70' ' ' ARG . 5.1 t -96.96 150.62 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 108.464 -0.939 . . . . 63.219999999999999 108.464 -176.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -154.79 140.88 18.43 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.758 0.313 . . . . 72.299999999999997 110.77 168.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 8' ' ' LEU . 45.4 mm -77.17 120.48 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.307 -0.861 . . . . 72.299999999999997 108.682 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.4 mt -115.45 147.83 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.35 1.06 . . . . 61.350000000000001 108.84 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 8' ' ' LEU . 86.6 tttt -108.13 101.8 43.3 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 123.821 0.848 . . . . 74.519999999999996 109.424 171.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' HG22 ' A' ' 67' ' ' VAL . 17.7 Cg_endo -60.58 115.97 3.03 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 122.067 1.845 . . . . 62.409999999999997 110.067 165.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.38 -34.07 71.97 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.159 0.984 . . . . 72.239999999999995 112.132 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 3' ' ' ILE . 22.2 t70 -69.31 -27.73 65.64 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.253 1.021 . . . . 73.120000000000005 111.899 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 34' ' ' GLU . 25.9 t -113.09 119.06 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.235 1.014 . . . . 55.299999999999997 111.24 -170.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -120.36 -5.52 9.87 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.116 0.566 . . . . 72.319999999999993 111.893 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 69.2 m -111.18 152.86 26.57 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.038 0.535 . . . . 64.319999999999993 110.347 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.589 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 55.6 ttt85 -64.27 -35.36 80.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 73.129999999999995 111.826 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.62 -38.72 84.3 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.951 0.5 . . . . 73.040000000000006 110.7 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HB2' HG13 ' A' ' 29' ' ' VAL . 33.8 mt-10 -67.39 -31.77 72.22 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.114 -0.948 . . . . 72.299999999999997 110.07 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.22 -23.05 32.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.977 0.911 . . . . 71.519999999999996 111.218 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.4 t -79.42 -27.6 41.73 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.769 0.828 . . . . 64.349999999999994 110.086 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -80.16 -9.19 59.7 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.329 -0.396 . . . . 74.450000000000003 110.758 170.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.432 HD21 HD12 ' A' ' 3' ' ' ILE . 47.2 mt -89.61 -3.45 58.27 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.139 0.576 . . . . 64.519999999999996 111.987 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.683 HD11 HG13 ' A' ' 60' ' ' VAL . 49.7 mm -63.65 107.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.242 -0.651 . . . . 64.409999999999997 109.242 174.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.1 5.4 30.62 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.323 -0.71 . . . . 72.319999999999993 114.145 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.436 ' HD2' HD22 ' A' ' 88' ' ' LEU . 28.9 mmt180 -84.72 159.72 20.46 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.364 1.082 . . . . 74.430000000000007 111.373 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 54' ' ' LYS . 61.0 tp -90.83 117.19 29.25 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.29 1.036 . . . . 75.510000000000005 109.331 -175.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 t -107.35 117.14 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.204 -0.665 . . . . 63.310000000000002 109.204 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -101.15 104.44 15.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.641 0.776 . . . . 75.219999999999999 109.529 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 34.6 t90 -91.75 141.95 28.12 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.554 -0.536 . . . . 73.200000000000003 109.554 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -103.08 108.95 20.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.962 -1.017 . . . . 73.349999999999994 108.87 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.2 p -60.3 160.82 15.57 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.731 0.813 . . . . 74.409999999999997 111.036 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.9 -21.67 71.65 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.937 2.424 . . . . 71.349999999999994 112.613 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.3 m -77.51 -6.96 55.44 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.017 0.927 . . . . 64.200000000000003 111.765 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.65 3.64 77.29 Favored Glycine 0 C--N 1.35 1.342 0 C-N-CA 123.197 0.427 . . . . 64.549999999999997 112.863 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -85.77 156.47 20.59 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.007 0.923 . . . . 74.030000000000001 108.898 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.8 mt -117.62 114.35 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.594 0.358 . . . . 62.25 110.367 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 73' ' ' LYS . 31.5 mt -92.25 150.58 20.8 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.723 -0.843 . . . . 74.25 108.723 173.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB3' HD11 ' A' ' 42' ' ' LEU . 23.5 mtmm -98.22 156.15 16.83 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.717 -0.475 . . . . 75.530000000000001 109.717 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.8 -174.97 29.21 Favored Glycine 0 C--O 1.239 0.441 0 N-CA-C 111.036 -0.825 . . . . 50.329999999999998 111.036 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -152.87 136.17 15.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 111.758 0.281 . . . . 70.239999999999995 111.758 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.411 HD11 HD13 ' A' ' 86' ' ' ILE . 78.2 mt -69.2 102.82 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.622 0 O-C-N 124.038 0.836 . . . . 70.540000000000006 108.895 171.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -84.29 -28.35 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.329 -0.851 . . . . 74.530000000000001 110.711 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -164.03 165.32 22.55 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.811 0.844 . . . . 74.099999999999994 109.396 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.683 HG13 HD11 ' A' ' 39' ' ' ILE . 35.4 m -92.8 169.41 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.508 0.723 . . . . 75.299999999999997 110.522 174.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -127.6 104.59 7.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.295 1.038 . . . . 73.340000000000003 109.223 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.49 -153.01 52.89 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.851 -0.613 . . . . 61.32 113.154 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 32.5 p -111.83 -0.63 15.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.789 0.836 . . . . 72.319999999999993 111.831 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -83.78 5.88 23.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.47 0.708 . . . . 72.319999999999993 112.425 -168.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.28 -16.37 57.61 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-O 119.909 -0.384 . . . . 75.299999999999997 113.063 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.68 122.55 14.41 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.613 0.765 . . . . 42.240000000000002 110.018 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.4 HG22 ' HD3' ' A' ' 26' ' ' PRO . 35.9 m -102.84 175.06 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.955 0.902 . . . . 74.540000000000006 110.632 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -128.5 111.39 13.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.278 1.031 . . . . 65.140000000000001 108.592 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.8 133.02 56.52 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.381 0.672 . . . . 63.109999999999999 110.774 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.553 ' HG2' HG22 ' A' ' 21' ' ' VAL . 97.0 mtt180 -103.75 128.85 51.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.947 0.899 . . . . 75.120000000000005 109.095 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 85.9 m-85 -106.11 134.6 48.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.494 0.717 . . . . 73.040000000000006 110.743 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.566 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 20.8 pt-20 -51.58 -48.09 63.3 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 124.89 1.369 . . . . 72.329999999999998 112.552 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.566 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 13.4 mmmm -92.93 -39.5 11.11 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.152 0.581 . . . . 73.200000000000003 109.478 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.99 55.0 28.11 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 124.284 0.99 . . . . 64.409999999999997 113.908 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.62 124.09 89.25 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.054 0.541 . . . . 74.519999999999996 110.591 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.14 150.67 33.67 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.107 2.538 . . . . 60.140000000000001 112.129 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.09 -151.79 14.6 Favored Glycine 0 C--N 1.344 0.972 0 N-CA-C 111.33 -0.708 . . . . 73.540000000000006 111.33 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -113.03 73.89 0.84 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.218 1.009 . . . . 73.430000000000007 108.882 172.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.27 -9.76 59.37 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.383 -1.28 . . . . 75.340000000000003 112.617 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.6 mt -61.24 115.1 3.55 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.621 0.768 . . . . 75.329999999999998 110.716 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.68 -18.87 49.29 Favored Glycine 0 N--CA 1.473 1.148 0 CA-C-N 116.465 -0.334 . . . . 73.329999999999998 112.826 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.08 163.49 27.06 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.698 0.799 . . . . 62.109999999999999 110.442 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -105.05 148.71 26.48 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.751 0.786 . . . . 55.219999999999999 112.279 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.14 164.45 17.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 114.35 -1.295 . . . . 75.310000000000002 108.269 171.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.13 107.66 11.0 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.008 -0.738 . . . . 62.310000000000002 109.008 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.411 HD13 HD11 ' A' ' 57' ' ' ILE . 57.4 mt -82.72 92.23 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.0 -1.111 . . . . 74.340000000000003 108.0 177.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.2 t -79.53 141.82 14.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 114.421 -1.263 . . . . 73.420000000000002 108.837 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' HD2' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -60.06 112.0 1.72 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 107.66 -1.237 . . . . 53.219999999999999 107.66 171.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.88 119.75 20.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.556 -0.905 . . . . 73.219999999999999 108.556 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -145.98 128.93 16.45 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.644 0.378 . . . . 72.030000000000001 110.972 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 68.6 m80 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.044 -0.979 . . . . 72.450000000000003 108.576 173.584 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 110.053 -0.351 . . . . 52.439999999999998 110.053 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -124.07 138.21 54.47 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.647 -1.242 . . . . 75.450000000000003 107.647 167.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.24 139.85 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.464 0.706 . . . . 71.439999999999998 109.142 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -88.14 119.16 28.26 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.283 -1.006 . . . . 51.210000000000001 108.283 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -116.98 168.84 12.89 Favored Glycine 0 C--N 1.34 0.802 0 O-C-N 123.673 0.608 . . . . 64.329999999999998 111.583 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.43 130.29 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.958 0.903 . . . . 53.210000000000001 109.175 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.2 t -68.11 104.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.095 0.958 . . . . 74.140000000000001 109.348 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 25' ' ' LYS . 83.1 mt -84.29 -55.13 4.34 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.462 0.305 . . . . 73.230000000000004 110.807 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m -154.22 170.27 21.65 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.524 0.564 . . . . 62.340000000000003 112.524 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -122.58 157.56 31.86 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.053 1.341 . . . . 71.299999999999997 109.193 170.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.55 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.7 tpt180 -137.75 115.6 11.49 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.656 -1.238 . . . . 75.099999999999994 107.656 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -85.61 117.51 24.55 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.327 0.491 . . . . 51.219999999999999 112.327 -168.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.3 m -86.26 148.17 25.75 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.501 -0.926 . . . . 50.420000000000002 108.501 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -74.39 87.19 2.03 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.819 0.448 . . . . 65.319999999999993 111.347 -173.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 51.91 -76.7 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.044 2.138 . . . . 74.340000000000003 115.245 165.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -61.86 -45.87 91.92 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.812 0.845 . . . . 72.349999999999994 111.32 -177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -85.57 46.62 1.32 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.93 0.492 . . . . 61.109999999999999 110.066 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.31 86.86 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.378 1.071 . . . . 61.130000000000003 111.762 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -130.29 39.71 3.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.674 -1.602 . . . . 65.109999999999999 106.674 172.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -51.58 126.58 17.89 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 113.986 -1.461 . . . . 65.310000000000002 110.315 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 85.8 t -86.41 145.0 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.32 -0.993 . . . . 63.549999999999997 108.32 -171.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.3 ttt -137.56 109.49 7.17 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.791 -1.559 . . . . 62.439999999999998 106.791 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.448 HG22 HD12 ' A' ' 8' ' ' LEU . 45.5 mm -81.14 120.32 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 107.119 -1.437 . . . . 64.230000000000004 107.119 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.409 HG21 HG21 ' A' ' 84' ' ' VAL . 85.5 mt -127.65 146.64 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.49 1.116 . . . . 63.030000000000001 108.319 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HB2' HD11 ' A' ' 8' ' ' LEU . 41.1 ttmt -118.68 112.84 36.66 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 109.292 -0.632 . . . . 71.010000000000005 109.292 168.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 17.2 Cg_exo -62.65 126.2 17.76 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.057 1.838 . . . . 63.240000000000002 110.229 168.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.76 -27.45 69.29 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.715 0.806 . . . . 71.540000000000006 111.7 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.76 -27.13 66.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.41 1.084 . . . . 75.209999999999994 111.868 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 34' ' ' GLU . 71.6 t -106.72 128.0 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.964 0.906 . . . . 72.329999999999998 111.823 -169.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -127.9 5.01 5.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.53 1.132 . . . . 61.200000000000003 110.839 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -132.48 157.79 43.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.477 0.711 . . . . 71.239999999999995 110.53 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 68.9 ttt180 -64.13 -42.92 96.62 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.769 0.827 . . . . 65.010000000000005 111.101 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.54 -38.88 92.53 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.867 0.73 . . . . 75.140000000000001 111.148 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HB2' HG13 ' A' ' 29' ' ' VAL . 41.0 mt-10 -64.94 -34.02 77.42 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 124.117 0.886 . . . . 72.310000000000002 110.448 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.497 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -82.08 -26.39 33.69 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.098 0.959 . . . . 52.329999999999998 111.537 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 t -82.06 -23.81 35.62 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.907 0.883 . . . . 61.109999999999999 110.931 -172.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.73 1.29 39.46 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.59 0.356 . . . . 75.420000000000002 110.834 170.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 75.7 mt -102.22 11.88 37.54 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.431 0.693 . . . . 54.530000000000001 111.343 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.543 HD11 HG13 ' A' ' 60' ' ' VAL . 49.9 mm -73.99 130.82 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 109.49 -0.559 . . . . 62.219999999999999 109.49 174.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.23 1.39 75.55 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.029 -0.532 . . . . 65.400000000000006 112.532 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.581 ' HG3' ' HA ' ' A' ' 88' ' ' LEU . 5.6 mpt_? -81.64 138.58 35.29 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.079 0.552 . . . . 74.439999999999998 109.98 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 55' ' ' GLY . 67.2 tp -90.37 113.56 25.47 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.63 -0.878 . . . . 74.120000000000005 108.63 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 t -98.09 116.05 39.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 123.427 0.691 . . . . 64.450000000000003 109.254 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.3 mt -102.01 129.19 48.24 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.464 1.106 . . . . 62.219999999999999 108.549 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -142.38 127.38 18.4 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.14 0.576 . . . . 74.019999999999996 109.484 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -89.76 115.24 26.97 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.123 -0.695 . . . . 74.519999999999996 109.123 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -64.71 158.45 68.5 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.823 0.849 . . . . 75.519999999999996 111.006 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -59.33 -20.17 54.38 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.465 2.776 . . . . 61.130000000000003 113.432 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.6 m -75.15 -3.28 31.93 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.89 0.876 . . . . 64.430000000000007 112.234 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.87 9.76 80.23 Favored Glycine 0 C--N 1.353 1.525 0 C-N-CA 123.069 0.366 . . . . 51.130000000000003 112.936 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -96.16 132.16 41.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.583 0.753 . . . . 74.310000000000002 110.001 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.1 mt -85.55 101.87 10.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-O 121.3 0.571 . . . . 72.099999999999994 109.613 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 75' ' ' LEU . 13.5 mt -80.97 128.49 33.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.462 -0.79 . . . . 71.099999999999994 108.879 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -117.43 132.47 56.56 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.106 0.963 . . . . 54.530000000000001 109.123 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -154.95 -177.79 28.6 Favored Glycine 0 C--N 1.336 0.55 0 O-C-N 123.635 0.584 . . . . 52.43 112.177 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -151.77 136.67 17.23 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.115 0.413 . . . . 74.420000000000002 112.115 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 39' ' ' ILE . 64.7 mt -67.94 103.62 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.935 0.894 . . . . 74.150000000000006 109.568 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.27 -30.83 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.532 -0.758 . . . . 73.450000000000003 111.547 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -163.95 160.45 21.98 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.62 0.768 . . . . 71.439999999999998 109.254 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.543 HG13 HD11 ' A' ' 39' ' ' ILE . 20.2 m -101.18 170.48 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.847 0.859 . . . . 73.010000000000005 111.065 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -131.3 103.14 6.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.06 0.944 . . . . 75.400000000000006 109.021 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.66 -166.85 26.08 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 115.74 -0.664 . . . . 72.25 114.452 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.429 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 75.7 p -90.77 8.56 34.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.382 1.073 . . . . 65.439999999999998 111.333 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -79.84 -2.72 44.71 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.871 0.869 . . . . 72.420000000000002 111.783 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.24 -4.89 61.23 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-O 120.103 -0.276 . . . . 52.530000000000001 113.645 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.96 112.28 5.51 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 123.429 0.692 . . . . 73.349999999999994 109.635 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 m -100.19 143.77 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.04 0.936 . . . . 75.109999999999999 109.153 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -101.72 103.07 13.82 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.322 -0.992 . . . . 63.329999999999998 108.322 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.82 120.28 41.58 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.556 0.742 . . . . 74.019999999999996 109.935 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -88.8 106.31 18.29 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.973 0.509 . . . . 73.340000000000003 109.699 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -88.15 120.99 30.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.632 -0.877 . . . . 74.140000000000001 108.632 170.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.42 -20.71 60.66 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.134 0.492 . . . . 70.219999999999999 109.876 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -76.68 -77.64 0.14 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.641 0.777 . . . . 73.430000000000007 109.197 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.1 45.01 63.42 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.646 0.591 . . . . 53.109999999999999 114.395 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.44 ' HB2' HD21 ' A' ' 53' ' ' LEU . 81.7 mt -73.15 157.08 88.88 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.759 0.824 . . . . 74.420000000000002 111.195 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.08 124.08 14.51 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 123.402 2.735 . . . . 75.439999999999998 113.273 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.09 87.74 0.08 OUTLIER Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.776 -1.33 . . . . 74.349999999999994 109.776 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -73.92 71.43 1.54 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.092 0.957 . . . . 65.209999999999994 109.846 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.05 29.01 8.16 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.445 1.098 . . . . 75.019999999999996 110.685 -169.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 mt -52.46 118.46 3.6 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.5 0.72 . . . . 64.25 110.378 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.07 -10.51 15.17 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 112.01 -0.436 . . . . 63.130000000000003 112.01 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -77.23 169.56 18.11 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.876 0.87 . . . . 70.439999999999998 109.678 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 63.0 m-85 -112.26 127.47 55.98 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.639 0.376 . . . . 75.430000000000007 111.952 -170.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 24' ' ' ILE . 15.2 m -100.38 162.72 3.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-N 115.171 -0.922 . . . . 72.0 109.824 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -111.62 108.99 18.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.905 0.882 . . . . 74.140000000000001 108.681 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.1 mt -92.18 92.9 3.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.1 -1.074 . . . . 72.049999999999997 108.1 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.81 134.03 27.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.082 -0.963 . . . . 64.439999999999998 109.09 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.581 ' HA ' ' HG3' ' A' ' 41' ' ' ARG . 4.4 mm? -60.61 126.79 28.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.751 0.82 . . . . 62.549999999999997 110.608 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.93 139.17 22.33 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.534 -0.913 . . . . 74.310000000000002 108.534 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -126.58 150.87 48.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.012 0.925 . . . . 71.120000000000005 110.382 -173.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 . . . . . 0 C--O 1.249 1.035 0 C-N-CA 123.899 0.879 . . . . 55.039999999999999 108.786 173.338 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 mmt . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.666 -0.494 . . . . 64.129999999999995 109.666 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -147.71 158.45 44.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.997 0.919 . . . . 64.140000000000001 110.364 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 40.1 mt -132.57 128.83 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.686 -1.227 . . . . 73.140000000000001 107.686 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -87.79 128.18 35.33 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.941 -0.763 . . . . 74.010000000000005 108.941 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 25' ' ' LYS . . . -124.74 142.44 13.94 Favored Glycine 0 C--N 1.34 0.799 0 O-C-N 123.914 0.759 . . . . 60.200000000000003 111.486 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -92.76 131.04 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 117.511 0.655 . . . . 72.409999999999997 109.906 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.8 97.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.951 0.9 . . . . 63.32 109.251 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.478 HD21 ' HE2' ' A' ' 25' ' ' LYS . 81.5 mt -77.34 -53.45 7.67 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.673 -0.492 . . . . 71.299999999999997 109.673 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -165.11 179.19 6.49 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.847 0.356 . . . . 60.509999999999998 111.411 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -129.96 134.8 47.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.793 1.237 . . . . 73.430000000000007 108.298 174.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.407 ' HD3' HD11 ' A' ' 23' ' ' ILE . 2.6 mpt_? -111.03 113.21 25.58 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.072 -1.455 . . . . 73.310000000000002 107.072 163.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . 32.4 ptt180 -73.82 145.61 44.83 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.909 -1.145 . . . . 74.409999999999997 107.909 173.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 m -56.9 148.12 21.83 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.659 0.784 . . . . 72.329999999999998 110.496 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -86.92 -56.32 3.44 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.933 -0.766 . . . . 65.219999999999999 108.933 -176.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.47 -23.11 61.0 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.481 -0.782 . . . . 53.049999999999997 111.071 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -125.0 -179.55 4.6 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.299 1.04 . . . . 72.349999999999994 109.311 -176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.59 13.86 3.73 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.758 0.823 . . . . 75.109999999999999 110.446 169.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -124.94 168.82 12.76 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.737 1.215 . . . . 73.230000000000004 109.053 169.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 m120 59.43 40.03 21.29 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 124.449 1.093 . . . . 74.140000000000001 109.436 -176.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 12' ' ' ARG . 23.2 m-80 -78.55 149.49 33.04 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.826 -1.079 . . . . 62.340000000000003 110.001 -172.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 70' ' ' ARG . 42.6 t -87.77 144.13 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.696 0.799 . . . . 55.149999999999999 109.56 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.6 ttt -131.15 117.16 18.68 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.168 -1.049 . . . . 71.120000000000005 108.168 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.459 HG22 HD12 ' A' ' 8' ' ' LEU . 28.0 mm -77.29 111.44 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.625 -0.879 . . . . 71.540000000000006 108.625 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.1 mt -112.74 145.6 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.403 1.081 . . . . 70.409999999999997 109.302 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HE2' HD21 ' A' ' 8' ' ' LEU . 22.6 ttmm -111.65 87.55 8.29 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.347 1.059 . . . . 72.030000000000001 109.012 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' HG22 ' A' ' 67' ' ' VAL . 32.2 Cg_endo -62.23 107.48 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.95 1.767 . . . . 73.030000000000001 110.212 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.13 -32.48 73.87 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.507 1.123 . . . . 62.420000000000002 112.073 -174.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.89 -26.11 68.63 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.335 1.054 . . . . 64.329999999999998 111.464 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.496 HG13 ' HB2' ' A' ' 34' ' ' GLU . 66.2 t -112.43 137.57 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 125.195 1.398 . . . . 72.540000000000006 111.489 -171.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -134.84 8.66 3.55 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.657 1.183 . . . . 72.010000000000005 110.504 170.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.5 m -124.37 147.27 48.34 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.773 0.829 . . . . 62.43 110.609 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.486 ' HD2' HG22 ' A' ' 63' ' ' THR . 71.2 ttt180 -67.81 -34.02 75.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.691 0.796 . . . . 75.329999999999998 111.193 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -67.1 -43.0 83.64 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.485 0.714 . . . . 62.140000000000001 110.485 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.496 ' HB2' HG13 ' A' ' 29' ' ' VAL . 27.2 mm-40 -72.77 -22.91 60.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.165 -0.925 . . . . 72.310000000000002 110.961 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.96 -32.58 30.67 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.554 0.742 . . . . 71.349999999999994 110.165 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.0 t -75.71 -24.47 56.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.573 0.749 . . . . 71.109999999999999 111.385 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -81.39 -2.29 48.79 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 122.311 -0.243 . . . . 71.420000000000002 111.224 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.402 HD12 HG11 ' A' ' 67' ' ' VAL . 53.3 mt -88.68 -12.15 43.21 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 123.331 0.652 . . . . 72.030000000000001 111.185 175.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.624 HD11 HG13 ' A' ' 60' ' ' VAL . 42.1 mm -65.79 104.57 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.084 0 C-N-CA 123.183 0.593 . . . . 75.310000000000002 110.174 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.13 -6.34 10.95 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.447 -0.641 . . . . 63.420000000000002 112.93 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -84.11 155.32 22.69 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 117.756 0.778 . . . . 75.430000000000007 111.257 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 54' ' ' LYS . 58.8 tp -93.14 117.26 29.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.49 1.116 . . . . 65.409999999999997 109.983 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.34 135.33 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.359 -0.608 . . . . 61.32 109.359 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.7 mt -118.37 105.15 11.42 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.392 1.077 . . . . 73.340000000000003 108.128 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 79' ' ' ALA . 44.8 t90 -110.23 128.4 55.48 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.644 -0.873 . . . . 53.399999999999999 108.644 171.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -98.25 117.43 32.62 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.674 -0.861 . . . . 64.239999999999995 108.674 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.3 p -74.56 162.36 73.99 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 124.024 0.93 . . . . 74.540000000000006 111.29 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.19 -14.55 45.75 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.973 2.448 . . . . 75.239999999999995 112.465 171.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -73.3 -19.38 61.05 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.707 1.203 . . . . 53.409999999999997 111.879 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.06 5.33 60.9 Favored Glycine 0 C--N 1.356 1.693 0 C-N-CA 123.437 0.542 . . . . 70.200000000000003 112.733 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -94.24 118.32 31.41 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.88 0.872 . . . . 62.420000000000002 109.817 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.85 97.2 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.017 -1.105 . . . . 72.230000000000004 108.017 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 mt -73.64 123.2 23.57 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.958 -1.127 . . . . 73.439999999999998 107.958 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.552 ' HB3' HD11 ' A' ' 42' ' ' LEU . 31.0 mtmm -104.26 140.53 37.73 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.32 -0.622 . . . . 72.049999999999997 109.32 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.93 173.42 25.42 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 116.207 -0.451 . . . . 75.329999999999998 112.112 -178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -127.57 131.77 49.94 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.071 -0.715 . . . . 72.400000000000006 109.071 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.563 HG22 HD13 ' A' ' 39' ' ' ILE . 62.8 mt -67.61 99.89 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 108.499 -0.926 . . . . 71.340000000000003 108.499 171.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.76 -34.31 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 115.256 -0.883 . . . . 73.420000000000002 111.24 -176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -154.2 157.11 38.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.786 -0.82 . . . . 71.049999999999997 108.786 -173.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.624 HG13 HD11 ' A' ' 39' ' ' ILE . 27.2 m -91.71 168.82 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.659 0.784 . . . . 74.519999999999996 110.05 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 68' ' ' ARG . 82.9 t60 -132.81 103.28 6.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.964 -1.125 . . . . 73.329999999999998 107.964 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.2 -162.76 49.0 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.379 -0.373 . . . . 53.310000000000002 113.181 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.486 HG22 ' HD2' ' A' ' 32' ' ' ARG . 73.5 p -110.96 -24.01 10.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.591 0.756 . . . . 64.329999999999998 112.18 -172.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -91.83 46.7 1.29 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.803 0.668 . . . . 63.219999999999999 112.803 -170.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA2' HG12 ' A' ' 29' ' ' VAL . . . 68.74 55.75 10.87 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.771 -0.65 . . . . 62.399999999999999 114.056 170.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.39 141.99 49.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.214 -1.032 . . . . 64.310000000000002 108.214 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 26' ' ' PRO . 22.1 m -130.85 171.94 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.141 0.977 . . . . 71.230000000000004 109.894 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HG3' ' HB2' ' A' ' 61' ' ' HIS . 73.0 mtm180 -134.35 109.1 8.57 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.218 1.007 . . . . 71.340000000000003 109.091 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.89 127.25 53.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.257 -0.883 . . . . 52.32 110.278 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HG2' HG22 ' A' ' 21' ' ' VAL . 33.8 mtm180 -90.27 110.06 21.13 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.254 -0.647 . . . . 75.239999999999995 109.254 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.29 142.11 29.6 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.236 1.014 . . . . 71.040000000000006 110.173 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 11.0 pt-20 -50.04 -45.36 52.13 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.568 1.547 . . . . 73.099999999999994 111.885 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.526 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 32.8 mmtp -96.48 -46.94 6.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.371 -0.831 . . . . 74.420000000000002 108.854 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.6 45.69 92.93 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 124.589 1.181 . . . . 50.200000000000003 112.87 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.0 140.58 86.0 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.147 0.579 . . . . 54.219999999999999 110.696 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.16 123.93 13.04 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.153 2.569 . . . . 73.299999999999997 111.88 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -110.65 131.91 10.66 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.934 -0.575 . . . . 70.439999999999998 111.94 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -83.24 3.9 29.21 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.038 0.935 . . . . 70.230000000000004 110.297 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HB3' ' HZ2' ' A' ' 45' ' ' TRP . . . -94.43 29.86 2.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.693 1.197 . . . . 71.450000000000003 112.014 -177.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.7 mt -53.11 108.68 0.35 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 122.7 0.4 . . . . 73.049999999999997 110.54 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.58 -10.63 7.59 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 123.836 0.731 . . . . 72.450000000000003 112.53 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.91 163.58 27.74 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.309 1.044 . . . . 72.239999999999995 111.64 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -96.71 124.63 40.75 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.526 0.73 . . . . 74.439999999999998 110.64 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 m -99.67 149.11 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.872 1.269 . . . . 72.109999999999999 107.748 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -108.73 107.36 17.78 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.839 -0.801 . . . . 72.420000000000002 108.839 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 53.6 mt -89.57 90.9 3.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.097 -1.446 . . . . 73.340000000000003 107.097 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.69 150.68 3.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 114.816 -1.084 . . . . 75.129999999999995 109.079 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.16 167.63 9.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.22 0.608 . . . . 64.120000000000005 110.854 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -68.01 82.72 0.22 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.867 0.867 . . . . 75.099999999999994 110.83 -169.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -66.76 -40.85 88.39 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.106 0.962 . . . . 72.430000000000007 110.924 -176.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 84.7 t60 . . . . . 0 CA--C 1.56 1.354 0 O-C-N 124.875 1.359 . . . . 74.430000000000007 109.907 -176.482 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 25.7 mmt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.213 -0.292 . . . . 73.239999999999995 110.213 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.638 ' HG2' HG22 ' A' ' 87' ' ' VAL . 61.4 mtt180 -128.19 118.34 23.17 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.256 -1.387 . . . . 63.119999999999997 107.256 163.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.479 HD12 HH11 ' A' ' 41' ' ' ARG . 61.5 mt -109.29 128.75 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.07 -1.085 . . . . 54.530000000000001 108.07 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -86.73 121.47 29.28 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.146 -0.687 . . . . 70.209999999999994 109.146 -170.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -127.44 169.63 19.22 Favored Glycine 0 C--N 1.341 0.847 0 O-C-N 124.003 0.814 . . . . 74.310000000000002 111.66 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.1 t -133.27 133.69 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.262 1.025 . . . . 53.310000000000002 109.167 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.97 102.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.539 0.736 . . . . 72.439999999999998 109.846 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 25' ' ' LYS . 86.7 mt -70.85 -53.86 13.65 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.688 -0.687 . . . . 73.510000000000005 109.471 174.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 t -158.61 168.83 25.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.759 -0.655 . . . . 71.340000000000003 111.113 -176.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.403 ' HB3' HD21 ' A' ' 20' ' ' ASN . 54.2 m-85 -107.74 142.97 36.93 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.289 1.036 . . . . 73.0 108.752 172.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -132.78 133.26 43.19 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.205 -1.406 . . . . 73.129999999999995 107.205 169.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -74.03 153.31 39.74 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.742 -0.836 . . . . 74.219999999999999 108.742 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.7 t -65.02 -77.27 0.06 Allowed 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.126 -1.064 . . . . 70.150000000000006 108.126 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.3 tttm 51.33 52.31 15.08 Favored 'General case' 0 C--N 1.366 1.314 0 N-CA-C 108.053 -1.092 . . . . 75.540000000000006 108.053 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -162.76 -58.85 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.239 -1.346 . . . . 74.400000000000006 109.424 -161.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -123.16 -61.64 1.4 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.867 0.867 . . . . 62.240000000000002 109.027 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -127.25 -167.68 1.77 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.369 1.068 . . . . 72.209999999999994 110.597 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -97.64 9.31 42.85 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.093 0.957 . . . . 73.420000000000002 110.199 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' A' ' 72' ' ' GLU . 2.0 m-20 -66.21 155.13 37.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.452 1.101 . . . . 71.439999999999998 110.673 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.527 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 21.7 t-20 -98.67 127.25 44.53 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.288 -0.634 . . . . 71.129999999999995 109.288 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 70' ' ' ARG . 22.0 t -89.27 104.68 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 106.451 -1.685 . . . . 74.340000000000003 106.451 172.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 47.7 ttm -93.27 130.15 39.09 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 122.681 0.392 . . . . 73.510000000000005 110.758 -171.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.455 HG22 HD12 ' A' ' 8' ' ' LEU . 32.9 mm -81.04 102.18 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.448 -0.945 . . . . 71.400000000000006 108.448 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -109.07 147.25 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.281 1.032 . . . . 62.25 109.009 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HB2' HD11 ' A' ' 8' ' ' LEU . 39.5 ttmt -118.35 102.37 50.41 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 108.622 -0.881 . . . . 65.299999999999997 108.622 167.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 18.1 Cg_endo -61.96 111.27 1.18 Allowed 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 121.545 1.497 . . . . 75.540000000000006 109.287 167.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.4 mt -55.39 -32.09 62.36 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.221 1.008 . . . . 54.329999999999998 112.266 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.14 -30.12 68.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.131 0.972 . . . . 61.32 111.718 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 34' ' ' GLU . 93.6 t -107.1 117.89 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.195 0.998 . . . . 74.420000000000002 110.13 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -121.19 4.63 10.33 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.36 0.664 . . . . 54.109999999999999 111.522 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.516 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 6.0 m -130.24 145.36 51.74 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.272 0.629 . . . . 70.209999999999994 109.69 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.666 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 73.3 ttt180 -59.09 -46.65 87.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.769 0.827 . . . . 64.519999999999996 111.302 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.25 -39.97 84.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 123.924 0.765 . . . . 73.209999999999994 111.719 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HB2' HG13 ' A' ' 29' ' ' VAL . 47.4 mt-10 -59.99 -49.79 76.29 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.172 0.92 . . . . 64.439999999999998 109.647 176.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -71.53 -24.02 61.88 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.128 0.971 . . . . 74.329999999999998 111.947 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -73.29 -39.19 65.53 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.749 0.82 . . . . 71.25 110.68 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -77.74 -10.36 59.49 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.412 -0.358 . . . . 71.109999999999999 110.976 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.61 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 55.6 mt -97.74 26.71 4.87 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.486 1.115 . . . . 73.400000000000006 111.625 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.663 HD11 HG13 ' A' ' 60' ' ' VAL . 45.2 mm -85.76 135.98 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 109.191 -0.67 . . . . 71.319999999999993 109.191 172.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.55 -7.24 39.25 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.579 -0.567 . . . . 75.310000000000002 113.517 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.61 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 16.5 ptt180 -80.59 154.17 27.6 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.223 0.511 . . . . 72.209999999999994 110.372 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 54' ' ' LYS . 60.8 tp -90.93 146.59 23.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.127 0.971 . . . . 75.120000000000005 109.408 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.548 HG22 HG23 ' A' ' 86' ' ' ILE . 47.4 t -122.19 125.82 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.851 0.86 . . . . 71.519999999999996 109.279 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.0 mt -103.79 100.26 10.06 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.855 -0.795 . . . . 74.519999999999996 108.855 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.432 ' HE1' ' HB3' ' A' ' 82' ' ' ASP . 32.7 t90 -104.52 147.95 27.03 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.934 0.894 . . . . 75.420000000000002 109.439 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -99.63 109.05 21.57 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.348 -0.982 . . . . 74.099999999999994 108.348 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.4 p -68.93 154.13 95.31 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.805 0.842 . . . . 73.420000000000002 111.045 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HG3' ' HB2' ' A' ' 79' ' ' ALA . 46.2 Cg_exo -59.98 -13.29 22.33 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.391 2.727 . . . . 74.349999999999994 113.506 172.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -81.37 -5.01 57.41 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.782 0.833 . . . . 71.439999999999998 111.606 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.08 -10.56 71.72 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-O 119.986 -0.341 . . . . 51.43 113.429 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -82.35 154.46 25.26 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.657 0.783 . . . . 62.310000000000002 110.373 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -102.29 103.64 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.383 -0.969 . . . . 71.239999999999995 108.383 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 74' ' ' GLY . 56.7 mt -82.43 153.41 25.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.367 -0.833 . . . . 73.420000000000002 110.892 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HB3' HD11 ' A' ' 42' ' ' LEU . 59.0 mtpt -117.03 117.0 28.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.529 -1.214 . . . . 34.25 108.02 -176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -128.2 132.82 7.5 Favored Glycine 0 CA--C 1.503 -0.672 0 N-CA-C 111.549 -0.62 . . . . 73.019999999999996 111.549 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -101.66 128.18 48.07 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 117.439 0.62 . . . . 74.450000000000003 109.86 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.411 HD12 ' HG3' ' A' ' 41' ' ' ARG . 78.9 mt -66.8 106.94 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 124.211 0.944 . . . . 71.310000000000002 109.373 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -84.31 -30.3 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.032 0.933 . . . . 71.219999999999999 111.162 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -168.4 167.27 11.98 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.126 0.571 . . . . 75.120000000000005 110.209 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.663 HG13 HD11 ' A' ' 39' ' ' ILE . 23.9 m -91.37 169.96 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.322 1.049 . . . . 50.240000000000002 111.292 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -141.57 105.56 4.77 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.84 1.256 . . . . 70.239999999999995 108.558 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.22 173.52 49.74 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.729 -0.214 . . . . 64.340000000000003 112.64 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.666 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 63.2 p -93.0 6.93 46.16 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.707 0.803 . . . . 74.319999999999993 111.372 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -93.67 14.96 17.46 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.185 0.994 . . . . 75.140000000000001 111.874 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.18 -4.65 70.5 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-O 119.722 -0.488 . . . . 65.200000000000003 113.959 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.97 143.89 55.42 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.379 0.672 . . . . 70.129999999999995 110.332 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 60' ' ' VAL . 14.0 m -126.49 169.91 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.678 1.191 . . . . 72.340000000000003 110.989 -175.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -128.13 107.64 9.97 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.221 1.008 . . . . 74.25 109.327 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.5 125.86 51.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.787 0.835 . . . . 44.409999999999997 110.141 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.555 ' HG2' HG22 ' A' ' 21' ' ' VAL . 88.3 mtt180 -89.0 104.51 17.05 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.246 -0.65 . . . . 70.299999999999997 109.246 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.77 135.42 34.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.013 0.925 . . . . 73.540000000000006 109.173 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HA ' ' ND2' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -55.94 -31.16 62.69 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.408 1.083 . . . . 64.230000000000004 112.075 -174.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -107.44 -63.11 1.34 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.082 0.953 . . . . 72.409999999999997 109.357 173.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 67.57 56.9 9.96 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.206 -0.907 . . . . 23.129999999999999 111.421 -171.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 97.0 mt -68.36 132.78 91.35 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.25 1.02 . . . . 72.109999999999999 111.257 -170.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 3.9 Cg_exo -76.48 176.35 10.19 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 123.216 2.611 . . . . 74.409999999999997 112.979 -170.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.02 177.69 15.03 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.766 -0.652 . . . . 72.430000000000007 111.595 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.8 76.46 7.98 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.894 0.854 . . . . 74.549999999999997 109.567 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . . . -119.75 28.03 8.37 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.982 -1.008 . . . . 73.25 110.201 172.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.08 109.14 4.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.343 -0.614 . . . . 73.120000000000005 109.343 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.15 -5.86 21.72 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-O 119.649 -0.529 . . . . 72.420000000000002 112.331 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 13.2 t70 -67.05 143.42 56.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.504 0.722 . . . . 71.530000000000001 110.074 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -93.69 123.99 37.39 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.693 0.797 . . . . 74.299999999999997 110.87 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 m -100.69 144.04 13.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.472 -0.785 . . . . 72.439999999999998 109.065 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.95 108.04 19.01 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.426 -0.953 . . . . 74.420000000000002 108.426 170.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.548 HG23 HG22 ' A' ' 43' ' ' VAL . 38.8 mt -89.04 97.97 7.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 115.067 -0.969 . . . . 73.099999999999994 108.858 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.638 HG22 ' HG2' ' A' ' 2' ' ' ARG . 13.0 t -89.89 131.39 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.675 -0.693 . . . . 74.420000000000002 110.316 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -116.72 121.8 42.65 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.822 -1.547 . . . . 72.450000000000003 106.822 172.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -90.82 147.96 22.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.887 0.875 . . . . 72.430000000000007 109.378 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -112.15 138.04 49.38 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.011 0.524 . . . . 72.310000000000002 109.709 175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 79.4 t60 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 108.095 -1.076 . . . . 72.530000000000001 108.095 178.659 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 109.366 -0.605 . . . . 70.329999999999998 109.366 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.429 ' HG2' ' HB3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -128.92 148.05 50.89 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.124 0.97 . . . . 70.019999999999996 109.074 177.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 56.6 mt -105.55 128.95 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.739 -1.208 . . . . 73.120000000000005 107.739 170.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -88.65 124.27 33.92 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.165 0.507 . . . . 72.230000000000004 110.009 -174.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -121.54 135.23 10.42 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.702 -0.681 . . . . 75.230000000000004 111.876 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.7 t -90.22 132.82 33.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 117.737 0.769 . . . . 74.549999999999997 109.988 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.85 103.06 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.721 0 O-C-N 124.504 1.127 . . . . 71.140000000000001 109.482 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 25' ' ' LYS . 71.8 mt -78.32 -56.09 4.73 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.547 0.529 . . . . 75.420000000000002 109.776 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.6 m -152.85 170.21 20.9 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.453 0.644 . . . . 71.349999999999994 111.712 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -117.81 147.46 43.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.589 1.156 . . . . 71.530000000000001 108.152 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 65.7 ttt180 -135.37 116.03 13.86 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 110.103 -0.332 . . . . 74.420000000000002 110.103 178.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -79.95 117.76 21.09 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 109.047 -0.723 . . . . 71.409999999999997 109.047 174.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.9 p -66.59 130.32 42.81 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.337 0.655 . . . . 43.43 110.34 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -84.03 61.64 6.57 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.722 0.772 . . . . 74.540000000000006 109.648 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -111.57 173.84 6.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.95 -1.023 . . . . 74.129999999999995 109.693 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.435 ' N ' HD22 ' A' ' 16' ' ' ASN . 0.8 OUTLIER -79.18 -38.92 34.7 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.192 -0.458 . . . . 75.010000000000005 109.845 176.053 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -171.51 91.0 0.13 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.943 0.897 . . . . 72.439999999999998 109.35 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -144.75 176.99 9.03 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.92 0.888 . . . . 61.399999999999999 110.482 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -72.8 161.5 30.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.251 0.621 . . . . 72.420000000000002 111.33 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -89.71 153.29 20.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.064 0.546 . . . . 73.219999999999999 110.221 -176.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 50.3 t -102.5 152.33 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.31 1.044 . . . . 72.239999999999995 108.867 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.1 ttt -150.04 129.78 13.24 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.399 -0.593 . . . . 73.400000000000006 109.399 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.431 HG22 ' HB2' ' A' ' 8' ' ' LEU . 49.6 mm -93.41 111.53 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.132 0.973 . . . . 63.140000000000001 109.363 -177.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.7 mt -125.71 149.3 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.087 0.955 . . . . 55.130000000000003 108.769 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.527 ' HB2' HD11 ' A' ' 8' ' ' LEU . 36.5 ttpt -133.19 116.83 14.44 Favored Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 109.994 -0.373 . . . . 74.030000000000001 109.994 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.7 Cg_exo -68.3 125.96 13.64 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 122.535 2.157 . . . . 61.030000000000001 110.528 173.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.6 mt -70.64 -30.25 66.83 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.86 0.464 . . . . 70.319999999999993 111.555 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.47 -19.11 62.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.365 0.666 . . . . 74.230000000000004 111.067 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.64 HG13 ' HB2' ' A' ' 34' ' ' GLU . 49.1 t -108.96 147.62 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.709 1.204 . . . . 63.439999999999998 109.678 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.04 -0.69 0.88 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.368 0.667 . . . . 73.140000000000001 112.358 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 m -128.04 147.39 50.51 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.575 0.75 . . . . 72.140000000000001 110.509 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 68.8 ttt180 -64.35 -34.62 78.58 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.474 0.71 . . . . 72.109999999999999 112.139 -176.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -58.11 -39.23 78.15 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.455 0.702 . . . . 75.25 111.49 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.64 ' HB2' HG13 ' A' ' 29' ' ' VAL . 29.5 mt-10 -69.88 -45.24 68.11 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.001 -0.999 . . . . 73.420000000000002 109.977 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.81 -30.08 69.85 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.044 0.538 . . . . 64.230000000000004 111.227 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 t -75.23 -30.5 60.57 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.099 0.96 . . . . 75.549999999999997 111.626 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -1.27 56.2 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 120.293 0.092 . . . . 73.010000000000005 111.157 173.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 34' ' ' GLU . 73.6 mt -91.76 -9.26 44.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.121 0.568 . . . . 52.329999999999998 111.632 174.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.527 HD13 HG22 ' A' ' 57' ' ' ILE . 42.8 mm -63.11 119.65 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 123.439 0.462 . . . . 73.549999999999997 110.306 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.35 -0.71 46.72 Favored Glycine 0 N--CA 1.466 0.673 0 CA-C-O 119.716 -0.491 . . . . 70.319999999999993 113.167 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -88.93 160.81 16.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.382 0.591 . . . . 61.549999999999997 111.053 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 55' ' ' GLY . 36.5 tp -90.28 144.37 25.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.998 -1.001 . . . . 64.299999999999997 109.794 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.9 t -124.96 115.75 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.922 0.889 . . . . 72.140000000000001 108.668 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.07 105.9 16.31 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.902 -0.777 . . . . 72.319999999999993 108.902 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.442 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 36.1 t90 -109.06 143.18 38.73 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.033 -0.729 . . . . 73.329999999999998 109.033 175.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -97.97 118.99 35.8 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.811 -0.811 . . . . 74.329999999999998 108.811 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.0 p -78.98 153.38 77.55 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.106 0.562 . . . . 65.450000000000003 109.83 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.84 -7.84 19.64 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.788 2.325 . . . . 73.420000000000002 112.434 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -71.25 -17.51 62.48 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 124.568 1.147 . . . . 70.010000000000005 110.983 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.58 16.23 46.81 Favored Glycine 0 C--N 1.356 1.666 0 C-N-CA 123.042 0.353 . . . . 45.43 113.131 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -109.85 149.32 30.03 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.709 0.804 . . . . 74.530000000000001 109.892 -176.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -93.75 98.51 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.617 -1.253 . . . . 61.140000000000001 107.617 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.442 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 54.6 mt -78.2 125.96 30.11 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.269 -0.641 . . . . 70.239999999999995 109.269 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -96.46 127.52 42.53 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.388 -0.823 . . . . 64.329999999999998 109.335 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -127.08 177.57 17.31 Favored Glycine 0 CA--C 1.504 -0.649 0 CA-C-N 114.862 -1.063 . . . . 41.25 110.738 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -149.38 135.28 18.82 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.7 -0.482 . . . . 62.240000000000002 109.7 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.527 HG22 HD13 ' A' ' 39' ' ' ILE . 78.5 mt -67.96 95.71 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 O-C-N 124.531 1.144 . . . . 74.25 108.826 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.41 -24.8 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.291 -0.868 . . . . 65.129999999999995 110.688 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -150.99 164.13 37.13 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.846 -0.616 . . . . 64.239999999999995 109.454 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 39' ' ' ILE . 32.9 m -92.09 168.39 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.778 -0.823 . . . . 64.109999999999999 108.778 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -142.05 103.65 4.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.834 -0.802 . . . . 75.420000000000002 108.834 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.91 -171.4 45.31 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 115.477 -0.783 . . . . 54.130000000000003 113.551 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 51.7 p -94.67 0.12 54.81 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.944 0.897 . . . . 64.120000000000005 111.43 176.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -81.12 2.04 29.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.457 1.103 . . . . 70.349999999999994 111.784 -173.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.494 ' HA3' HG12 ' A' ' 29' ' ' VAL . . . 78.44 6.74 88.06 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.261 0.351 . . . . 55.350000000000001 113.074 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.95 147.89 48.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.032 0.533 . . . . 54.43 110.138 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.452 ' HB ' HG23 ' A' ' 57' ' ' ILE . 30.5 m -121.69 140.53 45.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.678 0.791 . . . . 71.109999999999999 110.77 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -98.75 104.48 16.53 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.085 -1.08 . . . . 74.310000000000002 108.085 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.7 126.32 52.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.505 0.722 . . . . 70.239999999999995 110.147 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -101.56 126.14 48.32 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.854 0.462 . . . . 74.219999999999999 110.105 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.523 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 11.0 m-85 -93.37 126.34 38.45 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.025 0.93 . . . . 72.140000000000001 110.398 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 12.1 pt-20 -61.23 -28.83 69.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.273 1.029 . . . . 74.200000000000003 111.827 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.484 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 14.4 mmmm -101.07 -68.23 0.82 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.76 -0.83 . . . . 74.409999999999997 108.76 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.04 56.43 18.41 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.832 -0.622 . . . . 64.409999999999997 112.805 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.402 HD12 HD21 ' A' ' 53' ' ' LEU . 71.9 mt -68.7 156.55 90.72 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.7 0.8 . . . . 72.219999999999999 110.913 173.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.28 139.23 81.99 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.921 2.414 . . . . 45.439999999999998 112.695 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.72 140.62 2.96 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.633 -0.712 . . . . 74.010000000000005 112.207 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -121.11 97.09 5.36 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.919 0.888 . . . . 74.409999999999997 109.375 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.16 30.14 7.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.767 1.227 . . . . 62.109999999999999 110.899 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.4 mt -45.27 113.65 0.61 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.695 0.798 . . . . 62.32 112.242 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.41 -15.55 20.08 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-N 116.419 -0.355 . . . . 70.519999999999996 113.288 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.88 158.97 31.44 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.163 0.985 . . . . 65.040000000000006 111.908 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -100.83 127.3 47.34 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.806 0.842 . . . . 75.25 110.862 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 m -100.42 158.6 3.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 108.739 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 2' ' ' ARG . 35.3 mt-10 -103.96 108.13 19.33 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.99 0.516 . . . . 63.020000000000003 109.869 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 74.7 mt -86.68 94.11 4.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.612 -1.255 . . . . 61.140000000000001 107.612 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.418 HG22 ' HG3' ' A' ' 2' ' ' ARG . 31.5 t -89.63 137.31 21.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 114.633 -1.167 . . . . 52.25 109.164 -177.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.31 107.07 1.87 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.201 -1.407 . . . . 63.32 107.201 169.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . 37.2 tt0 -84.3 119.57 25.23 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.709 -0.848 . . . . 71.219999999999999 108.709 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -70.18 96.42 1.09 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.343 -0.614 . . . . 74.340000000000003 109.343 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 . . . . . 0 C--O 1.248 0.982 0 N-CA-C 108.098 -1.075 . . . . 74.019999999999996 108.098 169.583 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 121.382 0.611 . . . . 60.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HG2' HG22 ' A' ' 87' ' ' VAL . 82.3 mtm180 -116.06 133.98 55.45 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.934 1.294 . . . . 74.349999999999994 108.405 175.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.446 HD12 HH11 ' A' ' 41' ' ' ARG . 61.3 mt -95.65 136.4 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.483 -0.932 . . . . 64.230000000000004 108.483 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -88.36 126.82 35.39 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.214 0.605 . . . . 74.200000000000003 109.749 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -129.95 175.49 19.11 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 123.624 0.578 . . . . 64.200000000000003 112.115 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.4 t -140.13 132.03 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.528 1.131 . . . . 65.430000000000007 109.627 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.83 107.4 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.131 0.973 . . . . 72.129999999999995 110.308 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 23' ' ' ILE . 86.6 mt -79.99 -55.27 5.08 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.36 0.664 . . . . 73.040000000000006 110.004 176.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 p -158.71 173.25 16.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.616 -0.72 . . . . 62.229999999999997 111.254 -173.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.89 159.72 27.61 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.632 0.773 . . . . 63.329999999999998 109.058 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -136.09 107.42 6.84 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.462 -1.31 . . . . 63.219999999999999 107.462 161.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -97.29 131.82 43.63 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.384 0.611 . . . . 70.450000000000003 111.43 -172.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.7 t -83.72 108.74 16.97 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.993 -1.003 . . . . 44.119999999999997 108.415 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -80.56 -13.63 58.91 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.78 0.432 . . . . 70.430000000000007 111.3 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.46 -14.44 55.06 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.959 0.903 . . . . 70.109999999999999 111.137 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -171.89 97.04 0.17 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.129 -1.063 . . . . 54.210000000000001 108.129 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -83.38 62.55 6.79 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.801 1.286 . . . . 72.299999999999997 110.254 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -141.93 152.31 43.42 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 126.406 1.883 . . . . 74.430000000000007 106.195 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.9 m120 60.64 31.8 20.24 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.495 0.718 . . . . 64.129999999999995 110.915 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.592 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 36.1 t30 -58.57 145.06 40.74 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.782 0.833 . . . . 72.340000000000003 111.237 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.574 HG13 ' HG3' ' A' ' 68' ' ' ARG . 90.3 t -88.28 134.02 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 122.974 0.51 . . . . 44.240000000000002 109.658 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 43.1 ttm -130.85 112.88 13.41 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.23 -1.396 . . . . 75.510000000000005 107.23 170.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 8' ' ' LEU . 50.8 mm -78.52 111.71 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.079 -1.082 . . . . 63.509999999999998 108.079 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.51 HD13 HG21 ' A' ' 84' ' ' VAL . 84.6 mt -109.98 137.48 42.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 C-N-CA 124.221 1.008 . . . . 74.450000000000003 109.427 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB2' HD11 ' A' ' 8' ' ' LEU . 81.9 tttt -96.96 104.0 17.09 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.624 -0.88 . . . . 75.129999999999995 108.624 166.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 3.3 Cg_exo -68.68 112.27 2.82 Favored 'Trans proline' 0 C--N 1.369 1.622 0 N-CA-C 107.802 -1.653 . . . . 72.209999999999994 107.802 168.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.66 -27.27 69.11 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.588 0.755 . . . . 62.0 112.576 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.43 -28.31 64.95 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.606 0.762 . . . . 71.209999999999994 111.238 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 34' ' ' GLU . 88.7 t -98.5 145.61 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.98 1.312 . . . . 74.340000000000003 109.785 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -158.12 33.0 0.25 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.272 0.558 . . . . 55.240000000000002 109.734 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.5 m -150.19 141.22 22.97 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.403 0.681 . . . . 73.010000000000005 110.116 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.649 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 59.2 ttt180 -62.71 -32.65 73.79 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.353 0.661 . . . . 70.420000000000002 110.971 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -52.15 -51.81 55.62 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.93 0.769 . . . . 70.310000000000002 110.271 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' HB2' HG13 ' A' ' 29' ' ' VAL . 44.0 mt-10 -60.24 -52.49 65.06 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 114.577 -1.192 . . . . 74.209999999999994 110.361 177.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.12 70.56 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.666 0.787 . . . . 62.140000000000001 112.193 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.5 t -76.91 -28.62 55.37 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.9 0.88 . . . . 61.25 111.321 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -94.3 2.52 55.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.733 0.413 . . . . 75.239999999999995 110.922 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.561 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 46.6 mt -113.11 24.2 12.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.473 1.109 . . . . 75.150000000000006 110.678 175.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.76 132.13 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.938 -0.764 . . . . 72.120000000000005 108.938 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.02 -14.74 19.09 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.866 -0.408 . . . . 75.230000000000004 113.333 171.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.561 ' NE ' ' HB3' ' A' ' 38' ' ' LEU . 15.1 ptt180 -75.62 155.77 35.55 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.143 0.471 . . . . 73.310000000000002 110.449 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 55' ' ' GLY . 24.8 tp -89.78 154.34 19.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.144 0.977 . . . . 64.140000000000001 109.959 -173.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 86' ' ' ILE . 36.4 t -132.73 144.39 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.331 1.052 . . . . 64.129999999999995 108.418 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -127.53 117.99 23.12 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.7 -0.852 . . . . 75.409999999999997 108.7 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -130.3 132.36 45.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.64 0.776 . . . . 73.040000000000006 109.385 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -83.8 118.88 24.22 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.972 -0.751 . . . . 61.149999999999999 108.972 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.7 p -66.8 163.13 45.84 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.808 0.843 . . . . 61.310000000000002 111.437 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.36 -13.3 37.5 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.282 1.988 . . . . 64.549999999999997 112.123 167.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -85.2 -8.8 58.41 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.251 1.02 . . . . 64.439999999999998 110.878 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.56 -21.12 47.55 Favored Glycine 0 C--N 1.352 1.434 0 C-N-CA 123.013 0.339 . . . . 62.299999999999997 113.593 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -76.59 132.36 39.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.516 0.727 . . . . 44.25 111.049 -176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -78.33 102.15 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.936 -0.764 . . . . 74.120000000000005 108.936 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.51 135.43 39.32 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.038 -0.983 . . . . 74.030000000000001 109.862 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -96.31 133.52 40.56 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.971 -0.751 . . . . 72.400000000000006 108.971 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -131.25 169.84 21.61 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 110.821 -0.912 . . . . 53.32 110.821 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -145.15 134.86 23.46 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.171 -0.677 . . . . 73.310000000000002 109.171 177.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.512 HD12 ' HG3' ' A' ' 41' ' ' ARG . 93.7 mt -72.27 102.45 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 114.908 -1.042 . . . . 71.450000000000003 109.308 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.72 -19.33 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 115.056 -0.975 . . . . 55.030000000000001 111.521 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -153.89 168.43 26.38 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 122.562 0.345 . . . . 74.530000000000001 110.165 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.52 169.79 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 123.532 0.733 . . . . 72.450000000000003 110.359 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -141.32 104.09 4.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.683 0.793 . . . . 73.239999999999995 109.203 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.3 -172.39 34.59 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 115.934 -0.575 . . . . 64.010000000000005 113.519 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 17.5 p -91.4 2.93 56.05 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.197 0.999 . . . . 70.109999999999999 111.728 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -84.75 -3.34 58.54 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.43 1.092 . . . . 73.150000000000006 112.132 -171.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.14 -1.71 88.59 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.966 -0.352 . . . . 74.140000000000001 113.264 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.63 135.44 55.93 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 109.28 -0.637 . . . . 72.120000000000005 109.28 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.464 ' HB ' HG23 ' A' ' 57' ' ' ILE . 29.2 m -111.63 157.14 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.996 0.918 . . . . 75.219999999999999 110.889 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.574 ' HG3' HG13 ' A' ' 21' ' ' VAL . 41.3 ttm180 -106.52 109.27 21.14 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.002 0.921 . . . . 75.109999999999999 109.226 174.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.05 121.85 45.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.421 0.688 . . . . 73.030000000000001 110.267 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -88.07 111.24 21.33 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.276 -0.639 . . . . 71.430000000000007 109.276 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.411 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 39.2 m-85 -87.26 147.14 25.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.606 0.762 . . . . 71.540000000000006 110.758 175.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -49.66 -47.47 50.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.157 1.383 . . . . 72.25 111.822 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -108.7 -57.73 2.1 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.211 1.004 . . . . 75.219999999999999 108.411 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 20' ' ' ASN . . . 63.42 57.16 15.97 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 114.598 -1.183 . . . . 53.399999999999999 111.661 -175.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 39.0 mt -67.56 115.49 27.5 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 109.653 -0.499 . . . . 64.329999999999998 109.653 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 12.4 Cg_exo -68.44 164.59 32.13 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 123.337 2.691 . . . . 73.120000000000005 111.949 -173.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 170.72 168.6 32.7 Favored Glycine 0 C--N 1.329 0.176 0 N-CA-C 111.139 -0.784 . . . . 75.209999999999994 111.139 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -85.6 28.71 0.74 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.299 0.639 . . . . 70.540000000000006 111.798 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.78 23.73 1.14 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.587 1.155 . . . . 71.329999999999998 111.404 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.61 113.76 3.53 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.682 0.793 . . . . 73.0 109.578 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.66 -5.67 14.32 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.948 -0.569 . . . . 21.239999999999998 112.487 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -80.44 152.73 28.64 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.508 0.723 . . . . 70.019999999999996 111.201 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -85.82 145.26 27.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.848 0.459 . . . . 73.329999999999998 111.765 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 24' ' ' ILE . 18.2 m -116.73 157.7 17.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 C-N-CA 124.144 0.978 . . . . 71.239999999999995 108.97 171.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -113.69 109.94 19.39 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.323 -0.621 . . . . 65.319999999999993 109.323 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 3' ' ' ILE . 69.3 mt -89.13 98.04 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.57 0.748 . . . . 63.130000000000003 109.443 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 2' ' ' ARG . 59.9 t -79.69 136.41 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.496 -0.775 . . . . 72.239999999999995 109.703 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -78.52 99.98 6.72 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 108.438 -0.949 . . . . 61.5 108.438 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -137.21 135.46 37.28 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.015 0.926 . . . . 74.340000000000003 109.402 172.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -81.33 -21.98 38.8 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.394 -0.821 . . . . 65.049999999999997 109.605 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 . . . . . 0 CA--C 1.549 0.928 0 C-N-CA 125.242 1.417 . . . . 72.549999999999997 110.94 178.85 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ttt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.12 -0.326 . . . . 64.140000000000001 110.12 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 39.1 ptt180 -101.51 128.57 47.69 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.021 0.439 . . . . 73.219999999999999 110.998 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 86' ' ' ILE . 56.8 mt -101.07 145.28 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 108.016 -1.105 . . . . 65.340000000000003 108.016 174.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.454 ' HE2' HD12 ' A' ' 27' ' ' LEU . 20.5 ptmt -90.29 124.73 35.14 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.413 -0.588 . . . . 63.009999999999998 109.413 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -123.59 150.98 16.95 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 111.273 -0.731 . . . . 74.150000000000006 111.273 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 74.7 t -99.05 135.5 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.015 0.908 . . . . 72.340000000000003 110.802 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.82 104.07 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.876 1.27 . . . . 75.099999999999994 109.057 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.563 HD21 ' HG2' ' A' ' 25' ' ' LYS . 59.4 mt -82.28 -60.74 2.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.671 -0.492 . . . . 75.450000000000003 109.671 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -153.45 169.77 22.35 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.357 0.663 . . . . 34.32 111.701 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -122.82 143.09 50.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.508 1.123 . . . . 73.400000000000006 108.611 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.42 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 41.6 ttm180 -136.53 117.5 14.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.958 0.903 . . . . 73.109999999999999 108.893 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -73.75 145.05 45.4 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 109.623 -0.51 . . . . 64.109999999999999 109.623 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.6 p -111.5 -24.55 10.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.641 0.776 . . . . 74.319999999999993 109.797 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -156.91 150.59 24.53 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.411 0.684 . . . . 63.100000000000001 110.575 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -60.59 -48.84 80.01 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.169 1.387 . . . . 63.509999999999998 111.818 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.88 171.41 14.46 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.607 0.363 . . . . 64.400000000000006 111.444 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -57.14 97.62 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.782 1.233 . . . . 70.340000000000003 111.23 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -148.76 155.95 41.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.46 1.104 . . . . 72.010000000000005 109.343 -173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -66.29 90.61 0.15 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 120.825 0.345 . . . . 73.400000000000006 110.092 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -84.87 156.5 21.25 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.542 -0.911 . . . . 72.439999999999998 108.542 173.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 11' ' ' ARG . 21.9 t -87.36 146.81 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.522 0.729 . . . . 63.310000000000002 109.208 -172.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -138.54 112.79 8.68 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.159 -1.423 . . . . 71.319999999999993 107.159 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 8' ' ' LEU . 24.7 mm -75.06 112.43 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.272 -1.01 . . . . 72.510000000000005 108.272 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -122.62 162.63 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.703 1.201 . . . . 65.439999999999998 107.832 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG2' HD21 ' A' ' 8' ' ' LEU . 20.3 ptmt -145.94 131.05 9.09 Favored Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 109.511 -0.552 . . . . 71.230000000000004 109.511 163.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.481 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 9.8 Cg_exo -69.94 127.94 15.15 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 121.967 1.778 . . . . 72.25 110.562 171.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.454 HD12 ' HE2' ' A' ' 4' ' ' LYS . 64.6 mt -60.68 -37.0 80.15 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.327 0.651 . . . . 53.340000000000003 112.107 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -74.4 -29.26 61.45 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.971 -0.558 . . . . 64.129999999999995 110.8 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 34' ' ' GLU . 45.8 t -87.39 97.78 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.914 0.864 . . . . 63.200000000000003 109.98 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -101.04 -6.63 24.15 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.815 1.246 . . . . 73.040000000000006 110.169 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 m -117.44 147.13 42.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.923 0.889 . . . . 74.549999999999997 110.352 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.58 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 75.6 ttt-85 -65.16 -34.75 79.12 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.035 0.534 . . . . 64.150000000000006 111.576 178.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -59.67 -43.62 93.91 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.538 0.685 . . . . 65.109999999999999 109.759 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.524 ' HB2' HG13 ' A' ' 29' ' ' VAL . 21.2 mm-40 -68.86 -31.67 70.78 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.724 -1.125 . . . . 73.439999999999998 111.062 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.56 -35.0 58.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.53 0.732 . . . . 50.43 111.766 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -79.91 -25.63 40.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.395 1.078 . . . . 65.319999999999993 111.152 -168.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 63.3 pttt -77.61 -13.63 59.86 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 116.419 -0.355 . . . . 72.230000000000004 110.848 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.555 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 96.1 mt -89.05 8.34 30.28 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.777 0.831 . . . . 62.549999999999997 111.834 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.472 HD11 HG13 ' A' ' 60' ' ' VAL . 33.1 mm -65.87 103.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.272 -1.01 . . . . 61.130000000000003 108.272 172.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.61 0.8 17.96 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.52 -0.6 . . . . 60.140000000000001 113.446 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.782 ' HD3' HG23 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -74.37 156.24 37.28 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.747 0.773 . . . . 43.149999999999999 110.585 177.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 tp -94.43 143.88 26.04 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.172 0.589 . . . . 74.150000000000006 109.894 176.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.93 125.79 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.992 -1.114 . . . . 75.329999999999998 107.992 172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -115.01 109.5 18.19 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.735 -1.209 . . . . 73.209999999999994 107.735 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.3 t90 -131.74 117.51 18.69 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.251 -0.648 . . . . 75.239999999999995 109.251 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -86.46 105.86 17.07 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.653 0.781 . . . . 74.049999999999997 109.048 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.6 p -64.22 153.73 84.86 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 124.318 1.047 . . . . 61.43 112.459 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.33 -8.07 17.7 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.075 2.517 . . . . 65.340000000000003 112.622 168.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -61.63 -27.52 68.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.881 0.872 . . . . 73.349999999999994 110.693 167.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.42 24.85 13.18 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 115.253 -0.885 . . . . 22.440000000000001 111.901 -175.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -124.08 139.49 53.89 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.791 0.836 . . . . 70.109999999999999 110.554 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -85.18 95.1 4.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.235 -1.024 . . . . 75.129999999999995 108.235 173.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.445 HD22 ' HB2' ' A' ' 73' ' ' LYS . 28.6 mt -75.4 111.37 10.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.937 -0.764 . . . . 74.420000000000002 108.937 177.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -97.26 135.1 39.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.464 0.706 . . . . 71.010000000000005 109.662 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.46 170.98 24.51 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.581 0.551 . . . . 54.310000000000002 113.069 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -152.85 141.99 21.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.819 0.848 . . . . 75.25 109.66 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 29.9 mt -70.38 122.43 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 123.418 0.449 . . . . 75.400000000000006 110.284 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.3 m -87.25 -34.1 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.416 0.686 . . . . 70.049999999999997 110.08 172.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -167.36 150.52 6.26 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.337 0.655 . . . . 73.439999999999998 109.878 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.472 HG13 HD11 ' A' ' 39' ' ' ILE . 16.6 m -90.44 169.69 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.175 0.59 . . . . 73.329999999999998 109.639 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -135.59 101.88 4.93 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.833 -0.803 . . . . 73.409999999999997 108.833 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.79 -171.7 25.87 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 115.386 0.914 . . . . 43.409999999999997 115.386 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 40.3 p -93.81 12.1 26.95 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.646 1.179 . . . . 61.32 111.8 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -74.15 -17.76 60.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.816 0.846 . . . . 73.120000000000005 110.642 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.14 -4.95 78.24 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.515 -0.634 . . . . 72.099999999999994 111.515 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.89 141.69 51.18 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.605 0.762 . . . . 64.25 110.945 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.481 HG21 ' NH2' ' A' ' 41' ' ' ARG . 27.4 m -135.7 152.47 31.24 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 C-N-CA 124.539 1.135 . . . . 64.209999999999994 109.691 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -107.27 102.7 11.99 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.006 -1.109 . . . . 73.409999999999997 108.006 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -107.24 116.03 31.21 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.237 -0.892 . . . . 73.25 108.948 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -89.1 131.81 35.08 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.566 -0.531 . . . . 75.230000000000004 109.566 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -101.62 135.49 43.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.402 1.081 . . . . 74.230000000000004 109.432 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -54.62 -44.39 73.1 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.482 1.114 . . . . 74.540000000000006 111.15 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.445 ' HB2' HD22 ' A' ' 53' ' ' LEU . 73.3 mmtt -77.86 -42.49 33.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.507 -0.77 . . . . 74.530000000000001 109.293 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.55 33.7 72.93 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 124.137 0.898 . . . . 64.5 114.101 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.441 HD12 HD21 ' A' ' 53' ' ' LEU . 43.6 mt -69.71 121.57 82.98 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.067 0.547 . . . . 73.510000000000005 110.782 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.39 123.38 8.15 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.601 2.201 . . . . 74.319999999999993 110.969 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -135.17 142.78 14.25 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.916 -0.474 . . . . 72.25 111.916 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -88.38 70.28 9.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.159 -1.052 . . . . 74.439999999999998 108.159 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.39 28.58 7.93 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.139 -1.391 . . . . 74.409999999999997 110.315 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.29 104.05 1.4 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.841 -0.618 . . . . 74.209999999999994 110.209 -174.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.81 -1.76 8.57 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.019 -0.537 . . . . 60.310000000000002 113.015 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.81 174.16 10.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.38 0.672 . . . . 75.109999999999999 111.318 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 85.8 m-85 -115.62 129.86 56.65 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.209 0.603 . . . . 61.310000000000002 111.344 -173.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.6 m -99.71 156.52 3.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 124.383 1.073 . . . . 72.109999999999999 109.583 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -103.9 109.86 21.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.282 0.633 . . . . 73.329999999999998 109.513 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.782 HG23 ' HD3' ' A' ' 41' ' ' ARG . 82.1 mt -91.51 93.06 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.239 1.015 . . . . 71.430000000000007 108.91 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.99 105.98 12.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 115.257 -0.883 . . . . 74.239999999999995 109.896 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -73.7 102.35 3.93 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.403 -1.703 . . . . 63.119999999999997 106.403 166.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.09 161.91 27.07 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.413 -0.812 . . . . 73.409999999999997 111.508 -174.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -64.74 157.46 27.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.555 -1.202 . . . . 72.0 111.127 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 . . . . . 0 N--CA 1.484 1.238 0 C-N-CA 123.724 0.81 . . . . 72.5 109.782 -178.207 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 121.598 0.713 . . . . 73.109999999999999 110.067 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.21 155.05 35.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.863 -1.062 . . . . 73.209999999999994 109.648 172.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 mt -106.11 118.68 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.017 -1.105 . . . . 70.400000000000006 108.017 170.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.447 ' HG3' HD12 ' A' ' 27' ' ' LEU . 17.4 ptpt -88.01 149.27 24.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.401 -0.592 . . . . 73.209999999999994 109.401 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 83' ' ' TYR . . . -147.01 177.65 25.16 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 123.522 0.514 . . . . 63.32 112.082 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.6 t -113.03 132.66 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.893 0.877 . . . . 64.140000000000001 110.167 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.8 t -66.83 118.2 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.576 0.75 . . . . 74.329999999999998 109.636 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.525 HD12 HG22 ' A' ' 23' ' ' ILE . 88.8 mt -90.64 -51.64 5.29 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.973 0.509 . . . . 74.540000000000006 109.918 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.1 p -164.77 163.02 21.41 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.098 -0.501 . . . . 64.450000000000003 111.551 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -111.32 157.29 20.35 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.782 0.833 . . . . 61.240000000000002 108.953 171.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -137.3 106.82 6.14 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 108.893 -0.78 . . . . 72.310000000000002 108.893 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' HD3' ' HD3' ' A' ' 76' ' ' PRO . 32.2 mmm180 -80.05 121.93 26.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.933 -1.136 . . . . 70.510000000000005 107.933 170.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 t -137.69 137.52 38.45 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.897 -0.779 . . . . 53.210000000000001 108.897 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.44 146.92 42.85 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.356 1.063 . . . . 64.329999999999998 111.374 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -65.56 116.2 6.57 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.086 0.554 . . . . 71.5 112.41 -173.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -159.01 -81.86 0.05 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.276 1.03 . . . . 71.319999999999993 109.009 174.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.14 140.77 3.65 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 107.983 -1.117 . . . . 53.310000000000002 107.983 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.0 m80 68.36 26.01 6.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.161 1.384 . . . . 64.239999999999995 112.303 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -102.14 178.44 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.315 0.646 . . . . 71.310000000000002 112.5 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 54.49 63.85 2.01 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.691 1.196 . . . . 73.230000000000004 110.524 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.42 140.71 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.967 -1.015 . . . . 72.5 108.867 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.5 ttt -132.29 116.52 17.0 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.027 -1.101 . . . . 74.349999999999994 108.027 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.525 HG22 HD12 ' A' ' 8' ' ' LEU . 31.2 mm -83.98 120.41 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.563 0.745 . . . . 52.299999999999997 109.028 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 84' ' ' VAL . 87.2 mt -126.12 152.67 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.654 1.182 . . . . 74.200000000000003 108.262 -176.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.523 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -125.81 102.69 28.32 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.104 -1.073 . . . . 73.310000000000002 108.104 170.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.538 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 24.3 Cg_exo -61.05 143.0 99.0 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.756 2.304 . . . . 71.319999999999993 112.064 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.447 HD12 ' HG3' ' A' ' 4' ' ' LYS . 88.9 mt -67.99 -43.11 79.66 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.394 0.677 . . . . 74.030000000000001 111.541 -177.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.56 -25.99 66.07 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.812 0.845 . . . . 62.340000000000003 111.597 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 55.6 t -105.29 116.3 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.273 1.029 . . . . 52.420000000000002 110.981 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -128.64 13.64 6.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.389 0.676 . . . . 74.329999999999998 110.68 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.1 t -145.6 164.45 31.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.557 0.743 . . . . 64.329999999999998 110.525 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.611 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 74.5 ttt180 -59.26 -51.04 71.66 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.404 1.082 . . . . 71.420000000000002 112.141 -170.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -75.08 -29.08 60.57 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.406 -0.815 . . . . 71.310000000000002 110.82 -169.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 29' ' ' VAL . 42.4 mt-10 -64.86 -30.81 71.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.538 -0.756 . . . . 73.420000000000002 109.917 173.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.74 -32.74 23.31 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.011 0.924 . . . . 73.109999999999999 111.169 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.0 m -78.04 -16.45 58.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.35 0.66 . . . . 51.43 111.898 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -82.31 -16.11 50.53 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.807 0.337 . . . . 75.010000000000005 110.495 171.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.13 5.93 42.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.126 0.57 . . . . 74.439999999999998 112.033 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.579 HD11 HG13 ' A' ' 60' ' ' VAL . 46.5 mm -68.54 104.68 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.741 -0.837 . . . . 65.129999999999995 108.741 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.79 -4.79 11.63 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.787 -0.642 . . . . 53.520000000000003 113.143 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HD2' HD13 ' A' ' 88' ' ' LEU . 24.1 mmt180 -84.58 149.77 25.66 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.82 0.81 . . . . 64.340000000000003 110.604 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 55' ' ' GLY . 48.0 tp -89.78 138.12 31.75 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 124.177 0.991 . . . . 72.420000000000002 108.754 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 86' ' ' ILE . 16.3 t -119.69 138.01 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.852 -0.795 . . . . 74.450000000000003 108.852 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.4 132.95 52.67 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.269 -1.012 . . . . 72.349999999999994 108.269 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -138.93 128.69 24.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.075 0.55 . . . . 74.530000000000001 109.571 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 17.6 tppt? -78.98 120.89 24.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.718 0.807 . . . . 73.310000000000002 109.354 174.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 7.6 m -83.83 138.16 40.59 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 115.259 -0.882 . . . . 74.120000000000005 109.23 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.07 -17.77 39.97 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.225 2.617 . . . . 61.049999999999997 113.619 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -82.81 13.05 4.12 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.586 0.755 . . . . 74.329999999999998 111.89 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.95 41.27 49.31 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 112.539 -0.224 . . . . 72.0 112.539 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 75.3 mmtt -124.12 169.61 11.53 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.947 0.899 . . . . 71.200000000000003 109.403 -178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -131.85 107.83 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.216 -1.031 . . . . 53.399999999999999 108.216 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.556 HD22 ' HB2' ' A' ' 73' ' ' LYS . 22.6 mt -83.45 124.89 31.14 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.88 -0.6 . . . . 71.329999999999998 109.399 176.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -105.1 130.44 53.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.429 -0.952 . . . . 73.200000000000003 108.429 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.438 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -145.28 -179.6 21.69 Favored Glycine 0 N--CA 1.464 0.562 0 O-C-N 123.31 0.381 . . . . 74.340000000000003 112.304 -175.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -152.56 133.32 13.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.875 0.337 . . . . 64.510000000000005 110.819 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.562 HD11 HD13 ' A' ' 86' ' ' ILE . 68.3 mt -67.87 103.92 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 124.08 0.862 . . . . 73.299999999999997 109.524 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.2 m -89.58 -35.24 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.287 0.635 . . . . 73.209999999999994 111.517 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -164.41 149.82 10.29 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.37 -0.604 . . . . 71.120000000000005 109.37 -175.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.579 HG13 HD11 ' A' ' 39' ' ' ILE . 13.9 m -94.78 171.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.473 0.709 . . . . 55.109999999999999 110.853 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -128.46 113.96 16.19 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.887 0.875 . . . . 73.230000000000004 109.651 174.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.76 -154.97 50.64 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 123.902 0.751 . . . . 64.209999999999994 113.549 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.611 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 22.7 p -105.04 7.56 34.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.56 1.144 . . . . 74.129999999999995 111.826 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -85.75 2.42 45.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.407 0.683 . . . . 72.329999999999998 112.832 -171.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.35 71.52 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.142 -0.255 . . . . 51.409999999999997 113.423 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.4 117.86 17.66 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.427 0.691 . . . . 73.319999999999993 110.077 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 57' ' ' ILE . 34.6 m -102.18 150.84 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.755 0.822 . . . . 64.409999999999997 110.719 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -103.12 104.52 14.68 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.641 -1.244 . . . . 73.150000000000006 107.641 171.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.13 118.04 35.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.11 -1.07 . . . . 65.400000000000006 108.11 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.8 mtm105 -89.98 118.21 29.37 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.566 -0.531 . . . . 72.239999999999995 109.566 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -98.19 132.06 44.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.9 0.88 . . . . 72.109999999999999 109.809 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -52.88 -41.94 64.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.947 1.299 . . . . 64.129999999999995 112.264 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HB2' HD22 ' A' ' 53' ' ' LEU . 43.6 mmtm -90.06 -47.8 7.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.128 0.971 . . . . 74.239999999999995 109.281 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.12 38.39 94.3 Favored Glycine 0 C--N 1.356 1.686 0 O-C-N 123.887 0.742 . . . . 50.020000000000003 114.331 175.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.06 131.37 92.27 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 122.934 0.493 . . . . 72.519999999999996 110.68 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' HD3' ' HD3' ' A' ' 12' ' ' ARG . 86.9 Cg_endo -75.7 176.24 10.25 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.801 2.334 . . . . 73.120000000000005 111.919 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.18 157.81 19.0 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.174 -0.466 . . . . 61.329999999999998 112.31 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -94.19 26.37 3.33 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.607 0.718 . . . . 64.400000000000006 110.555 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.48 28.63 1.08 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.432 1.093 . . . . 53.329999999999998 111.033 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -61.76 109.36 1.2 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.746 0.818 . . . . 73.299999999999997 110.036 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.94 -14.79 7.05 Favored Glycine 0 C--N 1.347 1.144 0 O-C-N 123.31 0.381 . . . . 54.299999999999997 113.011 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.12 160.39 31.28 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.661 0.784 . . . . 74.310000000000002 111.287 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 13.0 m-85 -87.32 131.67 34.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.614 0.766 . . . . 74.340000000000003 111.69 -177.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 24' ' ' ILE . 16.6 m -104.5 151.14 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.452 -0.944 . . . . 73.0 108.452 167.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -108.97 108.72 19.57 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.085 -0.709 . . . . 52.140000000000001 109.085 171.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.562 HD13 HD11 ' A' ' 57' ' ' ILE . 59.6 mt -85.88 91.39 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.721 -1.214 . . . . 74.25 107.721 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.2 t -75.62 147.47 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.69 -1.141 . . . . 65.219999999999999 109.83 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.478 HD13 ' HD2' ' A' ' 41' ' ' ARG . 4.5 mm? -69.59 -169.12 0.21 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.552 0.741 . . . . 54.32 110.735 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -62.65 90.06 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.045 0.538 . . . . 75.230000000000004 111.922 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -71.05 89.08 0.8 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.743 -1.117 . . . . 71.519999999999996 109.219 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 115.231 -0.895 . . . . 72.239999999999995 108.897 177.639 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 121.459 0.647 . . . . 51.439999999999998 109.58 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.46 ' HD2' HG22 ' A' ' 87' ' ' VAL . 34.2 mtm-85 -132.88 130.78 40.15 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.789 1.236 . . . . 74.450000000000003 107.894 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.701 HD12 HD21 ' A' ' 38' ' ' LEU . 25.9 mt -101.1 134.96 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 109.713 -0.477 . . . . 64.430000000000007 109.713 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -89.69 121.52 31.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.577 0.751 . . . . 71.400000000000006 109.417 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 26' ' ' PRO . . . -114.57 167.86 12.42 Favored Glycine 0 N--CA 1.48 1.611 0 CA-C-O 119.698 -0.501 . . . . 60.439999999999998 113.055 -175.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.2 t -124.13 122.9 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.973 0.909 . . . . 75.140000000000001 109.571 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.2 t -69.76 97.85 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.26 0.624 . . . . 54.539999999999999 109.777 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 25' ' ' LYS . 67.6 mt -75.83 -47.84 23.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.212 0.605 . . . . 73.5 110.853 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.7 m -151.43 152.45 33.07 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.7 0.8 . . . . 73.129999999999995 110.927 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.32 142.11 35.66 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.664 0.786 . . . . 74.099999999999994 109.44 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -130.96 103.85 6.78 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 105.286 -2.116 . . . . 73.5 105.286 159.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -89.12 146.41 24.82 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.262 -0.644 . . . . 74.230000000000004 109.262 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 t -136.24 142.93 44.07 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.559 -0.746 . . . . 44.329999999999998 110.089 -171.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -151.16 -5.46 0.28 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 124.382 1.073 . . . . 60.140000000000001 110.06 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.49 -59.56 4.18 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.608 0.763 . . . . 64.109999999999999 110.909 -172.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -105.93 -62.62 1.35 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.24 -1.022 . . . . 53.119999999999997 108.24 173.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -96.58 140.94 30.46 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.161 -0.927 . . . . 62.310000000000002 109.47 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -95.3 68.54 3.06 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.085 0.945 . . . . 74.049999999999997 109.816 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -124.07 124.87 43.47 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.582 -0.735 . . . . 72.519999999999996 111.382 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . 4.5 t30 -75.55 93.23 2.98 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 106.91 -1.515 . . . . 62.140000000000001 106.91 164.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 70' ' ' ARG . 14.6 t -88.08 148.89 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.067 -1.457 . . . . 54.240000000000002 107.067 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.6 ptp -153.34 144.96 23.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.669 0.271 . . . . 74.540000000000006 110.678 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.07 119.81 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.179 -1.045 . . . . 50.32 108.179 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.511 HD13 HG21 ' A' ' 84' ' ' VAL . 89.2 mt -121.25 123.03 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.951 0.9 . . . . 64.209999999999994 109.644 -175.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.594 ' HB2' HD11 ' A' ' 8' ' ' LEU . 87.9 tttt -99.64 109.26 54.78 Favored Pre-proline 0 N--CA 1.482 1.173 0 CA-C-N 119.172 0.896 . . . . 71.219999999999999 109.859 172.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.642 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 20.4 Cg_exo -67.46 138.12 45.09 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.799 2.333 . . . . 72.420000000000002 112.39 171.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.33 -39.04 89.08 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.657 1.183 . . . . 74.409999999999997 111.82 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -77.72 -28.22 50.78 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.642 0.777 . . . . 70.510000000000005 112.097 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 34' ' ' GLU . 54.7 t -92.02 113.52 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.789 0.836 . . . . 61.049999999999997 110.67 -170.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.44 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -101.17 -30.21 11.68 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.917 0.887 . . . . 72.530000000000001 111.066 -174.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.8 p -119.99 166.72 12.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.948 0.499 . . . . 54.210000000000001 111.331 -172.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 67.7 ttt180 -61.97 -37.55 85.2 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.845 0.858 . . . . 74.239999999999995 111.022 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.87 -45.3 93.2 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.014 0.526 . . . . 70.340000000000003 111.137 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HB2' HG13 ' A' ' 29' ' ' VAL . 41.5 mt-10 -66.87 -22.09 65.99 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.384 -0.825 . . . . 71.450000000000003 111.215 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.62 -28.25 28.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.617 0.767 . . . . 73.230000000000004 110.877 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -79.29 -24.2 43.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.217 0.607 . . . . 72.450000000000003 111.517 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -61.63 -20.47 63.41 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.165 0.439 . . . . 60.420000000000002 110.622 169.447 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.701 HD21 HD12 ' A' ' 3' ' ' ILE . 88.9 mt -88.36 -1.15 57.87 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.761 0.824 . . . . 72.549999999999997 112.913 -175.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.659 HD11 HG13 ' A' ' 60' ' ' VAL . 38.6 mm -72.3 103.91 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.475 0.579 . . . . 72.299999999999997 109.553 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.7 -4.54 17.01 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.696 -0.684 . . . . 74.310000000000002 113.025 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HA ' HD23 ' A' ' 88' ' ' LEU . 27.6 mmt180 -75.52 153.54 37.4 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.774 0.787 . . . . 74.540000000000006 109.759 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 55' ' ' GLY . 56.2 tp -89.33 146.01 24.98 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.047 -1.094 . . . . 63.450000000000003 108.047 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.2 t -126.24 115.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.951 -0.759 . . . . 74.030000000000001 108.951 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.3 mt -100.36 106.19 17.78 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.917 0.887 . . . . 72.219999999999999 108.718 176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 53.9 t90 -123.72 130.64 52.95 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.903 0.881 . . . . 72.340000000000003 108.866 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -88.0 113.88 24.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.369 0.667 . . . . 74.329999999999998 109.271 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.0 p -65.96 152.4 93.58 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.55 0.74 . . . . 73.099999999999994 111.501 176.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.8 -7.98 22.44 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.516 2.144 . . . . 55.530000000000001 112.039 170.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 t -71.17 -29.69 65.51 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.59 0.756 . . . . 74.129999999999995 110.302 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.59 -34.46 2.67 Favored Glycine 0 C--N 1.354 1.581 0 C-N-CA 122.951 0.31 . . . . 63.450000000000003 113.311 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -73.13 157.17 37.76 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.509 0.724 . . . . 72.439999999999998 111.483 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.82 104.12 15.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.537 -1.283 . . . . 51.240000000000002 107.537 167.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 75' ' ' LEU . 26.9 mt -74.78 136.31 41.69 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.717 -0.674 . . . . 74.530000000000001 110.363 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -103.93 128.45 51.44 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.868 0.867 . . . . 43.310000000000002 109.004 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.439 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -135.38 176.94 19.78 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 123.896 0.747 . . . . 43.450000000000003 112.03 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -146.63 129.59 16.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.492 -0.559 . . . . 74.340000000000003 109.492 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.431 HG23 ' HB ' ' A' ' 67' ' ' VAL . 80.9 mt -67.81 97.22 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.583 -0.895 . . . . 75.299999999999997 108.583 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.92 -31.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.09 -0.959 . . . . 54.350000000000001 111.143 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -158.57 162.88 37.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.61 0.764 . . . . 74.040000000000006 109.03 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.659 HG13 HD11 ' A' ' 39' ' ' ILE . 34.1 m -92.3 168.62 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.501 0.721 . . . . 73.150000000000006 110.382 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -137.22 103.8 5.22 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.285 -0.635 . . . . 61.32 109.285 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.6 178.66 50.37 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 116.028 -0.533 . . . . 71.049999999999997 113.651 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 71.7 p -97.76 1.19 48.15 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.963 0.905 . . . . 71.430000000000007 111.692 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.03 12.18 8.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.669 0.787 . . . . 61.509999999999998 112.014 -176.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.85 -12.16 70.21 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 120.083 -0.287 . . . . 51.140000000000001 113.435 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.32 143.2 56.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.959 0.504 . . . . 54.310000000000002 110.722 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 35.9 m -118.87 -171.91 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.527 1.531 . . . . 75.420000000000002 109.339 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -145.63 108.4 4.51 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.05 -0.722 . . . . 65.340000000000003 109.05 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.03 125.32 50.87 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.874 0.87 . . . . 74.420000000000002 111.125 -176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.514 ' HG2' HG22 ' A' ' 21' ' ' VAL . 97.2 mtt180 -91.13 115.1 27.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.762 0.825 . . . . 73.530000000000001 110.139 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.4 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 14.9 m-85 -89.19 119.94 30.12 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.886 -0.783 . . . . 75.349999999999994 108.886 172.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.44 -19.74 62.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.5 0.72 . . . . 70.219999999999999 112.2 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -69.79 -55.9 8.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.061 0.945 . . . . 73.209999999999994 110.541 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 20' ' ' ASN . . . 81.0 46.33 7.14 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 114.6 0.6 . . . . 74.519999999999996 114.6 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.514 ' HB2' HD11 ' A' ' 53' ' ' LEU . 31.5 mt -96.77 143.3 25.89 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 117.659 0.73 . . . . 73.329999999999998 110.668 171.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -90.08 -174.84 0.87 Allowed 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.435 2.756 . . . . 72.439999999999998 113.44 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 146.87 153.47 5.91 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.039 -0.982 . . . . 73.340000000000003 111.46 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -99.8 87.46 3.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.236 0.614 . . . . 73.329999999999998 109.483 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.04 31.33 6.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.818 0.847 . . . . 43.530000000000001 111.041 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.09 105.53 0.33 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.924 -0.398 . . . . 75.519999999999996 109.924 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.27 3.61 18.99 Favored Glycine 0 C--N 1.35 1.333 0 C-N-CA 123.929 0.776 . . . . 53.119999999999997 112.548 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -86.82 163.55 17.16 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.967 0.507 . . . . 74.430000000000007 110.428 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 97.0 m-85 -109.55 125.55 52.64 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.12 0.568 . . . . 71.049999999999997 111.513 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.511 HG21 HD13 ' A' ' 24' ' ' ILE . 18.8 m -100.99 162.35 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.165 0.986 . . . . 74.340000000000003 111.008 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -103.98 110.25 22.32 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.033 0.933 . . . . 74.019999999999996 109.69 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.0 mt -87.82 91.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 107.372 -1.344 . . . . 72.129999999999995 107.372 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.46 HG22 ' HD2' ' A' ' 2' ' ' ARG . 21.9 t -98.27 151.83 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.781 1.233 . . . . 51.450000000000003 109.632 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 41' ' ' ARG . 2.0 tm? -159.11 116.6 2.77 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.611 -0.885 . . . . 72.5 108.611 169.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -67.69 103.53 1.42 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.629 -0.878 . . . . 73.310000000000002 108.629 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -67.57 103.15 1.28 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.841 0.713 . . . . 70.040000000000006 110.682 -173.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 . . . . . 0 CA--C 1.55 0.961 0 C-N-CA 124.631 1.172 . . . . 65.310000000000002 109.283 174.311 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 109.21 -0.663 . . . . 61.229999999999997 109.21 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.498 ' HG3' ' HB3' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -152.64 158.05 41.85 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.378 0.671 . . . . 74.010000000000005 109.702 170.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.509 HG23 ' HB2' ' A' ' 28' ' ' ASP . 80.3 mt -95.56 135.72 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.767 0.827 . . . . 71.400000000000006 109.7 -175.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HE2' ' CD2' ' A' ' 83' ' ' TYR . 85.6 tttt -90.25 138.49 31.48 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.691 -0.855 . . . . 74.519999999999996 108.691 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.69 -179.79 16.97 Favored Glycine 0 N--CA 1.469 0.847 0 N-CA-C 111.606 -0.598 . . . . 50.420000000000002 111.606 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.17 130.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.847 0.859 . . . . 65.120000000000005 109.641 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.18 100.87 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 124.599 1.159 . . . . 54.109999999999999 109.743 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 25' ' ' LYS . 67.0 mt -82.52 -56.66 3.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.822 0.449 . . . . 71.209999999999994 111.565 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 m -147.21 135.23 21.41 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.671 0.389 . . . . 64.239999999999995 111.352 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -80.98 122.63 27.53 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.516 -0.92 . . . . 73.219999999999999 108.516 168.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.659 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 37.0 mmt180 -117.39 107.24 14.12 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.592 -0.892 . . . . 75.519999999999996 108.592 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -84.24 114.28 21.71 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.886 0.474 . . . . 73.430000000000007 109.903 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.7 m -73.47 -74.88 0.16 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.411 0.684 . . . . 63.310000000000002 110.441 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 18' ' ' HIS . 68.2 mttm -140.86 161.34 38.05 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.076 0.55 . . . . 74.5 110.076 176.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -68.05 -48.59 65.19 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.083 0.953 . . . . 62.329999999999998 111.311 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -82.73 79.12 9.22 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.35 -0.841 . . . . 70.120000000000005 111.718 -167.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 64.57 2.0 1.5 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.396 1.478 . . . . 72.120000000000005 114.501 165.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . 93.2 m-70 -82.83 127.55 33.57 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.063 -0.718 . . . . 71.129999999999995 109.063 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' A' ' 72' ' ' GLU . 7.6 m120 -63.61 117.74 7.22 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.859 0.724 . . . . 71.030000000000001 111.031 -169.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.446 ' OD1' ' HA2' ' A' ' 74' ' ' GLY . 2.9 p-10 -69.05 150.19 47.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.449 0.7 . . . . 62.520000000000003 109.137 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.659 ' HB ' ' HB2' ' A' ' 11' ' ' ARG . 10.7 t -87.95 157.17 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.221 -1.029 . . . . 74.010000000000005 108.221 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 36.6 ttp -141.71 114.18 8.3 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.263 -1.384 . . . . 74.420000000000002 107.263 169.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.6 mm -67.42 124.45 22.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 N-CA-C 108.108 -1.071 . . . . 64.349999999999994 108.108 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.462 HG21 HG21 ' A' ' 84' ' ' VAL . 96.3 mt -134.27 137.06 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.948 -1.13 . . . . 72.25 107.948 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.512 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -102.11 113.43 65.86 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.727 -0.842 . . . . 75.420000000000002 108.727 169.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.621 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 15.8 Cg_exo -68.3 119.8 6.79 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.585 1.523 . . . . 71.209999999999994 110.177 169.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.88 -35.99 81.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.485 0.714 . . . . 65.420000000000002 111.602 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 3' ' ' ILE . 7.8 m-20 -76.45 -28.95 56.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.755 0.422 . . . . 74.530000000000001 111.23 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' A' ' 26' ' ' PRO . 50.0 t -115.56 102.27 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.475 0.71 . . . . 74.120000000000005 110.459 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.525 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 26.3 p30 -110.15 2.14 19.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.036 0.934 . . . . 74.010000000000005 111.425 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.9 m -97.83 156.14 16.72 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.65 0.78 . . . . 52.130000000000003 110.477 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 31.7 ttt180 -74.54 -42.8 58.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.2 0.6 . . . . 73.510000000000005 110.918 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -65.53 -40.43 92.91 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.788 0.835 . . . . 74.219999999999999 110.987 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HB2' HG13 ' A' ' 29' ' ' VAL . 5.9 mm-40 -70.83 -28.57 64.7 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.268 -0.878 . . . . 65.510000000000005 110.243 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.26 43.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.561 0.744 . . . . 44.25 111.192 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.8 t -78.78 -23.54 45.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.915 0.886 . . . . 72.120000000000005 110.018 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -92.75 2.12 56.91 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.642 0.377 . . . . 74.109999999999999 111.124 171.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD21 HD12 ' A' ' 3' ' ' ILE . 43.2 mt -85.94 -11.23 53.65 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.092 0.557 . . . . 73.239999999999995 111.137 170.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.531 HD11 HG13 ' A' ' 60' ' ' VAL . 42.7 mm -63.38 126.64 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 109.214 -0.661 . . . . 71.040000000000006 109.214 177.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.64 7.67 66.48 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.612 -0.549 . . . . 72.329999999999998 113.426 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -96.1 150.86 20.03 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 117.851 0.826 . . . . 73.310000000000002 111.202 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 89' ' ' GLU . 43.8 tp -91.17 115.95 28.42 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.758 -1.11 . . . . 75.099999999999994 109.897 -171.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 86' ' ' ILE . 62.0 t -97.38 115.04 36.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.29 -0.633 . . . . 41.420000000000002 109.29 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.9 mt -93.7 101.88 14.03 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.153 0.981 . . . . 75.430000000000007 108.419 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.403 ' CD1' HG12 ' A' ' 84' ' ' VAL . 31.2 t90 -104.38 131.21 51.99 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.399 -0.963 . . . . 72.239999999999995 108.399 172.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -96.03 114.67 26.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.16 -1.422 . . . . 73.010000000000005 107.16 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.1 p -57.95 155.74 22.44 Favored Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 124.115 0.966 . . . . 74.439999999999998 111.026 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.78 -25.25 50.75 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.126 2.551 . . . . 53.5 112.82 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -58.55 -38.15 77.21 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.921 1.288 . . . . 72.099999999999994 111.505 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.68 -8.91 11.73 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 115.635 -0.711 . . . . 72.209999999999994 112.015 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -82.05 153.54 26.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.602 1.161 . . . . 73.549999999999997 110.141 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.7 mt -110.12 109.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.816 0.446 . . . . 74.430000000000007 110.203 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.571 HD21 HD12 ' A' ' 75' ' ' LEU . 57.3 mt -80.54 142.26 34.31 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.991 0.916 . . . . 62.149999999999999 110.319 174.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 42' ' ' LEU . 13.9 mmmm -96.24 128.73 43.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.886 0.874 . . . . 71.109999999999999 109.513 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.05 173.31 22.48 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 111.459 -0.656 . . . . 55.130000000000003 111.459 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -152.61 132.06 12.94 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.991 0.396 . . . . 74.019999999999996 110.709 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.464 HG22 HD13 ' A' ' 39' ' ' ILE . 65.5 mt -68.22 104.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 123.878 0.736 . . . . 43.130000000000003 109.692 176.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.79 -38.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.182 -0.463 . . . . 71.109999999999999 110.132 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -136.23 176.89 8.28 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.835 0.854 . . . . 75.409999999999997 110.532 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.531 HG13 HD11 ' A' ' 39' ' ' ILE . 31.0 m -123.45 169.99 14.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 124.529 1.132 . . . . 74.450000000000003 109.651 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -144.61 105.31 4.14 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.303 -0.999 . . . . 72.150000000000006 108.303 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.17 168.73 42.2 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.182 -0.463 . . . . 71.409999999999997 113.587 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 59.8 p -93.78 2.28 56.27 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.04 0.936 . . . . 63.130000000000003 110.987 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -84.54 7.92 18.37 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.094 0.958 . . . . 72.049999999999997 112.476 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 30' ' ' ASN . . . 69.12 63.91 3.23 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 112.004 -0.438 . . . . 61.409999999999997 112.004 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.67 113.45 15.39 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.232 -1.395 . . . . 74.010000000000005 107.232 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.42 167.17 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.087 0.955 . . . . 74.010000000000005 110.42 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -123.13 102.56 8.04 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.173 0.989 . . . . 75.099999999999994 108.786 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.29 116.91 32.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.776 0.83 . . . . 53.420000000000002 110.397 -176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 22.1 mtm180 -91.33 119.75 31.62 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 122.338 0.255 . . . . 73.200000000000003 111.254 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -93.29 129.3 39.42 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.339 1.056 . . . . 71.510000000000005 110.756 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.426 ' HA ' ' ND2' ' A' ' 19' ' ' ASN . 10.4 pt-20 -74.27 -31.04 62.38 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.908 -1.042 . . . . 75.420000000000002 112.649 -173.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.62 -31.71 24.1 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.547 0.339 . . . . 64.519999999999996 110.883 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.446 ' HA2' ' OD1' ' A' ' 20' ' ' ASN . . . 61.87 37.1 93.79 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 115.595 0.998 . . . . 73.230000000000004 115.595 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD12 HD21 ' A' ' 53' ' ' LEU . 79.7 mt -85.04 150.02 54.36 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 122.565 0.346 . . . . 73.219999999999999 110.466 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.99 -176.04 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.1 2.533 . . . . 55.310000000000002 112.516 174.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.83 -39.7 0.02 OUTLIER Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.556 -0.747 . . . . 63.240000000000002 112.403 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 56.55 30.4 17.18 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 123.047 1.403 . . . . 62.210000000000001 109.402 -171.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.82 31.47 5.81 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.935 -1.484 . . . . 54.25 110.564 -169.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 74.6 mt -56.01 111.79 1.03 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.661 -0.496 . . . . 60.520000000000003 109.661 172.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.58 -7.26 18.0 Favored Glycine 0 N--CA 1.476 1.342 0 C-N-CA 123.233 0.444 . . . . 71.209999999999994 112.447 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.07 169.86 17.57 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.925 0.89 . . . . 70.109999999999999 108.664 175.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CD2' ' HE2' ' A' ' 4' ' ' LYS . 92.7 m-85 -115.36 135.24 54.33 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.097 0.408 . . . . 64.230000000000004 111.173 -171.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 24' ' ' ILE . 13.8 m -101.28 168.34 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.973 0.909 . . . . 70.530000000000001 109.249 174.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 2' ' ' ARG . 49.3 mt-10 -132.43 107.13 8.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.043 -0.725 . . . . 73.109999999999999 109.043 173.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.422 HD13 HD11 ' A' ' 57' ' ' ILE . 46.7 mt -85.21 94.45 3.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 125.227 1.411 . . . . 75.510000000000005 109.258 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.62 150.14 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.421 0.688 . . . . 72.530000000000001 109.599 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.07 120.35 15.64 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 107.065 -1.457 . . . . 74.439999999999998 107.065 169.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 8.5 pt-20 -66.69 -37.7 85.26 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.448 0.536 . . . . 63.200000000000003 112.448 -173.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -68.23 -24.43 64.91 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.203 0.601 . . . . 73.129999999999995 110.743 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 . . . . . 0 C--O 1.254 1.29 0 N-CA-C 108.756 -0.831 . . . . 73.549999999999997 108.756 172.584 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.581 -0.526 . . . . 72.230000000000004 109.581 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -108.03 134.49 50.84 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.994 0.918 . . . . 74.519999999999996 108.651 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.71 124.75 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.635 0.774 . . . . 63.25 109.061 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -88.52 127.67 35.54 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.938 -0.764 . . . . 75.25 108.938 -176.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.62 -168.95 12.26 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 116.373 -0.376 . . . . 61.32 112.299 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -144.3 135.38 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 125.026 1.33 . . . . 61.140000000000001 109.695 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.5 t -72.61 115.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.833 0.853 . . . . 71.420000000000002 109.62 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 25' ' ' LYS . 84.3 mt -89.69 -47.81 7.69 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 123.461 0.476 . . . . 74.420000000000002 110.541 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.2 m -152.02 154.82 36.75 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.919 0.488 . . . . 33.409999999999997 111.535 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -110.47 137.85 47.63 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.397 1.079 . . . . 70.510000000000005 108.691 171.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.422 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 87.9 mtt180 -127.1 108.88 11.31 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.706 -1.22 . . . . 72.299999999999997 107.706 172.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -73.56 150.5 41.42 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.309 0.644 . . . . 70.230000000000004 111.849 -168.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 p -64.13 101.02 0.37 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.119 0.968 . . . . 62.030000000000001 110.235 175.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -161.21 158.19 26.94 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.694 0.797 . . . . 72.530000000000001 110.132 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 72.31 -81.74 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.024 1.73 . . . . 54.439999999999998 110.972 175.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -96.84 161.03 14.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.703 1.201 . . . . 72.349999999999994 108.082 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -72.69 87.3 1.25 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.722 0.772 . . . . 73.200000000000003 110.404 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -149.16 157.1 43.1 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.212 1.405 . . . . 71.310000000000002 108.67 174.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' A' ' 72' ' ' GLU . 7.0 t-20 -94.66 -169.27 1.99 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.964 -0.754 . . . . 64.109999999999999 108.964 176.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.69 112.35 4.75 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.133 0.424 . . . . 74.519999999999996 110.327 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' HD3' ' A' ' 68' ' ' ARG . 84.3 t -90.39 106.09 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.565 0.746 . . . . 62.439999999999998 109.019 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.7 ttm -100.46 124.75 46.39 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.294 -0.632 . . . . 74.420000000000002 109.294 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -82.02 115.54 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 107.786 -1.19 . . . . 72.450000000000003 107.786 172.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.414 ' HB ' HG23 ' A' ' 67' ' ' VAL . 69.4 mt -109.24 150.41 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.799 0.84 . . . . 65.200000000000003 109.938 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 8' ' ' LEU . 59.5 tttp -119.49 96.97 50.06 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 125.007 1.323 . . . . 64.319999999999993 108.962 175.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.7 106.64 0.94 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.083 1.855 . . . . 74.230000000000004 110.164 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.1 mt -53.08 -38.43 62.53 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.793 1.237 . . . . 72.209999999999994 113.324 -172.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.73 -27.11 58.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.978 0.511 . . . . 62.509999999999998 111.631 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.1 t -100.98 107.73 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.32 0.648 . . . . 64.019999999999996 111.529 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -91.62 -19.26 22.9 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.369 1.068 . . . . 73.230000000000004 111.875 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -104.53 133.42 49.42 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 122.025 -0.422 . . . . 64.219999999999999 111.05 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 49.1 ttt180 -58.97 -43.93 91.46 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.375 1.07 . . . . 62.219999999999999 111.553 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.7 -40.5 97.33 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.006 0.922 . . . . 60.340000000000003 111.524 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.69 -33.51 75.05 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.479 -0.782 . . . . 42.5 111.14 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.93 -25.77 60.15 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 122.996 0.518 . . . . 61.210000000000001 111.637 171.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -74.99 -34.11 61.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.763 0.825 . . . . 60.210000000000001 111.924 -172.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -68.93 -22.42 64.14 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 120.922 0.391 . . . . 71.420000000000002 110.39 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.55 1.74 52.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.051 0.94 . . . . 61.219999999999999 112.449 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.462 HD11 HG13 ' A' ' 60' ' ' VAL . 31.7 mm -66.53 135.79 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 118.394 0.543 . . . . 64.239999999999995 110.729 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.16 -8.58 31.16 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.683 -0.689 . . . . 65.239999999999995 113.367 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.9 ptt-85 -80.26 153.44 28.5 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.362 0.581 . . . . 73.120000000000005 110.959 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 54' ' ' LYS . 59.5 tp -90.28 146.75 23.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.471 -0.786 . . . . 72.310000000000002 109.257 -174.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.431 HG22 HG12 ' A' ' 86' ' ' ILE . 40.1 t -116.95 131.83 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 108.83 -0.804 . . . . 70.129999999999995 108.83 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -113.14 105.73 13.8 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.603 -1.258 . . . . 65.519999999999996 107.603 175.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -125.28 124.3 41.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.33 0.652 . . . . 73.409999999999997 109.468 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HE3' ' HA2' ' A' ' 50' ' ' GLY . 45.9 tttp -81.22 122.52 27.5 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.99 -0.744 . . . . 70.140000000000001 108.99 176.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 82.2 p -65.39 152.62 91.75 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.034 0.534 . . . . 75.030000000000001 110.346 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.47 -12.9 30.0 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.268 1.979 . . . . 74.420000000000002 112.145 173.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.6 m -70.27 -42.78 71.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.417 1.087 . . . . 75.409999999999997 110.726 170.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.464 ' HA2' ' HE3' ' A' ' 46' ' ' LYS . . . 135.06 -22.78 3.56 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 116.104 -0.498 . . . . 33.009999999999998 113.126 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -74.09 122.51 22.81 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.605 0.762 . . . . 71.430000000000007 110.292 -174.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 72.3 mt -78.83 106.95 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.593 -0.892 . . . . 65.549999999999997 108.593 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.401 HD13 ' H ' ' A' ' 75' ' ' LEU . 13.2 mt -86.73 155.34 20.39 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.409 1.084 . . . . 72.209999999999994 109.791 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' HD11 ' A' ' 42' ' ' LEU . 47.1 mtpt -123.7 145.46 48.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.934 0.894 . . . . 72.340000000000003 109.229 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.76 132.61 3.04 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-O 119.824 -0.431 . . . . 74.519999999999996 112.903 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -93.05 128.77 39.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.285 0.543 . . . . 74.030000000000001 109.976 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.2 mt -72.13 116.52 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.618 0.767 . . . . 72.439999999999998 109.411 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -112.92 -3.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.727 0.811 . . . . 71.129999999999995 112.284 -172.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -165.57 161.47 18.48 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.909 0.484 . . . . 73.349999999999994 110.48 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.462 HG13 HD11 ' A' ' 39' ' ' ILE . 16.0 m -91.5 168.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.781 0.832 . . . . 74.010000000000005 109.732 168.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -143.94 105.07 4.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.076 -0.511 . . . . 74.150000000000006 109.767 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.19 176.31 38.17 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 123.377 0.423 . . . . 62.229999999999997 113.841 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 30.1 p -91.04 10.1 28.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.394 1.077 . . . . 70.030000000000001 111.059 177.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -91.75 12.37 21.53 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.907 0.883 . . . . 73.540000000000006 111.749 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.07 12.03 75.23 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 113.984 0.354 . . . . 53.229999999999997 113.984 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.55 162.26 27.25 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.174 0.59 . . . . 73.430000000000007 109.728 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 15.2 m -132.18 177.92 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.098 0.959 . . . . 61.109999999999999 110.521 -178.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.454 ' HD3' HG13 ' A' ' 21' ' ' VAL . 7.4 tmm_? -138.59 116.45 11.56 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.25 -1.389 . . . . 72.400000000000006 107.25 -175.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.41 146.05 42.8 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.715 0.806 . . . . 53.0 111.496 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -99.25 100.83 11.98 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.235 1.014 . . . . 73.519999999999996 109.311 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -77.24 124.17 27.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.321 0.648 . . . . 74.120000000000005 110.984 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HG3' ' HG2' ' A' ' 73' ' ' LYS . 9.9 pt-20 -62.1 -35.9 80.1 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.05 0.94 . . . . 60.210000000000001 111.122 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' HG2' ' HG3' ' A' ' 72' ' ' GLU . 74.5 mmtt -99.65 -65.38 0.97 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.595 0.758 . . . . 75.420000000000002 109.017 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.0 52.97 36.22 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 124.131 0.894 . . . . 61.420000000000002 114.61 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.401 ' H ' HD13 ' A' ' 53' ' ' LEU . 85.5 mt -67.51 137.33 93.33 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.35 0.66 . . . . 64.129999999999995 110.563 175.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.52 169.74 15.11 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.024 2.482 . . . . 64.209999999999994 112.845 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.73 161.67 22.69 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 115.266 -0.879 . . . . 73.129999999999995 110.905 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -91.0 38.8 0.97 Allowed 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.301 1.048 . . . . 75.25 109.306 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.21 29.8 4.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.647 1.179 . . . . 63.229999999999997 110.538 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.12 107.9 0.96 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.703 -0.851 . . . . 74.019999999999996 108.703 169.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.46 -12.14 16.16 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 116.279 -0.419 . . . . 61.030000000000001 112.645 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -77.62 152.82 33.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.842 0.457 . . . . 73.299999999999997 110.693 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -87.8 135.58 33.32 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.193 0.997 . . . . 71.230000000000004 112.349 -169.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.5 152.69 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.947 0.899 . . . . 55.32 109.138 171.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -114.14 108.72 17.35 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.19 -1.041 . . . . 72.209999999999994 108.19 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.431 HG12 HG22 ' A' ' 43' ' ' VAL . 61.9 mt -96.22 119.25 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.358 0.663 . . . . 71.049999999999997 109.62 -174.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.7 t -113.44 142.83 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 123.348 0.659 . . . . 71.349999999999994 111.183 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.08 -178.66 6.25 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.119 0.968 . . . . 74.420000000000002 111.845 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -68.42 136.22 52.95 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.231 -0.895 . . . . 71.040000000000006 112.046 -170.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -105.19 -54.34 2.5 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.61 0.764 . . . . 61.240000000000002 109.388 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 . . . . . 0 C--O 1.256 1.425 0 C-N-CA 124.018 0.927 . . . . 70.019999999999996 108.823 177.82 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.0 mtm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 121.205 0.526 . . . . 74.310000000000002 109.584 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.6 mtm180 -140.85 141.67 34.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.346 1.058 . . . . 73.340000000000003 108.51 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.626 HD12 HD21 ' A' ' 38' ' ' LEU . 73.4 mt -129.97 130.45 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.596 0.758 . . . . 74.120000000000005 109.164 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.412 ' HG3' HD12 ' A' ' 27' ' ' LEU . 19.6 ptmt -88.54 130.07 35.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.765 -0.828 . . . . 71.400000000000006 108.765 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -128.18 140.64 11.93 Favored Glycine 0 C--O 1.217 -0.954 0 CA-C-N 116.459 -0.337 . . . . 71.310000000000002 112.363 -175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.7 t -91.93 121.98 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.01 0.524 . . . . 75.430000000000007 111.086 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.52 97.48 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.378 1.071 . . . . 71.409999999999997 109.65 172.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 25' ' ' LYS . 88.1 mt -72.91 -48.83 33.7 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.52 -0.764 . . . . 65.329999999999998 110.036 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.463 ' HA ' HD22 ' A' ' 80' ' ' LEU . 70.0 p -162.37 168.05 22.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.869 -0.605 . . . . 71.420000000000002 110.932 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -105.13 123.77 48.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.927 -1.138 . . . . 72.150000000000006 107.927 169.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -118.42 107.46 13.85 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.734 -1.209 . . . . 74.239999999999995 107.734 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.527 ' HG3' ' HB3' ' A' ' 20' ' ' ASN . 55.1 ttp180 -85.14 154.12 22.23 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.072 0.463 . . . . 74.230000000000004 110.08 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -130.25 -173.68 3.12 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.573 0.749 . . . . 71.200000000000003 109.142 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.1 110.02 4.31 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.385 -0.969 . . . . 71.109999999999999 108.385 175.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.05 -33.22 67.01 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.702 0.801 . . . . 64.450000000000003 111.993 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -69.03 -23.9 64.12 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.611 0.765 . . . . 73.109999999999999 111.188 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -88.59 -68.95 0.73 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.919 -0.771 . . . . 63.530000000000001 108.919 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -149.31 150.03 31.86 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.759 1.224 . . . . 74.5 109.001 173.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -66.65 174.64 2.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.209 0.603 . . . . 72.409999999999997 111.784 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.527 ' HB3' ' HG3' ' A' ' 12' ' ' ARG . 8.8 p30 -61.24 143.61 55.29 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.087 -0.96 . . . . 73.530000000000001 112.015 -174.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t -106.88 121.24 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 114.266 -1.334 . . . . 74.319999999999993 109.251 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 45.7 ttm -89.52 123.78 33.93 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.507 -0.923 . . . . 54.539999999999999 108.507 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.7 116.02 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.31 -0.996 . . . . 61.439999999999998 108.31 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.6 HD13 HG21 ' A' ' 84' ' ' VAL . 84.8 mt -120.46 150.67 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.036 0.935 . . . . 73.329999999999998 109.647 -172.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HB2' HD11 ' A' ' 8' ' ' LEU . 78.9 tttt -123.45 91.73 49.48 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.496 0.719 . . . . 75.310000000000002 109.416 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' A' ' 66' ' ' ALA . 36.9 Cg_endo -63.72 110.4 1.27 Allowed 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 122.751 2.301 . . . . 60.100000000000001 111.272 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.412 HD12 ' HG3' ' A' ' 4' ' ' LYS . 85.8 mt -62.18 -37.72 86.35 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.639 1.176 . . . . 63.520000000000003 112.875 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -65.86 -26.25 67.56 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.265 0.626 . . . . 75.510000000000005 111.546 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.685 HG13 ' HB2' ' A' ' 34' ' ' GLU . 40.3 t -100.32 131.59 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.197 0.999 . . . . 74.219999999999999 110.96 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -130.32 -3.48 4.37 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.664 0.785 . . . . 62.329999999999998 111.451 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.8 m -123.28 154.48 38.79 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.447 0.699 . . . . 72.150000000000006 110.563 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.566 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 63.0 ttt180 -64.95 -30.84 71.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.134 0.974 . . . . 64.310000000000002 111.634 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -69.48 -39.66 77.55 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.889 0.876 . . . . 63.0 110.146 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.685 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.5 mt-10 -70.42 -38.61 74.61 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.667 -1.151 . . . . 73.519999999999996 109.526 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.36 -30.81 69.84 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.645 0.778 . . . . 72.540000000000006 111.228 174.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 t -74.15 -30.82 62.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.397 0.679 . . . . 72.409999999999997 110.041 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -90.78 4.1 52.57 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.743 0.417 . . . . 53.450000000000003 110.98 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.626 HD21 HD12 ' A' ' 3' ' ' ILE . 34.3 mt -87.83 -18.31 29.57 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.618 0.367 . . . . 74.239999999999995 110.415 165.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.565 HD13 HG22 ' A' ' 57' ' ' ILE . 50.2 mm -59.86 106.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.195 0.598 . . . . 73.530000000000001 109.393 174.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.19 -29.35 4.6 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 116.052 -0.522 . . . . 15.539999999999999 112.527 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 153.94 39.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.208 0.603 . . . . 74.209999999999994 111.901 -173.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.58 HD11 ' HE2' ' A' ' 54' ' ' LYS . 60.9 tp -90.41 123.73 34.38 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.42 1.088 . . . . 65.109999999999999 109.674 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.8 115.18 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 109.412 -0.588 . . . . 75.340000000000003 109.412 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt -104.36 110.12 22.24 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.557 1.143 . . . . 52.240000000000002 108.732 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -124.49 127.73 47.91 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.307 -0.627 . . . . 64.319999999999993 109.307 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -88.12 106.7 18.34 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.367 -0.975 . . . . 62.210000000000001 108.367 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.9 p -64.31 157.37 71.53 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.046 0.938 . . . . 62.450000000000003 112.406 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.92 -23.78 73.88 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.842 2.361 . . . . 62.100000000000001 112.074 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.1 t -61.91 -23.27 66.22 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.538 1.135 . . . . 62.329999999999998 111.343 173.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.86 19.18 34.94 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.712 -0.676 . . . . 60.240000000000002 112.64 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.0 143.02 40.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.554 0.742 . . . . 73.010000000000005 110.105 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.5 mt -89.08 102.09 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.724 -0.843 . . . . 72.010000000000005 108.724 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 75' ' ' LEU . 26.3 mt -82.71 138.09 34.2 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.142 0.577 . . . . 75.209999999999994 110.369 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.58 ' HE2' HD11 ' A' ' 42' ' ' LEU . 13.4 mmmm -96.09 132.92 40.97 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.572 -0.899 . . . . 73.120000000000005 108.572 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.18 172.94 22.7 Favored Glycine 0 C--N 1.332 0.353 0 O-C-N 123.618 0.574 . . . . 65.329999999999998 112.075 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -151.81 131.71 13.34 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.122 0.569 . . . . 74.140000000000001 109.843 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.565 HG22 HD13 ' A' ' 39' ' ' ILE . 73.0 mt -70.8 108.93 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 109.137 -0.69 . . . . 54.109999999999999 109.137 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.75 -14.94 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.182 0.993 . . . . 63.100000000000001 111.225 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 23.7 tpp180 -149.29 148.82 30.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.327 0.651 . . . . 71.409999999999997 109.371 -173.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 39' ' ' ILE . 21.2 m -98.74 171.41 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.335 0.654 . . . . 74.129999999999995 109.988 173.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -124.13 103.64 8.39 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.386 -0.968 . . . . 72.450000000000003 108.386 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.94 -134.1 52.3 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 124.144 0.903 . . . . 75.519999999999996 113.602 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.566 ' HA ' ' HB2' ' A' ' 32' ' ' ARG . 69.3 p -119.62 -4.55 10.28 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.741 0.816 . . . . 54.329999999999998 111.993 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -73.93 -7.81 53.75 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.069 0.548 . . . . 75.140000000000001 112.017 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.51 -10.98 70.71 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 119.649 -0.528 . . . . 53.340000000000003 113.209 176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . . . -60.68 149.68 34.5 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.999 0.52 . . . . 52.229999999999997 109.652 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.542 HG22 ' HD3' ' A' ' 26' ' ' PRO . 35.1 m -131.13 178.97 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 121.921 0.867 . . . . 72.329999999999998 111.96 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 97.8 mtt180 -133.86 118.99 18.59 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.259 1.424 . . . . 74.530000000000001 108.379 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.72 133.57 55.85 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.968 0.507 . . . . 64.439999999999998 110.715 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -88.7 123.21 32.92 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.182 0.593 . . . . 74.150000000000006 109.633 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -105.23 133.41 50.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.716 0.806 . . . . 75.409999999999997 109.46 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -61.13 -37.02 81.32 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.678 0.791 . . . . 74.120000000000005 111.852 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -98.08 -61.03 1.44 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.82 0.848 . . . . 74.109999999999999 108.974 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.436 ' HA3' ' OD1' ' A' ' 20' ' ' ASN . . . 60.91 54.68 34.91 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 124.083 0.864 . . . . 73.209999999999994 112.93 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.496 ' HB2' HD11 ' A' ' 53' ' ' LEU . 51.6 mt -68.46 115.92 34.77 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.24 1.016 . . . . 63.020000000000003 110.513 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.7 179.84 5.85 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 123.283 2.656 . . . . 52.140000000000001 112.332 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.81 176.94 25.07 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 110.723 -0.951 . . . . 44.420000000000002 110.723 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -77.39 70.02 3.73 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 122.038 0.923 . . . . 71.310000000000002 109.086 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.73 13.6 11.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.811 -1.086 . . . . 73.299999999999997 111.922 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 9' ' ' SER . 60.9 mt -74.27 103.21 4.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.464 -0.939 . . . . 72.120000000000005 108.464 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.4 -18.2 6.89 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 112.116 -0.394 . . . . 52.219999999999999 112.116 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.96 169.93 16.99 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.986 0.514 . . . . 64.310000000000002 111.336 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -108.28 155.9 19.98 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.232 0.613 . . . . 73.239999999999995 111.043 -170.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.6 HG21 HD13 ' A' ' 24' ' ' ILE . 20.2 m -122.15 160.28 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.462 1.105 . . . . 65.530000000000001 108.773 174.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -106.02 108.5 20.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.177 -0.675 . . . . 43.140000000000001 109.177 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' ARG . 77.9 mt -93.93 92.12 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.336 -1.357 . . . . 34.409999999999997 107.336 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.507 HG12 ' HG3' ' A' ' 89' ' ' GLU . 21.4 t -96.66 127.6 48.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 124.247 1.019 . . . . 73.450000000000003 110.266 -172.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.33 104.56 13.04 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.915 -1.143 . . . . 72.239999999999995 107.915 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.507 ' HG3' HG12 ' A' ' 87' ' ' VAL . 36.8 mt-10 -110.23 147.72 33.24 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.043 0.937 . . . . 73.510000000000005 109.172 175.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -102.29 98.44 8.57 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.179 0.592 . . . . 73.109999999999999 109.634 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 123.949 0.9 . . . . 71.140000000000001 109.502 172.391 . . . . . . . . 0 0 . 1 stop_ save_